data_1ssn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ssn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.1 p90 . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 114.882 1.438 . . . . 0.35 114.882 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -149.86 32.21 0.69 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.141 0.976 . . . . 0.35 110.443 165.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -131.27 -58.93 0.99 Allowed 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.717 1.607 . . . . 0.35 108.555 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.89 90.49 0.33 Allowed Glycine 0 C--N 1.341 0.834 0 C-N-CA 123.82 0.724 . . . . 0.35 111.902 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 56.82 42.46 26.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.193 1.397 . . . . 0.35 111.852 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -88.97 -40.83 12.75 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.681 1.193 . . . . 0.35 111.703 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.35 48.88 10.47 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 126.584 1.953 . . . . 0.35 112.699 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.2 pttp 67.47 -12.31 0.27 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.173 2.189 . . . . 0.35 115.015 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.68 -36.92 2.86 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.923 1.249 . . . . 0.35 110.46 -170.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.27 85.55 4.41 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.689 1.195 . . . . 0.35 110.094 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -99.64 73.48 1.82 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.918 1.287 . . . . 0.35 108.579 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.83 79.81 9.49 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.208 1.003 . . . . 0.35 109.178 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.3 p -70.65 -59.01 3.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.666 0.786 . . . . 0.35 111.58 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -158.99 -143.33 0.1 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.612 -0.885 . . . . 0.35 108.612 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.5 t80 56.97 88.14 0.05 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.256 1.822 . . . . 0.35 112.207 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 68.27 162.95 0.14 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 126.054 1.742 . . . . 0.33 112.09 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.08 99.9 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.131 2.554 . . . . 0.35 110.251 171.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.1 p -90.12 -76.66 0.42 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.447 1.099 . . . . 0.35 110.25 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.82 149.02 10.96 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 110.593 -1.003 . . . . 0.33 110.593 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.11 169.97 21.0 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 124.133 3.222 . . . . 0.35 112.506 -170.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -163.53 162.6 24.62 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.558 1.143 . . . . 0.35 110.673 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 tt -138.66 97.43 3.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.979 1.312 . . . . 0.35 107.583 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.8 ttm -98.96 108.25 20.89 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.069 1.748 . . . . 0.35 110.781 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.2 t -110.14 99.82 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.793 1.237 . . . . 0.35 110.867 -167.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -150.14 -163.92 1.9 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.89 1.276 . . . . 0.36 109.948 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.0 150.69 24.98 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 C-N-CA 124.648 1.179 . . . . 0.35 110.923 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 83.8 m -84.09 79.96 9.34 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.431 -1.692 . . . . 0.35 106.431 163.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.84 100.43 1.85 Allowed Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.481 -1.048 . . . . 0.35 110.481 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.79 169.55 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 124.893 1.277 . . . . 0.35 110.348 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -63.8 -49.34 73.29 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.942 0.897 . . . . 0.35 110.757 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.2 p -178.47 -58.48 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.598 1.959 . . . . 0.35 108.624 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.5 tttp -75.7 -73.7 0.25 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.791 0.836 . . . . 0.35 109.622 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.25 28.32 0.07 OUTLIER Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.219 -0.767 . . . . 0.35 112.976 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -90.46 94.25 9.65 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 107.252 -1.388 . . . . 0.36 107.252 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.38 110.22 3.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.06 0.944 . . . . 0.35 111.562 -168.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.6 mt -70.65 -41.51 72.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.759 1.223 . . . . 0.35 110.09 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 pp -143.98 138.24 28.3 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.727 0.811 . . . . 0.35 111.205 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.7 m -88.36 141.99 31.1 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 124.494 1.118 . . . . 0.33 110.039 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.47 -171.57 0.86 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.976 3.117 . . . . 0.35 111.688 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.7 m170 87.16 17.77 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.482 2.313 . . . . 0.35 114.087 168.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -94.0 -38.95 10.9 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.778 0.717 . . . . 0.35 112.417 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.3 t -99.08 137.96 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.204 1.002 . . . . 0.35 109.237 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -157.85 135.32 10.38 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.104 0.962 . . . . 0.35 109.431 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -120.31 143.69 36.42 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 125.362 1.465 . . . . 0.33 108.941 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.33 137.53 40.25 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.543 2.162 . . . . 0.35 109.106 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.5 tt -64.21 135.26 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 122.845 0.458 . . . . 0.35 111.999 -170.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -142.56 97.38 6.06 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 106.828 -1.545 . . . . 0.33 106.828 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.61 135.61 24.32 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.82 2.347 . . . . 0.35 110.325 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 162.95 -41.73 0.34 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.925 -0.87 . . . . 0.35 110.925 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.4 t -61.21 145.65 50.44 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.97 0.908 . . . . 0.35 110.952 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.7 m -78.77 97.49 5.93 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.877 0.871 . . . . 0.35 108.895 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -74.32 81.17 1.86 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.29 1.436 . . . . 0.35 109.56 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.5 p -150.42 165.6 32.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.56 1.544 . . . . 0.35 109.152 -171.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -54.39 -43.49 71.47 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.87 1.268 . . . . 0.35 111.69 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -50.82 -50.57 56.14 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.832 0.853 . . . . 0.35 112.381 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -102.83 38.04 1.81 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.638 0.775 . . . . 0.35 111.565 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.27 -38.06 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.488 1.515 . . . . 0.35 107.94 165.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -54.55 -67.7 0.24 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 127.053 2.141 . . . . 0.35 110.988 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -81.71 -18.13 45.44 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.078 0.551 . . . . 0.35 112.471 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -66.65 -49.46 66.14 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.142 0.577 . . . . 0.35 111.224 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.8 m -68.47 -31.12 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.391 0.676 . . . . 0.35 111.373 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.05 -40.96 97.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.745 0.818 . . . . 0.35 110.748 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.84 -33.3 72.12 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.491 0.716 . . . . 0.35 111.532 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.29 -52.92 51.1 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.122 0.569 . . . . 0.35 111.207 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.74 -33.73 76.28 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.672 0.389 . . . . 0.35 111.642 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -67.62 -30.49 70.08 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 122.699 0.4 . . . . 0.35 111.256 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.87 38.67 0.53 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.718 0.807 . . . . 0.35 110.967 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.3 m -150.83 -53.17 0.14 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.946 1.698 . . . . 0.35 107.992 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.46 -94.09 0.4 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.098 1.359 . . . . 0.35 110.505 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.4 t80 55.04 64.06 1.92 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.714 1.606 . . . . 0.35 111.623 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -137.8 -54.2 0.66 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.835 1.254 . . . . 0.35 108.797 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -125.25 78.2 1.7 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.107 1.363 . . . . 0.35 108.07 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -159.45 126.81 4.73 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.099 0.96 . . . . 0.35 108.972 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -146.37 -38.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.575 1.15 . . . . 0.35 111.537 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 t 76.65 119.55 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 126.408 1.883 . . . . 0.35 111.492 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 55.6 t -68.46 -59.16 3.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 N-CA-C 108.088 -1.079 . . . . 0.35 108.088 166.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -153.24 154.17 34.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.48 1.512 . . . . 0.35 109.023 -175.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 pp -118.6 140.74 49.41 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.472 1.109 . . . . 0.35 108.782 170.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.47 137.29 67.58 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 109.721 -0.474 . . . . 0.33 109.721 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.81 -33.77 15.74 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.449 2.766 . . . . 0.35 111.361 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -85.14 65.64 9.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.495 1.118 . . . . 0.35 109.966 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.65 158.67 35.8 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.325 0.65 . . . . 0.35 109.346 170.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -142.07 155.06 45.37 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 121.204 0.526 . . . . 0.35 112.217 -171.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mp -129.88 117.62 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.687 1.595 . . . . 0.35 107.159 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -103.72 67.41 0.89 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.357 1.063 . . . . 0.35 109.615 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.68 119.09 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 122.921 0.489 . . . . 0.35 109.883 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 m -119.42 117.46 28.53 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.508 1.123 . . . . 0.35 108.816 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.0 110.68 20.43 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.839 1.256 . . . . 0.35 109.983 -168.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -101.63 56.95 0.83 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.94 1.296 . . . . 0.35 112.316 -164.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.48 87.4 6.39 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.289 0.636 . . . . 0.35 109.404 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -77.41 65.69 3.01 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.177 0.591 . . . . 0.35 110.384 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -152.6 -48.93 0.1 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.203 1.801 . . . . 0.36 108.893 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -140.42 -66.14 0.44 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.465 1.106 . . . . 0.35 110.63 -173.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -78.72 -51.16 10.21 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.877 0.471 . . . . 0.35 111.501 -167.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 75.63 167.04 0.27 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.901 1.681 . . . . 0.35 113.013 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.84 111.98 0.94 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.333 1.853 . . . . 0.35 111.297 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -141.31 104.82 4.68 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.131 1.373 . . . . 0.35 107.656 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.5 m -77.53 88.57 3.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.617 -0.883 . . . . 0.35 108.617 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -80.26 95.81 6.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.427 -0.953 . . . . 0.35 108.427 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.6 p -90.54 61.19 4.83 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.85 1.26 . . . . 0.35 110.617 -175.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -71.12 145.13 90.83 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.582 -0.525 . . . . 0.33 109.582 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.81 -118.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.519 2.813 . . . . 0.35 109.732 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.4 tp -162.89 159.15 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.62 0.768 . . . . 0.35 110.176 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.4 p -133.97 155.7 49.49 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.873 1.269 . . . . 0.35 109.538 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -64.35 -48.82 74.07 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.074 0.95 . . . . 0.35 112.425 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -138.77 62.81 1.54 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.064 0.946 . . . . 0.35 108.915 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.3 -84.22 0.5 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.6 1.095 . . . . 0.35 112.755 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -158.0 159.17 36.13 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.421 0.526 . . . . 0.35 112.421 -158.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.6 t -82.83 154.02 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.947 1.699 . . . . 0.35 109.135 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.0 t -48.83 115.08 4.18 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.763 1.225 . . . . 0.33 109.647 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.17 165.21 26.15 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.003 2.469 . . . . 0.35 110.797 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -68.88 158.46 34.49 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.504 0.721 . . . . 0.35 110.417 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -84.09 48.68 1.51 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.546 1.138 . . . . 0.35 112.845 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.9 t 53.35 -99.78 0.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.658 1.583 . . . . 0.35 112.319 173.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -165.16 -53.83 0.03 OUTLIER 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.571 1.148 . . . . 0.35 109.305 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -90.32 44.46 1.2 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.074 1.749 . . . . 0.35 112.247 -170.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.3 tp -164.15 138.34 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.642 0.777 . . . . 0.35 110.244 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -99.54 -43.85 6.36 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.095 1.758 . . . . 0.35 110.515 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.411 ' H ' HD21 ' A' ' 122' ' ' ASN . 0.1 OUTLIER -123.25 71.17 44.73 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 115.182 1.549 . . . . 0.36 115.182 -164.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.87 140.39 92.85 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.756 2.304 . . . . 0.35 110.848 163.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.32 67.21 0.32 Allowed Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.648 -1.381 . . . . 0.35 109.648 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -58.02 103.24 0.13 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 125.047 1.339 . . . . 0.35 110.48 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -99.09 86.36 3.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.89 0.876 . . . . 0.36 109.225 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.86 86.23 0.34 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.717 1.607 . . . . 0.35 108.046 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.4 mt -134.14 115.83 21.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 124.792 1.237 . . . . 0.35 108.316 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 40.5 m -116.48 130.41 56.74 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.832 1.253 . . . . 0.35 109.566 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -75.87 128.05 34.29 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.667 -0.864 . . . . 0.35 108.667 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.38 153.54 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.116 0.966 . . . . 0.35 111.057 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.6 t -96.84 97.08 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.781 1.633 . . . . 0.35 107.555 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.5 mt -83.02 138.42 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.299 0.639 . . . . 0.35 110.865 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -103.28 113.44 26.93 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 107.537 -1.283 . . . . 0.35 107.537 164.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -91.64 91.5 8.04 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.881 0.872 . . . . 0.35 108.865 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 C--N 1.342 0.263 0 CA-C-O 121.51 0.671 . . . . 0.25 109.362 177.057 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.5 p90 . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 112.97 0.73 . . . . 0.35 112.97 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -61.8 165.21 5.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.854 1.261 . . . . 0.35 110.062 172.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.32 60.73 2.68 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.479 1.512 . . . . 0.35 110.797 -175.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.07 109.8 3.1 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.859 1.219 . . . . 0.35 112.102 -168.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt 58.48 53.01 6.53 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.326 1.45 . . . . 0.35 110.572 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -127.56 72.28 1.38 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.352 1.061 . . . . 0.35 108.836 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.34 66.94 9.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.671 1.188 . . . . 0.35 108.681 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.4 mptt 51.47 -107.33 0.3 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.29 1.836 . . . . 0.35 110.022 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.01 52.82 0.55 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 108.244 -1.942 . . . . 0.35 108.244 168.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -132.31 75.63 1.65 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.364 1.466 . . . . 0.35 108.156 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -157.93 44.58 0.33 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.823 1.249 . . . . 0.35 109.718 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.42 95.05 2.65 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.471 1.108 . . . . 0.35 108.587 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 t -53.73 -51.24 63.95 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.301 1.04 . . . . 0.35 112.118 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -154.17 57.72 0.71 Allowed 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.547 0.739 . . . . 0.35 110.462 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -138.58 69.29 1.38 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 122.722 0.409 . . . . 0.35 111.522 -170.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 68.42 163.89 0.13 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.93 1.692 . . . . 0.33 113.663 161.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -54.29 104.64 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.791 2.994 . . . . 0.35 111.047 164.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.9 p -143.35 -51.56 0.35 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.601 1.16 . . . . 0.35 109.938 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.97 81.01 0.06 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.182 -1.167 . . . . 0.33 110.182 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -70.85 170.84 16.9 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.714 2.942 . . . . 0.35 111.44 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -154.77 168.26 27.46 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.51 0.671 . . . . 0.35 112.46 -161.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -147.32 93.28 2.22 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.275 -1.75 . . . . 0.35 106.275 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 62.6 mtm -85.16 96.65 9.53 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.518 0.727 . . . . 0.35 111.339 -169.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.54 89.11 2.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 125.128 1.371 . . . . 0.35 108.359 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -151.41 176.55 11.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.429 1.092 . . . . 0.36 109.954 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 t -136.46 145.7 30.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 C-N-CA 123.873 0.869 . . . . 0.35 110.958 -171.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.6 m -82.69 84.38 7.33 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.564 -1.643 . . . . 0.35 106.564 164.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.33 83.14 1.58 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.462 -0.655 . . . . 0.35 111.462 -169.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.93 164.43 3.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 C-N-CA 123.575 0.75 . . . . 0.35 111.37 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -72.43 -45.82 57.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.069 0.948 . . . . 0.35 110.96 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.9 t 169.54 -58.02 0.01 OUTLIER 'General case' 0 C--N 1.341 0.226 0 C-N-CA 127.984 2.514 . . . . 0.35 107.586 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -71.6 -66.75 0.59 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.22 1.008 . . . . 0.35 109.891 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.73 62.91 0.02 OUTLIER Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.001 -1.239 . . . . 0.35 110.001 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -133.04 97.23 3.95 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 107.645 -1.242 . . . . 0.36 107.645 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.22 119.68 9.48 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.78 1.232 . . . . 0.35 111.276 -173.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.0 mp -84.75 -39.41 18.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.153 0.981 . . . . 0.35 110.006 170.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 pp -141.88 149.04 39.72 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.535 0.734 . . . . 0.35 112.467 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.7 m -89.33 155.26 49.03 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.558 1.143 . . . . 0.33 111.544 -167.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -83.7 44.71 1.64 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.811 3.007 . . . . 0.35 111.952 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -177.71 111.39 0.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.421 1.089 . . . . 0.35 109.936 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -163.83 -51.8 0.03 OUTLIER 'General case' 0 C--N 1.341 0.236 0 CA-C-O 118.668 -0.682 . . . . 0.35 112.518 170.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.28 -57.13 6.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 CA-C-N 119.134 0.879 . . . . 0.35 110.594 -173.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 65.9 155.08 0.08 Allowed 'General case' 0 C--N 1.343 0.292 0 C-N-CA 126.19 1.796 . . . . 0.35 113.061 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -138.55 147.02 53.32 Favored Pre-proline 0 N--CA 1.454 -0.275 0 C-N-CA 125.603 1.561 . . . . 0.33 107.521 171.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.63 144.54 55.07 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.582 2.188 . . . . 0.35 109.985 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.97 116.85 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.679 0.792 . . . . 0.35 109.437 -177.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -137.88 116.16 9.68 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.841 1.256 . . . . 0.33 108.484 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.09 178.56 7.36 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.438 2.759 . . . . 0.35 110.881 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.23 -30.29 10.67 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.9 0.762 . . . . 0.35 112.55 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.4 t -68.13 144.65 54.92 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.797 0.798 . . . . 0.35 111.088 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.6 m -71.89 145.65 48.39 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.746 -0.835 . . . . 0.35 108.746 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.98 113.89 7.63 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.443 0.697 . . . . 0.35 109.531 -167.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 t -162.22 175.25 11.85 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.686 1.594 . . . . 0.35 108.898 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -47.97 -60.45 2.6 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.359 1.463 . . . . 0.35 111.054 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -59.77 -35.24 74.22 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.375 0.88 . . . . 0.35 113.375 -174.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.42 -55.41 28.1 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 118.676 0.671 . . . . 0.35 110.62 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.3 mm -60.43 -39.33 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.281 1.033 . . . . 0.35 111.754 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -55.65 -59.19 5.2 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.645 0.657 . . . . 0.35 111.936 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -66.56 -38.1 86.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.942 0.792 . . . . 0.35 111.751 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -66.07 -45.52 81.0 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.516 0.727 . . . . 0.35 111.363 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.79 -26.17 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.61 0.764 . . . . 0.35 111.736 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -62.92 -35.55 80.45 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.11 0.564 . . . . 0.35 110.878 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -71.11 -32.53 69.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.329 0.652 . . . . 0.35 111.308 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.58 -36.44 82.72 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.066 0.546 . . . . 0.35 111.335 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.0 mt -72.76 -41.49 65.01 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 122.884 0.474 . . . . 0.35 111.065 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.49 67.6 6.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.66 0.784 . . . . 0.35 109.641 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.57 -60.48 0.1 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.783 1.233 . . . . 0.35 108.796 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.0 p -96.79 -56.42 2.58 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.617 1.167 . . . . 0.35 109.671 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.79 63.7 7.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.695 -1.224 . . . . 0.35 107.695 169.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -72.77 -57.47 4.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.282 0.633 . . . . 0.35 112.058 -164.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -93.99 -52.3 4.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.438 0.695 . . . . 0.35 111.109 -164.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.52 68.43 10.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.032 0.933 . . . . 0.35 110.235 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -163.18 155.35 18.1 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.115 0.966 . . . . 0.35 109.575 169.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -163.28 111.21 1.23 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.985 -1.117 . . . . 0.35 107.985 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.92 92.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.17 -0.678 . . . . 0.35 109.17 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.51 -40.93 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.596 1.158 . . . . 0.35 111.332 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -149.15 160.5 43.3 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.615 0.766 . . . . 0.35 110.268 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -137.61 142.54 41.24 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.901 1.28 . . . . 0.35 110.441 -175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.77 132.76 82.87 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 109.398 -0.593 . . . . 0.33 109.398 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.74 -34.96 13.6 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.194 2.596 . . . . 0.35 110.751 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -81.53 78.83 8.24 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.152 0.981 . . . . 0.35 110.473 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.85 166.07 16.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.37 0.668 . . . . 0.35 109.269 164.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -153.7 122.06 6.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.73 0.3 . . . . 0.35 111.637 -168.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.0 mp -94.28 124.27 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.546 1.538 . . . . 0.35 107.325 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -111.25 84.29 1.91 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.486 -1.301 . . . . 0.35 107.486 174.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.95 96.86 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 108.975 -0.75 . . . . 0.35 108.975 171.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -86.57 87.45 7.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.273 -1.751 . . . . 0.35 106.273 171.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -86.78 80.63 8.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.234 0.54 . . . . 0.35 110.168 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -91.11 144.09 26.0 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.883 1.273 . . . . 0.35 111.034 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -166.38 89.8 0.4 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.039 -1.467 . . . . 0.35 107.039 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -77.54 74.36 4.1 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.142 0.977 . . . . 0.35 108.636 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -154.67 -48.98 0.09 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.581 1.952 . . . . 0.36 108.339 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.23 -45.99 0.1 Allowed 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.554 0.742 . . . . 0.35 112.561 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -73.64 -57.37 4.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.614 0.643 . . . . 0.35 111.495 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt 82.96 158.05 0.12 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.974 1.71 . . . . 0.35 111.7 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.91 135.26 20.2 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 126.438 1.895 . . . . 0.35 113.243 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -150.05 103.67 3.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.743 1.217 . . . . 0.35 107.997 170.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.2 m -77.19 87.43 3.65 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.408 1.083 . . . . 0.35 108.757 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -97.88 103.64 15.6 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.572 1.149 . . . . 0.35 108.32 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.6 p -83.32 143.16 30.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.276 1.03 . . . . 0.35 111.266 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -151.45 152.97 31.71 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.422 1.089 . . . . 0.33 108.856 169.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.43 -117.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.357 2.705 . . . . 0.35 110.897 -171.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tp -158.76 150.16 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.901 0.88 . . . . 0.35 109.559 -173.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.3 p -91.85 172.68 8.3 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.025 0.93 . . . . 0.35 110.807 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -102.9 -28.39 12.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.324 1.45 . . . . 0.35 109.386 165.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -62.63 -76.04 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.0 1.32 . . . . 0.35 111.777 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 133.93 73.73 0.09 OUTLIER Glycine 0 C--N 1.341 0.86 0 N-CA-C 110.354 -1.099 . . . . 0.35 110.354 -172.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -77.21 131.1 38.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.336 0.568 . . . . 0.35 109.685 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.63 127.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.678 -1.23 . . . . 0.35 107.678 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.16 115.35 12.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.698 -1.223 . . . . 0.33 107.698 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -82.84 -174.04 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.115 2.543 . . . . 0.35 110.866 -170.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -69.37 -171.57 0.37 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.858 0.863 . . . . 0.35 110.109 167.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.27 1.76 2.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.663 0.785 . . . . 0.35 113.094 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 t 65.08 -154.62 0.28 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.177 0.991 . . . . 0.35 111.516 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -96.6 -50.14 4.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.715 1.206 . . . . 0.35 111.483 -166.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -50.45 -41.77 53.24 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.965 1.306 . . . . 0.35 112.896 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.3 tp -105.36 144.23 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.783 1.233 . . . . 0.35 108.488 168.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -149.93 17.4 0.87 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.553 1.141 . . . . 0.35 111.405 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.81 70.16 2.02 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.359 1.064 . . . . 0.36 110.074 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -87.98 -172.69 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.434 3.423 . . . . 0.35 112.26 -170.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.88 84.26 0.17 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.596 -1.402 . . . . 0.35 109.596 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -74.88 81.24 2.14 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.31 1.444 . . . . 0.35 109.917 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -90.58 104.31 16.9 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.048 0.539 . . . . 0.36 110.437 -169.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.88 90.59 4.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.005 -1.109 . . . . 0.35 108.005 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.2 mt -96.59 74.76 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 106.97 -1.493 . . . . 0.35 106.97 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.1 m -78.67 170.73 16.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.641 1.176 . . . . 0.35 109.127 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -141.94 133.81 27.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.43 1.092 . . . . 0.35 108.861 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.3 m -142.52 159.62 19.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 123.652 0.781 . . . . 0.35 110.803 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.4 t -90.85 126.83 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.117 1.367 . . . . 0.35 108.205 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 34.9 mt -116.65 120.35 64.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.295 1.038 . . . . 0.35 110.159 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -80.29 120.43 24.34 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.267 1.427 . . . . 0.35 108.073 164.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -89.07 -3.51 58.65 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.414 1.086 . . . . 0.35 112.997 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? . . . . . 0 C--N 1.343 0.323 0 C-N-CA 125.52 1.528 . . . . 0.25 110.333 -164.267 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 115.274 1.583 . . . . 0.35 115.274 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -93.59 71.78 4.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.803 0.841 . . . . 0.35 108.917 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -157.47 -51.39 0.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.409 1.083 . . . . 0.35 110.163 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.49 67.45 0.89 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.825 -0.91 . . . . 0.35 110.825 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt 56.14 -121.45 1.62 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.431 1.492 . . . . 0.35 110.904 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.9 t80 61.71 99.64 0.03 OUTLIER 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.499 1.92 . . . . 0.35 112.181 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.81 52.43 0.94 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.685 1.194 . . . . 0.35 110.678 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.6 mttt 79.55 -65.18 0.2 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 126.915 2.086 . . . . 0.35 111.866 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 147.09 -47.8 0.67 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 108.387 -1.885 . . . . 0.35 108.387 -168.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 48.4 51.15 15.66 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.881 2.073 . . . . 0.35 113.809 167.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 56.66 54.39 7.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.901 1.281 . . . . 0.35 111.778 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.16 -158.33 0.32 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.553 1.141 . . . . 0.35 112.984 171.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 p -162.79 -35.6 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.482 1.113 . . . . 0.35 111.812 -171.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -133.8 39.44 3.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.705 1.202 . . . . 0.35 109.944 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -147.37 73.05 1.27 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 122.775 0.43 . . . . 0.35 110.788 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 65.8 177.99 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.191 1.396 . . . . 0.33 112.886 162.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -74.89 60.41 5.34 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.596 2.864 . . . . 0.35 113.742 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.2 p -68.01 -40.97 82.9 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.566 0.746 . . . . 0.35 109.915 170.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.96 166.79 22.36 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 111.881 -0.488 . . . . 0.33 111.881 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.03 -177.45 3.72 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.875 3.717 . . . . 0.35 111.807 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -156.46 171.8 19.65 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.594 1.157 . . . . 0.35 110.452 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tt -149.16 82.61 1.43 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.957 -1.127 . . . . 0.35 107.957 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -67.42 133.14 49.01 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.378 0.671 . . . . 0.35 110.166 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.8 t -128.67 86.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 125.076 1.35 . . . . 0.35 108.423 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -146.93 177.97 8.72 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.989 1.315 . . . . 0.36 109.254 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.3 m -137.71 144.05 32.21 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 C-N-CA 124.348 1.059 . . . . 0.35 110.34 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.7 m -75.99 97.35 3.99 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.305 -0.998 . . . . 0.35 108.305 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.92 84.01 1.57 Allowed Glycine 0 C--N 1.338 0.686 0 C-N-CA 123.988 0.804 . . . . 0.35 111.535 -172.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.8 m -77.14 165.5 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.25 0.62 . . . . 0.35 110.315 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.4 -66.53 0.89 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.884 0.474 . . . . 0.35 109.862 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.6 m -158.42 -56.0 0.07 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.61 1.564 . . . . 0.35 108.249 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.25 45.42 1.02 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.763 1.225 . . . . 0.35 110.17 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.59 29.03 73.45 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.161 0.886 . . . . 0.35 113.419 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -96.75 97.71 9.56 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 117.933 0.866 . . . . 0.36 108.887 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.08 116.26 4.39 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.506 1.123 . . . . 0.35 111.541 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.7 mp -73.16 -45.82 54.34 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.327 0.651 . . . . 0.35 109.386 168.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 pp -138.58 138.82 38.29 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.308 1.043 . . . . 0.35 111.978 -171.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.7 t -82.32 138.08 45.27 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 124.658 1.183 . . . . 0.33 109.107 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -86.31 61.36 4.73 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.648 2.899 . . . . 0.35 111.825 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -149.11 65.31 1.03 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.609 0.764 . . . . 0.35 109.845 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -128.61 -52.74 1.25 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.159 0.984 . . . . 0.35 111.261 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.1 t -101.47 140.49 20.02 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 123.214 0.606 . . . . 0.35 109.893 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.7 170.06 19.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.643 0.777 . . . . 0.35 110.109 164.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -140.13 147.94 52.49 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.133 0.973 . . . . 0.33 109.373 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.38 126.89 14.86 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.346 2.031 . . . . 0.35 107.911 168.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.3 tt -57.83 137.57 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.36 0.664 . . . . 0.35 112.585 -168.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 86.62 8.99 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.961 1.705 . . . . 0.33 107.765 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.16 168.47 23.94 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.193 2.595 . . . . 0.35 111.371 -170.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.51 -28.64 14.14 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.025 0.821 . . . . 0.35 111.802 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.0 t -65.58 148.03 52.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.722 0.809 . . . . 0.35 110.879 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -74.61 124.27 26.36 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.419 0.688 . . . . 0.35 109.702 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.96 102.28 7.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.34 1.456 . . . . 0.35 107.435 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.2 t -139.8 -175.99 4.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.596 1.158 . . . . 0.35 108.882 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -55.71 -60.16 3.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.668 0.787 . . . . 0.35 110.672 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.6 -33.19 74.5 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.376 0.88 . . . . 0.35 113.376 -173.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -61.23 2.5 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.246 0.93 . . . . 0.35 110.055 175.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.13 -31.78 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.35 1.06 . . . . 0.35 111.342 -170.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.74 -62.46 1.64 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.653 1.181 . . . . 0.35 111.572 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.04 -34.97 78.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.166 0.439 . . . . 0.35 111.539 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -63.6 -46.8 84.11 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.621 0.768 . . . . 0.35 111.663 -175.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.8 p -73.66 -31.93 33.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 122.809 0.443 . . . . 0.35 111.724 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -58.95 -31.89 69.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.279 0.632 . . . . 0.35 111.512 173.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -76.54 -38.33 55.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.922 0.489 . . . . 0.35 110.771 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.31 -62.27 1.96 Allowed 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.335 1.054 . . . . 0.35 111.942 -174.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.13 -23.88 67.48 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.048 0.758 . . . . 0.35 113.048 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -80.43 66.66 6.01 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.813 1.245 . . . . 0.35 110.972 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.07 49.86 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.798 1.639 . . . . 0.35 108.672 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.2 p -140.08 -62.41 0.51 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.047 1.339 . . . . 0.35 108.873 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.29 -64.93 1.01 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.118 1.367 . . . . 0.35 108.686 172.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.62 68.99 0.78 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.873 1.669 . . . . 0.35 110.802 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -132.8 47.7 2.48 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.993 1.317 . . . . 0.35 108.53 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 63.6 111.51 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.065 2.146 . . . . 0.35 112.36 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -111.57 99.52 8.25 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.271 1.428 . . . . 0.35 108.107 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -81.28 98.49 8.15 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.369 -0.604 . . . . 0.35 109.369 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.5 96.83 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.907 -0.775 . . . . 0.35 108.907 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.53 -46.02 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.652 0.781 . . . . 0.35 111.035 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -137.96 164.41 29.11 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.71 1.204 . . . . 0.35 110.225 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 pp -157.66 158.29 35.17 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.861 1.264 . . . . 0.35 110.316 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.23 121.22 68.86 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 108.533 -0.914 . . . . 0.33 108.533 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.77 -39.46 3.4 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.019 2.479 . . . . 0.35 110.938 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -79.49 83.48 5.49 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.006 0.923 . . . . 0.35 109.291 176.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.07 129.75 41.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.628 0.771 . . . . 0.35 109.778 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -100.23 136.38 40.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.575 1.15 . . . . 0.35 110.82 -172.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.43 120.27 58.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 125.633 1.573 . . . . 0.35 108.492 -173.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -117.9 90.56 3.36 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.819 1.248 . . . . 0.35 108.647 -172.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 m -77.06 94.08 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.261 1.024 . . . . 0.35 110.544 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 88.1 m -91.88 90.62 7.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.634 1.574 . . . . 0.35 108.532 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.75 93.9 7.78 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.823 0.849 . . . . 0.35 110.534 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -86.09 62.55 7.51 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.71 1.604 . . . . 0.35 109.615 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -98.99 78.63 2.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.996 1.319 . . . . 0.35 107.469 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.12 80.28 4.55 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.656 1.182 . . . . 0.35 109.376 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -150.75 -41.43 0.12 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.784 2.034 . . . . 0.36 108.442 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.65 -39.75 0.18 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.817 1.647 . . . . 0.35 110.894 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -85.77 -54.75 4.34 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.0 0.92 . . . . 0.35 111.439 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 83.3 tttt 69.52 158.51 0.17 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.877 1.671 . . . . 0.35 110.856 -172.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.73 123.62 14.74 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.105 0.562 . . . . 0.35 111.446 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -145.0 105.64 4.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.91 1.284 . . . . 0.35 107.841 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.7 m -82.62 86.85 6.75 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.949 1.299 . . . . 0.35 108.968 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.3 101.61 14.28 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.014 0.926 . . . . 0.35 108.85 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.8 p -80.35 144.21 32.92 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.415 1.086 . . . . 0.35 111.266 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -158.95 137.0 7.46 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 123.282 0.633 . . . . 0.33 110.719 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.6 161.73 27.77 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.858 3.039 . . . . 0.35 110.525 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.0 tp -95.42 151.66 3.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 123.788 0.835 . . . . 0.35 110.339 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 67.6 p -86.67 112.18 21.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.835 -1.172 . . . . 0.35 107.835 169.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.15 -21.76 66.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.478 1.111 . . . . 0.35 113.596 -173.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.05 -44.05 97.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.899 0.88 . . . . 0.35 111.713 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.32 135.15 1.77 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.519 -1.033 . . . . 0.35 110.519 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -159.27 166.86 30.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.372 1.069 . . . . 0.35 109.555 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.67 144.6 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.283 1.433 . . . . 0.35 109.229 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.19 116.33 15.58 Favored Pre-proline 0 C--N 1.345 0.405 0 N-CA-C 108.156 -1.053 . . . . 0.33 108.156 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.42 -101.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.921 2.414 . . . . 0.35 110.902 -167.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -166.17 169.04 14.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.098 0.959 . . . . 0.35 109.376 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.53 17.54 0.86 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.767 1.227 . . . . 0.35 112.635 172.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.8 t 63.04 -95.13 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.647 1.579 . . . . 0.35 111.024 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -167.36 -48.76 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.167 0.987 . . . . 0.35 109.855 -174.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -70.76 -0.34 8.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.495 1.518 . . . . 0.35 114.943 -168.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.7 pt -133.24 -172.98 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.411 1.084 . . . . 0.35 110.188 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -130.6 -45.32 1.08 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.414 1.486 . . . . 0.35 110.62 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -119.92 74.49 19.71 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 0.36 112.772 -162.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -69.27 141.27 46.74 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.17 1.913 . . . . 0.35 109.935 171.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.24 79.7 0.28 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.405 -1.478 . . . . 0.35 109.405 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -66.67 92.92 0.23 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.713 1.205 . . . . 0.35 110.713 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -85.37 98.68 10.69 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.877 -1.157 . . . . 0.36 107.877 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.93 53.82 2.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.171 0.988 . . . . 0.35 109.196 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.0 mt -99.03 99.29 8.31 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 124.462 1.105 . . . . 0.35 108.681 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 96.3 m -105.63 140.53 38.56 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.102 1.361 . . . . 0.35 109.231 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 126.46 31.63 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.525 0.73 . . . . 0.35 109.326 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.34 148.33 32.77 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 C-N-CA 123.888 0.875 . . . . 0.35 110.299 172.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 t -96.51 130.83 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.689 1.196 . . . . 0.35 108.364 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mt -126.97 105.95 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.829 1.251 . . . . 0.35 109.222 -173.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -71.58 132.07 44.13 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.79 -1.189 . . . . 0.35 107.79 159.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 94.83 4.4 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.403 0.681 . . . . 0.35 109.497 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.344 0.337 0 C-N-CA 124.969 1.307 . . . . 0.25 109.438 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 t80 . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 110.102 -0.333 . . . . 0.35 110.102 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -164.96 99.07 0.76 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.752 0.821 . . . . 0.35 110.077 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -157.89 37.68 0.26 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.257 1.023 . . . . 0.35 109.946 168.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.43 159.93 9.74 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.017 0.818 . . . . 0.35 111.18 -174.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -74.76 96.95 3.15 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.985 0.514 . . . . 0.35 110.189 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -85.88 79.12 9.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.305 1.042 . . . . 0.35 110.609 -174.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -137.84 -158.12 0.83 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.913 0.885 . . . . 0.35 109.187 170.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.9 tttt 62.61 46.86 5.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.197 0.999 . . . . 0.35 109.542 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.11 -42.88 1.85 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.046 1.308 . . . . 0.35 111.653 -172.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -85.47 56.52 3.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.588 1.155 . . . . 0.35 110.558 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 54.85 28.71 10.78 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.682 1.993 . . . . 0.35 113.693 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.17 140.63 29.3 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.384 0.674 . . . . 0.35 110.889 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -166.32 -130.13 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.154 0.982 . . . . 0.35 109.511 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -138.82 164.83 28.61 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.306 1.842 . . . . 0.35 108.951 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.7 t80 66.72 103.62 0.04 OUTLIER 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.763 1.625 . . . . 0.35 110.673 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 75.66 144.65 0.1 Allowed Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 126.109 1.764 . . . . 0.33 110.079 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.62 96.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.443 2.762 . . . . 0.35 111.847 171.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.1 p -94.33 -44.3 8.0 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.008 0.923 . . . . 0.35 110.291 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.21 150.38 8.64 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 112.032 -0.427 . . . . 0.33 112.032 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -92.21 -170.12 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.939 3.093 . . . . 0.35 111.098 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -168.75 165.32 11.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.006 0.922 . . . . 0.35 111.73 172.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.0 tp -134.42 88.54 2.46 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.94 1.696 . . . . 0.35 107.731 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -78.41 125.57 29.55 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.883 1.273 . . . . 0.35 108.312 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -135.65 91.09 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.882 0.873 . . . . 0.35 109.382 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -149.28 157.68 43.55 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.465 1.506 . . . . 0.36 109.169 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.13 161.09 42.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 123.806 0.843 . . . . 0.35 112.146 -168.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.3 m -87.91 91.15 8.66 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.841 1.257 . . . . 0.35 108.438 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.06 104.24 2.66 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.653 -0.979 . . . . 0.35 110.653 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.35 174.0 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.224 1.01 . . . . 0.35 111.033 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -71.62 -55.82 7.03 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.065 0.546 . . . . 0.35 109.675 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.2 p -150.1 -71.04 0.18 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.067 0.947 . . . . 0.35 110.559 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -85.45 -73.33 0.45 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.862 0.865 . . . . 0.35 110.541 -171.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.49 50.77 0.41 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.341 -1.104 . . . . 0.35 110.341 -176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -115.82 79.99 1.38 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.338 1.455 . . . . 0.36 108.714 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.46 138.76 58.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.036 1.334 . . . . 0.35 112.256 -173.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mp -113.96 -24.84 8.85 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.311 1.445 . . . . 0.35 110.666 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.51 146.0 32.16 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.355 1.062 . . . . 0.35 111.738 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.8 m -81.33 153.6 71.51 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.367 1.067 . . . . 0.33 110.331 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.99 50.44 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.78 2.987 . . . . 0.35 111.521 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -173.21 103.96 0.13 Allowed 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.09 0.556 . . . . 0.35 111.038 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -164.88 14.02 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.5 0.926 . . . . 0.35 113.5 172.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.6 t -149.16 135.22 12.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 C-N-CA 125.241 1.416 . . . . 0.35 107.441 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -139.46 171.05 14.82 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.128 0.571 . . . . 0.35 111.295 169.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -140.81 151.7 63.61 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.765 1.226 . . . . 0.33 109.967 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.04 100.61 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.487 2.791 . . . . 0.35 109.397 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.77 138.17 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.262 1.025 . . . . 0.35 111.508 -171.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -138.53 137.11 19.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.717 1.207 . . . . 0.33 108.733 171.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.24 169.36 22.67 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.647 2.898 . . . . 0.35 110.864 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 110.63 -31.21 7.51 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.108 0.861 . . . . 0.35 111.841 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 t -66.13 146.27 54.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.559 0.744 . . . . 0.35 111.146 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.7 m -74.21 152.91 39.67 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.455 1.102 . . . . 0.35 109.282 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.04 121.13 8.28 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.4 0.68 . . . . 0.35 109.482 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 t -166.09 174.53 9.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.689 1.996 . . . . 0.35 107.846 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.62 -52.18 64.67 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.692 0.797 . . . . 0.35 111.23 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.75 -24.72 67.88 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.184 0.809 . . . . 0.35 113.184 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -71.85 -51.66 21.3 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.371 0.668 . . . . 0.35 110.582 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.2 -33.25 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.51 1.124 . . . . 0.35 111.886 -172.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -55.29 -55.23 33.82 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.463 1.105 . . . . 0.35 111.714 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -66.99 -30.29 70.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.073 0.397 . . . . 0.35 111.867 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -52.88 61.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.483 0.713 . . . . 0.35 110.209 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -61.13 -38.95 80.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 CA-C-O 119.038 -0.506 . . . . 0.35 111.343 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.92 -36.16 76.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.586 0.755 . . . . 0.35 111.875 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -70.2 -48.04 58.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.93 0.492 . . . . 0.35 110.844 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.95 97.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.427 0.691 . . . . 0.35 111.52 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 mt -54.51 -58.78 6.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.22 1.408 . . . . 0.35 110.304 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -61.38 -59.62 4.99 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.01 0.924 . . . . 0.35 111.652 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -41.23 -48.8 3.58 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 126.131 1.772 . . . . 0.35 113.429 -171.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.5 m -74.13 -63.61 1.19 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.348 0.659 . . . . 0.35 109.924 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.56 96.08 5.69 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.01 1.324 . . . . 0.35 109.915 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -112.18 70.67 0.72 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.196 1.399 . . . . 0.35 109.571 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -137.95 -113.17 0.17 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.745 0.818 . . . . 0.35 109.906 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.42 83.22 6.86 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.414 1.086 . . . . 0.35 110.81 -173.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -152.43 162.87 40.58 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.317 0.647 . . . . 0.35 111.469 176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -173.98 125.05 0.35 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.549 1.94 . . . . 0.35 106.789 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.96 91.74 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.297 -1.001 . . . . 0.35 108.297 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 p -61.2 -43.92 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.885 0.874 . . . . 0.35 110.985 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -151.1 169.16 22.52 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.943 0.897 . . . . 0.35 110.12 169.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 pp -144.64 149.56 35.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.285 1.034 . . . . 0.35 109.992 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.86 135.73 55.35 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.578 -0.897 . . . . 0.33 108.578 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.46 -24.44 22.46 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.162 2.575 . . . . 0.35 111.923 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 m -86.21 70.03 10.51 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.57 1.148 . . . . 0.35 110.855 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.39 164.35 26.49 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.767 0.827 . . . . 0.35 109.965 168.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -150.02 121.72 8.07 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.134 0.493 . . . . 0.35 112.313 -174.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 mp -77.74 114.69 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.663 -1.606 . . . . 0.35 106.663 165.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -110.23 63.42 0.61 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.34 -0.985 . . . . 0.35 108.34 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.09 111.11 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.405 0.682 . . . . 0.35 110.945 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.5 m -98.45 81.85 2.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.49 1.516 . . . . 0.35 108.263 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -87.27 112.56 22.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.245 1.018 . . . . 0.35 108.577 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -104.67 117.49 34.23 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.547 1.139 . . . . 0.35 110.578 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -128.37 89.34 2.89 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.597 1.159 . . . . 0.35 110.236 -172.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -82.82 67.83 9.06 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.04 -0.726 . . . . 0.35 109.04 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -149.0 -54.17 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.225 1.41 . . . . 0.36 109.134 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.74 -48.11 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.634 0.773 . . . . 0.35 112.823 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -71.94 -34.32 68.94 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.884 0.874 . . . . 0.35 112.17 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt 72.68 174.9 0.29 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.118 1.367 . . . . 0.35 110.945 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -79.16 132.23 36.48 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.209 0.604 . . . . 0.35 110.876 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -139.87 113.4 8.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.585 1.154 . . . . 0.35 108.562 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.6 m -80.2 84.88 5.81 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.658 -1.238 . . . . 0.35 107.658 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -78.82 105.66 10.29 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.898 0.879 . . . . 0.35 109.35 -173.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.5 m -87.95 67.79 9.08 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.585 1.154 . . . . 0.35 111.163 -172.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -69.56 140.87 89.97 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.216 1.006 . . . . 0.33 108.74 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -78.78 -116.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.265 2.644 . . . . 0.35 110.335 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.1 tp -160.52 150.83 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.17 0.988 . . . . 0.35 108.862 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.0 p -103.4 175.7 5.39 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.036 0.934 . . . . 0.35 110.611 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.83 -10.79 15.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.592 1.557 . . . . 0.35 110.573 164.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -77.31 -82.97 0.08 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 124.813 1.245 . . . . 0.35 110.713 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 145.4 63.85 0.02 OUTLIER Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.155 -1.178 . . . . 0.35 110.155 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -72.27 129.71 39.07 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 117.508 0.654 . . . . 0.35 109.728 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.71 130.99 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.395 -0.965 . . . . 0.35 108.395 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.6 117.24 29.51 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 107.918 -1.141 . . . . 0.33 107.918 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.27 172.02 16.05 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.199 2.6 . . . . 0.35 110.898 -173.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.11 34.53 0.62 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.146 0.978 . . . . 0.35 110.932 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 32.66 54.0 0.36 Allowed 'General case' 0 C--N 1.346 0.43 0 C-N-CA 128.041 2.536 . . . . 0.35 113.878 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.1 t 56.47 -105.84 0.29 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.893 1.677 . . . . 0.35 111.467 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -163.22 -38.17 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.233 1.013 . . . . 0.35 110.654 -172.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -55.22 -13.6 1.37 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.26 1.824 . . . . 0.35 115.169 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -153.14 148.23 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.574 1.15 . . . . 0.35 108.978 171.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.49 34.77 3.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.37 1.868 . . . . 0.35 111.337 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -153.37 79.48 5.48 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.318 0.647 . . . . 0.36 111.378 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.59 167.67 25.1 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.022 2.482 . . . . 0.35 111.527 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.0 68.2 0.47 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.194 -1.163 . . . . 0.35 110.194 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -59.73 103.05 0.18 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.165 1.386 . . . . 0.35 111.26 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -100.39 98.41 9.05 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.072 0.949 . . . . 0.36 109.449 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.96 73.83 10.24 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.116 0.966 . . . . 0.35 108.535 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.6 mt -91.05 91.29 3.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.093 -1.447 . . . . 0.35 107.093 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.1 m -111.58 150.48 29.98 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.688 1.195 . . . . 0.35 109.468 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -91.75 130.3 37.56 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.151 1.38 . . . . 0.35 109.053 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 m -137.5 169.46 19.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 123.753 0.821 . . . . 0.35 110.351 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 37.9 t -119.73 139.75 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.035 1.334 . . . . 0.35 108.111 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.7 mt -130.54 119.35 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.232 1.013 . . . . 0.35 109.503 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -78.71 127.2 31.76 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.923 -1.14 . . . . 0.35 107.923 161.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -95.24 60.32 2.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.241 1.017 . . . . 0.35 111.252 -168.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.186 0 C-N-CA 124.004 0.921 . . . . 0.25 110.021 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.7 p90 . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 110.817 -0.068 . . . . 0.35 110.817 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -95.02 162.29 13.79 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.125 0.97 . . . . 0.35 110.33 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 pttm 50.51 83.36 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.557 1.943 . . . . 0.35 112.57 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.22 103.32 0.33 Allowed Glycine 0 C--N 1.341 0.845 0 C-N-CA 126.387 1.946 . . . . 0.35 112.621 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt 75.1 -33.68 0.24 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 126.688 1.995 . . . . 0.35 113.743 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -55.1 123.13 12.65 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.138 0.975 . . . . 0.35 110.173 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -101.43 27.85 5.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.491 -0.766 . . . . 0.35 112.996 -159.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? 69.53 -63.95 0.36 Allowed 'General case' 0 C--N 1.346 0.435 0 C-N-CA 126.21 1.804 . . . . 0.35 109.907 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.59 -151.49 6.7 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.605 -1.798 . . . . 0.35 108.605 172.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 57.62 37.73 27.54 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.371 1.068 . . . . 0.35 111.753 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.91 64.63 0.96 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.507 1.123 . . . . 0.35 109.335 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.51 -41.53 60.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.009 0.924 . . . . 0.35 110.345 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.6 t 74.26 -74.67 0.08 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.779 2.032 . . . . 0.35 112.064 175.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -155.22 171.56 19.62 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.332 0.653 . . . . 0.35 111.257 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 70.11 121.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.709 2.004 . . . . 0.35 112.633 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 73.93 137.81 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 126.17 1.788 . . . . 0.33 112.223 168.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.79 109.62 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.19 3.26 . . . . 0.35 111.922 160.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 p -138.06 -62.54 0.58 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.847 1.259 . . . . 0.35 109.588 -174.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.0 113.08 0.31 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.46 -1.056 . . . . 0.33 110.46 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.24 176.58 9.87 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.003 2.469 . . . . 0.35 111.803 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -159.06 163.09 36.61 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.207 1.003 . . . . 0.35 110.344 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.8 tt -145.11 94.61 2.55 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.458 -1.312 . . . . 0.35 107.458 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.3 ptp -88.74 139.06 30.85 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.884 0.874 . . . . 0.35 110.357 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.6 91.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.205 0 C-N-CA 124.636 1.174 . . . . 0.35 107.874 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -153.59 166.1 33.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.699 1.2 . . . . 0.36 110.139 -171.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -144.94 170.59 6.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 123.147 0.579 . . . . 0.35 112.352 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -107.0 121.46 44.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.155 1.382 . . . . 0.35 108.264 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.55 92.41 1.72 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.15 0.881 . . . . 0.35 111.624 -174.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.0 m -99.08 168.63 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 124.316 1.046 . . . . 0.35 112.852 -174.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -83.09 172.72 12.41 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.626 1.17 . . . . 0.35 109.563 166.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -57.18 -40.94 78.33 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.722 0.809 . . . . 0.35 110.39 170.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -62.02 -55.29 30.67 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.061 0.945 . . . . 0.35 110.186 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.1 4.29 0.59 Allowed Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.938 -0.923 . . . . 0.35 114.017 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -79.32 123.18 27.22 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.774 1.287 . . . . 0.36 110.217 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -65.21 104.11 0.87 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.912 0.885 . . . . 0.35 110.976 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 mp -69.65 -56.77 6.34 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.751 -1.203 . . . . 0.35 107.751 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.5 mt -120.65 164.91 15.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.188 1.795 . . . . 0.35 108.789 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.8 m -142.74 68.26 19.17 Favored Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 124.522 1.129 . . . . 0.33 108.015 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.08 106.29 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.578 2.852 . . . . 0.35 110.073 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -146.34 90.58 1.96 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.926 1.69 . . . . 0.35 108.187 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -155.55 -33.36 0.09 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.056 0.762 . . . . 0.35 113.056 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.6 t -76.22 98.7 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.975 0.91 . . . . 0.35 111.216 -176.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -86.97 170.09 11.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.317 0.647 . . . . 0.35 110.141 167.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -155.41 131.1 5.47 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.269 -1.011 . . . . 0.33 108.269 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.48 121.84 8.8 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.815 2.343 . . . . 0.35 109.059 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.0 tt -57.53 133.85 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.32 1.048 . . . . 0.35 112.856 -168.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -142.77 98.39 5.77 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 125.565 1.546 . . . . 0.33 107.495 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.77 173.66 13.76 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.247 2.631 . . . . 0.35 111.288 -174.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.42 -26.48 24.17 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.013 0.816 . . . . 0.35 112.159 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.1 t -66.32 151.51 46.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.889 0.844 . . . . 0.35 110.796 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -62.46 148.62 45.07 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.959 0.903 . . . . 0.35 110.118 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.51 101.23 2.64 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.368 -0.975 . . . . 0.35 108.368 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 t -144.89 -171.07 3.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.165 1.386 . . . . 0.35 108.752 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -58.19 -57.41 12.99 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.35 110.674 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -61.96 -29.03 69.96 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.518 0.562 . . . . 0.35 112.518 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -62.39 -54.01 46.54 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.547 -0.538 . . . . 0.35 109.547 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 mm -51.14 -55.38 7.76 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 124.526 1.13 . . . . 0.35 109.786 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -45.98 -63.75 0.91 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.675 1.19 . . . . 0.35 112.406 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -63.62 -38.46 91.19 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.465 0.575 . . . . 0.35 111.894 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.1 -49.15 62.97 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.491 0.716 . . . . 0.35 110.644 -173.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.61 -37.22 79.46 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 118.454 0.57 . . . . 0.35 111.551 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -58.83 -44.37 90.88 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.357 0.663 . . . . 0.35 110.589 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -67.57 -34.8 77.79 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.568 0.347 . . . . 0.35 110.85 176.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.04 -64.78 0.83 Allowed 'General case' 0 C--N 1.343 0.287 0 CA-C-O 118.605 -0.712 . . . . 0.35 111.502 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -66.43 -35.32 79.99 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.647 0.658 . . . . 0.35 112.368 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -90.14 49.39 1.69 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.489 0.715 . . . . 0.35 110.578 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.0 -51.99 2.88 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.328 1.451 . . . . 0.35 107.362 164.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.5 p -79.56 -45.76 18.6 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.566 1.146 . . . . 0.35 110.291 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.18 -93.22 0.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.633 0.773 . . . . 0.35 110.695 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 62.28 -151.14 0.36 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.978 1.311 . . . . 0.35 110.674 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? 66.38 -80.45 0.03 OUTLIER 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.678 1.991 . . . . 0.35 111.549 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -84.28 -115.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.05 -1.093 . . . . 0.35 108.05 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 59.3 82.39 0.15 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.248 1.419 . . . . 0.35 111.455 171.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.5 ttm105 -66.14 -55.23 17.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.698 0.799 . . . . 0.35 109.98 172.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 t 60.89 78.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 125.189 1.396 . . . . 0.35 109.11 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.38 -43.71 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.083 0.953 . . . . 0.35 112.232 -171.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -138.44 170.53 15.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.247 1.019 . . . . 0.35 110.552 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 pp -153.5 159.84 42.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.359 1.464 . . . . 0.35 109.159 171.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.05 120.57 82.19 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 109.222 -0.658 . . . . 0.33 109.222 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -70.72 -33.0 13.62 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.186 2.591 . . . . 0.35 110.97 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -82.7 70.49 9.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.52 1.128 . . . . 0.35 109.384 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.0 160.66 30.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.642 0.777 . . . . 0.35 109.951 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.7 145.47 34.93 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.899 0.48 . . . . 0.35 111.818 -171.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mp -122.84 99.4 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 126.728 2.011 . . . . 0.35 106.294 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -88.93 72.53 8.46 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.175 0.99 . . . . 0.35 109.34 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.83 115.14 5.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.401 0.68 . . . . 0.35 110.3 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.1 m -103.01 91.6 4.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.862 1.265 . . . . 0.35 108.303 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -81.19 94.35 6.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.306 0.642 . . . . 0.35 109.89 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -105.68 129.7 53.85 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.056 1.342 . . . . 0.35 110.505 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -161.37 94.4 0.98 Allowed 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 106.429 -1.693 . . . . 0.35 106.429 172.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -56.12 -28.23 57.06 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.409 0.892 . . . . 0.35 113.409 -169.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -56.34 -41.79 76.64 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.93 1.292 . . . . 0.36 112.133 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -144.18 -56.12 0.36 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 112.852 0.686 . . . . 0.35 112.852 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.61 -61.2 1.92 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.65 0.659 . . . . 0.35 111.069 -171.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 80.41 149.26 0.1 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.503 1.921 . . . . 0.35 110.905 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -49.38 126.43 13.12 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.983 1.713 . . . . 0.35 112.153 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -155.24 101.42 2.22 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.148 0.979 . . . . 0.35 109.04 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.7 m -77.23 97.86 4.95 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.939 1.296 . . . . 0.35 109.708 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -91.66 108.38 19.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.569 1.148 . . . . 0.35 108.39 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.0 p -82.68 77.95 9.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.51 1.124 . . . . 0.35 111.44 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -72.33 131.9 84.53 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 108.567 -0.901 . . . . 0.33 108.567 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.89 -125.03 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.653 2.902 . . . . 0.35 109.03 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.51 154.12 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 119.268 0.94 . . . . 0.35 110.013 173.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.7 p -108.01 123.21 48.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.366 1.067 . . . . 0.35 108.558 169.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -61.23 -36.56 80.27 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.531 1.132 . . . . 0.35 110.658 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -56.01 -56.55 19.45 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.426 1.091 . . . . 0.35 111.238 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.51 139.42 2.71 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 112.26 -0.336 . . . . 0.35 112.26 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -155.39 165.9 35.19 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.571 1.548 . . . . 0.35 108.783 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -137.19 146.1 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.264 1.426 . . . . 0.35 108.71 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.33 116.95 29.24 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.348 -0.982 . . . . 0.33 108.348 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.83 175.52 10.43 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.094 2.53 . . . . 0.35 111.504 -171.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.8 -166.01 0.26 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.616 1.166 . . . . 0.35 110.356 171.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.26 28.65 1.67 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.581 0.752 . . . . 0.35 112.536 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.6 t 53.1 -113.4 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.984 1.314 . . . . 0.35 111.796 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -158.09 -33.44 0.07 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.428 1.091 . . . . 0.35 111.595 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -60.45 -39.24 86.84 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.057 0.943 . . . . 0.35 111.227 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.6 tp -102.13 137.09 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.247 1.419 . . . . 0.35 108.13 171.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -137.28 13.47 3.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.494 1.117 . . . . 0.35 111.211 175.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.66 63.86 2.27 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.056 0.942 . . . . 0.36 109.995 -173.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.89 -176.22 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.65 2.9 . . . . 0.35 111.914 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.76 78.18 0.25 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 109.608 -1.397 . . . . 0.35 109.608 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -66.43 118.09 9.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.981 0.912 . . . . 0.35 109.441 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -121.06 90.99 3.43 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.812 1.245 . . . . 0.36 108.803 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.73 69.84 10.35 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.743 0.817 . . . . 0.35 109.178 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.3 mt -97.25 89.84 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.553 1.141 . . . . 0.35 108.678 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 57.7 m -92.07 169.13 10.88 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.306 1.442 . . . . 0.35 108.621 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -116.92 132.86 56.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.592 1.157 . . . . 0.35 108.934 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.9 m -124.66 138.58 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.509 1.124 . . . . 0.35 109.956 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -92.45 96.3 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.283 -1.006 . . . . 0.35 108.283 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.7 mt -80.86 110.21 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 123.311 0.644 . . . . 0.35 110.03 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -98.09 155.88 16.92 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.703 -1.221 . . . . 0.35 107.703 153.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -107.97 132.67 53.26 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.314 1.046 . . . . 0.35 109.134 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 N--CA 1.453 -0.311 0 C-N-CA 124.541 1.136 . . . . 0.25 110.291 -174.03 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 p90 . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 112.548 0.573 . . . . 0.35 112.548 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -40.09 88.72 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.13 2.172 . . . . 0.35 114.438 -163.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt 156.72 143.5 0.0 OUTLIER 'General case' 0 C--N 1.344 0.328 0 C-N-CA 130.097 3.359 . . . . 0.35 108.539 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.48 87.27 1.5 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.06 -1.216 . . . . 0.35 110.06 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 59.59 -96.59 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.751 1.621 . . . . 0.35 110.423 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.8 t80 52.75 76.44 0.19 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.086 1.354 . . . . 0.35 109.897 -172.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -81.64 65.09 6.63 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.753 1.221 . . . . 0.35 110.67 -171.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? 71.66 -71.5 0.13 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.68 2.392 . . . . 0.35 112.798 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.86 -19.86 0.29 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.725 1.155 . . . . 0.35 111.515 -167.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.68 138.61 17.86 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.667 1.587 . . . . 0.35 111.357 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -87.44 81.4 7.83 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.189 0.996 . . . . 0.35 109.806 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.83 158.43 18.74 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.506 1.123 . . . . 0.35 109.545 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -159.96 170.61 20.99 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.092 0.557 . . . . 0.35 111.184 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -122.36 43.43 2.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.11 1.364 . . . . 0.35 107.451 164.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -173.52 107.14 0.14 Allowed 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.051 1.34 . . . . 0.35 108.529 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 71.02 153.86 0.15 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 126.544 1.938 . . . . 0.33 111.655 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.62 85.59 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.987 2.458 . . . . 0.35 110.121 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.8 p -77.32 -56.79 4.25 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.021 0.929 . . . . 0.35 110.401 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.43 158.34 23.67 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 111.736 -0.546 . . . . 0.33 111.736 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -80.56 172.12 13.83 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.243 3.295 . . . . 0.35 111.815 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -163.62 175.48 10.59 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.597 1.159 . . . . 0.35 110.111 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 tt -144.55 92.41 2.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.071 -1.455 . . . . 0.35 107.071 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -78.7 129.26 34.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.08 1.352 . . . . 0.35 109.595 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.68 91.19 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.295 0 C-N-CA 124.813 1.245 . . . . 0.35 108.658 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -152.53 161.98 41.84 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.255 1.022 . . . . 0.36 109.9 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.5 m -121.4 155.3 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.784 1.234 . . . . 0.35 111.329 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.8 m -87.96 77.83 8.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.156 -1.424 . . . . 0.35 107.156 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.1 126.84 26.63 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 109.039 -1.625 . . . . 0.35 109.039 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.46 168.75 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 124.534 1.134 . . . . 0.35 110.172 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.08 -177.55 2.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.767 0.827 . . . . 0.35 109.326 164.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 t -83.09 42.71 0.82 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.939 0.496 . . . . 0.35 110.415 172.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.2 -59.07 0.49 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.833 2.053 . . . . 0.35 107.86 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.33 -9.43 0.81 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.21 0.91 . . . . 0.35 113.058 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -71.01 124.23 23.89 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.526 1.163 . . . . 0.36 110.143 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.38 125.19 25.67 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.559 0.743 . . . . 0.35 111.766 -171.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.7 mt -92.81 -45.53 7.96 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.859 1.664 . . . . 0.35 109.487 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.87 151.5 44.35 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.822 0.849 . . . . 0.35 111.753 175.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.5 t -89.48 149.56 42.77 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 126.078 1.751 . . . . 0.33 111.077 -169.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.17 47.16 1.98 Allowed 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.414 2.743 . . . . 0.35 111.848 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -174.52 116.78 0.2 Allowed 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.155 0.982 . . . . 0.35 110.09 173.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -170.93 -11.24 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.19 1.396 . . . . 0.35 113.127 173.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.03 143.47 26.61 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 C-N-CA 124.671 1.188 . . . . 0.35 109.278 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -152.79 142.59 22.04 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.327 1.051 . . . . 0.35 109.946 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.65 145.82 32.42 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 124.236 1.015 . . . . 0.33 110.156 -168.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.9 118.67 5.69 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.739 2.293 . . . . 0.35 108.385 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 tt -60.93 140.86 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.413 0.685 . . . . 0.35 112.654 -164.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -127.58 103.61 22.04 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 106.356 -1.72 . . . . 0.33 106.356 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.22 159.54 29.82 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.993 2.462 . . . . 0.35 111.002 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.99 66.37 1.58 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.291 -1.524 . . . . 0.35 109.291 -175.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.8 t -152.28 145.87 24.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.492 1.117 . . . . 0.35 109.705 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 87.9 m -70.2 115.46 9.42 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.346 1.058 . . . . 0.35 110.499 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -119.52 102.77 8.88 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.885 1.674 . . . . 0.35 108.217 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t -148.72 167.79 24.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.153 0.981 . . . . 0.35 109.092 173.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -56.13 -49.27 74.39 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.072 0.949 . . . . 0.35 111.102 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -73.04 -9.78 59.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.139 0.792 . . . . 0.35 113.139 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.15 37.46 3.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.259 1.424 . . . . 0.35 109.667 172.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mm -141.44 -40.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.243 0 C-N-CA 125.698 1.599 . . . . 0.35 109.472 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -52.19 -37.51 55.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.644 1.178 . . . . 0.35 113.128 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.06 -32.89 26.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.588 1.155 . . . . 0.35 111.835 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -71.09 -41.12 71.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.594 1.158 . . . . 0.35 111.84 -170.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.03 -35.59 75.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 C-N-CA 123.481 0.713 . . . . 0.35 111.482 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.89 -35.38 79.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.098 0.559 . . . . 0.35 110.944 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.77 -34.24 69.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.245 0.618 . . . . 0.35 111.496 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.97 -46.77 70.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.661 0.385 . . . . 0.35 111.153 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -73.04 -26.02 61.14 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 118.845 -0.598 . . . . 0.35 112.462 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.4 -41.33 76.11 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 123.84 0.856 . . . . 0.35 110.939 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -48.65 -51.17 29.62 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.042 1.337 . . . . 0.35 112.346 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.6 p -72.48 -49.64 31.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.205 0.602 . . . . 0.35 111.257 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.02 146.47 17.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.594 0.758 . . . . 0.35 110.197 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -149.11 45.66 0.99 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.751 0.82 . . . . 0.35 111.201 -171.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -132.64 -59.57 0.9 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.755 0.822 . . . . 0.35 110.684 -173.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -93.39 70.77 4.35 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.715 0.806 . . . . 0.35 110.948 -164.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.98 161.05 40.54 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.016 0.926 . . . . 0.35 112.999 -175.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.93 77.98 0.45 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.803 -1.925 . . . . 0.35 105.803 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.27 100.47 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.059 0.944 . . . . 0.35 109.803 -167.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.33 -61.72 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.88 1.272 . . . . 0.35 110.583 -175.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -156.25 117.29 3.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.186 0.594 . . . . 0.35 110.192 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -78.21 144.98 35.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.906 0.882 . . . . 0.35 109.782 168.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.52 131.61 67.8 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.181 -0.674 . . . . 0.33 109.181 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.73 -24.02 22.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.474 2.783 . . . . 0.35 111.566 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.9 m -85.21 60.05 6.01 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 124.396 1.078 . . . . 0.35 110.442 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.56 162.44 29.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.189 0.996 . . . . 0.35 109.459 169.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -153.74 147.68 25.51 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.46 0.541 . . . . 0.35 112.46 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 mp -90.44 135.47 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.388 -1.708 . . . . 0.35 106.388 165.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.2 66.67 1.53 Allowed 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.303 -0.999 . . . . 0.35 108.303 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.77 125.22 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.061 0.944 . . . . 0.35 110.751 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 m -123.89 109.72 13.94 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.346 1.058 . . . . 0.35 109.429 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.52 110.58 22.91 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 125.128 1.371 . . . . 0.35 108.878 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.44 52.97 2.58 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.612 1.565 . . . . 0.35 110.14 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.65 84.44 5.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.072 0.949 . . . . 0.35 110.186 -172.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -61.19 -11.94 11.05 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.667 1.187 . . . . 0.35 113.376 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -55.62 -50.78 69.25 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.153 0.981 . . . . 0.36 111.145 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.52 -42.14 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.98 0.733 . . . . 0.35 112.98 176.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -65.84 -40.76 92.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.319 0.509 . . . . 0.35 112.101 -172.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? 77.7 160.32 0.21 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.482 1.913 . . . . 0.35 111.181 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -50.7 121.33 5.7 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.821 1.248 . . . . 0.35 110.109 171.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -154.19 107.08 2.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.092 0.957 . . . . 0.35 108.446 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.2 m -78.98 89.82 4.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.969 0.908 . . . . 0.35 108.555 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -77.35 97.27 4.85 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.107 0.963 . . . . 0.35 108.6 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.2 p -88.72 139.91 29.98 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.308 1.043 . . . . 0.35 110.358 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.96 140.28 8.7 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 123.891 0.877 . . . . 0.33 109.63 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.46 140.71 33.69 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.221 2.614 . . . . 0.35 109.788 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tt -72.42 148.92 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.05 0.54 . . . . 0.35 110.099 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.7 p -73.1 160.26 32.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.307 0.643 . . . . 0.35 110.739 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -88.3 -21.68 24.29 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.377 1.071 . . . . 0.35 111.026 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -86.85 -79.61 0.26 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.278 1.031 . . . . 0.35 110.932 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -177.42 74.4 0.07 OUTLIER Glycine 0 CA--C 1.528 0.844 0 CA-C-N 118.215 0.461 . . . . 0.35 112.448 -170.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -77.47 154.51 32.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.866 -0.79 . . . . 0.35 108.866 165.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.0 t -131.88 140.73 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.367 1.067 . . . . 0.35 108.719 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.9 t -67.94 122.02 82.12 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 108.502 -0.925 . . . . 0.33 108.502 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.27 158.16 41.28 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.069 2.513 . . . . 0.35 111.052 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.74 80.35 2.69 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.627 1.171 . . . . 0.35 109.296 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -84.96 99.93 11.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.998 1.319 . . . . 0.35 109.071 -169.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.9 t -167.57 79.14 0.18 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.253 1.021 . . . . 0.35 108.998 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.39 -99.23 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.651 0.78 . . . . 0.35 110.035 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -70.23 -16.65 63.08 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.512 1.051 . . . . 0.35 112.304 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.6 pt -142.21 160.45 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 125.701 1.6 . . . . 0.35 109.22 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 29.56 0.37 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.89 0.7 . . . . 0.35 112.89 -175.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.35 46.51 0.69 Allowed Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.403 0.519 . . . . 0.36 112.403 172.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.39 135.13 41.47 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.094 2.53 . . . . 0.35 111.339 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -116.05 74.14 0.26 Allowed Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.959 -1.256 . . . . 0.35 109.959 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -60.74 95.99 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.625 1.57 . . . . 0.35 111.109 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -91.24 99.16 12.2 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.784 0.834 . . . . 0.36 109.694 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.2 80.35 9.09 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 108.366 -0.976 . . . . 0.35 108.366 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 94.5 mt -94.82 121.11 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.442 -1.318 . . . . 0.35 107.442 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.8 m -141.17 136.77 32.15 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.431 1.092 . . . . 0.35 109.005 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.21 131.78 34.09 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.387 1.075 . . . . 0.35 108.593 -178.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.05 141.06 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.48 0.712 . . . . 0.35 110.422 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 51.0 t -93.81 140.52 16.36 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 124.477 1.111 . . . . 0.35 108.843 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.5 mt -139.64 154.5 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.825 1.65 . . . . 0.35 107.742 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -143.07 23.78 1.85 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.67 0.989 . . . . 0.35 113.67 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.61 134.58 0.05 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.936 1.294 . . . . 0.35 111.474 169.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? . . . . . 0 C--N 1.342 0.251 0 C-N-CA 124.703 1.201 . . . . 0.25 110.637 177.878 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 110.061 -0.348 . . . . 0.35 110.061 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -83.9 68.38 9.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.415 1.086 . . . . 0.35 108.894 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -134.73 -24.48 1.51 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.879 1.672 . . . . 0.35 110.736 -172.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.05 26.78 30.34 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.537 1.065 . . . . 0.35 112.166 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 49.92 51.37 16.71 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.699 1.6 . . . . 0.35 111.566 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -103.85 94.33 5.37 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.966 0.906 . . . . 0.35 110.603 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.32 36.94 0.71 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.526 1.13 . . . . 0.35 111.075 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? 54.04 -95.3 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.206 1.802 . . . . 0.35 110.903 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.14 56.42 0.26 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.549 -1.82 . . . . 0.35 108.549 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -130.17 67.11 1.48 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.981 1.312 . . . . 0.35 108.888 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -167.71 113.95 0.72 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.174 0.989 . . . . 0.35 109.645 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.75 -65.96 0.97 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.029 0.932 . . . . 0.35 110.339 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.3 t 69.63 -73.4 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.923 2.089 . . . . 0.35 111.654 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -140.03 75.67 1.52 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.766 -1.198 . . . . 0.35 107.766 162.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -145.73 33.03 1.04 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.041 0.937 . . . . 0.35 110.054 173.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 66.62 168.71 0.11 Allowed Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.534 1.934 . . . . 0.33 112.101 171.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -69.12 99.95 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.121 2.548 . . . . 0.35 111.361 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.3 p -110.34 -40.93 4.51 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.589 1.556 . . . . 0.35 109.602 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.87 155.03 9.73 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.538 -1.025 . . . . 0.33 110.538 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.13 161.16 29.57 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.072 3.181 . . . . 0.35 111.024 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -156.58 164.62 37.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.611 0.764 . . . . 0.35 111.135 -170.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.5 tt -149.13 132.03 16.13 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.146 1.378 . . . . 0.35 108.012 -177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.2 mtp -125.31 133.11 52.74 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.889 1.275 . . . . 0.35 109.453 -171.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.54 95.29 2.89 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 C-N-CA 124.075 0.95 . . . . 0.35 110.409 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -149.31 178.35 8.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.568 0.747 . . . . 0.36 111.278 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.08 146.35 26.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 124.802 1.241 . . . . 0.35 110.948 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.1 m -84.06 86.31 7.22 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.918 -1.141 . . . . 0.35 107.918 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.64 119.7 6.63 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.527 -1.029 . . . . 0.35 110.527 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.81 170.43 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.496 1.118 . . . . 0.35 110.962 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -84.45 177.62 8.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.357 1.063 . . . . 0.35 109.639 166.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -58.67 -38.29 77.87 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.805 0.842 . . . . 0.35 110.649 171.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -57.38 -49.06 77.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.666 1.186 . . . . 0.35 110.719 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.96 5.98 7.91 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.142 1.353 . . . . 0.35 111.869 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.11 123.2 24.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.081 0.941 . . . . 0.36 109.19 -176.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.96 107.15 3.0 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.383 0.673 . . . . 0.35 111.414 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.93 -42.26 70.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.536 1.134 . . . . 0.35 109.781 170.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -152.06 150.06 29.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.998 0.919 . . . . 0.35 111.184 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.7 m -84.52 159.54 58.33 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 124.955 1.302 . . . . 0.33 110.463 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -84.75 53.99 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.52 2.813 . . . . 0.35 111.079 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -158.75 111.56 2.29 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.587 0.755 . . . . 0.35 110.991 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -160.81 -54.88 0.05 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.206 0.603 . . . . 0.35 111.461 152.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.47 147.17 5.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.48 0.582 . . . . 0.35 110.822 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.26 174.61 7.59 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.323 1.849 . . . . 0.35 110.156 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -161.98 131.81 3.35 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.756 0.822 . . . . 0.33 109.286 -176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -73.63 124.03 9.0 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.658 2.239 . . . . 0.35 108.722 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.5 tp -48.19 132.52 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.115 1.366 . . . . 0.35 112.391 -174.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -140.66 104.05 6.39 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 124.927 1.291 . . . . 0.33 108.009 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -81.11 -171.37 1.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.573 2.849 . . . . 0.35 110.467 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.26 -37.49 3.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.342 -0.703 . . . . 0.35 111.342 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.3 t -62.68 146.77 51.41 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.099 0.959 . . . . 0.35 111.007 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.8 m -73.6 149.83 41.82 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.628 0.771 . . . . 0.35 109.271 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.6 108.67 12.85 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.808 1.243 . . . . 0.35 107.794 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.0 t -154.94 162.06 41.21 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.72 1.208 . . . . 0.35 109.677 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -48.51 -54.7 13.33 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.694 1.198 . . . . 0.35 111.276 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -61.7 -32.27 72.46 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.837 0.681 . . . . 0.35 112.837 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -62.9 -56.85 13.62 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.438 0.563 . . . . 0.35 109.906 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.1 mm -53.95 -43.96 59.8 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.761 1.224 . . . . 0.35 111.761 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -51.24 -63.11 1.24 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.642 0.777 . . . . 0.35 111.674 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -67.66 -33.65 75.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.195 0.452 . . . . 0.35 112.053 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -62.55 -50.0 73.08 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.713 0.805 . . . . 0.35 111.637 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.54 -37.29 78.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 118.931 -0.557 . . . . 0.35 111.417 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.31 -45.94 92.34 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.911 0.884 . . . . 0.35 111.295 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -41.33 99.38 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.314 0.646 . . . . 0.35 110.941 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.95 91.85 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.841 0.857 . . . . 0.35 111.597 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.3 -12.3 60.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.103 1.149 . . . . 0.35 114.103 -177.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -73.01 3.09 5.78 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.347 0.976 . . . . 0.35 113.513 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.79 15.12 6.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.153 0.888 . . . . 0.35 111.947 169.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.0 t -161.47 -45.62 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.774 1.23 . . . . 0.35 110.552 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.95 79.78 1.36 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.61 1.564 . . . . 0.35 109.952 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -132.88 -43.41 0.89 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.737 1.615 . . . . 0.35 109.422 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -60.11 -57.32 13.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.468 1.507 . . . . 0.35 110.379 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.32 72.93 0.86 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.666 1.186 . . . . 0.35 108.633 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -157.62 76.97 0.83 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.019 0.528 . . . . 0.35 110.161 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -84.66 -53.15 5.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.929 1.292 . . . . 0.35 109.949 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 t 71.03 114.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.093 1.757 . . . . 0.35 111.226 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.73 -49.3 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.384 0.674 . . . . 0.35 110.556 174.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.68 172.94 12.29 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.693 1.197 . . . . 0.35 110.86 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.62 163.23 38.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.358 1.463 . . . . 0.35 110.34 172.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.08 122.69 87.96 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.364 0.666 . . . . 0.33 109.718 -176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.0 -32.49 11.01 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.956 2.437 . . . . 0.35 110.451 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.3 m -80.88 74.75 7.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.434 1.094 . . . . 0.35 109.339 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.71 162.78 17.87 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.307 1.043 . . . . 0.35 110.53 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 142.54 23.94 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.344 0.657 . . . . 0.35 111.118 -173.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -127.3 113.38 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.86 1.664 . . . . 0.35 107.623 -174.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -94.62 75.03 3.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.858 0.863 . . . . 0.35 109.151 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.94 108.21 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.768 -1.197 . . . . 0.35 107.768 168.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.2 m -86.88 67.75 9.9 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.463 1.105 . . . . 0.35 108.35 -170.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -60.64 99.79 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.846 1.258 . . . . 0.35 111.772 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -130.7 134.79 47.21 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.604 1.961 . . . . 0.35 109.86 -166.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -160.32 121.27 3.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.15 0.98 . . . . 0.35 109.067 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -89.9 65.71 6.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.966 0.907 . . . . 0.35 110.341 -172.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -142.8 -47.47 0.32 Allowed 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.078 1.351 . . . . 0.36 109.134 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.16 -31.46 0.54 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.39 1.076 . . . . 0.35 112.046 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -80.99 -42.8 20.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.852 0.686 . . . . 0.35 112.852 -161.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? 70.01 173.25 0.3 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.543 1.537 . . . . 0.35 110.118 -169.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -77.28 93.87 4.07 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.719 -0.474 . . . . 0.35 109.719 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -96.64 158.26 15.51 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.616 1.167 . . . . 0.35 108.16 170.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.9 m -136.62 110.41 8.14 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.526 0.731 . . . . 0.35 109.686 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -95.57 100.58 12.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.582 1.153 . . . . 0.35 108.332 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.7 p -86.92 65.29 8.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.198 0.999 . . . . 0.35 110.051 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -65.92 136.64 95.72 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.217 1.007 . . . . 0.33 109.388 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.23 -113.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.46 2.773 . . . . 0.35 109.701 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.4 tp -160.46 153.69 4.45 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 CA-C-N 119.032 0.833 . . . . 0.35 109.694 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.6 p -130.74 128.36 40.64 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.366 1.067 . . . . 0.35 108.955 173.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -64.94 -25.68 67.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.212 1.005 . . . . 0.35 111.47 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.16 -65.18 0.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.26 1.424 . . . . 0.35 111.486 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 125.24 143.8 6.14 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 124.139 0.876 . . . . 0.35 111.391 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.1 131.69 7.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.366 1.066 . . . . 0.35 109.068 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.76 141.61 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.54 0.736 . . . . 0.35 109.387 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 83.2 t -61.99 117.35 28.38 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 108.341 -0.985 . . . . 0.33 108.341 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.83 -21.59 24.62 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.425 2.75 . . . . 0.35 112.32 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.0 t70 68.77 77.21 0.23 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.721 1.608 . . . . 0.35 111.008 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 35.64 70.58 0.14 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.203 2.201 . . . . 0.35 114.713 166.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.7 t 25.65 -103.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.951 2.5 . . . . 0.35 113.716 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.88 -33.72 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.684 1.194 . . . . 0.35 111.491 172.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -83.2 43.91 0.91 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.46 1.504 . . . . 0.35 111.526 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.6 tt -167.82 155.28 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.958 1.703 . . . . 0.35 108.136 -172.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -146.17 -13.41 0.47 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.2 0.815 . . . . 0.35 113.2 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.26 78.39 8.65 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 119.661 1.119 . . . . 0.36 112.447 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.49 -84.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.548 2.832 . . . . 0.35 111.433 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.17 74.7 0.67 Allowed Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.285 -1.126 . . . . 0.35 110.285 -168.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -68.91 95.02 0.67 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.937 1.295 . . . . 0.35 109.3 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -99.04 95.34 7.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.973 0.509 . . . . 0.36 109.829 -173.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.32 98.46 3.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.844 -1.169 . . . . 0.35 107.844 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.4 mt -125.54 109.76 22.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 124.983 1.313 . . . . 0.35 107.588 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.2 m -133.98 125.48 28.28 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.281 1.032 . . . . 0.35 108.807 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -67.31 128.12 35.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.583 0.753 . . . . 0.35 110.141 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.28 138.31 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.305 1.042 . . . . 0.35 108.6 169.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -90.68 94.69 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.158 -1.423 . . . . 0.35 107.158 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 44.9 mt -71.43 131.46 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.259 0.624 . . . . 0.35 109.83 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -106.36 133.92 50.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.344 -1.725 . . . . 0.35 106.344 163.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -84.38 118.38 24.2 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.175 0.59 . . . . 0.35 109.465 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? . . . . . 0 N--CA 1.455 -0.203 0 C-N-CA 123.285 0.634 . . . . 0.25 109.784 178.545 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 p90 . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 113.822 1.045 . . . . 0.35 113.822 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -66.67 168.89 8.63 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.332 0.653 . . . . 0.35 110.2 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mptt 78.36 -38.25 0.23 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.163 2.185 . . . . 0.35 111.71 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.7 53.55 11.81 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 110.959 -0.856 . . . . 0.35 110.959 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 56.31 59.24 3.76 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.125 1.37 . . . . 0.35 111.442 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -117.18 119.12 34.24 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.952 1.301 . . . . 0.35 108.391 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.13 40.67 3.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.002 1.321 . . . . 0.35 109.768 -171.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 59.2 -93.05 0.04 OUTLIER 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.175 1.39 . . . . 0.35 109.817 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.06 48.03 0.4 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.562 -1.415 . . . . 0.35 109.562 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 26.38 55.73 0.05 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 128.84 2.856 . . . . 0.35 114.136 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 44.35 71.0 0.28 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.513 1.525 . . . . 0.35 111.38 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.34 71.64 0.56 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.985 1.314 . . . . 0.35 110.55 -172.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.3 t -66.62 112.26 4.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.845 1.258 . . . . 0.35 109.01 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 62.38 -174.23 0.15 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.65 1.18 . . . . 0.35 112.087 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 76.8 t80 65.02 88.39 0.11 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.346 1.859 . . . . 0.35 111.697 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 67.58 167.33 0.12 Allowed Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.198 1.799 . . . . 0.33 113.018 166.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.67 105.65 0.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.227 2.618 . . . . 0.35 111.134 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.0 p -141.95 -54.02 0.44 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.996 0.919 . . . . 0.35 111.403 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.44 122.22 1.03 Allowed Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.98 -0.9 . . . . 0.33 112.261 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.99 170.62 2.02 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.542 3.495 . . . . 0.35 114.041 170.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -161.34 165.17 29.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.286 1.034 . . . . 0.35 110.844 171.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -160.55 93.0 0.99 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.327 1.451 . . . . 0.35 107.235 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.5 mtm -87.54 105.23 17.17 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.477 0.711 . . . . 0.35 111.151 -170.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -101.51 96.6 4.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 124.792 1.237 . . . . 0.35 110.578 -174.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -163.64 171.59 15.49 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.502 1.121 . . . . 0.36 110.809 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.1 m -100.7 -177.52 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.145 1.378 . . . . 0.35 111.45 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.2 m -130.8 104.07 6.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.863 1.665 . . . . 0.35 106.686 167.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.31 121.52 6.5 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.626 -0.59 . . . . 0.35 111.626 -173.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.28 166.26 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.863 0.865 . . . . 0.35 110.657 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -72.79 174.64 7.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.958 1.303 . . . . 0.35 110.576 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -79.32 31.38 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.236 1.014 . . . . 0.35 112.181 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -138.04 -55.96 0.66 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.104 1.762 . . . . 0.35 107.669 170.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.89 65.61 0.02 OUTLIER Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.697 -1.361 . . . . 0.35 109.697 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -139.09 122.63 17.33 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.445 1.098 . . . . 0.36 108.493 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.58 106.03 0.51 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.218 1.007 . . . . 0.35 111.49 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.74 -57.23 3.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.166 0.986 . . . . 0.35 108.706 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.4 mt -124.51 167.69 14.11 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.785 1.234 . . . . 0.35 110.13 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -146.02 73.48 13.41 Favored Pre-proline 0 N--CA 1.455 -0.199 0 N-CA-C 106.817 -1.549 . . . . 0.33 106.817 167.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -87.25 58.75 3.5 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.844 3.029 . . . . 0.35 110.208 -168.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -107.58 54.58 0.66 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.779 1.232 . . . . 0.35 109.443 -172.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -114.45 15.46 17.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.2 1.4 . . . . 0.35 113.478 -169.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.51 165.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 CA-C-N 118.849 0.749 . . . . 0.35 110.275 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.42 177.54 10.19 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.269 1.027 . . . . 0.35 110.843 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -134.57 141.34 38.5 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.574 1.55 . . . . 0.33 108.027 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -84.81 26.24 0.66 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.14 2.56 . . . . 0.35 113.86 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 69.97 136.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.765 2.026 . . . . 0.35 111.717 -176.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.05 128.52 5.01 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.647 -0.872 . . . . 0.33 108.647 157.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.15 165.51 21.4 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.209 2.606 . . . . 0.35 110.49 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.64 63.57 1.75 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.681 -0.968 . . . . 0.35 110.681 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -153.05 138.78 17.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.733 1.213 . . . . 0.35 108.738 173.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 m -73.47 87.45 1.58 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.374 1.069 . . . . 0.35 109.748 -173.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 106.13 9.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.06 1.344 . . . . 0.35 109.012 -174.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -140.09 177.65 7.83 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 125.742 1.617 . . . . 0.35 109.411 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -41.2 88.54 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.933 -0.395 . . . . 0.35 109.933 170.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.43 -45.83 78.54 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.428 0.691 . . . . 0.35 111.936 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -86.26 31.04 0.66 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.779 0.718 . . . . 0.35 112.293 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 mm -133.34 -44.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 125.396 1.478 . . . . 0.35 108.61 172.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -53.44 -50.98 64.09 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.196 0.998 . . . . 0.35 112.052 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -70.81 -34.31 71.6 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.598 0.636 . . . . 0.35 111.615 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -64.5 -51.82 61.03 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.999 0.92 . . . . 0.35 111.069 -172.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.8 m -63.5 -32.14 55.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 124.098 0.959 . . . . 0.35 111.937 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -65.43 -38.19 89.15 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.97 0.508 . . . . 0.35 111.059 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -70.82 -31.18 67.83 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.068 0.547 . . . . 0.35 111.363 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.58 -49.08 67.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.653 0.781 . . . . 0.35 111.047 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.18 -13.3 60.44 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.772 0.829 . . . . 0.35 113.145 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -74.62 89.24 2.21 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.442 0.697 . . . . 0.35 109.992 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.56 -52.44 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.533 1.533 . . . . 0.35 108.846 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 66.1 p -98.19 -52.46 3.67 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.315 1.046 . . . . 0.35 110.517 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.59 95.41 5.13 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.178 1.391 . . . . 0.35 108.487 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -147.38 4.71 0.8 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.953 0.901 . . . . 0.35 112.806 -173.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -148.39 -46.27 0.15 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.981 0.912 . . . . 0.35 109.651 -169.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -54.4 -48.53 71.48 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.385 1.474 . . . . 0.35 110.611 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.78 176.92 9.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.046 0.938 . . . . 0.35 112.094 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -155.78 105.16 2.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.519 -0.919 . . . . 0.35 108.519 168.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.62 131.5 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.153 0.981 . . . . 0.35 109.74 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.56 -60.65 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.318 -0.993 . . . . 0.35 108.318 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -133.34 154.29 50.85 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.136 1.374 . . . . 0.35 110.185 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.4 mt -99.68 124.94 45.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.175 -1.417 . . . . 0.35 107.175 165.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -73.64 127.66 88.24 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.299 -0.63 . . . . 0.33 109.299 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.78 -21.69 18.57 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.44 2.76 . . . . 0.35 111.672 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.8 m -85.21 66.44 9.73 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.052 0.941 . . . . 0.35 110.604 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.32 165.91 23.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.361 0.665 . . . . 0.35 109.446 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -136.81 117.9 14.38 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.06 0.544 . . . . 0.35 111.344 -170.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.0 mm -86.95 90.79 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.762 1.625 . . . . 0.35 108.017 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.37 72.88 8.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.633 -0.877 . . . . 0.35 108.633 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.66 94.57 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 CA-C-O 121.6 0.714 . . . . 0.35 110.052 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.5 m -79.74 108.91 13.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.982 -1.118 . . . . 0.35 107.982 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -78.41 70.37 4.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.808 -0.812 . . . . 0.35 108.808 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -71.06 124.21 23.88 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.107 0.479 . . . . 0.35 110.133 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -153.21 163.99 38.89 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.385 1.474 . . . . 0.35 107.839 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.65 61.83 1.08 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.36 -0.978 . . . . 0.35 108.36 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -149.64 -54.37 0.17 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.686 1.194 . . . . 0.36 109.78 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 -42.41 0.12 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.842 0.857 . . . . 0.35 112.281 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -73.5 -46.55 47.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.1 0.96 . . . . 0.35 110.955 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 81.7 tttt 71.0 163.48 0.26 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.076 1.35 . . . . 0.35 110.984 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -47.77 124.1 6.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.561 1.144 . . . . 0.35 110.408 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -149.46 86.43 1.47 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.922 -0.77 . . . . 0.35 108.922 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.4 m -69.41 94.34 0.72 Allowed 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.008 1.323 . . . . 0.35 109.581 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -89.01 95.16 10.21 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.108 -1.071 . . . . 0.35 108.108 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p -72.53 133.47 44.79 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.688 0.795 . . . . 0.35 110.34 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -151.02 139.05 12.58 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 125.058 1.343 . . . . 0.33 107.627 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.76 -139.34 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.766 2.977 . . . . 0.35 109.986 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.8 tp -158.75 156.41 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 119.272 0.942 . . . . 0.35 109.616 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -130.29 166.63 19.96 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.397 1.079 . . . . 0.35 110.335 176.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.6 -51.27 70.53 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.791 1.236 . . . . 0.35 111.328 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -80.17 -33.89 37.98 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.856 0.863 . . . . 0.35 110.992 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.85 -127.57 45.35 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.238 0.923 . . . . 0.35 112.38 170.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -165.46 149.11 8.19 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.019 0.928 . . . . 0.35 110.126 -173.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.1 t -78.45 132.3 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.565 -1.272 . . . . 0.35 107.565 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.4 t -52.95 113.28 4.39 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.0 0.92 . . . . 0.33 109.769 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -84.31 -174.2 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.516 2.811 . . . . 0.35 110.833 -171.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -63.81 143.45 57.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.564 0.746 . . . . 0.35 109.792 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.45 61.2 2.31 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.724 1.209 . . . . 0.35 109.169 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.0 t 55.97 -122.65 1.8 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.936 1.694 . . . . 0.35 111.207 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -159.25 -48.51 0.06 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.252 1.021 . . . . 0.35 109.687 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -75.01 7.89 2.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.981 1.312 . . . . 0.35 113.596 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.6 tt -142.35 141.3 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.305 1.442 . . . . 0.35 108.821 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.37 29.11 2.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.287 1.035 . . . . 0.35 111.427 174.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.89 60.6 3.72 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.997 0.919 . . . . 0.36 112.38 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -71.76 -166.87 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.56 2.173 . . . . 0.35 112.655 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.81 78.38 0.21 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 108.718 -1.753 . . . . 0.35 108.718 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -72.7 76.6 1.11 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.546 1.538 . . . . 0.35 109.658 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -86.17 102.49 13.95 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.004 0.522 . . . . 0.36 110.14 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.48 81.62 7.53 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.909 1.284 . . . . 0.35 108.494 174.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.8 mt -94.91 76.19 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 107.203 -1.406 . . . . 0.35 107.203 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.6 m -75.37 172.64 12.12 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.984 1.313 . . . . 0.35 109.542 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.28 138.78 31.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.769 1.228 . . . . 0.35 108.389 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.95 150.72 26.78 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 C-N-CA 123.936 0.894 . . . . 0.35 110.987 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.42 132.85 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.842 1.257 . . . . 0.35 108.811 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 68.2 mt -134.58 150.5 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.438 1.495 . . . . 0.35 109.551 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -120.62 113.3 20.05 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.141 1.376 . . . . 0.35 107.731 162.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.19 166.03 17.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.03 0.932 . . . . 0.35 111.861 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt . . . . . 0 C--N 1.34 0.164 0 C-N-CA 124.611 1.165 . . . . 0.25 109.288 179.454 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 t80 . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 110.144 -0.317 . . . . 0.35 110.144 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -158.97 174.06 15.54 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.357 1.063 . . . . 0.35 110.41 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.64 25.24 7.89 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 128.282 2.633 . . . . 0.35 116.128 168.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.42 -164.42 37.64 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 118.617 0.644 . . . . 0.35 111.569 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -93.6 56.65 2.42 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.55 0.74 . . . . 0.35 109.232 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -85.29 89.4 7.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.589 1.156 . . . . 0.35 109.497 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -77.27 46.14 0.49 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.349 1.459 . . . . 0.35 113.21 -172.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.41 -75.05 0.08 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.923 2.489 . . . . 0.35 111.969 175.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.6 -38.44 0.09 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.79 -1.324 . . . . 0.35 109.79 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -49.99 117.83 2.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.528 1.531 . . . . 0.35 110.0 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -170.32 133.38 1.08 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.166 0.986 . . . . 0.35 109.392 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.5 148.64 7.95 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.4 1.08 . . . . 0.35 109.958 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.4 t -161.34 115.86 2.03 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.062 0.945 . . . . 0.35 109.073 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 61.19 172.66 0.11 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.354 1.862 . . . . 0.35 113.426 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 60.07 89.18 0.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.421 1.888 . . . . 0.35 112.186 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 71.23 154.38 0.15 Allowed Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 126.211 1.804 . . . . 0.33 112.738 165.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.11 97.92 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.388 2.725 . . . . 0.35 110.009 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -104.05 -58.76 1.83 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.628 1.171 . . . . 0.35 110.987 -173.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.97 110.75 0.43 Allowed Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.896 -0.947 . . . . 0.33 111.767 -171.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -80.3 169.42 17.35 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.472 2.781 . . . . 0.35 111.294 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -162.41 170.04 19.45 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 113.281 0.845 . . . . 0.35 113.281 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.07 94.88 3.01 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.825 2.05 . . . . 0.35 107.955 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 31.7 ttp -87.5 104.37 16.41 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.027 0.531 . . . . 0.35 110.545 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.72 97.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 125.16 1.384 . . . . 0.35 108.832 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.35 170.3 21.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.366 1.066 . . . . 0.36 109.158 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.44 139.45 32.3 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 C-N-CA 124.004 0.922 . . . . 0.35 110.555 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.1 m -73.2 101.02 3.24 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.188 0.995 . . . . 0.35 108.723 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.92 82.44 1.63 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 123.933 0.778 . . . . 0.35 111.757 -170.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 m -85.18 157.69 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 C-N-CA 123.512 0.725 . . . . 0.35 110.566 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.47 -69.56 0.45 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.464 -0.569 . . . . 0.35 109.464 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.4 m -156.07 -56.21 0.09 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.104 1.362 . . . . 0.35 109.299 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -91.56 42.05 1.09 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.759 1.223 . . . . 0.35 110.819 -175.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.03 35.62 87.87 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.032 0.825 . . . . 0.35 112.491 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -102.6 96.36 6.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.448 1.099 . . . . 0.36 108.563 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.49 101.54 0.09 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.76 1.224 . . . . 0.35 111.169 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.32 -63.47 1.23 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.426 -0.953 . . . . 0.35 108.426 171.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -89.97 121.08 31.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.399 -0.963 . . . . 0.35 108.399 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.5 m -87.07 108.13 17.49 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.335 1.054 . . . . 0.33 108.399 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.96 -172.87 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.695 2.93 . . . . 0.35 112.717 -164.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.5 m170 72.13 54.63 0.18 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.077 1.751 . . . . 0.35 111.47 172.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -120.64 -2.4 9.91 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.725 1.21 . . . . 0.35 112.575 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.12 142.17 40.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 125.042 1.337 . . . . 0.35 108.284 170.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -141.14 -84.82 0.2 Allowed 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.312 -0.852 . . . . 0.35 110.463 -177.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.1 t80 74.81 140.0 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.561 1.544 . . . . 0.33 110.381 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.74 159.36 51.66 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.777 2.318 . . . . 0.35 112.668 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 tp -61.33 137.36 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.886 1.274 . . . . 0.35 112.007 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -138.57 102.76 7.84 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.414 1.486 . . . . 0.33 107.404 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.11 175.55 11.01 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.306 2.671 . . . . 0.35 110.709 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.26 -29.47 8.72 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.996 0.808 . . . . 0.35 112.248 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 t -67.43 142.0 56.82 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.704 0.752 . . . . 0.35 111.311 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.8 m -71.11 144.35 50.3 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.938 0.895 . . . . 0.35 108.876 172.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.03 75.27 1.59 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.755 0.822 . . . . 0.35 109.302 -166.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.1 p -104.99 173.57 6.25 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 125.57 1.548 . . . . 0.35 110.265 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -57.83 -50.99 71.42 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.431 1.092 . . . . 0.35 109.579 171.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.75 -28.3 67.51 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.58 0.956 . . . . 0.35 113.58 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -68.6 -53.27 23.75 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.056 0.844 . . . . 0.35 109.68 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.3 mm -55.3 -40.93 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.931 1.292 . . . . 0.35 111.39 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -47.51 -64.45 0.78 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.241 1.416 . . . . 0.35 111.908 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -69.56 -32.59 71.46 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.856 0.317 . . . . 0.35 111.856 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -65.25 -49.86 68.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.629 0.772 . . . . 0.35 111.543 -172.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 m -67.35 -34.31 68.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.011 0.524 . . . . 0.35 111.474 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.32 -48.24 80.74 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 122.862 0.465 . . . . 0.35 110.397 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -40.86 97.47 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.204 0.456 . . . . 0.35 110.967 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.03 -50.3 73.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.167 0.987 . . . . 0.35 111.129 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 pp -71.59 -29.43 64.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.076 0.55 . . . . 0.35 111.605 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -70.32 -1.13 9.57 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 113.302 0.853 . . . . 0.35 113.302 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.16 -43.47 61.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.719 0.691 . . . . 0.35 110.28 164.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.5 p -86.37 -47.93 8.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.053 0.941 . . . . 0.35 110.935 173.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.85 -105.84 0.03 OUTLIER 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.319 0.509 . . . . 0.35 112.135 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 71.4 144.68 0.06 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.907 1.683 . . . . 0.35 111.114 -171.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 70.17 -82.59 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.799 2.039 . . . . 0.35 110.853 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -72.8 171.7 12.17 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.44 0.696 . . . . 0.35 109.123 172.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 70.8 146.66 0.07 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.5 1.52 . . . . 0.35 110.108 -162.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -158.18 133.82 8.97 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.911 0.884 . . . . 0.35 109.162 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -85.22 128.64 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.037 0.935 . . . . 0.35 108.915 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.3 t -69.78 -65.06 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.41 -1.33 . . . . 0.35 107.41 167.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.57 139.14 5.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.795 0.838 . . . . 0.35 109.135 170.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.16 170.22 16.97 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.63 0.772 . . . . 0.35 109.777 170.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -67.81 129.47 93.28 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 108.927 -0.768 . . . . 0.33 108.927 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.53 -36.07 35.59 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.503 2.135 . . . . 0.35 109.697 172.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -89.78 69.46 7.62 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.798 1.239 . . . . 0.35 109.163 170.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.08 172.73 4.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.629 0.772 . . . . 0.35 109.99 168.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -152.17 151.46 31.04 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.359 0.503 . . . . 0.35 112.359 -167.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.26 101.15 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 126.205 1.802 . . . . 0.35 107.375 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -96.27 63.18 2.17 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.42 1.088 . . . . 0.35 110.203 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.67 122.22 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 122.763 0.425 . . . . 0.35 110.246 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.4 m -118.03 106.31 12.78 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.408 1.483 . . . . 0.35 107.413 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -124.32 119.0 28.03 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.698 1.199 . . . . 0.35 109.726 -167.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -132.38 55.66 1.87 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.979 1.311 . . . . 0.35 112.246 -158.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -74.34 137.47 42.85 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 122.067 -0.396 . . . . 0.35 110.996 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -93.92 70.3 3.99 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.821 -1.177 . . . . 0.35 107.821 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -143.3 -50.57 0.33 Allowed 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.44 1.096 . . . . 0.36 109.533 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.76 -40.65 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.163 0.585 . . . . 0.35 112.359 -170.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -53.53 4.61 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.069 0.547 . . . . 0.35 112.033 -168.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt 71.02 -177.82 0.21 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.846 1.258 . . . . 0.35 110.064 -167.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -69.25 127.66 33.85 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.465 0.706 . . . . 0.35 111.756 -170.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -142.65 104.29 4.35 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.619 1.168 . . . . 0.35 109.459 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.7 m -80.75 108.8 14.71 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.66 -0.867 . . . . 0.35 108.66 173.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -109.91 102.6 11.34 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.627 1.171 . . . . 0.35 108.46 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.8 p -90.62 64.64 5.78 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.976 1.311 . . . . 0.35 110.779 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -77.08 141.67 67.67 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.033 0.533 . . . . 0.33 109.67 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.84 170.96 18.11 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.581 2.854 . . . . 0.35 112.136 -171.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.4 tp -77.01 161.44 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.844 1.258 . . . . 0.35 109.86 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 73.4 p -132.01 129.0 39.54 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.091 0.957 . . . . 0.35 108.966 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.83 -29.29 70.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.489 0.716 . . . . 0.35 111.487 172.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.4 -50.02 75.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.172 0.989 . . . . 0.35 109.635 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.98 170.95 24.23 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 124.328 0.966 . . . . 0.35 112.562 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -158.35 136.03 10.39 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.112 0.965 . . . . 0.35 109.204 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.8 t -70.48 130.96 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.465 -1.309 . . . . 0.35 107.465 166.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.6 t -57.51 112.51 4.8 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 107.311 -1.366 . . . . 0.33 107.311 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.05 -95.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.597 2.198 . . . . 0.35 112.193 -158.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -158.38 150.22 21.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.009 0.924 . . . . 0.35 109.737 -173.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.85 56.7 0.7 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.528 1.531 . . . . 0.35 109.552 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.4 t 34.5 -103.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.754 2.422 . . . . 0.35 113.436 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -161.93 -51.7 0.04 OUTLIER 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.649 1.18 . . . . 0.35 109.396 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -61.78 -44.39 96.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.062 0.945 . . . . 0.35 111.264 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.9 tp -83.74 111.74 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.933 0.893 . . . . 0.35 109.494 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -134.94 43.85 2.67 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.446 1.098 . . . . 0.35 110.154 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -151.76 47.33 0.41 Allowed Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 114.0 1.111 . . . . 0.36 114.0 163.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -55.86 145.44 72.9 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.839 1.693 . . . . 0.35 113.31 168.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.47 76.72 0.38 Allowed Glycine 0 C--N 1.338 0.657 0 N-CA-C 108.641 -1.783 . . . . 0.35 108.641 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -69.59 96.74 0.96 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.675 1.19 . . . . 0.35 110.781 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -87.93 109.93 20.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.131 -1.063 . . . . 0.36 108.131 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -94.82 52.69 1.51 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.245 -1.02 . . . . 0.35 108.245 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -94.3 130.93 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.838 1.255 . . . . 0.35 108.783 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 81.6 m -149.05 140.6 23.41 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.163 1.385 . . . . 0.35 108.016 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 135.47 45.01 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.292 0.637 . . . . 0.35 109.348 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.4 m -133.37 136.0 55.4 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 123.341 0.656 . . . . 0.35 110.454 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.5 t -84.75 130.19 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.921 1.288 . . . . 0.35 107.779 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 55.4 mt -123.14 131.79 72.58 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 124.122 0.969 . . . . 0.35 110.588 -171.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -87.96 103.4 15.65 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.74 1.616 . . . . 0.35 107.273 165.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -70.61 140.88 51.76 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.083 0.553 . . . . 0.35 110.584 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt . . . . . 0 N--CA 1.456 -0.161 0 C-N-CA 125.474 1.51 . . . . 0.25 108.385 -175.109 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 107.236 -1.394 . . . . 0.35 107.236 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -51.54 -47.44 63.4 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 127.244 2.218 . . . . 0.35 112.661 -167.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -66.35 107.66 2.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.668 -1.234 . . . . 0.35 107.668 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.55 82.37 1.68 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.304 -1.119 . . . . 0.35 110.304 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt 56.61 60.34 3.14 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.108 1.363 . . . . 0.35 110.853 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -82.75 -64.16 1.23 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.616 1.167 . . . . 0.35 110.089 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.95 25.47 0.31 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.002 2.521 . . . . 0.35 114.772 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 57.27 -87.57 0.02 OUTLIER 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.847 1.659 . . . . 0.35 111.06 -170.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.53 -55.98 0.13 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 107.83 -2.108 . . . . 0.35 107.83 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 t0 57.54 38.13 27.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.669 1.588 . . . . 0.35 111.396 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 42.95 63.33 1.51 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.948 1.699 . . . . 0.35 111.438 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.82 -175.67 4.9 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.082 0.553 . . . . 0.35 112.282 -170.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 m 65.63 79.21 0.25 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.988 1.715 . . . . 0.35 110.195 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 54.64 65.56 1.47 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.521 1.528 . . . . 0.35 111.03 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -145.8 34.3 1.03 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.182 1.393 . . . . 0.35 109.716 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.52 162.99 0.12 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.005 1.722 . . . . 0.33 112.805 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -65.68 94.48 0.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.257 2.638 . . . . 0.35 110.224 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.3 p -138.98 -46.64 0.48 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.247 1.419 . . . . 0.35 110.088 -171.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.04 86.89 0.26 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.883 0.754 . . . . 0.33 111.931 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.65 153.75 10.45 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.341 3.361 . . . . 0.35 112.718 166.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -146.48 173.64 12.11 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.447 0.699 . . . . 0.35 110.992 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 tt -151.11 93.36 1.91 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.774 -1.195 . . . . 0.35 107.774 176.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.4 mtp -78.71 141.99 37.45 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.941 1.296 . . . . 0.35 109.996 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 37.0 t -136.18 94.99 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 124.861 1.265 . . . . 0.35 108.85 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -148.28 174.6 11.85 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.179 0.992 . . . . 0.36 110.391 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.01 -170.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 125.323 1.449 . . . . 0.35 109.231 174.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.6 m -121.24 103.5 9.03 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.603 -1.628 . . . . 0.35 106.603 162.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.78 85.11 1.45 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.986 -0.846 . . . . 0.35 110.986 -173.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.6 m -102.23 172.08 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.258 1.023 . . . . 0.35 111.321 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -63.99 -52.69 58.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.792 1.237 . . . . 0.35 110.709 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 m -178.88 -56.07 0.01 OUTLIER 'General case' 0 C--N 1.339 0.144 0 C-N-CA 128.189 2.596 . . . . 0.35 107.197 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.52 -61.37 1.8 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.752 1.221 . . . . 0.35 110.748 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.0 -19.82 0.04 OUTLIER Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.168 -0.795 . . . . 0.35 113.351 -170.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -64.33 111.07 2.47 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.155 0.978 . . . . 0.36 109.693 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -76.64 123.51 26.24 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.385 1.074 . . . . 0.35 111.142 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.88 -65.2 1.04 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.61 -0.885 . . . . 0.35 108.61 170.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.5 mt -98.65 136.02 39.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.464 1.106 . . . . 0.35 109.95 -168.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.9 m -85.04 102.42 2.32 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.657 1.583 . . . . 0.33 110.926 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.78 -165.4 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.25 2.633 . . . . 0.35 111.677 -169.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 75.0 57.57 0.07 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.651 1.58 . . . . 0.35 111.036 166.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -138.16 -5.13 1.66 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.053 1.131 . . . . 0.35 114.053 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -130.26 143.78 39.97 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 123.739 0.816 . . . . 0.35 109.582 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.23 177.07 11.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.541 0.736 . . . . 0.35 112.284 -173.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -137.34 154.13 75.22 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 126.497 1.919 . . . . 0.33 107.555 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -84.12 34.79 0.53 Allowed 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.235 2.623 . . . . 0.35 112.323 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.257 13.8 tt 54.21 149.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 129.603 3.161 . . . . 0.35 115.732 176.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -158.18 123.35 2.31 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.172 0.989 . . . . 0.33 109.321 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -80.12 179.18 6.41 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.32 2.68 . . . . 0.35 110.949 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.21 -33.72 4.95 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.774 0.702 . . . . 0.35 111.527 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 t -63.87 144.83 56.75 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.24 1.016 . . . . 0.35 110.948 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.9 m -73.72 145.1 45.43 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.909 -0.774 . . . . 0.35 108.909 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.6 104.51 7.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.171 -1.418 . . . . 0.35 107.171 177.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -143.53 157.58 44.32 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.402 1.081 . . . . 0.35 110.4 -173.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.31 -57.55 10.18 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.493 1.117 . . . . 0.35 111.57 -174.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -58.72 -29.11 66.44 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.01 0.744 . . . . 0.35 113.01 -175.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -72.1 -48.34 44.69 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.714 0.806 . . . . 0.35 110.684 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.8 mm -56.21 -39.09 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.66 1.184 . . . . 0.35 111.944 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -47.87 -57.98 4.97 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.425 1.09 . . . . 0.35 112.397 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -78.83 -29.7 44.87 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.061 0.544 . . . . 0.35 112.347 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -64.01 -45.95 86.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.187 0.595 . . . . 0.35 111.636 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.4 m -68.83 -31.81 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 122.916 0.487 . . . . 0.35 111.406 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.46 -36.94 85.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.616 0.767 . . . . 0.35 111.053 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -74.8 -36.09 62.48 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.801 0.841 . . . . 0.35 111.134 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.92 78.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.125 0.57 . . . . 0.35 111.026 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.02 -17.72 62.01 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.983 0.735 . . . . 0.35 112.983 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -58.0 -33.61 69.11 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.492 0.717 . . . . 0.35 112.095 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -41.57 -47.66 3.86 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 125.547 1.539 . . . . 0.35 112.573 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 65.1 p -97.21 -51.54 4.16 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.95 1.3 . . . . 0.35 110.797 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.21 82.17 2.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.221 1.408 . . . . 0.35 110.288 -171.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -109.96 -36.53 5.85 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.34 1.456 . . . . 0.35 110.965 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -87.9 -73.11 0.5 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.611 0.765 . . . . 0.35 110.643 -173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -96.09 62.08 2.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.24 0.616 . . . . 0.35 111.085 -165.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.42 153.02 32.72 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.817 0.447 . . . . 0.35 110.568 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -158.27 105.97 1.94 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.35 108.675 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -75.05 97.98 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.541 -0.911 . . . . 0.35 108.541 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.41 -42.64 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.302 0.641 . . . . 0.35 110.712 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -140.94 161.22 38.34 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.738 1.215 . . . . 0.35 109.634 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.58 163.38 32.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.773 1.229 . . . . 0.35 109.942 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -90.32 126.79 55.49 Favored Pre-proline 0 N--CA 1.455 -0.199 0 N-CA-C 108.078 -1.082 . . . . 0.33 108.078 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.68 -20.39 30.53 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.682 2.255 . . . . 0.35 110.915 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.7 m -84.64 70.71 10.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.707 1.203 . . . . 0.35 110.476 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.64 162.18 18.91 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.556 0.742 . . . . 0.35 109.746 165.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -151.86 107.58 3.35 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.979 0.419 . . . . 0.35 111.935 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.26 130.23 30.27 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 125.34 1.456 . . . . 0.35 107.481 168.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -131.13 80.96 1.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.119 -1.067 . . . . 0.35 108.119 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.56 98.25 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.833 0.853 . . . . 0.35 110.205 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 62.1 m -93.52 97.67 10.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.074 1.35 . . . . 0.35 107.931 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -103.63 93.46 4.94 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.989 0.916 . . . . 0.35 111.24 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -73.07 52.48 0.33 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.648 2.379 . . . . 0.35 111.336 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -82.06 102.1 10.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.289 1.035 . . . . 0.35 110.605 -171.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -87.78 71.7 9.53 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.164 0.986 . . . . 0.35 108.617 174.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -148.88 -58.51 0.22 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.056 1.343 . . . . 0.36 109.478 172.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.13 -38.39 0.16 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.242 0.83 . . . . 0.35 113.242 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -84.08 -45.7 12.75 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.893 0.477 . . . . 0.35 112.128 -164.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt 73.54 162.43 0.26 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.713 1.605 . . . . 0.35 112.264 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.76 109.93 1.58 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.548 1.139 . . . . 0.35 111.823 -175.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.5 102.71 5.02 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.003 -1.48 . . . . 0.35 107.003 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.2 m -79.43 93.16 5.32 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.644 0.777 . . . . 0.35 109.181 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -83.31 106.36 15.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.766 -0.827 . . . . 0.35 108.766 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.4 p -84.5 69.64 10.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.829 1.252 . . . . 0.35 111.192 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -64.99 137.19 97.07 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 108.595 -0.891 . . . . 0.33 108.595 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.09 -115.76 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.409 2.739 . . . . 0.35 110.579 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 tp -168.42 158.24 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.609 1.164 . . . . 0.35 108.828 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.4 p -136.41 137.69 40.74 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.835 0.854 . . . . 0.35 109.744 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -71.88 -22.6 61.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.987 0.915 . . . . 0.35 111.039 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -58.76 -50.18 74.91 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.792 0.837 . . . . 0.35 109.558 168.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.62 169.95 26.61 Favored Glycine 0 C--N 1.341 0.835 0 C-N-CA 124.056 0.836 . . . . 0.35 112.769 171.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -163.37 137.35 5.92 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.995 1.318 . . . . 0.35 109.124 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.5 138.29 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.75 0.82 . . . . 0.35 109.512 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.32 118.01 55.23 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 107.712 -1.218 . . . . 0.33 107.712 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.27 -66.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.616 2.211 . . . . 0.35 111.486 -170.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 t70 173.09 -66.4 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 126.506 1.922 . . . . 0.35 107.544 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 55.35 60.07 3.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.633 1.573 . . . . 0.35 110.201 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.0 m -138.17 45.64 2.09 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.589 1.156 . . . . 0.35 108.791 174.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -104.89 -62.67 1.31 Allowed 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.046 1.339 . . . . 0.35 109.974 -170.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -101.57 -55.65 2.47 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.934 1.293 . . . . 0.35 109.298 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.8 pt -93.95 158.03 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.724 0.81 . . . . 0.35 108.83 167.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -135.56 60.55 1.68 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.223 1.009 . . . . 0.35 108.303 173.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -170.34 58.75 0.3 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.847 1.259 . . . . 0.36 111.093 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -57.21 -51.54 8.44 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.738 2.292 . . . . 0.35 111.4 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.82 66.0 2.31 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.539 -0.625 . . . . 0.35 111.539 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -69.11 100.09 1.21 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.129 1.372 . . . . 0.35 111.081 -175.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -88.61 92.96 9.4 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.294 -0.632 . . . . 0.36 109.294 172.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.49 109.67 8.16 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 107.802 -1.184 . . . . 0.35 107.802 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.7 mt -127.38 133.74 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.913 1.285 . . . . 0.35 107.915 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.2 m -146.46 116.09 7.18 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.811 1.244 . . . . 0.35 107.775 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -69.09 132.62 46.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.859 -0.423 . . . . 0.35 109.859 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.34 153.86 36.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 123.799 0.84 . . . . 0.35 110.976 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.5 t -93.82 103.82 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.258 1.423 . . . . 0.35 108.058 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.8 mt -94.92 132.67 38.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.508 0.723 . . . . 0.35 109.225 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -113.82 98.19 6.87 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.042 1.337 . . . . 0.35 107.774 170.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -72.15 131.28 42.58 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.484 -0.562 . . . . 0.35 109.484 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt . . . . . 0 N--CA 1.456 -0.163 0 C-N-CA 124.336 1.054 . . . . 0.25 109.566 -176.225 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.331 0 CA-C-O 120.748 0.309 . . . . 0.35 110.908 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.4 148.92 44.77 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.835 0.854 . . . . 0.35 110.494 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? 78.14 156.35 0.16 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.896 2.078 . . . . 0.35 110.856 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.59 80.89 0.66 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 124.401 1.0 . . . . 0.35 110.706 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? 57.56 44.15 21.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.974 1.31 . . . . 0.35 110.744 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -93.41 87.32 5.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.637 0.775 . . . . 0.35 109.627 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -84.02 52.52 2.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.88 1.272 . . . . 0.35 111.096 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm 68.68 -72.41 0.1 Allowed 'General case' 0 C--N 1.342 0.277 0 C-N-CA 127.15 2.18 . . . . 0.35 111.993 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.24 -40.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.611 -0.996 . . . . 0.35 110.611 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -57.96 136.61 57.11 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.385 1.074 . . . . 0.35 110.623 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -157.97 59.91 0.47 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.873 -0.788 . . . . 0.35 108.873 174.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.11 78.71 6.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.649 1.18 . . . . 0.35 108.476 173.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.6 m -113.46 -42.12 3.53 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.949 1.3 . . . . 0.35 111.05 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.96 170.04 19.24 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.581 0.753 . . . . 0.35 111.712 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.7 t80 64.76 91.23 0.08 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 126.73 2.012 . . . . 0.35 111.241 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 70.84 150.56 0.13 Allowed Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.559 1.944 . . . . 0.33 111.676 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.42 80.58 2.23 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.443 2.762 . . . . 0.35 110.03 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.3 p -71.32 -48.27 51.5 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.992 0.917 . . . . 0.35 110.641 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.83 -179.01 44.58 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 117.994 0.361 . . . . 0.33 112.887 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -76.63 177.2 9.13 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.217 3.278 . . . . 0.35 112.715 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -160.05 -177.5 6.35 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.165 1.386 . . . . 0.35 109.524 157.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -153.81 99.32 2.27 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.23 -0.656 . . . . 0.35 109.23 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 77.6 mtm -84.44 111.82 19.81 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.552 1.141 . . . . 0.35 110.587 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.7 t -101.0 90.66 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 125.43 1.492 . . . . 0.35 108.064 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -146.21 178.01 8.56 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.371 0.668 . . . . 0.36 111.962 -173.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.77 142.53 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.222 1.409 . . . . 0.35 109.835 -172.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.6 m -93.34 81.6 4.44 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.204 -1.406 . . . . 0.35 107.204 168.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.74 113.86 3.78 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.915 -0.874 . . . . 0.35 110.915 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.41 164.42 15.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.849 1.259 . . . . 0.35 111.179 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -77.3 174.07 11.19 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.784 0.833 . . . . 0.35 110.703 172.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -55.81 -40.37 72.66 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.248 1.019 . . . . 0.35 110.41 167.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -59.13 -59.05 6.08 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.287 1.035 . . . . 0.35 109.94 171.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 140.17 -0.99 2.13 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.26 0.933 . . . . 0.35 112.924 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -72.63 128.06 34.42 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.478 1.139 . . . . 0.36 109.839 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -70.01 106.49 3.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.46 0.704 . . . . 0.35 110.89 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.8 mt -67.37 -47.16 71.2 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.591 1.156 . . . . 0.35 110.553 174.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -142.98 152.77 42.32 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.479 0.712 . . . . 0.35 111.316 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.0 m -108.0 152.23 41.63 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 125.389 1.476 . . . . 0.33 109.993 -175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.8 -173.02 1.58 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.656 2.904 . . . . 0.35 112.304 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.1 m170 74.19 66.76 0.09 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 127.055 2.142 . . . . 0.35 111.306 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -153.55 -2.55 0.21 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.863 0.865 . . . . 0.35 113.041 177.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.6 t -135.39 115.73 18.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 N-CA-C 106.426 -1.694 . . . . 0.35 106.426 170.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -143.82 148.8 36.05 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.317 1.047 . . . . 0.35 109.503 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -139.61 148.64 56.82 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 124.284 1.034 . . . . 0.33 109.889 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.64 135.89 34.53 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.648 2.232 . . . . 0.35 108.544 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.4 tt -66.61 144.35 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 122.927 0.491 . . . . 0.35 112.161 -168.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -137.97 87.31 16.71 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 125.401 1.48 . . . . 0.33 107.5 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.55 155.5 31.76 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.38 2.72 . . . . 0.35 110.878 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.41 -32.41 2.48 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.077 0.846 . . . . 0.35 111.698 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.3 t -70.39 155.22 40.98 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.983 0.913 . . . . 0.35 111.357 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.1 m -72.53 145.46 47.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.741 0.816 . . . . 0.35 109.069 172.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.42 76.74 1.69 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.416 1.086 . . . . 0.35 108.901 -172.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t -114.86 171.22 7.78 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.171 1.788 . . . . 0.35 109.88 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -56.61 -44.79 81.5 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.693 1.197 . . . . 0.35 111.63 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.79 -27.79 67.05 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.931 0.715 . . . . 0.35 112.931 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -73.82 -25.58 60.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.37 1.068 . . . . 0.35 112.065 174.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.8 mm -90.51 -51.4 11.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-N 118.564 0.62 . . . . 0.35 110.94 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.36 -41.01 75.45 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.691 0.626 . . . . 0.35 112.691 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.36 -30.37 57.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.032 0.533 . . . . 0.35 111.697 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -76.11 -42.18 47.89 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.411 1.084 . . . . 0.35 111.02 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.3 m -72.32 -23.76 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.001 0.52 . . . . 0.35 111.329 173.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -68.9 -34.39 75.32 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.242 0.474 . . . . 0.35 110.579 171.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -24.52 63.2 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.07 -0.491 . . . . 0.35 111.732 174.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.3 -38.6 75.03 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.513 0.597 . . . . 0.35 110.925 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.7 -45.42 92.86 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.38 0.672 . . . . 0.35 110.366 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -64.67 153.55 39.21 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.006 0.366 . . . . 0.35 110.279 172.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 82.51 -47.54 0.17 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.801 2.04 . . . . 0.35 110.94 -167.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.3 p -91.69 -99.28 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.095 0.958 . . . . 0.35 110.087 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.15 96.44 9.62 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.994 1.318 . . . . 0.35 111.228 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -153.89 6.73 0.33 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.537 1.135 . . . . 0.35 111.724 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -74.33 -60.56 2.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.265 1.026 . . . . 0.35 109.612 -173.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -104.5 -21.96 13.37 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.665 1.586 . . . . 0.35 110.542 171.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -70.28 133.79 47.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.279 1.432 . . . . 0.35 109.921 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -152.43 114.49 4.42 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.792 0.837 . . . . 0.35 110.078 -175.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -70.05 117.24 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.272 1.029 . . . . 0.35 109.861 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.6 -46.7 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.976 0.911 . . . . 0.35 110.698 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -136.94 163.18 31.31 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.651 1.181 . . . . 0.35 109.623 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -137.04 153.06 50.72 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.766 1.226 . . . . 0.35 110.135 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.59 126.36 71.37 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 108.437 -0.949 . . . . 0.33 108.437 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.25 -30.79 15.33 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.917 2.411 . . . . 0.35 111.028 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.6 t -87.13 72.7 9.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.553 1.141 . . . . 0.35 110.502 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.03 168.69 14.93 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.112 0.965 . . . . 0.35 110.335 168.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -139.13 152.85 47.79 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.696 0.798 . . . . 0.35 111.735 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.92 87.55 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 126.128 1.771 . . . . 0.35 106.923 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -86.15 93.74 9.1 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 108.86 -0.793 . . . . 0.35 108.86 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.2 m -73.56 85.02 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 108.09 -1.078 . . . . 0.35 108.09 171.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.7 m -87.72 78.71 8.39 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.659 1.183 . . . . 0.35 108.521 -174.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -88.3 165.28 15.11 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.935 0.894 . . . . 0.35 110.102 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -154.16 28.87 0.45 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.682 1.593 . . . . 0.35 109.647 -168.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.95 125.49 20.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.318 1.447 . . . . 0.35 112.02 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -85.49 63.02 7.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.206 -1.035 . . . . 0.35 108.206 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -144.17 -60.76 0.39 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.715 1.206 . . . . 0.36 109.933 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -152.68 -56.32 0.13 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.013 0.746 . . . . 0.35 113.013 -172.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -80.02 -41.93 24.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.114 0.87 . . . . 0.35 112.044 -171.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt 69.57 -148.77 0.11 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.918 1.287 . . . . 0.35 111.341 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -75.66 115.92 15.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.754 0.822 . . . . 0.35 111.442 -167.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.17 113.32 6.87 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.365 1.066 . . . . 0.35 109.206 173.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.8 m -79.47 81.93 5.66 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 107.4 -1.333 . . . . 0.35 107.4 169.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -86.74 86.25 7.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.279 1.032 . . . . 0.35 109.415 -169.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.5 p -77.08 84.03 3.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.023 1.329 . . . . 0.35 111.387 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -83.38 127.62 67.75 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 123.915 0.886 . . . . 0.33 108.95 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.89 163.55 28.48 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.198 2.598 . . . . 0.35 111.908 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 tp -78.84 163.83 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.714 1.206 . . . . 0.35 110.355 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.6 p -124.34 165.3 17.93 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.849 1.26 . . . . 0.35 110.358 176.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.37 -28.46 14.94 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.875 1.27 . . . . 0.35 110.715 171.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -70.0 -60.25 2.41 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.012 0.925 . . . . 0.35 109.848 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.14 98.65 2.28 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 123.993 0.806 . . . . 0.35 111.587 174.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -78.23 136.97 37.89 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.099 -0.704 . . . . 0.35 109.099 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.36 136.67 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.708 -0.849 . . . . 0.35 108.708 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.83 118.22 46.43 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.469 -0.937 . . . . 0.33 108.469 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -84.58 162.06 12.56 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.065 2.51 . . . . 0.35 111.184 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -83.67 168.05 16.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.898 0.879 . . . . 0.35 109.458 166.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -158.44 130.98 7.03 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.22 0.608 . . . . 0.35 111.02 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.1 t -163.21 69.84 0.23 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.436 1.095 . . . . 0.35 108.581 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -158.22 -63.89 0.09 Allowed 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.851 0.86 . . . . 0.35 108.996 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -89.39 -47.29 8.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.353 1.061 . . . . 0.35 111.382 -175.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.7 pt -136.65 169.1 20.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 C-N-CA 123.879 0.872 . . . . 0.35 111.633 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -144.03 38.79 1.32 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.995 1.718 . . . . 0.35 108.162 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -169.77 58.52 0.32 Allowed Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.906 0.882 . . . . 0.36 110.502 -172.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -63.69 -57.1 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.512 2.808 . . . . 0.35 111.993 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.38 72.91 0.86 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.457 -1.057 . . . . 0.35 110.457 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -68.99 97.79 0.89 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.311 1.444 . . . . 0.35 110.46 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -87.41 96.2 10.29 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.595 -0.52 . . . . 0.36 109.595 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -88.27 62.96 6.95 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.278 -1.008 . . . . 0.35 108.278 170.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -94.72 104.36 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.501 -2.037 . . . . 0.35 105.501 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 68.5 p -97.94 -162.89 0.99 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.288 1.035 . . . . 0.35 109.244 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.53 121.77 4.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.232 -1.395 . . . . 0.35 107.232 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.36 157.02 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.224 0.61 . . . . 0.35 110.223 175.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.81 143.85 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.942 1.297 . . . . 0.35 108.364 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.6 mp -130.82 145.06 36.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 C-N-CA 124.767 1.227 . . . . 0.35 110.383 -175.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.84 157.17 34.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.161 1.385 . . . . 0.35 108.255 160.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -90.2 126.02 35.67 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.29 -0.633 . . . . 0.35 109.29 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 C--N 1.34 0.192 0 C-N-CA 123.834 0.854 . . . . 0.25 110.635 -175.895 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 109.751 -0.463 . . . . 0.35 109.751 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -77.46 70.04 3.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.505 1.122 . . . . 0.35 110.067 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -175.81 173.5 2.32 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.373 1.869 . . . . 0.35 109.454 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.77 -155.4 8.65 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.859 0.742 . . . . 0.35 111.775 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -71.17 109.74 5.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.811 0.844 . . . . 0.35 109.059 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -138.94 80.51 1.79 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.056 0.943 . . . . 0.35 109.004 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -89.47 35.1 0.81 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.633 1.173 . . . . 0.35 112.013 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.6 -82.77 0.03 OUTLIER 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.849 1.66 . . . . 0.35 110.43 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.17 2.94 0.03 OUTLIER Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.389 1.471 . . . . 0.35 112.752 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 p30 50.02 26.93 2.24 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 127.351 2.261 . . . . 0.35 115.799 174.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 49.35 38.17 13.29 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.807 1.643 . . . . 0.35 112.572 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.74 -44.41 0.01 OUTLIER 'General case' 0 C--N 1.339 0.11 0 C-N-CA 125.044 1.337 . . . . 0.35 109.511 -171.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.7 t 68.64 45.72 1.04 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.294 1.838 . . . . 0.35 110.51 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.2 t80 49.21 61.74 2.98 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.287 1.435 . . . . 0.35 110.325 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -160.49 92.89 0.99 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.237 0.615 . . . . 0.35 109.899 -170.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 66.5 166.21 0.12 Allowed Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 126.117 1.767 . . . . 0.33 113.595 165.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.85 96.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.365 3.377 . . . . 0.35 111.811 169.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.8 p -144.38 -38.49 0.29 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.917 1.287 . . . . 0.35 110.496 -174.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.82 143.88 6.82 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 110.921 -0.872 . . . . 0.33 110.921 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -86.44 168.32 8.68 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.052 3.168 . . . . 0.35 112.087 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -165.08 160.03 18.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.163 0.985 . . . . 0.35 111.215 -172.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.9 tt -158.27 113.2 2.61 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.09 1.356 . . . . 0.35 108.748 -170.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -96.73 152.12 18.98 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.55 1.14 . . . . 0.35 110.774 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.01 89.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.301 0 C-N-CA 124.654 1.182 . . . . 0.35 108.709 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -144.66 -162.93 1.59 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.711 0.805 . . . . 0.36 110.3 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.5 m -137.91 148.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 124.675 1.19 . . . . 0.35 110.024 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.4 m -85.54 93.38 8.78 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.088 -1.449 . . . . 0.35 107.088 169.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.89 89.32 1.43 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.819 0.723 . . . . 0.35 111.758 -169.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.4 m -101.74 170.61 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.749 1.22 . . . . 0.35 112.627 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.06 179.09 7.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.961 1.304 . . . . 0.35 109.438 165.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.3 t -58.36 -40.41 82.17 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.03 0.932 . . . . 0.35 110.786 172.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.53 -54.98 40.34 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.265 1.026 . . . . 0.35 110.423 175.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.84 26.79 0.56 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.726 1.155 . . . . 0.35 111.905 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -100.11 115.54 30.02 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.187 0.995 . . . . 0.36 109.21 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.84 114.23 4.36 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.463 0.705 . . . . 0.35 110.552 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mp -77.75 -51.01 11.23 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.987 -0.746 . . . . 0.35 108.987 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.0 mt -91.99 -149.45 0.24 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.997 1.319 . . . . 0.35 110.189 -167.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.4 m -154.87 123.54 3.02 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.474 1.11 . . . . 0.33 109.126 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.16 -171.29 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.257 2.638 . . . . 0.35 110.311 171.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.2 m170 64.14 75.63 0.37 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.696 1.199 . . . . 0.35 111.171 174.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -145.44 -61.44 0.34 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.328 0.651 . . . . 0.35 110.646 174.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.59 124.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 107.926 -1.139 . . . . 0.35 107.926 166.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -149.9 151.32 33.24 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.67 1.188 . . . . 0.35 109.541 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -140.17 146.15 44.86 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.812 1.245 . . . . 0.33 109.333 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.71 128.76 17.51 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.329 2.019 . . . . 0.35 107.713 166.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.4 tt -59.82 142.62 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.418 0.525 . . . . 0.35 112.418 -167.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -128.72 97.9 26.21 Favored Pre-proline 0 N--CA 1.453 -0.287 0 N-CA-C 107.31 -1.367 . . . . 0.33 107.31 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.29 157.47 49.88 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.454 2.103 . . . . 0.35 109.811 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.02 58.32 1.8 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.146 -1.182 . . . . 0.35 110.146 -174.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.3 t -152.56 147.26 25.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.979 1.311 . . . . 0.35 108.981 174.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.1 m -61.2 138.77 58.22 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.236 0.614 . . . . 0.35 110.379 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.89 80.95 1.71 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.446 1.098 . . . . 0.35 108.722 -173.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.3 p -133.39 178.66 6.74 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.869 1.268 . . . . 0.35 109.288 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -54.75 -54.37 42.86 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.109 0.564 . . . . 0.35 111.208 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.54 -42.93 67.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.383 1.073 . . . . 0.35 112.603 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.8 -60.24 4.11 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.231 0.612 . . . . 0.35 110.609 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.2 mm -57.54 -42.23 80.65 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 C-N-CA 124.61 1.164 . . . . 0.35 111.603 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -49.77 -59.24 4.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.75 1.22 . . . . 0.35 111.999 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -73.65 -29.61 62.43 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.497 0.555 . . . . 0.35 112.497 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -69.87 -40.03 75.99 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.518 0.727 . . . . 0.35 111.898 -170.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.34 -30.79 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.017 0.527 . . . . 0.35 111.512 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.3 -33.67 74.76 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.223 0.609 . . . . 0.35 111.019 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -31.56 67.52 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.332 0.653 . . . . 0.35 111.337 176.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 -55.4 22.23 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.228 0.611 . . . . 0.35 110.994 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 pp -64.12 -27.33 69.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.171 0.988 . . . . 0.35 112.811 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.62 -43.56 63.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.281 0.632 . . . . 0.35 110.32 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.51 50.47 1.89 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.64 1.176 . . . . 0.35 111.401 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.0 t -168.07 -42.69 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.358 1.463 . . . . 0.35 109.945 173.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.94 88.58 0.83 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.74 0.816 . . . . 0.35 110.023 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -107.71 46.81 0.92 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.278 1.031 . . . . 0.35 108.717 167.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -84.89 -57.64 3.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.771 1.228 . . . . 0.35 109.038 -175.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.74 -139.25 0.33 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.601 1.561 . . . . 0.35 108.42 176.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 82.56 109.82 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.284 1.433 . . . . 0.35 111.436 162.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -41.86 9.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.907 1.283 . . . . 0.35 111.209 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.1 t 69.11 92.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 126.219 1.808 . . . . 0.35 109.463 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.6 t -67.95 -63.72 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.419 0.688 . . . . 0.35 109.767 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -160.33 117.82 2.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.15 0.58 . . . . 0.35 109.742 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.04 145.95 44.11 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.195 0.598 . . . . 0.35 110.019 172.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.99 123.07 85.16 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.518 -0.919 . . . . 0.33 108.518 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.31 -32.96 19.33 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.232 2.621 . . . . 0.35 111.045 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.3 m -79.67 76.25 6.32 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.976 0.911 . . . . 0.35 109.184 173.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.01 154.23 23.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.242 1.017 . . . . 0.35 110.07 172.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -133.93 134.42 42.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.109 0.964 . . . . 0.35 109.952 -171.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.4 mp -122.5 111.76 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 125.669 1.587 . . . . 0.35 107.964 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -99.04 63.39 1.33 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.117 0.967 . . . . 0.35 108.648 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.01 99.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.358 0.599 . . . . 0.35 109.896 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.6 m -80.39 150.46 29.82 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.532 1.133 . . . . 0.35 108.94 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -139.1 66.42 1.42 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.322 1.049 . . . . 0.35 108.726 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -91.55 121.59 33.37 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 127.396 2.278 . . . . 0.35 109.863 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.3 p-10 -131.29 -165.06 1.51 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.687 0.795 . . . . 0.35 110.56 169.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -144.51 63.8 1.31 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.826 -1.176 . . . . 0.35 107.826 169.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -134.04 -53.35 0.85 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 125.468 1.507 . . . . 0.36 109.21 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -155.88 -41.3 0.08 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.063 0.945 . . . . 0.35 111.679 -172.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.6 tppt? -83.67 -59.54 2.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.88 0.872 . . . . 0.35 111.467 -166.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? 68.03 177.84 0.25 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.933 1.693 . . . . 0.35 111.401 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -63.47 110.91 2.11 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 112.514 0.561 . . . . 0.35 112.514 -165.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -132.93 137.25 46.55 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.229 1.811 . . . . 0.35 106.66 170.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.5 m -116.01 102.12 9.36 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.894 0.878 . . . . 0.35 109.35 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -79.59 101.32 8.24 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.678 -0.86 . . . . 0.35 108.678 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.4 m -90.16 67.52 6.92 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.211 1.005 . . . . 0.35 110.07 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -71.01 134.34 85.56 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.103 0.961 . . . . 0.33 109.398 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.15 -113.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.474 2.783 . . . . 0.35 109.622 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.1 tp -163.05 158.43 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.245 0 CA-C-N 119.156 0.889 . . . . 0.35 110.087 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.8 p -133.69 151.82 51.73 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.798 1.239 . . . . 0.35 109.183 169.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.13 -35.16 66.8 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.957 1.303 . . . . 0.35 112.965 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -141.58 74.26 1.45 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.961 1.304 . . . . 0.35 107.883 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.69 -92.03 0.41 Allowed Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.141 0.877 . . . . 0.35 112.184 -175.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -162.03 171.01 18.26 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.304 0.573 . . . . 0.35 112.076 -163.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 99.3 t -90.21 145.35 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.204 1.802 . . . . 0.35 107.73 169.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.5 t -52.92 115.14 6.83 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 123.846 0.859 . . . . 0.33 109.371 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -82.6 -178.67 4.08 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.275 2.65 . . . . 0.35 110.931 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -72.38 -178.45 2.54 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.873 0.869 . . . . 0.35 109.922 170.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.31 61.11 1.53 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.912 0.885 . . . . 0.35 110.388 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t 56.84 -103.0 0.17 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.97 1.708 . . . . 0.35 112.129 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -163.49 -58.12 0.04 OUTLIER 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.557 1.143 . . . . 0.35 108.623 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -57.92 -47.55 82.53 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.257 1.423 . . . . 0.35 112.124 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.3 tp -81.39 133.54 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.692 0.797 . . . . 0.35 110.684 -176.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.39 29.61 0.49 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.272 1.029 . . . . 0.35 111.643 166.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.49 60.56 10.23 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.227 1.411 . . . . 0.36 108.988 167.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.92 -73.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.743 2.962 . . . . 0.35 113.074 -168.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.71 78.36 1.4 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.927 -1.669 . . . . 0.35 108.927 -164.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -80.03 95.99 6.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.904 -1.147 . . . . 0.35 107.904 171.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -83.16 101.27 11.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.748 -0.834 . . . . 0.36 108.748 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.07 49.98 1.71 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.148 -1.056 . . . . 0.35 108.148 166.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.85 109.79 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.205 -1.776 . . . . 0.35 106.205 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 67.1 p -94.09 -133.69 0.17 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.226 1.011 . . . . 0.35 109.109 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -162.33 133.69 5.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.601 1.16 . . . . 0.35 108.065 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 m -142.34 143.45 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.718 0.807 . . . . 0.35 110.031 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.38 134.03 28.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.838 -1.171 . . . . 0.35 107.838 173.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.7 mt -123.5 143.58 36.12 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 C-N-CA 124.47 1.108 . . . . 0.35 110.652 -169.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -128.69 102.77 6.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.686 1.595 . . . . 0.35 106.76 166.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -60.85 128.26 35.64 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.2 0.6 . . . . 0.35 109.392 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.184 0 C-N-CA 123.79 0.836 . . . . 0.25 109.383 -164.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 111.833 0.309 . . . . 0.35 111.833 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.8 t70 60.79 171.07 0.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.155 1.382 . . . . 0.35 110.994 -167.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.3 pttt 47.57 -106.16 0.15 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.373 1.469 . . . . 0.35 112.396 171.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.1 -136.49 2.03 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.546 -1.022 . . . . 0.35 110.546 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -85.7 71.46 10.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.941 -1.133 . . . . 0.35 107.941 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -67.15 -56.88 8.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.065 0.946 . . . . 0.35 113.061 -162.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 76.84 110.58 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.921 2.088 . . . . 0.35 108.297 -170.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -55.41 -61.54 2.27 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.365 1.066 . . . . 0.35 111.817 -167.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.58 80.28 0.1 OUTLIER Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.516 -1.434 . . . . 0.35 109.516 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -127.82 41.18 3.55 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.251 1.021 . . . . 0.35 109.914 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.7 t0 50.71 55.25 9.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.185 1.394 . . . . 0.35 109.552 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -129.58 -168.62 1.97 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.77 1.228 . . . . 0.35 111.454 -155.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.5 m 63.65 69.64 0.55 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.952 1.701 . . . . 0.35 111.025 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 60.65 -145.43 0.47 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.242 1.417 . . . . 0.35 110.169 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 77.0 t80 57.8 73.87 0.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.468 1.507 . . . . 0.35 111.867 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 65.43 168.09 0.11 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.992 1.717 . . . . 0.33 113.28 168.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.32 113.53 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.981 2.454 . . . . 0.35 110.557 168.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 p -142.36 -73.32 0.31 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.558 0.743 . . . . 0.35 111.564 -170.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.43 112.97 0.53 Allowed Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.892 -0.949 . . . . 0.33 111.088 -170.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.97 175.61 10.61 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.816 3.011 . . . . 0.35 112.758 -171.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -155.28 166.98 31.88 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.835 0.68 . . . . 0.35 112.835 -172.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.2 tp -139.0 80.94 1.81 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.469 1.908 . . . . 0.35 107.743 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.1 mtm -74.45 100.89 3.96 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 122.674 0.39 . . . . 0.35 111.196 -172.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 t -84.57 76.72 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.521 -1.289 . . . . 0.35 107.521 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -149.02 148.18 29.42 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.618 1.167 . . . . 0.36 109.708 -171.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.6 m -140.37 144.36 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.266 1.026 . . . . 0.35 111.249 -170.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.1 m -70.2 105.49 2.97 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.731 1.212 . . . . 0.35 109.34 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.49 81.04 1.48 Allowed Glycine 0 C--N 1.34 0.776 0 C-N-CA 124.204 0.907 . . . . 0.35 111.711 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.9 m -87.16 170.27 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.154 0.982 . . . . 0.35 111.909 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -77.1 -44.56 30.06 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.928 0.891 . . . . 0.35 110.571 173.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.8 t 169.72 -59.8 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.097 2.559 . . . . 0.35 107.077 -171.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.9 43.66 1.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.115 1.366 . . . . 0.35 111.915 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.04 32.39 63.32 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.784 -1.009 . . . . 0.35 114.297 167.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -103.43 90.77 3.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.483 1.141 . . . . 0.36 108.132 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.89 109.5 1.47 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.848 0.859 . . . . 0.35 110.077 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mp -77.52 -53.8 7.18 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.38 0.672 . . . . 0.35 109.845 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.9 mt -86.07 -169.43 2.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.406 1.082 . . . . 0.35 110.247 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.3 m -126.48 68.51 67.79 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.553 0.741 . . . . 0.33 111.051 -174.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.99 164.29 35.32 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.909 3.073 . . . . 0.35 112.893 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.1 m170 79.1 80.67 0.06 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 127.222 2.209 . . . . 0.35 108.357 -172.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -147.31 -48.64 0.18 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.352 0.661 . . . . 0.35 111.957 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -83.86 77.51 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 108.568 -0.901 . . . . 0.35 108.568 169.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -72.2 -38.06 69.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.897 -0.573 . . . . 0.35 111.924 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 64.67 154.26 0.12 Allowed Pre-proline 0 C--N 1.345 0.399 0 C-N-CA 126.634 1.974 . . . . 0.33 113.454 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.87 134.57 8.44 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.085 2.523 . . . . 0.35 108.378 165.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.5 tt -70.51 148.57 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.505 0.322 . . . . 0.35 111.196 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -135.08 107.39 10.4 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 107.287 -1.375 . . . . 0.33 107.287 172.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.63 161.69 27.71 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.12 2.547 . . . . 0.35 110.563 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.32 61.61 1.98 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.711 -1.356 . . . . 0.35 109.711 -173.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 t -151.9 142.98 23.18 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.55 1.14 . . . . 0.35 109.431 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.5 m -62.79 121.03 12.44 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.699 0.799 . . . . 0.35 110.034 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.85 78.63 1.64 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.893 1.277 . . . . 0.35 108.621 -173.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.3 p -116.02 172.1 7.37 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.746 1.618 . . . . 0.35 109.59 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.87 -49.78 75.52 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.69 1.196 . . . . 0.35 110.531 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -65.06 -28.94 69.81 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.61 0.764 . . . . 0.35 112.926 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -74.36 4.02 6.51 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.471 -0.775 . . . . 0.35 112.844 172.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.2 mm -100.36 -49.51 11.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 CA-C-N 119.324 0.965 . . . . 0.35 109.039 168.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -43.75 -64.78 0.59 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.691 1.597 . . . . 0.35 113.607 -167.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -82.11 -28.65 32.14 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.779 0.832 . . . . 0.35 111.795 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -60.18 -49.41 77.75 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.626 1.17 . . . . 0.35 111.691 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.0 m -66.9 -38.19 80.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 C-N-CA 123.371 0.668 . . . . 0.35 110.983 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.89 -39.22 84.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.779 0.832 . . . . 0.35 111.127 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -72.46 -40.8 66.73 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.0 0.92 . . . . 0.35 111.466 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.74 95.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.358 0.663 . . . . 0.35 111.218 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -85.95 -22.38 27.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.963 0.905 . . . . 0.35 113.025 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.7 -41.77 91.51 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.512 0.725 . . . . 0.35 110.573 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.85 64.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.0 0.92 . . . . 0.35 112.091 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.7 p -83.58 -62.03 1.68 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.857 0.863 . . . . 0.35 112.276 -173.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.01 -67.85 0.39 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-N 118.495 0.588 . . . . 0.35 110.076 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 71.48 149.42 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.966 1.707 . . . . 0.35 113.202 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? 68.59 -90.18 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.101 1.76 . . . . 0.35 112.775 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -84.5 72.35 10.64 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 123.901 0.88 . . . . 0.35 111.078 -169.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -167.74 147.96 5.12 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.256 1.422 . . . . 0.35 108.248 173.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.3 tpt85 -114.1 -60.04 1.94 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.591 0.757 . . . . 0.35 111.473 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.3 t 71.76 82.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 125.304 1.442 . . . . 0.35 107.963 -160.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.5 t -69.38 -57.33 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.623 1.169 . . . . 0.35 109.99 -172.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -131.11 169.52 15.78 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.627 1.171 . . . . 0.35 110.842 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -153.68 156.4 37.78 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.712 1.605 . . . . 0.35 109.013 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -87.33 138.27 32.25 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.276 -0.639 . . . . 0.33 109.276 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.06 -17.92 24.43 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.436 2.758 . . . . 0.35 111.856 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.4 m -59.01 -31.87 69.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.436 1.095 . . . . 0.35 112.291 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 15.69 74.38 0.01 OUTLIER 'General case' 0 C--N 1.348 0.511 0 C-N-CA 128.813 2.845 . . . . 0.35 113.728 172.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -78.9 128.77 33.75 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.122 0.969 . . . . 0.35 113.092 -161.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.8 124.03 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 125.988 1.715 . . . . 0.35 107.354 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -122.57 90.26 3.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.377 1.071 . . . . 0.35 108.601 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 m -78.8 92.19 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.786 1.234 . . . . 0.35 110.548 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.1 m -85.5 94.37 9.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.616 1.167 . . . . 0.35 108.645 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.74 84.1 4.94 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.509 0.724 . . . . 0.35 110.38 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -76.11 91.74 3.16 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.878 1.671 . . . . 0.35 110.003 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -134.19 78.95 1.78 Allowed 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.896 -0.779 . . . . 0.35 108.896 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -75.67 83.31 2.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.724 1.21 . . . . 0.35 108.667 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -155.19 -37.86 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.857 1.663 . . . . 0.36 110.018 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -154.7 -41.35 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.93 1.292 . . . . 0.35 110.624 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -79.85 -63.2 1.47 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 123.246 0.618 . . . . 0.35 110.699 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.48 125.49 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.322 1.849 . . . . 0.35 109.84 -177.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -10.17 108.18 0.01 OUTLIER 'General case' 0 C--N 1.344 0.369 0 C-N-CA 129.516 3.126 . . . . 0.35 115.261 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -140.86 123.33 15.95 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.03 1.332 . . . . 0.35 107.989 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.7 m -102.32 103.9 14.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.748 1.219 . . . . 0.35 109.726 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.86 109.15 14.01 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.491 -0.929 . . . . 0.35 108.491 173.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.8 p -89.29 75.24 7.77 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.607 1.163 . . . . 0.35 111.151 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -81.21 142.57 51.2 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.679 1.192 . . . . 0.33 109.52 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -77.33 -129.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.79 2.993 . . . . 0.35 110.157 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.8 tp -167.43 159.92 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 119.663 1.12 . . . . 0.35 110.211 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.9 p -136.42 151.89 50.01 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.687 1.195 . . . . 0.35 109.84 170.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.5 -11.26 60.68 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.722 1.209 . . . . 0.35 114.062 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -142.05 59.15 1.47 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.973 -1.121 . . . . 0.35 107.973 172.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.38 -82.67 1.0 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.183 0.897 . . . . 0.35 111.558 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -163.54 159.83 22.41 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.193 0.521 . . . . 0.35 112.013 -163.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.4 t -91.08 144.85 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.005 1.722 . . . . 0.35 106.998 166.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 80.7 t -57.28 117.2 16.74 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 108.522 -0.918 . . . . 0.33 108.522 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.55 -109.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.009 2.473 . . . . 0.35 109.349 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -156.33 -137.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.591 -1.263 . . . . 0.35 107.591 173.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 mp -137.27 151.54 48.81 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.821 1.248 . . . . 0.35 109.595 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.3 t -77.11 -71.05 0.43 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.569 0.748 . . . . 0.35 109.74 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -168.02 -46.21 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.593 1.157 . . . . 0.35 109.799 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -39.4 -45.56 1.51 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.213 2.205 . . . . 0.35 115.151 -169.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.39 161.15 41.06 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 C-N-CA 123.444 0.698 . . . . 0.35 111.386 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -91.21 -68.18 0.81 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.209 1.404 . . . . 0.35 110.092 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.94 103.34 49.46 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.234 1.014 . . . . 0.36 112.407 -165.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.43 -177.68 3.72 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.926 2.417 . . . . 0.35 111.174 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -153.3 68.0 0.31 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.876 -1.289 . . . . 0.35 109.876 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -57.71 129.11 40.38 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.787 1.235 . . . . 0.35 109.376 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -131.89 116.0 16.62 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.523 -0.918 . . . . 0.36 108.523 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -88.5 60.13 5.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.257 1.023 . . . . 0.35 109.628 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.8 mt -78.66 130.9 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.408 1.083 . . . . 0.35 109.542 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.4 m -143.85 139.23 29.16 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.174 1.39 . . . . 0.35 108.354 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.76 93.52 9.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.187 0.995 . . . . 0.35 108.467 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.73 138.29 30.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 C-N-CA 124.198 0.999 . . . . 0.35 111.222 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.79 100.62 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.427 1.491 . . . . 0.35 108.751 -175.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 18.5 mt -90.98 145.84 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.089 0.956 . . . . 0.35 110.234 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -138.59 127.05 23.15 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.845 1.258 . . . . 0.35 109.208 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -66.71 125.71 26.7 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.316 1.046 . . . . 0.35 109.579 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? . . . . . 0 C--N 1.34 0.183 0 C-N-CA 123.128 0.571 . . . . 0.25 109.745 176.586 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.7 p90 . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 109.697 -0.483 . . . . 0.35 109.697 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -79.83 -171.74 3.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.402 0.681 . . . . 0.35 110.596 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 17.8 pttm 47.75 -134.34 1.15 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.464 1.506 . . . . 0.35 111.816 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.02 74.95 0.07 OUTLIER Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.339 0.972 . . . . 0.35 111.842 -175.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt 52.56 62.56 2.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.537 1.135 . . . . 0.35 110.344 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -135.86 133.43 37.77 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.317 1.047 . . . . 0.35 110.512 -170.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.33 45.2 0.64 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.962 1.305 . . . . 0.35 109.016 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt 64.17 -89.54 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.401 1.48 . . . . 0.35 108.929 -168.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.33 32.58 0.12 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.338 -1.105 . . . . 0.35 110.338 168.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 55.3 20.08 3.33 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.014 1.726 . . . . 0.35 113.016 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 47.78 40.47 12.44 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.518 1.527 . . . . 0.35 111.618 -173.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.05 85.35 0.15 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.373 0.669 . . . . 0.35 109.904 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -86.86 -112.54 0.05 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.794 0.838 . . . . 0.35 109.452 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -149.11 67.68 1.04 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.268 1.027 . . . . 0.35 110.355 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -154.28 91.56 1.43 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.324 1.05 . . . . 0.35 108.363 166.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 69.49 150.36 0.12 Allowed Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.875 1.67 . . . . 0.33 111.661 173.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.45 93.14 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.0 2.467 . . . . 0.35 111.187 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 p -74.41 -52.57 11.69 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.155 0.982 . . . . 0.35 109.162 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.4 163.42 29.31 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.147 -0.781 . . . . 0.33 111.147 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -80.85 -174.44 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.482 3.455 . . . . 0.35 112.092 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -163.15 -178.45 6.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.077 1.751 . . . . 0.35 108.807 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 tt -155.05 83.63 1.08 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.712 -1.218 . . . . 0.35 107.712 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.1 ttp -82.27 118.63 23.27 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.324 0.65 . . . . 0.35 110.56 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.0 t -107.78 101.11 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 126.019 1.728 . . . . 0.35 108.281 -174.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -156.82 -177.4 6.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.582 1.153 . . . . 0.36 110.71 -172.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.85 -164.63 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.268 1.427 . . . . 0.35 109.162 172.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 m -133.2 99.76 4.65 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.382 -1.34 . . . . 0.35 107.382 169.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.35 87.57 1.21 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.823 1.201 . . . . 0.35 111.857 -171.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -104.44 166.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 124.15 0.98 . . . . 0.35 111.943 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.32 176.46 9.3 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.638 1.575 . . . . 0.35 109.288 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 t -53.55 -41.52 66.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.708 0.803 . . . . 0.35 110.755 166.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -91.86 18.87 7.16 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.612 1.165 . . . . 0.35 112.459 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 -5.7 76.79 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.926 -0.93 . . . . 0.35 114.921 168.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -75.07 123.57 25.44 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.921 1.361 . . . . 0.36 110.09 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.14 102.24 0.48 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.162 0.985 . . . . 0.35 110.841 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.68 -72.32 0.3 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.845 0.858 . . . . 0.35 108.828 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 mt -93.63 156.37 16.75 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.23 -1.026 . . . . 0.35 108.23 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.1 t -119.43 71.33 13.02 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 124.021 0.928 . . . . 0.33 109.652 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.61 91.84 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 124.539 3.493 . . . . 0.35 109.893 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -156.73 55.15 0.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.713 1.205 . . . . 0.35 109.032 -172.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -154.92 15.22 0.42 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.732 1.012 . . . . 0.35 113.732 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.8 t -125.94 119.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 C-N-CA 123.842 0.857 . . . . 0.35 108.859 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.68 169.52 17.64 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.291 0.636 . . . . 0.35 111.9 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.94 157.93 53.48 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 125.907 1.683 . . . . 0.33 108.486 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.98 168.62 22.64 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.858 2.372 . . . . 0.35 110.413 171.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 tp -65.21 118.79 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.628 0.771 . . . . 0.35 110.419 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -144.64 83.63 9.57 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.622 1.169 . . . . 0.33 108.636 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -84.58 -168.53 0.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.014 3.143 . . . . 0.35 109.907 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.17 -15.7 61.41 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.665 0.65 . . . . 0.35 112.356 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.0 t -75.36 148.03 39.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.799 0.84 . . . . 0.35 110.491 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.7 m -66.77 148.51 51.83 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.056 0.942 . . . . 0.35 108.94 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.99 116.03 7.88 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.401 -0.592 . . . . 0.35 109.401 -172.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -164.05 171.29 15.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.281 1.832 . . . . 0.35 108.099 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -52.69 -41.37 63.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.138 0.975 . . . . 0.35 112.143 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -83.98 -2.54 56.77 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.661 0.784 . . . . 0.35 113.042 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.42 50.81 2.2 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.503 1.121 . . . . 0.35 110.196 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -159.68 -48.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.378 1.071 . . . . 0.35 109.234 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.16 -47.34 62.16 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.044 1.338 . . . . 0.35 112.996 -174.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -63.77 -41.27 98.0 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.996 0.362 . . . . 0.35 111.79 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -65.09 -44.97 87.13 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.037 0.935 . . . . 0.35 111.745 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 m -69.2 -29.38 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.417 0.687 . . . . 0.35 112.497 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -72.21 -36.88 69.29 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 122.813 0.445 . . . . 0.35 111.08 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.21 -28.19 65.08 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.055 0.542 . . . . 0.35 111.394 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.01 -60.05 3.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.42 0.688 . . . . 0.35 110.618 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.69 -23.81 67.37 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.661 0.615 . . . . 0.35 112.661 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.15 -22.62 64.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.516 0.726 . . . . 0.35 112.252 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.62 -54.07 42.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.944 0.898 . . . . 0.35 111.802 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.7 p -75.23 -70.14 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.441 0.696 . . . . 0.35 110.832 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.8 148.56 25.96 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.102 1.361 . . . . 0.35 109.841 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -167.08 44.01 0.05 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.543 0.737 . . . . 0.35 111.221 -173.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -139.26 -71.39 0.4 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.026 0.531 . . . . 0.35 111.206 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -62.99 -57.28 11.24 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.065 0.946 . . . . 0.35 112.215 -167.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -62.72 145.15 55.46 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.746 0.418 . . . . 0.35 111.802 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.36 -41.5 2.04 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.498 1.919 . . . . 0.35 109.059 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t 79.33 126.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.283 0 C-N-CA 126.569 1.948 . . . . 0.35 111.539 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.14 -60.57 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 124.98 1.312 . . . . 0.35 108.982 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -153.81 128.73 9.53 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.868 0.867 . . . . 0.35 109.93 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.4 mt -78.49 118.7 20.88 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.801 -1.555 . . . . 0.35 106.801 164.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.15 137.09 95.67 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.979 -0.378 . . . . 0.33 109.979 -172.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -66.22 -33.93 37.94 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.41 2.74 . . . . 0.35 111.088 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -83.87 75.27 10.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.537 1.135 . . . . 0.35 110.165 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.89 165.05 13.74 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.654 0.782 . . . . 0.35 109.884 167.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -153.48 121.27 6.01 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.177 0.513 . . . . 0.35 111.794 -167.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.61 122.32 44.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 126.673 1.989 . . . . 0.35 107.093 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -111.96 77.73 1.07 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.415 -1.328 . . . . 0.35 107.415 173.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -72.79 86.94 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.591 0.71 . . . . 0.35 109.555 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.4 m -94.36 92.52 7.21 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.395 1.478 . . . . 0.35 108.816 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -91.37 169.22 10.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.648 1.179 . . . . 0.35 109.757 172.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -149.66 63.01 1.0 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.604 1.162 . . . . 0.35 108.033 173.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.87 86.69 4.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.525 1.13 . . . . 0.35 108.803 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -78.98 71.92 5.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.047 1.339 . . . . 0.35 109.214 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -149.31 -57.5 0.2 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.34 1.456 . . . . 0.36 109.168 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.84 35.56 0.4 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.658 0.783 . . . . 0.35 111.57 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.6 -51.06 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.937 0.495 . . . . 0.35 110.47 -170.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt 69.26 -153.18 0.14 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.689 1.596 . . . . 0.35 110.229 -173.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -95.18 130.91 41.72 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.503 1.121 . . . . 0.35 110.857 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -141.74 121.17 13.21 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.466 1.106 . . . . 0.35 108.463 171.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.6 m -81.29 85.4 6.4 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.304 -1.369 . . . . 0.35 107.304 170.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -79.75 95.75 6.08 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.058 0.943 . . . . 0.35 109.266 -173.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.5 p -88.17 70.1 9.24 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.667 1.187 . . . . 0.35 111.642 -171.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -68.12 136.48 91.66 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.709 0.804 . . . . 0.33 108.985 171.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -79.73 -111.76 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.338 2.692 . . . . 0.35 110.275 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.5 tp -163.21 153.37 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.987 1.315 . . . . 0.35 108.478 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.8 p -129.69 156.17 44.7 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.759 0.823 . . . . 0.35 109.928 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.2 -26.08 52.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.311 1.444 . . . . 0.35 112.017 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.83 -44.0 94.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.436 1.095 . . . . 0.35 113.099 -165.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.71 64.97 0.62 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.031 -1.228 . . . . 0.35 110.031 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -73.95 126.08 29.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.617 -0.512 . . . . 0.35 109.617 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.9 t -76.27 130.56 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.263 -1.014 . . . . 0.35 108.263 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.23 120.89 77.8 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 107.712 -1.218 . . . . 0.33 107.712 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.35 -94.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.977 2.451 . . . . 0.35 109.312 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -169.81 -82.69 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.395 1.478 . . . . 0.35 107.275 166.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.7 mt -150.81 160.6 43.76 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.051 1.34 . . . . 0.35 110.444 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.3 t -100.6 -72.7 0.66 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.658 1.183 . . . . 0.35 108.992 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -166.77 -48.39 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.191 0.996 . . . . 0.35 110.066 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.17 -35.63 12.06 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.675 1.99 . . . . 0.35 115.385 -168.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.2 pt -132.23 171.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 124.163 0.985 . . . . 0.35 110.963 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.09 42.34 0.59 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.277 1.031 . . . . 0.35 111.064 172.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.01 54.47 0.56 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.785 1.234 . . . . 0.36 110.214 170.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -44.09 -55.27 3.23 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 125.027 3.818 . . . . 0.35 113.759 -173.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.39 67.95 1.83 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.162 -0.775 . . . . 0.35 111.162 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -67.21 139.17 57.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.143 0.977 . . . . 0.35 111.12 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -127.58 87.9 2.7 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.767 1.227 . . . . 0.36 108.292 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -75.25 98.76 3.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.939 -1.504 . . . . 0.35 106.939 174.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.53 96.67 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.679 1.192 . . . . 0.35 108.398 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.3 m -84.88 146.8 27.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.185 0.994 . . . . 0.35 109.783 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.14 122.82 29.36 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.776 -1.194 . . . . 0.35 107.776 173.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.71 137.2 57.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 123.211 0.604 . . . . 0.35 110.517 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.9 t -97.48 103.23 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.674 1.189 . . . . 0.35 108.361 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.3 mt -82.05 126.13 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.231 1.012 . . . . 0.35 109.977 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -100.44 140.63 34.42 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 107.84 -1.17 . . . . 0.35 107.84 155.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.75 138.22 45.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.518 1.127 . . . . 0.35 110.381 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 124.101 0.96 . . . . 0.25 109.013 178.358 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.9 t80 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 107.893 -1.151 . . . . 0.35 107.893 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.77 92.76 0.16 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.953 1.301 . . . . 0.35 111.967 -163.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -146.46 80.39 1.55 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.081 1.753 . . . . 0.35 107.146 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.14 98.79 1.5 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.996 0.808 . . . . 0.35 111.298 -175.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 54.65 63.48 2.13 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.204 1.402 . . . . 0.35 109.744 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -109.61 -69.55 0.86 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.513 1.525 . . . . 0.35 109.525 -174.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 65.17 165.64 0.17 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.686 1.594 . . . . 0.35 111.83 -170.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -46.36 -53.45 10.88 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.368 1.467 . . . . 0.35 112.054 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.61 -23.65 0.56 Allowed Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.952 0.787 . . . . 0.35 111.648 -175.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.11 -22.6 65.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.929 1.292 . . . . 0.35 112.604 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.67 130.0 44.69 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 123.625 0.77 . . . . 0.35 110.865 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.43 52.7 0.73 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.831 0.852 . . . . 0.35 109.103 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -61.85 140.37 58.27 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.307 1.043 . . . . 0.35 111.104 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 64.73 174.27 0.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.352 1.461 . . . . 0.35 113.156 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.5 t80 56.59 88.56 0.05 OUTLIER 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.85 2.06 . . . . 0.35 112.028 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 70.43 154.72 0.15 Allowed Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.431 1.892 . . . . 0.33 111.474 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -63.61 100.65 0.29 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.146 2.564 . . . . 0.35 109.58 163.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -107.35 -70.79 0.78 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.931 0.892 . . . . 0.35 111.263 -172.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.23 111.5 0.45 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.884 -0.953 . . . . 0.33 110.801 -169.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.5 -179.29 4.33 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.403 2.735 . . . . 0.35 112.294 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -165.65 178.84 6.38 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.145 0.978 . . . . 0.35 110.549 -166.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -153.02 92.63 1.65 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.059 1.344 . . . . 0.35 107.586 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 68.3 mtp -88.05 101.42 13.76 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.402 1.481 . . . . 0.35 110.409 -168.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.2 t -98.78 112.32 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.187 0.995 . . . . 0.35 109.591 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -175.46 171.44 2.83 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.502 1.121 . . . . 0.36 109.964 174.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.87 140.33 36.15 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.11 0.964 . . . . 0.35 111.785 -178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.6 m -70.55 101.25 1.97 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.448 1.899 . . . . 0.35 108.947 175.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.08 87.0 1.33 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.04 0.829 . . . . 0.35 111.654 -172.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.2 m -85.04 166.46 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 123.895 0.878 . . . . 0.35 110.477 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.23 -42.8 30.13 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.804 -0.443 . . . . 0.35 109.804 166.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 t -173.11 -53.72 0.02 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 125.246 1.418 . . . . 0.35 110.022 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -92.6 41.87 1.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.484 1.114 . . . . 0.35 113.92 -159.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.81 60.47 8.4 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.494 -0.642 . . . . 0.35 111.494 172.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -157.19 98.67 1.74 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.163 0.985 . . . . 0.36 109.42 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.65 118.64 7.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.805 1.242 . . . . 0.35 111.01 -173.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.89 -48.07 26.68 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.941 0.896 . . . . 0.35 110.036 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.5 mt -86.62 -169.37 2.61 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.405 1.082 . . . . 0.35 111.053 -171.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.8 p -130.32 78.62 74.09 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 106.87 -1.53 . . . . 0.33 106.87 163.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -85.49 77.14 2.8 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 124.804 3.669 . . . . 0.35 109.636 -166.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -150.12 85.67 1.41 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.132 0.973 . . . . 0.35 108.602 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -155.55 -48.42 0.08 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.249 0.62 . . . . 0.35 112.273 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.55 119.88 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.009 0.822 . . . . 0.35 110.048 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -156.43 151.84 26.73 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.541 1.137 . . . . 0.35 109.788 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -129.93 153.32 80.95 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 125.502 1.521 . . . . 0.33 108.742 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.39 60.9 7.51 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.711 2.94 . . . . 0.35 110.345 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 tp 39.97 89.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.689 1.996 . . . . 0.35 112.578 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -107.87 92.24 8.73 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.879 1.272 . . . . 0.33 108.633 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.87 155.96 48.31 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.127 2.551 . . . . 0.35 110.804 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.08 -50.4 0.7 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.573 -1.011 . . . . 0.35 110.573 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.4 t -63.01 146.48 53.11 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.905 0.882 . . . . 0.35 110.729 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 m -77.97 116.88 18.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.622 -0.51 . . . . 0.35 109.622 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -77.08 86.19 3.58 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.021 1.328 . . . . 0.35 108.572 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 p -150.0 151.85 33.97 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.682 1.193 . . . . 0.35 110.558 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -52.51 -53.06 50.93 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.178 1.391 . . . . 0.35 111.208 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -49.78 -45.32 49.61 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.677 1.191 . . . . 0.35 112.978 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -76.52 -50.01 15.05 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.018 0.372 . . . . 0.35 111.506 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.7 mm -54.22 -38.18 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.646 1.178 . . . . 0.35 112.402 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -52.9 -61.01 2.57 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.957 0.799 . . . . 0.35 112.015 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -71.41 -36.83 71.47 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.697 0.258 . . . . 0.35 111.697 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -64.77 -47.99 76.14 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.759 0.824 . . . . 0.35 111.786 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 p -71.89 -28.19 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.497 0.719 . . . . 0.35 111.322 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.69 -44.5 90.09 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 123.019 0.528 . . . . 0.35 109.643 172.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -66.18 -20.86 66.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.45 0.7 . . . . 0.35 112.369 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.33 -47.3 64.82 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.886 0.766 . . . . 0.35 110.914 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -39.36 84.98 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 109.936 -0.394 . . . . 0.35 109.936 173.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -93.42 52.12 1.7 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.876 1.271 . . . . 0.35 110.033 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.96 -58.84 2.01 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.019 1.328 . . . . 0.35 108.541 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.1 p -80.87 -50.16 10.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.622 1.169 . . . . 0.35 110.658 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.46 -97.61 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.971 0.908 . . . . 0.35 109.917 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.3 t80 54.98 87.63 0.05 OUTLIER 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.914 1.686 . . . . 0.35 113.072 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -161.23 -49.33 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.237 0.615 . . . . 0.35 109.954 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -120.75 50.73 1.3 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.026 1.33 . . . . 0.35 109.521 -175.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -139.04 92.0 2.56 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.371 1.068 . . . . 0.35 109.855 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -73.43 -40.0 64.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.463 1.105 . . . . 0.35 111.35 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.5 t 74.24 115.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 126.169 1.788 . . . . 0.35 110.798 -175.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.05 -67.37 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 108.13 -1.063 . . . . 0.35 108.13 172.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -145.12 165.02 29.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.844 1.658 . . . . 0.35 109.116 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -130.67 129.17 42.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.058 1.343 . . . . 0.35 107.431 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.91 132.28 84.97 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.946 -0.39 . . . . 0.33 109.946 -168.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.99 -22.71 22.68 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.505 2.803 . . . . 0.35 111.517 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.2 m -82.61 68.04 8.91 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.371 1.068 . . . . 0.35 110.328 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.99 165.09 25.76 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.864 0.865 . . . . 0.35 110.267 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -148.71 132.62 17.1 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.219 0.533 . . . . 0.35 112.119 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.2 114.69 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.877 -1.897 . . . . 0.35 105.877 171.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -107.94 58.1 0.62 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.957 0.903 . . . . 0.35 108.628 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.77 103.69 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.953 0.901 . . . . 0.35 110.372 -174.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 89.9 m -99.61 100.76 11.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.399 1.48 . . . . 0.35 108.114 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -98.87 84.89 3.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.015 0.926 . . . . 0.35 110.314 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -69.92 75.95 0.47 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.373 1.869 . . . . 0.35 109.769 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -120.5 65.53 0.84 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.14 1.376 . . . . 0.35 108.677 -170.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.7 110.35 6.19 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.35 0.66 . . . . 0.35 110.269 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -178.68 -47.6 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.293 1.837 . . . . 0.36 108.801 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -37.48 0.11 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.367 1.067 . . . . 0.35 110.883 172.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -78.06 -52.6 8.5 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.612 0.765 . . . . 0.35 110.651 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt 72.95 170.46 0.31 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.799 1.639 . . . . 0.35 111.382 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.16 125.23 24.33 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.663 0.785 . . . . 0.35 111.157 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -140.51 108.74 5.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.579 -1.267 . . . . 0.35 107.579 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.4 m -76.0 86.54 2.92 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.026 -1.102 . . . . 0.35 108.026 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -80.47 98.29 7.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.066 0.946 . . . . 0.35 108.553 -175.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.6 p -87.29 64.54 8.33 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.719 1.208 . . . . 0.35 111.116 -174.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -65.9 134.73 95.15 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.727 -0.842 . . . . 0.33 108.727 170.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.35 -114.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.24 2.627 . . . . 0.35 109.511 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 tp -161.67 151.57 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.973 0.806 . . . . 0.35 109.74 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.9 p -127.16 150.05 49.68 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.057 1.343 . . . . 0.35 109.678 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -67.37 0.48 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.477 0.711 . . . . 0.35 110.023 -176.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -108.78 101.71 10.81 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 106.607 -1.627 . . . . 0.35 106.607 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.15 -97.91 0.87 Allowed Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.332 0.968 . . . . 0.35 111.86 -168.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -159.37 177.54 10.89 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.261 0.624 . . . . 0.35 111.443 -163.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.1 t -102.71 150.63 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.982 1.713 . . . . 0.35 110.142 -175.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.3 t -54.52 114.91 7.5 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.308 1.043 . . . . 0.33 108.88 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.08 148.81 19.55 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.791 2.327 . . . . 0.35 111.016 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -94.18 -178.19 4.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.956 1.303 . . . . 0.35 110.132 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.85 165.35 25.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.725 0.81 . . . . 0.35 111.518 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.3 t -142.22 -68.42 0.37 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.464 1.106 . . . . 0.35 109.57 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -163.87 -52.71 0.03 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.208 1.003 . . . . 0.35 109.497 -174.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -42.08 -43.81 3.38 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.872 2.069 . . . . 0.35 114.068 -173.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.1 pt -133.82 173.9 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.606 0.762 . . . . 0.35 111.398 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -107.06 -44.92 4.27 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 126.203 1.801 . . . . 0.35 108.685 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -120.4 101.56 46.39 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.907 1.283 . . . . 0.36 110.865 -170.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -57.83 -59.51 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.452 2.768 . . . . 0.35 111.926 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 64.92 66.89 2.25 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.759 -0.937 . . . . 0.35 110.759 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -70.72 144.67 50.89 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.392 1.077 . . . . 0.35 111.162 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -132.16 92.93 3.18 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.371 1.068 . . . . 0.36 108.995 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.74 62.92 7.76 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.442 1.097 . . . . 0.35 108.628 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.98 125.14 54.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 125.465 1.506 . . . . 0.35 107.141 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.9 m -141.88 172.65 12.39 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.251 1.82 . . . . 0.35 107.631 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.69 131.55 56.92 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.556 1.142 . . . . 0.35 109.49 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.4 m -130.24 155.21 41.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 C-N-CA 124.677 1.191 . . . . 0.35 110.371 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.63 103.51 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.977 1.311 . . . . 0.35 108.716 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 29.1 mt -81.37 139.05 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.122 0.969 . . . . 0.35 110.772 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -102.66 128.99 49.13 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.417 -1.697 . . . . 0.35 106.417 162.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -84.33 74.2 10.37 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.497 -0.927 . . . . 0.35 108.497 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.341 0.228 0 C-N-CA 125.735 1.614 . . . . 0.25 109.475 -173.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 t80 . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.441 -0.577 . . . . 0.35 109.441 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -124.96 53.37 1.5 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.335 1.054 . . . . 0.35 110.392 -174.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -122.52 -51.78 1.94 Allowed 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.497 1.119 . . . . 0.35 108.573 173.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.61 78.85 0.8 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.648 . . . . 0.35 112.331 169.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp 58.21 73.4 0.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.686 1.194 . . . . 0.35 111.484 166.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -111.84 60.55 0.62 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.44 1.096 . . . . 0.35 109.802 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.19 177.89 8.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.756 0.823 . . . . 0.35 112.482 -168.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.7 tttm 60.48 52.86 4.44 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 127.111 2.165 . . . . 0.35 110.447 -172.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.42 -86.38 0.46 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 106.828 -2.509 . . . . 0.35 106.828 172.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t0 53.28 61.96 2.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.259 1.024 . . . . 0.35 109.499 176.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 64.87 53.92 1.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.425 1.49 . . . . 0.35 110.953 -171.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.74 91.06 0.05 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.936 1.694 . . . . 0.35 112.362 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -55.23 -53.86 50.76 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.503 1.121 . . . . 0.35 111.44 -176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -77.12 175.84 9.26 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.11 0.964 . . . . 0.35 111.851 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.3 t80 60.12 84.86 0.11 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 126.38 1.872 . . . . 0.35 111.107 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 66.37 158.92 0.13 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 126.491 1.916 . . . . 0.33 112.144 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.06 129.97 35.82 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.157 2.572 . . . . 0.35 111.592 167.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.5 p -121.92 -57.54 1.79 Allowed 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.506 1.123 . . . . 0.35 109.122 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.69 172.96 43.61 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 112.343 -0.303 . . . . 0.33 112.343 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.48 166.47 19.52 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 124.223 3.282 . . . . 0.35 113.835 -173.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -154.75 161.52 41.48 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.811 1.244 . . . . 0.35 109.668 167.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 tt -157.32 99.15 1.76 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.446 -0.946 . . . . 0.35 108.446 -170.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.9 mtp -92.14 146.34 23.8 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.396 1.479 . . . . 0.35 110.329 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.6 t -146.05 90.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.4 0 C-N-CA 124.046 0.939 . . . . 0.35 110.458 -167.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -156.01 -179.7 8.39 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.356 1.062 . . . . 0.36 110.949 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.7 m -129.33 150.61 34.79 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 125.028 1.331 . . . . 0.35 111.494 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.1 m -80.62 91.77 5.88 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.014 -1.476 . . . . 0.35 107.014 169.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.31 73.05 2.71 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.071 -0.812 . . . . 0.35 111.071 -172.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.89 147.29 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 122.944 0.498 . . . . 0.35 110.679 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.99 178.88 5.95 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.598 1.159 . . . . 0.35 109.323 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -47.31 -45.31 24.25 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.202 1.001 . . . . 0.35 110.599 164.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -105.95 34.36 3.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.723 1.209 . . . . 0.35 111.562 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.62 -25.14 8.7 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.111 -0.827 . . . . 0.35 115.032 167.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -61.32 124.93 21.99 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.344 1.072 . . . . 0.36 111.64 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.62 101.01 0.95 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.581 0.752 . . . . 0.35 110.205 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.74 -50.09 39.85 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.384 1.074 . . . . 0.35 110.007 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 pp -130.47 150.76 51.53 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.663 1.185 . . . . 0.35 110.224 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 t -82.8 147.49 55.13 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.044 0.937 . . . . 0.33 111.604 -164.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.03 27.58 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.31 3.34 . . . . 0.35 112.588 171.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -169.09 132.44 1.33 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.931 0.893 . . . . 0.35 109.652 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -165.28 -72.47 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.381 1.073 . . . . 0.35 109.481 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.07 147.05 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.702 0.801 . . . . 0.35 109.716 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -142.94 166.79 23.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.723 0.809 . . . . 0.35 111.142 174.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -141.04 144.82 36.53 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 125.049 1.339 . . . . 0.33 108.576 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.06 64.77 8.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.948 3.099 . . . . 0.35 110.655 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.258 9.0 tt 39.42 110.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 129.567 3.147 . . . . 0.35 114.608 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -119.83 82.32 27.48 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.263 1.025 . . . . 0.33 108.528 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -82.9 -170.31 0.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.952 3.101 . . . . 0.35 110.576 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.41 -41.57 2.1 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.739 -0.945 . . . . 0.35 110.739 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.9 t -66.32 152.61 44.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.604 0.762 . . . . 0.35 110.347 174.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.5 m -69.18 150.31 47.64 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.779 -0.823 . . . . 0.35 108.779 171.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.3 tp -127.41 102.93 7.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.912 -1.144 . . . . 0.35 107.912 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -151.61 176.07 11.72 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.505 1.522 . . . . 0.35 109.43 -170.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -63.13 -47.49 82.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.738 0.415 . . . . 0.35 111.46 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.93 -30.73 70.95 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.012 0.745 . . . . 0.35 113.012 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -64.39 -54.61 30.17 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.205 0.602 . . . . 0.35 109.377 171.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mm -51.55 -49.88 31.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 125.143 1.377 . . . . 0.35 111.18 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -45.49 -56.71 4.77 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.665 1.186 . . . . 0.35 112.518 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -75.31 -37.14 60.96 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.969 0.359 . . . . 0.35 111.969 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -67.11 -48.65 67.48 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.669 0.787 . . . . 0.35 111.958 -169.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.4 m -67.99 -33.0 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.884 0.473 . . . . 0.35 111.266 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -65.13 -41.17 95.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.541 0.737 . . . . 0.35 110.678 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -35.12 75.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.453 0.701 . . . . 0.35 111.148 176.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.77 -48.58 76.39 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.592 0.757 . . . . 0.35 111.334 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.8 -19.98 61.24 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.386 0.675 . . . . 0.35 112.423 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -77.29 13.41 1.18 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.448 0.699 . . . . 0.35 112.197 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.57 -41.4 65.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.375 -0.602 . . . . 0.35 109.375 160.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 70.2 p -103.35 -49.4 3.73 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.208 1.403 . . . . 0.35 111.748 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.75 -85.67 0.09 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.8 0.84 . . . . 0.35 111.32 -170.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.8 p90 51.62 18.17 0.68 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.3 2.24 . . . . 0.35 116.016 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -131.99 -81.02 0.51 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.31 0.959 . . . . 0.35 112.097 -164.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -97.26 -54.46 3.15 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.577 0.751 . . . . 0.35 111.943 -158.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -45.37 145.57 1.16 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.433 2.293 . . . . 0.35 114.378 -173.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -85.69 -63.08 1.38 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.872 1.269 . . . . 0.35 111.348 -172.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.3 t 72.1 97.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 126.071 1.748 . . . . 0.35 108.984 -164.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.69 -65.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.085 0.954 . . . . 0.35 109.305 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -162.51 135.78 6.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.879 0.872 . . . . 0.35 109.186 -174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.67 152.83 24.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.838 0.855 . . . . 0.35 110.927 177.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.87 145.53 50.25 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.948 -0.76 . . . . 0.33 108.948 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.12 -17.12 40.64 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.47 2.78 . . . . 0.35 111.993 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -83.39 61.51 6.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.509 1.124 . . . . 0.35 111.069 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.98 141.24 45.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.223 -1.399 . . . . 0.35 107.223 159.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -148.61 131.57 16.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.191 0.52 . . . . 0.35 112.4 -171.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 mp -75.88 116.41 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.439 -1.689 . . . . 0.35 106.439 168.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -107.68 68.82 0.72 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.343 -1.354 . . . . 0.35 107.343 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.98 115.01 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.924 0.89 . . . . 0.35 110.519 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.0 m -110.16 87.33 2.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.47 1.508 . . . . 0.35 108.496 -172.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.62 87.12 3.99 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.018 1.327 . . . . 0.35 111.22 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -74.77 85.5 2.17 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.961 1.305 . . . . 0.35 109.674 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -132.81 71.77 1.48 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.376 -0.972 . . . . 0.35 108.376 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -53.12 -22.43 6.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.646 1.578 . . . . 0.35 113.834 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -58.14 -31.41 67.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.73 1.212 . . . . 0.36 112.438 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.7 -52.48 0.34 Allowed 'General case' 0 C--N 1.344 0.367 0 N-CA-C 112.662 0.615 . . . . 0.35 112.662 173.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -87.4 -58.45 2.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.647 0.658 . . . . 0.35 111.644 -168.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt 85.65 160.99 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.975 2.11 . . . . 0.35 110.492 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.41 97.9 0.6 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.791 1.236 . . . . 0.35 111.506 -174.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -119.18 123.63 44.82 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 107.729 -1.211 . . . . 0.35 107.729 168.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.1 m -87.99 83.14 7.07 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.453 1.101 . . . . 0.35 108.179 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -75.16 119.81 19.81 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.344 1.057 . . . . 0.35 109.916 -170.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.6 m -83.09 74.75 9.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.101 1.361 . . . . 0.35 111.488 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -80.52 132.99 56.93 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.75 -1.204 . . . . 0.33 107.75 165.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.72 -118.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.309 2.673 . . . . 0.35 110.178 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.4 tp -159.87 155.38 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.462 1.105 . . . . 0.35 108.777 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.8 p -124.01 136.8 54.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.147 0.979 . . . . 0.35 109.058 174.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -73.17 -33.1 65.26 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.945 0.898 . . . . 0.35 110.776 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -21.13 65.1 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.424 0.69 . . . . 0.35 112.205 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.96 174.96 43.56 Favored Glycine 0 C--N 1.341 0.85 0 C-N-CA 123.904 0.764 . . . . 0.35 114.223 166.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -161.43 136.16 7.25 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.406 1.083 . . . . 0.35 109.867 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.16 126.48 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.653 -0.869 . . . . 0.35 108.653 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.2 t -73.02 121.62 85.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 107.475 -1.305 . . . . 0.33 107.475 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.43 -102.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.246 2.63 . . . . 0.35 110.432 -173.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -163.52 111.44 1.2 Allowed 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.497 1.119 . . . . 0.35 108.271 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.9 97.22 10.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.157 0.983 . . . . 0.35 108.587 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.5 t -170.76 86.68 0.11 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.951 1.3 . . . . 0.35 108.391 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -153.34 -71.48 0.14 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.329 0.652 . . . . 0.35 109.485 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -92.76 -52.29 4.69 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.469 1.108 . . . . 0.35 109.355 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.5 pt -109.51 169.13 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.392 1.477 . . . . 0.35 108.934 170.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.89 19.63 0.26 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.372 1.249 . . . . 0.35 114.372 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.96 61.52 28.68 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.093 0.86 . . . . 0.36 111.85 175.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.53 172.73 15.13 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.219 3.279 . . . . 0.35 111.36 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.38 68.49 0.43 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.051 -1.219 . . . . 0.35 110.051 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -64.02 88.93 0.05 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.353 1.461 . . . . 0.35 110.407 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -99.51 100.65 11.7 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.641 -0.874 . . . . 0.36 108.641 -174.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.6 93.47 8.38 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.385 1.074 . . . . 0.35 109.055 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.17 134.49 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.504 -1.295 . . . . 0.35 107.504 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 44.7 m -142.67 116.58 9.34 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 107.269 -1.382 . . . . 0.35 107.269 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -73.42 133.17 43.67 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.421 -0.585 . . . . 0.35 109.421 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.9 m -134.36 136.7 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.111 0.965 . . . . 0.35 109.604 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 77.6 t -82.58 137.35 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.406 -0.961 . . . . 0.35 108.406 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 47.2 mt -137.26 133.45 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.697 1.199 . . . . 0.35 108.978 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -97.44 130.26 44.57 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.324 -1.361 . . . . 0.35 107.324 161.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -72.2 96.26 1.78 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.724 -0.843 . . . . 0.35 108.724 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.34 0.168 0 C-N-CA 125.538 1.535 . . . . 0.25 109.325 -167.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.1 t80 . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 120.655 0.264 . . . . 0.35 110.885 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -112.57 42.03 1.91 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.405 1.082 . . . . 0.35 109.101 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.63 -47.7 0.69 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.029 1.732 . . . . 0.35 109.523 -177.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.67 56.16 1.92 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.766 -0.934 . . . . 0.35 110.766 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 56.99 70.72 0.63 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.295 1.438 . . . . 0.35 111.458 176.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -90.58 0.41 57.37 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.178 1.391 . . . . 0.35 112.449 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -175.59 3.24 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.268 1.027 . . . . 0.35 112.009 -176.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.5 tttp 93.94 -22.41 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.601 2.36 . . . . 0.35 112.456 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.6 81.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.859 1.219 . . . . 0.35 114.523 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -84.55 56.02 3.65 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.227 1.013 . . . . 0.35 111.068 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 48.99 45.05 22.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.494 1.517 . . . . 0.35 111.758 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.46 53.08 0.89 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.401 1.081 . . . . 0.35 109.679 -172.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 m -87.47 -122.26 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.762 0.825 . . . . 0.35 110.526 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -163.41 145.11 9.58 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.043 1.337 . . . . 0.35 108.11 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.1 t80 66.85 119.22 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.828 1.651 . . . . 0.35 111.369 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 68.55 151.85 0.13 Allowed Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 126.454 1.902 . . . . 0.33 111.699 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.71 92.08 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.335 2.69 . . . . 0.35 110.82 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.5 p -75.47 -42.96 51.82 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.807 0.843 . . . . 0.35 109.938 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.78 166.06 26.22 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.468 -0.653 . . . . 0.33 111.468 172.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.93 168.43 19.1 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.186 3.258 . . . . 0.35 111.09 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -163.34 176.62 9.69 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.389 1.076 . . . . 0.35 110.628 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 tt -156.59 94.14 1.44 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.079 0.951 . . . . 0.35 108.706 -175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -89.1 143.28 26.95 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.327 0.651 . . . . 0.35 109.923 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.9 t -144.67 91.41 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.244 1.017 . . . . 0.35 108.585 -172.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -153.31 162.49 41.24 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.607 1.163 . . . . 0.36 110.709 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -95.85 153.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 124.963 1.305 . . . . 0.35 110.097 174.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -88.91 93.84 9.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.412 -1.699 . . . . 0.35 106.412 169.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.77 105.77 1.63 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.505 -1.038 . . . . 0.35 110.505 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.49 169.64 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.927 1.291 . . . . 0.35 109.996 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -87.3 -179.78 6.47 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.829 0.852 . . . . 0.35 109.128 166.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 t -60.54 -38.79 85.6 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.663 0.785 . . . . 0.35 110.869 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -76.78 -0.91 25.59 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.427 1.091 . . . . 0.35 112.571 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.59 52.13 6.15 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 110.968 -0.853 . . . . 0.35 110.968 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -120.45 108.35 14.0 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.623 1.169 . . . . 0.36 108.416 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -65.96 118.29 9.54 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.793 0.837 . . . . 0.35 111.79 -172.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.34 -40.22 30.79 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.5 1.12 . . . . 0.35 109.875 169.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 pp -151.89 154.42 36.09 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.358 1.063 . . . . 0.35 112.304 -164.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.7 m -88.5 154.31 50.98 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.151 1.38 . . . . 0.33 110.353 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -86.14 49.79 2.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.314 3.342 . . . . 0.35 110.47 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -149.13 97.2 2.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.685 0.794 . . . . 0.35 109.523 -166.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -162.15 -55.73 0.04 OUTLIER 'General case' 0 C--N 1.344 0.352 0 CA-C-O 118.85 -0.595 . . . . 0.35 112.451 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 m -82.66 141.06 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.328 0.967 . . . . 0.35 109.304 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -146.49 109.83 4.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.297 1.039 . . . . 0.35 109.089 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -94.28 154.4 40.41 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 125.366 1.466 . . . . 0.33 109.72 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.77 147.46 44.7 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.189 2.593 . . . . 0.35 109.844 169.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.81 137.0 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 122.977 0.511 . . . . 0.35 110.404 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -142.49 114.09 6.14 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.801 1.24 . . . . 0.33 107.837 171.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.74 179.87 6.1 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.61 2.874 . . . . 0.35 110.903 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.56 -26.66 18.92 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.424 -0.653 . . . . 0.35 112.643 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 t -67.07 141.36 57.52 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.801 0.8 . . . . 0.35 111.021 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.5 m -72.62 139.12 47.18 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.606 -0.887 . . . . 0.35 108.606 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.67 117.24 16.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.978 0.911 . . . . 0.35 108.963 -171.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.5 t -167.44 176.07 6.81 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.151 1.781 . . . . 0.35 108.458 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -57.76 -52.38 65.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.933 0.893 . . . . 0.35 110.796 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -64.56 -32.43 74.07 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.934 0.716 . . . . 0.35 112.934 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -65.98 -57.69 7.22 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.567 0.621 . . . . 0.35 110.369 175.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.79 -23.37 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.166 0.986 . . . . 0.35 111.805 -172.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.54 -58.35 8.93 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.174 0.99 . . . . 0.35 111.067 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -66.04 -37.85 86.88 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.14 0.427 . . . . 0.35 111.2 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -62.96 -48.7 77.75 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.559 0.744 . . . . 0.35 111.795 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.9 -36.77 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 118.256 0.48 . . . . 0.35 111.585 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -63.53 -37.1 86.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.807 0.843 . . . . 0.35 111.111 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -74.12 -37.8 64.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.872 0.469 . . . . 0.35 111.041 176.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.16 -44.03 97.52 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.297 1.039 . . . . 0.35 111.485 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.19 -41.49 63.78 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.904 0.482 . . . . 0.35 111.644 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -76.83 -3.4 38.23 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.436 0.694 . . . . 0.35 112.758 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.71 -42.45 83.77 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.866 0.757 . . . . 0.35 110.33 173.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.9 t -103.2 -38.93 7.06 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.105 1.362 . . . . 0.35 111.579 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.89 -101.18 0.03 OUTLIER 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.676 -0.678 . . . . 0.35 110.795 -173.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.1 t80 75.74 -43.33 0.48 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 126.572 1.949 . . . . 0.35 113.751 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -55.27 -67.1 0.3 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.345 1.458 . . . . 0.35 112.593 -169.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -107.11 24.22 13.16 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.235 0.614 . . . . 0.35 112.189 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -92.63 136.75 32.96 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.243 0.617 . . . . 0.35 111.431 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -164.05 109.24 1.02 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.962 1.305 . . . . 0.35 108.485 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 p -77.61 148.63 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.299 0.64 . . . . 0.35 109.87 171.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.47 -44.48 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.699 1.2 . . . . 0.35 109.888 173.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -129.39 151.54 49.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.269 1.428 . . . . 0.35 108.853 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.75 143.52 32.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.313 1.045 . . . . 0.35 109.909 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -72.39 117.24 57.04 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.787 0.835 . . . . 0.33 108.978 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.89 -27.4 21.12 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.867 2.378 . . . . 0.35 111.118 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.1 m -87.87 58.03 4.64 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.513 1.125 . . . . 0.35 110.358 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.97 167.08 5.05 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.26 0.624 . . . . 0.35 109.624 169.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -155.85 142.32 18.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.531 0.681 . . . . 0.35 112.352 -171.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 mp -85.74 111.73 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 106.144 -1.798 . . . . 0.35 106.144 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -100.99 70.78 1.38 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.614 -1.254 . . . . 0.35 107.614 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.16 99.16 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.333 0.653 . . . . 0.35 109.819 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 94.0 m -98.83 125.19 44.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.195 1.398 . . . . 0.35 109.012 -173.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -139.43 132.84 30.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.255 1.022 . . . . 0.35 109.484 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -101.26 60.34 0.91 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.451 1.5 . . . . 0.35 108.669 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -81.71 82.29 7.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.226 0.61 . . . . 0.35 109.665 -177.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -83.19 67.43 9.19 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.423 -0.955 . . . . 0.35 108.423 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -143.77 -49.14 0.3 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.905 1.682 . . . . 0.36 108.729 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 pttt -159.03 -54.93 0.06 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.512 0.725 . . . . 0.35 111.856 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -74.97 -22.24 58.67 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.884 0.698 . . . . 0.35 112.884 -172.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 81.0 tttt 75.5 164.18 0.26 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.785 1.634 . . . . 0.35 111.973 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -56.62 106.18 0.27 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.332 1.453 . . . . 0.35 110.528 172.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -145.17 145.28 31.29 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.414 1.086 . . . . 0.35 109.637 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 94.0 m -119.6 95.84 4.95 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 125.182 1.393 . . . . 0.35 108.056 176.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -70.64 125.44 26.83 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.253 -0.647 . . . . 0.35 109.253 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -96.18 63.16 2.2 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.886 1.274 . . . . 0.35 110.094 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -75.35 124.64 89.21 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 109.337 -0.616 . . . . 0.33 109.337 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.76 162.47 26.93 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.205 2.604 . . . . 0.35 111.454 -175.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.3 tp -76.97 152.68 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.017 0.927 . . . . 0.35 109.866 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.1 p -105.24 -179.41 3.94 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.137 0.975 . . . . 0.35 110.419 178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.57 -11.3 14.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.694 1.597 . . . . 0.35 110.81 166.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -78.06 -87.69 0.05 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.625 1.17 . . . . 0.35 110.506 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.15 63.79 0.01 OUTLIER Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.475 -1.05 . . . . 0.35 110.475 -172.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -73.56 126.03 29.33 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.285 -0.635 . . . . 0.35 109.285 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.67 135.25 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.663 -0.866 . . . . 0.35 108.663 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.9 112.05 6.02 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 107.592 -1.262 . . . . 0.33 107.592 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -89.32 14.66 2.16 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.927 2.418 . . . . 0.35 112.673 -165.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.3 t70 60.11 -157.44 0.33 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.266 1.027 . . . . 0.35 109.572 -168.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.5 tt -163.6 146.31 9.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.64 0.655 . . . . 0.35 110.396 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.5 t -154.33 164.72 38.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.299 1.04 . . . . 0.35 110.025 172.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 82.42 -76.7 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.172 1.789 . . . . 0.35 112.635 165.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -69.15 -41.14 77.69 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.886 0.875 . . . . 0.35 113.039 -168.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.1 pt -135.17 -173.35 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.699 0.8 . . . . 0.35 109.367 169.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -158.81 28.86 0.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.176 0.59 . . . . 0.35 112.113 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.1 50.13 0.45 Allowed Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.783 0.66 . . . . 0.36 112.783 175.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -66.57 120.82 7.98 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.163 2.575 . . . . 0.35 111.32 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.11 75.84 0.22 Allowed Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.91 1.243 . . . . 0.35 110.419 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -64.05 85.79 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.515 1.926 . . . . 0.35 112.157 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -92.41 99.49 12.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.24 0.616 . . . . 0.36 109.603 -176.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.83 95.16 3.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.618 -0.882 . . . . 0.35 108.618 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.6 mt -108.8 121.76 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 124.838 1.255 . . . . 0.35 108.22 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.4 m -119.36 175.27 5.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.918 1.687 . . . . 0.35 107.402 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -136.06 114.47 11.7 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.133 0.973 . . . . 0.35 108.442 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.5 146.12 32.89 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 C-N-CA 123.462 0.705 . . . . 0.35 110.841 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.1 t -81.22 111.63 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.297 1.039 . . . . 0.35 108.318 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mt -101.09 110.39 27.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 108.219 -1.03 . . . . 0.35 108.219 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -85.85 97.52 10.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.914 -1.143 . . . . 0.35 107.914 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -61.57 126.75 28.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.427 0.691 . . . . 0.35 110.832 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt . . . . . 0 N--CA 1.455 -0.185 0 C-N-CA 123.53 0.732 . . . . 0.25 109.915 179.171 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 t80 . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 120.962 0.41 . . . . 0.35 109.914 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -89.13 75.78 7.83 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.43 1.092 . . . . 0.35 110.111 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -162.19 -62.88 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.441 1.096 . . . . 0.35 108.881 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.43 92.88 0.21 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.538 0.59 . . . . 0.35 112.536 169.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt 58.8 51.69 7.31 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.764 1.225 . . . . 0.35 111.674 164.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -85.17 -64.9 1.08 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.589 0.756 . . . . 0.35 111.499 -174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp 75.96 118.82 0.05 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 127.143 2.177 . . . . 0.35 109.664 -165.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -50.11 -47.94 53.71 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.024 1.329 . . . . 0.35 110.418 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.33 -92.79 0.22 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.283 -1.527 . . . . 0.35 109.283 175.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t70 52.51 66.62 1.16 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.218 1.407 . . . . 0.35 110.688 -173.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -93.64 47.3 1.23 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.135 -1.061 . . . . 0.35 108.135 170.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.05 70.13 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.152 1.781 . . . . 0.35 107.083 -170.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 t -67.72 -71.29 0.21 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.308 0.643 . . . . 0.35 111.523 -168.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -162.31 39.64 0.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 117.622 0.192 . . . . 0.35 111.325 -167.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -157.36 115.67 3.19 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.032 0.533 . . . . 0.35 110.726 -173.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 65.74 164.67 0.12 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.91 2.084 . . . . 0.33 112.951 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -63.19 74.48 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.577 3.518 . . . . 0.35 112.84 172.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 p -100.71 -39.91 7.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.063 1.745 . . . . 0.35 109.077 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.84 157.43 10.03 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 112.02 -0.432 . . . . 0.33 112.02 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -82.24 -178.62 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.504 3.469 . . . . 0.35 110.827 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -157.46 169.4 24.78 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.115 0.966 . . . . 0.35 110.39 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.1 tp -142.81 86.24 1.92 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.355 1.462 . . . . 0.35 107.806 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.7 mtp -82.56 89.56 6.7 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.605 1.162 . . . . 0.35 110.59 -176.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.49 91.95 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.362 1.065 . . . . 0.35 109.059 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -149.18 172.58 14.6 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.492 1.117 . . . . 0.36 109.985 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.58 153.45 19.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 123.993 0.917 . . . . 0.35 111.204 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.5 m -94.39 94.66 8.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.885 1.274 . . . . 0.35 107.909 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.78 116.26 7.64 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 109.479 -1.448 . . . . 0.35 109.479 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -122.98 157.15 28.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 C-N-CA 125.661 1.584 . . . . 0.35 109.191 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -79.43 178.33 8.19 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.581 -0.525 . . . . 0.35 109.581 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 t -60.04 -46.11 90.61 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.533 0.733 . . . . 0.35 110.304 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -68.98 -16.77 63.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.382 1.073 . . . . 0.35 112.91 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.05 29.09 7.38 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.314 0.959 . . . . 0.35 113.09 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -91.17 114.25 26.72 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 117.818 0.809 . . . . 0.36 108.9 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.15 123.77 21.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.327 0.651 . . . . 0.35 110.817 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 mp -93.63 -38.66 11.23 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.844 1.258 . . . . 0.35 109.957 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -144.52 152.59 40.8 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.254 1.022 . . . . 0.35 111.549 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.2 t -99.26 148.75 35.07 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.002 1.721 . . . . 0.33 109.664 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -84.33 70.45 5.86 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.624 2.883 . . . . 0.35 111.456 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -148.74 -177.74 5.96 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.783 0.833 . . . . 0.35 110.508 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . 0.314 0.0 OUTLIER 100.02 -44.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.597 2.759 . . . . 0.35 112.854 173.361 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.74 136.62 23.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 109.553 -0.536 . . . . 0.35 109.553 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.04 171.98 15.5 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.091 0.956 . . . . 0.35 109.35 164.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -161.12 132.9 4.1 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.657 -0.687 . . . . 0.33 109.731 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.31 111.78 1.91 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.654 2.236 . . . . 0.35 108.66 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 tt -60.92 144.8 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.147 0.979 . . . . 0.35 112.944 -162.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -130.54 87.16 50.91 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.593 1.557 . . . . 0.33 107.372 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.97 159.66 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.492 2.795 . . . . 0.35 111.263 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.03 -33.4 2.46 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.268 0.937 . . . . 0.35 111.364 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.7 t -71.58 157.43 38.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.211 1.004 . . . . 0.35 111.321 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.4 p -72.81 167.24 21.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.191 0.996 . . . . 0.35 110.953 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.29 119.64 3.5 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.754 0.822 . . . . 0.35 108.888 -174.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -167.4 178.66 5.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.191 1.796 . . . . 0.35 108.015 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -57.08 -46.92 82.16 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.56 -0.712 . . . . 0.35 111.343 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.47 -34.25 77.76 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.197 0.599 . . . . 0.35 111.967 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -104.06 53.66 0.74 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.788 1.235 . . . . 0.35 109.97 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -159.18 -41.94 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.655 1.182 . . . . 0.35 108.674 170.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.02 -44.38 82.78 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.11 0.964 . . . . 0.35 111.765 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -59.33 -39.41 83.07 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.612 0.765 . . . . 0.35 111.029 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -50.29 62.95 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.295 1.438 . . . . 0.35 110.18 -171.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.28 -32.33 42.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 124.565 1.146 . . . . 0.35 112.121 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -60.29 -49.18 78.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.531 -0.544 . . . . 0.35 109.531 172.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -33.29 75.68 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.791 0.437 . . . . 0.35 111.517 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.77 -55.23 32.36 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.564 0.746 . . . . 0.35 110.965 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 pp -74.69 -15.76 60.78 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.956 0.724 . . . . 0.35 112.956 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -79.41 71.39 5.97 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 123.878 0.871 . . . . 0.35 110.033 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -168.68 -53.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.372 1.869 . . . . 0.35 107.723 172.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.2 p -88.08 -35.11 17.68 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.656 1.583 . . . . 0.35 111.202 -178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.19 74.76 1.32 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.273 1.429 . . . . 0.35 108.436 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -133.3 -19.14 2.2 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.987 1.106 . . . . 0.35 113.987 -165.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -59.58 -41.19 89.7 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.676 0.791 . . . . 0.35 112.542 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -141.65 -66.62 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.151 1.38 . . . . 0.35 109.311 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.9 p90 34.85 88.45 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.172 2.589 . . . . 0.35 114.193 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -73.63 106.73 5.52 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 109.322 -0.622 . . . . 0.35 109.322 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.21 120.4 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.332 -0.988 . . . . 0.35 108.332 174.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.3 t -75.92 -73.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.587 -1.264 . . . . 0.35 107.587 171.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -167.78 146.58 4.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.381 1.073 . . . . 0.35 109.446 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.85 156.84 29.53 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.546 0.738 . . . . 0.35 111.262 173.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.49 135.56 81.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 108.136 -1.061 . . . . 0.33 108.136 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.62 -33.02 29.53 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.318 2.679 . . . . 0.35 111.774 -176.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.0 m -86.77 70.21 10.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.337 1.055 . . . . 0.35 110.263 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.61 169.99 16.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.379 0.672 . . . . 0.35 109.746 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -159.41 143.43 14.95 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.512 0.56 . . . . 0.35 112.512 -167.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.74 122.53 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 126.855 2.062 . . . . 0.35 106.133 172.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -118.1 64.73 0.75 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.97 0.908 . . . . 0.35 109.183 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.04 118.33 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.416 0.686 . . . . 0.35 110.942 -176.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.2 m -111.57 100.59 9.11 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.509 1.123 . . . . 0.35 109.529 -173.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.29 99.4 12.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.154 0.982 . . . . 0.35 109.851 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -94.38 47.89 1.21 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.596 1.558 . . . . 0.35 111.099 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -69.68 106.92 3.24 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.03 0.932 . . . . 0.35 109.628 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -32.6 73.13 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.07 1.348 . . . . 0.35 111.635 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -55.06 -50.15 69.85 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.702 1.201 . . . . 0.36 113.017 -170.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 -41.44 0.09 Allowed 'General case' 0 C--N 1.342 0.279 0 N-CA-C 113.347 0.869 . . . . 0.35 113.347 -175.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -70.56 -47.84 58.33 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.326 0.512 . . . . 0.35 112.016 -168.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt 80.56 155.9 0.14 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.328 1.851 . . . . 0.35 110.741 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -43.8 124.4 3.68 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 126.719 2.008 . . . . 0.35 111.265 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.35 106.53 2.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.216 -1.031 . . . . 0.35 108.216 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.3 m -78.15 97.96 5.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.454 1.102 . . . . 0.35 109.171 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -82.13 96.94 7.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.785 0.834 . . . . 0.35 108.957 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.8 m -76.07 120.01 20.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.671 0.789 . . . . 0.35 109.272 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -134.79 125.33 17.3 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 125.351 1.46 . . . . 0.33 108.527 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.51 162.36 33.31 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.063 2.509 . . . . 0.35 111.559 -175.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.7 tp -73.88 159.96 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.574 1.149 . . . . 0.35 110.13 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 p -116.21 177.79 4.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.221 1.009 . . . . 0.35 110.202 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -103.11 -12.3 17.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.111 1.364 . . . . 0.35 110.924 165.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -76.31 -76.34 0.16 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.606 1.163 . . . . 0.35 111.116 -171.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 139.43 61.91 0.04 OUTLIER Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.846 -0.902 . . . . 0.35 110.846 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -71.53 132.91 45.36 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 117.351 0.575 . . . . 0.35 109.918 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.5 t -73.13 136.18 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.073 -0.714 . . . . 0.35 109.073 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.98 118.49 43.05 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 107.33 -1.359 . . . . 0.33 107.33 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.24 165.98 27.02 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.019 2.479 . . . . 0.35 112.37 -165.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.42 165.85 22.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.6 1.16 . . . . 0.35 110.866 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.1 mp -94.86 30.99 1.93 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.993 0.917 . . . . 0.35 111.412 -173.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.0 t 46.71 -102.34 0.07 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.092 1.757 . . . . 0.35 112.468 175.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -162.24 -44.22 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.986 1.315 . . . . 0.35 109.653 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -83.1 22.17 1.0 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.244 1.418 . . . . 0.35 113.186 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.4 tp -160.53 129.61 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.514 0.726 . . . . 0.35 110.082 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -140.7 27.73 2.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.831 1.252 . . . . 0.35 111.61 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -150.2 51.05 0.82 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 113.221 0.822 . . . . 0.36 113.221 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -70.45 115.02 4.0 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.856 2.371 . . . . 0.35 109.291 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -92.79 79.22 1.13 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.866 -1.294 . . . . 0.35 109.866 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -62.4 107.15 0.86 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.003 0.921 . . . . 0.35 110.387 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -99.79 94.56 6.39 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.34 1.056 . . . . 0.36 108.743 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.75 74.72 10.14 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.554 -1.276 . . . . 0.35 107.554 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.67 126.54 71.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 126.041 1.736 . . . . 0.35 107.948 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.8 m -148.94 142.47 25.36 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.917 0.887 . . . . 0.35 110.26 -173.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -72.85 140.35 47.54 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.264 1.026 . . . . 0.35 109.96 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.1 m -142.36 144.52 24.75 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 123.891 0.876 . . . . 0.35 109.661 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.05 100.23 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.876 -0.787 . . . . 0.35 108.876 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 75.3 mt -119.67 144.14 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.46 1.504 . . . . 0.35 109.062 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -131.29 80.79 1.95 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.556 1.542 . . . . 0.35 107.773 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -58.41 150.2 22.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.731 0.812 . . . . 0.35 111.954 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.196 -1.039 . . . . 0.25 108.196 178.62 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.6 p90 . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 114.966 1.469 . . . . 0.35 114.966 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 53.42 -141.45 0.86 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.046 0.938 . . . . 0.35 109.73 -171.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.4 pttt 11.29 76.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.631 2.772 . . . . 0.35 114.922 169.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.53 113.02 5.28 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 124.683 1.135 . . . . 0.35 111.663 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt 56.64 69.64 0.72 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.251 1.42 . . . . 0.35 110.278 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -70.82 -45.9 63.73 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.611 0.764 . . . . 0.35 111.143 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 66.34 5.31 3.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.165 1.786 . . . . 0.35 114.006 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 tttm 54.07 -92.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.898 1.279 . . . . 0.35 110.808 -172.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.86 58.72 0.07 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.393 -1.483 . . . . 0.35 109.393 173.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -132.55 66.58 1.55 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.382 1.073 . . . . 0.35 109.254 -176.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 64.47 -176.74 0.17 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.267 1.427 . . . . 0.35 112.12 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.88 178.23 9.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.294 1.037 . . . . 0.35 110.696 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.7 m -76.55 147.76 37.49 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.614 1.166 . . . . 0.35 111.234 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 65.31 175.98 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.014 1.726 . . . . 0.35 113.421 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.4 t80 59.35 90.56 0.05 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 126.448 1.899 . . . . 0.35 111.257 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 66.96 161.33 0.14 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 125.573 1.549 . . . . 0.33 111.131 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.28 90.52 1.0 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.359 2.039 . . . . 0.35 108.619 173.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.2 p -63.86 -60.52 3.18 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.234 1.014 . . . . 0.35 111.724 -166.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.68 172.0 32.55 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.962 -0.855 . . . . 0.33 110.962 174.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -66.53 149.0 84.46 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.469 2.779 . . . . 0.35 112.212 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -163.04 168.48 20.92 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.508 0.723 . . . . 0.35 111.292 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tt -145.11 100.86 3.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.737 1.215 . . . . 0.35 108.304 -173.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.6 mtp -88.16 134.06 33.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.722 1.609 . . . . 0.35 109.541 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.1 t -137.01 87.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.346 0 C-N-CA 124.075 0.95 . . . . 0.35 110.485 -168.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -159.35 165.64 32.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.958 1.303 . . . . 0.36 110.395 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -94.02 153.17 3.44 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 124.627 1.171 . . . . 0.35 112.267 -172.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -82.68 92.65 7.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.755 -1.572 . . . . 0.35 106.755 163.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.88 80.79 1.64 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.95 -0.86 . . . . 0.35 110.95 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 m -92.56 165.58 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.447 1.099 . . . . 0.35 110.318 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -82.4 -162.1 0.53 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.877 0.871 . . . . 0.35 110.41 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -53.28 -50.42 64.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.753 1.221 . . . . 0.35 111.598 175.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -75.37 -84.11 0.05 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.368 1.067 . . . . 0.35 110.33 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.76 46.89 0.06 OUTLIER Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.049 -0.82 . . . . 0.35 111.049 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -112.37 108.09 17.14 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.152 1.381 . . . . 0.36 108.257 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -70.49 112.34 6.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.886 0.874 . . . . 0.35 111.433 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.1 mp -73.88 -45.87 48.23 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.749 0.82 . . . . 0.35 109.442 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.2 147.3 36.33 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.858 0.863 . . . . 0.35 111.413 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.0 m -91.75 159.45 38.32 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.282 1.433 . . . . 0.33 111.29 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -87.27 49.86 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.507 2.805 . . . . 0.35 111.914 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -168.72 120.49 0.78 Allowed 'General case' 0 C--N 1.343 0.293 0 N-CA-C 112.915 0.709 . . . . 0.35 112.915 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -162.26 -45.09 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.528 1.531 . . . . 0.35 109.223 159.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.98 130.87 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.522 -0.918 . . . . 0.35 108.522 169.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -144.77 154.09 42.35 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.364 1.066 . . . . 0.35 109.05 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -131.77 155.1 81.83 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 125.31 1.444 . . . . 0.33 108.735 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.71 34.75 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.554 2.836 . . . . 0.35 111.945 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.25 2.8 tt 59.45 134.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 128.679 2.792 . . . . 0.35 114.372 -175.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -142.61 98.24 5.9 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.815 1.246 . . . . 0.33 107.793 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.61 177.96 8.12 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.533 2.822 . . . . 0.35 110.999 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.07 -32.99 6.95 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.977 0.799 . . . . 0.35 111.695 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.6 t -67.18 148.71 51.44 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.471 0.708 . . . . 0.35 110.682 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.2 m -76.63 109.93 10.79 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.892 -0.781 . . . . 0.35 108.892 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.08 96.58 7.81 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.573 -1.269 . . . . 0.35 107.573 176.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.3 t -147.31 160.56 42.37 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.502 1.121 . . . . 0.35 109.924 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -60.29 -42.84 96.33 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 119.5 -0.286 . . . . 0.35 111.576 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.06 -22.4 66.42 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.86 0.689 . . . . 0.35 112.86 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -75.31 -58.85 3.03 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 123.401 0.68 . . . . 0.35 109.895 167.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.4 mm -63.15 -39.42 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.457 1.103 . . . . 0.35 112.813 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -52.25 -48.1 65.4 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.881 0.872 . . . . 0.35 112.037 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -76.52 -39.84 51.78 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.063 0.392 . . . . 0.35 111.526 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -69.89 -39.3 76.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.45 0.7 . . . . 0.35 112.407 -169.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.89 -35.77 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.626 0.771 . . . . 0.35 110.752 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -72.4 -34.64 68.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.303 1.041 . . . . 0.35 111.071 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -47.08 73.86 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.746 0.819 . . . . 0.35 110.051 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.8 -39.96 75.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.276 1.03 . . . . 0.35 111.237 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.9 tp -69.1 -50.67 46.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.28 1.032 . . . . 0.35 111.467 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -74.43 8.29 2.36 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.727 1.01 . . . . 0.35 113.727 -174.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.84 -46.41 89.61 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.51 0.724 . . . . 0.35 109.959 166.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 m -118.58 -51.93 2.37 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.679 1.192 . . . . 0.35 110.352 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.96 82.38 6.7 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.164 0.985 . . . . 0.35 110.866 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -128.89 -43.87 1.34 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.057 1.343 . . . . 0.35 111.437 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -59.08 -71.31 0.12 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.212 1.405 . . . . 0.35 110.576 -173.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.08 -35.74 74.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.378 1.071 . . . . 0.35 110.771 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -58.32 146.41 34.52 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.833 1.253 . . . . 0.35 111.629 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -156.13 141.24 17.37 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.564 1.146 . . . . 0.35 109.562 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.6 t -88.06 137.16 21.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 124.317 1.047 . . . . 0.35 109.449 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.95 -56.87 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.067 1.347 . . . . 0.35 107.666 167.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -156.96 110.42 2.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.198 0.999 . . . . 0.35 108.395 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 pp -87.82 132.22 34.25 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.36 0.664 . . . . 0.35 109.823 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.77 124.46 90.77 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 108.322 -0.992 . . . . 0.33 108.322 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.91 -54.1 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.829 2.353 . . . . 0.35 111.793 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.7 m -74.5 96.14 2.87 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.989 0.916 . . . . 0.35 109.969 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.44 133.58 49.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.871 0.868 . . . . 0.35 110.132 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -95.81 108.77 21.14 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.166 0.987 . . . . 0.35 110.26 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.04 113.04 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.694 -1.595 . . . . 0.35 106.694 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.7 64.73 0.65 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.417 1.087 . . . . 0.35 108.984 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.3 p -67.86 115.33 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.347 0.659 . . . . 0.35 110.627 -176.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 m -111.32 101.38 9.86 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.418 1.087 . . . . 0.35 108.985 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -92.92 102.91 15.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.748 1.219 . . . . 0.35 108.962 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -81.03 61.65 4.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.647 1.179 . . . . 0.35 109.611 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -99.03 85.66 3.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.391 1.477 . . . . 0.35 108.453 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -82.59 52.19 2.03 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.763 0.825 . . . . 0.35 110.706 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -137.36 -44.53 0.55 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.839 1.256 . . . . 0.36 109.828 -170.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -140.64 -66.46 0.43 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.23 1.012 . . . . 0.35 110.1 -173.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -89.58 -22.0 22.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.487 0.921 . . . . 0.35 113.487 -164.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 tttm 74.92 159.43 0.22 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.855 1.662 . . . . 0.35 111.494 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -53.8 117.63 3.32 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.506 1.122 . . . . 0.35 109.951 168.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -141.33 111.74 6.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.827 -1.175 . . . . 0.35 107.827 171.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.2 m -75.76 86.17 2.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.828 -1.175 . . . . 0.35 107.828 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -80.42 97.17 6.96 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.051 0.94 . . . . 0.35 108.957 -171.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.9 m -90.24 132.7 35.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.083 1.353 . . . . 0.35 110.348 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -163.71 141.2 5.77 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 123.625 0.77 . . . . 0.33 110.377 176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.24 178.91 6.36 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 124.256 3.304 . . . . 0.35 110.952 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.0 tp -138.02 143.44 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.228 0.611 . . . . 0.35 110.56 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.2 p -100.27 -179.97 4.29 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.999 1.32 . . . . 0.35 111.376 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.99 -36.36 72.52 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.738 1.615 . . . . 0.35 112.805 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -88.54 -50.73 6.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.269 1.028 . . . . 0.35 109.895 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.67 -144.27 45.17 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.156 -0.777 . . . . 0.35 111.156 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -161.0 152.57 19.34 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.74 0.816 . . . . 0.35 110.756 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.9 t -78.35 133.08 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.097 0.959 . . . . 0.35 109.677 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.71 126.22 91.95 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 108.479 -0.934 . . . . 0.33 108.479 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.21 -80.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.782 2.322 . . . . 0.35 110.77 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -169.05 -56.55 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.902 1.281 . . . . 0.35 109.205 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 tm? 69.48 99.08 0.06 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.491 1.916 . . . . 0.35 110.434 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.8 t -171.12 78.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.092 1.357 . . . . 0.35 108.273 173.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -153.86 -77.35 0.11 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 122.782 0.433 . . . . 0.35 110.146 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -88.24 -50.15 6.54 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.265 1.026 . . . . 0.35 110.282 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.7 pt -103.51 169.37 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.38 1.072 . . . . 0.35 109.333 166.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -137.53 -26.95 0.96 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.027 0.931 . . . . 0.35 112.631 -166.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.05 58.1 27.38 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 123.702 0.801 . . . . 0.36 112.92 -169.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.09 119.64 6.45 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.178 2.585 . . . . 0.35 110.65 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.9 77.72 0.69 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 109.574 -1.411 . . . . 0.35 109.574 177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -62.67 96.69 0.09 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.163 1.385 . . . . 0.35 110.65 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -92.62 98.69 11.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.629 -0.878 . . . . 0.36 108.629 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.36 76.97 8.28 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 108.075 -1.083 . . . . 0.35 108.075 176.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.9 mt -90.24 122.34 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.181 -1.415 . . . . 0.35 107.181 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.3 m -131.0 111.67 12.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.97 -1.122 . . . . 0.35 107.97 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -62.99 137.01 58.15 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.365 0.666 . . . . 0.35 110.299 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.7 149.67 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.869 0.867 . . . . 0.35 109.517 169.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.96 142.54 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.857 1.263 . . . . 0.35 108.214 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.6 mt -129.96 147.7 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.698 1.199 . . . . 0.35 109.569 -171.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -126.28 -23.85 3.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.326 1.45 . . . . 0.35 112.487 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? 93.08 134.88 0.02 OUTLIER 'General case' 0 C--N 1.345 0.395 0 C-N-CA 127.834 2.454 . . . . 0.35 110.418 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? . . . . . 0 N--CA 1.455 -0.213 0 C-N-CA 125.007 1.323 . . . . 0.25 109.956 178.655 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 109.082 -0.71 . . . . 0.35 109.082 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -155.22 65.42 0.63 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.292 1.037 . . . . 0.35 108.83 -174.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -95.34 57.3 1.96 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.251 1.02 . . . . 0.35 110.186 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 49.9 26.33 8.29 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.275 1.893 . . . . 0.35 114.922 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 47.16 49.01 15.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.645 1.578 . . . . 0.35 112.582 -176.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -86.23 105.13 16.39 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.649 0.78 . . . . 0.35 109.958 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -77.6 72.34 4.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.307 1.443 . . . . 0.35 110.608 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 42.57 -91.05 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.029 2.532 . . . . 0.35 112.721 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.39 -111.04 0.89 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 108.718 -1.753 . . . . 0.35 108.718 175.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 50.73 65.25 1.52 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 125.038 1.335 . . . . 0.35 110.938 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -84.02 75.8 10.11 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.938 0.895 . . . . 0.35 109.158 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -128.36 73.15 1.46 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.374 1.47 . . . . 0.35 108.776 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 t -74.71 175.39 7.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.24 1.016 . . . . 0.35 110.996 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -80.94 76.71 7.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.566 1.147 . . . . 0.35 109.771 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -154.07 76.82 1.07 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.013 1.325 . . . . 0.35 107.559 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 68.04 169.65 0.11 Allowed Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.378 1.471 . . . . 0.33 111.108 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.46 108.01 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.56 2.84 . . . . 0.35 113.051 170.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.0 p -106.0 -60.32 1.66 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.408 1.483 . . . . 0.35 108.695 175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.7 150.24 7.65 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 110.451 -1.06 . . . . 0.33 110.451 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.76 162.78 27.08 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.81 2.34 . . . . 0.35 113.332 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -158.68 164.46 35.92 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.331 1.052 . . . . 0.35 110.085 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 tt -148.51 103.28 3.4 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.295 -1.002 . . . . 0.35 108.295 -173.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 41.9 mtm -82.17 120.68 25.64 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.985 0.914 . . . . 0.35 111.128 -176.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -114.87 96.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 124.824 1.249 . . . . 0.35 110.092 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -156.33 -176.01 5.73 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.529 0.732 . . . . 0.36 110.998 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.2 m -140.27 -170.62 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.767 1.227 . . . . 0.35 110.248 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.2 m -135.89 94.12 3.02 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.897 -1.52 . . . . 0.35 106.897 168.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.09 98.33 2.39 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 124.649 1.119 . . . . 0.35 111.885 -169.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.12 162.64 3.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 124.466 1.106 . . . . 0.35 111.731 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -74.03 -52.25 13.31 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.468 -0.938 . . . . 0.35 108.468 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 m -157.58 -64.37 0.09 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.989 1.316 . . . . 0.35 109.474 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -106.7 63.78 0.64 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.2 1.0 . . . . 0.35 111.264 -165.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.75 -40.62 3.04 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 119.758 -0.468 . . . . 0.35 113.012 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -49.41 103.77 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.751 2.02 . . . . 0.36 112.509 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.81 136.43 34.14 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.489 1.115 . . . . 0.35 110.731 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 mp -79.09 -62.3 1.74 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.456 0.703 . . . . 0.35 109.457 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mt -94.88 -148.28 0.28 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.695 1.198 . . . . 0.35 108.879 -170.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.9 m -143.07 68.11 17.65 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 108.036 -1.098 . . . . 0.33 108.036 164.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -83.18 75.58 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.567 2.845 . . . . 0.35 110.006 -166.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -152.86 54.22 0.77 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.58 1.552 . . . . 0.35 108.016 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.99 48.38 0.44 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.272 0.842 . . . . 0.35 113.272 -171.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -169.71 136.74 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.722 0.809 . . . . 0.35 109.875 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -161.27 178.18 9.48 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.632 0.773 . . . . 0.35 111.378 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -145.39 157.81 52.0 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.627 1.571 . . . . 0.33 108.848 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.17 168.76 18.32 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.0 2.467 . . . . 0.35 110.866 171.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 tp -61.41 144.64 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.707 0.803 . . . . 0.35 111.33 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -156.68 94.75 2.28 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.823 -1.177 . . . . 0.33 107.823 173.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.96 -179.03 4.94 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.393 2.729 . . . . 0.35 110.585 -175.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.96 -37.47 3.7 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.748 0.69 . . . . 0.35 111.555 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.1 t -62.85 142.87 58.07 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.847 0.859 . . . . 0.35 111.459 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.6 m -82.29 135.94 35.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.475 1.11 . . . . 0.35 109.187 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 mp -117.03 131.37 56.96 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.232 1.413 . . . . 0.35 109.794 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 t -172.59 172.05 4.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.073 2.549 . . . . 0.35 106.808 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -61.06 -29.54 69.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.366 0.876 . . . . 0.35 113.366 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -83.7 -13.08 54.92 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.863 0.69 . . . . 0.35 112.863 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -98.27 -27.54 14.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.6 1.16 . . . . 0.35 111.913 173.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -39.71 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.219 -0.66 . . . . 0.35 109.219 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -67.92 -54.99 14.53 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.401 1.081 . . . . 0.35 113.198 -169.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -66.27 -35.02 79.32 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.78 0.718 . . . . 0.35 111.226 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -64.09 -53.81 43.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.954 1.302 . . . . 0.35 111.5 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.1 m -69.32 -36.36 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 123.007 0.523 . . . . 0.35 111.656 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.79 -41.37 95.46 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.824 0.85 . . . . 0.35 111.254 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -33.53 68.78 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.806 0.443 . . . . 0.35 111.201 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.64 -53.83 35.95 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.357 0.663 . . . . 0.35 110.861 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.3 -27.87 67.53 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.225 0.61 . . . . 0.35 112.01 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -67.78 -33.43 74.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.264 0.484 . . . . 0.35 110.439 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.9 28.58 0.35 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.456 0.702 . . . . 0.35 112.15 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 88.5 m -146.27 -65.36 0.3 Allowed 'General case' 0 C--N 1.344 0.336 0 C-N-CA 125.063 1.345 . . . . 0.35 108.229 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.85 -52.25 13.62 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.741 1.216 . . . . 0.35 111.207 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 73.42 150.86 0.11 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.532 1.933 . . . . 0.35 113.776 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.4 tttm 100.72 37.05 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 129.17 2.988 . . . . 0.35 111.29 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 62.21 -74.43 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.176 2.19 . . . . 0.35 114.308 166.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 87.75 159.26 0.07 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 128.459 2.703 . . . . 0.35 110.689 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -54.69 -59.96 4.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.128 0.971 . . . . 0.35 110.209 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t 56.25 76.64 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.952 1.301 . . . . 0.35 108.736 -171.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.9 t -56.99 -60.92 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 124.612 1.165 . . . . 0.35 109.984 -177.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -162.76 126.93 3.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.773 0.829 . . . . 0.35 109.0 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.0 157.36 25.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.342 0.657 . . . . 0.35 110.206 172.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.63 123.73 89.13 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.457 -0.942 . . . . 0.33 108.457 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.86 -31.81 30.68 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.171 2.581 . . . . 0.35 110.67 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 52.8 m -89.64 60.91 5.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.763 1.225 . . . . 0.35 109.536 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.34 170.1 7.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.249 1.02 . . . . 0.35 110.458 171.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -150.74 148.36 28.45 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 113.137 0.791 . . . . 0.35 113.137 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.5 mp -119.68 105.33 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.692 1.597 . . . . 0.35 107.19 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.88 76.83 9.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.607 -0.886 . . . . 0.35 108.607 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.31 94.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.065 -1.087 . . . . 0.35 108.065 172.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.8 m -88.14 75.51 8.64 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.202 -1.036 . . . . 0.35 108.202 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -68.92 121.09 15.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.035 -0.53 . . . . 0.35 110.951 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -138.94 146.71 41.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.9 1.68 . . . . 0.35 109.785 -172.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -154.2 -177.54 6.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.108 1.363 . . . . 0.35 109.48 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -133.45 59.29 1.74 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.571 -1.27 . . . . 0.35 107.571 167.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -143.78 -66.62 0.35 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.498 1.119 . . . . 0.36 109.71 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 56.54 0.23 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.827 0.451 . . . . 0.35 111.998 -171.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -159.84 -55.85 0.06 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-O 119.118 -0.468 . . . . 0.35 111.761 169.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt 80.52 160.18 0.16 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.35 110.122 -168.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.34 136.66 58.04 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.139 0.976 . . . . 0.35 110.969 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -151.85 113.25 4.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.468 1.107 . . . . 0.35 108.272 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.1 m -79.89 82.92 5.9 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.672 1.189 . . . . 0.35 109.05 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -82.66 108.27 15.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.674 -0.861 . . . . 0.35 108.674 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.6 p -85.86 63.66 8.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.743 1.217 . . . . 0.35 110.504 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -61.51 111.85 5.04 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.262 1.425 . . . . 0.33 107.904 172.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.67 -109.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.661 2.241 . . . . 0.35 111.461 -160.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.3 tp -160.64 155.84 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.893 0.877 . . . . 0.35 109.132 -177.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.7 p -106.87 173.02 6.5 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.3 1.04 . . . . 0.35 110.073 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.07 51.12 0.98 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.337 -1.357 . . . . 0.35 107.337 167.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -156.37 -76.65 0.09 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.308 1.043 . . . . 0.35 109.29 -169.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 152.07 143.46 3.7 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.85 -0.9 . . . . 0.35 110.85 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -153.17 128.01 9.54 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.694 0.798 . . . . 0.35 109.757 167.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.06 130.62 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.201 1.0 . . . . 0.35 108.983 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.76 122.69 86.71 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.727 -1.212 . . . . 0.33 107.727 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.02 -98.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.152 2.568 . . . . 0.35 111.059 -172.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -169.25 172.0 7.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.607 1.163 . . . . 0.35 110.08 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.26 137.3 13.62 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.646 1.178 . . . . 0.35 109.767 176.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.9 t -167.69 -174.81 2.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.65 0.78 . . . . 0.35 110.706 -171.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 74.05 -82.03 0.03 OUTLIER 'General case' 0 C--N 1.342 0.245 0 C-N-CA 127.055 2.142 . . . . 0.35 111.366 170.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -104.57 -50.27 3.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.983 1.313 . . . . 0.35 109.162 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.0 tp -78.67 104.77 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.238 1.015 . . . . 0.35 109.207 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -143.47 10.03 1.63 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.275 1.03 . . . . 0.35 112.502 -170.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.32 63.48 4.62 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.31 0.959 . . . . 0.36 111.817 170.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.2 -90.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.941 3.094 . . . . 0.35 112.974 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.96 78.75 0.52 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 109.338 -1.505 . . . . 0.35 109.338 -168.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -75.02 95.18 2.98 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.909 1.284 . . . . 0.35 108.894 176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -91.6 91.4 8.02 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.634 0.374 . . . . 0.36 110.683 -168.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.96 61.39 1.95 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.274 1.429 . . . . 0.35 109.027 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.58 127.91 58.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.143 1.777 . . . . 0.35 106.748 174.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 51.6 m -147.42 131.58 17.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.376 1.07 . . . . 0.35 109.371 -171.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -64.38 131.55 47.53 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.493 0.717 . . . . 0.35 109.56 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.5 m -136.98 159.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.159 0 C-N-CA 123.922 0.889 . . . . 0.35 109.655 174.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.2 124.84 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 124.369 1.067 . . . . 0.35 108.203 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.5 mt -129.43 145.49 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.854 1.261 . . . . 0.35 109.548 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -127.22 156.28 42.1 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.567 1.547 . . . . 0.35 108.822 168.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -77.02 140.79 40.47 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.561 -0.533 . . . . 0.35 109.561 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.147 0 C-N-CA 124.307 1.043 . . . . 0.25 110.667 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.028 -0.36 . . . . 0.35 110.028 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.8 t -158.31 -54.32 0.07 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.67 0.788 . . . . 0.35 109.227 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t -86.1 69.35 10.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.438 1.095 . . . . 0.35 110.88 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.1 p90 51.91 -174.35 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.389 2.275 . . . . 0.35 114.882 170.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -149.86 32.21 0.69 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.141 0.976 . . . . 0.35 110.443 165.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -131.27 -58.93 0.99 Allowed 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.717 1.607 . . . . 0.35 108.555 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.89 90.49 0.33 Allowed Glycine 0 C--N 1.341 0.834 0 C-N-CA 123.82 0.724 . . . . 0.35 111.902 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 56.82 42.46 26.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.193 1.397 . . . . 0.35 111.852 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -88.97 -40.83 12.75 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.681 1.193 . . . . 0.35 111.703 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.35 48.88 10.47 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 126.584 1.953 . . . . 0.35 112.699 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.2 pttp 67.47 -12.31 0.27 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.173 2.189 . . . . 0.35 115.015 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.68 -36.92 2.86 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.923 1.249 . . . . 0.35 110.46 -170.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.27 85.55 4.41 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.689 1.195 . . . . 0.35 110.094 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -99.64 73.48 1.82 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.918 1.287 . . . . 0.35 108.579 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.83 79.81 9.49 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.208 1.003 . . . . 0.35 109.178 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.3 p -70.65 -59.01 3.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.666 0.786 . . . . 0.35 111.58 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -158.99 -143.33 0.1 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.612 -0.885 . . . . 0.35 108.612 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.5 t80 56.97 88.14 0.05 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.256 1.822 . . . . 0.35 112.207 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 68.27 162.95 0.14 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 126.054 1.742 . . . . 0.33 112.09 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.08 99.9 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.131 2.554 . . . . 0.35 110.251 171.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.1 p -90.12 -76.66 0.42 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.447 1.099 . . . . 0.35 110.25 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.82 149.02 10.96 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 110.593 -1.003 . . . . 0.33 110.593 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.11 169.97 21.0 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 124.133 3.222 . . . . 0.35 112.506 -170.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -163.53 162.6 24.62 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.558 1.143 . . . . 0.35 110.673 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 tt -138.66 97.43 3.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.979 1.312 . . . . 0.35 107.583 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.8 ttm -98.96 108.25 20.89 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.069 1.748 . . . . 0.35 110.781 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.2 t -110.14 99.82 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.793 1.237 . . . . 0.35 110.867 -167.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -150.14 -163.92 1.9 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.89 1.276 . . . . 0.36 109.948 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.0 150.69 24.98 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 C-N-CA 124.648 1.179 . . . . 0.35 110.923 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 83.8 m -84.09 79.96 9.34 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.431 -1.692 . . . . 0.35 106.431 163.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.84 100.43 1.85 Allowed Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.481 -1.048 . . . . 0.35 110.481 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.79 169.55 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 124.893 1.277 . . . . 0.35 110.348 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -63.8 -49.34 73.29 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.942 0.897 . . . . 0.35 110.757 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.2 p -178.47 -58.48 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.598 1.959 . . . . 0.35 108.624 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.5 tttp -75.7 -73.7 0.25 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.791 0.836 . . . . 0.35 109.622 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.25 28.32 0.07 OUTLIER Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.219 -0.767 . . . . 0.35 112.976 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -90.46 94.25 9.65 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 107.252 -1.388 . . . . 0.36 107.252 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.38 110.22 3.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.06 0.944 . . . . 0.35 111.562 -168.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.6 mt -70.65 -41.51 72.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.759 1.223 . . . . 0.35 110.09 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 pp -143.98 138.24 28.3 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.727 0.811 . . . . 0.35 111.205 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.7 m -88.36 141.99 31.1 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 124.494 1.118 . . . . 0.33 110.039 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.47 -171.57 0.86 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.976 3.117 . . . . 0.35 111.688 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.7 m170 87.16 17.77 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.482 2.313 . . . . 0.35 114.087 168.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -94.0 -38.95 10.9 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.778 0.717 . . . . 0.35 112.417 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.3 t -99.08 137.96 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.204 1.002 . . . . 0.35 109.237 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -157.85 135.32 10.38 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.104 0.962 . . . . 0.35 109.431 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -120.31 143.69 36.42 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 125.362 1.465 . . . . 0.33 108.941 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.33 137.53 40.25 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.543 2.162 . . . . 0.35 109.106 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.5 tt -64.21 135.26 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 122.845 0.458 . . . . 0.35 111.999 -170.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -142.56 97.38 6.06 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 106.828 -1.545 . . . . 0.33 106.828 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.61 135.61 24.32 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.82 2.347 . . . . 0.35 110.325 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 162.95 -41.73 0.34 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.925 -0.87 . . . . 0.35 110.925 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.4 t -61.21 145.65 50.44 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.97 0.908 . . . . 0.35 110.952 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.7 m -78.77 97.49 5.93 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.877 0.871 . . . . 0.35 108.895 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -74.32 81.17 1.86 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.29 1.436 . . . . 0.35 109.56 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.5 p -150.42 165.6 32.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.56 1.544 . . . . 0.35 109.152 -171.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -54.39 -43.49 71.47 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.87 1.268 . . . . 0.35 111.69 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -50.82 -50.57 56.14 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.832 0.853 . . . . 0.35 112.381 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -102.83 38.04 1.81 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.638 0.775 . . . . 0.35 111.565 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.27 -38.06 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.488 1.515 . . . . 0.35 107.94 165.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -54.55 -67.7 0.24 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 127.053 2.141 . . . . 0.35 110.988 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -81.71 -18.13 45.44 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.078 0.551 . . . . 0.35 112.471 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -66.65 -49.46 66.14 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.142 0.577 . . . . 0.35 111.224 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.8 m -68.47 -31.12 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.391 0.676 . . . . 0.35 111.373 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.05 -40.96 97.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.745 0.818 . . . . 0.35 110.748 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.84 -33.3 72.12 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.491 0.716 . . . . 0.35 111.532 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.29 -52.92 51.1 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.122 0.569 . . . . 0.35 111.207 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.74 -33.73 76.28 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.672 0.389 . . . . 0.35 111.642 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -67.62 -30.49 70.08 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 122.699 0.4 . . . . 0.35 111.256 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.87 38.67 0.53 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.718 0.807 . . . . 0.35 110.967 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.3 m -150.83 -53.17 0.14 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.946 1.698 . . . . 0.35 107.992 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.46 -94.09 0.4 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.098 1.359 . . . . 0.35 110.505 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.4 t80 55.04 64.06 1.92 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.714 1.606 . . . . 0.35 111.623 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -137.8 -54.2 0.66 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.835 1.254 . . . . 0.35 108.797 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -125.25 78.2 1.7 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.107 1.363 . . . . 0.35 108.07 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -159.45 126.81 4.73 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.099 0.96 . . . . 0.35 108.972 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -146.37 -38.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.575 1.15 . . . . 0.35 111.537 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 t 76.65 119.55 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 126.408 1.883 . . . . 0.35 111.492 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 55.6 t -68.46 -59.16 3.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 N-CA-C 108.088 -1.079 . . . . 0.35 108.088 166.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -153.24 154.17 34.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.48 1.512 . . . . 0.35 109.023 -175.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 pp -118.6 140.74 49.41 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.472 1.109 . . . . 0.35 108.782 170.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.47 137.29 67.58 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 109.721 -0.474 . . . . 0.33 109.721 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.81 -33.77 15.74 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.449 2.766 . . . . 0.35 111.361 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -85.14 65.64 9.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.495 1.118 . . . . 0.35 109.966 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.65 158.67 35.8 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.325 0.65 . . . . 0.35 109.346 170.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -142.07 155.06 45.37 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 121.204 0.526 . . . . 0.35 112.217 -171.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mp -129.88 117.62 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.687 1.595 . . . . 0.35 107.159 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -103.72 67.41 0.89 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.357 1.063 . . . . 0.35 109.615 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.68 119.09 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 122.921 0.489 . . . . 0.35 109.883 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 m -119.42 117.46 28.53 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.508 1.123 . . . . 0.35 108.816 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.0 110.68 20.43 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.839 1.256 . . . . 0.35 109.983 -168.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -101.63 56.95 0.83 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.94 1.296 . . . . 0.35 112.316 -164.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.48 87.4 6.39 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.289 0.636 . . . . 0.35 109.404 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -77.41 65.69 3.01 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.177 0.591 . . . . 0.35 110.384 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -152.6 -48.93 0.1 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.203 1.801 . . . . 0.36 108.893 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -140.42 -66.14 0.44 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.465 1.106 . . . . 0.35 110.63 -173.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -78.72 -51.16 10.21 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.877 0.471 . . . . 0.35 111.501 -167.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 75.63 167.04 0.27 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.901 1.681 . . . . 0.35 113.013 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.84 111.98 0.94 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.333 1.853 . . . . 0.35 111.297 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -141.31 104.82 4.68 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.131 1.373 . . . . 0.35 107.656 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.5 m -77.53 88.57 3.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.617 -0.883 . . . . 0.35 108.617 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -80.26 95.81 6.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.427 -0.953 . . . . 0.35 108.427 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.6 p -90.54 61.19 4.83 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.85 1.26 . . . . 0.35 110.617 -175.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -71.12 145.13 90.83 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.582 -0.525 . . . . 0.33 109.582 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.81 -118.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.519 2.813 . . . . 0.35 109.732 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.4 tp -162.89 159.15 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.62 0.768 . . . . 0.35 110.176 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.4 p -133.97 155.7 49.49 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.873 1.269 . . . . 0.35 109.538 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -64.35 -48.82 74.07 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.074 0.95 . . . . 0.35 112.425 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -138.77 62.81 1.54 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.064 0.946 . . . . 0.35 108.915 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.3 -84.22 0.5 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.6 1.095 . . . . 0.35 112.755 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -158.0 159.17 36.13 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.421 0.526 . . . . 0.35 112.421 -158.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.6 t -82.83 154.02 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.947 1.699 . . . . 0.35 109.135 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.0 t -48.83 115.08 4.18 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.763 1.225 . . . . 0.33 109.647 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.17 165.21 26.15 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.003 2.469 . . . . 0.35 110.797 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -68.88 158.46 34.49 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.504 0.721 . . . . 0.35 110.417 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -84.09 48.68 1.51 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.546 1.138 . . . . 0.35 112.845 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.9 t 53.35 -99.78 0.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.658 1.583 . . . . 0.35 112.319 173.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -165.16 -53.83 0.03 OUTLIER 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.571 1.148 . . . . 0.35 109.305 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -90.32 44.46 1.2 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.074 1.749 . . . . 0.35 112.247 -170.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.3 tp -164.15 138.34 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.642 0.777 . . . . 0.35 110.244 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -99.54 -43.85 6.36 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.095 1.758 . . . . 0.35 110.515 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.411 ' H ' HD21 ' A' ' 122' ' ' ASN . 0.1 OUTLIER -123.25 71.17 44.73 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 115.182 1.549 . . . . 0.36 115.182 -164.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.87 140.39 92.85 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.756 2.304 . . . . 0.35 110.848 163.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.32 67.21 0.32 Allowed Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.648 -1.381 . . . . 0.35 109.648 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -58.02 103.24 0.13 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 125.047 1.339 . . . . 0.35 110.48 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -99.09 86.36 3.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.89 0.876 . . . . 0.36 109.225 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.86 86.23 0.34 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.717 1.607 . . . . 0.35 108.046 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.4 mt -134.14 115.83 21.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 124.792 1.237 . . . . 0.35 108.316 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 40.5 m -116.48 130.41 56.74 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.832 1.253 . . . . 0.35 109.566 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -75.87 128.05 34.29 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.667 -0.864 . . . . 0.35 108.667 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.38 153.54 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.116 0.966 . . . . 0.35 111.057 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.6 t -96.84 97.08 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.781 1.633 . . . . 0.35 107.555 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.5 mt -83.02 138.42 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.299 0.639 . . . . 0.35 110.865 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -103.28 113.44 26.93 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 107.537 -1.283 . . . . 0.35 107.537 164.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -91.64 91.5 8.04 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.881 0.872 . . . . 0.35 108.865 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 C--N 1.342 0.263 0 CA-C-O 121.51 0.671 . . . . 0.25 109.362 177.057 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 118.716 -0.659 . . . . 0.35 112.212 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t 74.62 -71.89 0.12 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 126.829 2.052 . . . . 0.35 110.617 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.4 p -71.87 95.15 1.5 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.256 -1.016 . . . . 0.35 108.256 171.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -41.65 117.05 0.86 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.882 2.073 . . . . 0.35 112.97 -175.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -61.8 165.21 5.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.854 1.261 . . . . 0.35 110.062 172.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.32 60.73 2.68 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.479 1.512 . . . . 0.35 110.797 -175.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.07 109.8 3.1 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.859 1.219 . . . . 0.35 112.102 -168.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt 58.48 53.01 6.53 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.326 1.45 . . . . 0.35 110.572 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -127.56 72.28 1.38 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.352 1.061 . . . . 0.35 108.836 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.34 66.94 9.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.671 1.188 . . . . 0.35 108.681 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.4 mptt 51.47 -107.33 0.3 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.29 1.836 . . . . 0.35 110.022 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.01 52.82 0.55 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 108.244 -1.942 . . . . 0.35 108.244 168.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -132.31 75.63 1.65 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.364 1.466 . . . . 0.35 108.156 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -157.93 44.58 0.33 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.823 1.249 . . . . 0.35 109.718 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.42 95.05 2.65 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.471 1.108 . . . . 0.35 108.587 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 t -53.73 -51.24 63.95 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.301 1.04 . . . . 0.35 112.118 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -154.17 57.72 0.71 Allowed 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.547 0.739 . . . . 0.35 110.462 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -138.58 69.29 1.38 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 122.722 0.409 . . . . 0.35 111.522 -170.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 68.42 163.89 0.13 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.93 1.692 . . . . 0.33 113.663 161.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -54.29 104.64 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.791 2.994 . . . . 0.35 111.047 164.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.9 p -143.35 -51.56 0.35 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.601 1.16 . . . . 0.35 109.938 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.97 81.01 0.06 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.182 -1.167 . . . . 0.33 110.182 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -70.85 170.84 16.9 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.714 2.942 . . . . 0.35 111.44 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -154.77 168.26 27.46 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.51 0.671 . . . . 0.35 112.46 -161.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -147.32 93.28 2.22 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.275 -1.75 . . . . 0.35 106.275 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 62.6 mtm -85.16 96.65 9.53 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.518 0.727 . . . . 0.35 111.339 -169.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.54 89.11 2.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 125.128 1.371 . . . . 0.35 108.359 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -151.41 176.55 11.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.429 1.092 . . . . 0.36 109.954 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 t -136.46 145.7 30.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 C-N-CA 123.873 0.869 . . . . 0.35 110.958 -171.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.6 m -82.69 84.38 7.33 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.564 -1.643 . . . . 0.35 106.564 164.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.33 83.14 1.58 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.462 -0.655 . . . . 0.35 111.462 -169.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.93 164.43 3.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 C-N-CA 123.575 0.75 . . . . 0.35 111.37 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -72.43 -45.82 57.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.069 0.948 . . . . 0.35 110.96 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.9 t 169.54 -58.02 0.01 OUTLIER 'General case' 0 C--N 1.341 0.226 0 C-N-CA 127.984 2.514 . . . . 0.35 107.586 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -71.6 -66.75 0.59 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.22 1.008 . . . . 0.35 109.891 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.73 62.91 0.02 OUTLIER Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.001 -1.239 . . . . 0.35 110.001 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -133.04 97.23 3.95 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 107.645 -1.242 . . . . 0.36 107.645 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.22 119.68 9.48 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.78 1.232 . . . . 0.35 111.276 -173.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.0 mp -84.75 -39.41 18.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.153 0.981 . . . . 0.35 110.006 170.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 pp -141.88 149.04 39.72 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.535 0.734 . . . . 0.35 112.467 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.7 m -89.33 155.26 49.03 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.558 1.143 . . . . 0.33 111.544 -167.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -83.7 44.71 1.64 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.811 3.007 . . . . 0.35 111.952 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -177.71 111.39 0.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.421 1.089 . . . . 0.35 109.936 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -163.83 -51.8 0.03 OUTLIER 'General case' 0 C--N 1.341 0.236 0 CA-C-O 118.668 -0.682 . . . . 0.35 112.518 170.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.28 -57.13 6.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 CA-C-N 119.134 0.879 . . . . 0.35 110.594 -173.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 65.9 155.08 0.08 Allowed 'General case' 0 C--N 1.343 0.292 0 C-N-CA 126.19 1.796 . . . . 0.35 113.061 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -138.55 147.02 53.32 Favored Pre-proline 0 N--CA 1.454 -0.275 0 C-N-CA 125.603 1.561 . . . . 0.33 107.521 171.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.63 144.54 55.07 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.582 2.188 . . . . 0.35 109.985 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.97 116.85 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.679 0.792 . . . . 0.35 109.437 -177.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -137.88 116.16 9.68 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.841 1.256 . . . . 0.33 108.484 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.09 178.56 7.36 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.438 2.759 . . . . 0.35 110.881 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.23 -30.29 10.67 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.9 0.762 . . . . 0.35 112.55 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.4 t -68.13 144.65 54.92 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.797 0.798 . . . . 0.35 111.088 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.6 m -71.89 145.65 48.39 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.746 -0.835 . . . . 0.35 108.746 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.98 113.89 7.63 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.443 0.697 . . . . 0.35 109.531 -167.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 t -162.22 175.25 11.85 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.686 1.594 . . . . 0.35 108.898 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -47.97 -60.45 2.6 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.359 1.463 . . . . 0.35 111.054 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -59.77 -35.24 74.22 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.375 0.88 . . . . 0.35 113.375 -174.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.42 -55.41 28.1 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 118.676 0.671 . . . . 0.35 110.62 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.3 mm -60.43 -39.33 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.281 1.033 . . . . 0.35 111.754 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -55.65 -59.19 5.2 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.645 0.657 . . . . 0.35 111.936 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -66.56 -38.1 86.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.942 0.792 . . . . 0.35 111.751 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -66.07 -45.52 81.0 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.516 0.727 . . . . 0.35 111.363 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.79 -26.17 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.61 0.764 . . . . 0.35 111.736 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -62.92 -35.55 80.45 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.11 0.564 . . . . 0.35 110.878 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -71.11 -32.53 69.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.329 0.652 . . . . 0.35 111.308 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.58 -36.44 82.72 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.066 0.546 . . . . 0.35 111.335 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.0 mt -72.76 -41.49 65.01 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 122.884 0.474 . . . . 0.35 111.065 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.49 67.6 6.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.66 0.784 . . . . 0.35 109.641 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.57 -60.48 0.1 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.783 1.233 . . . . 0.35 108.796 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.0 p -96.79 -56.42 2.58 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.617 1.167 . . . . 0.35 109.671 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.79 63.7 7.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.695 -1.224 . . . . 0.35 107.695 169.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -72.77 -57.47 4.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.282 0.633 . . . . 0.35 112.058 -164.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -93.99 -52.3 4.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.438 0.695 . . . . 0.35 111.109 -164.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.52 68.43 10.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.032 0.933 . . . . 0.35 110.235 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -163.18 155.35 18.1 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.115 0.966 . . . . 0.35 109.575 169.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -163.28 111.21 1.23 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.985 -1.117 . . . . 0.35 107.985 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.92 92.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.17 -0.678 . . . . 0.35 109.17 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.51 -40.93 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.596 1.158 . . . . 0.35 111.332 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -149.15 160.5 43.3 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.615 0.766 . . . . 0.35 110.268 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -137.61 142.54 41.24 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.901 1.28 . . . . 0.35 110.441 -175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.77 132.76 82.87 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 109.398 -0.593 . . . . 0.33 109.398 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.74 -34.96 13.6 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.194 2.596 . . . . 0.35 110.751 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -81.53 78.83 8.24 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.152 0.981 . . . . 0.35 110.473 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.85 166.07 16.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.37 0.668 . . . . 0.35 109.269 164.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -153.7 122.06 6.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.73 0.3 . . . . 0.35 111.637 -168.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.0 mp -94.28 124.27 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.546 1.538 . . . . 0.35 107.325 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -111.25 84.29 1.91 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.486 -1.301 . . . . 0.35 107.486 174.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.95 96.86 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 108.975 -0.75 . . . . 0.35 108.975 171.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -86.57 87.45 7.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.273 -1.751 . . . . 0.35 106.273 171.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -86.78 80.63 8.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.234 0.54 . . . . 0.35 110.168 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -91.11 144.09 26.0 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.883 1.273 . . . . 0.35 111.034 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -166.38 89.8 0.4 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.039 -1.467 . . . . 0.35 107.039 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -77.54 74.36 4.1 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.142 0.977 . . . . 0.35 108.636 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -154.67 -48.98 0.09 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.581 1.952 . . . . 0.36 108.339 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.23 -45.99 0.1 Allowed 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.554 0.742 . . . . 0.35 112.561 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -73.64 -57.37 4.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.614 0.643 . . . . 0.35 111.495 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt 82.96 158.05 0.12 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.974 1.71 . . . . 0.35 111.7 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.91 135.26 20.2 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 126.438 1.895 . . . . 0.35 113.243 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -150.05 103.67 3.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.743 1.217 . . . . 0.35 107.997 170.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.2 m -77.19 87.43 3.65 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.408 1.083 . . . . 0.35 108.757 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -97.88 103.64 15.6 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.572 1.149 . . . . 0.35 108.32 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.6 p -83.32 143.16 30.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.276 1.03 . . . . 0.35 111.266 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -151.45 152.97 31.71 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.422 1.089 . . . . 0.33 108.856 169.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.43 -117.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.357 2.705 . . . . 0.35 110.897 -171.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tp -158.76 150.16 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.901 0.88 . . . . 0.35 109.559 -173.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.3 p -91.85 172.68 8.3 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.025 0.93 . . . . 0.35 110.807 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -102.9 -28.39 12.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.324 1.45 . . . . 0.35 109.386 165.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -62.63 -76.04 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.0 1.32 . . . . 0.35 111.777 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 133.93 73.73 0.09 OUTLIER Glycine 0 C--N 1.341 0.86 0 N-CA-C 110.354 -1.099 . . . . 0.35 110.354 -172.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -77.21 131.1 38.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.336 0.568 . . . . 0.35 109.685 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.63 127.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.678 -1.23 . . . . 0.35 107.678 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.16 115.35 12.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.698 -1.223 . . . . 0.33 107.698 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -82.84 -174.04 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.115 2.543 . . . . 0.35 110.866 -170.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -69.37 -171.57 0.37 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.858 0.863 . . . . 0.35 110.109 167.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.27 1.76 2.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.663 0.785 . . . . 0.35 113.094 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 t 65.08 -154.62 0.28 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.177 0.991 . . . . 0.35 111.516 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -96.6 -50.14 4.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.715 1.206 . . . . 0.35 111.483 -166.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -50.45 -41.77 53.24 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.965 1.306 . . . . 0.35 112.896 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.3 tp -105.36 144.23 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.783 1.233 . . . . 0.35 108.488 168.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -149.93 17.4 0.87 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.553 1.141 . . . . 0.35 111.405 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.81 70.16 2.02 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.359 1.064 . . . . 0.36 110.074 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -87.98 -172.69 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.434 3.423 . . . . 0.35 112.26 -170.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.88 84.26 0.17 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.596 -1.402 . . . . 0.35 109.596 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -74.88 81.24 2.14 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.31 1.444 . . . . 0.35 109.917 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -90.58 104.31 16.9 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.048 0.539 . . . . 0.36 110.437 -169.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.88 90.59 4.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.005 -1.109 . . . . 0.35 108.005 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.2 mt -96.59 74.76 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 106.97 -1.493 . . . . 0.35 106.97 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.1 m -78.67 170.73 16.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.641 1.176 . . . . 0.35 109.127 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -141.94 133.81 27.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.43 1.092 . . . . 0.35 108.861 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.3 m -142.52 159.62 19.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 123.652 0.781 . . . . 0.35 110.803 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.4 t -90.85 126.83 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.117 1.367 . . . . 0.35 108.205 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 34.9 mt -116.65 120.35 64.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.295 1.038 . . . . 0.35 110.159 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -80.29 120.43 24.34 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.267 1.427 . . . . 0.35 108.073 164.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -89.07 -3.51 58.65 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.414 1.086 . . . . 0.35 112.997 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? . . . . . 0 C--N 1.343 0.323 0 C-N-CA 125.52 1.528 . . . . 0.25 110.333 -164.267 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 119.04 -0.505 . . . . 0.35 110.408 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m -14.15 -78.0 0.01 OUTLIER 'General case' 0 C--N 1.344 0.347 0 C-N-CA 129.317 3.047 . . . . 0.35 114.61 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.5 p -133.73 63.36 1.63 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.406 1.083 . . . . 0.35 108.746 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -9.22 96.55 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 129.445 3.098 . . . . 0.35 115.274 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -93.59 71.78 4.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.803 0.841 . . . . 0.35 108.917 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -157.47 -51.39 0.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.409 1.083 . . . . 0.35 110.163 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.49 67.45 0.89 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.825 -0.91 . . . . 0.35 110.825 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt 56.14 -121.45 1.62 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.431 1.492 . . . . 0.35 110.904 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.9 t80 61.71 99.64 0.03 OUTLIER 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.499 1.92 . . . . 0.35 112.181 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.81 52.43 0.94 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.685 1.194 . . . . 0.35 110.678 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.6 mttt 79.55 -65.18 0.2 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 126.915 2.086 . . . . 0.35 111.866 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 147.09 -47.8 0.67 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 108.387 -1.885 . . . . 0.35 108.387 -168.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 48.4 51.15 15.66 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.881 2.073 . . . . 0.35 113.809 167.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 56.66 54.39 7.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.901 1.281 . . . . 0.35 111.778 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.16 -158.33 0.32 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.553 1.141 . . . . 0.35 112.984 171.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 p -162.79 -35.6 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.482 1.113 . . . . 0.35 111.812 -171.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -133.8 39.44 3.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.705 1.202 . . . . 0.35 109.944 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -147.37 73.05 1.27 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 122.775 0.43 . . . . 0.35 110.788 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 65.8 177.99 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.191 1.396 . . . . 0.33 112.886 162.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -74.89 60.41 5.34 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.596 2.864 . . . . 0.35 113.742 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.2 p -68.01 -40.97 82.9 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.566 0.746 . . . . 0.35 109.915 170.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.96 166.79 22.36 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 111.881 -0.488 . . . . 0.33 111.881 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.03 -177.45 3.72 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.875 3.717 . . . . 0.35 111.807 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -156.46 171.8 19.65 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.594 1.157 . . . . 0.35 110.452 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tt -149.16 82.61 1.43 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.957 -1.127 . . . . 0.35 107.957 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -67.42 133.14 49.01 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.378 0.671 . . . . 0.35 110.166 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.8 t -128.67 86.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 125.076 1.35 . . . . 0.35 108.423 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -146.93 177.97 8.72 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.989 1.315 . . . . 0.36 109.254 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.3 m -137.71 144.05 32.21 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 C-N-CA 124.348 1.059 . . . . 0.35 110.34 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.7 m -75.99 97.35 3.99 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.305 -0.998 . . . . 0.35 108.305 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.92 84.01 1.57 Allowed Glycine 0 C--N 1.338 0.686 0 C-N-CA 123.988 0.804 . . . . 0.35 111.535 -172.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.8 m -77.14 165.5 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.25 0.62 . . . . 0.35 110.315 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.4 -66.53 0.89 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.884 0.474 . . . . 0.35 109.862 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.6 m -158.42 -56.0 0.07 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.61 1.564 . . . . 0.35 108.249 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.25 45.42 1.02 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.763 1.225 . . . . 0.35 110.17 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.59 29.03 73.45 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.161 0.886 . . . . 0.35 113.419 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -96.75 97.71 9.56 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 117.933 0.866 . . . . 0.36 108.887 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.08 116.26 4.39 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.506 1.123 . . . . 0.35 111.541 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.7 mp -73.16 -45.82 54.34 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.327 0.651 . . . . 0.35 109.386 168.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 pp -138.58 138.82 38.29 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.308 1.043 . . . . 0.35 111.978 -171.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.7 t -82.32 138.08 45.27 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 124.658 1.183 . . . . 0.33 109.107 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -86.31 61.36 4.73 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.648 2.899 . . . . 0.35 111.825 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -149.11 65.31 1.03 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.609 0.764 . . . . 0.35 109.845 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -128.61 -52.74 1.25 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.159 0.984 . . . . 0.35 111.261 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.1 t -101.47 140.49 20.02 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 123.214 0.606 . . . . 0.35 109.893 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.7 170.06 19.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.643 0.777 . . . . 0.35 110.109 164.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -140.13 147.94 52.49 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.133 0.973 . . . . 0.33 109.373 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.38 126.89 14.86 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.346 2.031 . . . . 0.35 107.911 168.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.3 tt -57.83 137.57 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.36 0.664 . . . . 0.35 112.585 -168.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 86.62 8.99 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.961 1.705 . . . . 0.33 107.765 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.16 168.47 23.94 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.193 2.595 . . . . 0.35 111.371 -170.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.51 -28.64 14.14 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.025 0.821 . . . . 0.35 111.802 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.0 t -65.58 148.03 52.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.722 0.809 . . . . 0.35 110.879 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -74.61 124.27 26.36 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.419 0.688 . . . . 0.35 109.702 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.96 102.28 7.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.34 1.456 . . . . 0.35 107.435 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.2 t -139.8 -175.99 4.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.596 1.158 . . . . 0.35 108.882 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -55.71 -60.16 3.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.668 0.787 . . . . 0.35 110.672 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.6 -33.19 74.5 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.376 0.88 . . . . 0.35 113.376 -173.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -61.23 2.5 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.246 0.93 . . . . 0.35 110.055 175.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.13 -31.78 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.35 1.06 . . . . 0.35 111.342 -170.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.74 -62.46 1.64 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.653 1.181 . . . . 0.35 111.572 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.04 -34.97 78.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.166 0.439 . . . . 0.35 111.539 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -63.6 -46.8 84.11 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.621 0.768 . . . . 0.35 111.663 -175.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.8 p -73.66 -31.93 33.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 122.809 0.443 . . . . 0.35 111.724 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -58.95 -31.89 69.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.279 0.632 . . . . 0.35 111.512 173.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -76.54 -38.33 55.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.922 0.489 . . . . 0.35 110.771 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.31 -62.27 1.96 Allowed 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.335 1.054 . . . . 0.35 111.942 -174.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.13 -23.88 67.48 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.048 0.758 . . . . 0.35 113.048 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -80.43 66.66 6.01 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.813 1.245 . . . . 0.35 110.972 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.07 49.86 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.798 1.639 . . . . 0.35 108.672 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.2 p -140.08 -62.41 0.51 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.047 1.339 . . . . 0.35 108.873 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.29 -64.93 1.01 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.118 1.367 . . . . 0.35 108.686 172.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.62 68.99 0.78 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.873 1.669 . . . . 0.35 110.802 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -132.8 47.7 2.48 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.993 1.317 . . . . 0.35 108.53 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 63.6 111.51 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.065 2.146 . . . . 0.35 112.36 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -111.57 99.52 8.25 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.271 1.428 . . . . 0.35 108.107 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -81.28 98.49 8.15 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.369 -0.604 . . . . 0.35 109.369 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.5 96.83 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.907 -0.775 . . . . 0.35 108.907 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.53 -46.02 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.652 0.781 . . . . 0.35 111.035 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -137.96 164.41 29.11 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.71 1.204 . . . . 0.35 110.225 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 pp -157.66 158.29 35.17 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.861 1.264 . . . . 0.35 110.316 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.23 121.22 68.86 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 108.533 -0.914 . . . . 0.33 108.533 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.77 -39.46 3.4 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.019 2.479 . . . . 0.35 110.938 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -79.49 83.48 5.49 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.006 0.923 . . . . 0.35 109.291 176.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.07 129.75 41.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.628 0.771 . . . . 0.35 109.778 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -100.23 136.38 40.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.575 1.15 . . . . 0.35 110.82 -172.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.43 120.27 58.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 125.633 1.573 . . . . 0.35 108.492 -173.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -117.9 90.56 3.36 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.819 1.248 . . . . 0.35 108.647 -172.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 m -77.06 94.08 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.261 1.024 . . . . 0.35 110.544 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 88.1 m -91.88 90.62 7.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.634 1.574 . . . . 0.35 108.532 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.75 93.9 7.78 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.823 0.849 . . . . 0.35 110.534 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -86.09 62.55 7.51 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.71 1.604 . . . . 0.35 109.615 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -98.99 78.63 2.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.996 1.319 . . . . 0.35 107.469 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.12 80.28 4.55 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.656 1.182 . . . . 0.35 109.376 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -150.75 -41.43 0.12 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.784 2.034 . . . . 0.36 108.442 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.65 -39.75 0.18 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.817 1.647 . . . . 0.35 110.894 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -85.77 -54.75 4.34 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.0 0.92 . . . . 0.35 111.439 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 83.3 tttt 69.52 158.51 0.17 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.877 1.671 . . . . 0.35 110.856 -172.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.73 123.62 14.74 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.105 0.562 . . . . 0.35 111.446 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -145.0 105.64 4.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.91 1.284 . . . . 0.35 107.841 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.7 m -82.62 86.85 6.75 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.949 1.299 . . . . 0.35 108.968 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.3 101.61 14.28 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.014 0.926 . . . . 0.35 108.85 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.8 p -80.35 144.21 32.92 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.415 1.086 . . . . 0.35 111.266 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -158.95 137.0 7.46 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 123.282 0.633 . . . . 0.33 110.719 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.6 161.73 27.77 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.858 3.039 . . . . 0.35 110.525 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.0 tp -95.42 151.66 3.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 123.788 0.835 . . . . 0.35 110.339 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 67.6 p -86.67 112.18 21.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.835 -1.172 . . . . 0.35 107.835 169.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.15 -21.76 66.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.478 1.111 . . . . 0.35 113.596 -173.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.05 -44.05 97.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.899 0.88 . . . . 0.35 111.713 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.32 135.15 1.77 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.519 -1.033 . . . . 0.35 110.519 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -159.27 166.86 30.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.372 1.069 . . . . 0.35 109.555 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.67 144.6 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.283 1.433 . . . . 0.35 109.229 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.19 116.33 15.58 Favored Pre-proline 0 C--N 1.345 0.405 0 N-CA-C 108.156 -1.053 . . . . 0.33 108.156 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.42 -101.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.921 2.414 . . . . 0.35 110.902 -167.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -166.17 169.04 14.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.098 0.959 . . . . 0.35 109.376 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.53 17.54 0.86 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.767 1.227 . . . . 0.35 112.635 172.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.8 t 63.04 -95.13 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.647 1.579 . . . . 0.35 111.024 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -167.36 -48.76 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.167 0.987 . . . . 0.35 109.855 -174.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -70.76 -0.34 8.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.495 1.518 . . . . 0.35 114.943 -168.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.7 pt -133.24 -172.98 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.411 1.084 . . . . 0.35 110.188 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -130.6 -45.32 1.08 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.414 1.486 . . . . 0.35 110.62 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -119.92 74.49 19.71 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 0.36 112.772 -162.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -69.27 141.27 46.74 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.17 1.913 . . . . 0.35 109.935 171.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.24 79.7 0.28 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.405 -1.478 . . . . 0.35 109.405 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -66.67 92.92 0.23 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.713 1.205 . . . . 0.35 110.713 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -85.37 98.68 10.69 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.877 -1.157 . . . . 0.36 107.877 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.93 53.82 2.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.171 0.988 . . . . 0.35 109.196 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.0 mt -99.03 99.29 8.31 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 124.462 1.105 . . . . 0.35 108.681 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 96.3 m -105.63 140.53 38.56 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.102 1.361 . . . . 0.35 109.231 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 126.46 31.63 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.525 0.73 . . . . 0.35 109.326 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.34 148.33 32.77 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 C-N-CA 123.888 0.875 . . . . 0.35 110.299 172.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 t -96.51 130.83 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.689 1.196 . . . . 0.35 108.364 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mt -126.97 105.95 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.829 1.251 . . . . 0.35 109.222 -173.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -71.58 132.07 44.13 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.79 -1.189 . . . . 0.35 107.79 159.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 94.83 4.4 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.403 0.681 . . . . 0.35 109.497 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.344 0.337 0 C-N-CA 124.969 1.307 . . . . 0.25 109.438 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 110.162 -0.31 . . . . 0.35 110.162 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.0 m -89.13 57.24 3.99 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.458 1.103 . . . . 0.35 108.263 172.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t 55.23 64.87 1.64 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.356 1.463 . . . . 0.35 110.648 -169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -60.66 135.48 57.78 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.878 0.871 . . . . 0.35 110.102 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -164.96 99.07 0.76 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.752 0.821 . . . . 0.35 110.077 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -157.89 37.68 0.26 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.257 1.023 . . . . 0.35 109.946 168.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.43 159.93 9.74 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.017 0.818 . . . . 0.35 111.18 -174.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -74.76 96.95 3.15 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.985 0.514 . . . . 0.35 110.189 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -85.88 79.12 9.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.305 1.042 . . . . 0.35 110.609 -174.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -137.84 -158.12 0.83 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.913 0.885 . . . . 0.35 109.187 170.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.9 tttt 62.61 46.86 5.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.197 0.999 . . . . 0.35 109.542 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.11 -42.88 1.85 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.046 1.308 . . . . 0.35 111.653 -172.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -85.47 56.52 3.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.588 1.155 . . . . 0.35 110.558 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 54.85 28.71 10.78 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.682 1.993 . . . . 0.35 113.693 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.17 140.63 29.3 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.384 0.674 . . . . 0.35 110.889 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -166.32 -130.13 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.154 0.982 . . . . 0.35 109.511 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -138.82 164.83 28.61 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.306 1.842 . . . . 0.35 108.951 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.7 t80 66.72 103.62 0.04 OUTLIER 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.763 1.625 . . . . 0.35 110.673 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 75.66 144.65 0.1 Allowed Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 126.109 1.764 . . . . 0.33 110.079 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.62 96.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.443 2.762 . . . . 0.35 111.847 171.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.1 p -94.33 -44.3 8.0 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.008 0.923 . . . . 0.35 110.291 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.21 150.38 8.64 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 112.032 -0.427 . . . . 0.33 112.032 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -92.21 -170.12 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.939 3.093 . . . . 0.35 111.098 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -168.75 165.32 11.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.006 0.922 . . . . 0.35 111.73 172.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.0 tp -134.42 88.54 2.46 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.94 1.696 . . . . 0.35 107.731 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -78.41 125.57 29.55 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.883 1.273 . . . . 0.35 108.312 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -135.65 91.09 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.882 0.873 . . . . 0.35 109.382 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -149.28 157.68 43.55 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.465 1.506 . . . . 0.36 109.169 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.13 161.09 42.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 123.806 0.843 . . . . 0.35 112.146 -168.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.3 m -87.91 91.15 8.66 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.841 1.257 . . . . 0.35 108.438 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.06 104.24 2.66 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.653 -0.979 . . . . 0.35 110.653 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.35 174.0 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.224 1.01 . . . . 0.35 111.033 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -71.62 -55.82 7.03 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.065 0.546 . . . . 0.35 109.675 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.2 p -150.1 -71.04 0.18 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.067 0.947 . . . . 0.35 110.559 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -85.45 -73.33 0.45 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.862 0.865 . . . . 0.35 110.541 -171.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.49 50.77 0.41 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.341 -1.104 . . . . 0.35 110.341 -176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -115.82 79.99 1.38 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.338 1.455 . . . . 0.36 108.714 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.46 138.76 58.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.036 1.334 . . . . 0.35 112.256 -173.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mp -113.96 -24.84 8.85 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.311 1.445 . . . . 0.35 110.666 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.51 146.0 32.16 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.355 1.062 . . . . 0.35 111.738 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.8 m -81.33 153.6 71.51 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.367 1.067 . . . . 0.33 110.331 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.99 50.44 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.78 2.987 . . . . 0.35 111.521 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -173.21 103.96 0.13 Allowed 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.09 0.556 . . . . 0.35 111.038 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -164.88 14.02 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.5 0.926 . . . . 0.35 113.5 172.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.6 t -149.16 135.22 12.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 C-N-CA 125.241 1.416 . . . . 0.35 107.441 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -139.46 171.05 14.82 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.128 0.571 . . . . 0.35 111.295 169.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -140.81 151.7 63.61 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.765 1.226 . . . . 0.33 109.967 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.04 100.61 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.487 2.791 . . . . 0.35 109.397 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.77 138.17 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.262 1.025 . . . . 0.35 111.508 -171.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -138.53 137.11 19.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.717 1.207 . . . . 0.33 108.733 171.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.24 169.36 22.67 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.647 2.898 . . . . 0.35 110.864 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 110.63 -31.21 7.51 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.108 0.861 . . . . 0.35 111.841 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 t -66.13 146.27 54.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.559 0.744 . . . . 0.35 111.146 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.7 m -74.21 152.91 39.67 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.455 1.102 . . . . 0.35 109.282 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.04 121.13 8.28 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.4 0.68 . . . . 0.35 109.482 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 t -166.09 174.53 9.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.689 1.996 . . . . 0.35 107.846 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.62 -52.18 64.67 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.692 0.797 . . . . 0.35 111.23 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.75 -24.72 67.88 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.184 0.809 . . . . 0.35 113.184 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -71.85 -51.66 21.3 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.371 0.668 . . . . 0.35 110.582 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.2 -33.25 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.51 1.124 . . . . 0.35 111.886 -172.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -55.29 -55.23 33.82 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.463 1.105 . . . . 0.35 111.714 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -66.99 -30.29 70.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.073 0.397 . . . . 0.35 111.867 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -52.88 61.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.483 0.713 . . . . 0.35 110.209 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -61.13 -38.95 80.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 CA-C-O 119.038 -0.506 . . . . 0.35 111.343 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.92 -36.16 76.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.586 0.755 . . . . 0.35 111.875 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -70.2 -48.04 58.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.93 0.492 . . . . 0.35 110.844 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.95 97.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.427 0.691 . . . . 0.35 111.52 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 mt -54.51 -58.78 6.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.22 1.408 . . . . 0.35 110.304 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -61.38 -59.62 4.99 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.01 0.924 . . . . 0.35 111.652 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -41.23 -48.8 3.58 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 126.131 1.772 . . . . 0.35 113.429 -171.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.5 m -74.13 -63.61 1.19 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.348 0.659 . . . . 0.35 109.924 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.56 96.08 5.69 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.01 1.324 . . . . 0.35 109.915 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -112.18 70.67 0.72 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.196 1.399 . . . . 0.35 109.571 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -137.95 -113.17 0.17 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.745 0.818 . . . . 0.35 109.906 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.42 83.22 6.86 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.414 1.086 . . . . 0.35 110.81 -173.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -152.43 162.87 40.58 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.317 0.647 . . . . 0.35 111.469 176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -173.98 125.05 0.35 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.549 1.94 . . . . 0.35 106.789 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.96 91.74 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.297 -1.001 . . . . 0.35 108.297 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 p -61.2 -43.92 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.885 0.874 . . . . 0.35 110.985 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -151.1 169.16 22.52 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.943 0.897 . . . . 0.35 110.12 169.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 pp -144.64 149.56 35.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.285 1.034 . . . . 0.35 109.992 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.86 135.73 55.35 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.578 -0.897 . . . . 0.33 108.578 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.46 -24.44 22.46 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.162 2.575 . . . . 0.35 111.923 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 m -86.21 70.03 10.51 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.57 1.148 . . . . 0.35 110.855 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.39 164.35 26.49 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.767 0.827 . . . . 0.35 109.965 168.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -150.02 121.72 8.07 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.134 0.493 . . . . 0.35 112.313 -174.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 mp -77.74 114.69 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.663 -1.606 . . . . 0.35 106.663 165.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -110.23 63.42 0.61 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.34 -0.985 . . . . 0.35 108.34 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.09 111.11 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.405 0.682 . . . . 0.35 110.945 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.5 m -98.45 81.85 2.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.49 1.516 . . . . 0.35 108.263 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -87.27 112.56 22.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.245 1.018 . . . . 0.35 108.577 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -104.67 117.49 34.23 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.547 1.139 . . . . 0.35 110.578 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -128.37 89.34 2.89 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.597 1.159 . . . . 0.35 110.236 -172.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -82.82 67.83 9.06 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.04 -0.726 . . . . 0.35 109.04 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -149.0 -54.17 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.225 1.41 . . . . 0.36 109.134 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.74 -48.11 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.634 0.773 . . . . 0.35 112.823 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -71.94 -34.32 68.94 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.884 0.874 . . . . 0.35 112.17 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt 72.68 174.9 0.29 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.118 1.367 . . . . 0.35 110.945 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -79.16 132.23 36.48 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.209 0.604 . . . . 0.35 110.876 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -139.87 113.4 8.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.585 1.154 . . . . 0.35 108.562 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.6 m -80.2 84.88 5.81 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.658 -1.238 . . . . 0.35 107.658 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -78.82 105.66 10.29 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.898 0.879 . . . . 0.35 109.35 -173.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.5 m -87.95 67.79 9.08 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.585 1.154 . . . . 0.35 111.163 -172.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -69.56 140.87 89.97 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.216 1.006 . . . . 0.33 108.74 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -78.78 -116.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.265 2.644 . . . . 0.35 110.335 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.1 tp -160.52 150.83 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.17 0.988 . . . . 0.35 108.862 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.0 p -103.4 175.7 5.39 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.036 0.934 . . . . 0.35 110.611 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.83 -10.79 15.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.592 1.557 . . . . 0.35 110.573 164.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -77.31 -82.97 0.08 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 124.813 1.245 . . . . 0.35 110.713 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 145.4 63.85 0.02 OUTLIER Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.155 -1.178 . . . . 0.35 110.155 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -72.27 129.71 39.07 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 117.508 0.654 . . . . 0.35 109.728 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.71 130.99 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.395 -0.965 . . . . 0.35 108.395 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.6 117.24 29.51 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 107.918 -1.141 . . . . 0.33 107.918 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.27 172.02 16.05 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.199 2.6 . . . . 0.35 110.898 -173.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.11 34.53 0.62 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.146 0.978 . . . . 0.35 110.932 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 32.66 54.0 0.36 Allowed 'General case' 0 C--N 1.346 0.43 0 C-N-CA 128.041 2.536 . . . . 0.35 113.878 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.1 t 56.47 -105.84 0.29 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.893 1.677 . . . . 0.35 111.467 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -163.22 -38.17 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.233 1.013 . . . . 0.35 110.654 -172.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -55.22 -13.6 1.37 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.26 1.824 . . . . 0.35 115.169 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -153.14 148.23 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.574 1.15 . . . . 0.35 108.978 171.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.49 34.77 3.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.37 1.868 . . . . 0.35 111.337 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -153.37 79.48 5.48 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.318 0.647 . . . . 0.36 111.378 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.59 167.67 25.1 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.022 2.482 . . . . 0.35 111.527 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.0 68.2 0.47 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.194 -1.163 . . . . 0.35 110.194 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -59.73 103.05 0.18 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.165 1.386 . . . . 0.35 111.26 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -100.39 98.41 9.05 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.072 0.949 . . . . 0.36 109.449 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.96 73.83 10.24 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.116 0.966 . . . . 0.35 108.535 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.6 mt -91.05 91.29 3.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.093 -1.447 . . . . 0.35 107.093 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.1 m -111.58 150.48 29.98 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.688 1.195 . . . . 0.35 109.468 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -91.75 130.3 37.56 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.151 1.38 . . . . 0.35 109.053 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 m -137.5 169.46 19.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 123.753 0.821 . . . . 0.35 110.351 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 37.9 t -119.73 139.75 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.035 1.334 . . . . 0.35 108.111 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.7 mt -130.54 119.35 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.232 1.013 . . . . 0.35 109.503 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -78.71 127.2 31.76 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.923 -1.14 . . . . 0.35 107.923 161.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -95.24 60.32 2.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.241 1.017 . . . . 0.35 111.252 -168.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.186 0 C-N-CA 124.004 0.921 . . . . 0.25 110.021 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 110.713 -0.106 . . . . 0.35 110.713 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -68.66 176.11 3.15 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.619 1.167 . . . . 0.35 112.094 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.9 p -137.13 166.45 23.7 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.294 1.438 . . . . 0.35 109.919 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -82.45 145.66 29.71 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.82 0.448 . . . . 0.35 110.817 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -95.02 162.29 13.79 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.125 0.97 . . . . 0.35 110.33 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 pttm 50.51 83.36 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.557 1.943 . . . . 0.35 112.57 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.22 103.32 0.33 Allowed Glycine 0 C--N 1.341 0.845 0 C-N-CA 126.387 1.946 . . . . 0.35 112.621 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt 75.1 -33.68 0.24 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 126.688 1.995 . . . . 0.35 113.743 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -55.1 123.13 12.65 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.138 0.975 . . . . 0.35 110.173 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -101.43 27.85 5.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.491 -0.766 . . . . 0.35 112.996 -159.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? 69.53 -63.95 0.36 Allowed 'General case' 0 C--N 1.346 0.435 0 C-N-CA 126.21 1.804 . . . . 0.35 109.907 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.59 -151.49 6.7 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.605 -1.798 . . . . 0.35 108.605 172.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 57.62 37.73 27.54 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.371 1.068 . . . . 0.35 111.753 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.91 64.63 0.96 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.507 1.123 . . . . 0.35 109.335 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.51 -41.53 60.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.009 0.924 . . . . 0.35 110.345 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.6 t 74.26 -74.67 0.08 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.779 2.032 . . . . 0.35 112.064 175.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -155.22 171.56 19.62 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.332 0.653 . . . . 0.35 111.257 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 70.11 121.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.709 2.004 . . . . 0.35 112.633 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 73.93 137.81 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 126.17 1.788 . . . . 0.33 112.223 168.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.79 109.62 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.19 3.26 . . . . 0.35 111.922 160.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 p -138.06 -62.54 0.58 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.847 1.259 . . . . 0.35 109.588 -174.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.0 113.08 0.31 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.46 -1.056 . . . . 0.33 110.46 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.24 176.58 9.87 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.003 2.469 . . . . 0.35 111.803 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -159.06 163.09 36.61 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.207 1.003 . . . . 0.35 110.344 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.8 tt -145.11 94.61 2.55 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.458 -1.312 . . . . 0.35 107.458 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.3 ptp -88.74 139.06 30.85 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.884 0.874 . . . . 0.35 110.357 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.6 91.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.205 0 C-N-CA 124.636 1.174 . . . . 0.35 107.874 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -153.59 166.1 33.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.699 1.2 . . . . 0.36 110.139 -171.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -144.94 170.59 6.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 123.147 0.579 . . . . 0.35 112.352 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -107.0 121.46 44.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.155 1.382 . . . . 0.35 108.264 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.55 92.41 1.72 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.15 0.881 . . . . 0.35 111.624 -174.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.0 m -99.08 168.63 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 124.316 1.046 . . . . 0.35 112.852 -174.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -83.09 172.72 12.41 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.626 1.17 . . . . 0.35 109.563 166.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -57.18 -40.94 78.33 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.722 0.809 . . . . 0.35 110.39 170.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -62.02 -55.29 30.67 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.061 0.945 . . . . 0.35 110.186 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.1 4.29 0.59 Allowed Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.938 -0.923 . . . . 0.35 114.017 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -79.32 123.18 27.22 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.774 1.287 . . . . 0.36 110.217 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -65.21 104.11 0.87 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.912 0.885 . . . . 0.35 110.976 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 mp -69.65 -56.77 6.34 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.751 -1.203 . . . . 0.35 107.751 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.5 mt -120.65 164.91 15.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.188 1.795 . . . . 0.35 108.789 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.8 m -142.74 68.26 19.17 Favored Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 124.522 1.129 . . . . 0.33 108.015 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.08 106.29 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.578 2.852 . . . . 0.35 110.073 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -146.34 90.58 1.96 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.926 1.69 . . . . 0.35 108.187 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -155.55 -33.36 0.09 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.056 0.762 . . . . 0.35 113.056 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.6 t -76.22 98.7 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.975 0.91 . . . . 0.35 111.216 -176.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -86.97 170.09 11.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.317 0.647 . . . . 0.35 110.141 167.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -155.41 131.1 5.47 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.269 -1.011 . . . . 0.33 108.269 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.48 121.84 8.8 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.815 2.343 . . . . 0.35 109.059 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.0 tt -57.53 133.85 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.32 1.048 . . . . 0.35 112.856 -168.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -142.77 98.39 5.77 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 125.565 1.546 . . . . 0.33 107.495 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.77 173.66 13.76 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.247 2.631 . . . . 0.35 111.288 -174.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.42 -26.48 24.17 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.013 0.816 . . . . 0.35 112.159 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.1 t -66.32 151.51 46.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.889 0.844 . . . . 0.35 110.796 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -62.46 148.62 45.07 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.959 0.903 . . . . 0.35 110.118 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.51 101.23 2.64 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.368 -0.975 . . . . 0.35 108.368 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 t -144.89 -171.07 3.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.165 1.386 . . . . 0.35 108.752 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -58.19 -57.41 12.99 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.35 110.674 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -61.96 -29.03 69.96 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.518 0.562 . . . . 0.35 112.518 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -62.39 -54.01 46.54 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.547 -0.538 . . . . 0.35 109.547 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 mm -51.14 -55.38 7.76 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 124.526 1.13 . . . . 0.35 109.786 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -45.98 -63.75 0.91 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.675 1.19 . . . . 0.35 112.406 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -63.62 -38.46 91.19 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.465 0.575 . . . . 0.35 111.894 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.1 -49.15 62.97 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.491 0.716 . . . . 0.35 110.644 -173.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.61 -37.22 79.46 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 118.454 0.57 . . . . 0.35 111.551 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -58.83 -44.37 90.88 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.357 0.663 . . . . 0.35 110.589 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -67.57 -34.8 77.79 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.568 0.347 . . . . 0.35 110.85 176.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.04 -64.78 0.83 Allowed 'General case' 0 C--N 1.343 0.287 0 CA-C-O 118.605 -0.712 . . . . 0.35 111.502 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -66.43 -35.32 79.99 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.647 0.658 . . . . 0.35 112.368 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -90.14 49.39 1.69 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.489 0.715 . . . . 0.35 110.578 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.0 -51.99 2.88 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.328 1.451 . . . . 0.35 107.362 164.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.5 p -79.56 -45.76 18.6 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.566 1.146 . . . . 0.35 110.291 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.18 -93.22 0.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.633 0.773 . . . . 0.35 110.695 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 62.28 -151.14 0.36 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.978 1.311 . . . . 0.35 110.674 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? 66.38 -80.45 0.03 OUTLIER 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.678 1.991 . . . . 0.35 111.549 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -84.28 -115.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.05 -1.093 . . . . 0.35 108.05 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 59.3 82.39 0.15 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.248 1.419 . . . . 0.35 111.455 171.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.5 ttm105 -66.14 -55.23 17.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.698 0.799 . . . . 0.35 109.98 172.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 t 60.89 78.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 125.189 1.396 . . . . 0.35 109.11 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.38 -43.71 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.083 0.953 . . . . 0.35 112.232 -171.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -138.44 170.53 15.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.247 1.019 . . . . 0.35 110.552 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 pp -153.5 159.84 42.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.359 1.464 . . . . 0.35 109.159 171.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.05 120.57 82.19 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 109.222 -0.658 . . . . 0.33 109.222 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -70.72 -33.0 13.62 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.186 2.591 . . . . 0.35 110.97 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -82.7 70.49 9.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.52 1.128 . . . . 0.35 109.384 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.0 160.66 30.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.642 0.777 . . . . 0.35 109.951 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.7 145.47 34.93 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.899 0.48 . . . . 0.35 111.818 -171.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mp -122.84 99.4 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 126.728 2.011 . . . . 0.35 106.294 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -88.93 72.53 8.46 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.175 0.99 . . . . 0.35 109.34 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.83 115.14 5.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.401 0.68 . . . . 0.35 110.3 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.1 m -103.01 91.6 4.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.862 1.265 . . . . 0.35 108.303 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -81.19 94.35 6.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.306 0.642 . . . . 0.35 109.89 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -105.68 129.7 53.85 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.056 1.342 . . . . 0.35 110.505 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -161.37 94.4 0.98 Allowed 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 106.429 -1.693 . . . . 0.35 106.429 172.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -56.12 -28.23 57.06 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.409 0.892 . . . . 0.35 113.409 -169.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -56.34 -41.79 76.64 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.93 1.292 . . . . 0.36 112.133 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -144.18 -56.12 0.36 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 112.852 0.686 . . . . 0.35 112.852 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.61 -61.2 1.92 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.65 0.659 . . . . 0.35 111.069 -171.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 80.41 149.26 0.1 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.503 1.921 . . . . 0.35 110.905 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -49.38 126.43 13.12 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.983 1.713 . . . . 0.35 112.153 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -155.24 101.42 2.22 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.148 0.979 . . . . 0.35 109.04 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.7 m -77.23 97.86 4.95 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.939 1.296 . . . . 0.35 109.708 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -91.66 108.38 19.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.569 1.148 . . . . 0.35 108.39 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.0 p -82.68 77.95 9.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.51 1.124 . . . . 0.35 111.44 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -72.33 131.9 84.53 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 108.567 -0.901 . . . . 0.33 108.567 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.89 -125.03 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.653 2.902 . . . . 0.35 109.03 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.51 154.12 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 119.268 0.94 . . . . 0.35 110.013 173.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.7 p -108.01 123.21 48.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.366 1.067 . . . . 0.35 108.558 169.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -61.23 -36.56 80.27 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.531 1.132 . . . . 0.35 110.658 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -56.01 -56.55 19.45 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.426 1.091 . . . . 0.35 111.238 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.51 139.42 2.71 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 112.26 -0.336 . . . . 0.35 112.26 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -155.39 165.9 35.19 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.571 1.548 . . . . 0.35 108.783 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -137.19 146.1 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.264 1.426 . . . . 0.35 108.71 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.33 116.95 29.24 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.348 -0.982 . . . . 0.33 108.348 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.83 175.52 10.43 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.094 2.53 . . . . 0.35 111.504 -171.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.8 -166.01 0.26 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.616 1.166 . . . . 0.35 110.356 171.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.26 28.65 1.67 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.581 0.752 . . . . 0.35 112.536 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.6 t 53.1 -113.4 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.984 1.314 . . . . 0.35 111.796 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -158.09 -33.44 0.07 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.428 1.091 . . . . 0.35 111.595 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -60.45 -39.24 86.84 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.057 0.943 . . . . 0.35 111.227 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.6 tp -102.13 137.09 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.247 1.419 . . . . 0.35 108.13 171.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -137.28 13.47 3.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.494 1.117 . . . . 0.35 111.211 175.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.66 63.86 2.27 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.056 0.942 . . . . 0.36 109.995 -173.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.89 -176.22 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.65 2.9 . . . . 0.35 111.914 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.76 78.18 0.25 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 109.608 -1.397 . . . . 0.35 109.608 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -66.43 118.09 9.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.981 0.912 . . . . 0.35 109.441 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -121.06 90.99 3.43 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.812 1.245 . . . . 0.36 108.803 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.73 69.84 10.35 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.743 0.817 . . . . 0.35 109.178 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.3 mt -97.25 89.84 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.553 1.141 . . . . 0.35 108.678 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 57.7 m -92.07 169.13 10.88 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.306 1.442 . . . . 0.35 108.621 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -116.92 132.86 56.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.592 1.157 . . . . 0.35 108.934 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.9 m -124.66 138.58 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.509 1.124 . . . . 0.35 109.956 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -92.45 96.3 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.283 -1.006 . . . . 0.35 108.283 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.7 mt -80.86 110.21 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 123.311 0.644 . . . . 0.35 110.03 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -98.09 155.88 16.92 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.703 -1.221 . . . . 0.35 107.703 153.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -107.97 132.67 53.26 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.314 1.046 . . . . 0.35 109.134 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 N--CA 1.453 -0.311 0 C-N-CA 124.541 1.136 . . . . 0.25 110.291 -174.03 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 97.6 p . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 110.637 -0.135 . . . . 0.35 110.637 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.7 m -81.18 -113.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.885 1.274 . . . . 0.35 109.225 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.9 t -113.83 45.22 1.49 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.561 1.144 . . . . 0.35 108.877 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 p90 35.88 58.71 0.91 Allowed 'General case' 0 C--N 1.344 0.355 0 C-N-CA 127.113 2.165 . . . . 0.35 112.548 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -40.09 88.72 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.13 2.172 . . . . 0.35 114.438 -163.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt 156.72 143.5 0.0 OUTLIER 'General case' 0 C--N 1.344 0.328 0 C-N-CA 130.097 3.359 . . . . 0.35 108.539 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.48 87.27 1.5 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.06 -1.216 . . . . 0.35 110.06 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 59.59 -96.59 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.751 1.621 . . . . 0.35 110.423 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.8 t80 52.75 76.44 0.19 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.086 1.354 . . . . 0.35 109.897 -172.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -81.64 65.09 6.63 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.753 1.221 . . . . 0.35 110.67 -171.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? 71.66 -71.5 0.13 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.68 2.392 . . . . 0.35 112.798 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.86 -19.86 0.29 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.725 1.155 . . . . 0.35 111.515 -167.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.68 138.61 17.86 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.667 1.587 . . . . 0.35 111.357 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -87.44 81.4 7.83 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.189 0.996 . . . . 0.35 109.806 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.83 158.43 18.74 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.506 1.123 . . . . 0.35 109.545 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -159.96 170.61 20.99 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.092 0.557 . . . . 0.35 111.184 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -122.36 43.43 2.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.11 1.364 . . . . 0.35 107.451 164.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -173.52 107.14 0.14 Allowed 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.051 1.34 . . . . 0.35 108.529 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 71.02 153.86 0.15 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 126.544 1.938 . . . . 0.33 111.655 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.62 85.59 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.987 2.458 . . . . 0.35 110.121 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.8 p -77.32 -56.79 4.25 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.021 0.929 . . . . 0.35 110.401 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.43 158.34 23.67 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 111.736 -0.546 . . . . 0.33 111.736 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -80.56 172.12 13.83 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.243 3.295 . . . . 0.35 111.815 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -163.62 175.48 10.59 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.597 1.159 . . . . 0.35 110.111 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 tt -144.55 92.41 2.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.071 -1.455 . . . . 0.35 107.071 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -78.7 129.26 34.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.08 1.352 . . . . 0.35 109.595 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.68 91.19 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.295 0 C-N-CA 124.813 1.245 . . . . 0.35 108.658 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -152.53 161.98 41.84 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.255 1.022 . . . . 0.36 109.9 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.5 m -121.4 155.3 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.784 1.234 . . . . 0.35 111.329 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.8 m -87.96 77.83 8.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.156 -1.424 . . . . 0.35 107.156 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.1 126.84 26.63 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 109.039 -1.625 . . . . 0.35 109.039 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.46 168.75 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 124.534 1.134 . . . . 0.35 110.172 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.08 -177.55 2.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.767 0.827 . . . . 0.35 109.326 164.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 t -83.09 42.71 0.82 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.939 0.496 . . . . 0.35 110.415 172.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.2 -59.07 0.49 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.833 2.053 . . . . 0.35 107.86 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.33 -9.43 0.81 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.21 0.91 . . . . 0.35 113.058 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -71.01 124.23 23.89 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.526 1.163 . . . . 0.36 110.143 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.38 125.19 25.67 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.559 0.743 . . . . 0.35 111.766 -171.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.7 mt -92.81 -45.53 7.96 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.859 1.664 . . . . 0.35 109.487 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.87 151.5 44.35 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.822 0.849 . . . . 0.35 111.753 175.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.5 t -89.48 149.56 42.77 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 126.078 1.751 . . . . 0.33 111.077 -169.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.17 47.16 1.98 Allowed 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.414 2.743 . . . . 0.35 111.848 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -174.52 116.78 0.2 Allowed 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.155 0.982 . . . . 0.35 110.09 173.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -170.93 -11.24 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.19 1.396 . . . . 0.35 113.127 173.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.03 143.47 26.61 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 C-N-CA 124.671 1.188 . . . . 0.35 109.278 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -152.79 142.59 22.04 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.327 1.051 . . . . 0.35 109.946 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.65 145.82 32.42 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 124.236 1.015 . . . . 0.33 110.156 -168.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.9 118.67 5.69 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.739 2.293 . . . . 0.35 108.385 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 tt -60.93 140.86 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.413 0.685 . . . . 0.35 112.654 -164.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -127.58 103.61 22.04 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 106.356 -1.72 . . . . 0.33 106.356 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.22 159.54 29.82 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.993 2.462 . . . . 0.35 111.002 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.99 66.37 1.58 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.291 -1.524 . . . . 0.35 109.291 -175.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.8 t -152.28 145.87 24.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.492 1.117 . . . . 0.35 109.705 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 87.9 m -70.2 115.46 9.42 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.346 1.058 . . . . 0.35 110.499 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -119.52 102.77 8.88 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.885 1.674 . . . . 0.35 108.217 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t -148.72 167.79 24.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.153 0.981 . . . . 0.35 109.092 173.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -56.13 -49.27 74.39 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.072 0.949 . . . . 0.35 111.102 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -73.04 -9.78 59.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.139 0.792 . . . . 0.35 113.139 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.15 37.46 3.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.259 1.424 . . . . 0.35 109.667 172.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mm -141.44 -40.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.243 0 C-N-CA 125.698 1.599 . . . . 0.35 109.472 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -52.19 -37.51 55.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.644 1.178 . . . . 0.35 113.128 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.06 -32.89 26.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.588 1.155 . . . . 0.35 111.835 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -71.09 -41.12 71.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.594 1.158 . . . . 0.35 111.84 -170.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.03 -35.59 75.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 C-N-CA 123.481 0.713 . . . . 0.35 111.482 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.89 -35.38 79.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.098 0.559 . . . . 0.35 110.944 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.77 -34.24 69.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.245 0.618 . . . . 0.35 111.496 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.97 -46.77 70.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.661 0.385 . . . . 0.35 111.153 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -73.04 -26.02 61.14 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 118.845 -0.598 . . . . 0.35 112.462 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.4 -41.33 76.11 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 123.84 0.856 . . . . 0.35 110.939 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -48.65 -51.17 29.62 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.042 1.337 . . . . 0.35 112.346 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.6 p -72.48 -49.64 31.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.205 0.602 . . . . 0.35 111.257 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.02 146.47 17.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.594 0.758 . . . . 0.35 110.197 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -149.11 45.66 0.99 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.751 0.82 . . . . 0.35 111.201 -171.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -132.64 -59.57 0.9 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.755 0.822 . . . . 0.35 110.684 -173.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -93.39 70.77 4.35 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.715 0.806 . . . . 0.35 110.948 -164.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.98 161.05 40.54 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.016 0.926 . . . . 0.35 112.999 -175.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.93 77.98 0.45 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.803 -1.925 . . . . 0.35 105.803 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.27 100.47 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.059 0.944 . . . . 0.35 109.803 -167.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.33 -61.72 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.88 1.272 . . . . 0.35 110.583 -175.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -156.25 117.29 3.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.186 0.594 . . . . 0.35 110.192 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -78.21 144.98 35.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.906 0.882 . . . . 0.35 109.782 168.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.52 131.61 67.8 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.181 -0.674 . . . . 0.33 109.181 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.73 -24.02 22.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.474 2.783 . . . . 0.35 111.566 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.9 m -85.21 60.05 6.01 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 124.396 1.078 . . . . 0.35 110.442 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.56 162.44 29.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.189 0.996 . . . . 0.35 109.459 169.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -153.74 147.68 25.51 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.46 0.541 . . . . 0.35 112.46 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 mp -90.44 135.47 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.388 -1.708 . . . . 0.35 106.388 165.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.2 66.67 1.53 Allowed 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.303 -0.999 . . . . 0.35 108.303 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.77 125.22 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.061 0.944 . . . . 0.35 110.751 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 m -123.89 109.72 13.94 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.346 1.058 . . . . 0.35 109.429 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.52 110.58 22.91 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 125.128 1.371 . . . . 0.35 108.878 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.44 52.97 2.58 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.612 1.565 . . . . 0.35 110.14 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.65 84.44 5.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.072 0.949 . . . . 0.35 110.186 -172.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -61.19 -11.94 11.05 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.667 1.187 . . . . 0.35 113.376 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -55.62 -50.78 69.25 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.153 0.981 . . . . 0.36 111.145 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.52 -42.14 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.98 0.733 . . . . 0.35 112.98 176.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -65.84 -40.76 92.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.319 0.509 . . . . 0.35 112.101 -172.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? 77.7 160.32 0.21 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.482 1.913 . . . . 0.35 111.181 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -50.7 121.33 5.7 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.821 1.248 . . . . 0.35 110.109 171.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -154.19 107.08 2.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.092 0.957 . . . . 0.35 108.446 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.2 m -78.98 89.82 4.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.969 0.908 . . . . 0.35 108.555 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -77.35 97.27 4.85 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.107 0.963 . . . . 0.35 108.6 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.2 p -88.72 139.91 29.98 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.308 1.043 . . . . 0.35 110.358 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.96 140.28 8.7 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 123.891 0.877 . . . . 0.33 109.63 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.46 140.71 33.69 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.221 2.614 . . . . 0.35 109.788 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tt -72.42 148.92 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.05 0.54 . . . . 0.35 110.099 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.7 p -73.1 160.26 32.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.307 0.643 . . . . 0.35 110.739 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -88.3 -21.68 24.29 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.377 1.071 . . . . 0.35 111.026 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -86.85 -79.61 0.26 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.278 1.031 . . . . 0.35 110.932 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -177.42 74.4 0.07 OUTLIER Glycine 0 CA--C 1.528 0.844 0 CA-C-N 118.215 0.461 . . . . 0.35 112.448 -170.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -77.47 154.51 32.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.866 -0.79 . . . . 0.35 108.866 165.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.0 t -131.88 140.73 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.367 1.067 . . . . 0.35 108.719 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.9 t -67.94 122.02 82.12 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 108.502 -0.925 . . . . 0.33 108.502 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.27 158.16 41.28 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.069 2.513 . . . . 0.35 111.052 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.74 80.35 2.69 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.627 1.171 . . . . 0.35 109.296 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -84.96 99.93 11.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.998 1.319 . . . . 0.35 109.071 -169.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.9 t -167.57 79.14 0.18 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.253 1.021 . . . . 0.35 108.998 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.39 -99.23 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.651 0.78 . . . . 0.35 110.035 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -70.23 -16.65 63.08 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.512 1.051 . . . . 0.35 112.304 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.6 pt -142.21 160.45 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 125.701 1.6 . . . . 0.35 109.22 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 29.56 0.37 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.89 0.7 . . . . 0.35 112.89 -175.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.35 46.51 0.69 Allowed Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.403 0.519 . . . . 0.36 112.403 172.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.39 135.13 41.47 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.094 2.53 . . . . 0.35 111.339 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -116.05 74.14 0.26 Allowed Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.959 -1.256 . . . . 0.35 109.959 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -60.74 95.99 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.625 1.57 . . . . 0.35 111.109 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -91.24 99.16 12.2 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.784 0.834 . . . . 0.36 109.694 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.2 80.35 9.09 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 108.366 -0.976 . . . . 0.35 108.366 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 94.5 mt -94.82 121.11 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.442 -1.318 . . . . 0.35 107.442 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.8 m -141.17 136.77 32.15 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.431 1.092 . . . . 0.35 109.005 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.21 131.78 34.09 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.387 1.075 . . . . 0.35 108.593 -178.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.05 141.06 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.48 0.712 . . . . 0.35 110.422 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 51.0 t -93.81 140.52 16.36 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 124.477 1.111 . . . . 0.35 108.843 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.5 mt -139.64 154.5 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.825 1.65 . . . . 0.35 107.742 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -143.07 23.78 1.85 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.67 0.989 . . . . 0.35 113.67 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.61 134.58 0.05 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.936 1.294 . . . . 0.35 111.474 169.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? . . . . . 0 C--N 1.342 0.251 0 C-N-CA 124.703 1.201 . . . . 0.25 110.637 177.878 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.1 m . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 119.648 -0.215 . . . . 0.35 110.599 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.8 p 51.39 -129.24 2.31 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.788 1.635 . . . . 0.35 111.878 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 t 67.8 2.06 2.91 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.609 1.563 . . . . 0.35 113.677 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 50.21 67.98 0.83 Allowed 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.213 1.405 . . . . 0.35 110.061 -169.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -83.9 68.38 9.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.415 1.086 . . . . 0.35 108.894 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -134.73 -24.48 1.51 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.879 1.672 . . . . 0.35 110.736 -172.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.05 26.78 30.34 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.537 1.065 . . . . 0.35 112.166 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 49.92 51.37 16.71 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.699 1.6 . . . . 0.35 111.566 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -103.85 94.33 5.37 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.966 0.906 . . . . 0.35 110.603 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.32 36.94 0.71 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.526 1.13 . . . . 0.35 111.075 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? 54.04 -95.3 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.206 1.802 . . . . 0.35 110.903 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.14 56.42 0.26 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.549 -1.82 . . . . 0.35 108.549 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -130.17 67.11 1.48 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.981 1.312 . . . . 0.35 108.888 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -167.71 113.95 0.72 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.174 0.989 . . . . 0.35 109.645 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.75 -65.96 0.97 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.029 0.932 . . . . 0.35 110.339 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.3 t 69.63 -73.4 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.923 2.089 . . . . 0.35 111.654 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -140.03 75.67 1.52 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.766 -1.198 . . . . 0.35 107.766 162.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -145.73 33.03 1.04 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.041 0.937 . . . . 0.35 110.054 173.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 66.62 168.71 0.11 Allowed Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.534 1.934 . . . . 0.33 112.101 171.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -69.12 99.95 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.121 2.548 . . . . 0.35 111.361 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.3 p -110.34 -40.93 4.51 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.589 1.556 . . . . 0.35 109.602 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.87 155.03 9.73 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.538 -1.025 . . . . 0.33 110.538 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.13 161.16 29.57 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.072 3.181 . . . . 0.35 111.024 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -156.58 164.62 37.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.611 0.764 . . . . 0.35 111.135 -170.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.5 tt -149.13 132.03 16.13 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.146 1.378 . . . . 0.35 108.012 -177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.2 mtp -125.31 133.11 52.74 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.889 1.275 . . . . 0.35 109.453 -171.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.54 95.29 2.89 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 C-N-CA 124.075 0.95 . . . . 0.35 110.409 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -149.31 178.35 8.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.568 0.747 . . . . 0.36 111.278 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.08 146.35 26.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 124.802 1.241 . . . . 0.35 110.948 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.1 m -84.06 86.31 7.22 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.918 -1.141 . . . . 0.35 107.918 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.64 119.7 6.63 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.527 -1.029 . . . . 0.35 110.527 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.81 170.43 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.496 1.118 . . . . 0.35 110.962 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -84.45 177.62 8.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.357 1.063 . . . . 0.35 109.639 166.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -58.67 -38.29 77.87 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.805 0.842 . . . . 0.35 110.649 171.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -57.38 -49.06 77.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.666 1.186 . . . . 0.35 110.719 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.96 5.98 7.91 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.142 1.353 . . . . 0.35 111.869 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.11 123.2 24.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.081 0.941 . . . . 0.36 109.19 -176.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.96 107.15 3.0 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.383 0.673 . . . . 0.35 111.414 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.93 -42.26 70.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.536 1.134 . . . . 0.35 109.781 170.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -152.06 150.06 29.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.998 0.919 . . . . 0.35 111.184 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.7 m -84.52 159.54 58.33 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 124.955 1.302 . . . . 0.33 110.463 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -84.75 53.99 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.52 2.813 . . . . 0.35 111.079 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -158.75 111.56 2.29 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.587 0.755 . . . . 0.35 110.991 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -160.81 -54.88 0.05 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.206 0.603 . . . . 0.35 111.461 152.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.47 147.17 5.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.48 0.582 . . . . 0.35 110.822 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.26 174.61 7.59 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.323 1.849 . . . . 0.35 110.156 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -161.98 131.81 3.35 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.756 0.822 . . . . 0.33 109.286 -176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -73.63 124.03 9.0 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.658 2.239 . . . . 0.35 108.722 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.5 tp -48.19 132.52 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.115 1.366 . . . . 0.35 112.391 -174.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -140.66 104.05 6.39 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 124.927 1.291 . . . . 0.33 108.009 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -81.11 -171.37 1.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.573 2.849 . . . . 0.35 110.467 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.26 -37.49 3.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.342 -0.703 . . . . 0.35 111.342 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.3 t -62.68 146.77 51.41 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.099 0.959 . . . . 0.35 111.007 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.8 m -73.6 149.83 41.82 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.628 0.771 . . . . 0.35 109.271 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.6 108.67 12.85 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.808 1.243 . . . . 0.35 107.794 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.0 t -154.94 162.06 41.21 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.72 1.208 . . . . 0.35 109.677 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -48.51 -54.7 13.33 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.694 1.198 . . . . 0.35 111.276 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -61.7 -32.27 72.46 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.837 0.681 . . . . 0.35 112.837 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -62.9 -56.85 13.62 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.438 0.563 . . . . 0.35 109.906 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.1 mm -53.95 -43.96 59.8 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.761 1.224 . . . . 0.35 111.761 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -51.24 -63.11 1.24 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.642 0.777 . . . . 0.35 111.674 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -67.66 -33.65 75.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.195 0.452 . . . . 0.35 112.053 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -62.55 -50.0 73.08 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.713 0.805 . . . . 0.35 111.637 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.54 -37.29 78.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 118.931 -0.557 . . . . 0.35 111.417 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.31 -45.94 92.34 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.911 0.884 . . . . 0.35 111.295 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -41.33 99.38 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.314 0.646 . . . . 0.35 110.941 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.95 91.85 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.841 0.857 . . . . 0.35 111.597 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.3 -12.3 60.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.103 1.149 . . . . 0.35 114.103 -177.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -73.01 3.09 5.78 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.347 0.976 . . . . 0.35 113.513 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.79 15.12 6.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.153 0.888 . . . . 0.35 111.947 169.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.0 t -161.47 -45.62 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.774 1.23 . . . . 0.35 110.552 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.95 79.78 1.36 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.61 1.564 . . . . 0.35 109.952 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -132.88 -43.41 0.89 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.737 1.615 . . . . 0.35 109.422 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -60.11 -57.32 13.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.468 1.507 . . . . 0.35 110.379 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.32 72.93 0.86 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.666 1.186 . . . . 0.35 108.633 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -157.62 76.97 0.83 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.019 0.528 . . . . 0.35 110.161 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -84.66 -53.15 5.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.929 1.292 . . . . 0.35 109.949 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 t 71.03 114.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.093 1.757 . . . . 0.35 111.226 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.73 -49.3 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.384 0.674 . . . . 0.35 110.556 174.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.68 172.94 12.29 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.693 1.197 . . . . 0.35 110.86 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.62 163.23 38.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.358 1.463 . . . . 0.35 110.34 172.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.08 122.69 87.96 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.364 0.666 . . . . 0.33 109.718 -176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.0 -32.49 11.01 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.956 2.437 . . . . 0.35 110.451 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.3 m -80.88 74.75 7.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.434 1.094 . . . . 0.35 109.339 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.71 162.78 17.87 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.307 1.043 . . . . 0.35 110.53 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 142.54 23.94 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.344 0.657 . . . . 0.35 111.118 -173.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -127.3 113.38 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.86 1.664 . . . . 0.35 107.623 -174.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -94.62 75.03 3.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.858 0.863 . . . . 0.35 109.151 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.94 108.21 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.768 -1.197 . . . . 0.35 107.768 168.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.2 m -86.88 67.75 9.9 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.463 1.105 . . . . 0.35 108.35 -170.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -60.64 99.79 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.846 1.258 . . . . 0.35 111.772 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -130.7 134.79 47.21 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.604 1.961 . . . . 0.35 109.86 -166.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -160.32 121.27 3.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.15 0.98 . . . . 0.35 109.067 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -89.9 65.71 6.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.966 0.907 . . . . 0.35 110.341 -172.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -142.8 -47.47 0.32 Allowed 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.078 1.351 . . . . 0.36 109.134 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.16 -31.46 0.54 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.39 1.076 . . . . 0.35 112.046 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -80.99 -42.8 20.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.852 0.686 . . . . 0.35 112.852 -161.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? 70.01 173.25 0.3 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.543 1.537 . . . . 0.35 110.118 -169.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -77.28 93.87 4.07 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.719 -0.474 . . . . 0.35 109.719 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -96.64 158.26 15.51 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.616 1.167 . . . . 0.35 108.16 170.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.9 m -136.62 110.41 8.14 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.526 0.731 . . . . 0.35 109.686 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -95.57 100.58 12.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.582 1.153 . . . . 0.35 108.332 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.7 p -86.92 65.29 8.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.198 0.999 . . . . 0.35 110.051 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -65.92 136.64 95.72 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.217 1.007 . . . . 0.33 109.388 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.23 -113.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.46 2.773 . . . . 0.35 109.701 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.4 tp -160.46 153.69 4.45 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 CA-C-N 119.032 0.833 . . . . 0.35 109.694 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.6 p -130.74 128.36 40.64 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.366 1.067 . . . . 0.35 108.955 173.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -64.94 -25.68 67.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.212 1.005 . . . . 0.35 111.47 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.16 -65.18 0.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.26 1.424 . . . . 0.35 111.486 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 125.24 143.8 6.14 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 124.139 0.876 . . . . 0.35 111.391 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.1 131.69 7.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.366 1.066 . . . . 0.35 109.068 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.76 141.61 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.54 0.736 . . . . 0.35 109.387 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 83.2 t -61.99 117.35 28.38 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 108.341 -0.985 . . . . 0.33 108.341 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.83 -21.59 24.62 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.425 2.75 . . . . 0.35 112.32 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.0 t70 68.77 77.21 0.23 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.721 1.608 . . . . 0.35 111.008 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 35.64 70.58 0.14 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.203 2.201 . . . . 0.35 114.713 166.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.7 t 25.65 -103.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.951 2.5 . . . . 0.35 113.716 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.88 -33.72 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.684 1.194 . . . . 0.35 111.491 172.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -83.2 43.91 0.91 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.46 1.504 . . . . 0.35 111.526 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.6 tt -167.82 155.28 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.958 1.703 . . . . 0.35 108.136 -172.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -146.17 -13.41 0.47 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.2 0.815 . . . . 0.35 113.2 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.26 78.39 8.65 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 119.661 1.119 . . . . 0.36 112.447 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.49 -84.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.548 2.832 . . . . 0.35 111.433 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.17 74.7 0.67 Allowed Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.285 -1.126 . . . . 0.35 110.285 -168.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -68.91 95.02 0.67 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.937 1.295 . . . . 0.35 109.3 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -99.04 95.34 7.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.973 0.509 . . . . 0.36 109.829 -173.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.32 98.46 3.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.844 -1.169 . . . . 0.35 107.844 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.4 mt -125.54 109.76 22.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 124.983 1.313 . . . . 0.35 107.588 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.2 m -133.98 125.48 28.28 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.281 1.032 . . . . 0.35 108.807 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -67.31 128.12 35.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.583 0.753 . . . . 0.35 110.141 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.28 138.31 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.305 1.042 . . . . 0.35 108.6 169.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -90.68 94.69 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.158 -1.423 . . . . 0.35 107.158 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 44.9 mt -71.43 131.46 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.259 0.624 . . . . 0.35 109.83 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -106.36 133.92 50.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.344 -1.725 . . . . 0.35 106.344 163.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -84.38 118.38 24.2 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.175 0.59 . . . . 0.35 109.465 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? . . . . . 0 N--CA 1.455 -0.203 0 C-N-CA 123.285 0.634 . . . . 0.25 109.784 178.545 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 111.873 0.323 . . . . 0.35 111.873 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -129.27 169.97 14.18 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.798 1.239 . . . . 0.35 110.699 -175.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.2 m -87.68 67.41 9.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.494 1.118 . . . . 0.35 108.991 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 p90 42.91 92.28 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.508 2.323 . . . . 0.35 113.822 -175.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -66.67 168.89 8.63 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.332 0.653 . . . . 0.35 110.2 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mptt 78.36 -38.25 0.23 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.163 2.185 . . . . 0.35 111.71 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.7 53.55 11.81 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 110.959 -0.856 . . . . 0.35 110.959 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 56.31 59.24 3.76 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.125 1.37 . . . . 0.35 111.442 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -117.18 119.12 34.24 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.952 1.301 . . . . 0.35 108.391 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.13 40.67 3.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.002 1.321 . . . . 0.35 109.768 -171.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 59.2 -93.05 0.04 OUTLIER 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.175 1.39 . . . . 0.35 109.817 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.06 48.03 0.4 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.562 -1.415 . . . . 0.35 109.562 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 26.38 55.73 0.05 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 128.84 2.856 . . . . 0.35 114.136 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 44.35 71.0 0.28 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.513 1.525 . . . . 0.35 111.38 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.34 71.64 0.56 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.985 1.314 . . . . 0.35 110.55 -172.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.3 t -66.62 112.26 4.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.845 1.258 . . . . 0.35 109.01 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 62.38 -174.23 0.15 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.65 1.18 . . . . 0.35 112.087 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 76.8 t80 65.02 88.39 0.11 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.346 1.859 . . . . 0.35 111.697 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 67.58 167.33 0.12 Allowed Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.198 1.799 . . . . 0.33 113.018 166.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.67 105.65 0.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.227 2.618 . . . . 0.35 111.134 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.0 p -141.95 -54.02 0.44 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.996 0.919 . . . . 0.35 111.403 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.44 122.22 1.03 Allowed Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.98 -0.9 . . . . 0.33 112.261 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.99 170.62 2.02 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.542 3.495 . . . . 0.35 114.041 170.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -161.34 165.17 29.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.286 1.034 . . . . 0.35 110.844 171.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -160.55 93.0 0.99 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.327 1.451 . . . . 0.35 107.235 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.5 mtm -87.54 105.23 17.17 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.477 0.711 . . . . 0.35 111.151 -170.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -101.51 96.6 4.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 124.792 1.237 . . . . 0.35 110.578 -174.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -163.64 171.59 15.49 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.502 1.121 . . . . 0.36 110.809 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.1 m -100.7 -177.52 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.145 1.378 . . . . 0.35 111.45 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.2 m -130.8 104.07 6.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.863 1.665 . . . . 0.35 106.686 167.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.31 121.52 6.5 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.626 -0.59 . . . . 0.35 111.626 -173.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.28 166.26 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.863 0.865 . . . . 0.35 110.657 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -72.79 174.64 7.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.958 1.303 . . . . 0.35 110.576 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -79.32 31.38 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.236 1.014 . . . . 0.35 112.181 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -138.04 -55.96 0.66 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.104 1.762 . . . . 0.35 107.669 170.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.89 65.61 0.02 OUTLIER Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.697 -1.361 . . . . 0.35 109.697 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -139.09 122.63 17.33 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.445 1.098 . . . . 0.36 108.493 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.58 106.03 0.51 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.218 1.007 . . . . 0.35 111.49 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.74 -57.23 3.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.166 0.986 . . . . 0.35 108.706 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.4 mt -124.51 167.69 14.11 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.785 1.234 . . . . 0.35 110.13 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -146.02 73.48 13.41 Favored Pre-proline 0 N--CA 1.455 -0.199 0 N-CA-C 106.817 -1.549 . . . . 0.33 106.817 167.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -87.25 58.75 3.5 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.844 3.029 . . . . 0.35 110.208 -168.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -107.58 54.58 0.66 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.779 1.232 . . . . 0.35 109.443 -172.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -114.45 15.46 17.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.2 1.4 . . . . 0.35 113.478 -169.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.51 165.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 CA-C-N 118.849 0.749 . . . . 0.35 110.275 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.42 177.54 10.19 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.269 1.027 . . . . 0.35 110.843 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -134.57 141.34 38.5 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.574 1.55 . . . . 0.33 108.027 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -84.81 26.24 0.66 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.14 2.56 . . . . 0.35 113.86 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 69.97 136.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.765 2.026 . . . . 0.35 111.717 -176.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.05 128.52 5.01 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.647 -0.872 . . . . 0.33 108.647 157.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.15 165.51 21.4 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.209 2.606 . . . . 0.35 110.49 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.64 63.57 1.75 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.681 -0.968 . . . . 0.35 110.681 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -153.05 138.78 17.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.733 1.213 . . . . 0.35 108.738 173.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 m -73.47 87.45 1.58 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.374 1.069 . . . . 0.35 109.748 -173.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 106.13 9.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.06 1.344 . . . . 0.35 109.012 -174.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -140.09 177.65 7.83 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 125.742 1.617 . . . . 0.35 109.411 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -41.2 88.54 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.933 -0.395 . . . . 0.35 109.933 170.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.43 -45.83 78.54 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.428 0.691 . . . . 0.35 111.936 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -86.26 31.04 0.66 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.779 0.718 . . . . 0.35 112.293 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 mm -133.34 -44.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 125.396 1.478 . . . . 0.35 108.61 172.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -53.44 -50.98 64.09 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.196 0.998 . . . . 0.35 112.052 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -70.81 -34.31 71.6 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.598 0.636 . . . . 0.35 111.615 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -64.5 -51.82 61.03 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.999 0.92 . . . . 0.35 111.069 -172.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.8 m -63.5 -32.14 55.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 124.098 0.959 . . . . 0.35 111.937 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -65.43 -38.19 89.15 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.97 0.508 . . . . 0.35 111.059 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -70.82 -31.18 67.83 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.068 0.547 . . . . 0.35 111.363 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.58 -49.08 67.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.653 0.781 . . . . 0.35 111.047 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.18 -13.3 60.44 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.772 0.829 . . . . 0.35 113.145 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -74.62 89.24 2.21 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.442 0.697 . . . . 0.35 109.992 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.56 -52.44 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.533 1.533 . . . . 0.35 108.846 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 66.1 p -98.19 -52.46 3.67 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.315 1.046 . . . . 0.35 110.517 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.59 95.41 5.13 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.178 1.391 . . . . 0.35 108.487 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -147.38 4.71 0.8 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.953 0.901 . . . . 0.35 112.806 -173.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -148.39 -46.27 0.15 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.981 0.912 . . . . 0.35 109.651 -169.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -54.4 -48.53 71.48 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.385 1.474 . . . . 0.35 110.611 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.78 176.92 9.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.046 0.938 . . . . 0.35 112.094 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -155.78 105.16 2.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.519 -0.919 . . . . 0.35 108.519 168.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.62 131.5 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.153 0.981 . . . . 0.35 109.74 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.56 -60.65 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.318 -0.993 . . . . 0.35 108.318 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -133.34 154.29 50.85 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.136 1.374 . . . . 0.35 110.185 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.4 mt -99.68 124.94 45.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.175 -1.417 . . . . 0.35 107.175 165.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -73.64 127.66 88.24 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.299 -0.63 . . . . 0.33 109.299 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.78 -21.69 18.57 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.44 2.76 . . . . 0.35 111.672 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.8 m -85.21 66.44 9.73 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.052 0.941 . . . . 0.35 110.604 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.32 165.91 23.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.361 0.665 . . . . 0.35 109.446 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -136.81 117.9 14.38 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.06 0.544 . . . . 0.35 111.344 -170.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.0 mm -86.95 90.79 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.762 1.625 . . . . 0.35 108.017 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.37 72.88 8.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.633 -0.877 . . . . 0.35 108.633 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.66 94.57 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 CA-C-O 121.6 0.714 . . . . 0.35 110.052 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.5 m -79.74 108.91 13.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.982 -1.118 . . . . 0.35 107.982 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -78.41 70.37 4.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.808 -0.812 . . . . 0.35 108.808 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -71.06 124.21 23.88 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.107 0.479 . . . . 0.35 110.133 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -153.21 163.99 38.89 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.385 1.474 . . . . 0.35 107.839 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.65 61.83 1.08 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.36 -0.978 . . . . 0.35 108.36 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -149.64 -54.37 0.17 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.686 1.194 . . . . 0.36 109.78 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 -42.41 0.12 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.842 0.857 . . . . 0.35 112.281 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -73.5 -46.55 47.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.1 0.96 . . . . 0.35 110.955 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 81.7 tttt 71.0 163.48 0.26 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.076 1.35 . . . . 0.35 110.984 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -47.77 124.1 6.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.561 1.144 . . . . 0.35 110.408 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -149.46 86.43 1.47 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.922 -0.77 . . . . 0.35 108.922 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.4 m -69.41 94.34 0.72 Allowed 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.008 1.323 . . . . 0.35 109.581 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -89.01 95.16 10.21 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.108 -1.071 . . . . 0.35 108.108 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p -72.53 133.47 44.79 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.688 0.795 . . . . 0.35 110.34 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -151.02 139.05 12.58 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 125.058 1.343 . . . . 0.33 107.627 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.76 -139.34 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.766 2.977 . . . . 0.35 109.986 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.8 tp -158.75 156.41 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 119.272 0.942 . . . . 0.35 109.616 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -130.29 166.63 19.96 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.397 1.079 . . . . 0.35 110.335 176.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.6 -51.27 70.53 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.791 1.236 . . . . 0.35 111.328 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -80.17 -33.89 37.98 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.856 0.863 . . . . 0.35 110.992 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.85 -127.57 45.35 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.238 0.923 . . . . 0.35 112.38 170.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -165.46 149.11 8.19 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.019 0.928 . . . . 0.35 110.126 -173.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.1 t -78.45 132.3 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.565 -1.272 . . . . 0.35 107.565 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.4 t -52.95 113.28 4.39 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.0 0.92 . . . . 0.33 109.769 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -84.31 -174.2 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.516 2.811 . . . . 0.35 110.833 -171.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -63.81 143.45 57.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.564 0.746 . . . . 0.35 109.792 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.45 61.2 2.31 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.724 1.209 . . . . 0.35 109.169 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.0 t 55.97 -122.65 1.8 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.936 1.694 . . . . 0.35 111.207 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -159.25 -48.51 0.06 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.252 1.021 . . . . 0.35 109.687 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -75.01 7.89 2.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.981 1.312 . . . . 0.35 113.596 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.6 tt -142.35 141.3 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.305 1.442 . . . . 0.35 108.821 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.37 29.11 2.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.287 1.035 . . . . 0.35 111.427 174.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.89 60.6 3.72 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.997 0.919 . . . . 0.36 112.38 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -71.76 -166.87 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.56 2.173 . . . . 0.35 112.655 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.81 78.38 0.21 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 108.718 -1.753 . . . . 0.35 108.718 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -72.7 76.6 1.11 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.546 1.538 . . . . 0.35 109.658 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -86.17 102.49 13.95 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.004 0.522 . . . . 0.36 110.14 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.48 81.62 7.53 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.909 1.284 . . . . 0.35 108.494 174.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.8 mt -94.91 76.19 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 107.203 -1.406 . . . . 0.35 107.203 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.6 m -75.37 172.64 12.12 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.984 1.313 . . . . 0.35 109.542 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.28 138.78 31.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.769 1.228 . . . . 0.35 108.389 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.95 150.72 26.78 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 C-N-CA 123.936 0.894 . . . . 0.35 110.987 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.42 132.85 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.842 1.257 . . . . 0.35 108.811 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 68.2 mt -134.58 150.5 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.438 1.495 . . . . 0.35 109.551 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -120.62 113.3 20.05 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.141 1.376 . . . . 0.35 107.731 162.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.19 166.03 17.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.03 0.932 . . . . 0.35 111.861 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt . . . . . 0 C--N 1.34 0.164 0 C-N-CA 124.611 1.165 . . . . 0.25 109.288 179.454 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 111.669 0.248 . . . . 0.35 111.669 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.9 p -158.81 -26.74 0.07 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.217 0.821 . . . . 0.35 113.217 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 p -152.13 -69.44 0.16 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.521 0.6 . . . . 0.35 111.685 -170.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -160.44 145.59 14.69 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.092 0.557 . . . . 0.35 110.144 -164.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -158.97 174.06 15.54 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.357 1.063 . . . . 0.35 110.41 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.64 25.24 7.89 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 128.282 2.633 . . . . 0.35 116.128 168.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.42 -164.42 37.64 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 118.617 0.644 . . . . 0.35 111.569 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -93.6 56.65 2.42 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.55 0.74 . . . . 0.35 109.232 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -85.29 89.4 7.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.589 1.156 . . . . 0.35 109.497 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -77.27 46.14 0.49 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.349 1.459 . . . . 0.35 113.21 -172.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.41 -75.05 0.08 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.923 2.489 . . . . 0.35 111.969 175.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.6 -38.44 0.09 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.79 -1.324 . . . . 0.35 109.79 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -49.99 117.83 2.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.528 1.531 . . . . 0.35 110.0 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -170.32 133.38 1.08 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.166 0.986 . . . . 0.35 109.392 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.5 148.64 7.95 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.4 1.08 . . . . 0.35 109.958 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.4 t -161.34 115.86 2.03 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.062 0.945 . . . . 0.35 109.073 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 61.19 172.66 0.11 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.354 1.862 . . . . 0.35 113.426 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 60.07 89.18 0.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.421 1.888 . . . . 0.35 112.186 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 71.23 154.38 0.15 Allowed Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 126.211 1.804 . . . . 0.33 112.738 165.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.11 97.92 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.388 2.725 . . . . 0.35 110.009 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -104.05 -58.76 1.83 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.628 1.171 . . . . 0.35 110.987 -173.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.97 110.75 0.43 Allowed Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.896 -0.947 . . . . 0.33 111.767 -171.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -80.3 169.42 17.35 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.472 2.781 . . . . 0.35 111.294 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -162.41 170.04 19.45 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 113.281 0.845 . . . . 0.35 113.281 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.07 94.88 3.01 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.825 2.05 . . . . 0.35 107.955 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 31.7 ttp -87.5 104.37 16.41 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.027 0.531 . . . . 0.35 110.545 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.72 97.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 125.16 1.384 . . . . 0.35 108.832 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.35 170.3 21.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.366 1.066 . . . . 0.36 109.158 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.44 139.45 32.3 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 C-N-CA 124.004 0.922 . . . . 0.35 110.555 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.1 m -73.2 101.02 3.24 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.188 0.995 . . . . 0.35 108.723 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.92 82.44 1.63 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 123.933 0.778 . . . . 0.35 111.757 -170.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 m -85.18 157.69 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 C-N-CA 123.512 0.725 . . . . 0.35 110.566 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.47 -69.56 0.45 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.464 -0.569 . . . . 0.35 109.464 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.4 m -156.07 -56.21 0.09 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.104 1.362 . . . . 0.35 109.299 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -91.56 42.05 1.09 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.759 1.223 . . . . 0.35 110.819 -175.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.03 35.62 87.87 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.032 0.825 . . . . 0.35 112.491 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -102.6 96.36 6.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.448 1.099 . . . . 0.36 108.563 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.49 101.54 0.09 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.76 1.224 . . . . 0.35 111.169 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.32 -63.47 1.23 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.426 -0.953 . . . . 0.35 108.426 171.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -89.97 121.08 31.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.399 -0.963 . . . . 0.35 108.399 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.5 m -87.07 108.13 17.49 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.335 1.054 . . . . 0.33 108.399 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.96 -172.87 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.695 2.93 . . . . 0.35 112.717 -164.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.5 m170 72.13 54.63 0.18 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.077 1.751 . . . . 0.35 111.47 172.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -120.64 -2.4 9.91 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.725 1.21 . . . . 0.35 112.575 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.12 142.17 40.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 125.042 1.337 . . . . 0.35 108.284 170.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -141.14 -84.82 0.2 Allowed 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.312 -0.852 . . . . 0.35 110.463 -177.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.1 t80 74.81 140.0 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.561 1.544 . . . . 0.33 110.381 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.74 159.36 51.66 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.777 2.318 . . . . 0.35 112.668 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 tp -61.33 137.36 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.886 1.274 . . . . 0.35 112.007 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -138.57 102.76 7.84 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.414 1.486 . . . . 0.33 107.404 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.11 175.55 11.01 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.306 2.671 . . . . 0.35 110.709 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.26 -29.47 8.72 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.996 0.808 . . . . 0.35 112.248 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 t -67.43 142.0 56.82 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.704 0.752 . . . . 0.35 111.311 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.8 m -71.11 144.35 50.3 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.938 0.895 . . . . 0.35 108.876 172.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.03 75.27 1.59 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.755 0.822 . . . . 0.35 109.302 -166.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.1 p -104.99 173.57 6.25 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 125.57 1.548 . . . . 0.35 110.265 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -57.83 -50.99 71.42 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.431 1.092 . . . . 0.35 109.579 171.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.75 -28.3 67.51 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.58 0.956 . . . . 0.35 113.58 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -68.6 -53.27 23.75 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.056 0.844 . . . . 0.35 109.68 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.3 mm -55.3 -40.93 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.931 1.292 . . . . 0.35 111.39 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -47.51 -64.45 0.78 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.241 1.416 . . . . 0.35 111.908 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -69.56 -32.59 71.46 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.856 0.317 . . . . 0.35 111.856 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -65.25 -49.86 68.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.629 0.772 . . . . 0.35 111.543 -172.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 m -67.35 -34.31 68.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.011 0.524 . . . . 0.35 111.474 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.32 -48.24 80.74 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 122.862 0.465 . . . . 0.35 110.397 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -40.86 97.47 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.204 0.456 . . . . 0.35 110.967 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.03 -50.3 73.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.167 0.987 . . . . 0.35 111.129 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 pp -71.59 -29.43 64.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.076 0.55 . . . . 0.35 111.605 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -70.32 -1.13 9.57 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 113.302 0.853 . . . . 0.35 113.302 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.16 -43.47 61.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.719 0.691 . . . . 0.35 110.28 164.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.5 p -86.37 -47.93 8.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.053 0.941 . . . . 0.35 110.935 173.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.85 -105.84 0.03 OUTLIER 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.319 0.509 . . . . 0.35 112.135 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 71.4 144.68 0.06 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.907 1.683 . . . . 0.35 111.114 -171.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 70.17 -82.59 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.799 2.039 . . . . 0.35 110.853 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -72.8 171.7 12.17 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.44 0.696 . . . . 0.35 109.123 172.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 70.8 146.66 0.07 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.5 1.52 . . . . 0.35 110.108 -162.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -158.18 133.82 8.97 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.911 0.884 . . . . 0.35 109.162 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -85.22 128.64 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.037 0.935 . . . . 0.35 108.915 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.3 t -69.78 -65.06 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.41 -1.33 . . . . 0.35 107.41 167.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.57 139.14 5.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.795 0.838 . . . . 0.35 109.135 170.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.16 170.22 16.97 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.63 0.772 . . . . 0.35 109.777 170.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -67.81 129.47 93.28 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 108.927 -0.768 . . . . 0.33 108.927 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.53 -36.07 35.59 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.503 2.135 . . . . 0.35 109.697 172.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -89.78 69.46 7.62 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.798 1.239 . . . . 0.35 109.163 170.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.08 172.73 4.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.629 0.772 . . . . 0.35 109.99 168.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -152.17 151.46 31.04 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.359 0.503 . . . . 0.35 112.359 -167.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.26 101.15 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 126.205 1.802 . . . . 0.35 107.375 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -96.27 63.18 2.17 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.42 1.088 . . . . 0.35 110.203 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.67 122.22 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 122.763 0.425 . . . . 0.35 110.246 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.4 m -118.03 106.31 12.78 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.408 1.483 . . . . 0.35 107.413 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -124.32 119.0 28.03 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.698 1.199 . . . . 0.35 109.726 -167.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -132.38 55.66 1.87 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.979 1.311 . . . . 0.35 112.246 -158.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -74.34 137.47 42.85 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 122.067 -0.396 . . . . 0.35 110.996 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -93.92 70.3 3.99 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.821 -1.177 . . . . 0.35 107.821 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -143.3 -50.57 0.33 Allowed 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.44 1.096 . . . . 0.36 109.533 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.76 -40.65 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.163 0.585 . . . . 0.35 112.359 -170.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -53.53 4.61 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.069 0.547 . . . . 0.35 112.033 -168.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt 71.02 -177.82 0.21 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.846 1.258 . . . . 0.35 110.064 -167.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -69.25 127.66 33.85 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.465 0.706 . . . . 0.35 111.756 -170.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -142.65 104.29 4.35 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.619 1.168 . . . . 0.35 109.459 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.7 m -80.75 108.8 14.71 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.66 -0.867 . . . . 0.35 108.66 173.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -109.91 102.6 11.34 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.627 1.171 . . . . 0.35 108.46 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.8 p -90.62 64.64 5.78 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.976 1.311 . . . . 0.35 110.779 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -77.08 141.67 67.67 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.033 0.533 . . . . 0.33 109.67 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.84 170.96 18.11 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.581 2.854 . . . . 0.35 112.136 -171.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.4 tp -77.01 161.44 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.844 1.258 . . . . 0.35 109.86 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 73.4 p -132.01 129.0 39.54 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.091 0.957 . . . . 0.35 108.966 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.83 -29.29 70.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.489 0.716 . . . . 0.35 111.487 172.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.4 -50.02 75.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.172 0.989 . . . . 0.35 109.635 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.98 170.95 24.23 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 124.328 0.966 . . . . 0.35 112.562 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -158.35 136.03 10.39 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.112 0.965 . . . . 0.35 109.204 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.8 t -70.48 130.96 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.465 -1.309 . . . . 0.35 107.465 166.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.6 t -57.51 112.51 4.8 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 107.311 -1.366 . . . . 0.33 107.311 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.05 -95.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.597 2.198 . . . . 0.35 112.193 -158.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -158.38 150.22 21.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.009 0.924 . . . . 0.35 109.737 -173.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.85 56.7 0.7 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.528 1.531 . . . . 0.35 109.552 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.4 t 34.5 -103.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.754 2.422 . . . . 0.35 113.436 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -161.93 -51.7 0.04 OUTLIER 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.649 1.18 . . . . 0.35 109.396 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -61.78 -44.39 96.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.062 0.945 . . . . 0.35 111.264 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.9 tp -83.74 111.74 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.933 0.893 . . . . 0.35 109.494 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -134.94 43.85 2.67 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.446 1.098 . . . . 0.35 110.154 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -151.76 47.33 0.41 Allowed Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 114.0 1.111 . . . . 0.36 114.0 163.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -55.86 145.44 72.9 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.839 1.693 . . . . 0.35 113.31 168.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.47 76.72 0.38 Allowed Glycine 0 C--N 1.338 0.657 0 N-CA-C 108.641 -1.783 . . . . 0.35 108.641 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -69.59 96.74 0.96 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.675 1.19 . . . . 0.35 110.781 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -87.93 109.93 20.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.131 -1.063 . . . . 0.36 108.131 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -94.82 52.69 1.51 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.245 -1.02 . . . . 0.35 108.245 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -94.3 130.93 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.838 1.255 . . . . 0.35 108.783 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 81.6 m -149.05 140.6 23.41 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.163 1.385 . . . . 0.35 108.016 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 135.47 45.01 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.292 0.637 . . . . 0.35 109.348 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.4 m -133.37 136.0 55.4 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 123.341 0.656 . . . . 0.35 110.454 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.5 t -84.75 130.19 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.921 1.288 . . . . 0.35 107.779 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 55.4 mt -123.14 131.79 72.58 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 124.122 0.969 . . . . 0.35 110.588 -171.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -87.96 103.4 15.65 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.74 1.616 . . . . 0.35 107.273 165.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -70.61 140.88 51.76 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.083 0.553 . . . . 0.35 110.584 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt . . . . . 0 N--CA 1.456 -0.161 0 C-N-CA 125.474 1.51 . . . . 0.25 108.385 -175.109 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 119.049 -0.501 . . . . 0.35 111.767 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.1 p 45.77 -131.5 1.07 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.079 1.351 . . . . 0.35 111.038 -172.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.8 m 75.68 -54.52 0.63 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.076 2.151 . . . . 0.35 114.218 167.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 55.46 60.38 3.39 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.236 -1.394 . . . . 0.35 107.236 -153.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -51.54 -47.44 63.4 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 127.244 2.218 . . . . 0.35 112.661 -167.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -66.35 107.66 2.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.668 -1.234 . . . . 0.35 107.668 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.55 82.37 1.68 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.304 -1.119 . . . . 0.35 110.304 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt 56.61 60.34 3.14 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.108 1.363 . . . . 0.35 110.853 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -82.75 -64.16 1.23 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.616 1.167 . . . . 0.35 110.089 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.95 25.47 0.31 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.002 2.521 . . . . 0.35 114.772 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 57.27 -87.57 0.02 OUTLIER 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.847 1.659 . . . . 0.35 111.06 -170.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.53 -55.98 0.13 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 107.83 -2.108 . . . . 0.35 107.83 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 t0 57.54 38.13 27.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.669 1.588 . . . . 0.35 111.396 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 42.95 63.33 1.51 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.948 1.699 . . . . 0.35 111.438 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.82 -175.67 4.9 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.082 0.553 . . . . 0.35 112.282 -170.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 m 65.63 79.21 0.25 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.988 1.715 . . . . 0.35 110.195 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 54.64 65.56 1.47 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.521 1.528 . . . . 0.35 111.03 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -145.8 34.3 1.03 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.182 1.393 . . . . 0.35 109.716 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.52 162.99 0.12 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.005 1.722 . . . . 0.33 112.805 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -65.68 94.48 0.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.257 2.638 . . . . 0.35 110.224 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.3 p -138.98 -46.64 0.48 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.247 1.419 . . . . 0.35 110.088 -171.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.04 86.89 0.26 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.883 0.754 . . . . 0.33 111.931 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.65 153.75 10.45 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.341 3.361 . . . . 0.35 112.718 166.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -146.48 173.64 12.11 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.447 0.699 . . . . 0.35 110.992 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 tt -151.11 93.36 1.91 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.774 -1.195 . . . . 0.35 107.774 176.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.4 mtp -78.71 141.99 37.45 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.941 1.296 . . . . 0.35 109.996 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 37.0 t -136.18 94.99 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 124.861 1.265 . . . . 0.35 108.85 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -148.28 174.6 11.85 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.179 0.992 . . . . 0.36 110.391 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.01 -170.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 125.323 1.449 . . . . 0.35 109.231 174.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.6 m -121.24 103.5 9.03 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.603 -1.628 . . . . 0.35 106.603 162.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.78 85.11 1.45 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.986 -0.846 . . . . 0.35 110.986 -173.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.6 m -102.23 172.08 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.258 1.023 . . . . 0.35 111.321 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -63.99 -52.69 58.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.792 1.237 . . . . 0.35 110.709 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 m -178.88 -56.07 0.01 OUTLIER 'General case' 0 C--N 1.339 0.144 0 C-N-CA 128.189 2.596 . . . . 0.35 107.197 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.52 -61.37 1.8 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.752 1.221 . . . . 0.35 110.748 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.0 -19.82 0.04 OUTLIER Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.168 -0.795 . . . . 0.35 113.351 -170.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -64.33 111.07 2.47 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.155 0.978 . . . . 0.36 109.693 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -76.64 123.51 26.24 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.385 1.074 . . . . 0.35 111.142 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.88 -65.2 1.04 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.61 -0.885 . . . . 0.35 108.61 170.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.5 mt -98.65 136.02 39.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.464 1.106 . . . . 0.35 109.95 -168.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.9 m -85.04 102.42 2.32 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.657 1.583 . . . . 0.33 110.926 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.78 -165.4 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.25 2.633 . . . . 0.35 111.677 -169.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 75.0 57.57 0.07 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.651 1.58 . . . . 0.35 111.036 166.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -138.16 -5.13 1.66 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.053 1.131 . . . . 0.35 114.053 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -130.26 143.78 39.97 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 123.739 0.816 . . . . 0.35 109.582 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.23 177.07 11.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.541 0.736 . . . . 0.35 112.284 -173.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -137.34 154.13 75.22 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 126.497 1.919 . . . . 0.33 107.555 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -84.12 34.79 0.53 Allowed 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.235 2.623 . . . . 0.35 112.323 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.257 13.8 tt 54.21 149.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 129.603 3.161 . . . . 0.35 115.732 176.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -158.18 123.35 2.31 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.172 0.989 . . . . 0.33 109.321 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -80.12 179.18 6.41 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.32 2.68 . . . . 0.35 110.949 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.21 -33.72 4.95 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.774 0.702 . . . . 0.35 111.527 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 t -63.87 144.83 56.75 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.24 1.016 . . . . 0.35 110.948 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.9 m -73.72 145.1 45.43 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.909 -0.774 . . . . 0.35 108.909 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.6 104.51 7.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.171 -1.418 . . . . 0.35 107.171 177.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -143.53 157.58 44.32 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.402 1.081 . . . . 0.35 110.4 -173.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.31 -57.55 10.18 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.493 1.117 . . . . 0.35 111.57 -174.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -58.72 -29.11 66.44 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.01 0.744 . . . . 0.35 113.01 -175.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -72.1 -48.34 44.69 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.714 0.806 . . . . 0.35 110.684 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.8 mm -56.21 -39.09 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.66 1.184 . . . . 0.35 111.944 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -47.87 -57.98 4.97 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.425 1.09 . . . . 0.35 112.397 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -78.83 -29.7 44.87 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.061 0.544 . . . . 0.35 112.347 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -64.01 -45.95 86.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.187 0.595 . . . . 0.35 111.636 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.4 m -68.83 -31.81 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 122.916 0.487 . . . . 0.35 111.406 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.46 -36.94 85.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.616 0.767 . . . . 0.35 111.053 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -74.8 -36.09 62.48 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.801 0.841 . . . . 0.35 111.134 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.92 78.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.125 0.57 . . . . 0.35 111.026 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.02 -17.72 62.01 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.983 0.735 . . . . 0.35 112.983 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -58.0 -33.61 69.11 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.492 0.717 . . . . 0.35 112.095 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -41.57 -47.66 3.86 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 125.547 1.539 . . . . 0.35 112.573 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 65.1 p -97.21 -51.54 4.16 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.95 1.3 . . . . 0.35 110.797 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.21 82.17 2.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.221 1.408 . . . . 0.35 110.288 -171.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -109.96 -36.53 5.85 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.34 1.456 . . . . 0.35 110.965 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -87.9 -73.11 0.5 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.611 0.765 . . . . 0.35 110.643 -173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -96.09 62.08 2.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.24 0.616 . . . . 0.35 111.085 -165.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.42 153.02 32.72 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.817 0.447 . . . . 0.35 110.568 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -158.27 105.97 1.94 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.35 108.675 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -75.05 97.98 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.541 -0.911 . . . . 0.35 108.541 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.41 -42.64 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.302 0.641 . . . . 0.35 110.712 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -140.94 161.22 38.34 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.738 1.215 . . . . 0.35 109.634 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.58 163.38 32.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.773 1.229 . . . . 0.35 109.942 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -90.32 126.79 55.49 Favored Pre-proline 0 N--CA 1.455 -0.199 0 N-CA-C 108.078 -1.082 . . . . 0.33 108.078 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.68 -20.39 30.53 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.682 2.255 . . . . 0.35 110.915 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.7 m -84.64 70.71 10.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.707 1.203 . . . . 0.35 110.476 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.64 162.18 18.91 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.556 0.742 . . . . 0.35 109.746 165.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -151.86 107.58 3.35 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.979 0.419 . . . . 0.35 111.935 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.26 130.23 30.27 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 125.34 1.456 . . . . 0.35 107.481 168.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -131.13 80.96 1.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.119 -1.067 . . . . 0.35 108.119 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.56 98.25 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.833 0.853 . . . . 0.35 110.205 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 62.1 m -93.52 97.67 10.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.074 1.35 . . . . 0.35 107.931 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -103.63 93.46 4.94 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.989 0.916 . . . . 0.35 111.24 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -73.07 52.48 0.33 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.648 2.379 . . . . 0.35 111.336 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -82.06 102.1 10.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.289 1.035 . . . . 0.35 110.605 -171.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -87.78 71.7 9.53 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.164 0.986 . . . . 0.35 108.617 174.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -148.88 -58.51 0.22 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.056 1.343 . . . . 0.36 109.478 172.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.13 -38.39 0.16 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.242 0.83 . . . . 0.35 113.242 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -84.08 -45.7 12.75 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.893 0.477 . . . . 0.35 112.128 -164.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt 73.54 162.43 0.26 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.713 1.605 . . . . 0.35 112.264 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.76 109.93 1.58 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.548 1.139 . . . . 0.35 111.823 -175.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.5 102.71 5.02 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.003 -1.48 . . . . 0.35 107.003 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.2 m -79.43 93.16 5.32 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.644 0.777 . . . . 0.35 109.181 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -83.31 106.36 15.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.766 -0.827 . . . . 0.35 108.766 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.4 p -84.5 69.64 10.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.829 1.252 . . . . 0.35 111.192 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -64.99 137.19 97.07 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 108.595 -0.891 . . . . 0.33 108.595 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.09 -115.76 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.409 2.739 . . . . 0.35 110.579 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 tp -168.42 158.24 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.609 1.164 . . . . 0.35 108.828 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.4 p -136.41 137.69 40.74 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.835 0.854 . . . . 0.35 109.744 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -71.88 -22.6 61.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.987 0.915 . . . . 0.35 111.039 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -58.76 -50.18 74.91 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.792 0.837 . . . . 0.35 109.558 168.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.62 169.95 26.61 Favored Glycine 0 C--N 1.341 0.835 0 C-N-CA 124.056 0.836 . . . . 0.35 112.769 171.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -163.37 137.35 5.92 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.995 1.318 . . . . 0.35 109.124 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.5 138.29 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.75 0.82 . . . . 0.35 109.512 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.32 118.01 55.23 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 107.712 -1.218 . . . . 0.33 107.712 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.27 -66.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.616 2.211 . . . . 0.35 111.486 -170.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 t70 173.09 -66.4 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 126.506 1.922 . . . . 0.35 107.544 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 55.35 60.07 3.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.633 1.573 . . . . 0.35 110.201 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.0 m -138.17 45.64 2.09 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.589 1.156 . . . . 0.35 108.791 174.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -104.89 -62.67 1.31 Allowed 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.046 1.339 . . . . 0.35 109.974 -170.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -101.57 -55.65 2.47 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.934 1.293 . . . . 0.35 109.298 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.8 pt -93.95 158.03 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.724 0.81 . . . . 0.35 108.83 167.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -135.56 60.55 1.68 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.223 1.009 . . . . 0.35 108.303 173.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -170.34 58.75 0.3 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.847 1.259 . . . . 0.36 111.093 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -57.21 -51.54 8.44 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.738 2.292 . . . . 0.35 111.4 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.82 66.0 2.31 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.539 -0.625 . . . . 0.35 111.539 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -69.11 100.09 1.21 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.129 1.372 . . . . 0.35 111.081 -175.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -88.61 92.96 9.4 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.294 -0.632 . . . . 0.36 109.294 172.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.49 109.67 8.16 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 107.802 -1.184 . . . . 0.35 107.802 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.7 mt -127.38 133.74 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.913 1.285 . . . . 0.35 107.915 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.2 m -146.46 116.09 7.18 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.811 1.244 . . . . 0.35 107.775 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -69.09 132.62 46.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.859 -0.423 . . . . 0.35 109.859 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.34 153.86 36.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 123.799 0.84 . . . . 0.35 110.976 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.5 t -93.82 103.82 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.258 1.423 . . . . 0.35 108.058 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.8 mt -94.92 132.67 38.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.508 0.723 . . . . 0.35 109.225 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -113.82 98.19 6.87 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.042 1.337 . . . . 0.35 107.774 170.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -72.15 131.28 42.58 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.484 -0.562 . . . . 0.35 109.484 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt . . . . . 0 N--CA 1.456 -0.163 0 C-N-CA 124.336 1.054 . . . . 0.25 109.566 -176.225 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 CA--C 1.534 0.337 0 CA-C-O 119.234 -0.412 . . . . 0.35 112.059 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m 62.13 50.12 4.14 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 125.153 1.381 . . . . 0.35 110.739 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.2 t -164.68 -38.03 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.546 0.738 . . . . 0.35 111.688 -171.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 67.96 120.83 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.202 2.201 . . . . 0.35 110.908 -168.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.4 148.92 44.77 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.835 0.854 . . . . 0.35 110.494 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? 78.14 156.35 0.16 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.896 2.078 . . . . 0.35 110.856 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.59 80.89 0.66 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 124.401 1.0 . . . . 0.35 110.706 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? 57.56 44.15 21.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.974 1.31 . . . . 0.35 110.744 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -93.41 87.32 5.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.637 0.775 . . . . 0.35 109.627 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -84.02 52.52 2.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.88 1.272 . . . . 0.35 111.096 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm 68.68 -72.41 0.1 Allowed 'General case' 0 C--N 1.342 0.277 0 C-N-CA 127.15 2.18 . . . . 0.35 111.993 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.24 -40.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.611 -0.996 . . . . 0.35 110.611 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -57.96 136.61 57.11 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.385 1.074 . . . . 0.35 110.623 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -157.97 59.91 0.47 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.873 -0.788 . . . . 0.35 108.873 174.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.11 78.71 6.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.649 1.18 . . . . 0.35 108.476 173.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.6 m -113.46 -42.12 3.53 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.949 1.3 . . . . 0.35 111.05 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.96 170.04 19.24 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.581 0.753 . . . . 0.35 111.712 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.7 t80 64.76 91.23 0.08 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 126.73 2.012 . . . . 0.35 111.241 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 70.84 150.56 0.13 Allowed Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.559 1.944 . . . . 0.33 111.676 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.42 80.58 2.23 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.443 2.762 . . . . 0.35 110.03 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.3 p -71.32 -48.27 51.5 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.992 0.917 . . . . 0.35 110.641 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.83 -179.01 44.58 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 117.994 0.361 . . . . 0.33 112.887 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -76.63 177.2 9.13 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.217 3.278 . . . . 0.35 112.715 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -160.05 -177.5 6.35 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.165 1.386 . . . . 0.35 109.524 157.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -153.81 99.32 2.27 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.23 -0.656 . . . . 0.35 109.23 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 77.6 mtm -84.44 111.82 19.81 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.552 1.141 . . . . 0.35 110.587 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.7 t -101.0 90.66 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 125.43 1.492 . . . . 0.35 108.064 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -146.21 178.01 8.56 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.371 0.668 . . . . 0.36 111.962 -173.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.77 142.53 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.222 1.409 . . . . 0.35 109.835 -172.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.6 m -93.34 81.6 4.44 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.204 -1.406 . . . . 0.35 107.204 168.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.74 113.86 3.78 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.915 -0.874 . . . . 0.35 110.915 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.41 164.42 15.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.849 1.259 . . . . 0.35 111.179 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -77.3 174.07 11.19 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.784 0.833 . . . . 0.35 110.703 172.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -55.81 -40.37 72.66 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.248 1.019 . . . . 0.35 110.41 167.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -59.13 -59.05 6.08 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.287 1.035 . . . . 0.35 109.94 171.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 140.17 -0.99 2.13 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.26 0.933 . . . . 0.35 112.924 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -72.63 128.06 34.42 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.478 1.139 . . . . 0.36 109.839 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -70.01 106.49 3.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.46 0.704 . . . . 0.35 110.89 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.8 mt -67.37 -47.16 71.2 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.591 1.156 . . . . 0.35 110.553 174.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -142.98 152.77 42.32 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.479 0.712 . . . . 0.35 111.316 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.0 m -108.0 152.23 41.63 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 125.389 1.476 . . . . 0.33 109.993 -175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.8 -173.02 1.58 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.656 2.904 . . . . 0.35 112.304 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.1 m170 74.19 66.76 0.09 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 127.055 2.142 . . . . 0.35 111.306 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -153.55 -2.55 0.21 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.863 0.865 . . . . 0.35 113.041 177.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.6 t -135.39 115.73 18.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 N-CA-C 106.426 -1.694 . . . . 0.35 106.426 170.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -143.82 148.8 36.05 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.317 1.047 . . . . 0.35 109.503 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -139.61 148.64 56.82 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 124.284 1.034 . . . . 0.33 109.889 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.64 135.89 34.53 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.648 2.232 . . . . 0.35 108.544 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.4 tt -66.61 144.35 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 122.927 0.491 . . . . 0.35 112.161 -168.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -137.97 87.31 16.71 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 125.401 1.48 . . . . 0.33 107.5 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.55 155.5 31.76 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.38 2.72 . . . . 0.35 110.878 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.41 -32.41 2.48 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.077 0.846 . . . . 0.35 111.698 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.3 t -70.39 155.22 40.98 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.983 0.913 . . . . 0.35 111.357 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.1 m -72.53 145.46 47.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.741 0.816 . . . . 0.35 109.069 172.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.42 76.74 1.69 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.416 1.086 . . . . 0.35 108.901 -172.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t -114.86 171.22 7.78 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.171 1.788 . . . . 0.35 109.88 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -56.61 -44.79 81.5 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.693 1.197 . . . . 0.35 111.63 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.79 -27.79 67.05 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.931 0.715 . . . . 0.35 112.931 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -73.82 -25.58 60.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.37 1.068 . . . . 0.35 112.065 174.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.8 mm -90.51 -51.4 11.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-N 118.564 0.62 . . . . 0.35 110.94 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.36 -41.01 75.45 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.691 0.626 . . . . 0.35 112.691 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.36 -30.37 57.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.032 0.533 . . . . 0.35 111.697 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -76.11 -42.18 47.89 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.411 1.084 . . . . 0.35 111.02 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.3 m -72.32 -23.76 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.001 0.52 . . . . 0.35 111.329 173.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -68.9 -34.39 75.32 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.242 0.474 . . . . 0.35 110.579 171.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -24.52 63.2 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.07 -0.491 . . . . 0.35 111.732 174.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.3 -38.6 75.03 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.513 0.597 . . . . 0.35 110.925 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.7 -45.42 92.86 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.38 0.672 . . . . 0.35 110.366 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -64.67 153.55 39.21 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.006 0.366 . . . . 0.35 110.279 172.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 82.51 -47.54 0.17 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.801 2.04 . . . . 0.35 110.94 -167.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.3 p -91.69 -99.28 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.095 0.958 . . . . 0.35 110.087 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.15 96.44 9.62 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.994 1.318 . . . . 0.35 111.228 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -153.89 6.73 0.33 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.537 1.135 . . . . 0.35 111.724 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -74.33 -60.56 2.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.265 1.026 . . . . 0.35 109.612 -173.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -104.5 -21.96 13.37 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.665 1.586 . . . . 0.35 110.542 171.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -70.28 133.79 47.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.279 1.432 . . . . 0.35 109.921 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -152.43 114.49 4.42 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.792 0.837 . . . . 0.35 110.078 -175.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -70.05 117.24 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.272 1.029 . . . . 0.35 109.861 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.6 -46.7 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.976 0.911 . . . . 0.35 110.698 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -136.94 163.18 31.31 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.651 1.181 . . . . 0.35 109.623 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -137.04 153.06 50.72 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.766 1.226 . . . . 0.35 110.135 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.59 126.36 71.37 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 108.437 -0.949 . . . . 0.33 108.437 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.25 -30.79 15.33 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.917 2.411 . . . . 0.35 111.028 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.6 t -87.13 72.7 9.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.553 1.141 . . . . 0.35 110.502 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.03 168.69 14.93 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.112 0.965 . . . . 0.35 110.335 168.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -139.13 152.85 47.79 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.696 0.798 . . . . 0.35 111.735 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.92 87.55 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 126.128 1.771 . . . . 0.35 106.923 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -86.15 93.74 9.1 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 108.86 -0.793 . . . . 0.35 108.86 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.2 m -73.56 85.02 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 108.09 -1.078 . . . . 0.35 108.09 171.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.7 m -87.72 78.71 8.39 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.659 1.183 . . . . 0.35 108.521 -174.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -88.3 165.28 15.11 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.935 0.894 . . . . 0.35 110.102 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -154.16 28.87 0.45 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.682 1.593 . . . . 0.35 109.647 -168.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.95 125.49 20.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.318 1.447 . . . . 0.35 112.02 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -85.49 63.02 7.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.206 -1.035 . . . . 0.35 108.206 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -144.17 -60.76 0.39 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.715 1.206 . . . . 0.36 109.933 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -152.68 -56.32 0.13 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.013 0.746 . . . . 0.35 113.013 -172.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -80.02 -41.93 24.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.114 0.87 . . . . 0.35 112.044 -171.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt 69.57 -148.77 0.11 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.918 1.287 . . . . 0.35 111.341 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -75.66 115.92 15.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.754 0.822 . . . . 0.35 111.442 -167.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.17 113.32 6.87 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.365 1.066 . . . . 0.35 109.206 173.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.8 m -79.47 81.93 5.66 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 107.4 -1.333 . . . . 0.35 107.4 169.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -86.74 86.25 7.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.279 1.032 . . . . 0.35 109.415 -169.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.5 p -77.08 84.03 3.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.023 1.329 . . . . 0.35 111.387 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -83.38 127.62 67.75 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 123.915 0.886 . . . . 0.33 108.95 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.89 163.55 28.48 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.198 2.598 . . . . 0.35 111.908 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 tp -78.84 163.83 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.714 1.206 . . . . 0.35 110.355 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.6 p -124.34 165.3 17.93 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.849 1.26 . . . . 0.35 110.358 176.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.37 -28.46 14.94 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.875 1.27 . . . . 0.35 110.715 171.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -70.0 -60.25 2.41 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.012 0.925 . . . . 0.35 109.848 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.14 98.65 2.28 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 123.993 0.806 . . . . 0.35 111.587 174.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -78.23 136.97 37.89 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.099 -0.704 . . . . 0.35 109.099 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.36 136.67 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.708 -0.849 . . . . 0.35 108.708 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.83 118.22 46.43 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.469 -0.937 . . . . 0.33 108.469 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -84.58 162.06 12.56 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.065 2.51 . . . . 0.35 111.184 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -83.67 168.05 16.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.898 0.879 . . . . 0.35 109.458 166.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -158.44 130.98 7.03 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.22 0.608 . . . . 0.35 111.02 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.1 t -163.21 69.84 0.23 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.436 1.095 . . . . 0.35 108.581 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -158.22 -63.89 0.09 Allowed 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.851 0.86 . . . . 0.35 108.996 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -89.39 -47.29 8.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.353 1.061 . . . . 0.35 111.382 -175.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.7 pt -136.65 169.1 20.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 C-N-CA 123.879 0.872 . . . . 0.35 111.633 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -144.03 38.79 1.32 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.995 1.718 . . . . 0.35 108.162 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -169.77 58.52 0.32 Allowed Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.906 0.882 . . . . 0.36 110.502 -172.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -63.69 -57.1 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.512 2.808 . . . . 0.35 111.993 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.38 72.91 0.86 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.457 -1.057 . . . . 0.35 110.457 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -68.99 97.79 0.89 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.311 1.444 . . . . 0.35 110.46 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -87.41 96.2 10.29 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.595 -0.52 . . . . 0.36 109.595 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -88.27 62.96 6.95 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.278 -1.008 . . . . 0.35 108.278 170.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -94.72 104.36 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.501 -2.037 . . . . 0.35 105.501 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 68.5 p -97.94 -162.89 0.99 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.288 1.035 . . . . 0.35 109.244 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.53 121.77 4.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.232 -1.395 . . . . 0.35 107.232 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.36 157.02 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.224 0.61 . . . . 0.35 110.223 175.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.81 143.85 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.942 1.297 . . . . 0.35 108.364 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.6 mp -130.82 145.06 36.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 C-N-CA 124.767 1.227 . . . . 0.35 110.383 -175.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.84 157.17 34.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.161 1.385 . . . . 0.35 108.255 160.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -90.2 126.02 35.67 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.29 -0.633 . . . . 0.35 109.29 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 C--N 1.34 0.192 0 C-N-CA 123.834 0.854 . . . . 0.25 110.635 -175.895 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 110.146 -0.316 . . . . 0.35 110.146 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.2 m 67.42 127.15 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.659 1.984 . . . . 0.35 112.658 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 m 54.35 42.27 31.52 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.879 1.271 . . . . 0.35 112.256 172.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 73.29 128.73 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.312 1.845 . . . . 0.35 109.751 -176.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -77.46 70.04 3.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.505 1.122 . . . . 0.35 110.067 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -175.81 173.5 2.32 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.373 1.869 . . . . 0.35 109.454 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.77 -155.4 8.65 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.859 0.742 . . . . 0.35 111.775 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -71.17 109.74 5.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.811 0.844 . . . . 0.35 109.059 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -138.94 80.51 1.79 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.056 0.943 . . . . 0.35 109.004 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -89.47 35.1 0.81 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.633 1.173 . . . . 0.35 112.013 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.6 -82.77 0.03 OUTLIER 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.849 1.66 . . . . 0.35 110.43 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.17 2.94 0.03 OUTLIER Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.389 1.471 . . . . 0.35 112.752 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 p30 50.02 26.93 2.24 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 127.351 2.261 . . . . 0.35 115.799 174.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 49.35 38.17 13.29 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.807 1.643 . . . . 0.35 112.572 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.74 -44.41 0.01 OUTLIER 'General case' 0 C--N 1.339 0.11 0 C-N-CA 125.044 1.337 . . . . 0.35 109.511 -171.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.7 t 68.64 45.72 1.04 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.294 1.838 . . . . 0.35 110.51 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.2 t80 49.21 61.74 2.98 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.287 1.435 . . . . 0.35 110.325 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -160.49 92.89 0.99 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.237 0.615 . . . . 0.35 109.899 -170.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 66.5 166.21 0.12 Allowed Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 126.117 1.767 . . . . 0.33 113.595 165.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.85 96.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.365 3.377 . . . . 0.35 111.811 169.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.8 p -144.38 -38.49 0.29 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.917 1.287 . . . . 0.35 110.496 -174.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.82 143.88 6.82 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 110.921 -0.872 . . . . 0.33 110.921 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -86.44 168.32 8.68 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.052 3.168 . . . . 0.35 112.087 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -165.08 160.03 18.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.163 0.985 . . . . 0.35 111.215 -172.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.9 tt -158.27 113.2 2.61 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.09 1.356 . . . . 0.35 108.748 -170.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -96.73 152.12 18.98 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.55 1.14 . . . . 0.35 110.774 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.01 89.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.301 0 C-N-CA 124.654 1.182 . . . . 0.35 108.709 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -144.66 -162.93 1.59 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.711 0.805 . . . . 0.36 110.3 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.5 m -137.91 148.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 124.675 1.19 . . . . 0.35 110.024 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.4 m -85.54 93.38 8.78 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.088 -1.449 . . . . 0.35 107.088 169.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.89 89.32 1.43 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.819 0.723 . . . . 0.35 111.758 -169.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.4 m -101.74 170.61 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.749 1.22 . . . . 0.35 112.627 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.06 179.09 7.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.961 1.304 . . . . 0.35 109.438 165.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.3 t -58.36 -40.41 82.17 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.03 0.932 . . . . 0.35 110.786 172.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.53 -54.98 40.34 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.265 1.026 . . . . 0.35 110.423 175.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.84 26.79 0.56 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.726 1.155 . . . . 0.35 111.905 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -100.11 115.54 30.02 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.187 0.995 . . . . 0.36 109.21 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.84 114.23 4.36 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.463 0.705 . . . . 0.35 110.552 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mp -77.75 -51.01 11.23 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.987 -0.746 . . . . 0.35 108.987 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.0 mt -91.99 -149.45 0.24 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.997 1.319 . . . . 0.35 110.189 -167.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.4 m -154.87 123.54 3.02 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.474 1.11 . . . . 0.33 109.126 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.16 -171.29 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.257 2.638 . . . . 0.35 110.311 171.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.2 m170 64.14 75.63 0.37 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.696 1.199 . . . . 0.35 111.171 174.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -145.44 -61.44 0.34 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.328 0.651 . . . . 0.35 110.646 174.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.59 124.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 107.926 -1.139 . . . . 0.35 107.926 166.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -149.9 151.32 33.24 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.67 1.188 . . . . 0.35 109.541 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -140.17 146.15 44.86 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.812 1.245 . . . . 0.33 109.333 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.71 128.76 17.51 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.329 2.019 . . . . 0.35 107.713 166.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.4 tt -59.82 142.62 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.418 0.525 . . . . 0.35 112.418 -167.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -128.72 97.9 26.21 Favored Pre-proline 0 N--CA 1.453 -0.287 0 N-CA-C 107.31 -1.367 . . . . 0.33 107.31 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.29 157.47 49.88 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.454 2.103 . . . . 0.35 109.811 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.02 58.32 1.8 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.146 -1.182 . . . . 0.35 110.146 -174.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.3 t -152.56 147.26 25.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.979 1.311 . . . . 0.35 108.981 174.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.1 m -61.2 138.77 58.22 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.236 0.614 . . . . 0.35 110.379 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.89 80.95 1.71 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.446 1.098 . . . . 0.35 108.722 -173.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.3 p -133.39 178.66 6.74 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.869 1.268 . . . . 0.35 109.288 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -54.75 -54.37 42.86 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.109 0.564 . . . . 0.35 111.208 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.54 -42.93 67.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.383 1.073 . . . . 0.35 112.603 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.8 -60.24 4.11 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.231 0.612 . . . . 0.35 110.609 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.2 mm -57.54 -42.23 80.65 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 C-N-CA 124.61 1.164 . . . . 0.35 111.603 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -49.77 -59.24 4.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.75 1.22 . . . . 0.35 111.999 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -73.65 -29.61 62.43 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.497 0.555 . . . . 0.35 112.497 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -69.87 -40.03 75.99 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.518 0.727 . . . . 0.35 111.898 -170.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.34 -30.79 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.017 0.527 . . . . 0.35 111.512 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.3 -33.67 74.76 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.223 0.609 . . . . 0.35 111.019 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -31.56 67.52 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.332 0.653 . . . . 0.35 111.337 176.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 -55.4 22.23 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.228 0.611 . . . . 0.35 110.994 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 pp -64.12 -27.33 69.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.171 0.988 . . . . 0.35 112.811 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.62 -43.56 63.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.281 0.632 . . . . 0.35 110.32 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.51 50.47 1.89 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.64 1.176 . . . . 0.35 111.401 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.0 t -168.07 -42.69 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.358 1.463 . . . . 0.35 109.945 173.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.94 88.58 0.83 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.74 0.816 . . . . 0.35 110.023 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -107.71 46.81 0.92 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.278 1.031 . . . . 0.35 108.717 167.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -84.89 -57.64 3.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.771 1.228 . . . . 0.35 109.038 -175.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.74 -139.25 0.33 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.601 1.561 . . . . 0.35 108.42 176.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 82.56 109.82 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.284 1.433 . . . . 0.35 111.436 162.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -41.86 9.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.907 1.283 . . . . 0.35 111.209 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.1 t 69.11 92.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 126.219 1.808 . . . . 0.35 109.463 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.6 t -67.95 -63.72 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.419 0.688 . . . . 0.35 109.767 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -160.33 117.82 2.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.15 0.58 . . . . 0.35 109.742 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.04 145.95 44.11 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.195 0.598 . . . . 0.35 110.019 172.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.99 123.07 85.16 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.518 -0.919 . . . . 0.33 108.518 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.31 -32.96 19.33 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.232 2.621 . . . . 0.35 111.045 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.3 m -79.67 76.25 6.32 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.976 0.911 . . . . 0.35 109.184 173.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.01 154.23 23.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.242 1.017 . . . . 0.35 110.07 172.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -133.93 134.42 42.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.109 0.964 . . . . 0.35 109.952 -171.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.4 mp -122.5 111.76 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 125.669 1.587 . . . . 0.35 107.964 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -99.04 63.39 1.33 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.117 0.967 . . . . 0.35 108.648 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.01 99.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.358 0.599 . . . . 0.35 109.896 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.6 m -80.39 150.46 29.82 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.532 1.133 . . . . 0.35 108.94 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -139.1 66.42 1.42 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.322 1.049 . . . . 0.35 108.726 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -91.55 121.59 33.37 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 127.396 2.278 . . . . 0.35 109.863 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.3 p-10 -131.29 -165.06 1.51 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.687 0.795 . . . . 0.35 110.56 169.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -144.51 63.8 1.31 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.826 -1.176 . . . . 0.35 107.826 169.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -134.04 -53.35 0.85 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 125.468 1.507 . . . . 0.36 109.21 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -155.88 -41.3 0.08 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.063 0.945 . . . . 0.35 111.679 -172.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.6 tppt? -83.67 -59.54 2.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.88 0.872 . . . . 0.35 111.467 -166.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? 68.03 177.84 0.25 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.933 1.693 . . . . 0.35 111.401 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -63.47 110.91 2.11 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 112.514 0.561 . . . . 0.35 112.514 -165.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -132.93 137.25 46.55 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.229 1.811 . . . . 0.35 106.66 170.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.5 m -116.01 102.12 9.36 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.894 0.878 . . . . 0.35 109.35 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -79.59 101.32 8.24 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.678 -0.86 . . . . 0.35 108.678 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.4 m -90.16 67.52 6.92 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.211 1.005 . . . . 0.35 110.07 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -71.01 134.34 85.56 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.103 0.961 . . . . 0.33 109.398 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.15 -113.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.474 2.783 . . . . 0.35 109.622 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.1 tp -163.05 158.43 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.245 0 CA-C-N 119.156 0.889 . . . . 0.35 110.087 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.8 p -133.69 151.82 51.73 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.798 1.239 . . . . 0.35 109.183 169.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.13 -35.16 66.8 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.957 1.303 . . . . 0.35 112.965 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -141.58 74.26 1.45 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.961 1.304 . . . . 0.35 107.883 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.69 -92.03 0.41 Allowed Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.141 0.877 . . . . 0.35 112.184 -175.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -162.03 171.01 18.26 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.304 0.573 . . . . 0.35 112.076 -163.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 99.3 t -90.21 145.35 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.204 1.802 . . . . 0.35 107.73 169.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.5 t -52.92 115.14 6.83 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 123.846 0.859 . . . . 0.33 109.371 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -82.6 -178.67 4.08 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.275 2.65 . . . . 0.35 110.931 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -72.38 -178.45 2.54 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.873 0.869 . . . . 0.35 109.922 170.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.31 61.11 1.53 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.912 0.885 . . . . 0.35 110.388 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t 56.84 -103.0 0.17 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.97 1.708 . . . . 0.35 112.129 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -163.49 -58.12 0.04 OUTLIER 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.557 1.143 . . . . 0.35 108.623 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -57.92 -47.55 82.53 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.257 1.423 . . . . 0.35 112.124 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.3 tp -81.39 133.54 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.692 0.797 . . . . 0.35 110.684 -176.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.39 29.61 0.49 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.272 1.029 . . . . 0.35 111.643 166.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.49 60.56 10.23 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.227 1.411 . . . . 0.36 108.988 167.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.92 -73.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.743 2.962 . . . . 0.35 113.074 -168.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.71 78.36 1.4 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.927 -1.669 . . . . 0.35 108.927 -164.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -80.03 95.99 6.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.904 -1.147 . . . . 0.35 107.904 171.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -83.16 101.27 11.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.748 -0.834 . . . . 0.36 108.748 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.07 49.98 1.71 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.148 -1.056 . . . . 0.35 108.148 166.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.85 109.79 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.205 -1.776 . . . . 0.35 106.205 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 67.1 p -94.09 -133.69 0.17 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.226 1.011 . . . . 0.35 109.109 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -162.33 133.69 5.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.601 1.16 . . . . 0.35 108.065 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 m -142.34 143.45 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.718 0.807 . . . . 0.35 110.031 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.38 134.03 28.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.838 -1.171 . . . . 0.35 107.838 173.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.7 mt -123.5 143.58 36.12 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 C-N-CA 124.47 1.108 . . . . 0.35 110.652 -169.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -128.69 102.77 6.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.686 1.595 . . . . 0.35 106.76 166.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -60.85 128.26 35.64 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.2 0.6 . . . . 0.35 109.392 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.184 0 C-N-CA 123.79 0.836 . . . . 0.25 109.383 -164.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.965 -0.383 . . . . 0.35 109.965 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 t -82.77 177.09 8.84 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.11 0.964 . . . . 0.35 110.584 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.0 p -81.71 51.57 1.73 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.568 1.147 . . . . 0.35 110.011 172.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 58.62 23.57 11.1 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.608 1.563 . . . . 0.35 111.833 -171.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.8 t70 60.79 171.07 0.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.155 1.382 . . . . 0.35 110.994 -167.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.3 pttt 47.57 -106.16 0.15 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.373 1.469 . . . . 0.35 112.396 171.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.1 -136.49 2.03 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.546 -1.022 . . . . 0.35 110.546 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -85.7 71.46 10.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.941 -1.133 . . . . 0.35 107.941 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -67.15 -56.88 8.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.065 0.946 . . . . 0.35 113.061 -162.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 76.84 110.58 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.921 2.088 . . . . 0.35 108.297 -170.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -55.41 -61.54 2.27 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.365 1.066 . . . . 0.35 111.817 -167.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.58 80.28 0.1 OUTLIER Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.516 -1.434 . . . . 0.35 109.516 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -127.82 41.18 3.55 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.251 1.021 . . . . 0.35 109.914 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.7 t0 50.71 55.25 9.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.185 1.394 . . . . 0.35 109.552 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -129.58 -168.62 1.97 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.77 1.228 . . . . 0.35 111.454 -155.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.5 m 63.65 69.64 0.55 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.952 1.701 . . . . 0.35 111.025 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 60.65 -145.43 0.47 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.242 1.417 . . . . 0.35 110.169 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 77.0 t80 57.8 73.87 0.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.468 1.507 . . . . 0.35 111.867 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 65.43 168.09 0.11 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.992 1.717 . . . . 0.33 113.28 168.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.32 113.53 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.981 2.454 . . . . 0.35 110.557 168.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 p -142.36 -73.32 0.31 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.558 0.743 . . . . 0.35 111.564 -170.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.43 112.97 0.53 Allowed Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.892 -0.949 . . . . 0.33 111.088 -170.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.97 175.61 10.61 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.816 3.011 . . . . 0.35 112.758 -171.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -155.28 166.98 31.88 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.835 0.68 . . . . 0.35 112.835 -172.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.2 tp -139.0 80.94 1.81 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.469 1.908 . . . . 0.35 107.743 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.1 mtm -74.45 100.89 3.96 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 122.674 0.39 . . . . 0.35 111.196 -172.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 t -84.57 76.72 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.521 -1.289 . . . . 0.35 107.521 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -149.02 148.18 29.42 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.618 1.167 . . . . 0.36 109.708 -171.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.6 m -140.37 144.36 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.266 1.026 . . . . 0.35 111.249 -170.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.1 m -70.2 105.49 2.97 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.731 1.212 . . . . 0.35 109.34 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.49 81.04 1.48 Allowed Glycine 0 C--N 1.34 0.776 0 C-N-CA 124.204 0.907 . . . . 0.35 111.711 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.9 m -87.16 170.27 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.154 0.982 . . . . 0.35 111.909 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -77.1 -44.56 30.06 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.928 0.891 . . . . 0.35 110.571 173.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.8 t 169.72 -59.8 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.097 2.559 . . . . 0.35 107.077 -171.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.9 43.66 1.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.115 1.366 . . . . 0.35 111.915 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.04 32.39 63.32 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.784 -1.009 . . . . 0.35 114.297 167.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -103.43 90.77 3.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.483 1.141 . . . . 0.36 108.132 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.89 109.5 1.47 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.848 0.859 . . . . 0.35 110.077 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mp -77.52 -53.8 7.18 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.38 0.672 . . . . 0.35 109.845 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.9 mt -86.07 -169.43 2.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.406 1.082 . . . . 0.35 110.247 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.3 m -126.48 68.51 67.79 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.553 0.741 . . . . 0.33 111.051 -174.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.99 164.29 35.32 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.909 3.073 . . . . 0.35 112.893 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.1 m170 79.1 80.67 0.06 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 127.222 2.209 . . . . 0.35 108.357 -172.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -147.31 -48.64 0.18 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.352 0.661 . . . . 0.35 111.957 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -83.86 77.51 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 108.568 -0.901 . . . . 0.35 108.568 169.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -72.2 -38.06 69.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.897 -0.573 . . . . 0.35 111.924 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 64.67 154.26 0.12 Allowed Pre-proline 0 C--N 1.345 0.399 0 C-N-CA 126.634 1.974 . . . . 0.33 113.454 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.87 134.57 8.44 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.085 2.523 . . . . 0.35 108.378 165.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.5 tt -70.51 148.57 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.505 0.322 . . . . 0.35 111.196 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -135.08 107.39 10.4 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 107.287 -1.375 . . . . 0.33 107.287 172.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.63 161.69 27.71 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.12 2.547 . . . . 0.35 110.563 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.32 61.61 1.98 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.711 -1.356 . . . . 0.35 109.711 -173.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 t -151.9 142.98 23.18 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.55 1.14 . . . . 0.35 109.431 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.5 m -62.79 121.03 12.44 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.699 0.799 . . . . 0.35 110.034 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.85 78.63 1.64 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.893 1.277 . . . . 0.35 108.621 -173.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.3 p -116.02 172.1 7.37 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.746 1.618 . . . . 0.35 109.59 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.87 -49.78 75.52 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.69 1.196 . . . . 0.35 110.531 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -65.06 -28.94 69.81 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.61 0.764 . . . . 0.35 112.926 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -74.36 4.02 6.51 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.471 -0.775 . . . . 0.35 112.844 172.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.2 mm -100.36 -49.51 11.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 CA-C-N 119.324 0.965 . . . . 0.35 109.039 168.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -43.75 -64.78 0.59 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.691 1.597 . . . . 0.35 113.607 -167.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -82.11 -28.65 32.14 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.779 0.832 . . . . 0.35 111.795 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -60.18 -49.41 77.75 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.626 1.17 . . . . 0.35 111.691 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.0 m -66.9 -38.19 80.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 C-N-CA 123.371 0.668 . . . . 0.35 110.983 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.89 -39.22 84.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.779 0.832 . . . . 0.35 111.127 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -72.46 -40.8 66.73 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.0 0.92 . . . . 0.35 111.466 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.74 95.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.358 0.663 . . . . 0.35 111.218 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -85.95 -22.38 27.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.963 0.905 . . . . 0.35 113.025 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.7 -41.77 91.51 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.512 0.725 . . . . 0.35 110.573 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.85 64.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.0 0.92 . . . . 0.35 112.091 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.7 p -83.58 -62.03 1.68 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.857 0.863 . . . . 0.35 112.276 -173.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.01 -67.85 0.39 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-N 118.495 0.588 . . . . 0.35 110.076 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 71.48 149.42 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.966 1.707 . . . . 0.35 113.202 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? 68.59 -90.18 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.101 1.76 . . . . 0.35 112.775 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -84.5 72.35 10.64 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 123.901 0.88 . . . . 0.35 111.078 -169.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -167.74 147.96 5.12 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.256 1.422 . . . . 0.35 108.248 173.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.3 tpt85 -114.1 -60.04 1.94 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.591 0.757 . . . . 0.35 111.473 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.3 t 71.76 82.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 125.304 1.442 . . . . 0.35 107.963 -160.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.5 t -69.38 -57.33 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.623 1.169 . . . . 0.35 109.99 -172.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -131.11 169.52 15.78 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.627 1.171 . . . . 0.35 110.842 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -153.68 156.4 37.78 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.712 1.605 . . . . 0.35 109.013 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -87.33 138.27 32.25 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.276 -0.639 . . . . 0.33 109.276 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.06 -17.92 24.43 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.436 2.758 . . . . 0.35 111.856 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.4 m -59.01 -31.87 69.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.436 1.095 . . . . 0.35 112.291 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 15.69 74.38 0.01 OUTLIER 'General case' 0 C--N 1.348 0.511 0 C-N-CA 128.813 2.845 . . . . 0.35 113.728 172.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -78.9 128.77 33.75 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.122 0.969 . . . . 0.35 113.092 -161.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.8 124.03 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 125.988 1.715 . . . . 0.35 107.354 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -122.57 90.26 3.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.377 1.071 . . . . 0.35 108.601 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 m -78.8 92.19 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.786 1.234 . . . . 0.35 110.548 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.1 m -85.5 94.37 9.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.616 1.167 . . . . 0.35 108.645 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.74 84.1 4.94 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.509 0.724 . . . . 0.35 110.38 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -76.11 91.74 3.16 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.878 1.671 . . . . 0.35 110.003 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -134.19 78.95 1.78 Allowed 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.896 -0.779 . . . . 0.35 108.896 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -75.67 83.31 2.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.724 1.21 . . . . 0.35 108.667 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -155.19 -37.86 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.857 1.663 . . . . 0.36 110.018 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -154.7 -41.35 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.93 1.292 . . . . 0.35 110.624 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -79.85 -63.2 1.47 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 123.246 0.618 . . . . 0.35 110.699 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.48 125.49 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.322 1.849 . . . . 0.35 109.84 -177.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -10.17 108.18 0.01 OUTLIER 'General case' 0 C--N 1.344 0.369 0 C-N-CA 129.516 3.126 . . . . 0.35 115.261 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -140.86 123.33 15.95 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.03 1.332 . . . . 0.35 107.989 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.7 m -102.32 103.9 14.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.748 1.219 . . . . 0.35 109.726 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.86 109.15 14.01 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.491 -0.929 . . . . 0.35 108.491 173.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.8 p -89.29 75.24 7.77 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.607 1.163 . . . . 0.35 111.151 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -81.21 142.57 51.2 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.679 1.192 . . . . 0.33 109.52 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -77.33 -129.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.79 2.993 . . . . 0.35 110.157 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.8 tp -167.43 159.92 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 119.663 1.12 . . . . 0.35 110.211 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.9 p -136.42 151.89 50.01 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.687 1.195 . . . . 0.35 109.84 170.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.5 -11.26 60.68 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.722 1.209 . . . . 0.35 114.062 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -142.05 59.15 1.47 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.973 -1.121 . . . . 0.35 107.973 172.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.38 -82.67 1.0 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.183 0.897 . . . . 0.35 111.558 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -163.54 159.83 22.41 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.193 0.521 . . . . 0.35 112.013 -163.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.4 t -91.08 144.85 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.005 1.722 . . . . 0.35 106.998 166.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 80.7 t -57.28 117.2 16.74 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 108.522 -0.918 . . . . 0.33 108.522 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.55 -109.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.009 2.473 . . . . 0.35 109.349 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -156.33 -137.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.591 -1.263 . . . . 0.35 107.591 173.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 mp -137.27 151.54 48.81 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.821 1.248 . . . . 0.35 109.595 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.3 t -77.11 -71.05 0.43 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.569 0.748 . . . . 0.35 109.74 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -168.02 -46.21 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.593 1.157 . . . . 0.35 109.799 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -39.4 -45.56 1.51 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.213 2.205 . . . . 0.35 115.151 -169.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.39 161.15 41.06 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 C-N-CA 123.444 0.698 . . . . 0.35 111.386 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -91.21 -68.18 0.81 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.209 1.404 . . . . 0.35 110.092 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.94 103.34 49.46 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.234 1.014 . . . . 0.36 112.407 -165.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.43 -177.68 3.72 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.926 2.417 . . . . 0.35 111.174 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -153.3 68.0 0.31 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.876 -1.289 . . . . 0.35 109.876 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -57.71 129.11 40.38 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.787 1.235 . . . . 0.35 109.376 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -131.89 116.0 16.62 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.523 -0.918 . . . . 0.36 108.523 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -88.5 60.13 5.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.257 1.023 . . . . 0.35 109.628 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.8 mt -78.66 130.9 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.408 1.083 . . . . 0.35 109.542 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.4 m -143.85 139.23 29.16 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.174 1.39 . . . . 0.35 108.354 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.76 93.52 9.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.187 0.995 . . . . 0.35 108.467 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.73 138.29 30.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 C-N-CA 124.198 0.999 . . . . 0.35 111.222 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.79 100.62 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.427 1.491 . . . . 0.35 108.751 -175.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 18.5 mt -90.98 145.84 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.089 0.956 . . . . 0.35 110.234 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -138.59 127.05 23.15 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.845 1.258 . . . . 0.35 109.208 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -66.71 125.71 26.7 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.316 1.046 . . . . 0.35 109.579 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? . . . . . 0 C--N 1.34 0.183 0 C-N-CA 123.128 0.571 . . . . 0.25 109.745 176.586 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 118.595 -0.717 . . . . 0.35 112.654 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.5 m 71.53 -74.05 0.09 Allowed 'General case' 0 C--N 1.344 0.365 0 C-N-CA 126.543 1.937 . . . . 0.35 112.261 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 82.2 p -91.89 138.39 31.59 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.414 1.086 . . . . 0.35 109.723 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -69.13 139.43 54.7 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.887 0.875 . . . . 0.35 109.697 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -79.83 -171.74 3.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.402 0.681 . . . . 0.35 110.596 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 17.8 pttm 47.75 -134.34 1.15 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.464 1.506 . . . . 0.35 111.816 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.02 74.95 0.07 OUTLIER Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.339 0.972 . . . . 0.35 111.842 -175.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt 52.56 62.56 2.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.537 1.135 . . . . 0.35 110.344 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -135.86 133.43 37.77 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.317 1.047 . . . . 0.35 110.512 -170.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.33 45.2 0.64 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.962 1.305 . . . . 0.35 109.016 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt 64.17 -89.54 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.401 1.48 . . . . 0.35 108.929 -168.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.33 32.58 0.12 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.338 -1.105 . . . . 0.35 110.338 168.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 55.3 20.08 3.33 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.014 1.726 . . . . 0.35 113.016 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 47.78 40.47 12.44 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.518 1.527 . . . . 0.35 111.618 -173.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.05 85.35 0.15 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.373 0.669 . . . . 0.35 109.904 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -86.86 -112.54 0.05 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.794 0.838 . . . . 0.35 109.452 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -149.11 67.68 1.04 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.268 1.027 . . . . 0.35 110.355 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -154.28 91.56 1.43 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.324 1.05 . . . . 0.35 108.363 166.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 69.49 150.36 0.12 Allowed Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.875 1.67 . . . . 0.33 111.661 173.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.45 93.14 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.0 2.467 . . . . 0.35 111.187 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 p -74.41 -52.57 11.69 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.155 0.982 . . . . 0.35 109.162 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.4 163.42 29.31 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.147 -0.781 . . . . 0.33 111.147 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -80.85 -174.44 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.482 3.455 . . . . 0.35 112.092 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -163.15 -178.45 6.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.077 1.751 . . . . 0.35 108.807 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 tt -155.05 83.63 1.08 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.712 -1.218 . . . . 0.35 107.712 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.1 ttp -82.27 118.63 23.27 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.324 0.65 . . . . 0.35 110.56 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.0 t -107.78 101.11 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 126.019 1.728 . . . . 0.35 108.281 -174.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -156.82 -177.4 6.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.582 1.153 . . . . 0.36 110.71 -172.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.85 -164.63 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.268 1.427 . . . . 0.35 109.162 172.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 m -133.2 99.76 4.65 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.382 -1.34 . . . . 0.35 107.382 169.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.35 87.57 1.21 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.823 1.201 . . . . 0.35 111.857 -171.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -104.44 166.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 124.15 0.98 . . . . 0.35 111.943 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.32 176.46 9.3 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.638 1.575 . . . . 0.35 109.288 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 t -53.55 -41.52 66.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.708 0.803 . . . . 0.35 110.755 166.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -91.86 18.87 7.16 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.612 1.165 . . . . 0.35 112.459 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 -5.7 76.79 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.926 -0.93 . . . . 0.35 114.921 168.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -75.07 123.57 25.44 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.921 1.361 . . . . 0.36 110.09 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.14 102.24 0.48 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.162 0.985 . . . . 0.35 110.841 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.68 -72.32 0.3 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.845 0.858 . . . . 0.35 108.828 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 mt -93.63 156.37 16.75 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.23 -1.026 . . . . 0.35 108.23 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.1 t -119.43 71.33 13.02 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 124.021 0.928 . . . . 0.33 109.652 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.61 91.84 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 124.539 3.493 . . . . 0.35 109.893 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -156.73 55.15 0.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.713 1.205 . . . . 0.35 109.032 -172.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -154.92 15.22 0.42 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.732 1.012 . . . . 0.35 113.732 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.8 t -125.94 119.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 C-N-CA 123.842 0.857 . . . . 0.35 108.859 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.68 169.52 17.64 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.291 0.636 . . . . 0.35 111.9 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.94 157.93 53.48 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 125.907 1.683 . . . . 0.33 108.486 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.98 168.62 22.64 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.858 2.372 . . . . 0.35 110.413 171.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 tp -65.21 118.79 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.628 0.771 . . . . 0.35 110.419 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -144.64 83.63 9.57 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.622 1.169 . . . . 0.33 108.636 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -84.58 -168.53 0.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.014 3.143 . . . . 0.35 109.907 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.17 -15.7 61.41 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.665 0.65 . . . . 0.35 112.356 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.0 t -75.36 148.03 39.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.799 0.84 . . . . 0.35 110.491 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.7 m -66.77 148.51 51.83 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.056 0.942 . . . . 0.35 108.94 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.99 116.03 7.88 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.401 -0.592 . . . . 0.35 109.401 -172.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -164.05 171.29 15.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.281 1.832 . . . . 0.35 108.099 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -52.69 -41.37 63.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.138 0.975 . . . . 0.35 112.143 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -83.98 -2.54 56.77 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.661 0.784 . . . . 0.35 113.042 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.42 50.81 2.2 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.503 1.121 . . . . 0.35 110.196 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -159.68 -48.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.378 1.071 . . . . 0.35 109.234 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.16 -47.34 62.16 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.044 1.338 . . . . 0.35 112.996 -174.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -63.77 -41.27 98.0 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.996 0.362 . . . . 0.35 111.79 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -65.09 -44.97 87.13 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.037 0.935 . . . . 0.35 111.745 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 m -69.2 -29.38 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.417 0.687 . . . . 0.35 112.497 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -72.21 -36.88 69.29 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 122.813 0.445 . . . . 0.35 111.08 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.21 -28.19 65.08 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.055 0.542 . . . . 0.35 111.394 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.01 -60.05 3.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.42 0.688 . . . . 0.35 110.618 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.69 -23.81 67.37 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.661 0.615 . . . . 0.35 112.661 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.15 -22.62 64.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.516 0.726 . . . . 0.35 112.252 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.62 -54.07 42.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.944 0.898 . . . . 0.35 111.802 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.7 p -75.23 -70.14 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.441 0.696 . . . . 0.35 110.832 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.8 148.56 25.96 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.102 1.361 . . . . 0.35 109.841 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -167.08 44.01 0.05 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.543 0.737 . . . . 0.35 111.221 -173.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -139.26 -71.39 0.4 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.026 0.531 . . . . 0.35 111.206 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -62.99 -57.28 11.24 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.065 0.946 . . . . 0.35 112.215 -167.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -62.72 145.15 55.46 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.746 0.418 . . . . 0.35 111.802 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.36 -41.5 2.04 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.498 1.919 . . . . 0.35 109.059 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t 79.33 126.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.283 0 C-N-CA 126.569 1.948 . . . . 0.35 111.539 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.14 -60.57 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 124.98 1.312 . . . . 0.35 108.982 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -153.81 128.73 9.53 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.868 0.867 . . . . 0.35 109.93 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.4 mt -78.49 118.7 20.88 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.801 -1.555 . . . . 0.35 106.801 164.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.15 137.09 95.67 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.979 -0.378 . . . . 0.33 109.979 -172.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -66.22 -33.93 37.94 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.41 2.74 . . . . 0.35 111.088 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -83.87 75.27 10.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.537 1.135 . . . . 0.35 110.165 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.89 165.05 13.74 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.654 0.782 . . . . 0.35 109.884 167.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -153.48 121.27 6.01 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.177 0.513 . . . . 0.35 111.794 -167.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.61 122.32 44.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 126.673 1.989 . . . . 0.35 107.093 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -111.96 77.73 1.07 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.415 -1.328 . . . . 0.35 107.415 173.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -72.79 86.94 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.591 0.71 . . . . 0.35 109.555 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.4 m -94.36 92.52 7.21 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.395 1.478 . . . . 0.35 108.816 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -91.37 169.22 10.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.648 1.179 . . . . 0.35 109.757 172.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -149.66 63.01 1.0 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.604 1.162 . . . . 0.35 108.033 173.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.87 86.69 4.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.525 1.13 . . . . 0.35 108.803 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -78.98 71.92 5.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.047 1.339 . . . . 0.35 109.214 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -149.31 -57.5 0.2 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.34 1.456 . . . . 0.36 109.168 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.84 35.56 0.4 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.658 0.783 . . . . 0.35 111.57 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.6 -51.06 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.937 0.495 . . . . 0.35 110.47 -170.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt 69.26 -153.18 0.14 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.689 1.596 . . . . 0.35 110.229 -173.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -95.18 130.91 41.72 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.503 1.121 . . . . 0.35 110.857 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -141.74 121.17 13.21 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.466 1.106 . . . . 0.35 108.463 171.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.6 m -81.29 85.4 6.4 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.304 -1.369 . . . . 0.35 107.304 170.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -79.75 95.75 6.08 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.058 0.943 . . . . 0.35 109.266 -173.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.5 p -88.17 70.1 9.24 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.667 1.187 . . . . 0.35 111.642 -171.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -68.12 136.48 91.66 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.709 0.804 . . . . 0.33 108.985 171.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -79.73 -111.76 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.338 2.692 . . . . 0.35 110.275 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.5 tp -163.21 153.37 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.987 1.315 . . . . 0.35 108.478 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.8 p -129.69 156.17 44.7 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.759 0.823 . . . . 0.35 109.928 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.2 -26.08 52.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.311 1.444 . . . . 0.35 112.017 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.83 -44.0 94.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.436 1.095 . . . . 0.35 113.099 -165.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.71 64.97 0.62 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.031 -1.228 . . . . 0.35 110.031 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -73.95 126.08 29.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.617 -0.512 . . . . 0.35 109.617 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.9 t -76.27 130.56 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.263 -1.014 . . . . 0.35 108.263 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.23 120.89 77.8 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 107.712 -1.218 . . . . 0.33 107.712 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.35 -94.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.977 2.451 . . . . 0.35 109.312 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -169.81 -82.69 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.395 1.478 . . . . 0.35 107.275 166.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.7 mt -150.81 160.6 43.76 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.051 1.34 . . . . 0.35 110.444 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.3 t -100.6 -72.7 0.66 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.658 1.183 . . . . 0.35 108.992 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -166.77 -48.39 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.191 0.996 . . . . 0.35 110.066 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.17 -35.63 12.06 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.675 1.99 . . . . 0.35 115.385 -168.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.2 pt -132.23 171.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 124.163 0.985 . . . . 0.35 110.963 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.09 42.34 0.59 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.277 1.031 . . . . 0.35 111.064 172.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.01 54.47 0.56 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.785 1.234 . . . . 0.36 110.214 170.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -44.09 -55.27 3.23 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 125.027 3.818 . . . . 0.35 113.759 -173.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.39 67.95 1.83 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.162 -0.775 . . . . 0.35 111.162 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -67.21 139.17 57.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.143 0.977 . . . . 0.35 111.12 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -127.58 87.9 2.7 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.767 1.227 . . . . 0.36 108.292 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -75.25 98.76 3.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.939 -1.504 . . . . 0.35 106.939 174.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.53 96.67 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.679 1.192 . . . . 0.35 108.398 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.3 m -84.88 146.8 27.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.185 0.994 . . . . 0.35 109.783 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.14 122.82 29.36 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.776 -1.194 . . . . 0.35 107.776 173.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.71 137.2 57.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 123.211 0.604 . . . . 0.35 110.517 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.9 t -97.48 103.23 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.674 1.189 . . . . 0.35 108.361 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.3 mt -82.05 126.13 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.231 1.012 . . . . 0.35 109.977 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -100.44 140.63 34.42 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 107.84 -1.17 . . . . 0.35 107.84 155.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.75 138.22 45.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.518 1.127 . . . . 0.35 110.381 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 124.101 0.96 . . . . 0.25 109.013 178.358 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.6 t . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 110.385 -0.228 . . . . 0.35 110.385 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.4 p -162.4 -173.96 3.82 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.048 0.939 . . . . 0.35 110.158 -172.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.5 p -63.92 104.12 0.66 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.45 1.1 . . . . 0.35 110.446 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -74.16 100.25 3.61 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.893 -1.151 . . . . 0.35 107.893 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.77 92.76 0.16 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.953 1.301 . . . . 0.35 111.967 -163.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -146.46 80.39 1.55 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.081 1.753 . . . . 0.35 107.146 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.14 98.79 1.5 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.996 0.808 . . . . 0.35 111.298 -175.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 54.65 63.48 2.13 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.204 1.402 . . . . 0.35 109.744 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -109.61 -69.55 0.86 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.513 1.525 . . . . 0.35 109.525 -174.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 65.17 165.64 0.17 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.686 1.594 . . . . 0.35 111.83 -170.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -46.36 -53.45 10.88 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.368 1.467 . . . . 0.35 112.054 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.61 -23.65 0.56 Allowed Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.952 0.787 . . . . 0.35 111.648 -175.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.11 -22.6 65.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.929 1.292 . . . . 0.35 112.604 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.67 130.0 44.69 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 123.625 0.77 . . . . 0.35 110.865 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.43 52.7 0.73 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.831 0.852 . . . . 0.35 109.103 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -61.85 140.37 58.27 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.307 1.043 . . . . 0.35 111.104 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 64.73 174.27 0.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.352 1.461 . . . . 0.35 113.156 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.5 t80 56.59 88.56 0.05 OUTLIER 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.85 2.06 . . . . 0.35 112.028 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 70.43 154.72 0.15 Allowed Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.431 1.892 . . . . 0.33 111.474 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -63.61 100.65 0.29 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.146 2.564 . . . . 0.35 109.58 163.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -107.35 -70.79 0.78 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.931 0.892 . . . . 0.35 111.263 -172.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.23 111.5 0.45 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.884 -0.953 . . . . 0.33 110.801 -169.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.5 -179.29 4.33 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.403 2.735 . . . . 0.35 112.294 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -165.65 178.84 6.38 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.145 0.978 . . . . 0.35 110.549 -166.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -153.02 92.63 1.65 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.059 1.344 . . . . 0.35 107.586 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 68.3 mtp -88.05 101.42 13.76 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.402 1.481 . . . . 0.35 110.409 -168.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.2 t -98.78 112.32 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.187 0.995 . . . . 0.35 109.591 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -175.46 171.44 2.83 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.502 1.121 . . . . 0.36 109.964 174.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.87 140.33 36.15 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.11 0.964 . . . . 0.35 111.785 -178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.6 m -70.55 101.25 1.97 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.448 1.899 . . . . 0.35 108.947 175.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.08 87.0 1.33 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.04 0.829 . . . . 0.35 111.654 -172.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.2 m -85.04 166.46 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 123.895 0.878 . . . . 0.35 110.477 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.23 -42.8 30.13 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.804 -0.443 . . . . 0.35 109.804 166.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 t -173.11 -53.72 0.02 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 125.246 1.418 . . . . 0.35 110.022 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -92.6 41.87 1.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.484 1.114 . . . . 0.35 113.92 -159.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.81 60.47 8.4 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.494 -0.642 . . . . 0.35 111.494 172.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -157.19 98.67 1.74 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.163 0.985 . . . . 0.36 109.42 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.65 118.64 7.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.805 1.242 . . . . 0.35 111.01 -173.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.89 -48.07 26.68 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.941 0.896 . . . . 0.35 110.036 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.5 mt -86.62 -169.37 2.61 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.405 1.082 . . . . 0.35 111.053 -171.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.8 p -130.32 78.62 74.09 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 106.87 -1.53 . . . . 0.33 106.87 163.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -85.49 77.14 2.8 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 124.804 3.669 . . . . 0.35 109.636 -166.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -150.12 85.67 1.41 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.132 0.973 . . . . 0.35 108.602 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -155.55 -48.42 0.08 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.249 0.62 . . . . 0.35 112.273 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.55 119.88 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.009 0.822 . . . . 0.35 110.048 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -156.43 151.84 26.73 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.541 1.137 . . . . 0.35 109.788 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -129.93 153.32 80.95 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 125.502 1.521 . . . . 0.33 108.742 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.39 60.9 7.51 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.711 2.94 . . . . 0.35 110.345 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 tp 39.97 89.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.689 1.996 . . . . 0.35 112.578 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -107.87 92.24 8.73 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.879 1.272 . . . . 0.33 108.633 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.87 155.96 48.31 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.127 2.551 . . . . 0.35 110.804 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.08 -50.4 0.7 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.573 -1.011 . . . . 0.35 110.573 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.4 t -63.01 146.48 53.11 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.905 0.882 . . . . 0.35 110.729 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 m -77.97 116.88 18.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.622 -0.51 . . . . 0.35 109.622 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -77.08 86.19 3.58 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.021 1.328 . . . . 0.35 108.572 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 p -150.0 151.85 33.97 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.682 1.193 . . . . 0.35 110.558 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -52.51 -53.06 50.93 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.178 1.391 . . . . 0.35 111.208 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -49.78 -45.32 49.61 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.677 1.191 . . . . 0.35 112.978 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -76.52 -50.01 15.05 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.018 0.372 . . . . 0.35 111.506 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.7 mm -54.22 -38.18 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.646 1.178 . . . . 0.35 112.402 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -52.9 -61.01 2.57 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.957 0.799 . . . . 0.35 112.015 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -71.41 -36.83 71.47 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.697 0.258 . . . . 0.35 111.697 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -64.77 -47.99 76.14 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.759 0.824 . . . . 0.35 111.786 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 p -71.89 -28.19 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.497 0.719 . . . . 0.35 111.322 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.69 -44.5 90.09 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 123.019 0.528 . . . . 0.35 109.643 172.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -66.18 -20.86 66.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.45 0.7 . . . . 0.35 112.369 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.33 -47.3 64.82 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.886 0.766 . . . . 0.35 110.914 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -39.36 84.98 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 109.936 -0.394 . . . . 0.35 109.936 173.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -93.42 52.12 1.7 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.876 1.271 . . . . 0.35 110.033 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.96 -58.84 2.01 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.019 1.328 . . . . 0.35 108.541 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.1 p -80.87 -50.16 10.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.622 1.169 . . . . 0.35 110.658 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.46 -97.61 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.971 0.908 . . . . 0.35 109.917 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.3 t80 54.98 87.63 0.05 OUTLIER 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.914 1.686 . . . . 0.35 113.072 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -161.23 -49.33 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.237 0.615 . . . . 0.35 109.954 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -120.75 50.73 1.3 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.026 1.33 . . . . 0.35 109.521 -175.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -139.04 92.0 2.56 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.371 1.068 . . . . 0.35 109.855 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -73.43 -40.0 64.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.463 1.105 . . . . 0.35 111.35 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.5 t 74.24 115.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 126.169 1.788 . . . . 0.35 110.798 -175.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.05 -67.37 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 108.13 -1.063 . . . . 0.35 108.13 172.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -145.12 165.02 29.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.844 1.658 . . . . 0.35 109.116 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -130.67 129.17 42.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.058 1.343 . . . . 0.35 107.431 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.91 132.28 84.97 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.946 -0.39 . . . . 0.33 109.946 -168.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.99 -22.71 22.68 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.505 2.803 . . . . 0.35 111.517 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.2 m -82.61 68.04 8.91 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.371 1.068 . . . . 0.35 110.328 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.99 165.09 25.76 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.864 0.865 . . . . 0.35 110.267 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -148.71 132.62 17.1 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.219 0.533 . . . . 0.35 112.119 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.2 114.69 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.877 -1.897 . . . . 0.35 105.877 171.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -107.94 58.1 0.62 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.957 0.903 . . . . 0.35 108.628 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.77 103.69 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.953 0.901 . . . . 0.35 110.372 -174.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 89.9 m -99.61 100.76 11.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.399 1.48 . . . . 0.35 108.114 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -98.87 84.89 3.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.015 0.926 . . . . 0.35 110.314 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -69.92 75.95 0.47 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.373 1.869 . . . . 0.35 109.769 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -120.5 65.53 0.84 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.14 1.376 . . . . 0.35 108.677 -170.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.7 110.35 6.19 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.35 0.66 . . . . 0.35 110.269 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -178.68 -47.6 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.293 1.837 . . . . 0.36 108.801 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -37.48 0.11 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.367 1.067 . . . . 0.35 110.883 172.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -78.06 -52.6 8.5 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.612 0.765 . . . . 0.35 110.651 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt 72.95 170.46 0.31 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.799 1.639 . . . . 0.35 111.382 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.16 125.23 24.33 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.663 0.785 . . . . 0.35 111.157 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -140.51 108.74 5.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.579 -1.267 . . . . 0.35 107.579 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.4 m -76.0 86.54 2.92 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.026 -1.102 . . . . 0.35 108.026 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -80.47 98.29 7.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.066 0.946 . . . . 0.35 108.553 -175.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.6 p -87.29 64.54 8.33 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.719 1.208 . . . . 0.35 111.116 -174.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -65.9 134.73 95.15 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.727 -0.842 . . . . 0.33 108.727 170.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.35 -114.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.24 2.627 . . . . 0.35 109.511 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 tp -161.67 151.57 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.973 0.806 . . . . 0.35 109.74 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.9 p -127.16 150.05 49.68 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.057 1.343 . . . . 0.35 109.678 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -67.37 0.48 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.477 0.711 . . . . 0.35 110.023 -176.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -108.78 101.71 10.81 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 106.607 -1.627 . . . . 0.35 106.607 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.15 -97.91 0.87 Allowed Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.332 0.968 . . . . 0.35 111.86 -168.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -159.37 177.54 10.89 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.261 0.624 . . . . 0.35 111.443 -163.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.1 t -102.71 150.63 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.982 1.713 . . . . 0.35 110.142 -175.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.3 t -54.52 114.91 7.5 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.308 1.043 . . . . 0.33 108.88 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.08 148.81 19.55 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.791 2.327 . . . . 0.35 111.016 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -94.18 -178.19 4.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.956 1.303 . . . . 0.35 110.132 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.85 165.35 25.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.725 0.81 . . . . 0.35 111.518 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.3 t -142.22 -68.42 0.37 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.464 1.106 . . . . 0.35 109.57 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -163.87 -52.71 0.03 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.208 1.003 . . . . 0.35 109.497 -174.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -42.08 -43.81 3.38 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.872 2.069 . . . . 0.35 114.068 -173.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.1 pt -133.82 173.9 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.606 0.762 . . . . 0.35 111.398 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -107.06 -44.92 4.27 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 126.203 1.801 . . . . 0.35 108.685 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -120.4 101.56 46.39 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.907 1.283 . . . . 0.36 110.865 -170.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -57.83 -59.51 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.452 2.768 . . . . 0.35 111.926 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 64.92 66.89 2.25 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.759 -0.937 . . . . 0.35 110.759 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -70.72 144.67 50.89 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.392 1.077 . . . . 0.35 111.162 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -132.16 92.93 3.18 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.371 1.068 . . . . 0.36 108.995 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.74 62.92 7.76 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.442 1.097 . . . . 0.35 108.628 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.98 125.14 54.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 125.465 1.506 . . . . 0.35 107.141 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.9 m -141.88 172.65 12.39 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.251 1.82 . . . . 0.35 107.631 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.69 131.55 56.92 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.556 1.142 . . . . 0.35 109.49 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.4 m -130.24 155.21 41.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 C-N-CA 124.677 1.191 . . . . 0.35 110.371 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.63 103.51 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.977 1.311 . . . . 0.35 108.716 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 29.1 mt -81.37 139.05 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.122 0.969 . . . . 0.35 110.772 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -102.66 128.99 49.13 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.417 -1.697 . . . . 0.35 106.417 162.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -84.33 74.2 10.37 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.497 -0.927 . . . . 0.35 108.497 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.341 0.228 0 C-N-CA 125.735 1.614 . . . . 0.25 109.475 -173.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.8 m . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 109.829 -0.434 . . . . 0.35 109.829 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 t 50.0 50.33 18.7 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.359 1.464 . . . . 0.35 111.407 -172.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 t -102.93 109.27 20.77 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.56 1.144 . . . . 0.35 108.722 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -73.16 104.72 4.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.674 0.79 . . . . 0.35 109.441 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -124.96 53.37 1.5 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.335 1.054 . . . . 0.35 110.392 -174.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -122.52 -51.78 1.94 Allowed 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.497 1.119 . . . . 0.35 108.573 173.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.61 78.85 0.8 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.648 . . . . 0.35 112.331 169.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp 58.21 73.4 0.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.686 1.194 . . . . 0.35 111.484 166.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -111.84 60.55 0.62 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.44 1.096 . . . . 0.35 109.802 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.19 177.89 8.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.756 0.823 . . . . 0.35 112.482 -168.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.7 tttm 60.48 52.86 4.44 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 127.111 2.165 . . . . 0.35 110.447 -172.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.42 -86.38 0.46 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 106.828 -2.509 . . . . 0.35 106.828 172.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t0 53.28 61.96 2.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.259 1.024 . . . . 0.35 109.499 176.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 64.87 53.92 1.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.425 1.49 . . . . 0.35 110.953 -171.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.74 91.06 0.05 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.936 1.694 . . . . 0.35 112.362 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -55.23 -53.86 50.76 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.503 1.121 . . . . 0.35 111.44 -176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -77.12 175.84 9.26 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.11 0.964 . . . . 0.35 111.851 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.3 t80 60.12 84.86 0.11 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 126.38 1.872 . . . . 0.35 111.107 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 66.37 158.92 0.13 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 126.491 1.916 . . . . 0.33 112.144 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.06 129.97 35.82 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.157 2.572 . . . . 0.35 111.592 167.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.5 p -121.92 -57.54 1.79 Allowed 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.506 1.123 . . . . 0.35 109.122 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.69 172.96 43.61 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 112.343 -0.303 . . . . 0.33 112.343 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.48 166.47 19.52 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 124.223 3.282 . . . . 0.35 113.835 -173.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -154.75 161.52 41.48 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.811 1.244 . . . . 0.35 109.668 167.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 tt -157.32 99.15 1.76 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.446 -0.946 . . . . 0.35 108.446 -170.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.9 mtp -92.14 146.34 23.8 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.396 1.479 . . . . 0.35 110.329 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.6 t -146.05 90.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.4 0 C-N-CA 124.046 0.939 . . . . 0.35 110.458 -167.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -156.01 -179.7 8.39 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.356 1.062 . . . . 0.36 110.949 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.7 m -129.33 150.61 34.79 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 125.028 1.331 . . . . 0.35 111.494 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.1 m -80.62 91.77 5.88 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.014 -1.476 . . . . 0.35 107.014 169.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.31 73.05 2.71 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.071 -0.812 . . . . 0.35 111.071 -172.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.89 147.29 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 122.944 0.498 . . . . 0.35 110.679 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.99 178.88 5.95 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.598 1.159 . . . . 0.35 109.323 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -47.31 -45.31 24.25 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.202 1.001 . . . . 0.35 110.599 164.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -105.95 34.36 3.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.723 1.209 . . . . 0.35 111.562 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.62 -25.14 8.7 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.111 -0.827 . . . . 0.35 115.032 167.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -61.32 124.93 21.99 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.344 1.072 . . . . 0.36 111.64 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.62 101.01 0.95 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.581 0.752 . . . . 0.35 110.205 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.74 -50.09 39.85 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.384 1.074 . . . . 0.35 110.007 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 pp -130.47 150.76 51.53 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.663 1.185 . . . . 0.35 110.224 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 t -82.8 147.49 55.13 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.044 0.937 . . . . 0.33 111.604 -164.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.03 27.58 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.31 3.34 . . . . 0.35 112.588 171.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -169.09 132.44 1.33 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.931 0.893 . . . . 0.35 109.652 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -165.28 -72.47 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.381 1.073 . . . . 0.35 109.481 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.07 147.05 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.702 0.801 . . . . 0.35 109.716 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -142.94 166.79 23.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.723 0.809 . . . . 0.35 111.142 174.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -141.04 144.82 36.53 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 125.049 1.339 . . . . 0.33 108.576 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.06 64.77 8.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.948 3.099 . . . . 0.35 110.655 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.258 9.0 tt 39.42 110.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 129.567 3.147 . . . . 0.35 114.608 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -119.83 82.32 27.48 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.263 1.025 . . . . 0.33 108.528 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -82.9 -170.31 0.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.952 3.101 . . . . 0.35 110.576 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.41 -41.57 2.1 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.739 -0.945 . . . . 0.35 110.739 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.9 t -66.32 152.61 44.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.604 0.762 . . . . 0.35 110.347 174.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.5 m -69.18 150.31 47.64 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.779 -0.823 . . . . 0.35 108.779 171.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.3 tp -127.41 102.93 7.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.912 -1.144 . . . . 0.35 107.912 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -151.61 176.07 11.72 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.505 1.522 . . . . 0.35 109.43 -170.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -63.13 -47.49 82.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.738 0.415 . . . . 0.35 111.46 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.93 -30.73 70.95 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.012 0.745 . . . . 0.35 113.012 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -64.39 -54.61 30.17 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.205 0.602 . . . . 0.35 109.377 171.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mm -51.55 -49.88 31.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 125.143 1.377 . . . . 0.35 111.18 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -45.49 -56.71 4.77 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.665 1.186 . . . . 0.35 112.518 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -75.31 -37.14 60.96 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.969 0.359 . . . . 0.35 111.969 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -67.11 -48.65 67.48 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.669 0.787 . . . . 0.35 111.958 -169.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.4 m -67.99 -33.0 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.884 0.473 . . . . 0.35 111.266 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -65.13 -41.17 95.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.541 0.737 . . . . 0.35 110.678 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -35.12 75.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.453 0.701 . . . . 0.35 111.148 176.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.77 -48.58 76.39 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.592 0.757 . . . . 0.35 111.334 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.8 -19.98 61.24 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.386 0.675 . . . . 0.35 112.423 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -77.29 13.41 1.18 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.448 0.699 . . . . 0.35 112.197 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.57 -41.4 65.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.375 -0.602 . . . . 0.35 109.375 160.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 70.2 p -103.35 -49.4 3.73 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.208 1.403 . . . . 0.35 111.748 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.75 -85.67 0.09 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.8 0.84 . . . . 0.35 111.32 -170.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.8 p90 51.62 18.17 0.68 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.3 2.24 . . . . 0.35 116.016 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -131.99 -81.02 0.51 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.31 0.959 . . . . 0.35 112.097 -164.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -97.26 -54.46 3.15 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.577 0.751 . . . . 0.35 111.943 -158.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -45.37 145.57 1.16 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.433 2.293 . . . . 0.35 114.378 -173.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -85.69 -63.08 1.38 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.872 1.269 . . . . 0.35 111.348 -172.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.3 t 72.1 97.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 126.071 1.748 . . . . 0.35 108.984 -164.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.69 -65.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.085 0.954 . . . . 0.35 109.305 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -162.51 135.78 6.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.879 0.872 . . . . 0.35 109.186 -174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.67 152.83 24.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.838 0.855 . . . . 0.35 110.927 177.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.87 145.53 50.25 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.948 -0.76 . . . . 0.33 108.948 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.12 -17.12 40.64 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.47 2.78 . . . . 0.35 111.993 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -83.39 61.51 6.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.509 1.124 . . . . 0.35 111.069 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.98 141.24 45.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.223 -1.399 . . . . 0.35 107.223 159.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -148.61 131.57 16.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.191 0.52 . . . . 0.35 112.4 -171.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 mp -75.88 116.41 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.439 -1.689 . . . . 0.35 106.439 168.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -107.68 68.82 0.72 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.343 -1.354 . . . . 0.35 107.343 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.98 115.01 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.924 0.89 . . . . 0.35 110.519 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.0 m -110.16 87.33 2.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.47 1.508 . . . . 0.35 108.496 -172.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.62 87.12 3.99 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.018 1.327 . . . . 0.35 111.22 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -74.77 85.5 2.17 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.961 1.305 . . . . 0.35 109.674 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -132.81 71.77 1.48 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.376 -0.972 . . . . 0.35 108.376 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -53.12 -22.43 6.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.646 1.578 . . . . 0.35 113.834 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -58.14 -31.41 67.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.73 1.212 . . . . 0.36 112.438 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.7 -52.48 0.34 Allowed 'General case' 0 C--N 1.344 0.367 0 N-CA-C 112.662 0.615 . . . . 0.35 112.662 173.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -87.4 -58.45 2.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.647 0.658 . . . . 0.35 111.644 -168.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt 85.65 160.99 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.975 2.11 . . . . 0.35 110.492 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.41 97.9 0.6 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.791 1.236 . . . . 0.35 111.506 -174.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -119.18 123.63 44.82 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 107.729 -1.211 . . . . 0.35 107.729 168.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.1 m -87.99 83.14 7.07 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.453 1.101 . . . . 0.35 108.179 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -75.16 119.81 19.81 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.344 1.057 . . . . 0.35 109.916 -170.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.6 m -83.09 74.75 9.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.101 1.361 . . . . 0.35 111.488 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -80.52 132.99 56.93 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.75 -1.204 . . . . 0.33 107.75 165.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.72 -118.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.309 2.673 . . . . 0.35 110.178 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.4 tp -159.87 155.38 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.462 1.105 . . . . 0.35 108.777 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.8 p -124.01 136.8 54.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.147 0.979 . . . . 0.35 109.058 174.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -73.17 -33.1 65.26 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.945 0.898 . . . . 0.35 110.776 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -21.13 65.1 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.424 0.69 . . . . 0.35 112.205 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.96 174.96 43.56 Favored Glycine 0 C--N 1.341 0.85 0 C-N-CA 123.904 0.764 . . . . 0.35 114.223 166.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -161.43 136.16 7.25 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.406 1.083 . . . . 0.35 109.867 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.16 126.48 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.653 -0.869 . . . . 0.35 108.653 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.2 t -73.02 121.62 85.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 107.475 -1.305 . . . . 0.33 107.475 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.43 -102.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.246 2.63 . . . . 0.35 110.432 -173.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -163.52 111.44 1.2 Allowed 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.497 1.119 . . . . 0.35 108.271 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.9 97.22 10.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.157 0.983 . . . . 0.35 108.587 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.5 t -170.76 86.68 0.11 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.951 1.3 . . . . 0.35 108.391 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -153.34 -71.48 0.14 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.329 0.652 . . . . 0.35 109.485 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -92.76 -52.29 4.69 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.469 1.108 . . . . 0.35 109.355 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.5 pt -109.51 169.13 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.392 1.477 . . . . 0.35 108.934 170.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.89 19.63 0.26 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.372 1.249 . . . . 0.35 114.372 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.96 61.52 28.68 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.093 0.86 . . . . 0.36 111.85 175.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.53 172.73 15.13 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.219 3.279 . . . . 0.35 111.36 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.38 68.49 0.43 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.051 -1.219 . . . . 0.35 110.051 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -64.02 88.93 0.05 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.353 1.461 . . . . 0.35 110.407 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -99.51 100.65 11.7 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.641 -0.874 . . . . 0.36 108.641 -174.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.6 93.47 8.38 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.385 1.074 . . . . 0.35 109.055 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.17 134.49 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.504 -1.295 . . . . 0.35 107.504 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 44.7 m -142.67 116.58 9.34 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 107.269 -1.382 . . . . 0.35 107.269 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -73.42 133.17 43.67 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.421 -0.585 . . . . 0.35 109.421 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.9 m -134.36 136.7 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.111 0.965 . . . . 0.35 109.604 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 77.6 t -82.58 137.35 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.406 -0.961 . . . . 0.35 108.406 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 47.2 mt -137.26 133.45 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.697 1.199 . . . . 0.35 108.978 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -97.44 130.26 44.57 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.324 -1.361 . . . . 0.35 107.324 161.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -72.2 96.26 1.78 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.724 -0.843 . . . . 0.35 108.724 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.34 0.168 0 C-N-CA 125.538 1.535 . . . . 0.25 109.325 -167.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.8 m . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 109.166 -0.679 . . . . 0.35 109.166 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 t 61.26 48.23 6.35 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.551 1.14 . . . . 0.35 111.404 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.4 t 66.07 159.88 0.13 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.922 1.689 . . . . 0.35 111.367 -171.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.1 t80 57.69 65.37 1.34 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.005 1.322 . . . . 0.35 110.885 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -112.57 42.03 1.91 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.405 1.082 . . . . 0.35 109.101 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.63 -47.7 0.69 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.029 1.732 . . . . 0.35 109.523 -177.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.67 56.16 1.92 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.766 -0.934 . . . . 0.35 110.766 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 56.99 70.72 0.63 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.295 1.438 . . . . 0.35 111.458 176.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -90.58 0.41 57.37 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.178 1.391 . . . . 0.35 112.449 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -175.59 3.24 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.268 1.027 . . . . 0.35 112.009 -176.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.5 tttp 93.94 -22.41 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.601 2.36 . . . . 0.35 112.456 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.6 81.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.859 1.219 . . . . 0.35 114.523 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -84.55 56.02 3.65 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.227 1.013 . . . . 0.35 111.068 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 48.99 45.05 22.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.494 1.517 . . . . 0.35 111.758 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.46 53.08 0.89 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.401 1.081 . . . . 0.35 109.679 -172.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 m -87.47 -122.26 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.762 0.825 . . . . 0.35 110.526 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -163.41 145.11 9.58 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.043 1.337 . . . . 0.35 108.11 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.1 t80 66.85 119.22 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.828 1.651 . . . . 0.35 111.369 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 68.55 151.85 0.13 Allowed Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 126.454 1.902 . . . . 0.33 111.699 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.71 92.08 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.335 2.69 . . . . 0.35 110.82 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.5 p -75.47 -42.96 51.82 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.807 0.843 . . . . 0.35 109.938 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.78 166.06 26.22 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.468 -0.653 . . . . 0.33 111.468 172.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.93 168.43 19.1 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.186 3.258 . . . . 0.35 111.09 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -163.34 176.62 9.69 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.389 1.076 . . . . 0.35 110.628 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 tt -156.59 94.14 1.44 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.079 0.951 . . . . 0.35 108.706 -175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -89.1 143.28 26.95 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.327 0.651 . . . . 0.35 109.923 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.9 t -144.67 91.41 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.244 1.017 . . . . 0.35 108.585 -172.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -153.31 162.49 41.24 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.607 1.163 . . . . 0.36 110.709 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -95.85 153.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 124.963 1.305 . . . . 0.35 110.097 174.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -88.91 93.84 9.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.412 -1.699 . . . . 0.35 106.412 169.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.77 105.77 1.63 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.505 -1.038 . . . . 0.35 110.505 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.49 169.64 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.927 1.291 . . . . 0.35 109.996 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -87.3 -179.78 6.47 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.829 0.852 . . . . 0.35 109.128 166.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 t -60.54 -38.79 85.6 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.663 0.785 . . . . 0.35 110.869 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -76.78 -0.91 25.59 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.427 1.091 . . . . 0.35 112.571 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.59 52.13 6.15 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 110.968 -0.853 . . . . 0.35 110.968 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -120.45 108.35 14.0 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.623 1.169 . . . . 0.36 108.416 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -65.96 118.29 9.54 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.793 0.837 . . . . 0.35 111.79 -172.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.34 -40.22 30.79 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.5 1.12 . . . . 0.35 109.875 169.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 pp -151.89 154.42 36.09 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.358 1.063 . . . . 0.35 112.304 -164.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.7 m -88.5 154.31 50.98 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.151 1.38 . . . . 0.33 110.353 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -86.14 49.79 2.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.314 3.342 . . . . 0.35 110.47 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -149.13 97.2 2.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.685 0.794 . . . . 0.35 109.523 -166.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -162.15 -55.73 0.04 OUTLIER 'General case' 0 C--N 1.344 0.352 0 CA-C-O 118.85 -0.595 . . . . 0.35 112.451 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 m -82.66 141.06 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.328 0.967 . . . . 0.35 109.304 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -146.49 109.83 4.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.297 1.039 . . . . 0.35 109.089 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -94.28 154.4 40.41 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 125.366 1.466 . . . . 0.33 109.72 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.77 147.46 44.7 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.189 2.593 . . . . 0.35 109.844 169.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.81 137.0 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 122.977 0.511 . . . . 0.35 110.404 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -142.49 114.09 6.14 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.801 1.24 . . . . 0.33 107.837 171.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.74 179.87 6.1 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.61 2.874 . . . . 0.35 110.903 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.56 -26.66 18.92 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.424 -0.653 . . . . 0.35 112.643 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 t -67.07 141.36 57.52 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.801 0.8 . . . . 0.35 111.021 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.5 m -72.62 139.12 47.18 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.606 -0.887 . . . . 0.35 108.606 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.67 117.24 16.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.978 0.911 . . . . 0.35 108.963 -171.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.5 t -167.44 176.07 6.81 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.151 1.781 . . . . 0.35 108.458 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -57.76 -52.38 65.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.933 0.893 . . . . 0.35 110.796 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -64.56 -32.43 74.07 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.934 0.716 . . . . 0.35 112.934 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -65.98 -57.69 7.22 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.567 0.621 . . . . 0.35 110.369 175.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.79 -23.37 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.166 0.986 . . . . 0.35 111.805 -172.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.54 -58.35 8.93 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.174 0.99 . . . . 0.35 111.067 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -66.04 -37.85 86.88 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.14 0.427 . . . . 0.35 111.2 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -62.96 -48.7 77.75 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.559 0.744 . . . . 0.35 111.795 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.9 -36.77 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 118.256 0.48 . . . . 0.35 111.585 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -63.53 -37.1 86.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.807 0.843 . . . . 0.35 111.111 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -74.12 -37.8 64.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.872 0.469 . . . . 0.35 111.041 176.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.16 -44.03 97.52 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.297 1.039 . . . . 0.35 111.485 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.19 -41.49 63.78 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.904 0.482 . . . . 0.35 111.644 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -76.83 -3.4 38.23 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.436 0.694 . . . . 0.35 112.758 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.71 -42.45 83.77 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.866 0.757 . . . . 0.35 110.33 173.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.9 t -103.2 -38.93 7.06 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.105 1.362 . . . . 0.35 111.579 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.89 -101.18 0.03 OUTLIER 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.676 -0.678 . . . . 0.35 110.795 -173.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.1 t80 75.74 -43.33 0.48 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 126.572 1.949 . . . . 0.35 113.751 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -55.27 -67.1 0.3 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.345 1.458 . . . . 0.35 112.593 -169.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -107.11 24.22 13.16 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.235 0.614 . . . . 0.35 112.189 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -92.63 136.75 32.96 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.243 0.617 . . . . 0.35 111.431 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -164.05 109.24 1.02 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.962 1.305 . . . . 0.35 108.485 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 p -77.61 148.63 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.299 0.64 . . . . 0.35 109.87 171.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.47 -44.48 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.699 1.2 . . . . 0.35 109.888 173.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -129.39 151.54 49.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.269 1.428 . . . . 0.35 108.853 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.75 143.52 32.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.313 1.045 . . . . 0.35 109.909 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -72.39 117.24 57.04 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.787 0.835 . . . . 0.33 108.978 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.89 -27.4 21.12 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.867 2.378 . . . . 0.35 111.118 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.1 m -87.87 58.03 4.64 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.513 1.125 . . . . 0.35 110.358 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.97 167.08 5.05 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.26 0.624 . . . . 0.35 109.624 169.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -155.85 142.32 18.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.531 0.681 . . . . 0.35 112.352 -171.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 mp -85.74 111.73 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 106.144 -1.798 . . . . 0.35 106.144 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -100.99 70.78 1.38 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.614 -1.254 . . . . 0.35 107.614 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.16 99.16 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.333 0.653 . . . . 0.35 109.819 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 94.0 m -98.83 125.19 44.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.195 1.398 . . . . 0.35 109.012 -173.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -139.43 132.84 30.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.255 1.022 . . . . 0.35 109.484 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -101.26 60.34 0.91 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.451 1.5 . . . . 0.35 108.669 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -81.71 82.29 7.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.226 0.61 . . . . 0.35 109.665 -177.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -83.19 67.43 9.19 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.423 -0.955 . . . . 0.35 108.423 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -143.77 -49.14 0.3 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.905 1.682 . . . . 0.36 108.729 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 pttt -159.03 -54.93 0.06 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.512 0.725 . . . . 0.35 111.856 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -74.97 -22.24 58.67 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.884 0.698 . . . . 0.35 112.884 -172.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 81.0 tttt 75.5 164.18 0.26 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.785 1.634 . . . . 0.35 111.973 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -56.62 106.18 0.27 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.332 1.453 . . . . 0.35 110.528 172.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -145.17 145.28 31.29 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.414 1.086 . . . . 0.35 109.637 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 94.0 m -119.6 95.84 4.95 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 125.182 1.393 . . . . 0.35 108.056 176.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -70.64 125.44 26.83 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.253 -0.647 . . . . 0.35 109.253 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -96.18 63.16 2.2 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.886 1.274 . . . . 0.35 110.094 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -75.35 124.64 89.21 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 109.337 -0.616 . . . . 0.33 109.337 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.76 162.47 26.93 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.205 2.604 . . . . 0.35 111.454 -175.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.3 tp -76.97 152.68 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.017 0.927 . . . . 0.35 109.866 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.1 p -105.24 -179.41 3.94 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.137 0.975 . . . . 0.35 110.419 178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.57 -11.3 14.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.694 1.597 . . . . 0.35 110.81 166.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -78.06 -87.69 0.05 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.625 1.17 . . . . 0.35 110.506 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.15 63.79 0.01 OUTLIER Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.475 -1.05 . . . . 0.35 110.475 -172.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -73.56 126.03 29.33 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.285 -0.635 . . . . 0.35 109.285 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.67 135.25 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.663 -0.866 . . . . 0.35 108.663 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.9 112.05 6.02 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 107.592 -1.262 . . . . 0.33 107.592 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -89.32 14.66 2.16 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.927 2.418 . . . . 0.35 112.673 -165.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.3 t70 60.11 -157.44 0.33 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.266 1.027 . . . . 0.35 109.572 -168.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.5 tt -163.6 146.31 9.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.64 0.655 . . . . 0.35 110.396 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.5 t -154.33 164.72 38.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.299 1.04 . . . . 0.35 110.025 172.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 82.42 -76.7 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.172 1.789 . . . . 0.35 112.635 165.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -69.15 -41.14 77.69 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.886 0.875 . . . . 0.35 113.039 -168.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.1 pt -135.17 -173.35 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.699 0.8 . . . . 0.35 109.367 169.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -158.81 28.86 0.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.176 0.59 . . . . 0.35 112.113 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.1 50.13 0.45 Allowed Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.783 0.66 . . . . 0.36 112.783 175.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -66.57 120.82 7.98 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.163 2.575 . . . . 0.35 111.32 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.11 75.84 0.22 Allowed Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.91 1.243 . . . . 0.35 110.419 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -64.05 85.79 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.515 1.926 . . . . 0.35 112.157 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -92.41 99.49 12.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.24 0.616 . . . . 0.36 109.603 -176.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.83 95.16 3.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.618 -0.882 . . . . 0.35 108.618 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.6 mt -108.8 121.76 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 124.838 1.255 . . . . 0.35 108.22 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.4 m -119.36 175.27 5.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.918 1.687 . . . . 0.35 107.402 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -136.06 114.47 11.7 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.133 0.973 . . . . 0.35 108.442 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.5 146.12 32.89 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 C-N-CA 123.462 0.705 . . . . 0.35 110.841 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.1 t -81.22 111.63 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.297 1.039 . . . . 0.35 108.318 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mt -101.09 110.39 27.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 108.219 -1.03 . . . . 0.35 108.219 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -85.85 97.52 10.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.914 -1.143 . . . . 0.35 107.914 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -61.57 126.75 28.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.427 0.691 . . . . 0.35 110.832 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt . . . . . 0 N--CA 1.455 -0.185 0 C-N-CA 123.53 0.732 . . . . 0.25 109.915 179.171 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 112.163 0.431 . . . . 0.35 112.163 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 t 55.03 49.64 17.16 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.369 1.468 . . . . 0.35 110.792 -173.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.7 p -164.78 3.3 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.875 0.87 . . . . 0.35 112.716 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 t80 55.15 69.09 0.77 Allowed 'General case' 0 C--N 1.344 0.336 0 C-N-CA 124.651 1.181 . . . . 0.35 109.914 -173.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -89.13 75.78 7.83 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.43 1.092 . . . . 0.35 110.111 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -162.19 -62.88 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.441 1.096 . . . . 0.35 108.881 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.43 92.88 0.21 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.538 0.59 . . . . 0.35 112.536 169.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt 58.8 51.69 7.31 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.764 1.225 . . . . 0.35 111.674 164.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -85.17 -64.9 1.08 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.589 0.756 . . . . 0.35 111.499 -174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp 75.96 118.82 0.05 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 127.143 2.177 . . . . 0.35 109.664 -165.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -50.11 -47.94 53.71 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.024 1.329 . . . . 0.35 110.418 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.33 -92.79 0.22 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.283 -1.527 . . . . 0.35 109.283 175.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t70 52.51 66.62 1.16 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.218 1.407 . . . . 0.35 110.688 -173.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -93.64 47.3 1.23 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.135 -1.061 . . . . 0.35 108.135 170.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.05 70.13 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.152 1.781 . . . . 0.35 107.083 -170.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 t -67.72 -71.29 0.21 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.308 0.643 . . . . 0.35 111.523 -168.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -162.31 39.64 0.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 117.622 0.192 . . . . 0.35 111.325 -167.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -157.36 115.67 3.19 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.032 0.533 . . . . 0.35 110.726 -173.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 65.74 164.67 0.12 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.91 2.084 . . . . 0.33 112.951 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -63.19 74.48 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.577 3.518 . . . . 0.35 112.84 172.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 p -100.71 -39.91 7.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.063 1.745 . . . . 0.35 109.077 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.84 157.43 10.03 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 112.02 -0.432 . . . . 0.33 112.02 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -82.24 -178.62 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.504 3.469 . . . . 0.35 110.827 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -157.46 169.4 24.78 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.115 0.966 . . . . 0.35 110.39 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.1 tp -142.81 86.24 1.92 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.355 1.462 . . . . 0.35 107.806 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.7 mtp -82.56 89.56 6.7 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.605 1.162 . . . . 0.35 110.59 -176.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.49 91.95 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.362 1.065 . . . . 0.35 109.059 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -149.18 172.58 14.6 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.492 1.117 . . . . 0.36 109.985 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.58 153.45 19.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 123.993 0.917 . . . . 0.35 111.204 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.5 m -94.39 94.66 8.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.885 1.274 . . . . 0.35 107.909 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.78 116.26 7.64 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 109.479 -1.448 . . . . 0.35 109.479 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -122.98 157.15 28.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 C-N-CA 125.661 1.584 . . . . 0.35 109.191 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -79.43 178.33 8.19 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.581 -0.525 . . . . 0.35 109.581 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 t -60.04 -46.11 90.61 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.533 0.733 . . . . 0.35 110.304 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -68.98 -16.77 63.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.382 1.073 . . . . 0.35 112.91 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.05 29.09 7.38 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.314 0.959 . . . . 0.35 113.09 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -91.17 114.25 26.72 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 117.818 0.809 . . . . 0.36 108.9 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.15 123.77 21.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.327 0.651 . . . . 0.35 110.817 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 mp -93.63 -38.66 11.23 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.844 1.258 . . . . 0.35 109.957 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -144.52 152.59 40.8 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.254 1.022 . . . . 0.35 111.549 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.2 t -99.26 148.75 35.07 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.002 1.721 . . . . 0.33 109.664 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -84.33 70.45 5.86 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.624 2.883 . . . . 0.35 111.456 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -148.74 -177.74 5.96 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.783 0.833 . . . . 0.35 110.508 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . 0.314 0.0 OUTLIER 100.02 -44.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.597 2.759 . . . . 0.35 112.854 173.361 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.74 136.62 23.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 109.553 -0.536 . . . . 0.35 109.553 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.04 171.98 15.5 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.091 0.956 . . . . 0.35 109.35 164.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -161.12 132.9 4.1 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.657 -0.687 . . . . 0.33 109.731 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.31 111.78 1.91 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.654 2.236 . . . . 0.35 108.66 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 tt -60.92 144.8 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.147 0.979 . . . . 0.35 112.944 -162.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -130.54 87.16 50.91 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.593 1.557 . . . . 0.33 107.372 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.97 159.66 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.492 2.795 . . . . 0.35 111.263 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.03 -33.4 2.46 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.268 0.937 . . . . 0.35 111.364 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.7 t -71.58 157.43 38.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.211 1.004 . . . . 0.35 111.321 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.4 p -72.81 167.24 21.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.191 0.996 . . . . 0.35 110.953 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.29 119.64 3.5 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.754 0.822 . . . . 0.35 108.888 -174.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -167.4 178.66 5.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.191 1.796 . . . . 0.35 108.015 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -57.08 -46.92 82.16 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.56 -0.712 . . . . 0.35 111.343 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.47 -34.25 77.76 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.197 0.599 . . . . 0.35 111.967 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -104.06 53.66 0.74 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.788 1.235 . . . . 0.35 109.97 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -159.18 -41.94 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.655 1.182 . . . . 0.35 108.674 170.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.02 -44.38 82.78 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.11 0.964 . . . . 0.35 111.765 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -59.33 -39.41 83.07 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.612 0.765 . . . . 0.35 111.029 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -50.29 62.95 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.295 1.438 . . . . 0.35 110.18 -171.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.28 -32.33 42.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 124.565 1.146 . . . . 0.35 112.121 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -60.29 -49.18 78.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.531 -0.544 . . . . 0.35 109.531 172.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -33.29 75.68 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.791 0.437 . . . . 0.35 111.517 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.77 -55.23 32.36 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.564 0.746 . . . . 0.35 110.965 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 pp -74.69 -15.76 60.78 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.956 0.724 . . . . 0.35 112.956 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -79.41 71.39 5.97 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 123.878 0.871 . . . . 0.35 110.033 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -168.68 -53.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.372 1.869 . . . . 0.35 107.723 172.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.2 p -88.08 -35.11 17.68 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.656 1.583 . . . . 0.35 111.202 -178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.19 74.76 1.32 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.273 1.429 . . . . 0.35 108.436 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -133.3 -19.14 2.2 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.987 1.106 . . . . 0.35 113.987 -165.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -59.58 -41.19 89.7 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.676 0.791 . . . . 0.35 112.542 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -141.65 -66.62 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.151 1.38 . . . . 0.35 109.311 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.9 p90 34.85 88.45 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.172 2.589 . . . . 0.35 114.193 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -73.63 106.73 5.52 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 109.322 -0.622 . . . . 0.35 109.322 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.21 120.4 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.332 -0.988 . . . . 0.35 108.332 174.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.3 t -75.92 -73.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.587 -1.264 . . . . 0.35 107.587 171.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -167.78 146.58 4.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.381 1.073 . . . . 0.35 109.446 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.85 156.84 29.53 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.546 0.738 . . . . 0.35 111.262 173.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.49 135.56 81.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 108.136 -1.061 . . . . 0.33 108.136 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.62 -33.02 29.53 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.318 2.679 . . . . 0.35 111.774 -176.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.0 m -86.77 70.21 10.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.337 1.055 . . . . 0.35 110.263 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.61 169.99 16.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.379 0.672 . . . . 0.35 109.746 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -159.41 143.43 14.95 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.512 0.56 . . . . 0.35 112.512 -167.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.74 122.53 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 126.855 2.062 . . . . 0.35 106.133 172.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -118.1 64.73 0.75 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.97 0.908 . . . . 0.35 109.183 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.04 118.33 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.416 0.686 . . . . 0.35 110.942 -176.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.2 m -111.57 100.59 9.11 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.509 1.123 . . . . 0.35 109.529 -173.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.29 99.4 12.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.154 0.982 . . . . 0.35 109.851 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -94.38 47.89 1.21 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.596 1.558 . . . . 0.35 111.099 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -69.68 106.92 3.24 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.03 0.932 . . . . 0.35 109.628 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -32.6 73.13 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.07 1.348 . . . . 0.35 111.635 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -55.06 -50.15 69.85 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.702 1.201 . . . . 0.36 113.017 -170.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 -41.44 0.09 Allowed 'General case' 0 C--N 1.342 0.279 0 N-CA-C 113.347 0.869 . . . . 0.35 113.347 -175.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -70.56 -47.84 58.33 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.326 0.512 . . . . 0.35 112.016 -168.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt 80.56 155.9 0.14 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.328 1.851 . . . . 0.35 110.741 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -43.8 124.4 3.68 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 126.719 2.008 . . . . 0.35 111.265 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.35 106.53 2.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.216 -1.031 . . . . 0.35 108.216 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.3 m -78.15 97.96 5.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.454 1.102 . . . . 0.35 109.171 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -82.13 96.94 7.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.785 0.834 . . . . 0.35 108.957 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.8 m -76.07 120.01 20.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.671 0.789 . . . . 0.35 109.272 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -134.79 125.33 17.3 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 125.351 1.46 . . . . 0.33 108.527 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.51 162.36 33.31 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.063 2.509 . . . . 0.35 111.559 -175.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.7 tp -73.88 159.96 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.574 1.149 . . . . 0.35 110.13 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 p -116.21 177.79 4.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.221 1.009 . . . . 0.35 110.202 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -103.11 -12.3 17.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.111 1.364 . . . . 0.35 110.924 165.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -76.31 -76.34 0.16 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.606 1.163 . . . . 0.35 111.116 -171.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 139.43 61.91 0.04 OUTLIER Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.846 -0.902 . . . . 0.35 110.846 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -71.53 132.91 45.36 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 117.351 0.575 . . . . 0.35 109.918 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.5 t -73.13 136.18 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.073 -0.714 . . . . 0.35 109.073 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.98 118.49 43.05 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 107.33 -1.359 . . . . 0.33 107.33 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.24 165.98 27.02 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.019 2.479 . . . . 0.35 112.37 -165.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.42 165.85 22.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.6 1.16 . . . . 0.35 110.866 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.1 mp -94.86 30.99 1.93 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.993 0.917 . . . . 0.35 111.412 -173.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.0 t 46.71 -102.34 0.07 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.092 1.757 . . . . 0.35 112.468 175.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -162.24 -44.22 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.986 1.315 . . . . 0.35 109.653 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -83.1 22.17 1.0 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.244 1.418 . . . . 0.35 113.186 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.4 tp -160.53 129.61 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.514 0.726 . . . . 0.35 110.082 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -140.7 27.73 2.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.831 1.252 . . . . 0.35 111.61 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -150.2 51.05 0.82 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 113.221 0.822 . . . . 0.36 113.221 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -70.45 115.02 4.0 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.856 2.371 . . . . 0.35 109.291 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -92.79 79.22 1.13 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.866 -1.294 . . . . 0.35 109.866 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -62.4 107.15 0.86 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.003 0.921 . . . . 0.35 110.387 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -99.79 94.56 6.39 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.34 1.056 . . . . 0.36 108.743 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.75 74.72 10.14 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.554 -1.276 . . . . 0.35 107.554 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.67 126.54 71.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 126.041 1.736 . . . . 0.35 107.948 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.8 m -148.94 142.47 25.36 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.917 0.887 . . . . 0.35 110.26 -173.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -72.85 140.35 47.54 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.264 1.026 . . . . 0.35 109.96 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.1 m -142.36 144.52 24.75 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 123.891 0.876 . . . . 0.35 109.661 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.05 100.23 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.876 -0.787 . . . . 0.35 108.876 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 75.3 mt -119.67 144.14 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.46 1.504 . . . . 0.35 109.062 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -131.29 80.79 1.95 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.556 1.542 . . . . 0.35 107.773 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -58.41 150.2 22.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.731 0.812 . . . . 0.35 111.954 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.196 -1.039 . . . . 0.25 108.196 178.62 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 119.31 -0.376 . . . . 0.35 110.902 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 p 65.33 146.21 0.03 OUTLIER 'General case' 0 C--N 1.344 0.339 0 C-N-CA 127.355 2.262 . . . . 0.35 111.823 -170.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 p 69.34 -6.33 0.98 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.372 1.869 . . . . 0.35 113.845 -170.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.6 p90 48.44 19.02 0.2 Allowed 'General case' 0 C--N 1.346 0.455 0 C-N-CA 127.686 2.394 . . . . 0.35 114.966 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 53.42 -141.45 0.86 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.046 0.938 . . . . 0.35 109.73 -171.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.4 pttt 11.29 76.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.631 2.772 . . . . 0.35 114.922 169.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.53 113.02 5.28 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 124.683 1.135 . . . . 0.35 111.663 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt 56.64 69.64 0.72 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.251 1.42 . . . . 0.35 110.278 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -70.82 -45.9 63.73 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.611 0.764 . . . . 0.35 111.143 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 66.34 5.31 3.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.165 1.786 . . . . 0.35 114.006 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 tttm 54.07 -92.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.898 1.279 . . . . 0.35 110.808 -172.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.86 58.72 0.07 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.393 -1.483 . . . . 0.35 109.393 173.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -132.55 66.58 1.55 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.382 1.073 . . . . 0.35 109.254 -176.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 64.47 -176.74 0.17 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.267 1.427 . . . . 0.35 112.12 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.88 178.23 9.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.294 1.037 . . . . 0.35 110.696 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.7 m -76.55 147.76 37.49 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.614 1.166 . . . . 0.35 111.234 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 65.31 175.98 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.014 1.726 . . . . 0.35 113.421 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.4 t80 59.35 90.56 0.05 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 126.448 1.899 . . . . 0.35 111.257 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 66.96 161.33 0.14 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 125.573 1.549 . . . . 0.33 111.131 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.28 90.52 1.0 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.359 2.039 . . . . 0.35 108.619 173.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.2 p -63.86 -60.52 3.18 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.234 1.014 . . . . 0.35 111.724 -166.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.68 172.0 32.55 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.962 -0.855 . . . . 0.33 110.962 174.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -66.53 149.0 84.46 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.469 2.779 . . . . 0.35 112.212 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -163.04 168.48 20.92 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.508 0.723 . . . . 0.35 111.292 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tt -145.11 100.86 3.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.737 1.215 . . . . 0.35 108.304 -173.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.6 mtp -88.16 134.06 33.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.722 1.609 . . . . 0.35 109.541 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.1 t -137.01 87.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.346 0 C-N-CA 124.075 0.95 . . . . 0.35 110.485 -168.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -159.35 165.64 32.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.958 1.303 . . . . 0.36 110.395 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -94.02 153.17 3.44 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 124.627 1.171 . . . . 0.35 112.267 -172.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -82.68 92.65 7.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.755 -1.572 . . . . 0.35 106.755 163.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.88 80.79 1.64 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.95 -0.86 . . . . 0.35 110.95 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 m -92.56 165.58 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.447 1.099 . . . . 0.35 110.318 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -82.4 -162.1 0.53 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.877 0.871 . . . . 0.35 110.41 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -53.28 -50.42 64.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.753 1.221 . . . . 0.35 111.598 175.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -75.37 -84.11 0.05 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.368 1.067 . . . . 0.35 110.33 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.76 46.89 0.06 OUTLIER Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.049 -0.82 . . . . 0.35 111.049 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -112.37 108.09 17.14 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.152 1.381 . . . . 0.36 108.257 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -70.49 112.34 6.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.886 0.874 . . . . 0.35 111.433 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.1 mp -73.88 -45.87 48.23 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.749 0.82 . . . . 0.35 109.442 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.2 147.3 36.33 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.858 0.863 . . . . 0.35 111.413 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.0 m -91.75 159.45 38.32 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.282 1.433 . . . . 0.33 111.29 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -87.27 49.86 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.507 2.805 . . . . 0.35 111.914 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -168.72 120.49 0.78 Allowed 'General case' 0 C--N 1.343 0.293 0 N-CA-C 112.915 0.709 . . . . 0.35 112.915 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -162.26 -45.09 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.528 1.531 . . . . 0.35 109.223 159.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.98 130.87 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.522 -0.918 . . . . 0.35 108.522 169.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -144.77 154.09 42.35 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.364 1.066 . . . . 0.35 109.05 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -131.77 155.1 81.83 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 125.31 1.444 . . . . 0.33 108.735 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.71 34.75 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.554 2.836 . . . . 0.35 111.945 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.25 2.8 tt 59.45 134.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 128.679 2.792 . . . . 0.35 114.372 -175.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -142.61 98.24 5.9 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.815 1.246 . . . . 0.33 107.793 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.61 177.96 8.12 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.533 2.822 . . . . 0.35 110.999 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.07 -32.99 6.95 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.977 0.799 . . . . 0.35 111.695 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.6 t -67.18 148.71 51.44 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.471 0.708 . . . . 0.35 110.682 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.2 m -76.63 109.93 10.79 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.892 -0.781 . . . . 0.35 108.892 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.08 96.58 7.81 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.573 -1.269 . . . . 0.35 107.573 176.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.3 t -147.31 160.56 42.37 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.502 1.121 . . . . 0.35 109.924 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -60.29 -42.84 96.33 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 119.5 -0.286 . . . . 0.35 111.576 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.06 -22.4 66.42 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.86 0.689 . . . . 0.35 112.86 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -75.31 -58.85 3.03 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 123.401 0.68 . . . . 0.35 109.895 167.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.4 mm -63.15 -39.42 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.457 1.103 . . . . 0.35 112.813 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -52.25 -48.1 65.4 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.881 0.872 . . . . 0.35 112.037 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -76.52 -39.84 51.78 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.063 0.392 . . . . 0.35 111.526 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -69.89 -39.3 76.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.45 0.7 . . . . 0.35 112.407 -169.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.89 -35.77 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.626 0.771 . . . . 0.35 110.752 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -72.4 -34.64 68.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.303 1.041 . . . . 0.35 111.071 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -47.08 73.86 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.746 0.819 . . . . 0.35 110.051 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.8 -39.96 75.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.276 1.03 . . . . 0.35 111.237 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.9 tp -69.1 -50.67 46.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.28 1.032 . . . . 0.35 111.467 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -74.43 8.29 2.36 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.727 1.01 . . . . 0.35 113.727 -174.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.84 -46.41 89.61 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.51 0.724 . . . . 0.35 109.959 166.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 m -118.58 -51.93 2.37 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.679 1.192 . . . . 0.35 110.352 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.96 82.38 6.7 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.164 0.985 . . . . 0.35 110.866 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -128.89 -43.87 1.34 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.057 1.343 . . . . 0.35 111.437 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -59.08 -71.31 0.12 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.212 1.405 . . . . 0.35 110.576 -173.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.08 -35.74 74.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.378 1.071 . . . . 0.35 110.771 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -58.32 146.41 34.52 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.833 1.253 . . . . 0.35 111.629 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -156.13 141.24 17.37 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.564 1.146 . . . . 0.35 109.562 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.6 t -88.06 137.16 21.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 124.317 1.047 . . . . 0.35 109.449 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.95 -56.87 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.067 1.347 . . . . 0.35 107.666 167.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -156.96 110.42 2.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.198 0.999 . . . . 0.35 108.395 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 pp -87.82 132.22 34.25 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.36 0.664 . . . . 0.35 109.823 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.77 124.46 90.77 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 108.322 -0.992 . . . . 0.33 108.322 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.91 -54.1 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.829 2.353 . . . . 0.35 111.793 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.7 m -74.5 96.14 2.87 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.989 0.916 . . . . 0.35 109.969 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.44 133.58 49.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.871 0.868 . . . . 0.35 110.132 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -95.81 108.77 21.14 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.166 0.987 . . . . 0.35 110.26 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.04 113.04 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.694 -1.595 . . . . 0.35 106.694 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.7 64.73 0.65 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.417 1.087 . . . . 0.35 108.984 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.3 p -67.86 115.33 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.347 0.659 . . . . 0.35 110.627 -176.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 m -111.32 101.38 9.86 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.418 1.087 . . . . 0.35 108.985 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -92.92 102.91 15.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.748 1.219 . . . . 0.35 108.962 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -81.03 61.65 4.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.647 1.179 . . . . 0.35 109.611 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -99.03 85.66 3.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.391 1.477 . . . . 0.35 108.453 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -82.59 52.19 2.03 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.763 0.825 . . . . 0.35 110.706 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -137.36 -44.53 0.55 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.839 1.256 . . . . 0.36 109.828 -170.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -140.64 -66.46 0.43 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.23 1.012 . . . . 0.35 110.1 -173.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -89.58 -22.0 22.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.487 0.921 . . . . 0.35 113.487 -164.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 tttm 74.92 159.43 0.22 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.855 1.662 . . . . 0.35 111.494 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -53.8 117.63 3.32 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.506 1.122 . . . . 0.35 109.951 168.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -141.33 111.74 6.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.827 -1.175 . . . . 0.35 107.827 171.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.2 m -75.76 86.17 2.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.828 -1.175 . . . . 0.35 107.828 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -80.42 97.17 6.96 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.051 0.94 . . . . 0.35 108.957 -171.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.9 m -90.24 132.7 35.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.083 1.353 . . . . 0.35 110.348 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -163.71 141.2 5.77 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 123.625 0.77 . . . . 0.33 110.377 176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.24 178.91 6.36 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 124.256 3.304 . . . . 0.35 110.952 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.0 tp -138.02 143.44 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.228 0.611 . . . . 0.35 110.56 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.2 p -100.27 -179.97 4.29 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.999 1.32 . . . . 0.35 111.376 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.99 -36.36 72.52 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.738 1.615 . . . . 0.35 112.805 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -88.54 -50.73 6.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.269 1.028 . . . . 0.35 109.895 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.67 -144.27 45.17 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.156 -0.777 . . . . 0.35 111.156 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -161.0 152.57 19.34 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.74 0.816 . . . . 0.35 110.756 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.9 t -78.35 133.08 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.097 0.959 . . . . 0.35 109.677 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.71 126.22 91.95 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 108.479 -0.934 . . . . 0.33 108.479 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.21 -80.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.782 2.322 . . . . 0.35 110.77 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -169.05 -56.55 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.902 1.281 . . . . 0.35 109.205 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 tm? 69.48 99.08 0.06 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.491 1.916 . . . . 0.35 110.434 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.8 t -171.12 78.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.092 1.357 . . . . 0.35 108.273 173.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -153.86 -77.35 0.11 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 122.782 0.433 . . . . 0.35 110.146 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -88.24 -50.15 6.54 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.265 1.026 . . . . 0.35 110.282 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.7 pt -103.51 169.37 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.38 1.072 . . . . 0.35 109.333 166.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -137.53 -26.95 0.96 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.027 0.931 . . . . 0.35 112.631 -166.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.05 58.1 27.38 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 123.702 0.801 . . . . 0.36 112.92 -169.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.09 119.64 6.45 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.178 2.585 . . . . 0.35 110.65 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.9 77.72 0.69 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 109.574 -1.411 . . . . 0.35 109.574 177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -62.67 96.69 0.09 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.163 1.385 . . . . 0.35 110.65 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -92.62 98.69 11.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.629 -0.878 . . . . 0.36 108.629 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.36 76.97 8.28 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 108.075 -1.083 . . . . 0.35 108.075 176.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.9 mt -90.24 122.34 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.181 -1.415 . . . . 0.35 107.181 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.3 m -131.0 111.67 12.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.97 -1.122 . . . . 0.35 107.97 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -62.99 137.01 58.15 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.365 0.666 . . . . 0.35 110.299 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.7 149.67 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.869 0.867 . . . . 0.35 109.517 169.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.96 142.54 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.857 1.263 . . . . 0.35 108.214 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.6 mt -129.96 147.7 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.698 1.199 . . . . 0.35 109.569 -171.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -126.28 -23.85 3.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.326 1.45 . . . . 0.35 112.487 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? 93.08 134.88 0.02 OUTLIER 'General case' 0 C--N 1.345 0.395 0 C-N-CA 127.834 2.454 . . . . 0.35 110.418 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? . . . . . 0 N--CA 1.455 -0.213 0 C-N-CA 125.007 1.323 . . . . 0.25 109.956 178.655 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 110.137 -0.32 . . . . 0.35 110.137 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -80.71 95.91 6.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.86 1.264 . . . . 0.35 109.283 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.8 p -80.7 75.81 7.6 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.212 1.005 . . . . 0.35 110.991 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -71.39 153.82 42.02 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.028 0.931 . . . . 0.35 109.082 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -155.22 65.42 0.63 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.292 1.037 . . . . 0.35 108.83 -174.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -95.34 57.3 1.96 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.251 1.02 . . . . 0.35 110.186 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 49.9 26.33 8.29 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.275 1.893 . . . . 0.35 114.922 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 47.16 49.01 15.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.645 1.578 . . . . 0.35 112.582 -176.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -86.23 105.13 16.39 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.649 0.78 . . . . 0.35 109.958 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -77.6 72.34 4.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.307 1.443 . . . . 0.35 110.608 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 42.57 -91.05 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.029 2.532 . . . . 0.35 112.721 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.39 -111.04 0.89 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 108.718 -1.753 . . . . 0.35 108.718 175.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 50.73 65.25 1.52 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 125.038 1.335 . . . . 0.35 110.938 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -84.02 75.8 10.11 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.938 0.895 . . . . 0.35 109.158 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -128.36 73.15 1.46 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.374 1.47 . . . . 0.35 108.776 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 t -74.71 175.39 7.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.24 1.016 . . . . 0.35 110.996 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -80.94 76.71 7.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.566 1.147 . . . . 0.35 109.771 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -154.07 76.82 1.07 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.013 1.325 . . . . 0.35 107.559 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 68.04 169.65 0.11 Allowed Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.378 1.471 . . . . 0.33 111.108 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.46 108.01 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.56 2.84 . . . . 0.35 113.051 170.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.0 p -106.0 -60.32 1.66 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.408 1.483 . . . . 0.35 108.695 175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.7 150.24 7.65 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 110.451 -1.06 . . . . 0.33 110.451 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.76 162.78 27.08 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.81 2.34 . . . . 0.35 113.332 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -158.68 164.46 35.92 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.331 1.052 . . . . 0.35 110.085 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 tt -148.51 103.28 3.4 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.295 -1.002 . . . . 0.35 108.295 -173.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 41.9 mtm -82.17 120.68 25.64 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.985 0.914 . . . . 0.35 111.128 -176.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -114.87 96.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 124.824 1.249 . . . . 0.35 110.092 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -156.33 -176.01 5.73 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.529 0.732 . . . . 0.36 110.998 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.2 m -140.27 -170.62 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.767 1.227 . . . . 0.35 110.248 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.2 m -135.89 94.12 3.02 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.897 -1.52 . . . . 0.35 106.897 168.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.09 98.33 2.39 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 124.649 1.119 . . . . 0.35 111.885 -169.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.12 162.64 3.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 124.466 1.106 . . . . 0.35 111.731 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -74.03 -52.25 13.31 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.468 -0.938 . . . . 0.35 108.468 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 m -157.58 -64.37 0.09 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.989 1.316 . . . . 0.35 109.474 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -106.7 63.78 0.64 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.2 1.0 . . . . 0.35 111.264 -165.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.75 -40.62 3.04 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 119.758 -0.468 . . . . 0.35 113.012 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -49.41 103.77 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.751 2.02 . . . . 0.36 112.509 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.81 136.43 34.14 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.489 1.115 . . . . 0.35 110.731 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 mp -79.09 -62.3 1.74 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.456 0.703 . . . . 0.35 109.457 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mt -94.88 -148.28 0.28 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.695 1.198 . . . . 0.35 108.879 -170.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.9 m -143.07 68.11 17.65 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 108.036 -1.098 . . . . 0.33 108.036 164.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -83.18 75.58 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.567 2.845 . . . . 0.35 110.006 -166.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -152.86 54.22 0.77 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.58 1.552 . . . . 0.35 108.016 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.99 48.38 0.44 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.272 0.842 . . . . 0.35 113.272 -171.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -169.71 136.74 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.722 0.809 . . . . 0.35 109.875 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -161.27 178.18 9.48 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.632 0.773 . . . . 0.35 111.378 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -145.39 157.81 52.0 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.627 1.571 . . . . 0.33 108.848 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.17 168.76 18.32 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.0 2.467 . . . . 0.35 110.866 171.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 tp -61.41 144.64 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.707 0.803 . . . . 0.35 111.33 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -156.68 94.75 2.28 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.823 -1.177 . . . . 0.33 107.823 173.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.96 -179.03 4.94 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.393 2.729 . . . . 0.35 110.585 -175.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.96 -37.47 3.7 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.748 0.69 . . . . 0.35 111.555 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.1 t -62.85 142.87 58.07 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.847 0.859 . . . . 0.35 111.459 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.6 m -82.29 135.94 35.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.475 1.11 . . . . 0.35 109.187 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 mp -117.03 131.37 56.96 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.232 1.413 . . . . 0.35 109.794 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 t -172.59 172.05 4.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.073 2.549 . . . . 0.35 106.808 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -61.06 -29.54 69.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.366 0.876 . . . . 0.35 113.366 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -83.7 -13.08 54.92 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.863 0.69 . . . . 0.35 112.863 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -98.27 -27.54 14.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.6 1.16 . . . . 0.35 111.913 173.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -39.71 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.219 -0.66 . . . . 0.35 109.219 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -67.92 -54.99 14.53 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.401 1.081 . . . . 0.35 113.198 -169.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -66.27 -35.02 79.32 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.78 0.718 . . . . 0.35 111.226 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -64.09 -53.81 43.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.954 1.302 . . . . 0.35 111.5 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.1 m -69.32 -36.36 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 123.007 0.523 . . . . 0.35 111.656 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.79 -41.37 95.46 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.824 0.85 . . . . 0.35 111.254 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -33.53 68.78 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.806 0.443 . . . . 0.35 111.201 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.64 -53.83 35.95 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.357 0.663 . . . . 0.35 110.861 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.3 -27.87 67.53 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.225 0.61 . . . . 0.35 112.01 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -67.78 -33.43 74.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.264 0.484 . . . . 0.35 110.439 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.9 28.58 0.35 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.456 0.702 . . . . 0.35 112.15 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 88.5 m -146.27 -65.36 0.3 Allowed 'General case' 0 C--N 1.344 0.336 0 C-N-CA 125.063 1.345 . . . . 0.35 108.229 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.85 -52.25 13.62 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.741 1.216 . . . . 0.35 111.207 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 73.42 150.86 0.11 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.532 1.933 . . . . 0.35 113.776 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.4 tttm 100.72 37.05 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 129.17 2.988 . . . . 0.35 111.29 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 62.21 -74.43 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.176 2.19 . . . . 0.35 114.308 166.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 87.75 159.26 0.07 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 128.459 2.703 . . . . 0.35 110.689 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -54.69 -59.96 4.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.128 0.971 . . . . 0.35 110.209 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t 56.25 76.64 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.952 1.301 . . . . 0.35 108.736 -171.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.9 t -56.99 -60.92 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 124.612 1.165 . . . . 0.35 109.984 -177.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -162.76 126.93 3.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.773 0.829 . . . . 0.35 109.0 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.0 157.36 25.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.342 0.657 . . . . 0.35 110.206 172.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.63 123.73 89.13 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.457 -0.942 . . . . 0.33 108.457 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.86 -31.81 30.68 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.171 2.581 . . . . 0.35 110.67 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 52.8 m -89.64 60.91 5.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.763 1.225 . . . . 0.35 109.536 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.34 170.1 7.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.249 1.02 . . . . 0.35 110.458 171.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -150.74 148.36 28.45 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 113.137 0.791 . . . . 0.35 113.137 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.5 mp -119.68 105.33 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.692 1.597 . . . . 0.35 107.19 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.88 76.83 9.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.607 -0.886 . . . . 0.35 108.607 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.31 94.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.065 -1.087 . . . . 0.35 108.065 172.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.8 m -88.14 75.51 8.64 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.202 -1.036 . . . . 0.35 108.202 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -68.92 121.09 15.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.035 -0.53 . . . . 0.35 110.951 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -138.94 146.71 41.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.9 1.68 . . . . 0.35 109.785 -172.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -154.2 -177.54 6.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.108 1.363 . . . . 0.35 109.48 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -133.45 59.29 1.74 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.571 -1.27 . . . . 0.35 107.571 167.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -143.78 -66.62 0.35 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.498 1.119 . . . . 0.36 109.71 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 56.54 0.23 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.827 0.451 . . . . 0.35 111.998 -171.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -159.84 -55.85 0.06 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-O 119.118 -0.468 . . . . 0.35 111.761 169.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt 80.52 160.18 0.16 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.35 110.122 -168.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.34 136.66 58.04 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.139 0.976 . . . . 0.35 110.969 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -151.85 113.25 4.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.468 1.107 . . . . 0.35 108.272 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.1 m -79.89 82.92 5.9 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.672 1.189 . . . . 0.35 109.05 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -82.66 108.27 15.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.674 -0.861 . . . . 0.35 108.674 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.6 p -85.86 63.66 8.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.743 1.217 . . . . 0.35 110.504 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -61.51 111.85 5.04 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.262 1.425 . . . . 0.33 107.904 172.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.67 -109.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.661 2.241 . . . . 0.35 111.461 -160.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.3 tp -160.64 155.84 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.893 0.877 . . . . 0.35 109.132 -177.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.7 p -106.87 173.02 6.5 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.3 1.04 . . . . 0.35 110.073 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.07 51.12 0.98 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.337 -1.357 . . . . 0.35 107.337 167.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -156.37 -76.65 0.09 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.308 1.043 . . . . 0.35 109.29 -169.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 152.07 143.46 3.7 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.85 -0.9 . . . . 0.35 110.85 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -153.17 128.01 9.54 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.694 0.798 . . . . 0.35 109.757 167.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.06 130.62 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.201 1.0 . . . . 0.35 108.983 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.76 122.69 86.71 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.727 -1.212 . . . . 0.33 107.727 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.02 -98.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.152 2.568 . . . . 0.35 111.059 -172.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -169.25 172.0 7.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.607 1.163 . . . . 0.35 110.08 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.26 137.3 13.62 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.646 1.178 . . . . 0.35 109.767 176.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.9 t -167.69 -174.81 2.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.65 0.78 . . . . 0.35 110.706 -171.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 74.05 -82.03 0.03 OUTLIER 'General case' 0 C--N 1.342 0.245 0 C-N-CA 127.055 2.142 . . . . 0.35 111.366 170.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -104.57 -50.27 3.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.983 1.313 . . . . 0.35 109.162 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.0 tp -78.67 104.77 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.238 1.015 . . . . 0.35 109.207 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -143.47 10.03 1.63 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.275 1.03 . . . . 0.35 112.502 -170.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.32 63.48 4.62 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.31 0.959 . . . . 0.36 111.817 170.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.2 -90.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.941 3.094 . . . . 0.35 112.974 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.96 78.75 0.52 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 109.338 -1.505 . . . . 0.35 109.338 -168.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -75.02 95.18 2.98 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.909 1.284 . . . . 0.35 108.894 176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -91.6 91.4 8.02 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.634 0.374 . . . . 0.36 110.683 -168.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.96 61.39 1.95 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.274 1.429 . . . . 0.35 109.027 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.58 127.91 58.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.143 1.777 . . . . 0.35 106.748 174.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 51.6 m -147.42 131.58 17.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.376 1.07 . . . . 0.35 109.371 -171.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -64.38 131.55 47.53 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.493 0.717 . . . . 0.35 109.56 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.5 m -136.98 159.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.159 0 C-N-CA 123.922 0.889 . . . . 0.35 109.655 174.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.2 124.84 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 124.369 1.067 . . . . 0.35 108.203 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.5 mt -129.43 145.49 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.854 1.261 . . . . 0.35 109.548 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -127.22 156.28 42.1 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.567 1.547 . . . . 0.35 108.822 168.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -77.02 140.79 40.47 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.561 -0.533 . . . . 0.35 109.561 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.147 0 C-N-CA 124.307 1.043 . . . . 0.25 110.667 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.1 p90 . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 114.882 1.438 . . . . 0.34999999999999998 114.882 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -149.86 32.21 0.69 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.141 0.976 . . . . 0.34999999999999998 110.443 165.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -131.27 -58.93 0.99 Allowed 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.717 1.607 . . . . 0.34999999999999998 108.555 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.89 90.49 0.33 Allowed Glycine 0 C--N 1.341 0.834 0 C-N-CA 123.82 0.724 . . . . 0.34999999999999998 111.902 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 56.82 42.46 26.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.193 1.397 . . . . 0.34999999999999998 111.852 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -88.97 -40.83 12.75 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.681 1.193 . . . . 0.34999999999999998 111.703 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.35 48.88 10.47 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 126.584 1.953 . . . . 0.34999999999999998 112.699 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.2 pttp 67.47 -12.31 0.27 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.173 2.189 . . . . 0.34999999999999998 115.015 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.68 -36.92 2.86 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.923 1.249 . . . . 0.34999999999999998 110.46 -170.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.27 85.55 4.41 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.689 1.195 . . . . 0.34999999999999998 110.094 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -99.64 73.48 1.82 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.918 1.287 . . . . 0.34999999999999998 108.579 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.83 79.81 9.49 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.208 1.003 . . . . 0.34999999999999998 109.178 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.3 p -70.65 -59.01 3.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.666 0.786 . . . . 0.34999999999999998 111.58 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -158.99 -143.33 0.1 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.612 -0.885 . . . . 0.34999999999999998 108.612 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.5 t80 56.97 88.14 0.05 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.256 1.822 . . . . 0.34999999999999998 112.207 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 68.27 162.95 0.14 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 126.054 1.742 . . . . 0.33000000000000002 112.09 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.08 99.9 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.131 2.554 . . . . 0.34999999999999998 110.251 171.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.1 p -90.12 -76.66 0.42 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.447 1.099 . . . . 0.34999999999999998 110.25 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.82 149.02 10.96 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 110.593 -1.003 . . . . 0.33000000000000002 110.593 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.11 169.97 21.0 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 124.133 3.222 . . . . 0.34999999999999998 112.506 -170.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -163.53 162.6 24.62 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.558 1.143 . . . . 0.34999999999999998 110.673 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 tt -138.66 97.43 3.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.979 1.312 . . . . 0.34999999999999998 107.583 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.8 ttm -98.96 108.25 20.89 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.069 1.748 . . . . 0.34999999999999998 110.781 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.2 t -110.14 99.82 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.793 1.237 . . . . 0.34999999999999998 110.867 -167.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -150.14 -163.92 1.9 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.89 1.276 . . . . 0.35999999999999999 109.948 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.0 150.69 24.98 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 C-N-CA 124.648 1.179 . . . . 0.34999999999999998 110.923 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 83.8 m -84.09 79.96 9.34 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.431 -1.692 . . . . 0.34999999999999998 106.431 163.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.84 100.43 1.85 Allowed Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.481 -1.048 . . . . 0.34999999999999998 110.481 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.79 169.55 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 124.893 1.277 . . . . 0.34999999999999998 110.348 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -63.8 -49.34 73.29 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.942 0.897 . . . . 0.34999999999999998 110.757 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.2 p -178.47 -58.48 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.598 1.959 . . . . 0.34999999999999998 108.624 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.5 tttp -75.7 -73.7 0.25 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.791 0.836 . . . . 0.34999999999999998 109.622 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.25 28.32 0.07 OUTLIER Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.219 -0.767 . . . . 0.34999999999999998 112.976 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -90.46 94.25 9.65 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 107.252 -1.388 . . . . 0.35999999999999999 107.252 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.38 110.22 3.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.06 0.944 . . . . 0.34999999999999998 111.562 -168.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.6 mt -70.65 -41.51 72.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.759 1.223 . . . . 0.34999999999999998 110.09 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 pp -143.98 138.24 28.3 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.727 0.811 . . . . 0.34999999999999998 111.205 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.7 m -88.36 141.99 31.1 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 124.494 1.118 . . . . 0.33000000000000002 110.039 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.47 -171.57 0.86 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.976 3.117 . . . . 0.34999999999999998 111.688 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.7 m170 87.16 17.77 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.482 2.313 . . . . 0.34999999999999998 114.087 168.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -94.0 -38.95 10.9 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.778 0.717 . . . . 0.34999999999999998 112.417 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.3 t -99.08 137.96 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.204 1.002 . . . . 0.34999999999999998 109.237 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -157.85 135.32 10.38 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.104 0.962 . . . . 0.34999999999999998 109.431 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -120.31 143.69 36.42 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 125.362 1.465 . . . . 0.33000000000000002 108.941 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.33 137.53 40.25 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.543 2.162 . . . . 0.34999999999999998 109.106 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.5 tt -64.21 135.26 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 122.845 0.458 . . . . 0.34999999999999998 111.999 -170.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -142.56 97.38 6.06 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 106.828 -1.545 . . . . 0.33000000000000002 106.828 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.61 135.61 24.32 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.82 2.347 . . . . 0.34999999999999998 110.325 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 162.95 -41.73 0.34 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.925 -0.87 . . . . 0.34999999999999998 110.925 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.4 t -61.21 145.65 50.44 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.97 0.908 . . . . 0.34999999999999998 110.952 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.7 m -78.77 97.49 5.93 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.877 0.871 . . . . 0.34999999999999998 108.895 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -74.32 81.17 1.86 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.29 1.436 . . . . 0.34999999999999998 109.56 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.5 p -150.42 165.6 32.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.56 1.544 . . . . 0.34999999999999998 109.152 -171.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -54.39 -43.49 71.47 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.87 1.268 . . . . 0.34999999999999998 111.69 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -50.82 -50.57 56.14 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.832 0.853 . . . . 0.34999999999999998 112.381 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -102.83 38.04 1.81 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.638 0.775 . . . . 0.34999999999999998 111.565 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.27 -38.06 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.488 1.515 . . . . 0.34999999999999998 107.94 165.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -54.55 -67.7 0.24 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 127.053 2.141 . . . . 0.34999999999999998 110.988 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -81.71 -18.13 45.44 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.078 0.551 . . . . 0.34999999999999998 112.471 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -66.65 -49.46 66.14 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.142 0.577 . . . . 0.34999999999999998 111.224 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.8 m -68.47 -31.12 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.391 0.676 . . . . 0.34999999999999998 111.373 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.05 -40.96 97.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.745 0.818 . . . . 0.34999999999999998 110.748 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.84 -33.3 72.12 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.491 0.716 . . . . 0.34999999999999998 111.532 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.29 -52.92 51.1 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.122 0.569 . . . . 0.34999999999999998 111.207 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.74 -33.73 76.28 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.672 0.389 . . . . 0.34999999999999998 111.642 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -67.62 -30.49 70.08 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 122.699 0.4 . . . . 0.34999999999999998 111.256 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.87 38.67 0.53 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.718 0.807 . . . . 0.34999999999999998 110.967 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.3 m -150.83 -53.17 0.14 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.946 1.698 . . . . 0.34999999999999998 107.992 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.46 -94.09 0.4 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.098 1.359 . . . . 0.34999999999999998 110.505 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.4 t80 55.04 64.06 1.92 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.714 1.606 . . . . 0.34999999999999998 111.623 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -137.8 -54.2 0.66 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.835 1.254 . . . . 0.34999999999999998 108.797 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -125.25 78.2 1.7 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.107 1.363 . . . . 0.34999999999999998 108.07 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -159.45 126.81 4.73 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.099 0.96 . . . . 0.34999999999999998 108.972 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -146.37 -38.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.575 1.15 . . . . 0.34999999999999998 111.537 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 t 76.65 119.55 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 126.408 1.883 . . . . 0.34999999999999998 111.492 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 55.6 t -68.46 -59.16 3.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 N-CA-C 108.088 -1.079 . . . . 0.34999999999999998 108.088 166.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -153.24 154.17 34.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.48 1.512 . . . . 0.34999999999999998 109.023 -175.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 pp -118.6 140.74 49.41 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.472 1.109 . . . . 0.34999999999999998 108.782 170.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.47 137.29 67.58 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 109.721 -0.474 . . . . 0.33000000000000002 109.721 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.81 -33.77 15.74 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.449 2.766 . . . . 0.34999999999999998 111.361 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -85.14 65.64 9.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.495 1.118 . . . . 0.34999999999999998 109.966 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.65 158.67 35.8 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.325 0.65 . . . . 0.34999999999999998 109.346 170.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -142.07 155.06 45.37 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 121.204 0.526 . . . . 0.34999999999999998 112.217 -171.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mp -129.88 117.62 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.687 1.595 . . . . 0.34999999999999998 107.159 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -103.72 67.41 0.89 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.357 1.063 . . . . 0.34999999999999998 109.615 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.68 119.09 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 122.921 0.489 . . . . 0.34999999999999998 109.883 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 m -119.42 117.46 28.53 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.508 1.123 . . . . 0.34999999999999998 108.816 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.0 110.68 20.43 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.839 1.256 . . . . 0.34999999999999998 109.983 -168.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -101.63 56.95 0.83 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.94 1.296 . . . . 0.34999999999999998 112.316 -164.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.48 87.4 6.39 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.289 0.636 . . . . 0.34999999999999998 109.404 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -77.41 65.69 3.01 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.177 0.591 . . . . 0.34999999999999998 110.384 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -152.6 -48.93 0.1 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.203 1.801 . . . . 0.35999999999999999 108.893 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -140.42 -66.14 0.44 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.465 1.106 . . . . 0.34999999999999998 110.63 -173.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -78.72 -51.16 10.21 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.877 0.471 . . . . 0.34999999999999998 111.501 -167.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 75.63 167.04 0.27 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.901 1.681 . . . . 0.34999999999999998 113.013 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.84 111.98 0.94 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.333 1.853 . . . . 0.34999999999999998 111.297 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -141.31 104.82 4.68 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.131 1.373 . . . . 0.34999999999999998 107.656 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.5 m -77.53 88.57 3.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.617 -0.883 . . . . 0.34999999999999998 108.617 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -80.26 95.81 6.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.427 -0.953 . . . . 0.34999999999999998 108.427 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.6 p -90.54 61.19 4.83 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.85 1.26 . . . . 0.34999999999999998 110.617 -175.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -71.12 145.13 90.83 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.582 -0.525 . . . . 0.33000000000000002 109.582 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.81 -118.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.519 2.813 . . . . 0.34999999999999998 109.732 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.4 tp -162.89 159.15 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.62 0.768 . . . . 0.34999999999999998 110.176 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.4 p -133.97 155.7 49.49 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.873 1.269 . . . . 0.34999999999999998 109.538 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -64.35 -48.82 74.07 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.074 0.95 . . . . 0.34999999999999998 112.425 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -138.77 62.81 1.54 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.064 0.946 . . . . 0.34999999999999998 108.915 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.3 -84.22 0.5 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.6 1.095 . . . . 0.34999999999999998 112.755 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -158.0 159.17 36.13 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.421 0.526 . . . . 0.34999999999999998 112.421 -158.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.6 t -82.83 154.02 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.947 1.699 . . . . 0.34999999999999998 109.135 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.0 t -48.83 115.08 4.18 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.763 1.225 . . . . 0.33000000000000002 109.647 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.17 165.21 26.15 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.003 2.469 . . . . 0.34999999999999998 110.797 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -68.88 158.46 34.49 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.504 0.721 . . . . 0.34999999999999998 110.417 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 116' ' ' LEU . 2.1 pt? -84.09 48.68 1.51 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.546 1.138 . . . . 0.34999999999999998 112.845 -175.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.9 t 53.35 -99.78 0.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.658 1.583 . . . . 0.34999999999999998 112.319 173.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -165.16 -53.83 0.03 OUTLIER 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.571 1.148 . . . . 0.34999999999999998 109.305 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -90.32 44.46 1.2 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.074 1.749 . . . . 0.34999999999999998 112.247 -170.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.3 tp -164.15 138.34 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.642 0.777 . . . . 0.34999999999999998 110.244 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -99.54 -43.85 6.36 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.095 1.758 . . . . 0.34999999999999998 110.515 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -123.25 71.17 44.73 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 115.182 1.549 . . . . 0.35999999999999999 115.182 -164.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.87 140.39 92.85 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.756 2.304 . . . . 0.34999999999999998 110.848 163.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.32 67.21 0.32 Allowed Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.648 -1.381 . . . . 0.34999999999999998 109.648 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -58.02 103.24 0.13 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 125.047 1.339 . . . . 0.34999999999999998 110.48 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -99.09 86.36 3.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.89 0.876 . . . . 0.35999999999999999 109.225 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.86 86.23 0.34 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.717 1.607 . . . . 0.34999999999999998 108.046 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.4 mt -134.14 115.83 21.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 124.792 1.237 . . . . 0.34999999999999998 108.316 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 40.5 m -116.48 130.41 56.74 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.832 1.253 . . . . 0.34999999999999998 109.566 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -75.87 128.05 34.29 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.667 -0.864 . . . . 0.34999999999999998 108.667 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.38 153.54 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.116 0.966 . . . . 0.34999999999999998 111.057 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.6 t -96.84 97.08 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.781 1.633 . . . . 0.34999999999999998 107.555 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.5 mt -83.02 138.42 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.299 0.639 . . . . 0.34999999999999998 110.865 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -103.28 113.44 26.93 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 107.537 -1.283 . . . . 0.34999999999999998 107.537 164.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -91.64 91.5 8.04 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.881 0.872 . . . . 0.34999999999999998 108.865 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 C--N 1.342 0.263 0 CA-C-O 121.51 0.671 . . . . 0.25 109.362 177.057 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.5 p90 . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 112.97 0.73 . . . . 0.34999999999999998 112.97 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -61.8 165.21 5.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.854 1.261 . . . . 0.34999999999999998 110.062 172.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.32 60.73 2.68 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.479 1.512 . . . . 0.34999999999999998 110.797 -175.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.07 109.8 3.1 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.859 1.219 . . . . 0.34999999999999998 112.102 -168.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt 58.48 53.01 6.53 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.326 1.45 . . . . 0.34999999999999998 110.572 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -127.56 72.28 1.38 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.352 1.061 . . . . 0.34999999999999998 108.836 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.34 66.94 9.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.671 1.188 . . . . 0.34999999999999998 108.681 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.4 mptt 51.47 -107.33 0.3 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.29 1.836 . . . . 0.34999999999999998 110.022 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.01 52.82 0.55 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 108.244 -1.942 . . . . 0.34999999999999998 108.244 168.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -132.31 75.63 1.65 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.364 1.466 . . . . 0.34999999999999998 108.156 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -157.93 44.58 0.33 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.823 1.249 . . . . 0.34999999999999998 109.718 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.42 95.05 2.65 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.471 1.108 . . . . 0.34999999999999998 108.587 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 t -53.73 -51.24 63.95 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.301 1.04 . . . . 0.34999999999999998 112.118 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -154.17 57.72 0.71 Allowed 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.547 0.739 . . . . 0.34999999999999998 110.462 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -138.58 69.29 1.38 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 122.722 0.409 . . . . 0.34999999999999998 111.522 -170.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 68.42 163.89 0.13 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.93 1.692 . . . . 0.33000000000000002 113.663 161.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -54.29 104.64 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.791 2.994 . . . . 0.34999999999999998 111.047 164.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.9 p -143.35 -51.56 0.35 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.601 1.16 . . . . 0.34999999999999998 109.938 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.97 81.01 0.06 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.182 -1.167 . . . . 0.33000000000000002 110.182 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -70.85 170.84 16.9 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.714 2.942 . . . . 0.34999999999999998 111.44 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -154.77 168.26 27.46 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.51 0.671 . . . . 0.34999999999999998 112.46 -161.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -147.32 93.28 2.22 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.275 -1.75 . . . . 0.34999999999999998 106.275 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 62.6 mtm -85.16 96.65 9.53 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.518 0.727 . . . . 0.34999999999999998 111.339 -169.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.54 89.11 2.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 125.128 1.371 . . . . 0.34999999999999998 108.359 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -151.41 176.55 11.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.429 1.092 . . . . 0.35999999999999999 109.954 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.417 HG11 HG22 ' A' ' 131' ' ' VAL . 6.8 t -136.46 145.7 30.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 C-N-CA 123.873 0.869 . . . . 0.34999999999999998 110.958 -171.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.6 m -82.69 84.38 7.33 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.564 -1.643 . . . . 0.34999999999999998 106.564 164.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.33 83.14 1.58 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.462 -0.655 . . . . 0.34999999999999998 111.462 -169.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.93 164.43 3.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 C-N-CA 123.575 0.75 . . . . 0.34999999999999998 111.37 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -72.43 -45.82 57.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.069 0.948 . . . . 0.34999999999999998 110.96 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.9 t 169.54 -58.02 0.01 OUTLIER 'General case' 0 C--N 1.341 0.226 0 C-N-CA 127.984 2.514 . . . . 0.34999999999999998 107.586 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -71.6 -66.75 0.59 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.22 1.008 . . . . 0.34999999999999998 109.891 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.73 62.91 0.02 OUTLIER Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.001 -1.239 . . . . 0.34999999999999998 110.001 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -133.04 97.23 3.95 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 107.645 -1.242 . . . . 0.35999999999999999 107.645 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.22 119.68 9.48 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.78 1.232 . . . . 0.34999999999999998 111.276 -173.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.0 mp -84.75 -39.41 18.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.153 0.981 . . . . 0.34999999999999998 110.006 170.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 pp -141.88 149.04 39.72 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.535 0.734 . . . . 0.34999999999999998 112.467 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.7 m -89.33 155.26 49.03 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.558 1.143 . . . . 0.33000000000000002 111.544 -167.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -83.7 44.71 1.64 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.811 3.007 . . . . 0.34999999999999998 111.952 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -177.71 111.39 0.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.421 1.089 . . . . 0.34999999999999998 109.936 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -163.83 -51.8 0.03 OUTLIER 'General case' 0 C--N 1.341 0.236 0 CA-C-O 118.668 -0.682 . . . . 0.34999999999999998 112.518 170.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.28 -57.13 6.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 CA-C-N 119.134 0.879 . . . . 0.34999999999999998 110.594 -173.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 65.9 155.08 0.08 Allowed 'General case' 0 C--N 1.343 0.292 0 C-N-CA 126.19 1.796 . . . . 0.34999999999999998 113.061 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -138.55 147.02 53.32 Favored Pre-proline 0 N--CA 1.454 -0.275 0 C-N-CA 125.603 1.561 . . . . 0.33000000000000002 107.521 171.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.63 144.54 55.07 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.582 2.188 . . . . 0.34999999999999998 109.985 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.97 116.85 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.679 0.792 . . . . 0.34999999999999998 109.437 -177.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -137.88 116.16 9.68 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.841 1.256 . . . . 0.33000000000000002 108.484 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.09 178.56 7.36 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.438 2.759 . . . . 0.34999999999999998 110.881 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.23 -30.29 10.67 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.9 0.762 . . . . 0.34999999999999998 112.55 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.4 t -68.13 144.65 54.92 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.797 0.798 . . . . 0.34999999999999998 111.088 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.6 m -71.89 145.65 48.39 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.746 -0.835 . . . . 0.34999999999999998 108.746 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.98 113.89 7.63 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.443 0.697 . . . . 0.34999999999999998 109.531 -167.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 t -162.22 175.25 11.85 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.686 1.594 . . . . 0.34999999999999998 108.898 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -47.97 -60.45 2.6 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.359 1.463 . . . . 0.34999999999999998 111.054 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -59.77 -35.24 74.22 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.375 0.88 . . . . 0.34999999999999998 113.375 -174.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.42 -55.41 28.1 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 118.676 0.671 . . . . 0.34999999999999998 110.62 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.3 mm -60.43 -39.33 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.281 1.033 . . . . 0.34999999999999998 111.754 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -55.65 -59.19 5.2 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.645 0.657 . . . . 0.34999999999999998 111.936 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -66.56 -38.1 86.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.942 0.792 . . . . 0.34999999999999998 111.751 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -66.07 -45.52 81.0 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.516 0.727 . . . . 0.34999999999999998 111.363 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.79 -26.17 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.61 0.764 . . . . 0.34999999999999998 111.736 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -62.92 -35.55 80.45 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.11 0.564 . . . . 0.34999999999999998 110.878 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -71.11 -32.53 69.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.329 0.652 . . . . 0.34999999999999998 111.308 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.58 -36.44 82.72 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.066 0.546 . . . . 0.34999999999999998 111.335 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.0 mt -72.76 -41.49 65.01 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 122.884 0.474 . . . . 0.34999999999999998 111.065 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.49 67.6 6.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.66 0.784 . . . . 0.34999999999999998 109.641 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.57 -60.48 0.1 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.783 1.233 . . . . 0.34999999999999998 108.796 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.0 p -96.79 -56.42 2.58 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.617 1.167 . . . . 0.34999999999999998 109.671 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.79 63.7 7.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.695 -1.224 . . . . 0.34999999999999998 107.695 169.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -72.77 -57.47 4.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.282 0.633 . . . . 0.34999999999999998 112.058 -164.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -93.99 -52.3 4.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.438 0.695 . . . . 0.34999999999999998 111.109 -164.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.52 68.43 10.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.032 0.933 . . . . 0.34999999999999998 110.235 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -163.18 155.35 18.1 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.115 0.966 . . . . 0.34999999999999998 109.575 169.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -163.28 111.21 1.23 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.985 -1.117 . . . . 0.34999999999999998 107.985 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.92 92.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.17 -0.678 . . . . 0.34999999999999998 109.17 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.51 -40.93 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.596 1.158 . . . . 0.34999999999999998 111.332 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -149.15 160.5 43.3 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.615 0.766 . . . . 0.34999999999999998 110.268 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.412 ' H ' HD23 ' A' ' 81' ' ' LEU . 1.7 pt? -137.61 142.54 41.24 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.901 1.28 . . . . 0.34999999999999998 110.441 -175.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.77 132.76 82.87 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 109.398 -0.593 . . . . 0.33000000000000002 109.398 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.74 -34.96 13.6 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.194 2.596 . . . . 0.34999999999999998 110.751 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -81.53 78.83 8.24 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.152 0.981 . . . . 0.34999999999999998 110.473 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.85 166.07 16.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.37 0.668 . . . . 0.34999999999999998 109.269 164.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -153.7 122.06 6.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.73 0.3 . . . . 0.34999999999999998 111.637 -168.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.0 mp -94.28 124.27 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.546 1.538 . . . . 0.34999999999999998 107.325 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -111.25 84.29 1.91 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.486 -1.301 . . . . 0.34999999999999998 107.486 174.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.95 96.86 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 108.975 -0.75 . . . . 0.34999999999999998 108.975 171.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -86.57 87.45 7.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.273 -1.751 . . . . 0.34999999999999998 106.273 171.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -86.78 80.63 8.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.234 0.54 . . . . 0.34999999999999998 110.168 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -91.11 144.09 26.0 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.883 1.273 . . . . 0.34999999999999998 111.034 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -166.38 89.8 0.4 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.039 -1.467 . . . . 0.34999999999999998 107.039 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -77.54 74.36 4.1 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.142 0.977 . . . . 0.34999999999999998 108.636 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -154.67 -48.98 0.09 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.581 1.952 . . . . 0.35999999999999999 108.339 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.23 -45.99 0.1 Allowed 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.554 0.742 . . . . 0.34999999999999998 112.561 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -73.64 -57.37 4.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.614 0.643 . . . . 0.34999999999999998 111.495 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt 82.96 158.05 0.12 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.974 1.71 . . . . 0.34999999999999998 111.7 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.91 135.26 20.2 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 126.438 1.895 . . . . 0.34999999999999998 113.243 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -150.05 103.67 3.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.743 1.217 . . . . 0.34999999999999998 107.997 170.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.2 m -77.19 87.43 3.65 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.408 1.083 . . . . 0.34999999999999998 108.757 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -97.88 103.64 15.6 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.572 1.149 . . . . 0.34999999999999998 108.32 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.6 p -83.32 143.16 30.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.276 1.03 . . . . 0.34999999999999998 111.266 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -151.45 152.97 31.71 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.422 1.089 . . . . 0.33000000000000002 108.856 169.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.43 -117.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.357 2.705 . . . . 0.34999999999999998 110.897 -171.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tp -158.76 150.16 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.901 0.88 . . . . 0.34999999999999998 109.559 -173.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.3 p -91.85 172.68 8.3 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.025 0.93 . . . . 0.34999999999999998 110.807 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -102.9 -28.39 12.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.324 1.45 . . . . 0.34999999999999998 109.386 165.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -62.63 -76.04 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.0 1.32 . . . . 0.34999999999999998 111.777 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 133.93 73.73 0.09 OUTLIER Glycine 0 C--N 1.341 0.86 0 N-CA-C 110.354 -1.099 . . . . 0.34999999999999998 110.354 -172.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -77.21 131.1 38.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.336 0.568 . . . . 0.34999999999999998 109.685 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.63 127.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.678 -1.23 . . . . 0.34999999999999998 107.678 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.16 115.35 12.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.698 -1.223 . . . . 0.33000000000000002 107.698 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -82.84 -174.04 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.115 2.543 . . . . 0.34999999999999998 110.866 -170.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -69.37 -171.57 0.37 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.858 0.863 . . . . 0.34999999999999998 110.109 167.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.27 1.76 2.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.663 0.785 . . . . 0.34999999999999998 113.094 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 t 65.08 -154.62 0.28 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.177 0.991 . . . . 0.34999999999999998 111.516 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -96.6 -50.14 4.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.715 1.206 . . . . 0.34999999999999998 111.483 -166.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -50.45 -41.77 53.24 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.965 1.306 . . . . 0.34999999999999998 112.896 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.3 tp -105.36 144.23 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.783 1.233 . . . . 0.34999999999999998 108.488 168.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -149.93 17.4 0.87 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.553 1.141 . . . . 0.34999999999999998 111.405 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -162.81 70.16 2.02 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.359 1.064 . . . . 0.35999999999999999 110.074 -175.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -87.98 -172.69 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.434 3.423 . . . . 0.34999999999999998 112.26 -170.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.88 84.26 0.17 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.596 -1.402 . . . . 0.34999999999999998 109.596 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -74.88 81.24 2.14 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.31 1.444 . . . . 0.34999999999999998 109.917 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -90.58 104.31 16.9 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.048 0.539 . . . . 0.35999999999999999 110.437 -169.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.88 90.59 4.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.005 -1.109 . . . . 0.34999999999999998 108.005 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.2 mt -96.59 74.76 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 106.97 -1.493 . . . . 0.34999999999999998 106.97 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.1 m -78.67 170.73 16.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.641 1.176 . . . . 0.34999999999999998 109.127 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -141.94 133.81 27.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.43 1.092 . . . . 0.34999999999999998 108.861 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.417 HG22 HG11 ' A' ' 29' ' ' VAL . 5.3 m -142.52 159.62 19.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 123.652 0.781 . . . . 0.34999999999999998 110.803 173.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.4 t -90.85 126.83 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.117 1.367 . . . . 0.34999999999999998 108.205 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 34.9 mt -116.65 120.35 64.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.295 1.038 . . . . 0.34999999999999998 110.159 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -80.29 120.43 24.34 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.267 1.427 . . . . 0.34999999999999998 108.073 164.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -89.07 -3.51 58.65 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.414 1.086 . . . . 0.34999999999999998 112.997 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? . . . . . 0 C--N 1.343 0.323 0 C-N-CA 125.52 1.528 . . . . 0.25 110.333 -164.267 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 115.274 1.583 . . . . 0.34999999999999998 115.274 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -93.59 71.78 4.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.803 0.841 . . . . 0.34999999999999998 108.917 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -157.47 -51.39 0.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.409 1.083 . . . . 0.34999999999999998 110.163 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.49 67.45 0.89 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.825 -0.91 . . . . 0.34999999999999998 110.825 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt 56.14 -121.45 1.62 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.431 1.492 . . . . 0.34999999999999998 110.904 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.9 t80 61.71 99.64 0.03 OUTLIER 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.499 1.92 . . . . 0.34999999999999998 112.181 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.81 52.43 0.94 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.685 1.194 . . . . 0.34999999999999998 110.678 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.6 mttt 79.55 -65.18 0.2 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 126.915 2.086 . . . . 0.34999999999999998 111.866 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 147.09 -47.8 0.67 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 108.387 -1.885 . . . . 0.34999999999999998 108.387 -168.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 48.4 51.15 15.66 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.881 2.073 . . . . 0.34999999999999998 113.809 167.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 56.66 54.39 7.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.901 1.281 . . . . 0.34999999999999998 111.778 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.16 -158.33 0.32 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.553 1.141 . . . . 0.34999999999999998 112.984 171.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 p -162.79 -35.6 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.482 1.113 . . . . 0.34999999999999998 111.812 -171.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -133.8 39.44 3.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.705 1.202 . . . . 0.34999999999999998 109.944 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -147.37 73.05 1.27 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 122.775 0.43 . . . . 0.34999999999999998 110.788 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 65.8 177.99 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.191 1.396 . . . . 0.33000000000000002 112.886 162.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -74.89 60.41 5.34 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.596 2.864 . . . . 0.34999999999999998 113.742 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.2 p -68.01 -40.97 82.9 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.566 0.746 . . . . 0.34999999999999998 109.915 170.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.96 166.79 22.36 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 111.881 -0.488 . . . . 0.33000000000000002 111.881 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.03 -177.45 3.72 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.875 3.717 . . . . 0.34999999999999998 111.807 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -156.46 171.8 19.65 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.594 1.157 . . . . 0.34999999999999998 110.452 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tt -149.16 82.61 1.43 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.957 -1.127 . . . . 0.34999999999999998 107.957 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -67.42 133.14 49.01 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.378 0.671 . . . . 0.34999999999999998 110.166 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.8 t -128.67 86.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 125.076 1.35 . . . . 0.34999999999999998 108.423 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -146.93 177.97 8.72 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.989 1.315 . . . . 0.35999999999999999 109.254 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.3 m -137.71 144.05 32.21 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 C-N-CA 124.348 1.059 . . . . 0.34999999999999998 110.34 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.7 m -75.99 97.35 3.99 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.305 -0.998 . . . . 0.34999999999999998 108.305 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.92 84.01 1.57 Allowed Glycine 0 C--N 1.338 0.686 0 C-N-CA 123.988 0.804 . . . . 0.34999999999999998 111.535 -172.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.8 m -77.14 165.5 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.25 0.62 . . . . 0.34999999999999998 110.315 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.4 -66.53 0.89 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.884 0.474 . . . . 0.34999999999999998 109.862 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.6 m -158.42 -56.0 0.07 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.61 1.564 . . . . 0.34999999999999998 108.249 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.25 45.42 1.02 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.763 1.225 . . . . 0.34999999999999998 110.17 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.59 29.03 73.45 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.161 0.886 . . . . 0.34999999999999998 113.419 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -96.75 97.71 9.56 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 117.933 0.866 . . . . 0.35999999999999999 108.887 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.08 116.26 4.39 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.506 1.123 . . . . 0.34999999999999998 111.541 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.7 mp -73.16 -45.82 54.34 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.327 0.651 . . . . 0.34999999999999998 109.386 168.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 pp -138.58 138.82 38.29 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.308 1.043 . . . . 0.34999999999999998 111.978 -171.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.7 t -82.32 138.08 45.27 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 124.658 1.183 . . . . 0.33000000000000002 109.107 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -86.31 61.36 4.73 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.648 2.899 . . . . 0.34999999999999998 111.825 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -149.11 65.31 1.03 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.609 0.764 . . . . 0.34999999999999998 109.845 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -128.61 -52.74 1.25 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.159 0.984 . . . . 0.34999999999999998 111.261 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.1 t -101.47 140.49 20.02 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 123.214 0.606 . . . . 0.34999999999999998 109.893 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.7 170.06 19.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.643 0.777 . . . . 0.34999999999999998 110.109 164.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -140.13 147.94 52.49 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.133 0.973 . . . . 0.33000000000000002 109.373 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.38 126.89 14.86 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.346 2.031 . . . . 0.34999999999999998 107.911 168.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.3 tt -57.83 137.57 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.36 0.664 . . . . 0.34999999999999998 112.585 -168.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 86.62 8.99 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.961 1.705 . . . . 0.33000000000000002 107.765 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.16 168.47 23.94 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.193 2.595 . . . . 0.34999999999999998 111.371 -170.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.51 -28.64 14.14 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.025 0.821 . . . . 0.34999999999999998 111.802 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.0 t -65.58 148.03 52.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.722 0.809 . . . . 0.34999999999999998 110.879 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -74.61 124.27 26.36 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.419 0.688 . . . . 0.34999999999999998 109.702 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.96 102.28 7.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.34 1.456 . . . . 0.34999999999999998 107.435 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.2 t -139.8 -175.99 4.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.596 1.158 . . . . 0.34999999999999998 108.882 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -55.71 -60.16 3.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.668 0.787 . . . . 0.34999999999999998 110.672 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.6 -33.19 74.5 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.376 0.88 . . . . 0.34999999999999998 113.376 -173.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -61.23 2.5 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.246 0.93 . . . . 0.34999999999999998 110.055 175.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.13 -31.78 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.35 1.06 . . . . 0.34999999999999998 111.342 -170.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.74 -62.46 1.64 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.653 1.181 . . . . 0.34999999999999998 111.572 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.04 -34.97 78.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.166 0.439 . . . . 0.34999999999999998 111.539 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -63.6 -46.8 84.11 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.621 0.768 . . . . 0.34999999999999998 111.663 -175.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.8 p -73.66 -31.93 33.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 122.809 0.443 . . . . 0.34999999999999998 111.724 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -58.95 -31.89 69.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.279 0.632 . . . . 0.34999999999999998 111.512 173.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -76.54 -38.33 55.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.922 0.489 . . . . 0.34999999999999998 110.771 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.31 -62.27 1.96 Allowed 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.335 1.054 . . . . 0.34999999999999998 111.942 -174.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.13 -23.88 67.48 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.048 0.758 . . . . 0.34999999999999998 113.048 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -80.43 66.66 6.01 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.813 1.245 . . . . 0.34999999999999998 110.972 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.07 49.86 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.798 1.639 . . . . 0.34999999999999998 108.672 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.2 p -140.08 -62.41 0.51 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.047 1.339 . . . . 0.34999999999999998 108.873 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.29 -64.93 1.01 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.118 1.367 . . . . 0.34999999999999998 108.686 172.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.62 68.99 0.78 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.873 1.669 . . . . 0.34999999999999998 110.802 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -132.8 47.7 2.48 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.993 1.317 . . . . 0.34999999999999998 108.53 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 63.6 111.51 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.065 2.146 . . . . 0.34999999999999998 112.36 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -111.57 99.52 8.25 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.271 1.428 . . . . 0.34999999999999998 108.107 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -81.28 98.49 8.15 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.369 -0.604 . . . . 0.34999999999999998 109.369 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.5 96.83 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.907 -0.775 . . . . 0.34999999999999998 108.907 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.53 -46.02 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.652 0.781 . . . . 0.34999999999999998 111.035 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -137.96 164.41 29.11 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.71 1.204 . . . . 0.34999999999999998 110.225 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 pp -157.66 158.29 35.17 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.861 1.264 . . . . 0.34999999999999998 110.316 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.23 121.22 68.86 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 108.533 -0.914 . . . . 0.33000000000000002 108.533 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.77 -39.46 3.4 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.019 2.479 . . . . 0.34999999999999998 110.938 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -79.49 83.48 5.49 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.006 0.923 . . . . 0.34999999999999998 109.291 176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.07 129.75 41.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.628 0.771 . . . . 0.34999999999999998 109.778 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -100.23 136.38 40.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.575 1.15 . . . . 0.34999999999999998 110.82 -172.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.43 120.27 58.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 125.633 1.573 . . . . 0.34999999999999998 108.492 -173.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -117.9 90.56 3.36 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.819 1.248 . . . . 0.34999999999999998 108.647 -172.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 m -77.06 94.08 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.261 1.024 . . . . 0.34999999999999998 110.544 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 88.1 m -91.88 90.62 7.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.634 1.574 . . . . 0.34999999999999998 108.532 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.75 93.9 7.78 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.823 0.849 . . . . 0.34999999999999998 110.534 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -86.09 62.55 7.51 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.71 1.604 . . . . 0.34999999999999998 109.615 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -98.99 78.63 2.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.996 1.319 . . . . 0.34999999999999998 107.469 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.12 80.28 4.55 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.656 1.182 . . . . 0.34999999999999998 109.376 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -150.75 -41.43 0.12 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.784 2.034 . . . . 0.35999999999999999 108.442 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.65 -39.75 0.18 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.817 1.647 . . . . 0.34999999999999998 110.894 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -85.77 -54.75 4.34 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.0 0.92 . . . . 0.34999999999999998 111.439 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 83.3 tttt 69.52 158.51 0.17 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.877 1.671 . . . . 0.34999999999999998 110.856 -172.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.73 123.62 14.74 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.105 0.562 . . . . 0.34999999999999998 111.446 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -145.0 105.64 4.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.91 1.284 . . . . 0.34999999999999998 107.841 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.7 m -82.62 86.85 6.75 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.949 1.299 . . . . 0.34999999999999998 108.968 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.3 101.61 14.28 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.014 0.926 . . . . 0.34999999999999998 108.85 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.8 p -80.35 144.21 32.92 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.415 1.086 . . . . 0.34999999999999998 111.266 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -158.95 137.0 7.46 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 123.282 0.633 . . . . 0.33000000000000002 110.719 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.6 161.73 27.77 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.858 3.039 . . . . 0.34999999999999998 110.525 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.0 tp -95.42 151.66 3.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 123.788 0.835 . . . . 0.34999999999999998 110.339 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 67.6 p -86.67 112.18 21.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.835 -1.172 . . . . 0.34999999999999998 107.835 169.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.15 -21.76 66.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.478 1.111 . . . . 0.34999999999999998 113.596 -173.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.05 -44.05 97.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.899 0.88 . . . . 0.34999999999999998 111.713 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.32 135.15 1.77 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.519 -1.033 . . . . 0.34999999999999998 110.519 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -159.27 166.86 30.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.372 1.069 . . . . 0.34999999999999998 109.555 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.67 144.6 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.283 1.433 . . . . 0.34999999999999998 109.229 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.19 116.33 15.58 Favored Pre-proline 0 C--N 1.345 0.405 0 N-CA-C 108.156 -1.053 . . . . 0.33000000000000002 108.156 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.42 -101.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.921 2.414 . . . . 0.34999999999999998 110.902 -167.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -166.17 169.04 14.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.098 0.959 . . . . 0.34999999999999998 109.376 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.53 17.54 0.86 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.767 1.227 . . . . 0.34999999999999998 112.635 172.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.8 t 63.04 -95.13 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.647 1.579 . . . . 0.34999999999999998 111.024 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -167.36 -48.76 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.167 0.987 . . . . 0.34999999999999998 109.855 -174.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -70.76 -0.34 8.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.495 1.518 . . . . 0.34999999999999998 114.943 -168.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.7 pt -133.24 -172.98 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.411 1.084 . . . . 0.34999999999999998 110.188 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -130.6 -45.32 1.08 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.414 1.486 . . . . 0.34999999999999998 110.62 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -119.92 74.49 19.71 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 0.35999999999999999 112.772 -162.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -69.27 141.27 46.74 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.17 1.913 . . . . 0.34999999999999998 109.935 171.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.24 79.7 0.28 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.405 -1.478 . . . . 0.34999999999999998 109.405 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -66.67 92.92 0.23 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.713 1.205 . . . . 0.34999999999999998 110.713 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -85.37 98.68 10.69 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.877 -1.157 . . . . 0.35999999999999999 107.877 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.93 53.82 2.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.171 0.988 . . . . 0.34999999999999998 109.196 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.0 mt -99.03 99.29 8.31 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 124.462 1.105 . . . . 0.34999999999999998 108.681 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 96.3 m -105.63 140.53 38.56 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.102 1.361 . . . . 0.34999999999999998 109.231 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 126.46 31.63 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.525 0.73 . . . . 0.34999999999999998 109.326 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.34 148.33 32.77 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 C-N-CA 123.888 0.875 . . . . 0.34999999999999998 110.299 172.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 t -96.51 130.83 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.689 1.196 . . . . 0.34999999999999998 108.364 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mt -126.97 105.95 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.829 1.251 . . . . 0.34999999999999998 109.222 -173.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -71.58 132.07 44.13 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.79 -1.189 . . . . 0.34999999999999998 107.79 159.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 94.83 4.4 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.403 0.681 . . . . 0.34999999999999998 109.497 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.344 0.337 0 C-N-CA 124.969 1.307 . . . . 0.25 109.438 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 t80 . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 110.102 -0.333 . . . . 0.34999999999999998 110.102 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -164.96 99.07 0.76 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.752 0.821 . . . . 0.34999999999999998 110.077 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -157.89 37.68 0.26 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.257 1.023 . . . . 0.34999999999999998 109.946 168.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.43 159.93 9.74 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.017 0.818 . . . . 0.34999999999999998 111.18 -174.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -74.76 96.95 3.15 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.985 0.514 . . . . 0.34999999999999998 110.189 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -85.88 79.12 9.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.305 1.042 . . . . 0.34999999999999998 110.609 -174.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -137.84 -158.12 0.83 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.913 0.885 . . . . 0.34999999999999998 109.187 170.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.9 tttt 62.61 46.86 5.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.197 0.999 . . . . 0.34999999999999998 109.542 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.11 -42.88 1.85 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.046 1.308 . . . . 0.34999999999999998 111.653 -172.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -85.47 56.52 3.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.588 1.155 . . . . 0.34999999999999998 110.558 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 54.85 28.71 10.78 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.682 1.993 . . . . 0.34999999999999998 113.693 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.17 140.63 29.3 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.384 0.674 . . . . 0.34999999999999998 110.889 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -166.32 -130.13 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.154 0.982 . . . . 0.34999999999999998 109.511 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -138.82 164.83 28.61 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.306 1.842 . . . . 0.34999999999999998 108.951 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.7 t80 66.72 103.62 0.04 OUTLIER 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.763 1.625 . . . . 0.34999999999999998 110.673 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 75.66 144.65 0.1 Allowed Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 126.109 1.764 . . . . 0.33000000000000002 110.079 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.62 96.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.443 2.762 . . . . 0.34999999999999998 111.847 171.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.1 p -94.33 -44.3 8.0 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.008 0.923 . . . . 0.34999999999999998 110.291 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.21 150.38 8.64 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 112.032 -0.427 . . . . 0.33000000000000002 112.032 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -92.21 -170.12 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.939 3.093 . . . . 0.34999999999999998 111.098 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -168.75 165.32 11.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.006 0.922 . . . . 0.34999999999999998 111.73 172.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.0 tp -134.42 88.54 2.46 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.94 1.696 . . . . 0.34999999999999998 107.731 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -78.41 125.57 29.55 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.883 1.273 . . . . 0.34999999999999998 108.312 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -135.65 91.09 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.882 0.873 . . . . 0.34999999999999998 109.382 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -149.28 157.68 43.55 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.465 1.506 . . . . 0.35999999999999999 109.169 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.13 161.09 42.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 123.806 0.843 . . . . 0.34999999999999998 112.146 -168.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.3 m -87.91 91.15 8.66 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.841 1.257 . . . . 0.34999999999999998 108.438 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.06 104.24 2.66 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.653 -0.979 . . . . 0.34999999999999998 110.653 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.35 174.0 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.224 1.01 . . . . 0.34999999999999998 111.033 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -71.62 -55.82 7.03 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.065 0.546 . . . . 0.34999999999999998 109.675 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.2 p -150.1 -71.04 0.18 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.067 0.947 . . . . 0.34999999999999998 110.559 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -85.45 -73.33 0.45 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.862 0.865 . . . . 0.34999999999999998 110.541 -171.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.49 50.77 0.41 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.341 -1.104 . . . . 0.34999999999999998 110.341 -176.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -115.82 79.99 1.38 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.338 1.455 . . . . 0.35999999999999999 108.714 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.46 138.76 58.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.036 1.334 . . . . 0.34999999999999998 112.256 -173.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mp -113.96 -24.84 8.85 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.311 1.445 . . . . 0.34999999999999998 110.666 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.51 146.0 32.16 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.355 1.062 . . . . 0.34999999999999998 111.738 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.8 m -81.33 153.6 71.51 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.367 1.067 . . . . 0.33000000000000002 110.331 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.99 50.44 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.78 2.987 . . . . 0.34999999999999998 111.521 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -173.21 103.96 0.13 Allowed 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.09 0.556 . . . . 0.34999999999999998 111.038 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -164.88 14.02 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.5 0.926 . . . . 0.34999999999999998 113.5 172.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.6 t -149.16 135.22 12.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 C-N-CA 125.241 1.416 . . . . 0.34999999999999998 107.441 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -139.46 171.05 14.82 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.128 0.571 . . . . 0.34999999999999998 111.295 169.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -140.81 151.7 63.61 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.765 1.226 . . . . 0.33000000000000002 109.967 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.04 100.61 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.487 2.791 . . . . 0.34999999999999998 109.397 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.77 138.17 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.262 1.025 . . . . 0.34999999999999998 111.508 -171.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -138.53 137.11 19.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.717 1.207 . . . . 0.33000000000000002 108.733 171.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.24 169.36 22.67 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.647 2.898 . . . . 0.34999999999999998 110.864 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 110.63 -31.21 7.51 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.108 0.861 . . . . 0.34999999999999998 111.841 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 t -66.13 146.27 54.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.559 0.744 . . . . 0.34999999999999998 111.146 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.7 m -74.21 152.91 39.67 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.455 1.102 . . . . 0.34999999999999998 109.282 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.04 121.13 8.28 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.4 0.68 . . . . 0.34999999999999998 109.482 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 t -166.09 174.53 9.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.689 1.996 . . . . 0.34999999999999998 107.846 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.62 -52.18 64.67 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.692 0.797 . . . . 0.34999999999999998 111.23 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.75 -24.72 67.88 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.184 0.809 . . . . 0.34999999999999998 113.184 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -71.85 -51.66 21.3 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.371 0.668 . . . . 0.34999999999999998 110.582 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.2 -33.25 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.51 1.124 . . . . 0.34999999999999998 111.886 -172.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -55.29 -55.23 33.82 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.463 1.105 . . . . 0.34999999999999998 111.714 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -66.99 -30.29 70.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.073 0.397 . . . . 0.34999999999999998 111.867 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -52.88 61.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.483 0.713 . . . . 0.34999999999999998 110.209 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -61.13 -38.95 80.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 CA-C-O 119.038 -0.506 . . . . 0.34999999999999998 111.343 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.92 -36.16 76.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.586 0.755 . . . . 0.34999999999999998 111.875 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -70.2 -48.04 58.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.93 0.492 . . . . 0.34999999999999998 110.844 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.95 97.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.427 0.691 . . . . 0.34999999999999998 111.52 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 mt -54.51 -58.78 6.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.22 1.408 . . . . 0.34999999999999998 110.304 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -61.38 -59.62 4.99 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.01 0.924 . . . . 0.34999999999999998 111.652 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -41.23 -48.8 3.58 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 126.131 1.772 . . . . 0.34999999999999998 113.429 -171.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.5 m -74.13 -63.61 1.19 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.348 0.659 . . . . 0.34999999999999998 109.924 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.56 96.08 5.69 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.01 1.324 . . . . 0.34999999999999998 109.915 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -112.18 70.67 0.72 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.196 1.399 . . . . 0.34999999999999998 109.571 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -137.95 -113.17 0.17 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.745 0.818 . . . . 0.34999999999999998 109.906 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.42 83.22 6.86 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.414 1.086 . . . . 0.34999999999999998 110.81 -173.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -152.43 162.87 40.58 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.317 0.647 . . . . 0.34999999999999998 111.469 176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -173.98 125.05 0.35 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.549 1.94 . . . . 0.34999999999999998 106.789 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.96 91.74 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.297 -1.001 . . . . 0.34999999999999998 108.297 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 p -61.2 -43.92 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.885 0.874 . . . . 0.34999999999999998 110.985 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -151.1 169.16 22.52 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.943 0.897 . . . . 0.34999999999999998 110.12 169.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 pp -144.64 149.56 35.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.285 1.034 . . . . 0.34999999999999998 109.992 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.86 135.73 55.35 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.578 -0.897 . . . . 0.33000000000000002 108.578 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.46 -24.44 22.46 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.162 2.575 . . . . 0.34999999999999998 111.923 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 m -86.21 70.03 10.51 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.57 1.148 . . . . 0.34999999999999998 110.855 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.39 164.35 26.49 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.767 0.827 . . . . 0.34999999999999998 109.965 168.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -150.02 121.72 8.07 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.134 0.493 . . . . 0.34999999999999998 112.313 -174.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 mp -77.74 114.69 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.663 -1.606 . . . . 0.34999999999999998 106.663 165.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -110.23 63.42 0.61 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.34 -0.985 . . . . 0.34999999999999998 108.34 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.09 111.11 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.405 0.682 . . . . 0.34999999999999998 110.945 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.5 m -98.45 81.85 2.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.49 1.516 . . . . 0.34999999999999998 108.263 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -87.27 112.56 22.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.245 1.018 . . . . 0.34999999999999998 108.577 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -104.67 117.49 34.23 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.547 1.139 . . . . 0.34999999999999998 110.578 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.411 ' HB2' HD12 ' A' ' 120' ' ' ILE . 27.1 t70 -128.37 89.34 2.89 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.597 1.159 . . . . 0.34999999999999998 110.236 -172.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -82.82 67.83 9.06 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.04 -0.726 . . . . 0.34999999999999998 109.04 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -149.0 -54.17 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.225 1.41 . . . . 0.35999999999999999 109.134 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.74 -48.11 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.634 0.773 . . . . 0.34999999999999998 112.823 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -71.94 -34.32 68.94 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.884 0.874 . . . . 0.34999999999999998 112.17 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt 72.68 174.9 0.29 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.118 1.367 . . . . 0.34999999999999998 110.945 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -79.16 132.23 36.48 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.209 0.604 . . . . 0.34999999999999998 110.876 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -139.87 113.4 8.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.585 1.154 . . . . 0.34999999999999998 108.562 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.6 m -80.2 84.88 5.81 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.658 -1.238 . . . . 0.34999999999999998 107.658 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -78.82 105.66 10.29 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.898 0.879 . . . . 0.34999999999999998 109.35 -173.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.5 m -87.95 67.79 9.08 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.585 1.154 . . . . 0.34999999999999998 111.163 -172.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -69.56 140.87 89.97 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.216 1.006 . . . . 0.33000000000000002 108.74 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -78.78 -116.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.265 2.644 . . . . 0.34999999999999998 110.335 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.1 tp -160.52 150.83 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.17 0.988 . . . . 0.34999999999999998 108.862 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.0 p -103.4 175.7 5.39 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.036 0.934 . . . . 0.34999999999999998 110.611 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.83 -10.79 15.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.592 1.557 . . . . 0.34999999999999998 110.573 164.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -77.31 -82.97 0.08 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 124.813 1.245 . . . . 0.34999999999999998 110.713 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 145.4 63.85 0.02 OUTLIER Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.155 -1.178 . . . . 0.34999999999999998 110.155 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -72.27 129.71 39.07 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 117.508 0.654 . . . . 0.34999999999999998 109.728 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.71 130.99 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.395 -0.965 . . . . 0.34999999999999998 108.395 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.6 117.24 29.51 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 107.918 -1.141 . . . . 0.33000000000000002 107.918 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.27 172.02 16.05 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.199 2.6 . . . . 0.34999999999999998 110.898 -173.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.11 34.53 0.62 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.146 0.978 . . . . 0.34999999999999998 110.932 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 32.66 54.0 0.36 Allowed 'General case' 0 C--N 1.346 0.43 0 C-N-CA 128.041 2.536 . . . . 0.34999999999999998 113.878 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.1 t 56.47 -105.84 0.29 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.893 1.677 . . . . 0.34999999999999998 111.467 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -163.22 -38.17 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.233 1.013 . . . . 0.34999999999999998 110.654 -172.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -13.6 1.37 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.26 1.824 . . . . 0.34999999999999998 115.169 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 93' ' ' ASP . 1.0 OUTLIER -153.14 148.23 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.574 1.15 . . . . 0.34999999999999998 108.978 171.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.49 34.77 3.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.37 1.868 . . . . 0.34999999999999998 111.337 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -153.37 79.48 5.48 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.318 0.647 . . . . 0.35999999999999999 111.378 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.59 167.67 25.1 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.022 2.482 . . . . 0.34999999999999998 111.527 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.0 68.2 0.47 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.194 -1.163 . . . . 0.34999999999999998 110.194 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -59.73 103.05 0.18 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.165 1.386 . . . . 0.34999999999999998 111.26 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -100.39 98.41 9.05 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.072 0.949 . . . . 0.35999999999999999 109.449 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.96 73.83 10.24 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.116 0.966 . . . . 0.34999999999999998 108.535 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.6 mt -91.05 91.29 3.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.093 -1.447 . . . . 0.34999999999999998 107.093 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.1 m -111.58 150.48 29.98 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.688 1.195 . . . . 0.34999999999999998 109.468 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -91.75 130.3 37.56 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.151 1.38 . . . . 0.34999999999999998 109.053 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 m -137.5 169.46 19.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 123.753 0.821 . . . . 0.34999999999999998 110.351 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 37.9 t -119.73 139.75 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.035 1.334 . . . . 0.34999999999999998 108.111 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.7 mt -130.54 119.35 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.232 1.013 . . . . 0.34999999999999998 109.503 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -78.71 127.2 31.76 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.923 -1.14 . . . . 0.34999999999999998 107.923 161.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -95.24 60.32 2.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.241 1.017 . . . . 0.34999999999999998 111.252 -168.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.186 0 C-N-CA 124.004 0.921 . . . . 0.25 110.021 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.7 p90 . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 110.817 -0.068 . . . . 0.34999999999999998 110.817 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -95.02 162.29 13.79 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.125 0.97 . . . . 0.34999999999999998 110.33 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 pttm 50.51 83.36 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.557 1.943 . . . . 0.34999999999999998 112.57 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.22 103.32 0.33 Allowed Glycine 0 C--N 1.341 0.845 0 C-N-CA 126.387 1.946 . . . . 0.34999999999999998 112.621 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt 75.1 -33.68 0.24 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 126.688 1.995 . . . . 0.34999999999999998 113.743 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -55.1 123.13 12.65 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.138 0.975 . . . . 0.34999999999999998 110.173 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -101.43 27.85 5.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.491 -0.766 . . . . 0.34999999999999998 112.996 -159.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? 69.53 -63.95 0.36 Allowed 'General case' 0 C--N 1.346 0.435 0 C-N-CA 126.21 1.804 . . . . 0.34999999999999998 109.907 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.59 -151.49 6.7 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.605 -1.798 . . . . 0.34999999999999998 108.605 172.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 57.62 37.73 27.54 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.371 1.068 . . . . 0.34999999999999998 111.753 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.91 64.63 0.96 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.507 1.123 . . . . 0.34999999999999998 109.335 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.51 -41.53 60.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.009 0.924 . . . . 0.34999999999999998 110.345 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.6 t 74.26 -74.67 0.08 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.779 2.032 . . . . 0.34999999999999998 112.064 175.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -155.22 171.56 19.62 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.332 0.653 . . . . 0.34999999999999998 111.257 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 70.11 121.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.709 2.004 . . . . 0.34999999999999998 112.633 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 73.93 137.81 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 126.17 1.788 . . . . 0.33000000000000002 112.223 168.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.79 109.62 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.19 3.26 . . . . 0.34999999999999998 111.922 160.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 p -138.06 -62.54 0.58 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.847 1.259 . . . . 0.34999999999999998 109.588 -174.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.0 113.08 0.31 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.46 -1.056 . . . . 0.33000000000000002 110.46 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.24 176.58 9.87 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.003 2.469 . . . . 0.34999999999999998 111.803 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -159.06 163.09 36.61 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.207 1.003 . . . . 0.34999999999999998 110.344 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.8 tt -145.11 94.61 2.55 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.458 -1.312 . . . . 0.34999999999999998 107.458 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.3 ptp -88.74 139.06 30.85 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.884 0.874 . . . . 0.34999999999999998 110.357 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.6 91.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.205 0 C-N-CA 124.636 1.174 . . . . 0.34999999999999998 107.874 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -153.59 166.1 33.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.699 1.2 . . . . 0.35999999999999999 110.139 -171.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -144.94 170.59 6.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 123.147 0.579 . . . . 0.34999999999999998 112.352 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -107.0 121.46 44.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.155 1.382 . . . . 0.34999999999999998 108.264 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.55 92.41 1.72 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.15 0.881 . . . . 0.34999999999999998 111.624 -174.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.0 m -99.08 168.63 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 124.316 1.046 . . . . 0.34999999999999998 112.852 -174.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -83.09 172.72 12.41 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.626 1.17 . . . . 0.34999999999999998 109.563 166.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -57.18 -40.94 78.33 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.722 0.809 . . . . 0.34999999999999998 110.39 170.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -62.02 -55.29 30.67 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.061 0.945 . . . . 0.34999999999999998 110.186 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.1 4.29 0.59 Allowed Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.938 -0.923 . . . . 0.34999999999999998 114.017 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -79.32 123.18 27.22 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.774 1.287 . . . . 0.35999999999999999 110.217 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -65.21 104.11 0.87 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.912 0.885 . . . . 0.34999999999999998 110.976 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 mp -69.65 -56.77 6.34 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.751 -1.203 . . . . 0.34999999999999998 107.751 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.5 mt -120.65 164.91 15.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.188 1.795 . . . . 0.34999999999999998 108.789 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.8 m -142.74 68.26 19.17 Favored Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 124.522 1.129 . . . . 0.33000000000000002 108.015 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.08 106.29 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.578 2.852 . . . . 0.34999999999999998 110.073 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -146.34 90.58 1.96 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.926 1.69 . . . . 0.34999999999999998 108.187 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -155.55 -33.36 0.09 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.056 0.762 . . . . 0.34999999999999998 113.056 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.6 t -76.22 98.7 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.975 0.91 . . . . 0.34999999999999998 111.216 -176.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -86.97 170.09 11.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.317 0.647 . . . . 0.34999999999999998 110.141 167.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -155.41 131.1 5.47 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.269 -1.011 . . . . 0.33000000000000002 108.269 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.48 121.84 8.8 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.815 2.343 . . . . 0.34999999999999998 109.059 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.0 tt -57.53 133.85 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.32 1.048 . . . . 0.34999999999999998 112.856 -168.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -142.77 98.39 5.77 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 125.565 1.546 . . . . 0.33000000000000002 107.495 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.77 173.66 13.76 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.247 2.631 . . . . 0.34999999999999998 111.288 -174.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.42 -26.48 24.17 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.013 0.816 . . . . 0.34999999999999998 112.159 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.1 t -66.32 151.51 46.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.889 0.844 . . . . 0.34999999999999998 110.796 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -62.46 148.62 45.07 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.959 0.903 . . . . 0.34999999999999998 110.118 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.51 101.23 2.64 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.368 -0.975 . . . . 0.34999999999999998 108.368 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 t -144.89 -171.07 3.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.165 1.386 . . . . 0.34999999999999998 108.752 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -58.19 -57.41 12.99 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.34999999999999998 110.674 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -61.96 -29.03 69.96 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.518 0.562 . . . . 0.34999999999999998 112.518 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -62.39 -54.01 46.54 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.547 -0.538 . . . . 0.34999999999999998 109.547 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 mm -51.14 -55.38 7.76 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 124.526 1.13 . . . . 0.34999999999999998 109.786 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -45.98 -63.75 0.91 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.675 1.19 . . . . 0.34999999999999998 112.406 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -63.62 -38.46 91.19 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.465 0.575 . . . . 0.34999999999999998 111.894 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.1 -49.15 62.97 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.491 0.716 . . . . 0.34999999999999998 110.644 -173.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.61 -37.22 79.46 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 118.454 0.57 . . . . 0.34999999999999998 111.551 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -58.83 -44.37 90.88 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.357 0.663 . . . . 0.34999999999999998 110.589 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -67.57 -34.8 77.79 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.568 0.347 . . . . 0.34999999999999998 110.85 176.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.04 -64.78 0.83 Allowed 'General case' 0 C--N 1.343 0.287 0 CA-C-O 118.605 -0.712 . . . . 0.34999999999999998 111.502 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -66.43 -35.32 79.99 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.647 0.658 . . . . 0.34999999999999998 112.368 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -90.14 49.39 1.69 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.489 0.715 . . . . 0.34999999999999998 110.578 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.0 -51.99 2.88 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.328 1.451 . . . . 0.34999999999999998 107.362 164.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.5 p -79.56 -45.76 18.6 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.566 1.146 . . . . 0.34999999999999998 110.291 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.18 -93.22 0.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.633 0.773 . . . . 0.34999999999999998 110.695 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 62.28 -151.14 0.36 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.978 1.311 . . . . 0.34999999999999998 110.674 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? 66.38 -80.45 0.03 OUTLIER 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.678 1.991 . . . . 0.34999999999999998 111.549 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -84.28 -115.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.05 -1.093 . . . . 0.34999999999999998 108.05 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 59.3 82.39 0.15 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.248 1.419 . . . . 0.34999999999999998 111.455 171.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.5 ttm105 -66.14 -55.23 17.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.698 0.799 . . . . 0.34999999999999998 109.98 172.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 t 60.89 78.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 125.189 1.396 . . . . 0.34999999999999998 109.11 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.38 -43.71 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.083 0.953 . . . . 0.34999999999999998 112.232 -171.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -138.44 170.53 15.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.247 1.019 . . . . 0.34999999999999998 110.552 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 pp -153.5 159.84 42.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.359 1.464 . . . . 0.34999999999999998 109.159 171.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.05 120.57 82.19 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 109.222 -0.658 . . . . 0.33000000000000002 109.222 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -70.72 -33.0 13.62 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.186 2.591 . . . . 0.34999999999999998 110.97 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -82.7 70.49 9.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.52 1.128 . . . . 0.34999999999999998 109.384 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.0 160.66 30.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.642 0.777 . . . . 0.34999999999999998 109.951 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.7 145.47 34.93 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.899 0.48 . . . . 0.34999999999999998 111.818 -171.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mp -122.84 99.4 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 126.728 2.011 . . . . 0.34999999999999998 106.294 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -88.93 72.53 8.46 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.175 0.99 . . . . 0.34999999999999998 109.34 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.83 115.14 5.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.401 0.68 . . . . 0.34999999999999998 110.3 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.1 m -103.01 91.6 4.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.862 1.265 . . . . 0.34999999999999998 108.303 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -81.19 94.35 6.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.306 0.642 . . . . 0.34999999999999998 109.89 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -105.68 129.7 53.85 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.056 1.342 . . . . 0.34999999999999998 110.505 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -161.37 94.4 0.98 Allowed 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 106.429 -1.693 . . . . 0.34999999999999998 106.429 172.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -56.12 -28.23 57.06 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.409 0.892 . . . . 0.34999999999999998 113.409 -169.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -56.34 -41.79 76.64 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.93 1.292 . . . . 0.35999999999999999 112.133 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -144.18 -56.12 0.36 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 112.852 0.686 . . . . 0.34999999999999998 112.852 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.61 -61.2 1.92 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.65 0.659 . . . . 0.34999999999999998 111.069 -171.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 80.41 149.26 0.1 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.503 1.921 . . . . 0.34999999999999998 110.905 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -49.38 126.43 13.12 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.983 1.713 . . . . 0.34999999999999998 112.153 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -155.24 101.42 2.22 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.148 0.979 . . . . 0.34999999999999998 109.04 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.7 m -77.23 97.86 4.95 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.939 1.296 . . . . 0.34999999999999998 109.708 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -91.66 108.38 19.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.569 1.148 . . . . 0.34999999999999998 108.39 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.0 p -82.68 77.95 9.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.51 1.124 . . . . 0.34999999999999998 111.44 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -72.33 131.9 84.53 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 108.567 -0.901 . . . . 0.33000000000000002 108.567 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.89 -125.03 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.653 2.902 . . . . 0.34999999999999998 109.03 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.51 154.12 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 119.268 0.94 . . . . 0.34999999999999998 110.013 173.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.7 p -108.01 123.21 48.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.366 1.067 . . . . 0.34999999999999998 108.558 169.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -61.23 -36.56 80.27 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.531 1.132 . . . . 0.34999999999999998 110.658 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -56.01 -56.55 19.45 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.426 1.091 . . . . 0.34999999999999998 111.238 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.51 139.42 2.71 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 112.26 -0.336 . . . . 0.34999999999999998 112.26 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -155.39 165.9 35.19 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.571 1.548 . . . . 0.34999999999999998 108.783 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -137.19 146.1 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.264 1.426 . . . . 0.34999999999999998 108.71 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.33 116.95 29.24 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.348 -0.982 . . . . 0.33000000000000002 108.348 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.83 175.52 10.43 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.094 2.53 . . . . 0.34999999999999998 111.504 -171.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.8 -166.01 0.26 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.616 1.166 . . . . 0.34999999999999998 110.356 171.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.26 28.65 1.67 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.581 0.752 . . . . 0.34999999999999998 112.536 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.6 t 53.1 -113.4 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.984 1.314 . . . . 0.34999999999999998 111.796 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -158.09 -33.44 0.07 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.428 1.091 . . . . 0.34999999999999998 111.595 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -60.45 -39.24 86.84 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.057 0.943 . . . . 0.34999999999999998 111.227 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.6 tp -102.13 137.09 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.247 1.419 . . . . 0.34999999999999998 108.13 171.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -137.28 13.47 3.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.494 1.117 . . . . 0.34999999999999998 111.211 175.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -159.66 63.86 2.27 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.056 0.942 . . . . 0.35999999999999999 109.995 -173.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.89 -176.22 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.65 2.9 . . . . 0.34999999999999998 111.914 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.76 78.18 0.25 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 109.608 -1.397 . . . . 0.34999999999999998 109.608 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -66.43 118.09 9.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.981 0.912 . . . . 0.34999999999999998 109.441 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -121.06 90.99 3.43 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.812 1.245 . . . . 0.35999999999999999 108.803 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.73 69.84 10.35 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.743 0.817 . . . . 0.34999999999999998 109.178 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.3 mt -97.25 89.84 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.553 1.141 . . . . 0.34999999999999998 108.678 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 57.7 m -92.07 169.13 10.88 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.306 1.442 . . . . 0.34999999999999998 108.621 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -116.92 132.86 56.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.592 1.157 . . . . 0.34999999999999998 108.934 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.9 m -124.66 138.58 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.509 1.124 . . . . 0.34999999999999998 109.956 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -92.45 96.3 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.283 -1.006 . . . . 0.34999999999999998 108.283 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.7 mt -80.86 110.21 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 123.311 0.644 . . . . 0.34999999999999998 110.03 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -98.09 155.88 16.92 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.703 -1.221 . . . . 0.34999999999999998 107.703 153.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -107.97 132.67 53.26 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.314 1.046 . . . . 0.34999999999999998 109.134 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 N--CA 1.453 -0.311 0 C-N-CA 124.541 1.136 . . . . 0.25 110.291 -174.03 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 p90 . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 112.548 0.573 . . . . 0.34999999999999998 112.548 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -40.09 88.72 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.13 2.172 . . . . 0.34999999999999998 114.438 -163.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt 156.72 143.5 0.0 OUTLIER 'General case' 0 C--N 1.344 0.328 0 C-N-CA 130.097 3.359 . . . . 0.34999999999999998 108.539 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.48 87.27 1.5 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.06 -1.216 . . . . 0.34999999999999998 110.06 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 59.59 -96.59 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.751 1.621 . . . . 0.34999999999999998 110.423 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.8 t80 52.75 76.44 0.19 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.086 1.354 . . . . 0.34999999999999998 109.897 -172.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -81.64 65.09 6.63 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.753 1.221 . . . . 0.34999999999999998 110.67 -171.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? 71.66 -71.5 0.13 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.68 2.392 . . . . 0.34999999999999998 112.798 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.86 -19.86 0.29 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.725 1.155 . . . . 0.34999999999999998 111.515 -167.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.68 138.61 17.86 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.667 1.587 . . . . 0.34999999999999998 111.357 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -87.44 81.4 7.83 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.189 0.996 . . . . 0.34999999999999998 109.806 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.83 158.43 18.74 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.506 1.123 . . . . 0.34999999999999998 109.545 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -159.96 170.61 20.99 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.092 0.557 . . . . 0.34999999999999998 111.184 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -122.36 43.43 2.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.11 1.364 . . . . 0.34999999999999998 107.451 164.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -173.52 107.14 0.14 Allowed 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.051 1.34 . . . . 0.34999999999999998 108.529 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 71.02 153.86 0.15 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 126.544 1.938 . . . . 0.33000000000000002 111.655 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.62 85.59 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.987 2.458 . . . . 0.34999999999999998 110.121 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.8 p -77.32 -56.79 4.25 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.021 0.929 . . . . 0.34999999999999998 110.401 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.43 158.34 23.67 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 111.736 -0.546 . . . . 0.33000000000000002 111.736 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -80.56 172.12 13.83 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.243 3.295 . . . . 0.34999999999999998 111.815 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -163.62 175.48 10.59 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.597 1.159 . . . . 0.34999999999999998 110.111 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 tt -144.55 92.41 2.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.071 -1.455 . . . . 0.34999999999999998 107.071 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -78.7 129.26 34.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.08 1.352 . . . . 0.34999999999999998 109.595 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.68 91.19 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.295 0 C-N-CA 124.813 1.245 . . . . 0.34999999999999998 108.658 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -152.53 161.98 41.84 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.255 1.022 . . . . 0.35999999999999999 109.9 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.5 m -121.4 155.3 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.784 1.234 . . . . 0.34999999999999998 111.329 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.8 m -87.96 77.83 8.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.156 -1.424 . . . . 0.34999999999999998 107.156 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.1 126.84 26.63 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 109.039 -1.625 . . . . 0.34999999999999998 109.039 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.46 168.75 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 124.534 1.134 . . . . 0.34999999999999998 110.172 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.08 -177.55 2.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.767 0.827 . . . . 0.34999999999999998 109.326 164.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 t -83.09 42.71 0.82 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.939 0.496 . . . . 0.34999999999999998 110.415 172.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.2 -59.07 0.49 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.833 2.053 . . . . 0.34999999999999998 107.86 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.33 -9.43 0.81 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.21 0.91 . . . . 0.34999999999999998 113.058 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -71.01 124.23 23.89 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.526 1.163 . . . . 0.35999999999999999 110.143 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.38 125.19 25.67 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.559 0.743 . . . . 0.34999999999999998 111.766 -171.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.7 mt -92.81 -45.53 7.96 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.859 1.664 . . . . 0.34999999999999998 109.487 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.87 151.5 44.35 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.822 0.849 . . . . 0.34999999999999998 111.753 175.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.5 t -89.48 149.56 42.77 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 126.078 1.751 . . . . 0.33000000000000002 111.077 -169.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.17 47.16 1.98 Allowed 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.414 2.743 . . . . 0.34999999999999998 111.848 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -174.52 116.78 0.2 Allowed 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.155 0.982 . . . . 0.34999999999999998 110.09 173.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -170.93 -11.24 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.19 1.396 . . . . 0.34999999999999998 113.127 173.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.03 143.47 26.61 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 C-N-CA 124.671 1.188 . . . . 0.34999999999999998 109.278 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -152.79 142.59 22.04 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.327 1.051 . . . . 0.34999999999999998 109.946 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.65 145.82 32.42 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 124.236 1.015 . . . . 0.33000000000000002 110.156 -168.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.9 118.67 5.69 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.739 2.293 . . . . 0.34999999999999998 108.385 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 tt -60.93 140.86 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.413 0.685 . . . . 0.34999999999999998 112.654 -164.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -127.58 103.61 22.04 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 106.356 -1.72 . . . . 0.33000000000000002 106.356 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.22 159.54 29.82 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.993 2.462 . . . . 0.34999999999999998 111.002 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.99 66.37 1.58 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.291 -1.524 . . . . 0.34999999999999998 109.291 -175.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.8 t -152.28 145.87 24.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.492 1.117 . . . . 0.34999999999999998 109.705 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 87.9 m -70.2 115.46 9.42 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.346 1.058 . . . . 0.34999999999999998 110.499 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -119.52 102.77 8.88 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.885 1.674 . . . . 0.34999999999999998 108.217 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t -148.72 167.79 24.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.153 0.981 . . . . 0.34999999999999998 109.092 173.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -56.13 -49.27 74.39 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.072 0.949 . . . . 0.34999999999999998 111.102 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -73.04 -9.78 59.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.139 0.792 . . . . 0.34999999999999998 113.139 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.15 37.46 3.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.259 1.424 . . . . 0.34999999999999998 109.667 172.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mm -141.44 -40.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.243 0 C-N-CA 125.698 1.599 . . . . 0.34999999999999998 109.472 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -52.19 -37.51 55.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.644 1.178 . . . . 0.34999999999999998 113.128 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.06 -32.89 26.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.588 1.155 . . . . 0.34999999999999998 111.835 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -71.09 -41.12 71.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.594 1.158 . . . . 0.34999999999999998 111.84 -170.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.03 -35.59 75.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 C-N-CA 123.481 0.713 . . . . 0.34999999999999998 111.482 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.89 -35.38 79.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.098 0.559 . . . . 0.34999999999999998 110.944 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.77 -34.24 69.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.245 0.618 . . . . 0.34999999999999998 111.496 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.97 -46.77 70.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.661 0.385 . . . . 0.34999999999999998 111.153 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -73.04 -26.02 61.14 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 118.845 -0.598 . . . . 0.34999999999999998 112.462 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.4 -41.33 76.11 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 123.84 0.856 . . . . 0.34999999999999998 110.939 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -48.65 -51.17 29.62 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.042 1.337 . . . . 0.34999999999999998 112.346 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.6 p -72.48 -49.64 31.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.205 0.602 . . . . 0.34999999999999998 111.257 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.02 146.47 17.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.594 0.758 . . . . 0.34999999999999998 110.197 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -149.11 45.66 0.99 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.751 0.82 . . . . 0.34999999999999998 111.201 -171.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -132.64 -59.57 0.9 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.755 0.822 . . . . 0.34999999999999998 110.684 -173.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -93.39 70.77 4.35 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.715 0.806 . . . . 0.34999999999999998 110.948 -164.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.98 161.05 40.54 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.016 0.926 . . . . 0.34999999999999998 112.999 -175.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.93 77.98 0.45 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.803 -1.925 . . . . 0.34999999999999998 105.803 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.27 100.47 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.059 0.944 . . . . 0.34999999999999998 109.803 -167.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.33 -61.72 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.88 1.272 . . . . 0.34999999999999998 110.583 -175.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -156.25 117.29 3.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.186 0.594 . . . . 0.34999999999999998 110.192 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -78.21 144.98 35.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.906 0.882 . . . . 0.34999999999999998 109.782 168.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.52 131.61 67.8 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.181 -0.674 . . . . 0.33000000000000002 109.181 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.73 -24.02 22.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.474 2.783 . . . . 0.34999999999999998 111.566 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.9 m -85.21 60.05 6.01 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 124.396 1.078 . . . . 0.34999999999999998 110.442 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.56 162.44 29.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.189 0.996 . . . . 0.34999999999999998 109.459 169.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -153.74 147.68 25.51 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.46 0.541 . . . . 0.34999999999999998 112.46 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 mp -90.44 135.47 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.388 -1.708 . . . . 0.34999999999999998 106.388 165.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.2 66.67 1.53 Allowed 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.303 -0.999 . . . . 0.34999999999999998 108.303 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.77 125.22 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.061 0.944 . . . . 0.34999999999999998 110.751 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 m -123.89 109.72 13.94 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.346 1.058 . . . . 0.34999999999999998 109.429 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.52 110.58 22.91 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 125.128 1.371 . . . . 0.34999999999999998 108.878 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.44 52.97 2.58 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.612 1.565 . . . . 0.34999999999999998 110.14 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.65 84.44 5.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.072 0.949 . . . . 0.34999999999999998 110.186 -172.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -61.19 -11.94 11.05 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.667 1.187 . . . . 0.34999999999999998 113.376 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -55.62 -50.78 69.25 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.153 0.981 . . . . 0.35999999999999999 111.145 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.52 -42.14 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.98 0.733 . . . . 0.34999999999999998 112.98 176.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -65.84 -40.76 92.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.319 0.509 . . . . 0.34999999999999998 112.101 -172.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? 77.7 160.32 0.21 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.482 1.913 . . . . 0.34999999999999998 111.181 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -50.7 121.33 5.7 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.821 1.248 . . . . 0.34999999999999998 110.109 171.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -154.19 107.08 2.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.092 0.957 . . . . 0.34999999999999998 108.446 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.2 m -78.98 89.82 4.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.969 0.908 . . . . 0.34999999999999998 108.555 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -77.35 97.27 4.85 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.107 0.963 . . . . 0.34999999999999998 108.6 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.2 p -88.72 139.91 29.98 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.308 1.043 . . . . 0.34999999999999998 110.358 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.96 140.28 8.7 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 123.891 0.877 . . . . 0.33000000000000002 109.63 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.46 140.71 33.69 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.221 2.614 . . . . 0.34999999999999998 109.788 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tt -72.42 148.92 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.05 0.54 . . . . 0.34999999999999998 110.099 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.7 p -73.1 160.26 32.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.307 0.643 . . . . 0.34999999999999998 110.739 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -88.3 -21.68 24.29 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.377 1.071 . . . . 0.34999999999999998 111.026 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -86.85 -79.61 0.26 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.278 1.031 . . . . 0.34999999999999998 110.932 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -177.42 74.4 0.07 OUTLIER Glycine 0 CA--C 1.528 0.844 0 CA-C-N 118.215 0.461 . . . . 0.34999999999999998 112.448 -170.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -77.47 154.51 32.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.866 -0.79 . . . . 0.34999999999999998 108.866 165.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.0 t -131.88 140.73 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.367 1.067 . . . . 0.34999999999999998 108.719 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.9 t -67.94 122.02 82.12 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 108.502 -0.925 . . . . 0.33000000000000002 108.502 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.27 158.16 41.28 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.069 2.513 . . . . 0.34999999999999998 111.052 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.74 80.35 2.69 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.627 1.171 . . . . 0.34999999999999998 109.296 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.405 HD11 HG13 ' A' ' 120' ' ' ILE . 2.1 tm? -84.96 99.93 11.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.998 1.319 . . . . 0.34999999999999998 109.071 -169.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.9 t -167.57 79.14 0.18 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.253 1.021 . . . . 0.34999999999999998 108.998 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.39 -99.23 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.651 0.78 . . . . 0.34999999999999998 110.035 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -70.23 -16.65 63.08 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.512 1.051 . . . . 0.34999999999999998 112.304 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.405 HG13 HD11 ' A' ' 116' ' ' LEU . 9.6 pt -142.21 160.45 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 125.701 1.6 . . . . 0.34999999999999998 109.22 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 29.56 0.37 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.89 0.7 . . . . 0.34999999999999998 112.89 -175.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.35 46.51 0.69 Allowed Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.403 0.519 . . . . 0.35999999999999999 112.403 172.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.39 135.13 41.47 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.094 2.53 . . . . 0.34999999999999998 111.339 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -116.05 74.14 0.26 Allowed Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.959 -1.256 . . . . 0.34999999999999998 109.959 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -60.74 95.99 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.625 1.57 . . . . 0.34999999999999998 111.109 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -91.24 99.16 12.2 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.784 0.834 . . . . 0.35999999999999999 109.694 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.2 80.35 9.09 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 108.366 -0.976 . . . . 0.34999999999999998 108.366 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 94.5 mt -94.82 121.11 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.442 -1.318 . . . . 0.34999999999999998 107.442 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.8 m -141.17 136.77 32.15 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.431 1.092 . . . . 0.34999999999999998 109.005 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.21 131.78 34.09 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.387 1.075 . . . . 0.34999999999999998 108.593 -178.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.05 141.06 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.48 0.712 . . . . 0.34999999999999998 110.422 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 51.0 t -93.81 140.52 16.36 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 124.477 1.111 . . . . 0.34999999999999998 108.843 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.5 mt -139.64 154.5 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.825 1.65 . . . . 0.34999999999999998 107.742 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -143.07 23.78 1.85 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.67 0.989 . . . . 0.34999999999999998 113.67 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.61 134.58 0.05 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.936 1.294 . . . . 0.34999999999999998 111.474 169.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? . . . . . 0 C--N 1.342 0.251 0 C-N-CA 124.703 1.201 . . . . 0.25 110.637 177.878 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 110.061 -0.348 . . . . 0.34999999999999998 110.061 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -83.9 68.38 9.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.415 1.086 . . . . 0.34999999999999998 108.894 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -134.73 -24.48 1.51 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.879 1.672 . . . . 0.34999999999999998 110.736 -172.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.05 26.78 30.34 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.537 1.065 . . . . 0.34999999999999998 112.166 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 49.92 51.37 16.71 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.699 1.6 . . . . 0.34999999999999998 111.566 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -103.85 94.33 5.37 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.966 0.906 . . . . 0.34999999999999998 110.603 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.32 36.94 0.71 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.526 1.13 . . . . 0.34999999999999998 111.075 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? 54.04 -95.3 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.206 1.802 . . . . 0.34999999999999998 110.903 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.14 56.42 0.26 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.549 -1.82 . . . . 0.34999999999999998 108.549 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -130.17 67.11 1.48 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.981 1.312 . . . . 0.34999999999999998 108.888 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -167.71 113.95 0.72 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.174 0.989 . . . . 0.34999999999999998 109.645 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.75 -65.96 0.97 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.029 0.932 . . . . 0.34999999999999998 110.339 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.3 t 69.63 -73.4 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.923 2.089 . . . . 0.34999999999999998 111.654 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -140.03 75.67 1.52 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.766 -1.198 . . . . 0.34999999999999998 107.766 162.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -145.73 33.03 1.04 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.041 0.937 . . . . 0.34999999999999998 110.054 173.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 66.62 168.71 0.11 Allowed Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.534 1.934 . . . . 0.33000000000000002 112.101 171.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -69.12 99.95 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.121 2.548 . . . . 0.34999999999999998 111.361 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.3 p -110.34 -40.93 4.51 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.589 1.556 . . . . 0.34999999999999998 109.602 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.87 155.03 9.73 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.538 -1.025 . . . . 0.33000000000000002 110.538 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.13 161.16 29.57 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.072 3.181 . . . . 0.34999999999999998 111.024 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -156.58 164.62 37.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.611 0.764 . . . . 0.34999999999999998 111.135 -170.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.5 tt -149.13 132.03 16.13 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.146 1.378 . . . . 0.34999999999999998 108.012 -177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.2 mtp -125.31 133.11 52.74 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.889 1.275 . . . . 0.34999999999999998 109.453 -171.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.54 95.29 2.89 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 C-N-CA 124.075 0.95 . . . . 0.34999999999999998 110.409 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -149.31 178.35 8.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.568 0.747 . . . . 0.35999999999999999 111.278 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.08 146.35 26.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 124.802 1.241 . . . . 0.34999999999999998 110.948 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.1 m -84.06 86.31 7.22 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.918 -1.141 . . . . 0.34999999999999998 107.918 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.64 119.7 6.63 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.527 -1.029 . . . . 0.34999999999999998 110.527 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.81 170.43 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.496 1.118 . . . . 0.34999999999999998 110.962 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -84.45 177.62 8.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.357 1.063 . . . . 0.34999999999999998 109.639 166.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -58.67 -38.29 77.87 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.805 0.842 . . . . 0.34999999999999998 110.649 171.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -57.38 -49.06 77.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.666 1.186 . . . . 0.34999999999999998 110.719 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.96 5.98 7.91 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.142 1.353 . . . . 0.34999999999999998 111.869 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.11 123.2 24.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.081 0.941 . . . . 0.35999999999999999 109.19 -176.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.96 107.15 3.0 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.383 0.673 . . . . 0.34999999999999998 111.414 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.93 -42.26 70.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.536 1.134 . . . . 0.34999999999999998 109.781 170.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -152.06 150.06 29.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.998 0.919 . . . . 0.34999999999999998 111.184 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.7 m -84.52 159.54 58.33 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 124.955 1.302 . . . . 0.33000000000000002 110.463 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -84.75 53.99 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.52 2.813 . . . . 0.34999999999999998 111.079 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -158.75 111.56 2.29 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.587 0.755 . . . . 0.34999999999999998 110.991 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -160.81 -54.88 0.05 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.206 0.603 . . . . 0.34999999999999998 111.461 152.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.47 147.17 5.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.48 0.582 . . . . 0.34999999999999998 110.822 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.26 174.61 7.59 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.323 1.849 . . . . 0.34999999999999998 110.156 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -161.98 131.81 3.35 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.756 0.822 . . . . 0.33000000000000002 109.286 -176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -73.63 124.03 9.0 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.658 2.239 . . . . 0.34999999999999998 108.722 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.5 tp -48.19 132.52 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.115 1.366 . . . . 0.34999999999999998 112.391 -174.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -140.66 104.05 6.39 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 124.927 1.291 . . . . 0.33000000000000002 108.009 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -81.11 -171.37 1.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.573 2.849 . . . . 0.34999999999999998 110.467 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.26 -37.49 3.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.342 -0.703 . . . . 0.34999999999999998 111.342 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.3 t -62.68 146.77 51.41 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.099 0.959 . . . . 0.34999999999999998 111.007 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.8 m -73.6 149.83 41.82 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.628 0.771 . . . . 0.34999999999999998 109.271 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.6 108.67 12.85 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.808 1.243 . . . . 0.34999999999999998 107.794 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.0 t -154.94 162.06 41.21 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.72 1.208 . . . . 0.34999999999999998 109.677 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -48.51 -54.7 13.33 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.694 1.198 . . . . 0.34999999999999998 111.276 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -61.7 -32.27 72.46 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.837 0.681 . . . . 0.34999999999999998 112.837 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -62.9 -56.85 13.62 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.438 0.563 . . . . 0.34999999999999998 109.906 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.1 mm -53.95 -43.96 59.8 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.761 1.224 . . . . 0.34999999999999998 111.761 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -51.24 -63.11 1.24 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.642 0.777 . . . . 0.34999999999999998 111.674 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -67.66 -33.65 75.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.195 0.452 . . . . 0.34999999999999998 112.053 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -62.55 -50.0 73.08 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.713 0.805 . . . . 0.34999999999999998 111.637 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.54 -37.29 78.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 118.931 -0.557 . . . . 0.34999999999999998 111.417 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.31 -45.94 92.34 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.911 0.884 . . . . 0.34999999999999998 111.295 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -41.33 99.38 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.314 0.646 . . . . 0.34999999999999998 110.941 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.95 91.85 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.841 0.857 . . . . 0.34999999999999998 111.597 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.3 -12.3 60.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.103 1.149 . . . . 0.34999999999999998 114.103 -177.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -73.01 3.09 5.78 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.347 0.976 . . . . 0.34999999999999998 113.513 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.79 15.12 6.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.153 0.888 . . . . 0.34999999999999998 111.947 169.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.0 t -161.47 -45.62 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.774 1.23 . . . . 0.34999999999999998 110.552 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.95 79.78 1.36 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.61 1.564 . . . . 0.34999999999999998 109.952 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -132.88 -43.41 0.89 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.737 1.615 . . . . 0.34999999999999998 109.422 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -60.11 -57.32 13.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.468 1.507 . . . . 0.34999999999999998 110.379 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.32 72.93 0.86 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.666 1.186 . . . . 0.34999999999999998 108.633 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -157.62 76.97 0.83 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.019 0.528 . . . . 0.34999999999999998 110.161 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -84.66 -53.15 5.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.929 1.292 . . . . 0.34999999999999998 109.949 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 t 71.03 114.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.093 1.757 . . . . 0.34999999999999998 111.226 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.73 -49.3 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.384 0.674 . . . . 0.34999999999999998 110.556 174.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.68 172.94 12.29 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.693 1.197 . . . . 0.34999999999999998 110.86 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.62 163.23 38.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.358 1.463 . . . . 0.34999999999999998 110.34 172.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.08 122.69 87.96 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.364 0.666 . . . . 0.33000000000000002 109.718 -176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.0 -32.49 11.01 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.956 2.437 . . . . 0.34999999999999998 110.451 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.3 m -80.88 74.75 7.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.434 1.094 . . . . 0.34999999999999998 109.339 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.71 162.78 17.87 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.307 1.043 . . . . 0.34999999999999998 110.53 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 142.54 23.94 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.344 0.657 . . . . 0.34999999999999998 111.118 -173.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -127.3 113.38 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.86 1.664 . . . . 0.34999999999999998 107.623 -174.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -94.62 75.03 3.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.858 0.863 . . . . 0.34999999999999998 109.151 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.94 108.21 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.768 -1.197 . . . . 0.34999999999999998 107.768 168.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.2 m -86.88 67.75 9.9 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.463 1.105 . . . . 0.34999999999999998 108.35 -170.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -60.64 99.79 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.846 1.258 . . . . 0.34999999999999998 111.772 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -130.7 134.79 47.21 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.604 1.961 . . . . 0.34999999999999998 109.86 -166.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -160.32 121.27 3.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.15 0.98 . . . . 0.34999999999999998 109.067 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -89.9 65.71 6.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.966 0.907 . . . . 0.34999999999999998 110.341 -172.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -142.8 -47.47 0.32 Allowed 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.078 1.351 . . . . 0.35999999999999999 109.134 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.16 -31.46 0.54 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.39 1.076 . . . . 0.34999999999999998 112.046 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -80.99 -42.8 20.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.852 0.686 . . . . 0.34999999999999998 112.852 -161.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? 70.01 173.25 0.3 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.543 1.537 . . . . 0.34999999999999998 110.118 -169.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -77.28 93.87 4.07 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.719 -0.474 . . . . 0.34999999999999998 109.719 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -96.64 158.26 15.51 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.616 1.167 . . . . 0.34999999999999998 108.16 170.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.9 m -136.62 110.41 8.14 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.526 0.731 . . . . 0.34999999999999998 109.686 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -95.57 100.58 12.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.582 1.153 . . . . 0.34999999999999998 108.332 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.7 p -86.92 65.29 8.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.198 0.999 . . . . 0.34999999999999998 110.051 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -65.92 136.64 95.72 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.217 1.007 . . . . 0.33000000000000002 109.388 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.23 -113.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.46 2.773 . . . . 0.34999999999999998 109.701 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.4 tp -160.46 153.69 4.45 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 CA-C-N 119.032 0.833 . . . . 0.34999999999999998 109.694 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.6 p -130.74 128.36 40.64 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.366 1.067 . . . . 0.34999999999999998 108.955 173.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -64.94 -25.68 67.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.212 1.005 . . . . 0.34999999999999998 111.47 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.16 -65.18 0.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.26 1.424 . . . . 0.34999999999999998 111.486 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 125.24 143.8 6.14 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 124.139 0.876 . . . . 0.34999999999999998 111.391 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.1 131.69 7.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.366 1.066 . . . . 0.34999999999999998 109.068 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.76 141.61 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.54 0.736 . . . . 0.34999999999999998 109.387 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 83.2 t -61.99 117.35 28.38 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 108.341 -0.985 . . . . 0.33000000000000002 108.341 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.83 -21.59 24.62 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.425 2.75 . . . . 0.34999999999999998 112.32 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.0 t70 68.77 77.21 0.23 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.721 1.608 . . . . 0.34999999999999998 111.008 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 35.64 70.58 0.14 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.203 2.201 . . . . 0.34999999999999998 114.713 166.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.7 t 25.65 -103.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.951 2.5 . . . . 0.34999999999999998 113.716 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.88 -33.72 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.684 1.194 . . . . 0.34999999999999998 111.491 172.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -83.2 43.91 0.91 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.46 1.504 . . . . 0.34999999999999998 111.526 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.6 tt -167.82 155.28 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.958 1.703 . . . . 0.34999999999999998 108.136 -172.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -146.17 -13.41 0.47 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.2 0.815 . . . . 0.34999999999999998 113.2 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.26 78.39 8.65 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 119.661 1.119 . . . . 0.35999999999999999 112.447 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.49 -84.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.548 2.832 . . . . 0.34999999999999998 111.433 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.17 74.7 0.67 Allowed Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.285 -1.126 . . . . 0.34999999999999998 110.285 -168.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -68.91 95.02 0.67 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.937 1.295 . . . . 0.34999999999999998 109.3 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -99.04 95.34 7.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.973 0.509 . . . . 0.35999999999999999 109.829 -173.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.32 98.46 3.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.844 -1.169 . . . . 0.34999999999999998 107.844 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.4 mt -125.54 109.76 22.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 124.983 1.313 . . . . 0.34999999999999998 107.588 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.2 m -133.98 125.48 28.28 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.281 1.032 . . . . 0.34999999999999998 108.807 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -67.31 128.12 35.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.583 0.753 . . . . 0.34999999999999998 110.141 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.28 138.31 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.305 1.042 . . . . 0.34999999999999998 108.6 169.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -90.68 94.69 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.158 -1.423 . . . . 0.34999999999999998 107.158 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 44.9 mt -71.43 131.46 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.259 0.624 . . . . 0.34999999999999998 109.83 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -106.36 133.92 50.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.344 -1.725 . . . . 0.34999999999999998 106.344 163.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -84.38 118.38 24.2 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.175 0.59 . . . . 0.34999999999999998 109.465 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? . . . . . 0 N--CA 1.455 -0.203 0 C-N-CA 123.285 0.634 . . . . 0.25 109.784 178.545 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 p90 . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 113.822 1.045 . . . . 0.34999999999999998 113.822 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -66.67 168.89 8.63 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.332 0.653 . . . . 0.34999999999999998 110.2 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mptt 78.36 -38.25 0.23 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.163 2.185 . . . . 0.34999999999999998 111.71 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.7 53.55 11.81 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 110.959 -0.856 . . . . 0.34999999999999998 110.959 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 56.31 59.24 3.76 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.125 1.37 . . . . 0.34999999999999998 111.442 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -117.18 119.12 34.24 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.952 1.301 . . . . 0.34999999999999998 108.391 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.13 40.67 3.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.002 1.321 . . . . 0.34999999999999998 109.768 -171.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 59.2 -93.05 0.04 OUTLIER 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.175 1.39 . . . . 0.34999999999999998 109.817 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.06 48.03 0.4 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.562 -1.415 . . . . 0.34999999999999998 109.562 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 26.38 55.73 0.05 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 128.84 2.856 . . . . 0.34999999999999998 114.136 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 44.35 71.0 0.28 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.513 1.525 . . . . 0.34999999999999998 111.38 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.34 71.64 0.56 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.985 1.314 . . . . 0.34999999999999998 110.55 -172.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.3 t -66.62 112.26 4.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.845 1.258 . . . . 0.34999999999999998 109.01 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 62.38 -174.23 0.15 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.65 1.18 . . . . 0.34999999999999998 112.087 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 76.8 t80 65.02 88.39 0.11 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.346 1.859 . . . . 0.34999999999999998 111.697 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 67.58 167.33 0.12 Allowed Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.198 1.799 . . . . 0.33000000000000002 113.018 166.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.67 105.65 0.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.227 2.618 . . . . 0.34999999999999998 111.134 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.0 p -141.95 -54.02 0.44 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.996 0.919 . . . . 0.34999999999999998 111.403 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.44 122.22 1.03 Allowed Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.98 -0.9 . . . . 0.33000000000000002 112.261 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.99 170.62 2.02 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.542 3.495 . . . . 0.34999999999999998 114.041 170.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -161.34 165.17 29.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.286 1.034 . . . . 0.34999999999999998 110.844 171.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -160.55 93.0 0.99 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.327 1.451 . . . . 0.34999999999999998 107.235 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.5 mtm -87.54 105.23 17.17 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.477 0.711 . . . . 0.34999999999999998 111.151 -170.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -101.51 96.6 4.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 124.792 1.237 . . . . 0.34999999999999998 110.578 -174.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -163.64 171.59 15.49 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.502 1.121 . . . . 0.35999999999999999 110.809 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.1 m -100.7 -177.52 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.145 1.378 . . . . 0.34999999999999998 111.45 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.2 m -130.8 104.07 6.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.863 1.665 . . . . 0.34999999999999998 106.686 167.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.31 121.52 6.5 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.626 -0.59 . . . . 0.34999999999999998 111.626 -173.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.28 166.26 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.863 0.865 . . . . 0.34999999999999998 110.657 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -72.79 174.64 7.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.958 1.303 . . . . 0.34999999999999998 110.576 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -79.32 31.38 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.236 1.014 . . . . 0.34999999999999998 112.181 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -138.04 -55.96 0.66 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.104 1.762 . . . . 0.34999999999999998 107.669 170.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.89 65.61 0.02 OUTLIER Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.697 -1.361 . . . . 0.34999999999999998 109.697 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -139.09 122.63 17.33 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.445 1.098 . . . . 0.35999999999999999 108.493 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.58 106.03 0.51 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.218 1.007 . . . . 0.34999999999999998 111.49 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.74 -57.23 3.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.166 0.986 . . . . 0.34999999999999998 108.706 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.4 mt -124.51 167.69 14.11 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.785 1.234 . . . . 0.34999999999999998 110.13 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -146.02 73.48 13.41 Favored Pre-proline 0 N--CA 1.455 -0.199 0 N-CA-C 106.817 -1.549 . . . . 0.33000000000000002 106.817 167.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -87.25 58.75 3.5 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.844 3.029 . . . . 0.34999999999999998 110.208 -168.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -107.58 54.58 0.66 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.779 1.232 . . . . 0.34999999999999998 109.443 -172.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -114.45 15.46 17.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.2 1.4 . . . . 0.34999999999999998 113.478 -169.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.51 165.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 CA-C-N 118.849 0.749 . . . . 0.34999999999999998 110.275 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.42 177.54 10.19 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.269 1.027 . . . . 0.34999999999999998 110.843 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -134.57 141.34 38.5 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.574 1.55 . . . . 0.33000000000000002 108.027 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -84.81 26.24 0.66 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.14 2.56 . . . . 0.34999999999999998 113.86 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 69.97 136.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.765 2.026 . . . . 0.34999999999999998 111.717 -176.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.05 128.52 5.01 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.647 -0.872 . . . . 0.33000000000000002 108.647 157.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.15 165.51 21.4 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.209 2.606 . . . . 0.34999999999999998 110.49 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.64 63.57 1.75 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.681 -0.968 . . . . 0.34999999999999998 110.681 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -153.05 138.78 17.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.733 1.213 . . . . 0.34999999999999998 108.738 173.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 m -73.47 87.45 1.58 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.374 1.069 . . . . 0.34999999999999998 109.748 -173.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 106.13 9.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.06 1.344 . . . . 0.34999999999999998 109.012 -174.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -140.09 177.65 7.83 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 125.742 1.617 . . . . 0.34999999999999998 109.411 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -41.2 88.54 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.933 -0.395 . . . . 0.34999999999999998 109.933 170.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.43 -45.83 78.54 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.428 0.691 . . . . 0.34999999999999998 111.936 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -86.26 31.04 0.66 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.779 0.718 . . . . 0.34999999999999998 112.293 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 mm -133.34 -44.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 125.396 1.478 . . . . 0.34999999999999998 108.61 172.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -53.44 -50.98 64.09 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.196 0.998 . . . . 0.34999999999999998 112.052 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -70.81 -34.31 71.6 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.598 0.636 . . . . 0.34999999999999998 111.615 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -64.5 -51.82 61.03 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.999 0.92 . . . . 0.34999999999999998 111.069 -172.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.8 m -63.5 -32.14 55.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 124.098 0.959 . . . . 0.34999999999999998 111.937 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -65.43 -38.19 89.15 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.97 0.508 . . . . 0.34999999999999998 111.059 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -70.82 -31.18 67.83 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.068 0.547 . . . . 0.34999999999999998 111.363 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.58 -49.08 67.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.653 0.781 . . . . 0.34999999999999998 111.047 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.18 -13.3 60.44 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.772 0.829 . . . . 0.34999999999999998 113.145 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -74.62 89.24 2.21 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.442 0.697 . . . . 0.34999999999999998 109.992 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.56 -52.44 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.533 1.533 . . . . 0.34999999999999998 108.846 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 66.1 p -98.19 -52.46 3.67 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.315 1.046 . . . . 0.34999999999999998 110.517 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.59 95.41 5.13 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.178 1.391 . . . . 0.34999999999999998 108.487 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -147.38 4.71 0.8 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.953 0.901 . . . . 0.34999999999999998 112.806 -173.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -148.39 -46.27 0.15 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.981 0.912 . . . . 0.34999999999999998 109.651 -169.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -54.4 -48.53 71.48 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.385 1.474 . . . . 0.34999999999999998 110.611 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.78 176.92 9.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.046 0.938 . . . . 0.34999999999999998 112.094 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -155.78 105.16 2.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.519 -0.919 . . . . 0.34999999999999998 108.519 168.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.62 131.5 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.153 0.981 . . . . 0.34999999999999998 109.74 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.56 -60.65 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.318 -0.993 . . . . 0.34999999999999998 108.318 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -133.34 154.29 50.85 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.136 1.374 . . . . 0.34999999999999998 110.185 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.4 mt -99.68 124.94 45.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.175 -1.417 . . . . 0.34999999999999998 107.175 165.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -73.64 127.66 88.24 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.299 -0.63 . . . . 0.33000000000000002 109.299 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.78 -21.69 18.57 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.44 2.76 . . . . 0.34999999999999998 111.672 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.8 m -85.21 66.44 9.73 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.052 0.941 . . . . 0.34999999999999998 110.604 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.32 165.91 23.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.361 0.665 . . . . 0.34999999999999998 109.446 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -136.81 117.9 14.38 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.06 0.544 . . . . 0.34999999999999998 111.344 -170.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.0 mm -86.95 90.79 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.762 1.625 . . . . 0.34999999999999998 108.017 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.37 72.88 8.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.633 -0.877 . . . . 0.34999999999999998 108.633 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.66 94.57 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 CA-C-O 121.6 0.714 . . . . 0.34999999999999998 110.052 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.5 m -79.74 108.91 13.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.982 -1.118 . . . . 0.34999999999999998 107.982 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -78.41 70.37 4.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.808 -0.812 . . . . 0.34999999999999998 108.808 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -71.06 124.21 23.88 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.107 0.479 . . . . 0.34999999999999998 110.133 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -153.21 163.99 38.89 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.385 1.474 . . . . 0.34999999999999998 107.839 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.65 61.83 1.08 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.36 -0.978 . . . . 0.34999999999999998 108.36 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -149.64 -54.37 0.17 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.686 1.194 . . . . 0.35999999999999999 109.78 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 -42.41 0.12 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.842 0.857 . . . . 0.34999999999999998 112.281 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -73.5 -46.55 47.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.1 0.96 . . . . 0.34999999999999998 110.955 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 81.7 tttt 71.0 163.48 0.26 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.076 1.35 . . . . 0.34999999999999998 110.984 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -47.77 124.1 6.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.561 1.144 . . . . 0.34999999999999998 110.408 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -149.46 86.43 1.47 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.922 -0.77 . . . . 0.34999999999999998 108.922 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.4 m -69.41 94.34 0.72 Allowed 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.008 1.323 . . . . 0.34999999999999998 109.581 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -89.01 95.16 10.21 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.108 -1.071 . . . . 0.34999999999999998 108.108 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p -72.53 133.47 44.79 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.688 0.795 . . . . 0.34999999999999998 110.34 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -151.02 139.05 12.58 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 125.058 1.343 . . . . 0.33000000000000002 107.627 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.76 -139.34 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.766 2.977 . . . . 0.34999999999999998 109.986 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.8 tp -158.75 156.41 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 119.272 0.942 . . . . 0.34999999999999998 109.616 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -130.29 166.63 19.96 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.397 1.079 . . . . 0.34999999999999998 110.335 176.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.6 -51.27 70.53 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.791 1.236 . . . . 0.34999999999999998 111.328 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -80.17 -33.89 37.98 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.856 0.863 . . . . 0.34999999999999998 110.992 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.85 -127.57 45.35 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.238 0.923 . . . . 0.34999999999999998 112.38 170.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -165.46 149.11 8.19 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.019 0.928 . . . . 0.34999999999999998 110.126 -173.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.1 t -78.45 132.3 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.565 -1.272 . . . . 0.34999999999999998 107.565 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.4 t -52.95 113.28 4.39 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.0 0.92 . . . . 0.33000000000000002 109.769 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -84.31 -174.2 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.516 2.811 . . . . 0.34999999999999998 110.833 -171.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -63.81 143.45 57.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.564 0.746 . . . . 0.34999999999999998 109.792 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.45 61.2 2.31 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.724 1.209 . . . . 0.34999999999999998 109.169 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.0 t 55.97 -122.65 1.8 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.936 1.694 . . . . 0.34999999999999998 111.207 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -159.25 -48.51 0.06 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.252 1.021 . . . . 0.34999999999999998 109.687 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -75.01 7.89 2.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.981 1.312 . . . . 0.34999999999999998 113.596 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.6 tt -142.35 141.3 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.305 1.442 . . . . 0.34999999999999998 108.821 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.37 29.11 2.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.287 1.035 . . . . 0.34999999999999998 111.427 174.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.402 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 16.0 p-10 -151.89 60.6 3.72 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.997 0.919 . . . . 0.35999999999999999 112.38 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 122' ' ' ASN . 24.1 Cg_exo -71.76 -166.87 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.56 2.173 . . . . 0.34999999999999998 112.655 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.81 78.38 0.21 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 108.718 -1.753 . . . . 0.34999999999999998 108.718 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -72.7 76.6 1.11 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.546 1.538 . . . . 0.34999999999999998 109.658 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -86.17 102.49 13.95 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.004 0.522 . . . . 0.35999999999999999 110.14 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.48 81.62 7.53 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.909 1.284 . . . . 0.34999999999999998 108.494 174.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.8 mt -94.91 76.19 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 107.203 -1.406 . . . . 0.34999999999999998 107.203 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.6 m -75.37 172.64 12.12 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.984 1.313 . . . . 0.34999999999999998 109.542 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.28 138.78 31.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.769 1.228 . . . . 0.34999999999999998 108.389 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.95 150.72 26.78 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 C-N-CA 123.936 0.894 . . . . 0.34999999999999998 110.987 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.42 132.85 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.842 1.257 . . . . 0.34999999999999998 108.811 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 68.2 mt -134.58 150.5 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.438 1.495 . . . . 0.34999999999999998 109.551 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -120.62 113.3 20.05 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.141 1.376 . . . . 0.34999999999999998 107.731 162.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.19 166.03 17.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.03 0.932 . . . . 0.34999999999999998 111.861 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt . . . . . 0 C--N 1.34 0.164 0 C-N-CA 124.611 1.165 . . . . 0.25 109.288 179.454 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 t80 . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 110.144 -0.317 . . . . 0.34999999999999998 110.144 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -158.97 174.06 15.54 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.357 1.063 . . . . 0.34999999999999998 110.41 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.64 25.24 7.89 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 128.282 2.633 . . . . 0.34999999999999998 116.128 168.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.42 -164.42 37.64 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 118.617 0.644 . . . . 0.34999999999999998 111.569 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -93.6 56.65 2.42 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.55 0.74 . . . . 0.34999999999999998 109.232 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -85.29 89.4 7.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.589 1.156 . . . . 0.34999999999999998 109.497 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -77.27 46.14 0.49 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.349 1.459 . . . . 0.34999999999999998 113.21 -172.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.41 -75.05 0.08 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.923 2.489 . . . . 0.34999999999999998 111.969 175.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.6 -38.44 0.09 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.79 -1.324 . . . . 0.34999999999999998 109.79 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -49.99 117.83 2.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.528 1.531 . . . . 0.34999999999999998 110.0 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -170.32 133.38 1.08 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.166 0.986 . . . . 0.34999999999999998 109.392 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.5 148.64 7.95 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.4 1.08 . . . . 0.34999999999999998 109.958 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.4 t -161.34 115.86 2.03 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.062 0.945 . . . . 0.34999999999999998 109.073 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 61.19 172.66 0.11 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.354 1.862 . . . . 0.34999999999999998 113.426 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 60.07 89.18 0.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.421 1.888 . . . . 0.34999999999999998 112.186 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 71.23 154.38 0.15 Allowed Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 126.211 1.804 . . . . 0.33000000000000002 112.738 165.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.11 97.92 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.388 2.725 . . . . 0.34999999999999998 110.009 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -104.05 -58.76 1.83 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.628 1.171 . . . . 0.34999999999999998 110.987 -173.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.97 110.75 0.43 Allowed Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.896 -0.947 . . . . 0.33000000000000002 111.767 -171.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -80.3 169.42 17.35 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.472 2.781 . . . . 0.34999999999999998 111.294 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -162.41 170.04 19.45 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 113.281 0.845 . . . . 0.34999999999999998 113.281 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.07 94.88 3.01 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.825 2.05 . . . . 0.34999999999999998 107.955 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 31.7 ttp -87.5 104.37 16.41 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.027 0.531 . . . . 0.34999999999999998 110.545 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.72 97.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 125.16 1.384 . . . . 0.34999999999999998 108.832 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.35 170.3 21.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.366 1.066 . . . . 0.35999999999999999 109.158 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.44 139.45 32.3 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 C-N-CA 124.004 0.922 . . . . 0.34999999999999998 110.555 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.1 m -73.2 101.02 3.24 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.188 0.995 . . . . 0.34999999999999998 108.723 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.92 82.44 1.63 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 123.933 0.778 . . . . 0.34999999999999998 111.757 -170.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 m -85.18 157.69 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 C-N-CA 123.512 0.725 . . . . 0.34999999999999998 110.566 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.47 -69.56 0.45 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.464 -0.569 . . . . 0.34999999999999998 109.464 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.4 m -156.07 -56.21 0.09 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.104 1.362 . . . . 0.34999999999999998 109.299 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -91.56 42.05 1.09 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.759 1.223 . . . . 0.34999999999999998 110.819 -175.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.03 35.62 87.87 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.032 0.825 . . . . 0.34999999999999998 112.491 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -102.6 96.36 6.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.448 1.099 . . . . 0.35999999999999999 108.563 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.49 101.54 0.09 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.76 1.224 . . . . 0.34999999999999998 111.169 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.32 -63.47 1.23 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.426 -0.953 . . . . 0.34999999999999998 108.426 171.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -89.97 121.08 31.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.399 -0.963 . . . . 0.34999999999999998 108.399 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.5 m -87.07 108.13 17.49 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.335 1.054 . . . . 0.33000000000000002 108.399 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.96 -172.87 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.695 2.93 . . . . 0.34999999999999998 112.717 -164.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.5 m170 72.13 54.63 0.18 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.077 1.751 . . . . 0.34999999999999998 111.47 172.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -120.64 -2.4 9.91 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.725 1.21 . . . . 0.34999999999999998 112.575 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.12 142.17 40.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 125.042 1.337 . . . . 0.34999999999999998 108.284 170.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -141.14 -84.82 0.2 Allowed 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.312 -0.852 . . . . 0.34999999999999998 110.463 -177.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.1 t80 74.81 140.0 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.561 1.544 . . . . 0.33000000000000002 110.381 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.74 159.36 51.66 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.777 2.318 . . . . 0.34999999999999998 112.668 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 tp -61.33 137.36 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.886 1.274 . . . . 0.34999999999999998 112.007 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -138.57 102.76 7.84 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.414 1.486 . . . . 0.33000000000000002 107.404 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.11 175.55 11.01 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.306 2.671 . . . . 0.34999999999999998 110.709 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.26 -29.47 8.72 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.996 0.808 . . . . 0.34999999999999998 112.248 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 t -67.43 142.0 56.82 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.704 0.752 . . . . 0.34999999999999998 111.311 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.8 m -71.11 144.35 50.3 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.938 0.895 . . . . 0.34999999999999998 108.876 172.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.03 75.27 1.59 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.755 0.822 . . . . 0.34999999999999998 109.302 -166.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.1 p -104.99 173.57 6.25 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 125.57 1.548 . . . . 0.34999999999999998 110.265 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -57.83 -50.99 71.42 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.431 1.092 . . . . 0.34999999999999998 109.579 171.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.75 -28.3 67.51 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.58 0.956 . . . . 0.34999999999999998 113.58 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -68.6 -53.27 23.75 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.056 0.844 . . . . 0.34999999999999998 109.68 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.3 mm -55.3 -40.93 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.931 1.292 . . . . 0.34999999999999998 111.39 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -47.51 -64.45 0.78 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.241 1.416 . . . . 0.34999999999999998 111.908 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -69.56 -32.59 71.46 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.856 0.317 . . . . 0.34999999999999998 111.856 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -65.25 -49.86 68.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.629 0.772 . . . . 0.34999999999999998 111.543 -172.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 m -67.35 -34.31 68.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.011 0.524 . . . . 0.34999999999999998 111.474 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.32 -48.24 80.74 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 122.862 0.465 . . . . 0.34999999999999998 110.397 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -40.86 97.47 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.204 0.456 . . . . 0.34999999999999998 110.967 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.03 -50.3 73.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.167 0.987 . . . . 0.34999999999999998 111.129 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 pp -71.59 -29.43 64.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.076 0.55 . . . . 0.34999999999999998 111.605 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -70.32 -1.13 9.57 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 113.302 0.853 . . . . 0.34999999999999998 113.302 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.16 -43.47 61.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.719 0.691 . . . . 0.34999999999999998 110.28 164.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.5 p -86.37 -47.93 8.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.053 0.941 . . . . 0.34999999999999998 110.935 173.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.85 -105.84 0.03 OUTLIER 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.319 0.509 . . . . 0.34999999999999998 112.135 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 71.4 144.68 0.06 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.907 1.683 . . . . 0.34999999999999998 111.114 -171.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 70.17 -82.59 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.799 2.039 . . . . 0.34999999999999998 110.853 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -72.8 171.7 12.17 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.44 0.696 . . . . 0.34999999999999998 109.123 172.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 70.8 146.66 0.07 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.5 1.52 . . . . 0.34999999999999998 110.108 -162.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -158.18 133.82 8.97 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.911 0.884 . . . . 0.34999999999999998 109.162 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -85.22 128.64 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.037 0.935 . . . . 0.34999999999999998 108.915 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.3 t -69.78 -65.06 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.41 -1.33 . . . . 0.34999999999999998 107.41 167.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.57 139.14 5.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.795 0.838 . . . . 0.34999999999999998 109.135 170.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.16 170.22 16.97 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.63 0.772 . . . . 0.34999999999999998 109.777 170.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -67.81 129.47 93.28 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 108.927 -0.768 . . . . 0.33000000000000002 108.927 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.53 -36.07 35.59 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.503 2.135 . . . . 0.34999999999999998 109.697 172.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -89.78 69.46 7.62 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.798 1.239 . . . . 0.34999999999999998 109.163 170.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.08 172.73 4.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.629 0.772 . . . . 0.34999999999999998 109.99 168.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -152.17 151.46 31.04 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.359 0.503 . . . . 0.34999999999999998 112.359 -167.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.26 101.15 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 126.205 1.802 . . . . 0.34999999999999998 107.375 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -96.27 63.18 2.17 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.42 1.088 . . . . 0.34999999999999998 110.203 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.67 122.22 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 122.763 0.425 . . . . 0.34999999999999998 110.246 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.4 m -118.03 106.31 12.78 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.408 1.483 . . . . 0.34999999999999998 107.413 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -124.32 119.0 28.03 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.698 1.199 . . . . 0.34999999999999998 109.726 -167.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -132.38 55.66 1.87 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.979 1.311 . . . . 0.34999999999999998 112.246 -158.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -74.34 137.47 42.85 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 122.067 -0.396 . . . . 0.34999999999999998 110.996 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -93.92 70.3 3.99 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.821 -1.177 . . . . 0.34999999999999998 107.821 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -143.3 -50.57 0.33 Allowed 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.44 1.096 . . . . 0.35999999999999999 109.533 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.76 -40.65 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.163 0.585 . . . . 0.34999999999999998 112.359 -170.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -53.53 4.61 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.069 0.547 . . . . 0.34999999999999998 112.033 -168.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt 71.02 -177.82 0.21 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.846 1.258 . . . . 0.34999999999999998 110.064 -167.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -69.25 127.66 33.85 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.465 0.706 . . . . 0.34999999999999998 111.756 -170.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -142.65 104.29 4.35 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.619 1.168 . . . . 0.34999999999999998 109.459 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.7 m -80.75 108.8 14.71 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.66 -0.867 . . . . 0.34999999999999998 108.66 173.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -109.91 102.6 11.34 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.627 1.171 . . . . 0.34999999999999998 108.46 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.8 p -90.62 64.64 5.78 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.976 1.311 . . . . 0.34999999999999998 110.779 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -77.08 141.67 67.67 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.033 0.533 . . . . 0.33000000000000002 109.67 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.84 170.96 18.11 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.581 2.854 . . . . 0.34999999999999998 112.136 -171.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.4 tp -77.01 161.44 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.844 1.258 . . . . 0.34999999999999998 109.86 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 73.4 p -132.01 129.0 39.54 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.091 0.957 . . . . 0.34999999999999998 108.966 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.83 -29.29 70.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.489 0.716 . . . . 0.34999999999999998 111.487 172.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.4 -50.02 75.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.172 0.989 . . . . 0.34999999999999998 109.635 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.98 170.95 24.23 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 124.328 0.966 . . . . 0.34999999999999998 112.562 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -158.35 136.03 10.39 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.112 0.965 . . . . 0.34999999999999998 109.204 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.8 t -70.48 130.96 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.465 -1.309 . . . . 0.34999999999999998 107.465 166.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.6 t -57.51 112.51 4.8 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 107.311 -1.366 . . . . 0.33000000000000002 107.311 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.05 -95.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.597 2.198 . . . . 0.34999999999999998 112.193 -158.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -158.38 150.22 21.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.009 0.924 . . . . 0.34999999999999998 109.737 -173.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.85 56.7 0.7 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.528 1.531 . . . . 0.34999999999999998 109.552 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.4 t 34.5 -103.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.754 2.422 . . . . 0.34999999999999998 113.436 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -161.93 -51.7 0.04 OUTLIER 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.649 1.18 . . . . 0.34999999999999998 109.396 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -61.78 -44.39 96.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.062 0.945 . . . . 0.34999999999999998 111.264 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.9 tp -83.74 111.74 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.933 0.893 . . . . 0.34999999999999998 109.494 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -134.94 43.85 2.67 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.446 1.098 . . . . 0.34999999999999998 110.154 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -151.76 47.33 0.41 Allowed Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 114.0 1.111 . . . . 0.35999999999999999 114.0 163.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -55.86 145.44 72.9 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.839 1.693 . . . . 0.34999999999999998 113.31 168.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.47 76.72 0.38 Allowed Glycine 0 C--N 1.338 0.657 0 N-CA-C 108.641 -1.783 . . . . 0.34999999999999998 108.641 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -69.59 96.74 0.96 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.675 1.19 . . . . 0.34999999999999998 110.781 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -87.93 109.93 20.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.131 -1.063 . . . . 0.35999999999999999 108.131 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -94.82 52.69 1.51 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.245 -1.02 . . . . 0.34999999999999998 108.245 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -94.3 130.93 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.838 1.255 . . . . 0.34999999999999998 108.783 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 81.6 m -149.05 140.6 23.41 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.163 1.385 . . . . 0.34999999999999998 108.016 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 135.47 45.01 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.292 0.637 . . . . 0.34999999999999998 109.348 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.4 m -133.37 136.0 55.4 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 123.341 0.656 . . . . 0.34999999999999998 110.454 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.5 t -84.75 130.19 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.921 1.288 . . . . 0.34999999999999998 107.779 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 55.4 mt -123.14 131.79 72.58 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 124.122 0.969 . . . . 0.34999999999999998 110.588 -171.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -87.96 103.4 15.65 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.74 1.616 . . . . 0.34999999999999998 107.273 165.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -70.61 140.88 51.76 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.083 0.553 . . . . 0.34999999999999998 110.584 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt . . . . . 0 N--CA 1.456 -0.161 0 C-N-CA 125.474 1.51 . . . . 0.25 108.385 -175.109 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 107.236 -1.394 . . . . 0.34999999999999998 107.236 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -51.54 -47.44 63.4 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 127.244 2.218 . . . . 0.34999999999999998 112.661 -167.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -66.35 107.66 2.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.668 -1.234 . . . . 0.34999999999999998 107.668 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.55 82.37 1.68 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.304 -1.119 . . . . 0.34999999999999998 110.304 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt 56.61 60.34 3.14 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.108 1.363 . . . . 0.34999999999999998 110.853 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -82.75 -64.16 1.23 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.616 1.167 . . . . 0.34999999999999998 110.089 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.95 25.47 0.31 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.002 2.521 . . . . 0.34999999999999998 114.772 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 57.27 -87.57 0.02 OUTLIER 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.847 1.659 . . . . 0.34999999999999998 111.06 -170.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.53 -55.98 0.13 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 107.83 -2.108 . . . . 0.34999999999999998 107.83 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 t0 57.54 38.13 27.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.669 1.588 . . . . 0.34999999999999998 111.396 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 42.95 63.33 1.51 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.948 1.699 . . . . 0.34999999999999998 111.438 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.82 -175.67 4.9 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.082 0.553 . . . . 0.34999999999999998 112.282 -170.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 m 65.63 79.21 0.25 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.988 1.715 . . . . 0.34999999999999998 110.195 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 54.64 65.56 1.47 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.521 1.528 . . . . 0.34999999999999998 111.03 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -145.8 34.3 1.03 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.182 1.393 . . . . 0.34999999999999998 109.716 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.52 162.99 0.12 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.005 1.722 . . . . 0.33000000000000002 112.805 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -65.68 94.48 0.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.257 2.638 . . . . 0.34999999999999998 110.224 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.3 p -138.98 -46.64 0.48 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.247 1.419 . . . . 0.34999999999999998 110.088 -171.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.04 86.89 0.26 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.883 0.754 . . . . 0.33000000000000002 111.931 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.65 153.75 10.45 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.341 3.361 . . . . 0.34999999999999998 112.718 166.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -146.48 173.64 12.11 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.447 0.699 . . . . 0.34999999999999998 110.992 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 tt -151.11 93.36 1.91 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.774 -1.195 . . . . 0.34999999999999998 107.774 176.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.4 mtp -78.71 141.99 37.45 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.941 1.296 . . . . 0.34999999999999998 109.996 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 37.0 t -136.18 94.99 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 124.861 1.265 . . . . 0.34999999999999998 108.85 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -148.28 174.6 11.85 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.179 0.992 . . . . 0.35999999999999999 110.391 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.01 -170.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 125.323 1.449 . . . . 0.34999999999999998 109.231 174.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.6 m -121.24 103.5 9.03 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.603 -1.628 . . . . 0.34999999999999998 106.603 162.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.78 85.11 1.45 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.986 -0.846 . . . . 0.34999999999999998 110.986 -173.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.6 m -102.23 172.08 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.258 1.023 . . . . 0.34999999999999998 111.321 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -63.99 -52.69 58.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.792 1.237 . . . . 0.34999999999999998 110.709 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 m -178.88 -56.07 0.01 OUTLIER 'General case' 0 C--N 1.339 0.144 0 C-N-CA 128.189 2.596 . . . . 0.34999999999999998 107.197 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.52 -61.37 1.8 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.752 1.221 . . . . 0.34999999999999998 110.748 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.0 -19.82 0.04 OUTLIER Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.168 -0.795 . . . . 0.34999999999999998 113.351 -170.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -64.33 111.07 2.47 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.155 0.978 . . . . 0.35999999999999999 109.693 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -76.64 123.51 26.24 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.385 1.074 . . . . 0.34999999999999998 111.142 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.88 -65.2 1.04 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.61 -0.885 . . . . 0.34999999999999998 108.61 170.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.5 mt -98.65 136.02 39.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.464 1.106 . . . . 0.34999999999999998 109.95 -168.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.9 m -85.04 102.42 2.32 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.657 1.583 . . . . 0.33000000000000002 110.926 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.78 -165.4 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.25 2.633 . . . . 0.34999999999999998 111.677 -169.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 75.0 57.57 0.07 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.651 1.58 . . . . 0.34999999999999998 111.036 166.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -138.16 -5.13 1.66 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.053 1.131 . . . . 0.34999999999999998 114.053 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -130.26 143.78 39.97 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 123.739 0.816 . . . . 0.34999999999999998 109.582 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.23 177.07 11.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.541 0.736 . . . . 0.34999999999999998 112.284 -173.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -137.34 154.13 75.22 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 126.497 1.919 . . . . 0.33000000000000002 107.555 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -84.12 34.79 0.53 Allowed 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.235 2.623 . . . . 0.34999999999999998 112.323 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.257 13.8 tt 54.21 149.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 129.603 3.161 . . . . 0.34999999999999998 115.732 176.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -158.18 123.35 2.31 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.172 0.989 . . . . 0.33000000000000002 109.321 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -80.12 179.18 6.41 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.32 2.68 . . . . 0.34999999999999998 110.949 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.21 -33.72 4.95 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.774 0.702 . . . . 0.34999999999999998 111.527 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 t -63.87 144.83 56.75 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.24 1.016 . . . . 0.34999999999999998 110.948 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.9 m -73.72 145.1 45.43 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.909 -0.774 . . . . 0.34999999999999998 108.909 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.6 104.51 7.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.171 -1.418 . . . . 0.34999999999999998 107.171 177.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -143.53 157.58 44.32 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.402 1.081 . . . . 0.34999999999999998 110.4 -173.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.31 -57.55 10.18 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.493 1.117 . . . . 0.34999999999999998 111.57 -174.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -58.72 -29.11 66.44 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.01 0.744 . . . . 0.34999999999999998 113.01 -175.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -72.1 -48.34 44.69 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.714 0.806 . . . . 0.34999999999999998 110.684 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.8 mm -56.21 -39.09 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.66 1.184 . . . . 0.34999999999999998 111.944 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -47.87 -57.98 4.97 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.425 1.09 . . . . 0.34999999999999998 112.397 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -78.83 -29.7 44.87 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.061 0.544 . . . . 0.34999999999999998 112.347 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -64.01 -45.95 86.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.187 0.595 . . . . 0.34999999999999998 111.636 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.4 m -68.83 -31.81 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 122.916 0.487 . . . . 0.34999999999999998 111.406 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.46 -36.94 85.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.616 0.767 . . . . 0.34999999999999998 111.053 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -74.8 -36.09 62.48 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.801 0.841 . . . . 0.34999999999999998 111.134 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.92 78.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.125 0.57 . . . . 0.34999999999999998 111.026 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.02 -17.72 62.01 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.983 0.735 . . . . 0.34999999999999998 112.983 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -58.0 -33.61 69.11 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.492 0.717 . . . . 0.34999999999999998 112.095 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -41.57 -47.66 3.86 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 125.547 1.539 . . . . 0.34999999999999998 112.573 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 65.1 p -97.21 -51.54 4.16 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.95 1.3 . . . . 0.34999999999999998 110.797 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.21 82.17 2.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.221 1.408 . . . . 0.34999999999999998 110.288 -171.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -109.96 -36.53 5.85 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.34 1.456 . . . . 0.34999999999999998 110.965 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -87.9 -73.11 0.5 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.611 0.765 . . . . 0.34999999999999998 110.643 -173.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -96.09 62.08 2.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.24 0.616 . . . . 0.34999999999999998 111.085 -165.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.42 153.02 32.72 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.817 0.447 . . . . 0.34999999999999998 110.568 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -158.27 105.97 1.94 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.34999999999999998 108.675 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -75.05 97.98 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.541 -0.911 . . . . 0.34999999999999998 108.541 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.41 -42.64 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.302 0.641 . . . . 0.34999999999999998 110.712 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -140.94 161.22 38.34 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.738 1.215 . . . . 0.34999999999999998 109.634 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.58 163.38 32.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.773 1.229 . . . . 0.34999999999999998 109.942 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -90.32 126.79 55.49 Favored Pre-proline 0 N--CA 1.455 -0.199 0 N-CA-C 108.078 -1.082 . . . . 0.33000000000000002 108.078 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.68 -20.39 30.53 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.682 2.255 . . . . 0.34999999999999998 110.915 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.7 m -84.64 70.71 10.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.707 1.203 . . . . 0.34999999999999998 110.476 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.64 162.18 18.91 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.556 0.742 . . . . 0.34999999999999998 109.746 165.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -151.86 107.58 3.35 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.979 0.419 . . . . 0.34999999999999998 111.935 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.26 130.23 30.27 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 125.34 1.456 . . . . 0.34999999999999998 107.481 168.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -131.13 80.96 1.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.119 -1.067 . . . . 0.34999999999999998 108.119 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.56 98.25 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.833 0.853 . . . . 0.34999999999999998 110.205 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 62.1 m -93.52 97.67 10.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.074 1.35 . . . . 0.34999999999999998 107.931 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -103.63 93.46 4.94 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.989 0.916 . . . . 0.34999999999999998 111.24 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -73.07 52.48 0.33 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.648 2.379 . . . . 0.34999999999999998 111.336 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -82.06 102.1 10.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.289 1.035 . . . . 0.34999999999999998 110.605 -171.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -87.78 71.7 9.53 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.164 0.986 . . . . 0.34999999999999998 108.617 174.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -148.88 -58.51 0.22 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.056 1.343 . . . . 0.35999999999999999 109.478 172.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.13 -38.39 0.16 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.242 0.83 . . . . 0.34999999999999998 113.242 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -84.08 -45.7 12.75 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.893 0.477 . . . . 0.34999999999999998 112.128 -164.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt 73.54 162.43 0.26 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.713 1.605 . . . . 0.34999999999999998 112.264 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.76 109.93 1.58 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.548 1.139 . . . . 0.34999999999999998 111.823 -175.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.5 102.71 5.02 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.003 -1.48 . . . . 0.34999999999999998 107.003 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.2 m -79.43 93.16 5.32 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.644 0.777 . . . . 0.34999999999999998 109.181 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -83.31 106.36 15.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.766 -0.827 . . . . 0.34999999999999998 108.766 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.4 p -84.5 69.64 10.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.829 1.252 . . . . 0.34999999999999998 111.192 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -64.99 137.19 97.07 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 108.595 -0.891 . . . . 0.33000000000000002 108.595 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.09 -115.76 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.409 2.739 . . . . 0.34999999999999998 110.579 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 tp -168.42 158.24 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.609 1.164 . . . . 0.34999999999999998 108.828 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.4 p -136.41 137.69 40.74 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.835 0.854 . . . . 0.34999999999999998 109.744 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -71.88 -22.6 61.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.987 0.915 . . . . 0.34999999999999998 111.039 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -58.76 -50.18 74.91 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.792 0.837 . . . . 0.34999999999999998 109.558 168.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.62 169.95 26.61 Favored Glycine 0 C--N 1.341 0.835 0 C-N-CA 124.056 0.836 . . . . 0.34999999999999998 112.769 171.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -163.37 137.35 5.92 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.995 1.318 . . . . 0.34999999999999998 109.124 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.5 138.29 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.75 0.82 . . . . 0.34999999999999998 109.512 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.32 118.01 55.23 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 107.712 -1.218 . . . . 0.33000000000000002 107.712 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.27 -66.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.616 2.211 . . . . 0.34999999999999998 111.486 -170.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 t70 173.09 -66.4 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 126.506 1.922 . . . . 0.34999999999999998 107.544 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 55.35 60.07 3.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.633 1.573 . . . . 0.34999999999999998 110.201 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.0 m -138.17 45.64 2.09 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.589 1.156 . . . . 0.34999999999999998 108.791 174.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -104.89 -62.67 1.31 Allowed 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.046 1.339 . . . . 0.34999999999999998 109.974 -170.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -101.57 -55.65 2.47 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.934 1.293 . . . . 0.34999999999999998 109.298 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.8 pt -93.95 158.03 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.724 0.81 . . . . 0.34999999999999998 108.83 167.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -135.56 60.55 1.68 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.223 1.009 . . . . 0.34999999999999998 108.303 173.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -170.34 58.75 0.3 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.847 1.259 . . . . 0.35999999999999999 111.093 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -57.21 -51.54 8.44 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.738 2.292 . . . . 0.34999999999999998 111.4 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.82 66.0 2.31 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.539 -0.625 . . . . 0.34999999999999998 111.539 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -69.11 100.09 1.21 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.129 1.372 . . . . 0.34999999999999998 111.081 -175.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -88.61 92.96 9.4 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.294 -0.632 . . . . 0.35999999999999999 109.294 172.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.49 109.67 8.16 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 107.802 -1.184 . . . . 0.34999999999999998 107.802 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.7 mt -127.38 133.74 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.913 1.285 . . . . 0.34999999999999998 107.915 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.2 m -146.46 116.09 7.18 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.811 1.244 . . . . 0.34999999999999998 107.775 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -69.09 132.62 46.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.859 -0.423 . . . . 0.34999999999999998 109.859 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.34 153.86 36.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 123.799 0.84 . . . . 0.34999999999999998 110.976 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.5 t -93.82 103.82 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.258 1.423 . . . . 0.34999999999999998 108.058 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.8 mt -94.92 132.67 38.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.508 0.723 . . . . 0.34999999999999998 109.225 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -113.82 98.19 6.87 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.042 1.337 . . . . 0.34999999999999998 107.774 170.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -72.15 131.28 42.58 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.484 -0.562 . . . . 0.34999999999999998 109.484 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt . . . . . 0 N--CA 1.456 -0.163 0 C-N-CA 124.336 1.054 . . . . 0.25 109.566 -176.225 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.331 0 CA-C-O 120.748 0.309 . . . . 0.34999999999999998 110.908 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.4 148.92 44.77 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.835 0.854 . . . . 0.34999999999999998 110.494 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? 78.14 156.35 0.16 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.896 2.078 . . . . 0.34999999999999998 110.856 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.59 80.89 0.66 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 124.401 1.0 . . . . 0.34999999999999998 110.706 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? 57.56 44.15 21.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.974 1.31 . . . . 0.34999999999999998 110.744 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -93.41 87.32 5.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.637 0.775 . . . . 0.34999999999999998 109.627 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -84.02 52.52 2.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.88 1.272 . . . . 0.34999999999999998 111.096 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm 68.68 -72.41 0.1 Allowed 'General case' 0 C--N 1.342 0.277 0 C-N-CA 127.15 2.18 . . . . 0.34999999999999998 111.993 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.24 -40.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.611 -0.996 . . . . 0.34999999999999998 110.611 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -57.96 136.61 57.11 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.385 1.074 . . . . 0.34999999999999998 110.623 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -157.97 59.91 0.47 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.873 -0.788 . . . . 0.34999999999999998 108.873 174.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.11 78.71 6.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.649 1.18 . . . . 0.34999999999999998 108.476 173.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.6 m -113.46 -42.12 3.53 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.949 1.3 . . . . 0.34999999999999998 111.05 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.96 170.04 19.24 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.581 0.753 . . . . 0.34999999999999998 111.712 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.7 t80 64.76 91.23 0.08 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 126.73 2.012 . . . . 0.34999999999999998 111.241 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 70.84 150.56 0.13 Allowed Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.559 1.944 . . . . 0.33000000000000002 111.676 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.42 80.58 2.23 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.443 2.762 . . . . 0.34999999999999998 110.03 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.3 p -71.32 -48.27 51.5 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.992 0.917 . . . . 0.34999999999999998 110.641 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.83 -179.01 44.58 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 117.994 0.361 . . . . 0.33000000000000002 112.887 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -76.63 177.2 9.13 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.217 3.278 . . . . 0.34999999999999998 112.715 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -160.05 -177.5 6.35 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.165 1.386 . . . . 0.34999999999999998 109.524 157.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -153.81 99.32 2.27 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.23 -0.656 . . . . 0.34999999999999998 109.23 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 77.6 mtm -84.44 111.82 19.81 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.552 1.141 . . . . 0.34999999999999998 110.587 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.7 t -101.0 90.66 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 125.43 1.492 . . . . 0.34999999999999998 108.064 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -146.21 178.01 8.56 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.371 0.668 . . . . 0.35999999999999999 111.962 -173.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.77 142.53 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.222 1.409 . . . . 0.34999999999999998 109.835 -172.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.6 m -93.34 81.6 4.44 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.204 -1.406 . . . . 0.34999999999999998 107.204 168.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.74 113.86 3.78 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.915 -0.874 . . . . 0.34999999999999998 110.915 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.41 164.42 15.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.849 1.259 . . . . 0.34999999999999998 111.179 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -77.3 174.07 11.19 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.784 0.833 . . . . 0.34999999999999998 110.703 172.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -55.81 -40.37 72.66 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.248 1.019 . . . . 0.34999999999999998 110.41 167.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -59.13 -59.05 6.08 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.287 1.035 . . . . 0.34999999999999998 109.94 171.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 140.17 -0.99 2.13 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.26 0.933 . . . . 0.34999999999999998 112.924 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -72.63 128.06 34.42 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.478 1.139 . . . . 0.35999999999999999 109.839 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -70.01 106.49 3.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.46 0.704 . . . . 0.34999999999999998 110.89 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.8 mt -67.37 -47.16 71.2 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.591 1.156 . . . . 0.34999999999999998 110.553 174.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -142.98 152.77 42.32 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.479 0.712 . . . . 0.34999999999999998 111.316 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.0 m -108.0 152.23 41.63 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 125.389 1.476 . . . . 0.33000000000000002 109.993 -175.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.8 -173.02 1.58 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.656 2.904 . . . . 0.34999999999999998 112.304 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.1 m170 74.19 66.76 0.09 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 127.055 2.142 . . . . 0.34999999999999998 111.306 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -153.55 -2.55 0.21 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.863 0.865 . . . . 0.34999999999999998 113.041 177.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.6 t -135.39 115.73 18.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 N-CA-C 106.426 -1.694 . . . . 0.34999999999999998 106.426 170.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -143.82 148.8 36.05 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.317 1.047 . . . . 0.34999999999999998 109.503 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -139.61 148.64 56.82 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 124.284 1.034 . . . . 0.33000000000000002 109.889 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.64 135.89 34.53 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.648 2.232 . . . . 0.34999999999999998 108.544 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.4 tt -66.61 144.35 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 122.927 0.491 . . . . 0.34999999999999998 112.161 -168.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -137.97 87.31 16.71 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 125.401 1.48 . . . . 0.33000000000000002 107.5 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.55 155.5 31.76 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.38 2.72 . . . . 0.34999999999999998 110.878 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.41 -32.41 2.48 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.077 0.846 . . . . 0.34999999999999998 111.698 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.3 t -70.39 155.22 40.98 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.983 0.913 . . . . 0.34999999999999998 111.357 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.1 m -72.53 145.46 47.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.741 0.816 . . . . 0.34999999999999998 109.069 172.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.42 76.74 1.69 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.416 1.086 . . . . 0.34999999999999998 108.901 -172.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t -114.86 171.22 7.78 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.171 1.788 . . . . 0.34999999999999998 109.88 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -56.61 -44.79 81.5 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.693 1.197 . . . . 0.34999999999999998 111.63 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.79 -27.79 67.05 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.931 0.715 . . . . 0.34999999999999998 112.931 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -73.82 -25.58 60.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.37 1.068 . . . . 0.34999999999999998 112.065 174.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.8 mm -90.51 -51.4 11.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-N 118.564 0.62 . . . . 0.34999999999999998 110.94 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.36 -41.01 75.45 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.691 0.626 . . . . 0.34999999999999998 112.691 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.36 -30.37 57.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.032 0.533 . . . . 0.34999999999999998 111.697 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -76.11 -42.18 47.89 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.411 1.084 . . . . 0.34999999999999998 111.02 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.3 m -72.32 -23.76 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.001 0.52 . . . . 0.34999999999999998 111.329 173.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -68.9 -34.39 75.32 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.242 0.474 . . . . 0.34999999999999998 110.579 171.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -24.52 63.2 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.07 -0.491 . . . . 0.34999999999999998 111.732 174.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.3 -38.6 75.03 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.513 0.597 . . . . 0.34999999999999998 110.925 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.7 -45.42 92.86 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.38 0.672 . . . . 0.34999999999999998 110.366 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -64.67 153.55 39.21 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.006 0.366 . . . . 0.34999999999999998 110.279 172.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 82.51 -47.54 0.17 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.801 2.04 . . . . 0.34999999999999998 110.94 -167.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.3 p -91.69 -99.28 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.095 0.958 . . . . 0.34999999999999998 110.087 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.15 96.44 9.62 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.994 1.318 . . . . 0.34999999999999998 111.228 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -153.89 6.73 0.33 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.537 1.135 . . . . 0.34999999999999998 111.724 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -74.33 -60.56 2.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.265 1.026 . . . . 0.34999999999999998 109.612 -173.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -104.5 -21.96 13.37 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.665 1.586 . . . . 0.34999999999999998 110.542 171.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -70.28 133.79 47.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.279 1.432 . . . . 0.34999999999999998 109.921 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -152.43 114.49 4.42 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.792 0.837 . . . . 0.34999999999999998 110.078 -175.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -70.05 117.24 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.272 1.029 . . . . 0.34999999999999998 109.861 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.6 -46.7 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.976 0.911 . . . . 0.34999999999999998 110.698 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -136.94 163.18 31.31 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.651 1.181 . . . . 0.34999999999999998 109.623 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -137.04 153.06 50.72 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.766 1.226 . . . . 0.34999999999999998 110.135 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.59 126.36 71.37 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 108.437 -0.949 . . . . 0.33000000000000002 108.437 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.25 -30.79 15.33 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.917 2.411 . . . . 0.34999999999999998 111.028 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.6 t -87.13 72.7 9.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.553 1.141 . . . . 0.34999999999999998 110.502 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.03 168.69 14.93 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.112 0.965 . . . . 0.34999999999999998 110.335 168.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -139.13 152.85 47.79 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.696 0.798 . . . . 0.34999999999999998 111.735 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.92 87.55 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 126.128 1.771 . . . . 0.34999999999999998 106.923 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -86.15 93.74 9.1 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 108.86 -0.793 . . . . 0.34999999999999998 108.86 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.2 m -73.56 85.02 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 108.09 -1.078 . . . . 0.34999999999999998 108.09 171.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.7 m -87.72 78.71 8.39 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.659 1.183 . . . . 0.34999999999999998 108.521 -174.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -88.3 165.28 15.11 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.935 0.894 . . . . 0.34999999999999998 110.102 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -154.16 28.87 0.45 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.682 1.593 . . . . 0.34999999999999998 109.647 -168.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.95 125.49 20.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.318 1.447 . . . . 0.34999999999999998 112.02 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -85.49 63.02 7.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.206 -1.035 . . . . 0.34999999999999998 108.206 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -144.17 -60.76 0.39 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.715 1.206 . . . . 0.35999999999999999 109.933 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -152.68 -56.32 0.13 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.013 0.746 . . . . 0.34999999999999998 113.013 -172.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -80.02 -41.93 24.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.114 0.87 . . . . 0.34999999999999998 112.044 -171.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt 69.57 -148.77 0.11 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.918 1.287 . . . . 0.34999999999999998 111.341 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -75.66 115.92 15.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.754 0.822 . . . . 0.34999999999999998 111.442 -167.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.17 113.32 6.87 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.365 1.066 . . . . 0.34999999999999998 109.206 173.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.8 m -79.47 81.93 5.66 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 107.4 -1.333 . . . . 0.34999999999999998 107.4 169.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -86.74 86.25 7.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.279 1.032 . . . . 0.34999999999999998 109.415 -169.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.5 p -77.08 84.03 3.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.023 1.329 . . . . 0.34999999999999998 111.387 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -83.38 127.62 67.75 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 123.915 0.886 . . . . 0.33000000000000002 108.95 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.89 163.55 28.48 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.198 2.598 . . . . 0.34999999999999998 111.908 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 tp -78.84 163.83 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.714 1.206 . . . . 0.34999999999999998 110.355 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.6 p -124.34 165.3 17.93 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.849 1.26 . . . . 0.34999999999999998 110.358 176.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.37 -28.46 14.94 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.875 1.27 . . . . 0.34999999999999998 110.715 171.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -70.0 -60.25 2.41 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.012 0.925 . . . . 0.34999999999999998 109.848 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.14 98.65 2.28 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 123.993 0.806 . . . . 0.34999999999999998 111.587 174.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -78.23 136.97 37.89 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.099 -0.704 . . . . 0.34999999999999998 109.099 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.36 136.67 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.708 -0.849 . . . . 0.34999999999999998 108.708 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.83 118.22 46.43 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.469 -0.937 . . . . 0.33000000000000002 108.469 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -84.58 162.06 12.56 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.065 2.51 . . . . 0.34999999999999998 111.184 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -83.67 168.05 16.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.898 0.879 . . . . 0.34999999999999998 109.458 166.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -158.44 130.98 7.03 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.22 0.608 . . . . 0.34999999999999998 111.02 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.1 t -163.21 69.84 0.23 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.436 1.095 . . . . 0.34999999999999998 108.581 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -158.22 -63.89 0.09 Allowed 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.851 0.86 . . . . 0.34999999999999998 108.996 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -89.39 -47.29 8.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.353 1.061 . . . . 0.34999999999999998 111.382 -175.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.7 pt -136.65 169.1 20.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 C-N-CA 123.879 0.872 . . . . 0.34999999999999998 111.633 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -144.03 38.79 1.32 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.995 1.718 . . . . 0.34999999999999998 108.162 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -169.77 58.52 0.32 Allowed Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.906 0.882 . . . . 0.35999999999999999 110.502 -172.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -63.69 -57.1 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.512 2.808 . . . . 0.34999999999999998 111.993 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.38 72.91 0.86 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.457 -1.057 . . . . 0.34999999999999998 110.457 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -68.99 97.79 0.89 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.311 1.444 . . . . 0.34999999999999998 110.46 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -87.41 96.2 10.29 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.595 -0.52 . . . . 0.35999999999999999 109.595 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -88.27 62.96 6.95 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.278 -1.008 . . . . 0.34999999999999998 108.278 170.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -94.72 104.36 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.501 -2.037 . . . . 0.34999999999999998 105.501 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 68.5 p -97.94 -162.89 0.99 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.288 1.035 . . . . 0.34999999999999998 109.244 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.53 121.77 4.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.232 -1.395 . . . . 0.34999999999999998 107.232 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.36 157.02 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.224 0.61 . . . . 0.34999999999999998 110.223 175.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.81 143.85 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.942 1.297 . . . . 0.34999999999999998 108.364 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.6 mp -130.82 145.06 36.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 C-N-CA 124.767 1.227 . . . . 0.34999999999999998 110.383 -175.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.84 157.17 34.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.161 1.385 . . . . 0.34999999999999998 108.255 160.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -90.2 126.02 35.67 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.29 -0.633 . . . . 0.34999999999999998 109.29 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 C--N 1.34 0.192 0 C-N-CA 123.834 0.854 . . . . 0.25 110.635 -175.895 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 109.751 -0.463 . . . . 0.34999999999999998 109.751 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -77.46 70.04 3.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.505 1.122 . . . . 0.34999999999999998 110.067 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -175.81 173.5 2.32 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.373 1.869 . . . . 0.34999999999999998 109.454 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.77 -155.4 8.65 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.859 0.742 . . . . 0.34999999999999998 111.775 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -71.17 109.74 5.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.811 0.844 . . . . 0.34999999999999998 109.059 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -138.94 80.51 1.79 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.056 0.943 . . . . 0.34999999999999998 109.004 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -89.47 35.1 0.81 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.633 1.173 . . . . 0.34999999999999998 112.013 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.6 -82.77 0.03 OUTLIER 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.849 1.66 . . . . 0.34999999999999998 110.43 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 13' ' ' ASP . . . -176.17 2.94 0.03 OUTLIER Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.389 1.471 . . . . 0.34999999999999998 112.752 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.414 ' H ' ' H ' ' A' ' 12' ' ' GLY . 3.3 p30 50.02 26.93 2.24 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 127.351 2.261 . . . . 0.34999999999999998 115.799 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 49.35 38.17 13.29 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.807 1.643 . . . . 0.34999999999999998 112.572 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.74 -44.41 0.01 OUTLIER 'General case' 0 C--N 1.339 0.11 0 C-N-CA 125.044 1.337 . . . . 0.34999999999999998 109.511 -171.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.7 t 68.64 45.72 1.04 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.294 1.838 . . . . 0.34999999999999998 110.51 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.2 t80 49.21 61.74 2.98 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.287 1.435 . . . . 0.34999999999999998 110.325 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -160.49 92.89 0.99 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.237 0.615 . . . . 0.34999999999999998 109.899 -170.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 66.5 166.21 0.12 Allowed Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 126.117 1.767 . . . . 0.33000000000000002 113.595 165.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.85 96.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.365 3.377 . . . . 0.34999999999999998 111.811 169.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.8 p -144.38 -38.49 0.29 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.917 1.287 . . . . 0.34999999999999998 110.496 -174.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.82 143.88 6.82 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 110.921 -0.872 . . . . 0.33000000000000002 110.921 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -86.44 168.32 8.68 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.052 3.168 . . . . 0.34999999999999998 112.087 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -165.08 160.03 18.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.163 0.985 . . . . 0.34999999999999998 111.215 -172.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.9 tt -158.27 113.2 2.61 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.09 1.356 . . . . 0.34999999999999998 108.748 -170.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -96.73 152.12 18.98 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.55 1.14 . . . . 0.34999999999999998 110.774 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.01 89.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.301 0 C-N-CA 124.654 1.182 . . . . 0.34999999999999998 108.709 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -144.66 -162.93 1.59 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.711 0.805 . . . . 0.35999999999999999 110.3 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.5 m -137.91 148.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 124.675 1.19 . . . . 0.34999999999999998 110.024 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.4 m -85.54 93.38 8.78 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.088 -1.449 . . . . 0.34999999999999998 107.088 169.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.89 89.32 1.43 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.819 0.723 . . . . 0.34999999999999998 111.758 -169.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.4 m -101.74 170.61 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.749 1.22 . . . . 0.34999999999999998 112.627 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.06 179.09 7.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.961 1.304 . . . . 0.34999999999999998 109.438 165.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.3 t -58.36 -40.41 82.17 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.03 0.932 . . . . 0.34999999999999998 110.786 172.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.53 -54.98 40.34 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.265 1.026 . . . . 0.34999999999999998 110.423 175.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.84 26.79 0.56 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.726 1.155 . . . . 0.34999999999999998 111.905 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -100.11 115.54 30.02 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.187 0.995 . . . . 0.35999999999999999 109.21 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.84 114.23 4.36 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.463 0.705 . . . . 0.34999999999999998 110.552 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.417 HD12 ' H ' ' A' ' 39' ' ' LEU . 4.4 mp -77.75 -51.01 11.23 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.987 -0.746 . . . . 0.34999999999999998 108.987 173.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.0 mt -91.99 -149.45 0.24 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.997 1.319 . . . . 0.34999999999999998 110.189 -167.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.4 m -154.87 123.54 3.02 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.474 1.11 . . . . 0.33000000000000002 109.126 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.16 -171.29 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.257 2.638 . . . . 0.34999999999999998 110.311 171.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.2 m170 64.14 75.63 0.37 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.696 1.199 . . . . 0.34999999999999998 111.171 174.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -145.44 -61.44 0.34 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.328 0.651 . . . . 0.34999999999999998 110.646 174.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.59 124.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 107.926 -1.139 . . . . 0.34999999999999998 107.926 166.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -149.9 151.32 33.24 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.67 1.188 . . . . 0.34999999999999998 109.541 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -140.17 146.15 44.86 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.812 1.245 . . . . 0.33000000000000002 109.333 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.71 128.76 17.51 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.329 2.019 . . . . 0.34999999999999998 107.713 166.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.4 tt -59.82 142.62 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.418 0.525 . . . . 0.34999999999999998 112.418 -167.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -128.72 97.9 26.21 Favored Pre-proline 0 N--CA 1.453 -0.287 0 N-CA-C 107.31 -1.367 . . . . 0.33000000000000002 107.31 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.29 157.47 49.88 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.454 2.103 . . . . 0.34999999999999998 109.811 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.02 58.32 1.8 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.146 -1.182 . . . . 0.34999999999999998 110.146 -174.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.3 t -152.56 147.26 25.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.979 1.311 . . . . 0.34999999999999998 108.981 174.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.1 m -61.2 138.77 58.22 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.236 0.614 . . . . 0.34999999999999998 110.379 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.89 80.95 1.71 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.446 1.098 . . . . 0.34999999999999998 108.722 -173.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.3 p -133.39 178.66 6.74 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.869 1.268 . . . . 0.34999999999999998 109.288 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -54.75 -54.37 42.86 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.109 0.564 . . . . 0.34999999999999998 111.208 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.54 -42.93 67.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.383 1.073 . . . . 0.34999999999999998 112.603 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.8 -60.24 4.11 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.231 0.612 . . . . 0.34999999999999998 110.609 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.2 mm -57.54 -42.23 80.65 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 C-N-CA 124.61 1.164 . . . . 0.34999999999999998 111.603 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -49.77 -59.24 4.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.75 1.22 . . . . 0.34999999999999998 111.999 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -73.65 -29.61 62.43 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.497 0.555 . . . . 0.34999999999999998 112.497 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -69.87 -40.03 75.99 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.518 0.727 . . . . 0.34999999999999998 111.898 -170.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.34 -30.79 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.017 0.527 . . . . 0.34999999999999998 111.512 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.3 -33.67 74.76 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.223 0.609 . . . . 0.34999999999999998 111.019 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -31.56 67.52 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.332 0.653 . . . . 0.34999999999999998 111.337 176.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 -55.4 22.23 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.228 0.611 . . . . 0.34999999999999998 110.994 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 pp -64.12 -27.33 69.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.171 0.988 . . . . 0.34999999999999998 112.811 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.62 -43.56 63.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.281 0.632 . . . . 0.34999999999999998 110.32 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.51 50.47 1.89 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.64 1.176 . . . . 0.34999999999999998 111.401 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.0 t -168.07 -42.69 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.358 1.463 . . . . 0.34999999999999998 109.945 173.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.94 88.58 0.83 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.74 0.816 . . . . 0.34999999999999998 110.023 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -107.71 46.81 0.92 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.278 1.031 . . . . 0.34999999999999998 108.717 167.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -84.89 -57.64 3.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.771 1.228 . . . . 0.34999999999999998 109.038 -175.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.74 -139.25 0.33 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.601 1.561 . . . . 0.34999999999999998 108.42 176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 82.56 109.82 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.284 1.433 . . . . 0.34999999999999998 111.436 162.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -41.86 9.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.907 1.283 . . . . 0.34999999999999998 111.209 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.1 t 69.11 92.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 126.219 1.808 . . . . 0.34999999999999998 109.463 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.6 t -67.95 -63.72 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.419 0.688 . . . . 0.34999999999999998 109.767 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -160.33 117.82 2.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.15 0.58 . . . . 0.34999999999999998 109.742 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.04 145.95 44.11 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.195 0.598 . . . . 0.34999999999999998 110.019 172.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.99 123.07 85.16 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.518 -0.919 . . . . 0.33000000000000002 108.518 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.31 -32.96 19.33 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.232 2.621 . . . . 0.34999999999999998 111.045 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.3 m -79.67 76.25 6.32 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.976 0.911 . . . . 0.34999999999999998 109.184 173.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.01 154.23 23.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.242 1.017 . . . . 0.34999999999999998 110.07 172.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -133.93 134.42 42.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.109 0.964 . . . . 0.34999999999999998 109.952 -171.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.4 mp -122.5 111.76 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 125.669 1.587 . . . . 0.34999999999999998 107.964 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -99.04 63.39 1.33 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.117 0.967 . . . . 0.34999999999999998 108.648 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.01 99.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.358 0.599 . . . . 0.34999999999999998 109.896 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.6 m -80.39 150.46 29.82 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.532 1.133 . . . . 0.34999999999999998 108.94 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -139.1 66.42 1.42 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.322 1.049 . . . . 0.34999999999999998 108.726 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -91.55 121.59 33.37 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 127.396 2.278 . . . . 0.34999999999999998 109.863 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.3 p-10 -131.29 -165.06 1.51 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.687 0.795 . . . . 0.34999999999999998 110.56 169.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -144.51 63.8 1.31 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.826 -1.176 . . . . 0.34999999999999998 107.826 169.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -134.04 -53.35 0.85 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 125.468 1.507 . . . . 0.35999999999999999 109.21 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -155.88 -41.3 0.08 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.063 0.945 . . . . 0.34999999999999998 111.679 -172.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.6 tppt? -83.67 -59.54 2.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.88 0.872 . . . . 0.34999999999999998 111.467 -166.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? 68.03 177.84 0.25 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.933 1.693 . . . . 0.34999999999999998 111.401 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -63.47 110.91 2.11 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 112.514 0.561 . . . . 0.34999999999999998 112.514 -165.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -132.93 137.25 46.55 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.229 1.811 . . . . 0.34999999999999998 106.66 170.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.5 m -116.01 102.12 9.36 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.894 0.878 . . . . 0.34999999999999998 109.35 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -79.59 101.32 8.24 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.678 -0.86 . . . . 0.34999999999999998 108.678 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.4 m -90.16 67.52 6.92 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.211 1.005 . . . . 0.34999999999999998 110.07 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -71.01 134.34 85.56 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.103 0.961 . . . . 0.33000000000000002 109.398 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.15 -113.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.474 2.783 . . . . 0.34999999999999998 109.622 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.1 tp -163.05 158.43 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.245 0 CA-C-N 119.156 0.889 . . . . 0.34999999999999998 110.087 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.8 p -133.69 151.82 51.73 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.798 1.239 . . . . 0.34999999999999998 109.183 169.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.13 -35.16 66.8 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.957 1.303 . . . . 0.34999999999999998 112.965 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -141.58 74.26 1.45 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.961 1.304 . . . . 0.34999999999999998 107.883 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.69 -92.03 0.41 Allowed Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.141 0.877 . . . . 0.34999999999999998 112.184 -175.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -162.03 171.01 18.26 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.304 0.573 . . . . 0.34999999999999998 112.076 -163.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 99.3 t -90.21 145.35 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.204 1.802 . . . . 0.34999999999999998 107.73 169.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.5 t -52.92 115.14 6.83 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 123.846 0.859 . . . . 0.33000000000000002 109.371 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -82.6 -178.67 4.08 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.275 2.65 . . . . 0.34999999999999998 110.931 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -72.38 -178.45 2.54 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.873 0.869 . . . . 0.34999999999999998 109.922 170.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.31 61.11 1.53 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.912 0.885 . . . . 0.34999999999999998 110.388 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t 56.84 -103.0 0.17 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.97 1.708 . . . . 0.34999999999999998 112.129 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -163.49 -58.12 0.04 OUTLIER 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.557 1.143 . . . . 0.34999999999999998 108.623 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -57.92 -47.55 82.53 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.257 1.423 . . . . 0.34999999999999998 112.124 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.3 tp -81.39 133.54 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.692 0.797 . . . . 0.34999999999999998 110.684 -176.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.39 29.61 0.49 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.272 1.029 . . . . 0.34999999999999998 111.643 166.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -142.49 60.56 10.23 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.227 1.411 . . . . 0.35999999999999999 108.988 167.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.92 -73.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.743 2.962 . . . . 0.34999999999999998 113.074 -168.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.71 78.36 1.4 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.927 -1.669 . . . . 0.34999999999999998 108.927 -164.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -80.03 95.99 6.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.904 -1.147 . . . . 0.34999999999999998 107.904 171.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -83.16 101.27 11.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.748 -0.834 . . . . 0.35999999999999999 108.748 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.07 49.98 1.71 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.148 -1.056 . . . . 0.34999999999999998 108.148 166.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.85 109.79 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.205 -1.776 . . . . 0.34999999999999998 106.205 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 67.1 p -94.09 -133.69 0.17 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.226 1.011 . . . . 0.34999999999999998 109.109 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -162.33 133.69 5.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.601 1.16 . . . . 0.34999999999999998 108.065 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 m -142.34 143.45 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.718 0.807 . . . . 0.34999999999999998 110.031 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.38 134.03 28.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.838 -1.171 . . . . 0.34999999999999998 107.838 173.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.7 mt -123.5 143.58 36.12 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 C-N-CA 124.47 1.108 . . . . 0.34999999999999998 110.652 -169.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -128.69 102.77 6.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.686 1.595 . . . . 0.34999999999999998 106.76 166.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -60.85 128.26 35.64 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.2 0.6 . . . . 0.34999999999999998 109.392 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.184 0 C-N-CA 123.79 0.836 . . . . 0.25 109.383 -164.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 111.833 0.309 . . . . 0.34999999999999998 111.833 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.8 t70 60.79 171.07 0.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.155 1.382 . . . . 0.34999999999999998 110.994 -167.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.3 pttt 47.57 -106.16 0.15 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.373 1.469 . . . . 0.34999999999999998 112.396 171.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.1 -136.49 2.03 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.546 -1.022 . . . . 0.34999999999999998 110.546 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -85.7 71.46 10.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.941 -1.133 . . . . 0.34999999999999998 107.941 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -67.15 -56.88 8.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.065 0.946 . . . . 0.34999999999999998 113.061 -162.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 44' ' ' TYR . 47.3 mmtm 76.84 110.58 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.921 2.088 . . . . 0.34999999999999998 108.297 -170.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -55.41 -61.54 2.27 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.365 1.066 . . . . 0.34999999999999998 111.817 -167.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.58 80.28 0.1 OUTLIER Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.516 -1.434 . . . . 0.34999999999999998 109.516 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -127.82 41.18 3.55 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.251 1.021 . . . . 0.34999999999999998 109.914 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.7 t0 50.71 55.25 9.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.185 1.394 . . . . 0.34999999999999998 109.552 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -129.58 -168.62 1.97 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.77 1.228 . . . . 0.34999999999999998 111.454 -155.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.5 m 63.65 69.64 0.55 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.952 1.701 . . . . 0.34999999999999998 111.025 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 60.65 -145.43 0.47 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.242 1.417 . . . . 0.34999999999999998 110.169 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 77.0 t80 57.8 73.87 0.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.468 1.507 . . . . 0.34999999999999998 111.867 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 65.43 168.09 0.11 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.992 1.717 . . . . 0.33000000000000002 113.28 168.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.32 113.53 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.981 2.454 . . . . 0.34999999999999998 110.557 168.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 p -142.36 -73.32 0.31 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.558 0.743 . . . . 0.34999999999999998 111.564 -170.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.43 112.97 0.53 Allowed Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.892 -0.949 . . . . 0.33000000000000002 111.088 -170.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.97 175.61 10.61 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.816 3.011 . . . . 0.34999999999999998 112.758 -171.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -155.28 166.98 31.88 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.835 0.68 . . . . 0.34999999999999998 112.835 -172.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.2 tp -139.0 80.94 1.81 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.469 1.908 . . . . 0.34999999999999998 107.743 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.1 mtm -74.45 100.89 3.96 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 122.674 0.39 . . . . 0.34999999999999998 111.196 -172.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 t -84.57 76.72 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.521 -1.289 . . . . 0.34999999999999998 107.521 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -149.02 148.18 29.42 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.618 1.167 . . . . 0.35999999999999999 109.708 -171.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.6 m -140.37 144.36 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.266 1.026 . . . . 0.34999999999999998 111.249 -170.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.1 m -70.2 105.49 2.97 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.731 1.212 . . . . 0.34999999999999998 109.34 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.49 81.04 1.48 Allowed Glycine 0 C--N 1.34 0.776 0 C-N-CA 124.204 0.907 . . . . 0.34999999999999998 111.711 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.9 m -87.16 170.27 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.154 0.982 . . . . 0.34999999999999998 111.909 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -77.1 -44.56 30.06 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.928 0.891 . . . . 0.34999999999999998 110.571 173.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.8 t 169.72 -59.8 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.097 2.559 . . . . 0.34999999999999998 107.077 -171.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.9 43.66 1.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.115 1.366 . . . . 0.34999999999999998 111.915 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.04 32.39 63.32 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.784 -1.009 . . . . 0.34999999999999998 114.297 167.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -103.43 90.77 3.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.483 1.141 . . . . 0.35999999999999999 108.132 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.89 109.5 1.47 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.848 0.859 . . . . 0.34999999999999998 110.077 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mp -77.52 -53.8 7.18 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.38 0.672 . . . . 0.34999999999999998 109.845 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.9 mt -86.07 -169.43 2.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.406 1.082 . . . . 0.34999999999999998 110.247 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.3 m -126.48 68.51 67.79 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.553 0.741 . . . . 0.33000000000000002 111.051 -174.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.99 164.29 35.32 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.909 3.073 . . . . 0.34999999999999998 112.893 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.1 m170 79.1 80.67 0.06 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 127.222 2.209 . . . . 0.34999999999999998 108.357 -172.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.403 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 31.2 p90 -147.31 -48.64 0.18 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.352 0.661 . . . . 0.34999999999999998 111.957 -176.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -83.86 77.51 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 108.568 -0.901 . . . . 0.34999999999999998 108.568 169.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -72.2 -38.06 69.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.897 -0.573 . . . . 0.34999999999999998 111.924 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 64.67 154.26 0.12 Allowed Pre-proline 0 C--N 1.345 0.399 0 C-N-CA 126.634 1.974 . . . . 0.33000000000000002 113.454 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.87 134.57 8.44 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.085 2.523 . . . . 0.34999999999999998 108.378 165.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.5 tt -70.51 148.57 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.505 0.322 . . . . 0.34999999999999998 111.196 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -135.08 107.39 10.4 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 107.287 -1.375 . . . . 0.33000000000000002 107.287 172.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.63 161.69 27.71 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.12 2.547 . . . . 0.34999999999999998 110.563 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.32 61.61 1.98 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.711 -1.356 . . . . 0.34999999999999998 109.711 -173.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 t -151.9 142.98 23.18 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.55 1.14 . . . . 0.34999999999999998 109.431 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.5 m -62.79 121.03 12.44 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.699 0.799 . . . . 0.34999999999999998 110.034 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.85 78.63 1.64 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.893 1.277 . . . . 0.34999999999999998 108.621 -173.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.3 p -116.02 172.1 7.37 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.746 1.618 . . . . 0.34999999999999998 109.59 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.87 -49.78 75.52 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.69 1.196 . . . . 0.34999999999999998 110.531 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -65.06 -28.94 69.81 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.61 0.764 . . . . 0.34999999999999998 112.926 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -74.36 4.02 6.51 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.471 -0.775 . . . . 0.34999999999999998 112.844 172.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.2 mm -100.36 -49.51 11.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 CA-C-N 119.324 0.965 . . . . 0.34999999999999998 109.039 168.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -43.75 -64.78 0.59 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.691 1.597 . . . . 0.34999999999999998 113.607 -167.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -82.11 -28.65 32.14 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.779 0.832 . . . . 0.34999999999999998 111.795 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -60.18 -49.41 77.75 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.626 1.17 . . . . 0.34999999999999998 111.691 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.0 m -66.9 -38.19 80.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 C-N-CA 123.371 0.668 . . . . 0.34999999999999998 110.983 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.89 -39.22 84.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.779 0.832 . . . . 0.34999999999999998 111.127 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -72.46 -40.8 66.73 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.0 0.92 . . . . 0.34999999999999998 111.466 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.74 95.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.358 0.663 . . . . 0.34999999999999998 111.218 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -85.95 -22.38 27.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.963 0.905 . . . . 0.34999999999999998 113.025 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.7 -41.77 91.51 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.512 0.725 . . . . 0.34999999999999998 110.573 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.85 64.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.0 0.92 . . . . 0.34999999999999998 112.091 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.7 p -83.58 -62.03 1.68 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.857 0.863 . . . . 0.34999999999999998 112.276 -173.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.01 -67.85 0.39 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-N 118.495 0.588 . . . . 0.34999999999999998 110.076 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 71.48 149.42 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.966 1.707 . . . . 0.34999999999999998 113.202 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? 68.59 -90.18 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.101 1.76 . . . . 0.34999999999999998 112.775 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -84.5 72.35 10.64 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 123.901 0.88 . . . . 0.34999999999999998 111.078 -169.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -167.74 147.96 5.12 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.256 1.422 . . . . 0.34999999999999998 108.248 173.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.3 tpt85 -114.1 -60.04 1.94 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.591 0.757 . . . . 0.34999999999999998 111.473 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.3 t 71.76 82.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 125.304 1.442 . . . . 0.34999999999999998 107.963 -160.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.5 t -69.38 -57.33 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.623 1.169 . . . . 0.34999999999999998 109.99 -172.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -131.11 169.52 15.78 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.627 1.171 . . . . 0.34999999999999998 110.842 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -153.68 156.4 37.78 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.712 1.605 . . . . 0.34999999999999998 109.013 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -87.33 138.27 32.25 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.276 -0.639 . . . . 0.33000000000000002 109.276 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.06 -17.92 24.43 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.436 2.758 . . . . 0.34999999999999998 111.856 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.4 m -59.01 -31.87 69.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.436 1.095 . . . . 0.34999999999999998 112.291 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 15.69 74.38 0.01 OUTLIER 'General case' 0 C--N 1.348 0.511 0 C-N-CA 128.813 2.845 . . . . 0.34999999999999998 113.728 172.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -78.9 128.77 33.75 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.122 0.969 . . . . 0.34999999999999998 113.092 -161.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.8 124.03 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 125.988 1.715 . . . . 0.34999999999999998 107.354 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -122.57 90.26 3.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.377 1.071 . . . . 0.34999999999999998 108.601 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 m -78.8 92.19 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.786 1.234 . . . . 0.34999999999999998 110.548 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.1 m -85.5 94.37 9.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.616 1.167 . . . . 0.34999999999999998 108.645 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.74 84.1 4.94 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.509 0.724 . . . . 0.34999999999999998 110.38 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -76.11 91.74 3.16 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.878 1.671 . . . . 0.34999999999999998 110.003 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -134.19 78.95 1.78 Allowed 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.896 -0.779 . . . . 0.34999999999999998 108.896 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -75.67 83.31 2.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.724 1.21 . . . . 0.34999999999999998 108.667 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -155.19 -37.86 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.857 1.663 . . . . 0.35999999999999999 110.018 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -154.7 -41.35 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.93 1.292 . . . . 0.34999999999999998 110.624 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -79.85 -63.2 1.47 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 123.246 0.618 . . . . 0.34999999999999998 110.699 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.48 125.49 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.322 1.849 . . . . 0.34999999999999998 109.84 -177.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -10.17 108.18 0.01 OUTLIER 'General case' 0 C--N 1.344 0.369 0 C-N-CA 129.516 3.126 . . . . 0.34999999999999998 115.261 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -140.86 123.33 15.95 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.03 1.332 . . . . 0.34999999999999998 107.989 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.7 m -102.32 103.9 14.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.748 1.219 . . . . 0.34999999999999998 109.726 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.86 109.15 14.01 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.491 -0.929 . . . . 0.34999999999999998 108.491 173.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.8 p -89.29 75.24 7.77 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.607 1.163 . . . . 0.34999999999999998 111.151 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -81.21 142.57 51.2 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.679 1.192 . . . . 0.33000000000000002 109.52 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -77.33 -129.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.79 2.993 . . . . 0.34999999999999998 110.157 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.8 tp -167.43 159.92 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 119.663 1.12 . . . . 0.34999999999999998 110.211 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.9 p -136.42 151.89 50.01 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.687 1.195 . . . . 0.34999999999999998 109.84 170.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.5 -11.26 60.68 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.722 1.209 . . . . 0.34999999999999998 114.062 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -142.05 59.15 1.47 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.973 -1.121 . . . . 0.34999999999999998 107.973 172.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.38 -82.67 1.0 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.183 0.897 . . . . 0.34999999999999998 111.558 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -163.54 159.83 22.41 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.193 0.521 . . . . 0.34999999999999998 112.013 -163.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.4 t -91.08 144.85 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.005 1.722 . . . . 0.34999999999999998 106.998 166.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 80.7 t -57.28 117.2 16.74 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 108.522 -0.918 . . . . 0.33000000000000002 108.522 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.55 -109.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.009 2.473 . . . . 0.34999999999999998 109.349 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -156.33 -137.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.591 -1.263 . . . . 0.34999999999999998 107.591 173.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 mp -137.27 151.54 48.81 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.821 1.248 . . . . 0.34999999999999998 109.595 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.3 t -77.11 -71.05 0.43 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.569 0.748 . . . . 0.34999999999999998 109.74 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -168.02 -46.21 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.593 1.157 . . . . 0.34999999999999998 109.799 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -39.4 -45.56 1.51 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.213 2.205 . . . . 0.34999999999999998 115.151 -169.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.39 161.15 41.06 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 C-N-CA 123.444 0.698 . . . . 0.34999999999999998 111.386 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -91.21 -68.18 0.81 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.209 1.404 . . . . 0.34999999999999998 110.092 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.473 HD22 ' H ' ' A' ' 122' ' ' ASN . 0.1 OUTLIER -107.94 103.34 49.46 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.234 1.014 . . . . 0.35999999999999999 112.407 -165.671 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.43 -177.68 3.72 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.926 2.417 . . . . 0.34999999999999998 111.174 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -153.3 68.0 0.31 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.876 -1.289 . . . . 0.34999999999999998 109.876 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -57.71 129.11 40.38 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.787 1.235 . . . . 0.34999999999999998 109.376 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -131.89 116.0 16.62 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.523 -0.918 . . . . 0.35999999999999999 108.523 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -88.5 60.13 5.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.257 1.023 . . . . 0.34999999999999998 109.628 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.8 mt -78.66 130.9 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.408 1.083 . . . . 0.34999999999999998 109.542 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.4 m -143.85 139.23 29.16 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.174 1.39 . . . . 0.34999999999999998 108.354 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.76 93.52 9.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.187 0.995 . . . . 0.34999999999999998 108.467 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.73 138.29 30.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 C-N-CA 124.198 0.999 . . . . 0.34999999999999998 111.222 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.79 100.62 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.427 1.491 . . . . 0.34999999999999998 108.751 -175.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 18.5 mt -90.98 145.84 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.089 0.956 . . . . 0.34999999999999998 110.234 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -138.59 127.05 23.15 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.845 1.258 . . . . 0.34999999999999998 109.208 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -66.71 125.71 26.7 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.316 1.046 . . . . 0.34999999999999998 109.579 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? . . . . . 0 C--N 1.34 0.183 0 C-N-CA 123.128 0.571 . . . . 0.25 109.745 176.586 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.7 p90 . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 109.697 -0.483 . . . . 0.34999999999999998 109.697 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -79.83 -171.74 3.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.402 0.681 . . . . 0.34999999999999998 110.596 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 17.8 pttm 47.75 -134.34 1.15 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.464 1.506 . . . . 0.34999999999999998 111.816 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.02 74.95 0.07 OUTLIER Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.339 0.972 . . . . 0.34999999999999998 111.842 -175.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt 52.56 62.56 2.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.537 1.135 . . . . 0.34999999999999998 110.344 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -135.86 133.43 37.77 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.317 1.047 . . . . 0.34999999999999998 110.512 -170.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.33 45.2 0.64 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.962 1.305 . . . . 0.34999999999999998 109.016 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt 64.17 -89.54 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.401 1.48 . . . . 0.34999999999999998 108.929 -168.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.33 32.58 0.12 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.338 -1.105 . . . . 0.34999999999999998 110.338 168.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 55.3 20.08 3.33 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.014 1.726 . . . . 0.34999999999999998 113.016 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 47.78 40.47 12.44 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.518 1.527 . . . . 0.34999999999999998 111.618 -173.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.05 85.35 0.15 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.373 0.669 . . . . 0.34999999999999998 109.904 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -86.86 -112.54 0.05 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.794 0.838 . . . . 0.34999999999999998 109.452 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -149.11 67.68 1.04 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.268 1.027 . . . . 0.34999999999999998 110.355 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -154.28 91.56 1.43 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.324 1.05 . . . . 0.34999999999999998 108.363 166.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 69.49 150.36 0.12 Allowed Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.875 1.67 . . . . 0.33000000000000002 111.661 173.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.45 93.14 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.0 2.467 . . . . 0.34999999999999998 111.187 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 p -74.41 -52.57 11.69 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.155 0.982 . . . . 0.34999999999999998 109.162 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.4 163.42 29.31 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.147 -0.781 . . . . 0.33000000000000002 111.147 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -80.85 -174.44 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.482 3.455 . . . . 0.34999999999999998 112.092 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -163.15 -178.45 6.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.077 1.751 . . . . 0.34999999999999998 108.807 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 tt -155.05 83.63 1.08 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.712 -1.218 . . . . 0.34999999999999998 107.712 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.1 ttp -82.27 118.63 23.27 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.324 0.65 . . . . 0.34999999999999998 110.56 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.0 t -107.78 101.11 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 126.019 1.728 . . . . 0.34999999999999998 108.281 -174.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -156.82 -177.4 6.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.582 1.153 . . . . 0.35999999999999999 110.71 -172.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.85 -164.63 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.268 1.427 . . . . 0.34999999999999998 109.162 172.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 m -133.2 99.76 4.65 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.382 -1.34 . . . . 0.34999999999999998 107.382 169.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.35 87.57 1.21 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.823 1.201 . . . . 0.34999999999999998 111.857 -171.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -104.44 166.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 124.15 0.98 . . . . 0.34999999999999998 111.943 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.32 176.46 9.3 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.638 1.575 . . . . 0.34999999999999998 109.288 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 t -53.55 -41.52 66.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.708 0.803 . . . . 0.34999999999999998 110.755 166.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -91.86 18.87 7.16 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.612 1.165 . . . . 0.34999999999999998 112.459 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 -5.7 76.79 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.926 -0.93 . . . . 0.34999999999999998 114.921 168.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -75.07 123.57 25.44 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.921 1.361 . . . . 0.35999999999999999 110.09 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.14 102.24 0.48 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.162 0.985 . . . . 0.34999999999999998 110.841 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.68 -72.32 0.3 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.845 0.858 . . . . 0.34999999999999998 108.828 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 mt -93.63 156.37 16.75 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.23 -1.026 . . . . 0.34999999999999998 108.23 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.1 t -119.43 71.33 13.02 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 124.021 0.928 . . . . 0.33000000000000002 109.652 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.61 91.84 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 124.539 3.493 . . . . 0.34999999999999998 109.893 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -156.73 55.15 0.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.713 1.205 . . . . 0.34999999999999998 109.032 -172.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -154.92 15.22 0.42 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.732 1.012 . . . . 0.34999999999999998 113.732 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.8 t -125.94 119.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 C-N-CA 123.842 0.857 . . . . 0.34999999999999998 108.859 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.68 169.52 17.64 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.291 0.636 . . . . 0.34999999999999998 111.9 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.94 157.93 53.48 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 125.907 1.683 . . . . 0.33000000000000002 108.486 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.98 168.62 22.64 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.858 2.372 . . . . 0.34999999999999998 110.413 171.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 tp -65.21 118.79 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.628 0.771 . . . . 0.34999999999999998 110.419 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -144.64 83.63 9.57 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.622 1.169 . . . . 0.33000000000000002 108.636 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -84.58 -168.53 0.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.014 3.143 . . . . 0.34999999999999998 109.907 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.17 -15.7 61.41 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.665 0.65 . . . . 0.34999999999999998 112.356 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.0 t -75.36 148.03 39.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.799 0.84 . . . . 0.34999999999999998 110.491 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.7 m -66.77 148.51 51.83 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.056 0.942 . . . . 0.34999999999999998 108.94 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.99 116.03 7.88 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.401 -0.592 . . . . 0.34999999999999998 109.401 -172.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -164.05 171.29 15.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.281 1.832 . . . . 0.34999999999999998 108.099 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -52.69 -41.37 63.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.138 0.975 . . . . 0.34999999999999998 112.143 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -83.98 -2.54 56.77 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.661 0.784 . . . . 0.34999999999999998 113.042 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.42 50.81 2.2 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.503 1.121 . . . . 0.34999999999999998 110.196 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -159.68 -48.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.378 1.071 . . . . 0.34999999999999998 109.234 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.16 -47.34 62.16 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.044 1.338 . . . . 0.34999999999999998 112.996 -174.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -63.77 -41.27 98.0 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.996 0.362 . . . . 0.34999999999999998 111.79 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -65.09 -44.97 87.13 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.037 0.935 . . . . 0.34999999999999998 111.745 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 m -69.2 -29.38 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.417 0.687 . . . . 0.34999999999999998 112.497 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -72.21 -36.88 69.29 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 122.813 0.445 . . . . 0.34999999999999998 111.08 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.21 -28.19 65.08 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.055 0.542 . . . . 0.34999999999999998 111.394 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.01 -60.05 3.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.42 0.688 . . . . 0.34999999999999998 110.618 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.69 -23.81 67.37 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.661 0.615 . . . . 0.34999999999999998 112.661 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.15 -22.62 64.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.516 0.726 . . . . 0.34999999999999998 112.252 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.62 -54.07 42.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.944 0.898 . . . . 0.34999999999999998 111.802 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.7 p -75.23 -70.14 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.441 0.696 . . . . 0.34999999999999998 110.832 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.8 148.56 25.96 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.102 1.361 . . . . 0.34999999999999998 109.841 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -167.08 44.01 0.05 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.543 0.737 . . . . 0.34999999999999998 111.221 -173.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -139.26 -71.39 0.4 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.026 0.531 . . . . 0.34999999999999998 111.206 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -62.99 -57.28 11.24 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.065 0.946 . . . . 0.34999999999999998 112.215 -167.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -62.72 145.15 55.46 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.746 0.418 . . . . 0.34999999999999998 111.802 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.36 -41.5 2.04 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.498 1.919 . . . . 0.34999999999999998 109.059 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t 79.33 126.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.283 0 C-N-CA 126.569 1.948 . . . . 0.34999999999999998 111.539 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.14 -60.57 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 124.98 1.312 . . . . 0.34999999999999998 108.982 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -153.81 128.73 9.53 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.868 0.867 . . . . 0.34999999999999998 109.93 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.4 mt -78.49 118.7 20.88 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.801 -1.555 . . . . 0.34999999999999998 106.801 164.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.15 137.09 95.67 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.979 -0.378 . . . . 0.33000000000000002 109.979 -172.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -66.22 -33.93 37.94 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.41 2.74 . . . . 0.34999999999999998 111.088 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -83.87 75.27 10.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.537 1.135 . . . . 0.34999999999999998 110.165 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.89 165.05 13.74 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.654 0.782 . . . . 0.34999999999999998 109.884 167.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -153.48 121.27 6.01 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.177 0.513 . . . . 0.34999999999999998 111.794 -167.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.61 122.32 44.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 126.673 1.989 . . . . 0.34999999999999998 107.093 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -111.96 77.73 1.07 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.415 -1.328 . . . . 0.34999999999999998 107.415 173.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -72.79 86.94 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.591 0.71 . . . . 0.34999999999999998 109.555 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.4 m -94.36 92.52 7.21 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.395 1.478 . . . . 0.34999999999999998 108.816 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -91.37 169.22 10.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.648 1.179 . . . . 0.34999999999999998 109.757 172.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -149.66 63.01 1.0 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.604 1.162 . . . . 0.34999999999999998 108.033 173.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.87 86.69 4.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.525 1.13 . . . . 0.34999999999999998 108.803 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -78.98 71.92 5.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.047 1.339 . . . . 0.34999999999999998 109.214 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -149.31 -57.5 0.2 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.34 1.456 . . . . 0.35999999999999999 109.168 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.84 35.56 0.4 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.658 0.783 . . . . 0.34999999999999998 111.57 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.6 -51.06 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.937 0.495 . . . . 0.34999999999999998 110.47 -170.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt 69.26 -153.18 0.14 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.689 1.596 . . . . 0.34999999999999998 110.229 -173.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -95.18 130.91 41.72 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.503 1.121 . . . . 0.34999999999999998 110.857 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -141.74 121.17 13.21 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.466 1.106 . . . . 0.34999999999999998 108.463 171.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.6 m -81.29 85.4 6.4 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.304 -1.369 . . . . 0.34999999999999998 107.304 170.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -79.75 95.75 6.08 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.058 0.943 . . . . 0.34999999999999998 109.266 -173.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.5 p -88.17 70.1 9.24 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.667 1.187 . . . . 0.34999999999999998 111.642 -171.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -68.12 136.48 91.66 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.709 0.804 . . . . 0.33000000000000002 108.985 171.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -79.73 -111.76 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.338 2.692 . . . . 0.34999999999999998 110.275 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.5 tp -163.21 153.37 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.987 1.315 . . . . 0.34999999999999998 108.478 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.8 p -129.69 156.17 44.7 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.759 0.823 . . . . 0.34999999999999998 109.928 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.2 -26.08 52.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.311 1.444 . . . . 0.34999999999999998 112.017 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.83 -44.0 94.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.436 1.095 . . . . 0.34999999999999998 113.099 -165.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.71 64.97 0.62 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.031 -1.228 . . . . 0.34999999999999998 110.031 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -73.95 126.08 29.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.617 -0.512 . . . . 0.34999999999999998 109.617 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.9 t -76.27 130.56 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.263 -1.014 . . . . 0.34999999999999998 108.263 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.23 120.89 77.8 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 107.712 -1.218 . . . . 0.33000000000000002 107.712 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.35 -94.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.977 2.451 . . . . 0.34999999999999998 109.312 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -169.81 -82.69 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.395 1.478 . . . . 0.34999999999999998 107.275 166.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.7 mt -150.81 160.6 43.76 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.051 1.34 . . . . 0.34999999999999998 110.444 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.3 t -100.6 -72.7 0.66 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.658 1.183 . . . . 0.34999999999999998 108.992 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -166.77 -48.39 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.191 0.996 . . . . 0.34999999999999998 110.066 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.17 -35.63 12.06 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.675 1.99 . . . . 0.34999999999999998 115.385 -168.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.2 pt -132.23 171.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 124.163 0.985 . . . . 0.34999999999999998 110.963 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.09 42.34 0.59 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.277 1.031 . . . . 0.34999999999999998 111.064 172.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.01 54.47 0.56 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.785 1.234 . . . . 0.35999999999999999 110.214 170.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -44.09 -55.27 3.23 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 125.027 3.818 . . . . 0.34999999999999998 113.759 -173.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.39 67.95 1.83 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.162 -0.775 . . . . 0.34999999999999998 111.162 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -67.21 139.17 57.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.143 0.977 . . . . 0.34999999999999998 111.12 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -127.58 87.9 2.7 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.767 1.227 . . . . 0.35999999999999999 108.292 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -75.25 98.76 3.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.939 -1.504 . . . . 0.34999999999999998 106.939 174.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.53 96.67 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.679 1.192 . . . . 0.34999999999999998 108.398 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.3 m -84.88 146.8 27.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.185 0.994 . . . . 0.34999999999999998 109.783 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.14 122.82 29.36 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.776 -1.194 . . . . 0.34999999999999998 107.776 173.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.71 137.2 57.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 123.211 0.604 . . . . 0.34999999999999998 110.517 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.9 t -97.48 103.23 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.674 1.189 . . . . 0.34999999999999998 108.361 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.3 mt -82.05 126.13 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.231 1.012 . . . . 0.34999999999999998 109.977 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -100.44 140.63 34.42 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 107.84 -1.17 . . . . 0.34999999999999998 107.84 155.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.75 138.22 45.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.518 1.127 . . . . 0.34999999999999998 110.381 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 124.101 0.96 . . . . 0.25 109.013 178.358 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.9 t80 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 107.893 -1.151 . . . . 0.34999999999999998 107.893 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.77 92.76 0.16 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.953 1.301 . . . . 0.34999999999999998 111.967 -163.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -146.46 80.39 1.55 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.081 1.753 . . . . 0.34999999999999998 107.146 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.14 98.79 1.5 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.996 0.808 . . . . 0.34999999999999998 111.298 -175.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 54.65 63.48 2.13 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.204 1.402 . . . . 0.34999999999999998 109.744 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -109.61 -69.55 0.86 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.513 1.525 . . . . 0.34999999999999998 109.525 -174.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 65.17 165.64 0.17 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.686 1.594 . . . . 0.34999999999999998 111.83 -170.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -46.36 -53.45 10.88 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.368 1.467 . . . . 0.34999999999999998 112.054 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.61 -23.65 0.56 Allowed Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.952 0.787 . . . . 0.34999999999999998 111.648 -175.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.11 -22.6 65.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.929 1.292 . . . . 0.34999999999999998 112.604 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.67 130.0 44.69 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 123.625 0.77 . . . . 0.34999999999999998 110.865 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.43 52.7 0.73 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.831 0.852 . . . . 0.34999999999999998 109.103 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -61.85 140.37 58.27 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.307 1.043 . . . . 0.34999999999999998 111.104 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 64.73 174.27 0.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.352 1.461 . . . . 0.34999999999999998 113.156 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.5 t80 56.59 88.56 0.05 OUTLIER 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.85 2.06 . . . . 0.34999999999999998 112.028 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 70.43 154.72 0.15 Allowed Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.431 1.892 . . . . 0.33000000000000002 111.474 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -63.61 100.65 0.29 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.146 2.564 . . . . 0.34999999999999998 109.58 163.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -107.35 -70.79 0.78 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.931 0.892 . . . . 0.34999999999999998 111.263 -172.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.23 111.5 0.45 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.884 -0.953 . . . . 0.33000000000000002 110.801 -169.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.5 -179.29 4.33 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.403 2.735 . . . . 0.34999999999999998 112.294 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -165.65 178.84 6.38 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.145 0.978 . . . . 0.34999999999999998 110.549 -166.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -153.02 92.63 1.65 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.059 1.344 . . . . 0.34999999999999998 107.586 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 68.3 mtp -88.05 101.42 13.76 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.402 1.481 . . . . 0.34999999999999998 110.409 -168.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.2 t -98.78 112.32 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.187 0.995 . . . . 0.34999999999999998 109.591 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -175.46 171.44 2.83 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.502 1.121 . . . . 0.35999999999999999 109.964 174.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.87 140.33 36.15 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.11 0.964 . . . . 0.34999999999999998 111.785 -178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.6 m -70.55 101.25 1.97 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.448 1.899 . . . . 0.34999999999999998 108.947 175.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.08 87.0 1.33 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.04 0.829 . . . . 0.34999999999999998 111.654 -172.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.2 m -85.04 166.46 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 123.895 0.878 . . . . 0.34999999999999998 110.477 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.23 -42.8 30.13 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.804 -0.443 . . . . 0.34999999999999998 109.804 166.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 t -173.11 -53.72 0.02 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 125.246 1.418 . . . . 0.34999999999999998 110.022 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -92.6 41.87 1.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.484 1.114 . . . . 0.34999999999999998 113.92 -159.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.81 60.47 8.4 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.494 -0.642 . . . . 0.34999999999999998 111.494 172.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -157.19 98.67 1.74 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.163 0.985 . . . . 0.35999999999999999 109.42 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.65 118.64 7.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.805 1.242 . . . . 0.34999999999999998 111.01 -173.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.89 -48.07 26.68 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.941 0.896 . . . . 0.34999999999999998 110.036 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.5 mt -86.62 -169.37 2.61 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.405 1.082 . . . . 0.34999999999999998 111.053 -171.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.8 p -130.32 78.62 74.09 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 106.87 -1.53 . . . . 0.33000000000000002 106.87 163.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -85.49 77.14 2.8 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 124.804 3.669 . . . . 0.34999999999999998 109.636 -166.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -150.12 85.67 1.41 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.132 0.973 . . . . 0.34999999999999998 108.602 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -155.55 -48.42 0.08 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.249 0.62 . . . . 0.34999999999999998 112.273 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.55 119.88 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.009 0.822 . . . . 0.34999999999999998 110.048 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -156.43 151.84 26.73 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.541 1.137 . . . . 0.34999999999999998 109.788 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -129.93 153.32 80.95 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 125.502 1.521 . . . . 0.33000000000000002 108.742 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.39 60.9 7.51 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.711 2.94 . . . . 0.34999999999999998 110.345 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 tp 39.97 89.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.689 1.996 . . . . 0.34999999999999998 112.578 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -107.87 92.24 8.73 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.879 1.272 . . . . 0.33000000000000002 108.633 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.87 155.96 48.31 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.127 2.551 . . . . 0.34999999999999998 110.804 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.08 -50.4 0.7 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.573 -1.011 . . . . 0.34999999999999998 110.573 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.4 t -63.01 146.48 53.11 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.905 0.882 . . . . 0.34999999999999998 110.729 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 m -77.97 116.88 18.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.622 -0.51 . . . . 0.34999999999999998 109.622 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -77.08 86.19 3.58 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.021 1.328 . . . . 0.34999999999999998 108.572 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 p -150.0 151.85 33.97 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.682 1.193 . . . . 0.34999999999999998 110.558 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -52.51 -53.06 50.93 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.178 1.391 . . . . 0.34999999999999998 111.208 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -49.78 -45.32 49.61 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.677 1.191 . . . . 0.34999999999999998 112.978 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -76.52 -50.01 15.05 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.018 0.372 . . . . 0.34999999999999998 111.506 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.7 mm -54.22 -38.18 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.646 1.178 . . . . 0.34999999999999998 112.402 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -52.9 -61.01 2.57 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.957 0.799 . . . . 0.34999999999999998 112.015 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -71.41 -36.83 71.47 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.697 0.258 . . . . 0.34999999999999998 111.697 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -64.77 -47.99 76.14 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.759 0.824 . . . . 0.34999999999999998 111.786 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 p -71.89 -28.19 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.497 0.719 . . . . 0.34999999999999998 111.322 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.69 -44.5 90.09 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 123.019 0.528 . . . . 0.34999999999999998 109.643 172.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -66.18 -20.86 66.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.45 0.7 . . . . 0.34999999999999998 112.369 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.33 -47.3 64.82 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.886 0.766 . . . . 0.34999999999999998 110.914 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -39.36 84.98 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 109.936 -0.394 . . . . 0.34999999999999998 109.936 173.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -93.42 52.12 1.7 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.876 1.271 . . . . 0.34999999999999998 110.033 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.96 -58.84 2.01 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.019 1.328 . . . . 0.34999999999999998 108.541 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.1 p -80.87 -50.16 10.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.622 1.169 . . . . 0.34999999999999998 110.658 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.46 -97.61 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.971 0.908 . . . . 0.34999999999999998 109.917 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.3 t80 54.98 87.63 0.05 OUTLIER 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.914 1.686 . . . . 0.34999999999999998 113.072 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -161.23 -49.33 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.237 0.615 . . . . 0.34999999999999998 109.954 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -120.75 50.73 1.3 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.026 1.33 . . . . 0.34999999999999998 109.521 -175.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -139.04 92.0 2.56 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.371 1.068 . . . . 0.34999999999999998 109.855 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -73.43 -40.0 64.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.463 1.105 . . . . 0.34999999999999998 111.35 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.5 t 74.24 115.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 126.169 1.788 . . . . 0.34999999999999998 110.798 -175.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.05 -67.37 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 108.13 -1.063 . . . . 0.34999999999999998 108.13 172.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -145.12 165.02 29.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.844 1.658 . . . . 0.34999999999999998 109.116 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -130.67 129.17 42.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.058 1.343 . . . . 0.34999999999999998 107.431 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.91 132.28 84.97 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.946 -0.39 . . . . 0.33000000000000002 109.946 -168.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.99 -22.71 22.68 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.505 2.803 . . . . 0.34999999999999998 111.517 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.2 m -82.61 68.04 8.91 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.371 1.068 . . . . 0.34999999999999998 110.328 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.99 165.09 25.76 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.864 0.865 . . . . 0.34999999999999998 110.267 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -148.71 132.62 17.1 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.219 0.533 . . . . 0.34999999999999998 112.119 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.2 114.69 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.877 -1.897 . . . . 0.34999999999999998 105.877 171.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -107.94 58.1 0.62 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.957 0.903 . . . . 0.34999999999999998 108.628 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.77 103.69 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.953 0.901 . . . . 0.34999999999999998 110.372 -174.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 89.9 m -99.61 100.76 11.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.399 1.48 . . . . 0.34999999999999998 108.114 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -98.87 84.89 3.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.015 0.926 . . . . 0.34999999999999998 110.314 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -69.92 75.95 0.47 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.373 1.869 . . . . 0.34999999999999998 109.769 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -120.5 65.53 0.84 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.14 1.376 . . . . 0.34999999999999998 108.677 -170.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.7 110.35 6.19 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.35 0.66 . . . . 0.34999999999999998 110.269 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -178.68 -47.6 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.293 1.837 . . . . 0.35999999999999999 108.801 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -37.48 0.11 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.367 1.067 . . . . 0.34999999999999998 110.883 172.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -78.06 -52.6 8.5 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.612 0.765 . . . . 0.34999999999999998 110.651 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt 72.95 170.46 0.31 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.799 1.639 . . . . 0.34999999999999998 111.382 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.16 125.23 24.33 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.663 0.785 . . . . 0.34999999999999998 111.157 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -140.51 108.74 5.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.579 -1.267 . . . . 0.34999999999999998 107.579 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.4 m -76.0 86.54 2.92 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.026 -1.102 . . . . 0.34999999999999998 108.026 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -80.47 98.29 7.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.066 0.946 . . . . 0.34999999999999998 108.553 -175.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.6 p -87.29 64.54 8.33 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.719 1.208 . . . . 0.34999999999999998 111.116 -174.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -65.9 134.73 95.15 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.727 -0.842 . . . . 0.33000000000000002 108.727 170.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.35 -114.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.24 2.627 . . . . 0.34999999999999998 109.511 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 tp -161.67 151.57 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.973 0.806 . . . . 0.34999999999999998 109.74 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.9 p -127.16 150.05 49.68 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.057 1.343 . . . . 0.34999999999999998 109.678 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -67.37 0.48 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.477 0.711 . . . . 0.34999999999999998 110.023 -176.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -108.78 101.71 10.81 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 106.607 -1.627 . . . . 0.34999999999999998 106.607 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.15 -97.91 0.87 Allowed Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.332 0.968 . . . . 0.34999999999999998 111.86 -168.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -159.37 177.54 10.89 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.261 0.624 . . . . 0.34999999999999998 111.443 -163.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.1 t -102.71 150.63 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.982 1.713 . . . . 0.34999999999999998 110.142 -175.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.3 t -54.52 114.91 7.5 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.308 1.043 . . . . 0.33000000000000002 108.88 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.08 148.81 19.55 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.791 2.327 . . . . 0.34999999999999998 111.016 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -94.18 -178.19 4.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.956 1.303 . . . . 0.34999999999999998 110.132 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.85 165.35 25.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.725 0.81 . . . . 0.34999999999999998 111.518 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.3 t -142.22 -68.42 0.37 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.464 1.106 . . . . 0.34999999999999998 109.57 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -163.87 -52.71 0.03 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.208 1.003 . . . . 0.34999999999999998 109.497 -174.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -42.08 -43.81 3.38 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.872 2.069 . . . . 0.34999999999999998 114.068 -173.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.1 pt -133.82 173.9 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.606 0.762 . . . . 0.34999999999999998 111.398 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -107.06 -44.92 4.27 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 126.203 1.801 . . . . 0.34999999999999998 108.685 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -120.4 101.56 46.39 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.907 1.283 . . . . 0.35999999999999999 110.865 -170.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -57.83 -59.51 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.452 2.768 . . . . 0.34999999999999998 111.926 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 64.92 66.89 2.25 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.759 -0.937 . . . . 0.34999999999999998 110.759 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -70.72 144.67 50.89 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.392 1.077 . . . . 0.34999999999999998 111.162 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -132.16 92.93 3.18 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.371 1.068 . . . . 0.35999999999999999 108.995 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.74 62.92 7.76 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.442 1.097 . . . . 0.34999999999999998 108.628 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.98 125.14 54.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 125.465 1.506 . . . . 0.34999999999999998 107.141 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.9 m -141.88 172.65 12.39 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.251 1.82 . . . . 0.34999999999999998 107.631 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.69 131.55 56.92 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.556 1.142 . . . . 0.34999999999999998 109.49 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.4 m -130.24 155.21 41.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 C-N-CA 124.677 1.191 . . . . 0.34999999999999998 110.371 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.63 103.51 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.977 1.311 . . . . 0.34999999999999998 108.716 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 29.1 mt -81.37 139.05 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.122 0.969 . . . . 0.34999999999999998 110.772 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -102.66 128.99 49.13 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.417 -1.697 . . . . 0.34999999999999998 106.417 162.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -84.33 74.2 10.37 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.497 -0.927 . . . . 0.34999999999999998 108.497 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.341 0.228 0 C-N-CA 125.735 1.614 . . . . 0.25 109.475 -173.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 t80 . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.441 -0.577 . . . . 0.34999999999999998 109.441 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -124.96 53.37 1.5 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.335 1.054 . . . . 0.34999999999999998 110.392 -174.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -122.52 -51.78 1.94 Allowed 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.497 1.119 . . . . 0.34999999999999998 108.573 173.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.61 78.85 0.8 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.648 . . . . 0.34999999999999998 112.331 169.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp 58.21 73.4 0.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.686 1.194 . . . . 0.34999999999999998 111.484 166.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -111.84 60.55 0.62 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.44 1.096 . . . . 0.34999999999999998 109.802 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.19 177.89 8.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.756 0.823 . . . . 0.34999999999999998 112.482 -168.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.7 tttm 60.48 52.86 4.44 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 127.111 2.165 . . . . 0.34999999999999998 110.447 -172.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.42 -86.38 0.46 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 106.828 -2.509 . . . . 0.34999999999999998 106.828 172.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t0 53.28 61.96 2.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.259 1.024 . . . . 0.34999999999999998 109.499 176.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 64.87 53.92 1.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.425 1.49 . . . . 0.34999999999999998 110.953 -171.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.74 91.06 0.05 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.936 1.694 . . . . 0.34999999999999998 112.362 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -55.23 -53.86 50.76 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.503 1.121 . . . . 0.34999999999999998 111.44 -176.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -77.12 175.84 9.26 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.11 0.964 . . . . 0.34999999999999998 111.851 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.3 t80 60.12 84.86 0.11 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 126.38 1.872 . . . . 0.34999999999999998 111.107 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 66.37 158.92 0.13 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 126.491 1.916 . . . . 0.33000000000000002 112.144 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.06 129.97 35.82 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.157 2.572 . . . . 0.34999999999999998 111.592 167.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.5 p -121.92 -57.54 1.79 Allowed 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.506 1.123 . . . . 0.34999999999999998 109.122 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.69 172.96 43.61 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 112.343 -0.303 . . . . 0.33000000000000002 112.343 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.48 166.47 19.52 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 124.223 3.282 . . . . 0.34999999999999998 113.835 -173.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -154.75 161.52 41.48 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.811 1.244 . . . . 0.34999999999999998 109.668 167.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 tt -157.32 99.15 1.76 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.446 -0.946 . . . . 0.34999999999999998 108.446 -170.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.9 mtp -92.14 146.34 23.8 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.396 1.479 . . . . 0.34999999999999998 110.329 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.6 t -146.05 90.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.4 0 C-N-CA 124.046 0.939 . . . . 0.34999999999999998 110.458 -167.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -156.01 -179.7 8.39 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.356 1.062 . . . . 0.35999999999999999 110.949 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.7 m -129.33 150.61 34.79 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 125.028 1.331 . . . . 0.34999999999999998 111.494 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.1 m -80.62 91.77 5.88 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.014 -1.476 . . . . 0.34999999999999998 107.014 169.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.31 73.05 2.71 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.071 -0.812 . . . . 0.34999999999999998 111.071 -172.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.89 147.29 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 122.944 0.498 . . . . 0.34999999999999998 110.679 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.99 178.88 5.95 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.598 1.159 . . . . 0.34999999999999998 109.323 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -47.31 -45.31 24.25 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.202 1.001 . . . . 0.34999999999999998 110.599 164.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -105.95 34.36 3.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.723 1.209 . . . . 0.34999999999999998 111.562 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.62 -25.14 8.7 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.111 -0.827 . . . . 0.34999999999999998 115.032 167.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -61.32 124.93 21.99 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.344 1.072 . . . . 0.35999999999999999 111.64 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.62 101.01 0.95 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.581 0.752 . . . . 0.34999999999999998 110.205 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.74 -50.09 39.85 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.384 1.074 . . . . 0.34999999999999998 110.007 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 pp -130.47 150.76 51.53 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.663 1.185 . . . . 0.34999999999999998 110.224 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 t -82.8 147.49 55.13 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.044 0.937 . . . . 0.33000000000000002 111.604 -164.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.03 27.58 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.31 3.34 . . . . 0.34999999999999998 112.588 171.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -169.09 132.44 1.33 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.931 0.893 . . . . 0.34999999999999998 109.652 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -165.28 -72.47 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.381 1.073 . . . . 0.34999999999999998 109.481 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.07 147.05 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.702 0.801 . . . . 0.34999999999999998 109.716 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -142.94 166.79 23.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.723 0.809 . . . . 0.34999999999999998 111.142 174.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -141.04 144.82 36.53 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 125.049 1.339 . . . . 0.33000000000000002 108.576 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.06 64.77 8.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.948 3.099 . . . . 0.34999999999999998 110.655 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.258 9.0 tt 39.42 110.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 129.567 3.147 . . . . 0.34999999999999998 114.608 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -119.83 82.32 27.48 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.263 1.025 . . . . 0.33000000000000002 108.528 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -82.9 -170.31 0.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.952 3.101 . . . . 0.34999999999999998 110.576 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.41 -41.57 2.1 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.739 -0.945 . . . . 0.34999999999999998 110.739 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.9 t -66.32 152.61 44.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.604 0.762 . . . . 0.34999999999999998 110.347 174.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.5 m -69.18 150.31 47.64 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.779 -0.823 . . . . 0.34999999999999998 108.779 171.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.3 tp -127.41 102.93 7.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.912 -1.144 . . . . 0.34999999999999998 107.912 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -151.61 176.07 11.72 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.505 1.522 . . . . 0.34999999999999998 109.43 -170.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -63.13 -47.49 82.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.738 0.415 . . . . 0.34999999999999998 111.46 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.93 -30.73 70.95 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.012 0.745 . . . . 0.34999999999999998 113.012 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -64.39 -54.61 30.17 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.205 0.602 . . . . 0.34999999999999998 109.377 171.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mm -51.55 -49.88 31.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 125.143 1.377 . . . . 0.34999999999999998 111.18 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -45.49 -56.71 4.77 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.665 1.186 . . . . 0.34999999999999998 112.518 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -75.31 -37.14 60.96 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.969 0.359 . . . . 0.34999999999999998 111.969 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -67.11 -48.65 67.48 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.669 0.787 . . . . 0.34999999999999998 111.958 -169.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.4 m -67.99 -33.0 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.884 0.473 . . . . 0.34999999999999998 111.266 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -65.13 -41.17 95.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.541 0.737 . . . . 0.34999999999999998 110.678 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -35.12 75.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.453 0.701 . . . . 0.34999999999999998 111.148 176.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.77 -48.58 76.39 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.592 0.757 . . . . 0.34999999999999998 111.334 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.8 -19.98 61.24 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.386 0.675 . . . . 0.34999999999999998 112.423 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -77.29 13.41 1.18 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.448 0.699 . . . . 0.34999999999999998 112.197 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.57 -41.4 65.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.375 -0.602 . . . . 0.34999999999999998 109.375 160.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 70.2 p -103.35 -49.4 3.73 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.208 1.403 . . . . 0.34999999999999998 111.748 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.75 -85.67 0.09 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.8 0.84 . . . . 0.34999999999999998 111.32 -170.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.8 p90 51.62 18.17 0.68 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.3 2.24 . . . . 0.34999999999999998 116.016 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -131.99 -81.02 0.51 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.31 0.959 . . . . 0.34999999999999998 112.097 -164.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -97.26 -54.46 3.15 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.577 0.751 . . . . 0.34999999999999998 111.943 -158.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -45.37 145.57 1.16 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.433 2.293 . . . . 0.34999999999999998 114.378 -173.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -85.69 -63.08 1.38 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.872 1.269 . . . . 0.34999999999999998 111.348 -172.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.3 t 72.1 97.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 126.071 1.748 . . . . 0.34999999999999998 108.984 -164.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.69 -65.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.085 0.954 . . . . 0.34999999999999998 109.305 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -162.51 135.78 6.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.879 0.872 . . . . 0.34999999999999998 109.186 -174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.67 152.83 24.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.838 0.855 . . . . 0.34999999999999998 110.927 177.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.87 145.53 50.25 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.948 -0.76 . . . . 0.33000000000000002 108.948 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.12 -17.12 40.64 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.47 2.78 . . . . 0.34999999999999998 111.993 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -83.39 61.51 6.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.509 1.124 . . . . 0.34999999999999998 111.069 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.98 141.24 45.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.223 -1.399 . . . . 0.34999999999999998 107.223 159.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -148.61 131.57 16.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.191 0.52 . . . . 0.34999999999999998 112.4 -171.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 mp -75.88 116.41 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.439 -1.689 . . . . 0.34999999999999998 106.439 168.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -107.68 68.82 0.72 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.343 -1.354 . . . . 0.34999999999999998 107.343 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.98 115.01 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.924 0.89 . . . . 0.34999999999999998 110.519 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.0 m -110.16 87.33 2.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.47 1.508 . . . . 0.34999999999999998 108.496 -172.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.62 87.12 3.99 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.018 1.327 . . . . 0.34999999999999998 111.22 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -74.77 85.5 2.17 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.961 1.305 . . . . 0.34999999999999998 109.674 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -132.81 71.77 1.48 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.376 -0.972 . . . . 0.34999999999999998 108.376 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -53.12 -22.43 6.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.646 1.578 . . . . 0.34999999999999998 113.834 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -58.14 -31.41 67.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.73 1.212 . . . . 0.35999999999999999 112.438 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.7 -52.48 0.34 Allowed 'General case' 0 C--N 1.344 0.367 0 N-CA-C 112.662 0.615 . . . . 0.34999999999999998 112.662 173.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -87.4 -58.45 2.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.647 0.658 . . . . 0.34999999999999998 111.644 -168.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt 85.65 160.99 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.975 2.11 . . . . 0.34999999999999998 110.492 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.41 97.9 0.6 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.791 1.236 . . . . 0.34999999999999998 111.506 -174.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -119.18 123.63 44.82 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 107.729 -1.211 . . . . 0.34999999999999998 107.729 168.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.1 m -87.99 83.14 7.07 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.453 1.101 . . . . 0.34999999999999998 108.179 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -75.16 119.81 19.81 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.344 1.057 . . . . 0.34999999999999998 109.916 -170.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.6 m -83.09 74.75 9.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.101 1.361 . . . . 0.34999999999999998 111.488 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -80.52 132.99 56.93 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.75 -1.204 . . . . 0.33000000000000002 107.75 165.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.72 -118.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.309 2.673 . . . . 0.34999999999999998 110.178 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.4 tp -159.87 155.38 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.462 1.105 . . . . 0.34999999999999998 108.777 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.8 p -124.01 136.8 54.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.147 0.979 . . . . 0.34999999999999998 109.058 174.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -73.17 -33.1 65.26 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.945 0.898 . . . . 0.34999999999999998 110.776 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -21.13 65.1 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.424 0.69 . . . . 0.34999999999999998 112.205 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.96 174.96 43.56 Favored Glycine 0 C--N 1.341 0.85 0 C-N-CA 123.904 0.764 . . . . 0.34999999999999998 114.223 166.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -161.43 136.16 7.25 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.406 1.083 . . . . 0.34999999999999998 109.867 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.16 126.48 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.653 -0.869 . . . . 0.34999999999999998 108.653 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.2 t -73.02 121.62 85.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 107.475 -1.305 . . . . 0.33000000000000002 107.475 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.43 -102.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.246 2.63 . . . . 0.34999999999999998 110.432 -173.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -163.52 111.44 1.2 Allowed 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.497 1.119 . . . . 0.34999999999999998 108.271 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.413 HD12 ' HD3' ' A' ' 123' ' ' PRO . 2.9 tm? -87.9 97.22 10.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.157 0.983 . . . . 0.34999999999999998 108.587 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.5 t -170.76 86.68 0.11 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.951 1.3 . . . . 0.34999999999999998 108.391 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -153.34 -71.48 0.14 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.329 0.652 . . . . 0.34999999999999998 109.485 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -92.76 -52.29 4.69 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.469 1.108 . . . . 0.34999999999999998 109.355 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.5 pt -109.51 169.13 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.392 1.477 . . . . 0.34999999999999998 108.934 170.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.89 19.63 0.26 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.372 1.249 . . . . 0.34999999999999998 114.372 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -137.96 61.52 28.68 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.093 0.86 . . . . 0.35999999999999999 111.85 175.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.413 ' HD3' HD12 ' A' ' 116' ' ' LEU . 94.7 Cg_endo -73.53 172.73 15.13 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.219 3.279 . . . . 0.34999999999999998 111.36 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.38 68.49 0.43 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.051 -1.219 . . . . 0.34999999999999998 110.051 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -64.02 88.93 0.05 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.353 1.461 . . . . 0.34999999999999998 110.407 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -99.51 100.65 11.7 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.641 -0.874 . . . . 0.35999999999999999 108.641 -174.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.6 93.47 8.38 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.385 1.074 . . . . 0.34999999999999998 109.055 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.17 134.49 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.504 -1.295 . . . . 0.34999999999999998 107.504 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 44.7 m -142.67 116.58 9.34 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 107.269 -1.382 . . . . 0.34999999999999998 107.269 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -73.42 133.17 43.67 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.421 -0.585 . . . . 0.34999999999999998 109.421 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.9 m -134.36 136.7 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.111 0.965 . . . . 0.34999999999999998 109.604 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 77.6 t -82.58 137.35 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.406 -0.961 . . . . 0.34999999999999998 108.406 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 47.2 mt -137.26 133.45 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.697 1.199 . . . . 0.34999999999999998 108.978 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -97.44 130.26 44.57 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.324 -1.361 . . . . 0.34999999999999998 107.324 161.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -72.2 96.26 1.78 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.724 -0.843 . . . . 0.34999999999999998 108.724 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.34 0.168 0 C-N-CA 125.538 1.535 . . . . 0.25 109.325 -167.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.465 ' N ' ' HH ' ' A' ' 44' ' ' TYR . 47.1 t80 . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 120.655 0.264 . . . . 0.34999999999999998 110.885 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -112.57 42.03 1.91 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.405 1.082 . . . . 0.34999999999999998 109.101 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.63 -47.7 0.69 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.029 1.732 . . . . 0.34999999999999998 109.523 -177.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.67 56.16 1.92 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.766 -0.934 . . . . 0.34999999999999998 110.766 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 56.99 70.72 0.63 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.295 1.438 . . . . 0.34999999999999998 111.458 176.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -90.58 0.41 57.37 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.178 1.391 . . . . 0.34999999999999998 112.449 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -175.59 3.24 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.268 1.027 . . . . 0.34999999999999998 112.009 -176.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.5 tttp 93.94 -22.41 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.601 2.36 . . . . 0.34999999999999998 112.456 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.6 81.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.859 1.219 . . . . 0.34999999999999998 114.523 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -84.55 56.02 3.65 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.227 1.013 . . . . 0.34999999999999998 111.068 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 48.99 45.05 22.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.494 1.517 . . . . 0.34999999999999998 111.758 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.46 53.08 0.89 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.401 1.081 . . . . 0.34999999999999998 109.679 -172.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 m -87.47 -122.26 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.762 0.825 . . . . 0.34999999999999998 110.526 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -163.41 145.11 9.58 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.043 1.337 . . . . 0.34999999999999998 108.11 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.1 t80 66.85 119.22 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.828 1.651 . . . . 0.34999999999999998 111.369 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 68.55 151.85 0.13 Allowed Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 126.454 1.902 . . . . 0.33000000000000002 111.699 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.71 92.08 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.335 2.69 . . . . 0.34999999999999998 110.82 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.5 p -75.47 -42.96 51.82 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.807 0.843 . . . . 0.34999999999999998 109.938 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.78 166.06 26.22 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.468 -0.653 . . . . 0.33000000000000002 111.468 172.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.93 168.43 19.1 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.186 3.258 . . . . 0.34999999999999998 111.09 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -163.34 176.62 9.69 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.389 1.076 . . . . 0.34999999999999998 110.628 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 tt -156.59 94.14 1.44 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.079 0.951 . . . . 0.34999999999999998 108.706 -175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -89.1 143.28 26.95 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.327 0.651 . . . . 0.34999999999999998 109.923 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.9 t -144.67 91.41 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.244 1.017 . . . . 0.34999999999999998 108.585 -172.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -153.31 162.49 41.24 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.607 1.163 . . . . 0.35999999999999999 110.709 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -95.85 153.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 124.963 1.305 . . . . 0.34999999999999998 110.097 174.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -88.91 93.84 9.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.412 -1.699 . . . . 0.34999999999999998 106.412 169.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.77 105.77 1.63 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.505 -1.038 . . . . 0.34999999999999998 110.505 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.49 169.64 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.927 1.291 . . . . 0.34999999999999998 109.996 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -87.3 -179.78 6.47 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.829 0.852 . . . . 0.34999999999999998 109.128 166.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 t -60.54 -38.79 85.6 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.663 0.785 . . . . 0.34999999999999998 110.869 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -76.78 -0.91 25.59 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.427 1.091 . . . . 0.34999999999999998 112.571 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.59 52.13 6.15 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 110.968 -0.853 . . . . 0.34999999999999998 110.968 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -120.45 108.35 14.0 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.623 1.169 . . . . 0.35999999999999999 108.416 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -65.96 118.29 9.54 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.793 0.837 . . . . 0.34999999999999998 111.79 -172.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.34 -40.22 30.79 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.5 1.12 . . . . 0.34999999999999998 109.875 169.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 pp -151.89 154.42 36.09 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.358 1.063 . . . . 0.34999999999999998 112.304 -164.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.7 m -88.5 154.31 50.98 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.151 1.38 . . . . 0.33000000000000002 110.353 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -86.14 49.79 2.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.314 3.342 . . . . 0.34999999999999998 110.47 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -149.13 97.2 2.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.685 0.794 . . . . 0.34999999999999998 109.523 -166.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.465 ' HH ' ' N ' ' A' ' 4' ' ' PHE . 42.8 p90 -162.15 -55.73 0.04 OUTLIER 'General case' 0 C--N 1.344 0.352 0 CA-C-O 118.85 -0.595 . . . . 0.34999999999999998 112.451 171.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 m -82.66 141.06 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.328 0.967 . . . . 0.34999999999999998 109.304 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -146.49 109.83 4.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.297 1.039 . . . . 0.34999999999999998 109.089 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -94.28 154.4 40.41 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 125.366 1.466 . . . . 0.33000000000000002 109.72 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.77 147.46 44.7 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.189 2.593 . . . . 0.34999999999999998 109.844 169.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.81 137.0 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 122.977 0.511 . . . . 0.34999999999999998 110.404 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -142.49 114.09 6.14 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.801 1.24 . . . . 0.33000000000000002 107.837 171.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.74 179.87 6.1 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.61 2.874 . . . . 0.34999999999999998 110.903 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.56 -26.66 18.92 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.424 -0.653 . . . . 0.34999999999999998 112.643 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 t -67.07 141.36 57.52 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.801 0.8 . . . . 0.34999999999999998 111.021 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.5 m -72.62 139.12 47.18 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.606 -0.887 . . . . 0.34999999999999998 108.606 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.67 117.24 16.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.978 0.911 . . . . 0.34999999999999998 108.963 -171.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.5 t -167.44 176.07 6.81 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.151 1.781 . . . . 0.34999999999999998 108.458 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -57.76 -52.38 65.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.933 0.893 . . . . 0.34999999999999998 110.796 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -64.56 -32.43 74.07 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.934 0.716 . . . . 0.34999999999999998 112.934 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -65.98 -57.69 7.22 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.567 0.621 . . . . 0.34999999999999998 110.369 175.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.79 -23.37 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.166 0.986 . . . . 0.34999999999999998 111.805 -172.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.54 -58.35 8.93 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.174 0.99 . . . . 0.34999999999999998 111.067 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -66.04 -37.85 86.88 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.14 0.427 . . . . 0.34999999999999998 111.2 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -62.96 -48.7 77.75 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.559 0.744 . . . . 0.34999999999999998 111.795 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.9 -36.77 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 118.256 0.48 . . . . 0.34999999999999998 111.585 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -63.53 -37.1 86.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.807 0.843 . . . . 0.34999999999999998 111.111 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -74.12 -37.8 64.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.872 0.469 . . . . 0.34999999999999998 111.041 176.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.16 -44.03 97.52 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.297 1.039 . . . . 0.34999999999999998 111.485 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.19 -41.49 63.78 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.904 0.482 . . . . 0.34999999999999998 111.644 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -76.83 -3.4 38.23 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.436 0.694 . . . . 0.34999999999999998 112.758 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.71 -42.45 83.77 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.866 0.757 . . . . 0.34999999999999998 110.33 173.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.9 t -103.2 -38.93 7.06 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.105 1.362 . . . . 0.34999999999999998 111.579 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.89 -101.18 0.03 OUTLIER 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.676 -0.678 . . . . 0.34999999999999998 110.795 -173.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.1 t80 75.74 -43.33 0.48 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 126.572 1.949 . . . . 0.34999999999999998 113.751 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -55.27 -67.1 0.3 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.345 1.458 . . . . 0.34999999999999998 112.593 -169.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -107.11 24.22 13.16 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.235 0.614 . . . . 0.34999999999999998 112.189 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -92.63 136.75 32.96 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.243 0.617 . . . . 0.34999999999999998 111.431 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -164.05 109.24 1.02 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.962 1.305 . . . . 0.34999999999999998 108.485 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 p -77.61 148.63 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.299 0.64 . . . . 0.34999999999999998 109.87 171.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.47 -44.48 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.699 1.2 . . . . 0.34999999999999998 109.888 173.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -129.39 151.54 49.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.269 1.428 . . . . 0.34999999999999998 108.853 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.75 143.52 32.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.313 1.045 . . . . 0.34999999999999998 109.909 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -72.39 117.24 57.04 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.787 0.835 . . . . 0.33000000000000002 108.978 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.89 -27.4 21.12 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.867 2.378 . . . . 0.34999999999999998 111.118 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.1 m -87.87 58.03 4.64 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.513 1.125 . . . . 0.34999999999999998 110.358 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.97 167.08 5.05 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.26 0.624 . . . . 0.34999999999999998 109.624 169.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -155.85 142.32 18.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.531 0.681 . . . . 0.34999999999999998 112.352 -171.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 mp -85.74 111.73 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 106.144 -1.798 . . . . 0.34999999999999998 106.144 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -100.99 70.78 1.38 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.614 -1.254 . . . . 0.34999999999999998 107.614 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.16 99.16 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.333 0.653 . . . . 0.34999999999999998 109.819 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 94.0 m -98.83 125.19 44.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.195 1.398 . . . . 0.34999999999999998 109.012 -173.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -139.43 132.84 30.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.255 1.022 . . . . 0.34999999999999998 109.484 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -101.26 60.34 0.91 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.451 1.5 . . . . 0.34999999999999998 108.669 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -81.71 82.29 7.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.226 0.61 . . . . 0.34999999999999998 109.665 -177.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -83.19 67.43 9.19 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.423 -0.955 . . . . 0.34999999999999998 108.423 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -143.77 -49.14 0.3 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.905 1.682 . . . . 0.35999999999999999 108.729 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 pttt -159.03 -54.93 0.06 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.512 0.725 . . . . 0.34999999999999998 111.856 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -74.97 -22.24 58.67 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.884 0.698 . . . . 0.34999999999999998 112.884 -172.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 81.0 tttt 75.5 164.18 0.26 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.785 1.634 . . . . 0.34999999999999998 111.973 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -56.62 106.18 0.27 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.332 1.453 . . . . 0.34999999999999998 110.528 172.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -145.17 145.28 31.29 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.414 1.086 . . . . 0.34999999999999998 109.637 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 94.0 m -119.6 95.84 4.95 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 125.182 1.393 . . . . 0.34999999999999998 108.056 176.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -70.64 125.44 26.83 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.253 -0.647 . . . . 0.34999999999999998 109.253 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -96.18 63.16 2.2 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.886 1.274 . . . . 0.34999999999999998 110.094 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -75.35 124.64 89.21 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 109.337 -0.616 . . . . 0.33000000000000002 109.337 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.76 162.47 26.93 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.205 2.604 . . . . 0.34999999999999998 111.454 -175.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.3 tp -76.97 152.68 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.017 0.927 . . . . 0.34999999999999998 109.866 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.1 p -105.24 -179.41 3.94 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.137 0.975 . . . . 0.34999999999999998 110.419 178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.57 -11.3 14.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.694 1.597 . . . . 0.34999999999999998 110.81 166.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -78.06 -87.69 0.05 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.625 1.17 . . . . 0.34999999999999998 110.506 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.15 63.79 0.01 OUTLIER Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.475 -1.05 . . . . 0.34999999999999998 110.475 -172.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -73.56 126.03 29.33 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.285 -0.635 . . . . 0.34999999999999998 109.285 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.67 135.25 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.663 -0.866 . . . . 0.34999999999999998 108.663 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.9 112.05 6.02 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 107.592 -1.262 . . . . 0.33000000000000002 107.592 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -89.32 14.66 2.16 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.927 2.418 . . . . 0.34999999999999998 112.673 -165.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.3 t70 60.11 -157.44 0.33 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.266 1.027 . . . . 0.34999999999999998 109.572 -168.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.5 tt -163.6 146.31 9.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.64 0.655 . . . . 0.34999999999999998 110.396 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.5 t -154.33 164.72 38.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.299 1.04 . . . . 0.34999999999999998 110.025 172.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 82.42 -76.7 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.172 1.789 . . . . 0.34999999999999998 112.635 165.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -69.15 -41.14 77.69 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.886 0.875 . . . . 0.34999999999999998 113.039 -168.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.1 pt -135.17 -173.35 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.699 0.8 . . . . 0.34999999999999998 109.367 169.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -158.81 28.86 0.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.176 0.59 . . . . 0.34999999999999998 112.113 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.1 50.13 0.45 Allowed Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.783 0.66 . . . . 0.35999999999999999 112.783 175.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -66.57 120.82 7.98 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.163 2.575 . . . . 0.34999999999999998 111.32 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.11 75.84 0.22 Allowed Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.91 1.243 . . . . 0.34999999999999998 110.419 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -64.05 85.79 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.515 1.926 . . . . 0.34999999999999998 112.157 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -92.41 99.49 12.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.24 0.616 . . . . 0.35999999999999999 109.603 -176.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.83 95.16 3.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.618 -0.882 . . . . 0.34999999999999998 108.618 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.6 mt -108.8 121.76 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 124.838 1.255 . . . . 0.34999999999999998 108.22 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.4 m -119.36 175.27 5.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.918 1.687 . . . . 0.34999999999999998 107.402 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -136.06 114.47 11.7 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.133 0.973 . . . . 0.34999999999999998 108.442 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.5 146.12 32.89 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 C-N-CA 123.462 0.705 . . . . 0.34999999999999998 110.841 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.1 t -81.22 111.63 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.297 1.039 . . . . 0.34999999999999998 108.318 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mt -101.09 110.39 27.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 108.219 -1.03 . . . . 0.34999999999999998 108.219 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -85.85 97.52 10.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.914 -1.143 . . . . 0.34999999999999998 107.914 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -61.57 126.75 28.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.427 0.691 . . . . 0.34999999999999998 110.832 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt . . . . . 0 N--CA 1.455 -0.185 0 C-N-CA 123.53 0.732 . . . . 0.25 109.915 179.171 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 t80 . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 120.962 0.41 . . . . 0.34999999999999998 109.914 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -89.13 75.78 7.83 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.43 1.092 . . . . 0.34999999999999998 110.111 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -162.19 -62.88 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.441 1.096 . . . . 0.34999999999999998 108.881 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.43 92.88 0.21 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.538 0.59 . . . . 0.34999999999999998 112.536 169.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt 58.8 51.69 7.31 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.764 1.225 . . . . 0.34999999999999998 111.674 164.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -85.17 -64.9 1.08 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.589 0.756 . . . . 0.34999999999999998 111.499 -174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp 75.96 118.82 0.05 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 127.143 2.177 . . . . 0.34999999999999998 109.664 -165.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -50.11 -47.94 53.71 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.024 1.329 . . . . 0.34999999999999998 110.418 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.33 -92.79 0.22 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.283 -1.527 . . . . 0.34999999999999998 109.283 175.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t70 52.51 66.62 1.16 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.218 1.407 . . . . 0.34999999999999998 110.688 -173.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -93.64 47.3 1.23 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.135 -1.061 . . . . 0.34999999999999998 108.135 170.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.05 70.13 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.152 1.781 . . . . 0.34999999999999998 107.083 -170.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 t -67.72 -71.29 0.21 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.308 0.643 . . . . 0.34999999999999998 111.523 -168.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -162.31 39.64 0.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 117.622 0.192 . . . . 0.34999999999999998 111.325 -167.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -157.36 115.67 3.19 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.032 0.533 . . . . 0.34999999999999998 110.726 -173.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 65.74 164.67 0.12 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.91 2.084 . . . . 0.33000000000000002 112.951 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -63.19 74.48 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.577 3.518 . . . . 0.34999999999999998 112.84 172.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 p -100.71 -39.91 7.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.063 1.745 . . . . 0.34999999999999998 109.077 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.84 157.43 10.03 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 112.02 -0.432 . . . . 0.33000000000000002 112.02 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -82.24 -178.62 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.504 3.469 . . . . 0.34999999999999998 110.827 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -157.46 169.4 24.78 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.115 0.966 . . . . 0.34999999999999998 110.39 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.1 tp -142.81 86.24 1.92 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.355 1.462 . . . . 0.34999999999999998 107.806 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.7 mtp -82.56 89.56 6.7 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.605 1.162 . . . . 0.34999999999999998 110.59 -176.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.49 91.95 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.362 1.065 . . . . 0.34999999999999998 109.059 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -149.18 172.58 14.6 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.492 1.117 . . . . 0.35999999999999999 109.985 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.58 153.45 19.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 123.993 0.917 . . . . 0.34999999999999998 111.204 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.5 m -94.39 94.66 8.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.885 1.274 . . . . 0.34999999999999998 107.909 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.78 116.26 7.64 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 109.479 -1.448 . . . . 0.34999999999999998 109.479 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -122.98 157.15 28.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 C-N-CA 125.661 1.584 . . . . 0.34999999999999998 109.191 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -79.43 178.33 8.19 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.581 -0.525 . . . . 0.34999999999999998 109.581 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 t -60.04 -46.11 90.61 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.533 0.733 . . . . 0.34999999999999998 110.304 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -68.98 -16.77 63.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.382 1.073 . . . . 0.34999999999999998 112.91 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.05 29.09 7.38 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.314 0.959 . . . . 0.34999999999999998 113.09 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -91.17 114.25 26.72 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 117.818 0.809 . . . . 0.35999999999999999 108.9 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.15 123.77 21.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.327 0.651 . . . . 0.34999999999999998 110.817 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 mp -93.63 -38.66 11.23 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.844 1.258 . . . . 0.34999999999999998 109.957 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -144.52 152.59 40.8 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.254 1.022 . . . . 0.34999999999999998 111.549 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.2 t -99.26 148.75 35.07 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.002 1.721 . . . . 0.33000000000000002 109.664 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -84.33 70.45 5.86 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.624 2.883 . . . . 0.34999999999999998 111.456 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -148.74 -177.74 5.96 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.783 0.833 . . . . 0.34999999999999998 110.508 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . 0.314 0.0 OUTLIER 100.02 -44.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.597 2.759 . . . . 0.34999999999999998 112.854 173.361 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.74 136.62 23.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 109.553 -0.536 . . . . 0.34999999999999998 109.553 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.04 171.98 15.5 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.091 0.956 . . . . 0.34999999999999998 109.35 164.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -161.12 132.9 4.1 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.657 -0.687 . . . . 0.33000000000000002 109.731 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.31 111.78 1.91 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.654 2.236 . . . . 0.34999999999999998 108.66 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 tt -60.92 144.8 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.147 0.979 . . . . 0.34999999999999998 112.944 -162.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -130.54 87.16 50.91 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.593 1.557 . . . . 0.33000000000000002 107.372 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.97 159.66 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.492 2.795 . . . . 0.34999999999999998 111.263 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.03 -33.4 2.46 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.268 0.937 . . . . 0.34999999999999998 111.364 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.7 t -71.58 157.43 38.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.211 1.004 . . . . 0.34999999999999998 111.321 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.4 p -72.81 167.24 21.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.191 0.996 . . . . 0.34999999999999998 110.953 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.29 119.64 3.5 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.754 0.822 . . . . 0.34999999999999998 108.888 -174.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -167.4 178.66 5.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.191 1.796 . . . . 0.34999999999999998 108.015 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -57.08 -46.92 82.16 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.56 -0.712 . . . . 0.34999999999999998 111.343 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.47 -34.25 77.76 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.197 0.599 . . . . 0.34999999999999998 111.967 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -104.06 53.66 0.74 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.788 1.235 . . . . 0.34999999999999998 109.97 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -159.18 -41.94 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.655 1.182 . . . . 0.34999999999999998 108.674 170.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.02 -44.38 82.78 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.11 0.964 . . . . 0.34999999999999998 111.765 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -59.33 -39.41 83.07 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.612 0.765 . . . . 0.34999999999999998 111.029 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -50.29 62.95 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.295 1.438 . . . . 0.34999999999999998 110.18 -171.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.28 -32.33 42.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 124.565 1.146 . . . . 0.34999999999999998 112.121 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -60.29 -49.18 78.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.531 -0.544 . . . . 0.34999999999999998 109.531 172.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -33.29 75.68 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.791 0.437 . . . . 0.34999999999999998 111.517 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.77 -55.23 32.36 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.564 0.746 . . . . 0.34999999999999998 110.965 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 pp -74.69 -15.76 60.78 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.956 0.724 . . . . 0.34999999999999998 112.956 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -79.41 71.39 5.97 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 123.878 0.871 . . . . 0.34999999999999998 110.033 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -168.68 -53.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.372 1.869 . . . . 0.34999999999999998 107.723 172.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.2 p -88.08 -35.11 17.68 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.656 1.583 . . . . 0.34999999999999998 111.202 -178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.19 74.76 1.32 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.273 1.429 . . . . 0.34999999999999998 108.436 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -133.3 -19.14 2.2 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.987 1.106 . . . . 0.34999999999999998 113.987 -165.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -59.58 -41.19 89.7 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.676 0.791 . . . . 0.34999999999999998 112.542 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -141.65 -66.62 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.151 1.38 . . . . 0.34999999999999998 109.311 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.9 p90 34.85 88.45 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.172 2.589 . . . . 0.34999999999999998 114.193 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -73.63 106.73 5.52 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 109.322 -0.622 . . . . 0.34999999999999998 109.322 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.21 120.4 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.332 -0.988 . . . . 0.34999999999999998 108.332 174.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.3 t -75.92 -73.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.587 -1.264 . . . . 0.34999999999999998 107.587 171.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -167.78 146.58 4.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.381 1.073 . . . . 0.34999999999999998 109.446 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.85 156.84 29.53 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.546 0.738 . . . . 0.34999999999999998 111.262 173.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.49 135.56 81.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 108.136 -1.061 . . . . 0.33000000000000002 108.136 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.62 -33.02 29.53 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.318 2.679 . . . . 0.34999999999999998 111.774 -176.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.0 m -86.77 70.21 10.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.337 1.055 . . . . 0.34999999999999998 110.263 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.61 169.99 16.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.379 0.672 . . . . 0.34999999999999998 109.746 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -159.41 143.43 14.95 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.512 0.56 . . . . 0.34999999999999998 112.512 -167.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.74 122.53 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 126.855 2.062 . . . . 0.34999999999999998 106.133 172.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -118.1 64.73 0.75 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.97 0.908 . . . . 0.34999999999999998 109.183 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.04 118.33 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.416 0.686 . . . . 0.34999999999999998 110.942 -176.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.2 m -111.57 100.59 9.11 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.509 1.123 . . . . 0.34999999999999998 109.529 -173.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.29 99.4 12.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.154 0.982 . . . . 0.34999999999999998 109.851 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -94.38 47.89 1.21 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.596 1.558 . . . . 0.34999999999999998 111.099 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -69.68 106.92 3.24 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.03 0.932 . . . . 0.34999999999999998 109.628 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -32.6 73.13 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.07 1.348 . . . . 0.34999999999999998 111.635 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -55.06 -50.15 69.85 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.702 1.201 . . . . 0.35999999999999999 113.017 -170.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 -41.44 0.09 Allowed 'General case' 0 C--N 1.342 0.279 0 N-CA-C 113.347 0.869 . . . . 0.34999999999999998 113.347 -175.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -70.56 -47.84 58.33 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.326 0.512 . . . . 0.34999999999999998 112.016 -168.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt 80.56 155.9 0.14 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.328 1.851 . . . . 0.34999999999999998 110.741 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -43.8 124.4 3.68 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 126.719 2.008 . . . . 0.34999999999999998 111.265 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.35 106.53 2.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.216 -1.031 . . . . 0.34999999999999998 108.216 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.3 m -78.15 97.96 5.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.454 1.102 . . . . 0.34999999999999998 109.171 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -82.13 96.94 7.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.785 0.834 . . . . 0.34999999999999998 108.957 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.8 m -76.07 120.01 20.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.671 0.789 . . . . 0.34999999999999998 109.272 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -134.79 125.33 17.3 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 125.351 1.46 . . . . 0.33000000000000002 108.527 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.51 162.36 33.31 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.063 2.509 . . . . 0.34999999999999998 111.559 -175.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.7 tp -73.88 159.96 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.574 1.149 . . . . 0.34999999999999998 110.13 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 p -116.21 177.79 4.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.221 1.009 . . . . 0.34999999999999998 110.202 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -103.11 -12.3 17.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.111 1.364 . . . . 0.34999999999999998 110.924 165.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -76.31 -76.34 0.16 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.606 1.163 . . . . 0.34999999999999998 111.116 -171.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 139.43 61.91 0.04 OUTLIER Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.846 -0.902 . . . . 0.34999999999999998 110.846 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -71.53 132.91 45.36 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 117.351 0.575 . . . . 0.34999999999999998 109.918 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.5 t -73.13 136.18 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.073 -0.714 . . . . 0.34999999999999998 109.073 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.98 118.49 43.05 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 107.33 -1.359 . . . . 0.33000000000000002 107.33 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.24 165.98 27.02 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.019 2.479 . . . . 0.34999999999999998 112.37 -165.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.42 165.85 22.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.6 1.16 . . . . 0.34999999999999998 110.866 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.1 mp -94.86 30.99 1.93 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.993 0.917 . . . . 0.34999999999999998 111.412 -173.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.0 t 46.71 -102.34 0.07 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.092 1.757 . . . . 0.34999999999999998 112.468 175.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -162.24 -44.22 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.986 1.315 . . . . 0.34999999999999998 109.653 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -83.1 22.17 1.0 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.244 1.418 . . . . 0.34999999999999998 113.186 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.4 tp -160.53 129.61 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.514 0.726 . . . . 0.34999999999999998 110.082 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -140.7 27.73 2.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.831 1.252 . . . . 0.34999999999999998 111.61 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -150.2 51.05 0.82 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 113.221 0.822 . . . . 0.35999999999999999 113.221 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -70.45 115.02 4.0 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.856 2.371 . . . . 0.34999999999999998 109.291 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -92.79 79.22 1.13 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.866 -1.294 . . . . 0.34999999999999998 109.866 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -62.4 107.15 0.86 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.003 0.921 . . . . 0.34999999999999998 110.387 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -99.79 94.56 6.39 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.34 1.056 . . . . 0.35999999999999999 108.743 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.75 74.72 10.14 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.554 -1.276 . . . . 0.34999999999999998 107.554 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.67 126.54 71.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 126.041 1.736 . . . . 0.34999999999999998 107.948 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.8 m -148.94 142.47 25.36 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.917 0.887 . . . . 0.34999999999999998 110.26 -173.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -72.85 140.35 47.54 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.264 1.026 . . . . 0.34999999999999998 109.96 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.1 m -142.36 144.52 24.75 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 123.891 0.876 . . . . 0.34999999999999998 109.661 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.05 100.23 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.876 -0.787 . . . . 0.34999999999999998 108.876 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 75.3 mt -119.67 144.14 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.46 1.504 . . . . 0.34999999999999998 109.062 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -131.29 80.79 1.95 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.556 1.542 . . . . 0.34999999999999998 107.773 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -58.41 150.2 22.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.731 0.812 . . . . 0.34999999999999998 111.954 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.196 -1.039 . . . . 0.25 108.196 178.62 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.6 p90 . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 114.966 1.469 . . . . 0.34999999999999998 114.966 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 53.42 -141.45 0.86 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.046 0.938 . . . . 0.34999999999999998 109.73 -171.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.4 pttt 11.29 76.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.631 2.772 . . . . 0.34999999999999998 114.922 169.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.53 113.02 5.28 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 124.683 1.135 . . . . 0.34999999999999998 111.663 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt 56.64 69.64 0.72 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.251 1.42 . . . . 0.34999999999999998 110.278 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -70.82 -45.9 63.73 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.611 0.764 . . . . 0.34999999999999998 111.143 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 66.34 5.31 3.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.165 1.786 . . . . 0.34999999999999998 114.006 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 tttm 54.07 -92.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.898 1.279 . . . . 0.34999999999999998 110.808 -172.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.86 58.72 0.07 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.393 -1.483 . . . . 0.34999999999999998 109.393 173.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -132.55 66.58 1.55 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.382 1.073 . . . . 0.34999999999999998 109.254 -176.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 64.47 -176.74 0.17 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.267 1.427 . . . . 0.34999999999999998 112.12 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.88 178.23 9.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.294 1.037 . . . . 0.34999999999999998 110.696 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.7 m -76.55 147.76 37.49 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.614 1.166 . . . . 0.34999999999999998 111.234 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 65.31 175.98 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.014 1.726 . . . . 0.34999999999999998 113.421 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.4 t80 59.35 90.56 0.05 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 126.448 1.899 . . . . 0.34999999999999998 111.257 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 66.96 161.33 0.14 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 125.573 1.549 . . . . 0.33000000000000002 111.131 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.28 90.52 1.0 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.359 2.039 . . . . 0.34999999999999998 108.619 173.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.2 p -63.86 -60.52 3.18 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.234 1.014 . . . . 0.34999999999999998 111.724 -166.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.68 172.0 32.55 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.962 -0.855 . . . . 0.33000000000000002 110.962 174.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -66.53 149.0 84.46 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.469 2.779 . . . . 0.34999999999999998 112.212 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -163.04 168.48 20.92 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.508 0.723 . . . . 0.34999999999999998 111.292 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tt -145.11 100.86 3.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.737 1.215 . . . . 0.34999999999999998 108.304 -173.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.6 mtp -88.16 134.06 33.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.722 1.609 . . . . 0.34999999999999998 109.541 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.1 t -137.01 87.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.346 0 C-N-CA 124.075 0.95 . . . . 0.34999999999999998 110.485 -168.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -159.35 165.64 32.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.958 1.303 . . . . 0.35999999999999999 110.395 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -94.02 153.17 3.44 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 124.627 1.171 . . . . 0.34999999999999998 112.267 -172.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -82.68 92.65 7.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.755 -1.572 . . . . 0.34999999999999998 106.755 163.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.88 80.79 1.64 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.95 -0.86 . . . . 0.34999999999999998 110.95 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 m -92.56 165.58 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.447 1.099 . . . . 0.34999999999999998 110.318 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -82.4 -162.1 0.53 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.877 0.871 . . . . 0.34999999999999998 110.41 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -53.28 -50.42 64.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.753 1.221 . . . . 0.34999999999999998 111.598 175.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -75.37 -84.11 0.05 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.368 1.067 . . . . 0.34999999999999998 110.33 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.76 46.89 0.06 OUTLIER Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.049 -0.82 . . . . 0.34999999999999998 111.049 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -112.37 108.09 17.14 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.152 1.381 . . . . 0.35999999999999999 108.257 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -70.49 112.34 6.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.886 0.874 . . . . 0.34999999999999998 111.433 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.1 mp -73.88 -45.87 48.23 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.749 0.82 . . . . 0.34999999999999998 109.442 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.2 147.3 36.33 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.858 0.863 . . . . 0.34999999999999998 111.413 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.0 m -91.75 159.45 38.32 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.282 1.433 . . . . 0.33000000000000002 111.29 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -87.27 49.86 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.507 2.805 . . . . 0.34999999999999998 111.914 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -168.72 120.49 0.78 Allowed 'General case' 0 C--N 1.343 0.293 0 N-CA-C 112.915 0.709 . . . . 0.34999999999999998 112.915 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -162.26 -45.09 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.528 1.531 . . . . 0.34999999999999998 109.223 159.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.98 130.87 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.522 -0.918 . . . . 0.34999999999999998 108.522 169.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -144.77 154.09 42.35 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.364 1.066 . . . . 0.34999999999999998 109.05 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -131.77 155.1 81.83 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 125.31 1.444 . . . . 0.33000000000000002 108.735 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.71 34.75 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.554 2.836 . . . . 0.34999999999999998 111.945 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.25 2.8 tt 59.45 134.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 128.679 2.792 . . . . 0.34999999999999998 114.372 -175.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -142.61 98.24 5.9 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.815 1.246 . . . . 0.33000000000000002 107.793 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.61 177.96 8.12 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.533 2.822 . . . . 0.34999999999999998 110.999 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.07 -32.99 6.95 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.977 0.799 . . . . 0.34999999999999998 111.695 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.6 t -67.18 148.71 51.44 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.471 0.708 . . . . 0.34999999999999998 110.682 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.2 m -76.63 109.93 10.79 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.892 -0.781 . . . . 0.34999999999999998 108.892 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.08 96.58 7.81 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.573 -1.269 . . . . 0.34999999999999998 107.573 176.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.3 t -147.31 160.56 42.37 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.502 1.121 . . . . 0.34999999999999998 109.924 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -60.29 -42.84 96.33 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 119.5 -0.286 . . . . 0.34999999999999998 111.576 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.06 -22.4 66.42 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.86 0.689 . . . . 0.34999999999999998 112.86 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -75.31 -58.85 3.03 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 123.401 0.68 . . . . 0.34999999999999998 109.895 167.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.4 mm -63.15 -39.42 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.457 1.103 . . . . 0.34999999999999998 112.813 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -52.25 -48.1 65.4 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.881 0.872 . . . . 0.34999999999999998 112.037 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -76.52 -39.84 51.78 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.063 0.392 . . . . 0.34999999999999998 111.526 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -69.89 -39.3 76.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.45 0.7 . . . . 0.34999999999999998 112.407 -169.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.89 -35.77 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.626 0.771 . . . . 0.34999999999999998 110.752 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -72.4 -34.64 68.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.303 1.041 . . . . 0.34999999999999998 111.071 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -47.08 73.86 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.746 0.819 . . . . 0.34999999999999998 110.051 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.8 -39.96 75.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.276 1.03 . . . . 0.34999999999999998 111.237 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.9 tp -69.1 -50.67 46.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.28 1.032 . . . . 0.34999999999999998 111.467 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -74.43 8.29 2.36 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.727 1.01 . . . . 0.34999999999999998 113.727 -174.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.84 -46.41 89.61 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.51 0.724 . . . . 0.34999999999999998 109.959 166.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 m -118.58 -51.93 2.37 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.679 1.192 . . . . 0.34999999999999998 110.352 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.96 82.38 6.7 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.164 0.985 . . . . 0.34999999999999998 110.866 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -128.89 -43.87 1.34 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.057 1.343 . . . . 0.34999999999999998 111.437 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -59.08 -71.31 0.12 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.212 1.405 . . . . 0.34999999999999998 110.576 -173.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.08 -35.74 74.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.378 1.071 . . . . 0.34999999999999998 110.771 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -58.32 146.41 34.52 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.833 1.253 . . . . 0.34999999999999998 111.629 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -156.13 141.24 17.37 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.564 1.146 . . . . 0.34999999999999998 109.562 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.6 t -88.06 137.16 21.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 124.317 1.047 . . . . 0.34999999999999998 109.449 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.95 -56.87 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.067 1.347 . . . . 0.34999999999999998 107.666 167.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -156.96 110.42 2.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.198 0.999 . . . . 0.34999999999999998 108.395 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 pp -87.82 132.22 34.25 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.36 0.664 . . . . 0.34999999999999998 109.823 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.77 124.46 90.77 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 108.322 -0.992 . . . . 0.33000000000000002 108.322 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.91 -54.1 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.829 2.353 . . . . 0.34999999999999998 111.793 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.7 m -74.5 96.14 2.87 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.989 0.916 . . . . 0.34999999999999998 109.969 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.44 133.58 49.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.871 0.868 . . . . 0.34999999999999998 110.132 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -95.81 108.77 21.14 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.166 0.987 . . . . 0.34999999999999998 110.26 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.04 113.04 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.694 -1.595 . . . . 0.34999999999999998 106.694 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.7 64.73 0.65 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.417 1.087 . . . . 0.34999999999999998 108.984 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.3 p -67.86 115.33 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.347 0.659 . . . . 0.34999999999999998 110.627 -176.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 m -111.32 101.38 9.86 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.418 1.087 . . . . 0.34999999999999998 108.985 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -92.92 102.91 15.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.748 1.219 . . . . 0.34999999999999998 108.962 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -81.03 61.65 4.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.647 1.179 . . . . 0.34999999999999998 109.611 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -99.03 85.66 3.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.391 1.477 . . . . 0.34999999999999998 108.453 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -82.59 52.19 2.03 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.763 0.825 . . . . 0.34999999999999998 110.706 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -137.36 -44.53 0.55 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.839 1.256 . . . . 0.35999999999999999 109.828 -170.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -140.64 -66.46 0.43 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.23 1.012 . . . . 0.34999999999999998 110.1 -173.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -89.58 -22.0 22.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.487 0.921 . . . . 0.34999999999999998 113.487 -164.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 tttm 74.92 159.43 0.22 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.855 1.662 . . . . 0.34999999999999998 111.494 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -53.8 117.63 3.32 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.506 1.122 . . . . 0.34999999999999998 109.951 168.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -141.33 111.74 6.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.827 -1.175 . . . . 0.34999999999999998 107.827 171.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.2 m -75.76 86.17 2.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.828 -1.175 . . . . 0.34999999999999998 107.828 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -80.42 97.17 6.96 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.051 0.94 . . . . 0.34999999999999998 108.957 -171.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.9 m -90.24 132.7 35.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.083 1.353 . . . . 0.34999999999999998 110.348 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -163.71 141.2 5.77 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 123.625 0.77 . . . . 0.33000000000000002 110.377 176.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.24 178.91 6.36 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 124.256 3.304 . . . . 0.34999999999999998 110.952 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.0 tp -138.02 143.44 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.228 0.611 . . . . 0.34999999999999998 110.56 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.2 p -100.27 -179.97 4.29 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.999 1.32 . . . . 0.34999999999999998 111.376 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.99 -36.36 72.52 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.738 1.615 . . . . 0.34999999999999998 112.805 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -88.54 -50.73 6.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.269 1.028 . . . . 0.34999999999999998 109.895 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.67 -144.27 45.17 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.156 -0.777 . . . . 0.34999999999999998 111.156 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -161.0 152.57 19.34 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.74 0.816 . . . . 0.34999999999999998 110.756 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.9 t -78.35 133.08 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.097 0.959 . . . . 0.34999999999999998 109.677 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.71 126.22 91.95 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 108.479 -0.934 . . . . 0.33000000000000002 108.479 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.21 -80.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.782 2.322 . . . . 0.34999999999999998 110.77 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -169.05 -56.55 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.902 1.281 . . . . 0.34999999999999998 109.205 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.461 HD11 HG13 ' A' ' 120' ' ' ILE . 2.6 tm? 69.48 99.08 0.06 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.491 1.916 . . . . 0.34999999999999998 110.434 -179.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.8 t -171.12 78.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.092 1.357 . . . . 0.34999999999999998 108.273 173.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -153.86 -77.35 0.11 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 122.782 0.433 . . . . 0.34999999999999998 110.146 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -88.24 -50.15 6.54 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.265 1.026 . . . . 0.34999999999999998 110.282 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.461 HG13 HD11 ' A' ' 116' ' ' LEU . 10.7 pt -103.51 169.37 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.38 1.072 . . . . 0.34999999999999998 109.333 166.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -137.53 -26.95 0.96 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.027 0.931 . . . . 0.34999999999999998 112.631 -166.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.05 58.1 27.38 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 123.702 0.801 . . . . 0.35999999999999999 112.92 -169.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.09 119.64 6.45 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.178 2.585 . . . . 0.34999999999999998 110.65 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.9 77.72 0.69 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 109.574 -1.411 . . . . 0.34999999999999998 109.574 177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -62.67 96.69 0.09 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.163 1.385 . . . . 0.34999999999999998 110.65 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -92.62 98.69 11.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.629 -0.878 . . . . 0.35999999999999999 108.629 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.36 76.97 8.28 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 108.075 -1.083 . . . . 0.34999999999999998 108.075 176.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.9 mt -90.24 122.34 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.181 -1.415 . . . . 0.34999999999999998 107.181 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.3 m -131.0 111.67 12.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.97 -1.122 . . . . 0.34999999999999998 107.97 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -62.99 137.01 58.15 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.365 0.666 . . . . 0.34999999999999998 110.299 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.7 149.67 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.869 0.867 . . . . 0.34999999999999998 109.517 169.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.96 142.54 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.857 1.263 . . . . 0.34999999999999998 108.214 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.6 mt -129.96 147.7 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.698 1.199 . . . . 0.34999999999999998 109.569 -171.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -126.28 -23.85 3.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.326 1.45 . . . . 0.34999999999999998 112.487 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? 93.08 134.88 0.02 OUTLIER 'General case' 0 C--N 1.345 0.395 0 C-N-CA 127.834 2.454 . . . . 0.34999999999999998 110.418 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? . . . . . 0 N--CA 1.455 -0.213 0 C-N-CA 125.007 1.323 . . . . 0.25 109.956 178.655 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 109.082 -0.71 . . . . 0.34999999999999998 109.082 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -155.22 65.42 0.63 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.292 1.037 . . . . 0.34999999999999998 108.83 -174.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -95.34 57.3 1.96 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.251 1.02 . . . . 0.34999999999999998 110.186 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 49.9 26.33 8.29 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.275 1.893 . . . . 0.34999999999999998 114.922 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 47.16 49.01 15.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.645 1.578 . . . . 0.34999999999999998 112.582 -176.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -86.23 105.13 16.39 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.649 0.78 . . . . 0.34999999999999998 109.958 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -77.6 72.34 4.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.307 1.443 . . . . 0.34999999999999998 110.608 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 42.57 -91.05 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.029 2.532 . . . . 0.34999999999999998 112.721 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.39 -111.04 0.89 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 108.718 -1.753 . . . . 0.34999999999999998 108.718 175.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 50.73 65.25 1.52 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 125.038 1.335 . . . . 0.34999999999999998 110.938 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -84.02 75.8 10.11 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.938 0.895 . . . . 0.34999999999999998 109.158 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -128.36 73.15 1.46 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.374 1.47 . . . . 0.34999999999999998 108.776 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 t -74.71 175.39 7.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.24 1.016 . . . . 0.34999999999999998 110.996 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -80.94 76.71 7.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.566 1.147 . . . . 0.34999999999999998 109.771 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -154.07 76.82 1.07 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.013 1.325 . . . . 0.34999999999999998 107.559 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 68.04 169.65 0.11 Allowed Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.378 1.471 . . . . 0.33000000000000002 111.108 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.46 108.01 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.56 2.84 . . . . 0.34999999999999998 113.051 170.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.0 p -106.0 -60.32 1.66 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.408 1.483 . . . . 0.34999999999999998 108.695 175.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.7 150.24 7.65 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 110.451 -1.06 . . . . 0.33000000000000002 110.451 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.76 162.78 27.08 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.81 2.34 . . . . 0.34999999999999998 113.332 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -158.68 164.46 35.92 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.331 1.052 . . . . 0.34999999999999998 110.085 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 tt -148.51 103.28 3.4 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.295 -1.002 . . . . 0.34999999999999998 108.295 -173.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 41.9 mtm -82.17 120.68 25.64 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.985 0.914 . . . . 0.34999999999999998 111.128 -176.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -114.87 96.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 124.824 1.249 . . . . 0.34999999999999998 110.092 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -156.33 -176.01 5.73 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.529 0.732 . . . . 0.35999999999999999 110.998 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.2 m -140.27 -170.62 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.767 1.227 . . . . 0.34999999999999998 110.248 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.2 m -135.89 94.12 3.02 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.897 -1.52 . . . . 0.34999999999999998 106.897 168.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.09 98.33 2.39 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 124.649 1.119 . . . . 0.34999999999999998 111.885 -169.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.12 162.64 3.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 124.466 1.106 . . . . 0.34999999999999998 111.731 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -74.03 -52.25 13.31 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.468 -0.938 . . . . 0.34999999999999998 108.468 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 m -157.58 -64.37 0.09 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.989 1.316 . . . . 0.34999999999999998 109.474 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -106.7 63.78 0.64 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.2 1.0 . . . . 0.34999999999999998 111.264 -165.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.75 -40.62 3.04 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 119.758 -0.468 . . . . 0.34999999999999998 113.012 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -49.41 103.77 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.751 2.02 . . . . 0.35999999999999999 112.509 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.81 136.43 34.14 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.489 1.115 . . . . 0.34999999999999998 110.731 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 mp -79.09 -62.3 1.74 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.456 0.703 . . . . 0.34999999999999998 109.457 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mt -94.88 -148.28 0.28 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.695 1.198 . . . . 0.34999999999999998 108.879 -170.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.9 m -143.07 68.11 17.65 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 108.036 -1.098 . . . . 0.33000000000000002 108.036 164.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -83.18 75.58 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.567 2.845 . . . . 0.34999999999999998 110.006 -166.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -152.86 54.22 0.77 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.58 1.552 . . . . 0.34999999999999998 108.016 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.99 48.38 0.44 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.272 0.842 . . . . 0.34999999999999998 113.272 -171.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -169.71 136.74 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.722 0.809 . . . . 0.34999999999999998 109.875 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -161.27 178.18 9.48 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.632 0.773 . . . . 0.34999999999999998 111.378 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -145.39 157.81 52.0 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.627 1.571 . . . . 0.33000000000000002 108.848 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.17 168.76 18.32 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.0 2.467 . . . . 0.34999999999999998 110.866 171.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 tp -61.41 144.64 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.707 0.803 . . . . 0.34999999999999998 111.33 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -156.68 94.75 2.28 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.823 -1.177 . . . . 0.33000000000000002 107.823 173.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.96 -179.03 4.94 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.393 2.729 . . . . 0.34999999999999998 110.585 -175.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.96 -37.47 3.7 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.748 0.69 . . . . 0.34999999999999998 111.555 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.1 t -62.85 142.87 58.07 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.847 0.859 . . . . 0.34999999999999998 111.459 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.6 m -82.29 135.94 35.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.475 1.11 . . . . 0.34999999999999998 109.187 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 mp -117.03 131.37 56.96 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.232 1.413 . . . . 0.34999999999999998 109.794 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 t -172.59 172.05 4.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.073 2.549 . . . . 0.34999999999999998 106.808 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -61.06 -29.54 69.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.366 0.876 . . . . 0.34999999999999998 113.366 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -83.7 -13.08 54.92 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.863 0.69 . . . . 0.34999999999999998 112.863 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -98.27 -27.54 14.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.6 1.16 . . . . 0.34999999999999998 111.913 173.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -39.71 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.219 -0.66 . . . . 0.34999999999999998 109.219 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -67.92 -54.99 14.53 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.401 1.081 . . . . 0.34999999999999998 113.198 -169.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -66.27 -35.02 79.32 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.78 0.718 . . . . 0.34999999999999998 111.226 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -64.09 -53.81 43.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.954 1.302 . . . . 0.34999999999999998 111.5 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.1 m -69.32 -36.36 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 123.007 0.523 . . . . 0.34999999999999998 111.656 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.79 -41.37 95.46 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.824 0.85 . . . . 0.34999999999999998 111.254 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -33.53 68.78 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.806 0.443 . . . . 0.34999999999999998 111.201 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.64 -53.83 35.95 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.357 0.663 . . . . 0.34999999999999998 110.861 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.3 -27.87 67.53 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.225 0.61 . . . . 0.34999999999999998 112.01 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -67.78 -33.43 74.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.264 0.484 . . . . 0.34999999999999998 110.439 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.9 28.58 0.35 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.456 0.702 . . . . 0.34999999999999998 112.15 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 88.5 m -146.27 -65.36 0.3 Allowed 'General case' 0 C--N 1.344 0.336 0 C-N-CA 125.063 1.345 . . . . 0.34999999999999998 108.229 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.85 -52.25 13.62 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.741 1.216 . . . . 0.34999999999999998 111.207 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 73.42 150.86 0.11 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.532 1.933 . . . . 0.34999999999999998 113.776 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.4 tttm 100.72 37.05 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 129.17 2.988 . . . . 0.34999999999999998 111.29 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 62.21 -74.43 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.176 2.19 . . . . 0.34999999999999998 114.308 166.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 87.75 159.26 0.07 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 128.459 2.703 . . . . 0.34999999999999998 110.689 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -54.69 -59.96 4.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.128 0.971 . . . . 0.34999999999999998 110.209 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t 56.25 76.64 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.952 1.301 . . . . 0.34999999999999998 108.736 -171.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.9 t -56.99 -60.92 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 124.612 1.165 . . . . 0.34999999999999998 109.984 -177.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -162.76 126.93 3.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.773 0.829 . . . . 0.34999999999999998 109.0 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.507 HD13 ' H ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -81.0 157.36 25.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.342 0.657 . . . . 0.34999999999999998 110.206 172.7 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.63 123.73 89.13 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.457 -0.942 . . . . 0.33000000000000002 108.457 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.86 -31.81 30.68 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.171 2.581 . . . . 0.34999999999999998 110.67 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 52.8 m -89.64 60.91 5.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.763 1.225 . . . . 0.34999999999999998 109.536 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.34 170.1 7.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.249 1.02 . . . . 0.34999999999999998 110.458 171.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -150.74 148.36 28.45 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 113.137 0.791 . . . . 0.34999999999999998 113.137 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.5 mp -119.68 105.33 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.692 1.597 . . . . 0.34999999999999998 107.19 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.88 76.83 9.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.607 -0.886 . . . . 0.34999999999999998 108.607 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.31 94.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.065 -1.087 . . . . 0.34999999999999998 108.065 172.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.8 m -88.14 75.51 8.64 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.202 -1.036 . . . . 0.34999999999999998 108.202 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -68.92 121.09 15.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.035 -0.53 . . . . 0.34999999999999998 110.951 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -138.94 146.71 41.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.9 1.68 . . . . 0.34999999999999998 109.785 -172.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -154.2 -177.54 6.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.108 1.363 . . . . 0.34999999999999998 109.48 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -133.45 59.29 1.74 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.571 -1.27 . . . . 0.34999999999999998 107.571 167.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -143.78 -66.62 0.35 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.498 1.119 . . . . 0.35999999999999999 109.71 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 56.54 0.23 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.827 0.451 . . . . 0.34999999999999998 111.998 -171.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -159.84 -55.85 0.06 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-O 119.118 -0.468 . . . . 0.34999999999999998 111.761 169.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt 80.52 160.18 0.16 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.34999999999999998 110.122 -168.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.34 136.66 58.04 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.139 0.976 . . . . 0.34999999999999998 110.969 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -151.85 113.25 4.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.468 1.107 . . . . 0.34999999999999998 108.272 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.1 m -79.89 82.92 5.9 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.672 1.189 . . . . 0.34999999999999998 109.05 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -82.66 108.27 15.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.674 -0.861 . . . . 0.34999999999999998 108.674 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.6 p -85.86 63.66 8.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.743 1.217 . . . . 0.34999999999999998 110.504 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -61.51 111.85 5.04 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.262 1.425 . . . . 0.33000000000000002 107.904 172.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.67 -109.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.661 2.241 . . . . 0.34999999999999998 111.461 -160.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.3 tp -160.64 155.84 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.893 0.877 . . . . 0.34999999999999998 109.132 -177.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.7 p -106.87 173.02 6.5 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.3 1.04 . . . . 0.34999999999999998 110.073 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.07 51.12 0.98 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.337 -1.357 . . . . 0.34999999999999998 107.337 167.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -156.37 -76.65 0.09 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.308 1.043 . . . . 0.34999999999999998 109.29 -169.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 152.07 143.46 3.7 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.85 -0.9 . . . . 0.34999999999999998 110.85 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -153.17 128.01 9.54 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.694 0.798 . . . . 0.34999999999999998 109.757 167.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.06 130.62 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.201 1.0 . . . . 0.34999999999999998 108.983 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.76 122.69 86.71 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.727 -1.212 . . . . 0.33000000000000002 107.727 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.02 -98.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.152 2.568 . . . . 0.34999999999999998 111.059 -172.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -169.25 172.0 7.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.607 1.163 . . . . 0.34999999999999998 110.08 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.26 137.3 13.62 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.646 1.178 . . . . 0.34999999999999998 109.767 176.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.9 t -167.69 -174.81 2.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.65 0.78 . . . . 0.34999999999999998 110.706 -171.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 74.05 -82.03 0.03 OUTLIER 'General case' 0 C--N 1.342 0.245 0 C-N-CA 127.055 2.142 . . . . 0.34999999999999998 111.366 170.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -104.57 -50.27 3.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.983 1.313 . . . . 0.34999999999999998 109.162 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.0 tp -78.67 104.77 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.238 1.015 . . . . 0.34999999999999998 109.207 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -143.47 10.03 1.63 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.275 1.03 . . . . 0.34999999999999998 112.502 -170.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.32 63.48 4.62 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.31 0.959 . . . . 0.35999999999999999 111.817 170.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.2 -90.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.941 3.094 . . . . 0.34999999999999998 112.974 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.96 78.75 0.52 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 109.338 -1.505 . . . . 0.34999999999999998 109.338 -168.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -75.02 95.18 2.98 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.909 1.284 . . . . 0.34999999999999998 108.894 176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -91.6 91.4 8.02 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.634 0.374 . . . . 0.35999999999999999 110.683 -168.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.96 61.39 1.95 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.274 1.429 . . . . 0.34999999999999998 109.027 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.58 127.91 58.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.143 1.777 . . . . 0.34999999999999998 106.748 174.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 51.6 m -147.42 131.58 17.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.376 1.07 . . . . 0.34999999999999998 109.371 -171.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -64.38 131.55 47.53 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.493 0.717 . . . . 0.34999999999999998 109.56 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.5 m -136.98 159.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.159 0 C-N-CA 123.922 0.889 . . . . 0.34999999999999998 109.655 174.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.2 124.84 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 124.369 1.067 . . . . 0.34999999999999998 108.203 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.5 mt -129.43 145.49 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.854 1.261 . . . . 0.34999999999999998 109.548 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -127.22 156.28 42.1 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.567 1.547 . . . . 0.34999999999999998 108.822 168.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -77.02 140.79 40.47 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.561 -0.533 . . . . 0.34999999999999998 109.561 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.147 0 C-N-CA 124.307 1.043 . . . . 0.25 110.667 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.028 -0.36 . . . . 0.34999999999999998 110.028 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.8 t -158.31 -54.32 0.07 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.67 0.788 . . . . 0.34999999999999998 109.227 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t -86.1 69.35 10.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.438 1.095 . . . . 0.34999999999999998 110.88 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.1 p90 51.91 -174.35 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.389 2.275 . . . . 0.34999999999999998 114.882 170.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -149.86 32.21 0.69 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.141 0.976 . . . . 0.34999999999999998 110.443 165.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -131.27 -58.93 0.99 Allowed 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.717 1.607 . . . . 0.34999999999999998 108.555 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.89 90.49 0.33 Allowed Glycine 0 C--N 1.341 0.834 0 C-N-CA 123.82 0.724 . . . . 0.34999999999999998 111.902 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 56.82 42.46 26.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.193 1.397 . . . . 0.34999999999999998 111.852 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -88.97 -40.83 12.75 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.681 1.193 . . . . 0.34999999999999998 111.703 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.35 48.88 10.47 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 126.584 1.953 . . . . 0.34999999999999998 112.699 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.2 pttp 67.47 -12.31 0.27 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.173 2.189 . . . . 0.34999999999999998 115.015 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.68 -36.92 2.86 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.923 1.249 . . . . 0.34999999999999998 110.46 -170.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.27 85.55 4.41 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.689 1.195 . . . . 0.34999999999999998 110.094 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -99.64 73.48 1.82 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.918 1.287 . . . . 0.34999999999999998 108.579 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.83 79.81 9.49 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.208 1.003 . . . . 0.34999999999999998 109.178 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.3 p -70.65 -59.01 3.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.666 0.786 . . . . 0.34999999999999998 111.58 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -158.99 -143.33 0.1 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.612 -0.885 . . . . 0.34999999999999998 108.612 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.5 t80 56.97 88.14 0.05 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.256 1.822 . . . . 0.34999999999999998 112.207 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 68.27 162.95 0.14 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 126.054 1.742 . . . . 0.33000000000000002 112.09 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.08 99.9 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.131 2.554 . . . . 0.34999999999999998 110.251 171.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.1 p -90.12 -76.66 0.42 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.447 1.099 . . . . 0.34999999999999998 110.25 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.82 149.02 10.96 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 110.593 -1.003 . . . . 0.33000000000000002 110.593 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.11 169.97 21.0 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 124.133 3.222 . . . . 0.34999999999999998 112.506 -170.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -163.53 162.6 24.62 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.558 1.143 . . . . 0.34999999999999998 110.673 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 tt -138.66 97.43 3.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.979 1.312 . . . . 0.34999999999999998 107.583 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.8 ttm -98.96 108.25 20.89 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.069 1.748 . . . . 0.34999999999999998 110.781 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.2 t -110.14 99.82 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.793 1.237 . . . . 0.34999999999999998 110.867 -167.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -150.14 -163.92 1.9 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.89 1.276 . . . . 0.35999999999999999 109.948 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.0 150.69 24.98 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 C-N-CA 124.648 1.179 . . . . 0.34999999999999998 110.923 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 83.8 m -84.09 79.96 9.34 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.431 -1.692 . . . . 0.34999999999999998 106.431 163.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.84 100.43 1.85 Allowed Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.481 -1.048 . . . . 0.34999999999999998 110.481 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.79 169.55 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 124.893 1.277 . . . . 0.34999999999999998 110.348 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -63.8 -49.34 73.29 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.942 0.897 . . . . 0.34999999999999998 110.757 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.2 p -178.47 -58.48 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.598 1.959 . . . . 0.34999999999999998 108.624 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.5 tttp -75.7 -73.7 0.25 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.791 0.836 . . . . 0.34999999999999998 109.622 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.25 28.32 0.07 OUTLIER Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.219 -0.767 . . . . 0.34999999999999998 112.976 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -90.46 94.25 9.65 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 107.252 -1.388 . . . . 0.35999999999999999 107.252 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.38 110.22 3.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.06 0.944 . . . . 0.34999999999999998 111.562 -168.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.6 mt -70.65 -41.51 72.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.759 1.223 . . . . 0.34999999999999998 110.09 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 pp -143.98 138.24 28.3 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.727 0.811 . . . . 0.34999999999999998 111.205 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.7 m -88.36 141.99 31.1 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 124.494 1.118 . . . . 0.33000000000000002 110.039 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.47 -171.57 0.86 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.976 3.117 . . . . 0.34999999999999998 111.688 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.7 m170 87.16 17.77 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.482 2.313 . . . . 0.34999999999999998 114.087 168.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -94.0 -38.95 10.9 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.778 0.717 . . . . 0.34999999999999998 112.417 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.3 t -99.08 137.96 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.204 1.002 . . . . 0.34999999999999998 109.237 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -157.85 135.32 10.38 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.104 0.962 . . . . 0.34999999999999998 109.431 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -120.31 143.69 36.42 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 125.362 1.465 . . . . 0.33000000000000002 108.941 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.33 137.53 40.25 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.543 2.162 . . . . 0.34999999999999998 109.106 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.5 tt -64.21 135.26 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 122.845 0.458 . . . . 0.34999999999999998 111.999 -170.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -142.56 97.38 6.06 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 106.828 -1.545 . . . . 0.33000000000000002 106.828 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.61 135.61 24.32 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.82 2.347 . . . . 0.34999999999999998 110.325 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 162.95 -41.73 0.34 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.925 -0.87 . . . . 0.34999999999999998 110.925 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.4 t -61.21 145.65 50.44 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.97 0.908 . . . . 0.34999999999999998 110.952 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.7 m -78.77 97.49 5.93 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.877 0.871 . . . . 0.34999999999999998 108.895 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -74.32 81.17 1.86 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.29 1.436 . . . . 0.34999999999999998 109.56 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.5 p -150.42 165.6 32.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.56 1.544 . . . . 0.34999999999999998 109.152 -171.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -54.39 -43.49 71.47 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.87 1.268 . . . . 0.34999999999999998 111.69 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -50.82 -50.57 56.14 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.832 0.853 . . . . 0.34999999999999998 112.381 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -102.83 38.04 1.81 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.638 0.775 . . . . 0.34999999999999998 111.565 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.27 -38.06 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.488 1.515 . . . . 0.34999999999999998 107.94 165.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -54.55 -67.7 0.24 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 127.053 2.141 . . . . 0.34999999999999998 110.988 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -81.71 -18.13 45.44 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.078 0.551 . . . . 0.34999999999999998 112.471 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -66.65 -49.46 66.14 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.142 0.577 . . . . 0.34999999999999998 111.224 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.8 m -68.47 -31.12 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.391 0.676 . . . . 0.34999999999999998 111.373 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.05 -40.96 97.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.745 0.818 . . . . 0.34999999999999998 110.748 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.84 -33.3 72.12 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.491 0.716 . . . . 0.34999999999999998 111.532 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.29 -52.92 51.1 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.122 0.569 . . . . 0.34999999999999998 111.207 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.74 -33.73 76.28 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.672 0.389 . . . . 0.34999999999999998 111.642 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -67.62 -30.49 70.08 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 122.699 0.4 . . . . 0.34999999999999998 111.256 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.87 38.67 0.53 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.718 0.807 . . . . 0.34999999999999998 110.967 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.3 m -150.83 -53.17 0.14 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.946 1.698 . . . . 0.34999999999999998 107.992 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.46 -94.09 0.4 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.098 1.359 . . . . 0.34999999999999998 110.505 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.4 t80 55.04 64.06 1.92 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.714 1.606 . . . . 0.34999999999999998 111.623 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -137.8 -54.2 0.66 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.835 1.254 . . . . 0.34999999999999998 108.797 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -125.25 78.2 1.7 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.107 1.363 . . . . 0.34999999999999998 108.07 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -159.45 126.81 4.73 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.099 0.96 . . . . 0.34999999999999998 108.972 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -146.37 -38.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.575 1.15 . . . . 0.34999999999999998 111.537 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 t 76.65 119.55 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 126.408 1.883 . . . . 0.34999999999999998 111.492 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 55.6 t -68.46 -59.16 3.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 N-CA-C 108.088 -1.079 . . . . 0.34999999999999998 108.088 166.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -153.24 154.17 34.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.48 1.512 . . . . 0.34999999999999998 109.023 -175.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 pp -118.6 140.74 49.41 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.472 1.109 . . . . 0.34999999999999998 108.782 170.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.47 137.29 67.58 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 109.721 -0.474 . . . . 0.33000000000000002 109.721 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.81 -33.77 15.74 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.449 2.766 . . . . 0.34999999999999998 111.361 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -85.14 65.64 9.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.495 1.118 . . . . 0.34999999999999998 109.966 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.65 158.67 35.8 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.325 0.65 . . . . 0.34999999999999998 109.346 170.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -142.07 155.06 45.37 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 121.204 0.526 . . . . 0.34999999999999998 112.217 -171.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mp -129.88 117.62 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.687 1.595 . . . . 0.34999999999999998 107.159 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -103.72 67.41 0.89 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.357 1.063 . . . . 0.34999999999999998 109.615 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.68 119.09 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 122.921 0.489 . . . . 0.34999999999999998 109.883 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 m -119.42 117.46 28.53 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.508 1.123 . . . . 0.34999999999999998 108.816 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.0 110.68 20.43 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.839 1.256 . . . . 0.34999999999999998 109.983 -168.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -101.63 56.95 0.83 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.94 1.296 . . . . 0.34999999999999998 112.316 -164.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.48 87.4 6.39 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.289 0.636 . . . . 0.34999999999999998 109.404 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -77.41 65.69 3.01 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.177 0.591 . . . . 0.34999999999999998 110.384 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -152.6 -48.93 0.1 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.203 1.801 . . . . 0.35999999999999999 108.893 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -140.42 -66.14 0.44 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.465 1.106 . . . . 0.34999999999999998 110.63 -173.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -78.72 -51.16 10.21 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.877 0.471 . . . . 0.34999999999999998 111.501 -167.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 75.63 167.04 0.27 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.901 1.681 . . . . 0.34999999999999998 113.013 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.84 111.98 0.94 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.333 1.853 . . . . 0.34999999999999998 111.297 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -141.31 104.82 4.68 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.131 1.373 . . . . 0.34999999999999998 107.656 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.5 m -77.53 88.57 3.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.617 -0.883 . . . . 0.34999999999999998 108.617 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -80.26 95.81 6.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.427 -0.953 . . . . 0.34999999999999998 108.427 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.6 p -90.54 61.19 4.83 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.85 1.26 . . . . 0.34999999999999998 110.617 -175.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -71.12 145.13 90.83 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.582 -0.525 . . . . 0.33000000000000002 109.582 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.81 -118.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.519 2.813 . . . . 0.34999999999999998 109.732 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.4 tp -162.89 159.15 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.62 0.768 . . . . 0.34999999999999998 110.176 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.4 p -133.97 155.7 49.49 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.873 1.269 . . . . 0.34999999999999998 109.538 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -64.35 -48.82 74.07 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.074 0.95 . . . . 0.34999999999999998 112.425 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -138.77 62.81 1.54 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.064 0.946 . . . . 0.34999999999999998 108.915 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.3 -84.22 0.5 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.6 1.095 . . . . 0.34999999999999998 112.755 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -158.0 159.17 36.13 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.421 0.526 . . . . 0.34999999999999998 112.421 -158.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.6 t -82.83 154.02 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.947 1.699 . . . . 0.34999999999999998 109.135 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.0 t -48.83 115.08 4.18 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.763 1.225 . . . . 0.33000000000000002 109.647 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.17 165.21 26.15 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.003 2.469 . . . . 0.34999999999999998 110.797 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -68.88 158.46 34.49 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.504 0.721 . . . . 0.34999999999999998 110.417 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 116' ' ' LEU . 2.1 pt? -84.09 48.68 1.51 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.546 1.138 . . . . 0.34999999999999998 112.845 -175.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.9 t 53.35 -99.78 0.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.658 1.583 . . . . 0.34999999999999998 112.319 173.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -165.16 -53.83 0.03 OUTLIER 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.571 1.148 . . . . 0.34999999999999998 109.305 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -90.32 44.46 1.2 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.074 1.749 . . . . 0.34999999999999998 112.247 -170.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.3 tp -164.15 138.34 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.642 0.777 . . . . 0.34999999999999998 110.244 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -99.54 -43.85 6.36 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.095 1.758 . . . . 0.34999999999999998 110.515 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -123.25 71.17 44.73 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 115.182 1.549 . . . . 0.35999999999999999 115.182 -164.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.87 140.39 92.85 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.756 2.304 . . . . 0.34999999999999998 110.848 163.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.32 67.21 0.32 Allowed Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.648 -1.381 . . . . 0.34999999999999998 109.648 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -58.02 103.24 0.13 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 125.047 1.339 . . . . 0.34999999999999998 110.48 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -99.09 86.36 3.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.89 0.876 . . . . 0.35999999999999999 109.225 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.86 86.23 0.34 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.717 1.607 . . . . 0.34999999999999998 108.046 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.4 mt -134.14 115.83 21.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 124.792 1.237 . . . . 0.34999999999999998 108.316 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 40.5 m -116.48 130.41 56.74 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.832 1.253 . . . . 0.34999999999999998 109.566 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -75.87 128.05 34.29 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.667 -0.864 . . . . 0.34999999999999998 108.667 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.38 153.54 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.116 0.966 . . . . 0.34999999999999998 111.057 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.6 t -96.84 97.08 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.781 1.633 . . . . 0.34999999999999998 107.555 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.5 mt -83.02 138.42 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.299 0.639 . . . . 0.34999999999999998 110.865 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -103.28 113.44 26.93 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 107.537 -1.283 . . . . 0.34999999999999998 107.537 164.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -91.64 91.5 8.04 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.881 0.872 . . . . 0.34999999999999998 108.865 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 C--N 1.342 0.263 0 CA-C-O 121.51 0.671 . . . . 0.25 109.362 177.057 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 118.716 -0.659 . . . . 0.34999999999999998 112.212 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t 74.62 -71.89 0.12 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 126.829 2.052 . . . . 0.34999999999999998 110.617 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.4 p -71.87 95.15 1.5 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.256 -1.016 . . . . 0.34999999999999998 108.256 171.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -41.65 117.05 0.86 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.882 2.073 . . . . 0.34999999999999998 112.97 -175.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -61.8 165.21 5.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.854 1.261 . . . . 0.34999999999999998 110.062 172.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.32 60.73 2.68 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.479 1.512 . . . . 0.34999999999999998 110.797 -175.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.07 109.8 3.1 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.859 1.219 . . . . 0.34999999999999998 112.102 -168.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt 58.48 53.01 6.53 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.326 1.45 . . . . 0.34999999999999998 110.572 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -127.56 72.28 1.38 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.352 1.061 . . . . 0.34999999999999998 108.836 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.34 66.94 9.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.671 1.188 . . . . 0.34999999999999998 108.681 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.4 mptt 51.47 -107.33 0.3 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.29 1.836 . . . . 0.34999999999999998 110.022 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.01 52.82 0.55 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 108.244 -1.942 . . . . 0.34999999999999998 108.244 168.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -132.31 75.63 1.65 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.364 1.466 . . . . 0.34999999999999998 108.156 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -157.93 44.58 0.33 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.823 1.249 . . . . 0.34999999999999998 109.718 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.42 95.05 2.65 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.471 1.108 . . . . 0.34999999999999998 108.587 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 t -53.73 -51.24 63.95 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.301 1.04 . . . . 0.34999999999999998 112.118 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -154.17 57.72 0.71 Allowed 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.547 0.739 . . . . 0.34999999999999998 110.462 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -138.58 69.29 1.38 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 122.722 0.409 . . . . 0.34999999999999998 111.522 -170.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 68.42 163.89 0.13 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.93 1.692 . . . . 0.33000000000000002 113.663 161.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -54.29 104.64 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.791 2.994 . . . . 0.34999999999999998 111.047 164.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.9 p -143.35 -51.56 0.35 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.601 1.16 . . . . 0.34999999999999998 109.938 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.97 81.01 0.06 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.182 -1.167 . . . . 0.33000000000000002 110.182 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -70.85 170.84 16.9 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.714 2.942 . . . . 0.34999999999999998 111.44 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -154.77 168.26 27.46 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.51 0.671 . . . . 0.34999999999999998 112.46 -161.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -147.32 93.28 2.22 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.275 -1.75 . . . . 0.34999999999999998 106.275 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 62.6 mtm -85.16 96.65 9.53 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.518 0.727 . . . . 0.34999999999999998 111.339 -169.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.54 89.11 2.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 125.128 1.371 . . . . 0.34999999999999998 108.359 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -151.41 176.55 11.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.429 1.092 . . . . 0.35999999999999999 109.954 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.417 HG11 HG22 ' A' ' 131' ' ' VAL . 6.8 t -136.46 145.7 30.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 C-N-CA 123.873 0.869 . . . . 0.34999999999999998 110.958 -171.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.6 m -82.69 84.38 7.33 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.564 -1.643 . . . . 0.34999999999999998 106.564 164.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.33 83.14 1.58 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.462 -0.655 . . . . 0.34999999999999998 111.462 -169.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.93 164.43 3.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 C-N-CA 123.575 0.75 . . . . 0.34999999999999998 111.37 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -72.43 -45.82 57.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.069 0.948 . . . . 0.34999999999999998 110.96 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.9 t 169.54 -58.02 0.01 OUTLIER 'General case' 0 C--N 1.341 0.226 0 C-N-CA 127.984 2.514 . . . . 0.34999999999999998 107.586 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -71.6 -66.75 0.59 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.22 1.008 . . . . 0.34999999999999998 109.891 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.73 62.91 0.02 OUTLIER Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.001 -1.239 . . . . 0.34999999999999998 110.001 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -133.04 97.23 3.95 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 107.645 -1.242 . . . . 0.35999999999999999 107.645 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.22 119.68 9.48 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.78 1.232 . . . . 0.34999999999999998 111.276 -173.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.0 mp -84.75 -39.41 18.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.153 0.981 . . . . 0.34999999999999998 110.006 170.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 pp -141.88 149.04 39.72 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.535 0.734 . . . . 0.34999999999999998 112.467 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.7 m -89.33 155.26 49.03 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.558 1.143 . . . . 0.33000000000000002 111.544 -167.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -83.7 44.71 1.64 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.811 3.007 . . . . 0.34999999999999998 111.952 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -177.71 111.39 0.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.421 1.089 . . . . 0.34999999999999998 109.936 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -163.83 -51.8 0.03 OUTLIER 'General case' 0 C--N 1.341 0.236 0 CA-C-O 118.668 -0.682 . . . . 0.34999999999999998 112.518 170.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.28 -57.13 6.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 CA-C-N 119.134 0.879 . . . . 0.34999999999999998 110.594 -173.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 65.9 155.08 0.08 Allowed 'General case' 0 C--N 1.343 0.292 0 C-N-CA 126.19 1.796 . . . . 0.34999999999999998 113.061 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -138.55 147.02 53.32 Favored Pre-proline 0 N--CA 1.454 -0.275 0 C-N-CA 125.603 1.561 . . . . 0.33000000000000002 107.521 171.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.63 144.54 55.07 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.582 2.188 . . . . 0.34999999999999998 109.985 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.97 116.85 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.679 0.792 . . . . 0.34999999999999998 109.437 -177.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -137.88 116.16 9.68 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.841 1.256 . . . . 0.33000000000000002 108.484 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.09 178.56 7.36 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.438 2.759 . . . . 0.34999999999999998 110.881 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.23 -30.29 10.67 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.9 0.762 . . . . 0.34999999999999998 112.55 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.4 t -68.13 144.65 54.92 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.797 0.798 . . . . 0.34999999999999998 111.088 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.6 m -71.89 145.65 48.39 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.746 -0.835 . . . . 0.34999999999999998 108.746 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.98 113.89 7.63 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.443 0.697 . . . . 0.34999999999999998 109.531 -167.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 t -162.22 175.25 11.85 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.686 1.594 . . . . 0.34999999999999998 108.898 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -47.97 -60.45 2.6 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.359 1.463 . . . . 0.34999999999999998 111.054 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -59.77 -35.24 74.22 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.375 0.88 . . . . 0.34999999999999998 113.375 -174.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.42 -55.41 28.1 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 118.676 0.671 . . . . 0.34999999999999998 110.62 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.3 mm -60.43 -39.33 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.281 1.033 . . . . 0.34999999999999998 111.754 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -55.65 -59.19 5.2 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.645 0.657 . . . . 0.34999999999999998 111.936 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -66.56 -38.1 86.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.942 0.792 . . . . 0.34999999999999998 111.751 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -66.07 -45.52 81.0 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.516 0.727 . . . . 0.34999999999999998 111.363 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.79 -26.17 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.61 0.764 . . . . 0.34999999999999998 111.736 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -62.92 -35.55 80.45 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.11 0.564 . . . . 0.34999999999999998 110.878 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -71.11 -32.53 69.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.329 0.652 . . . . 0.34999999999999998 111.308 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.58 -36.44 82.72 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.066 0.546 . . . . 0.34999999999999998 111.335 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.0 mt -72.76 -41.49 65.01 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 122.884 0.474 . . . . 0.34999999999999998 111.065 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.49 67.6 6.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.66 0.784 . . . . 0.34999999999999998 109.641 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.57 -60.48 0.1 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.783 1.233 . . . . 0.34999999999999998 108.796 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.0 p -96.79 -56.42 2.58 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.617 1.167 . . . . 0.34999999999999998 109.671 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.79 63.7 7.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.695 -1.224 . . . . 0.34999999999999998 107.695 169.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -72.77 -57.47 4.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.282 0.633 . . . . 0.34999999999999998 112.058 -164.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -93.99 -52.3 4.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.438 0.695 . . . . 0.34999999999999998 111.109 -164.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.52 68.43 10.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.032 0.933 . . . . 0.34999999999999998 110.235 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -163.18 155.35 18.1 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.115 0.966 . . . . 0.34999999999999998 109.575 169.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -163.28 111.21 1.23 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.985 -1.117 . . . . 0.34999999999999998 107.985 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.92 92.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.17 -0.678 . . . . 0.34999999999999998 109.17 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.51 -40.93 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.596 1.158 . . . . 0.34999999999999998 111.332 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -149.15 160.5 43.3 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.615 0.766 . . . . 0.34999999999999998 110.268 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.412 ' H ' HD23 ' A' ' 81' ' ' LEU . 1.7 pt? -137.61 142.54 41.24 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.901 1.28 . . . . 0.34999999999999998 110.441 -175.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.77 132.76 82.87 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 109.398 -0.593 . . . . 0.33000000000000002 109.398 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.74 -34.96 13.6 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.194 2.596 . . . . 0.34999999999999998 110.751 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -81.53 78.83 8.24 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.152 0.981 . . . . 0.34999999999999998 110.473 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.85 166.07 16.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.37 0.668 . . . . 0.34999999999999998 109.269 164.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -153.7 122.06 6.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.73 0.3 . . . . 0.34999999999999998 111.637 -168.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.0 mp -94.28 124.27 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.546 1.538 . . . . 0.34999999999999998 107.325 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -111.25 84.29 1.91 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.486 -1.301 . . . . 0.34999999999999998 107.486 174.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.95 96.86 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 108.975 -0.75 . . . . 0.34999999999999998 108.975 171.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -86.57 87.45 7.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.273 -1.751 . . . . 0.34999999999999998 106.273 171.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -86.78 80.63 8.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.234 0.54 . . . . 0.34999999999999998 110.168 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -91.11 144.09 26.0 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.883 1.273 . . . . 0.34999999999999998 111.034 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -166.38 89.8 0.4 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.039 -1.467 . . . . 0.34999999999999998 107.039 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -77.54 74.36 4.1 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.142 0.977 . . . . 0.34999999999999998 108.636 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -154.67 -48.98 0.09 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.581 1.952 . . . . 0.35999999999999999 108.339 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.23 -45.99 0.1 Allowed 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.554 0.742 . . . . 0.34999999999999998 112.561 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -73.64 -57.37 4.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.614 0.643 . . . . 0.34999999999999998 111.495 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt 82.96 158.05 0.12 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.974 1.71 . . . . 0.34999999999999998 111.7 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.91 135.26 20.2 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 126.438 1.895 . . . . 0.34999999999999998 113.243 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -150.05 103.67 3.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.743 1.217 . . . . 0.34999999999999998 107.997 170.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.2 m -77.19 87.43 3.65 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.408 1.083 . . . . 0.34999999999999998 108.757 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -97.88 103.64 15.6 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.572 1.149 . . . . 0.34999999999999998 108.32 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.6 p -83.32 143.16 30.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.276 1.03 . . . . 0.34999999999999998 111.266 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -151.45 152.97 31.71 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.422 1.089 . . . . 0.33000000000000002 108.856 169.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.43 -117.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.357 2.705 . . . . 0.34999999999999998 110.897 -171.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tp -158.76 150.16 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.901 0.88 . . . . 0.34999999999999998 109.559 -173.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.3 p -91.85 172.68 8.3 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.025 0.93 . . . . 0.34999999999999998 110.807 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -102.9 -28.39 12.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.324 1.45 . . . . 0.34999999999999998 109.386 165.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -62.63 -76.04 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.0 1.32 . . . . 0.34999999999999998 111.777 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 133.93 73.73 0.09 OUTLIER Glycine 0 C--N 1.341 0.86 0 N-CA-C 110.354 -1.099 . . . . 0.34999999999999998 110.354 -172.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -77.21 131.1 38.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.336 0.568 . . . . 0.34999999999999998 109.685 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.63 127.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.678 -1.23 . . . . 0.34999999999999998 107.678 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.16 115.35 12.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.698 -1.223 . . . . 0.33000000000000002 107.698 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -82.84 -174.04 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.115 2.543 . . . . 0.34999999999999998 110.866 -170.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -69.37 -171.57 0.37 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.858 0.863 . . . . 0.34999999999999998 110.109 167.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.27 1.76 2.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.663 0.785 . . . . 0.34999999999999998 113.094 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 t 65.08 -154.62 0.28 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.177 0.991 . . . . 0.34999999999999998 111.516 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -96.6 -50.14 4.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.715 1.206 . . . . 0.34999999999999998 111.483 -166.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -50.45 -41.77 53.24 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.965 1.306 . . . . 0.34999999999999998 112.896 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.3 tp -105.36 144.23 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.783 1.233 . . . . 0.34999999999999998 108.488 168.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -149.93 17.4 0.87 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.553 1.141 . . . . 0.34999999999999998 111.405 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -162.81 70.16 2.02 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.359 1.064 . . . . 0.35999999999999999 110.074 -175.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -87.98 -172.69 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.434 3.423 . . . . 0.34999999999999998 112.26 -170.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.88 84.26 0.17 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.596 -1.402 . . . . 0.34999999999999998 109.596 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -74.88 81.24 2.14 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.31 1.444 . . . . 0.34999999999999998 109.917 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -90.58 104.31 16.9 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.048 0.539 . . . . 0.35999999999999999 110.437 -169.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.88 90.59 4.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.005 -1.109 . . . . 0.34999999999999998 108.005 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.2 mt -96.59 74.76 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 106.97 -1.493 . . . . 0.34999999999999998 106.97 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.1 m -78.67 170.73 16.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.641 1.176 . . . . 0.34999999999999998 109.127 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -141.94 133.81 27.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.43 1.092 . . . . 0.34999999999999998 108.861 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.417 HG22 HG11 ' A' ' 29' ' ' VAL . 5.3 m -142.52 159.62 19.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 123.652 0.781 . . . . 0.34999999999999998 110.803 173.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.4 t -90.85 126.83 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.117 1.367 . . . . 0.34999999999999998 108.205 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 34.9 mt -116.65 120.35 64.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.295 1.038 . . . . 0.34999999999999998 110.159 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -80.29 120.43 24.34 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.267 1.427 . . . . 0.34999999999999998 108.073 164.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -89.07 -3.51 58.65 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.414 1.086 . . . . 0.34999999999999998 112.997 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? . . . . . 0 C--N 1.343 0.323 0 C-N-CA 125.52 1.528 . . . . 0.25 110.333 -164.267 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 119.04 -0.505 . . . . 0.34999999999999998 110.408 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m -14.15 -78.0 0.01 OUTLIER 'General case' 0 C--N 1.344 0.347 0 C-N-CA 129.317 3.047 . . . . 0.34999999999999998 114.61 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.5 p -133.73 63.36 1.63 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.406 1.083 . . . . 0.34999999999999998 108.746 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -9.22 96.55 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 129.445 3.098 . . . . 0.34999999999999998 115.274 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -93.59 71.78 4.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.803 0.841 . . . . 0.34999999999999998 108.917 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -157.47 -51.39 0.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.409 1.083 . . . . 0.34999999999999998 110.163 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.49 67.45 0.89 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.825 -0.91 . . . . 0.34999999999999998 110.825 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt 56.14 -121.45 1.62 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.431 1.492 . . . . 0.34999999999999998 110.904 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.9 t80 61.71 99.64 0.03 OUTLIER 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.499 1.92 . . . . 0.34999999999999998 112.181 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.81 52.43 0.94 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.685 1.194 . . . . 0.34999999999999998 110.678 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.6 mttt 79.55 -65.18 0.2 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 126.915 2.086 . . . . 0.34999999999999998 111.866 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 147.09 -47.8 0.67 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 108.387 -1.885 . . . . 0.34999999999999998 108.387 -168.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 48.4 51.15 15.66 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.881 2.073 . . . . 0.34999999999999998 113.809 167.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 56.66 54.39 7.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.901 1.281 . . . . 0.34999999999999998 111.778 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.16 -158.33 0.32 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.553 1.141 . . . . 0.34999999999999998 112.984 171.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 p -162.79 -35.6 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.482 1.113 . . . . 0.34999999999999998 111.812 -171.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -133.8 39.44 3.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.705 1.202 . . . . 0.34999999999999998 109.944 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -147.37 73.05 1.27 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 122.775 0.43 . . . . 0.34999999999999998 110.788 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 65.8 177.99 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.191 1.396 . . . . 0.33000000000000002 112.886 162.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -74.89 60.41 5.34 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.596 2.864 . . . . 0.34999999999999998 113.742 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.2 p -68.01 -40.97 82.9 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.566 0.746 . . . . 0.34999999999999998 109.915 170.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.96 166.79 22.36 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 111.881 -0.488 . . . . 0.33000000000000002 111.881 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.03 -177.45 3.72 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.875 3.717 . . . . 0.34999999999999998 111.807 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -156.46 171.8 19.65 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.594 1.157 . . . . 0.34999999999999998 110.452 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tt -149.16 82.61 1.43 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.957 -1.127 . . . . 0.34999999999999998 107.957 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -67.42 133.14 49.01 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.378 0.671 . . . . 0.34999999999999998 110.166 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.8 t -128.67 86.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 125.076 1.35 . . . . 0.34999999999999998 108.423 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -146.93 177.97 8.72 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.989 1.315 . . . . 0.35999999999999999 109.254 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.3 m -137.71 144.05 32.21 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 C-N-CA 124.348 1.059 . . . . 0.34999999999999998 110.34 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.7 m -75.99 97.35 3.99 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.305 -0.998 . . . . 0.34999999999999998 108.305 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.92 84.01 1.57 Allowed Glycine 0 C--N 1.338 0.686 0 C-N-CA 123.988 0.804 . . . . 0.34999999999999998 111.535 -172.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.8 m -77.14 165.5 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.25 0.62 . . . . 0.34999999999999998 110.315 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.4 -66.53 0.89 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.884 0.474 . . . . 0.34999999999999998 109.862 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.6 m -158.42 -56.0 0.07 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.61 1.564 . . . . 0.34999999999999998 108.249 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.25 45.42 1.02 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.763 1.225 . . . . 0.34999999999999998 110.17 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.59 29.03 73.45 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.161 0.886 . . . . 0.34999999999999998 113.419 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -96.75 97.71 9.56 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 117.933 0.866 . . . . 0.35999999999999999 108.887 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.08 116.26 4.39 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.506 1.123 . . . . 0.34999999999999998 111.541 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.7 mp -73.16 -45.82 54.34 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.327 0.651 . . . . 0.34999999999999998 109.386 168.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 pp -138.58 138.82 38.29 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.308 1.043 . . . . 0.34999999999999998 111.978 -171.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.7 t -82.32 138.08 45.27 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 124.658 1.183 . . . . 0.33000000000000002 109.107 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -86.31 61.36 4.73 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.648 2.899 . . . . 0.34999999999999998 111.825 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -149.11 65.31 1.03 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.609 0.764 . . . . 0.34999999999999998 109.845 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -128.61 -52.74 1.25 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.159 0.984 . . . . 0.34999999999999998 111.261 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.1 t -101.47 140.49 20.02 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 123.214 0.606 . . . . 0.34999999999999998 109.893 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.7 170.06 19.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.643 0.777 . . . . 0.34999999999999998 110.109 164.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -140.13 147.94 52.49 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.133 0.973 . . . . 0.33000000000000002 109.373 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.38 126.89 14.86 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.346 2.031 . . . . 0.34999999999999998 107.911 168.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.3 tt -57.83 137.57 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.36 0.664 . . . . 0.34999999999999998 112.585 -168.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 86.62 8.99 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.961 1.705 . . . . 0.33000000000000002 107.765 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.16 168.47 23.94 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.193 2.595 . . . . 0.34999999999999998 111.371 -170.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.51 -28.64 14.14 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.025 0.821 . . . . 0.34999999999999998 111.802 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.0 t -65.58 148.03 52.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.722 0.809 . . . . 0.34999999999999998 110.879 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -74.61 124.27 26.36 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.419 0.688 . . . . 0.34999999999999998 109.702 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.96 102.28 7.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.34 1.456 . . . . 0.34999999999999998 107.435 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.2 t -139.8 -175.99 4.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.596 1.158 . . . . 0.34999999999999998 108.882 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -55.71 -60.16 3.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.668 0.787 . . . . 0.34999999999999998 110.672 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.6 -33.19 74.5 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.376 0.88 . . . . 0.34999999999999998 113.376 -173.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -61.23 2.5 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.246 0.93 . . . . 0.34999999999999998 110.055 175.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.13 -31.78 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.35 1.06 . . . . 0.34999999999999998 111.342 -170.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.74 -62.46 1.64 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.653 1.181 . . . . 0.34999999999999998 111.572 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.04 -34.97 78.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.166 0.439 . . . . 0.34999999999999998 111.539 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -63.6 -46.8 84.11 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.621 0.768 . . . . 0.34999999999999998 111.663 -175.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.8 p -73.66 -31.93 33.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 122.809 0.443 . . . . 0.34999999999999998 111.724 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -58.95 -31.89 69.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.279 0.632 . . . . 0.34999999999999998 111.512 173.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -76.54 -38.33 55.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.922 0.489 . . . . 0.34999999999999998 110.771 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.31 -62.27 1.96 Allowed 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.335 1.054 . . . . 0.34999999999999998 111.942 -174.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.13 -23.88 67.48 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.048 0.758 . . . . 0.34999999999999998 113.048 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -80.43 66.66 6.01 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.813 1.245 . . . . 0.34999999999999998 110.972 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.07 49.86 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.798 1.639 . . . . 0.34999999999999998 108.672 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.2 p -140.08 -62.41 0.51 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.047 1.339 . . . . 0.34999999999999998 108.873 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.29 -64.93 1.01 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.118 1.367 . . . . 0.34999999999999998 108.686 172.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.62 68.99 0.78 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.873 1.669 . . . . 0.34999999999999998 110.802 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -132.8 47.7 2.48 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.993 1.317 . . . . 0.34999999999999998 108.53 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 63.6 111.51 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.065 2.146 . . . . 0.34999999999999998 112.36 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -111.57 99.52 8.25 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.271 1.428 . . . . 0.34999999999999998 108.107 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -81.28 98.49 8.15 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.369 -0.604 . . . . 0.34999999999999998 109.369 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.5 96.83 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.907 -0.775 . . . . 0.34999999999999998 108.907 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.53 -46.02 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.652 0.781 . . . . 0.34999999999999998 111.035 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -137.96 164.41 29.11 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.71 1.204 . . . . 0.34999999999999998 110.225 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 pp -157.66 158.29 35.17 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.861 1.264 . . . . 0.34999999999999998 110.316 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.23 121.22 68.86 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 108.533 -0.914 . . . . 0.33000000000000002 108.533 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.77 -39.46 3.4 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.019 2.479 . . . . 0.34999999999999998 110.938 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -79.49 83.48 5.49 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.006 0.923 . . . . 0.34999999999999998 109.291 176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.07 129.75 41.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.628 0.771 . . . . 0.34999999999999998 109.778 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -100.23 136.38 40.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.575 1.15 . . . . 0.34999999999999998 110.82 -172.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.43 120.27 58.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 125.633 1.573 . . . . 0.34999999999999998 108.492 -173.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -117.9 90.56 3.36 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.819 1.248 . . . . 0.34999999999999998 108.647 -172.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 m -77.06 94.08 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.261 1.024 . . . . 0.34999999999999998 110.544 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 88.1 m -91.88 90.62 7.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.634 1.574 . . . . 0.34999999999999998 108.532 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.75 93.9 7.78 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.823 0.849 . . . . 0.34999999999999998 110.534 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -86.09 62.55 7.51 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.71 1.604 . . . . 0.34999999999999998 109.615 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -98.99 78.63 2.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.996 1.319 . . . . 0.34999999999999998 107.469 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.12 80.28 4.55 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.656 1.182 . . . . 0.34999999999999998 109.376 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -150.75 -41.43 0.12 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.784 2.034 . . . . 0.35999999999999999 108.442 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.65 -39.75 0.18 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.817 1.647 . . . . 0.34999999999999998 110.894 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -85.77 -54.75 4.34 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.0 0.92 . . . . 0.34999999999999998 111.439 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 83.3 tttt 69.52 158.51 0.17 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.877 1.671 . . . . 0.34999999999999998 110.856 -172.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.73 123.62 14.74 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.105 0.562 . . . . 0.34999999999999998 111.446 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -145.0 105.64 4.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.91 1.284 . . . . 0.34999999999999998 107.841 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.7 m -82.62 86.85 6.75 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.949 1.299 . . . . 0.34999999999999998 108.968 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.3 101.61 14.28 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.014 0.926 . . . . 0.34999999999999998 108.85 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.8 p -80.35 144.21 32.92 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.415 1.086 . . . . 0.34999999999999998 111.266 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -158.95 137.0 7.46 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 123.282 0.633 . . . . 0.33000000000000002 110.719 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.6 161.73 27.77 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.858 3.039 . . . . 0.34999999999999998 110.525 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.0 tp -95.42 151.66 3.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 123.788 0.835 . . . . 0.34999999999999998 110.339 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 67.6 p -86.67 112.18 21.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.835 -1.172 . . . . 0.34999999999999998 107.835 169.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.15 -21.76 66.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.478 1.111 . . . . 0.34999999999999998 113.596 -173.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.05 -44.05 97.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.899 0.88 . . . . 0.34999999999999998 111.713 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.32 135.15 1.77 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.519 -1.033 . . . . 0.34999999999999998 110.519 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -159.27 166.86 30.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.372 1.069 . . . . 0.34999999999999998 109.555 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.67 144.6 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.283 1.433 . . . . 0.34999999999999998 109.229 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.19 116.33 15.58 Favored Pre-proline 0 C--N 1.345 0.405 0 N-CA-C 108.156 -1.053 . . . . 0.33000000000000002 108.156 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.42 -101.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.921 2.414 . . . . 0.34999999999999998 110.902 -167.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -166.17 169.04 14.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.098 0.959 . . . . 0.34999999999999998 109.376 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.53 17.54 0.86 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.767 1.227 . . . . 0.34999999999999998 112.635 172.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.8 t 63.04 -95.13 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.647 1.579 . . . . 0.34999999999999998 111.024 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -167.36 -48.76 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.167 0.987 . . . . 0.34999999999999998 109.855 -174.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -70.76 -0.34 8.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.495 1.518 . . . . 0.34999999999999998 114.943 -168.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.7 pt -133.24 -172.98 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.411 1.084 . . . . 0.34999999999999998 110.188 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -130.6 -45.32 1.08 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.414 1.486 . . . . 0.34999999999999998 110.62 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -119.92 74.49 19.71 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 0.35999999999999999 112.772 -162.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -69.27 141.27 46.74 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.17 1.913 . . . . 0.34999999999999998 109.935 171.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.24 79.7 0.28 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.405 -1.478 . . . . 0.34999999999999998 109.405 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -66.67 92.92 0.23 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.713 1.205 . . . . 0.34999999999999998 110.713 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -85.37 98.68 10.69 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.877 -1.157 . . . . 0.35999999999999999 107.877 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.93 53.82 2.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.171 0.988 . . . . 0.34999999999999998 109.196 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.0 mt -99.03 99.29 8.31 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 124.462 1.105 . . . . 0.34999999999999998 108.681 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 96.3 m -105.63 140.53 38.56 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.102 1.361 . . . . 0.34999999999999998 109.231 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 126.46 31.63 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.525 0.73 . . . . 0.34999999999999998 109.326 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.34 148.33 32.77 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 C-N-CA 123.888 0.875 . . . . 0.34999999999999998 110.299 172.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 t -96.51 130.83 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.689 1.196 . . . . 0.34999999999999998 108.364 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mt -126.97 105.95 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.829 1.251 . . . . 0.34999999999999998 109.222 -173.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -71.58 132.07 44.13 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.79 -1.189 . . . . 0.34999999999999998 107.79 159.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 94.83 4.4 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.403 0.681 . . . . 0.34999999999999998 109.497 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.344 0.337 0 C-N-CA 124.969 1.307 . . . . 0.25 109.438 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 110.162 -0.31 . . . . 0.34999999999999998 110.162 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.0 m -89.13 57.24 3.99 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.458 1.103 . . . . 0.34999999999999998 108.263 172.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t 55.23 64.87 1.64 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.356 1.463 . . . . 0.34999999999999998 110.648 -169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -60.66 135.48 57.78 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.878 0.871 . . . . 0.34999999999999998 110.102 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -164.96 99.07 0.76 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.752 0.821 . . . . 0.34999999999999998 110.077 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -157.89 37.68 0.26 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.257 1.023 . . . . 0.34999999999999998 109.946 168.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.43 159.93 9.74 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.017 0.818 . . . . 0.34999999999999998 111.18 -174.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -74.76 96.95 3.15 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.985 0.514 . . . . 0.34999999999999998 110.189 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -85.88 79.12 9.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.305 1.042 . . . . 0.34999999999999998 110.609 -174.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -137.84 -158.12 0.83 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.913 0.885 . . . . 0.34999999999999998 109.187 170.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.9 tttt 62.61 46.86 5.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.197 0.999 . . . . 0.34999999999999998 109.542 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.11 -42.88 1.85 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.046 1.308 . . . . 0.34999999999999998 111.653 -172.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -85.47 56.52 3.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.588 1.155 . . . . 0.34999999999999998 110.558 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 54.85 28.71 10.78 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.682 1.993 . . . . 0.34999999999999998 113.693 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.17 140.63 29.3 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.384 0.674 . . . . 0.34999999999999998 110.889 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -166.32 -130.13 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.154 0.982 . . . . 0.34999999999999998 109.511 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -138.82 164.83 28.61 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.306 1.842 . . . . 0.34999999999999998 108.951 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.7 t80 66.72 103.62 0.04 OUTLIER 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.763 1.625 . . . . 0.34999999999999998 110.673 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 75.66 144.65 0.1 Allowed Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 126.109 1.764 . . . . 0.33000000000000002 110.079 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.62 96.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.443 2.762 . . . . 0.34999999999999998 111.847 171.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.1 p -94.33 -44.3 8.0 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.008 0.923 . . . . 0.34999999999999998 110.291 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.21 150.38 8.64 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 112.032 -0.427 . . . . 0.33000000000000002 112.032 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -92.21 -170.12 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.939 3.093 . . . . 0.34999999999999998 111.098 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -168.75 165.32 11.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.006 0.922 . . . . 0.34999999999999998 111.73 172.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.0 tp -134.42 88.54 2.46 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.94 1.696 . . . . 0.34999999999999998 107.731 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -78.41 125.57 29.55 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.883 1.273 . . . . 0.34999999999999998 108.312 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -135.65 91.09 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.882 0.873 . . . . 0.34999999999999998 109.382 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -149.28 157.68 43.55 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.465 1.506 . . . . 0.35999999999999999 109.169 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.13 161.09 42.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 123.806 0.843 . . . . 0.34999999999999998 112.146 -168.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.3 m -87.91 91.15 8.66 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.841 1.257 . . . . 0.34999999999999998 108.438 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.06 104.24 2.66 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.653 -0.979 . . . . 0.34999999999999998 110.653 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.35 174.0 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.224 1.01 . . . . 0.34999999999999998 111.033 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -71.62 -55.82 7.03 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.065 0.546 . . . . 0.34999999999999998 109.675 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.2 p -150.1 -71.04 0.18 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.067 0.947 . . . . 0.34999999999999998 110.559 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -85.45 -73.33 0.45 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.862 0.865 . . . . 0.34999999999999998 110.541 -171.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.49 50.77 0.41 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.341 -1.104 . . . . 0.34999999999999998 110.341 -176.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -115.82 79.99 1.38 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.338 1.455 . . . . 0.35999999999999999 108.714 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.46 138.76 58.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.036 1.334 . . . . 0.34999999999999998 112.256 -173.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mp -113.96 -24.84 8.85 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.311 1.445 . . . . 0.34999999999999998 110.666 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.51 146.0 32.16 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.355 1.062 . . . . 0.34999999999999998 111.738 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.8 m -81.33 153.6 71.51 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.367 1.067 . . . . 0.33000000000000002 110.331 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.99 50.44 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.78 2.987 . . . . 0.34999999999999998 111.521 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -173.21 103.96 0.13 Allowed 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.09 0.556 . . . . 0.34999999999999998 111.038 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -164.88 14.02 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.5 0.926 . . . . 0.34999999999999998 113.5 172.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.6 t -149.16 135.22 12.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 C-N-CA 125.241 1.416 . . . . 0.34999999999999998 107.441 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -139.46 171.05 14.82 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.128 0.571 . . . . 0.34999999999999998 111.295 169.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -140.81 151.7 63.61 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.765 1.226 . . . . 0.33000000000000002 109.967 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.04 100.61 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.487 2.791 . . . . 0.34999999999999998 109.397 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.77 138.17 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.262 1.025 . . . . 0.34999999999999998 111.508 -171.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -138.53 137.11 19.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.717 1.207 . . . . 0.33000000000000002 108.733 171.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.24 169.36 22.67 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.647 2.898 . . . . 0.34999999999999998 110.864 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 110.63 -31.21 7.51 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.108 0.861 . . . . 0.34999999999999998 111.841 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 t -66.13 146.27 54.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.559 0.744 . . . . 0.34999999999999998 111.146 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.7 m -74.21 152.91 39.67 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.455 1.102 . . . . 0.34999999999999998 109.282 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.04 121.13 8.28 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.4 0.68 . . . . 0.34999999999999998 109.482 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 t -166.09 174.53 9.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.689 1.996 . . . . 0.34999999999999998 107.846 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.62 -52.18 64.67 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.692 0.797 . . . . 0.34999999999999998 111.23 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.75 -24.72 67.88 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.184 0.809 . . . . 0.34999999999999998 113.184 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -71.85 -51.66 21.3 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.371 0.668 . . . . 0.34999999999999998 110.582 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.2 -33.25 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.51 1.124 . . . . 0.34999999999999998 111.886 -172.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -55.29 -55.23 33.82 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.463 1.105 . . . . 0.34999999999999998 111.714 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -66.99 -30.29 70.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.073 0.397 . . . . 0.34999999999999998 111.867 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -52.88 61.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.483 0.713 . . . . 0.34999999999999998 110.209 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -61.13 -38.95 80.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 CA-C-O 119.038 -0.506 . . . . 0.34999999999999998 111.343 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.92 -36.16 76.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.586 0.755 . . . . 0.34999999999999998 111.875 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -70.2 -48.04 58.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.93 0.492 . . . . 0.34999999999999998 110.844 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.95 97.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.427 0.691 . . . . 0.34999999999999998 111.52 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 mt -54.51 -58.78 6.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.22 1.408 . . . . 0.34999999999999998 110.304 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -61.38 -59.62 4.99 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.01 0.924 . . . . 0.34999999999999998 111.652 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -41.23 -48.8 3.58 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 126.131 1.772 . . . . 0.34999999999999998 113.429 -171.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.5 m -74.13 -63.61 1.19 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.348 0.659 . . . . 0.34999999999999998 109.924 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.56 96.08 5.69 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.01 1.324 . . . . 0.34999999999999998 109.915 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -112.18 70.67 0.72 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.196 1.399 . . . . 0.34999999999999998 109.571 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -137.95 -113.17 0.17 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.745 0.818 . . . . 0.34999999999999998 109.906 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.42 83.22 6.86 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.414 1.086 . . . . 0.34999999999999998 110.81 -173.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -152.43 162.87 40.58 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.317 0.647 . . . . 0.34999999999999998 111.469 176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -173.98 125.05 0.35 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.549 1.94 . . . . 0.34999999999999998 106.789 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.96 91.74 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.297 -1.001 . . . . 0.34999999999999998 108.297 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 p -61.2 -43.92 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.885 0.874 . . . . 0.34999999999999998 110.985 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -151.1 169.16 22.52 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.943 0.897 . . . . 0.34999999999999998 110.12 169.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 pp -144.64 149.56 35.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.285 1.034 . . . . 0.34999999999999998 109.992 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.86 135.73 55.35 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.578 -0.897 . . . . 0.33000000000000002 108.578 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.46 -24.44 22.46 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.162 2.575 . . . . 0.34999999999999998 111.923 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 m -86.21 70.03 10.51 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.57 1.148 . . . . 0.34999999999999998 110.855 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.39 164.35 26.49 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.767 0.827 . . . . 0.34999999999999998 109.965 168.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -150.02 121.72 8.07 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.134 0.493 . . . . 0.34999999999999998 112.313 -174.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 mp -77.74 114.69 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.663 -1.606 . . . . 0.34999999999999998 106.663 165.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -110.23 63.42 0.61 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.34 -0.985 . . . . 0.34999999999999998 108.34 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.09 111.11 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.405 0.682 . . . . 0.34999999999999998 110.945 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.5 m -98.45 81.85 2.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.49 1.516 . . . . 0.34999999999999998 108.263 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -87.27 112.56 22.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.245 1.018 . . . . 0.34999999999999998 108.577 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -104.67 117.49 34.23 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.547 1.139 . . . . 0.34999999999999998 110.578 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.411 ' HB2' HD12 ' A' ' 120' ' ' ILE . 27.1 t70 -128.37 89.34 2.89 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.597 1.159 . . . . 0.34999999999999998 110.236 -172.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -82.82 67.83 9.06 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.04 -0.726 . . . . 0.34999999999999998 109.04 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -149.0 -54.17 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.225 1.41 . . . . 0.35999999999999999 109.134 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.74 -48.11 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.634 0.773 . . . . 0.34999999999999998 112.823 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -71.94 -34.32 68.94 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.884 0.874 . . . . 0.34999999999999998 112.17 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt 72.68 174.9 0.29 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.118 1.367 . . . . 0.34999999999999998 110.945 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -79.16 132.23 36.48 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.209 0.604 . . . . 0.34999999999999998 110.876 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -139.87 113.4 8.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.585 1.154 . . . . 0.34999999999999998 108.562 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.6 m -80.2 84.88 5.81 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.658 -1.238 . . . . 0.34999999999999998 107.658 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -78.82 105.66 10.29 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.898 0.879 . . . . 0.34999999999999998 109.35 -173.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.5 m -87.95 67.79 9.08 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.585 1.154 . . . . 0.34999999999999998 111.163 -172.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -69.56 140.87 89.97 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.216 1.006 . . . . 0.33000000000000002 108.74 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -78.78 -116.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.265 2.644 . . . . 0.34999999999999998 110.335 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.1 tp -160.52 150.83 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.17 0.988 . . . . 0.34999999999999998 108.862 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.0 p -103.4 175.7 5.39 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.036 0.934 . . . . 0.34999999999999998 110.611 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.83 -10.79 15.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.592 1.557 . . . . 0.34999999999999998 110.573 164.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -77.31 -82.97 0.08 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 124.813 1.245 . . . . 0.34999999999999998 110.713 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 145.4 63.85 0.02 OUTLIER Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.155 -1.178 . . . . 0.34999999999999998 110.155 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -72.27 129.71 39.07 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 117.508 0.654 . . . . 0.34999999999999998 109.728 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.71 130.99 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.395 -0.965 . . . . 0.34999999999999998 108.395 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.6 117.24 29.51 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 107.918 -1.141 . . . . 0.33000000000000002 107.918 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.27 172.02 16.05 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.199 2.6 . . . . 0.34999999999999998 110.898 -173.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.11 34.53 0.62 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.146 0.978 . . . . 0.34999999999999998 110.932 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 32.66 54.0 0.36 Allowed 'General case' 0 C--N 1.346 0.43 0 C-N-CA 128.041 2.536 . . . . 0.34999999999999998 113.878 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.1 t 56.47 -105.84 0.29 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.893 1.677 . . . . 0.34999999999999998 111.467 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -163.22 -38.17 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.233 1.013 . . . . 0.34999999999999998 110.654 -172.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -13.6 1.37 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.26 1.824 . . . . 0.34999999999999998 115.169 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 93' ' ' ASP . 1.0 OUTLIER -153.14 148.23 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.574 1.15 . . . . 0.34999999999999998 108.978 171.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.49 34.77 3.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.37 1.868 . . . . 0.34999999999999998 111.337 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -153.37 79.48 5.48 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.318 0.647 . . . . 0.35999999999999999 111.378 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.59 167.67 25.1 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.022 2.482 . . . . 0.34999999999999998 111.527 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.0 68.2 0.47 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.194 -1.163 . . . . 0.34999999999999998 110.194 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -59.73 103.05 0.18 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.165 1.386 . . . . 0.34999999999999998 111.26 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -100.39 98.41 9.05 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.072 0.949 . . . . 0.35999999999999999 109.449 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.96 73.83 10.24 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.116 0.966 . . . . 0.34999999999999998 108.535 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.6 mt -91.05 91.29 3.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.093 -1.447 . . . . 0.34999999999999998 107.093 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.1 m -111.58 150.48 29.98 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.688 1.195 . . . . 0.34999999999999998 109.468 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -91.75 130.3 37.56 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.151 1.38 . . . . 0.34999999999999998 109.053 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 m -137.5 169.46 19.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 123.753 0.821 . . . . 0.34999999999999998 110.351 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 37.9 t -119.73 139.75 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.035 1.334 . . . . 0.34999999999999998 108.111 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.7 mt -130.54 119.35 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.232 1.013 . . . . 0.34999999999999998 109.503 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -78.71 127.2 31.76 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.923 -1.14 . . . . 0.34999999999999998 107.923 161.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -95.24 60.32 2.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.241 1.017 . . . . 0.34999999999999998 111.252 -168.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.186 0 C-N-CA 124.004 0.921 . . . . 0.25 110.021 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 110.713 -0.106 . . . . 0.34999999999999998 110.713 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -68.66 176.11 3.15 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.619 1.167 . . . . 0.34999999999999998 112.094 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.9 p -137.13 166.45 23.7 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.294 1.438 . . . . 0.34999999999999998 109.919 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -82.45 145.66 29.71 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.82 0.448 . . . . 0.34999999999999998 110.817 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -95.02 162.29 13.79 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.125 0.97 . . . . 0.34999999999999998 110.33 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 pttm 50.51 83.36 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.557 1.943 . . . . 0.34999999999999998 112.57 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.22 103.32 0.33 Allowed Glycine 0 C--N 1.341 0.845 0 C-N-CA 126.387 1.946 . . . . 0.34999999999999998 112.621 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt 75.1 -33.68 0.24 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 126.688 1.995 . . . . 0.34999999999999998 113.743 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -55.1 123.13 12.65 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.138 0.975 . . . . 0.34999999999999998 110.173 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -101.43 27.85 5.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.491 -0.766 . . . . 0.34999999999999998 112.996 -159.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? 69.53 -63.95 0.36 Allowed 'General case' 0 C--N 1.346 0.435 0 C-N-CA 126.21 1.804 . . . . 0.34999999999999998 109.907 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.59 -151.49 6.7 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.605 -1.798 . . . . 0.34999999999999998 108.605 172.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 57.62 37.73 27.54 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.371 1.068 . . . . 0.34999999999999998 111.753 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.91 64.63 0.96 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.507 1.123 . . . . 0.34999999999999998 109.335 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.51 -41.53 60.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.009 0.924 . . . . 0.34999999999999998 110.345 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.6 t 74.26 -74.67 0.08 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.779 2.032 . . . . 0.34999999999999998 112.064 175.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -155.22 171.56 19.62 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.332 0.653 . . . . 0.34999999999999998 111.257 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 70.11 121.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.709 2.004 . . . . 0.34999999999999998 112.633 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 73.93 137.81 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 126.17 1.788 . . . . 0.33000000000000002 112.223 168.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.79 109.62 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.19 3.26 . . . . 0.34999999999999998 111.922 160.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 p -138.06 -62.54 0.58 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.847 1.259 . . . . 0.34999999999999998 109.588 -174.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.0 113.08 0.31 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.46 -1.056 . . . . 0.33000000000000002 110.46 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.24 176.58 9.87 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.003 2.469 . . . . 0.34999999999999998 111.803 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -159.06 163.09 36.61 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.207 1.003 . . . . 0.34999999999999998 110.344 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.8 tt -145.11 94.61 2.55 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.458 -1.312 . . . . 0.34999999999999998 107.458 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.3 ptp -88.74 139.06 30.85 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.884 0.874 . . . . 0.34999999999999998 110.357 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.6 91.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.205 0 C-N-CA 124.636 1.174 . . . . 0.34999999999999998 107.874 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -153.59 166.1 33.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.699 1.2 . . . . 0.35999999999999999 110.139 -171.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -144.94 170.59 6.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 123.147 0.579 . . . . 0.34999999999999998 112.352 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -107.0 121.46 44.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.155 1.382 . . . . 0.34999999999999998 108.264 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.55 92.41 1.72 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.15 0.881 . . . . 0.34999999999999998 111.624 -174.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.0 m -99.08 168.63 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 124.316 1.046 . . . . 0.34999999999999998 112.852 -174.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -83.09 172.72 12.41 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.626 1.17 . . . . 0.34999999999999998 109.563 166.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -57.18 -40.94 78.33 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.722 0.809 . . . . 0.34999999999999998 110.39 170.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -62.02 -55.29 30.67 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.061 0.945 . . . . 0.34999999999999998 110.186 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.1 4.29 0.59 Allowed Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.938 -0.923 . . . . 0.34999999999999998 114.017 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -79.32 123.18 27.22 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.774 1.287 . . . . 0.35999999999999999 110.217 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -65.21 104.11 0.87 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.912 0.885 . . . . 0.34999999999999998 110.976 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 mp -69.65 -56.77 6.34 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.751 -1.203 . . . . 0.34999999999999998 107.751 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.5 mt -120.65 164.91 15.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.188 1.795 . . . . 0.34999999999999998 108.789 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.8 m -142.74 68.26 19.17 Favored Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 124.522 1.129 . . . . 0.33000000000000002 108.015 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.08 106.29 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.578 2.852 . . . . 0.34999999999999998 110.073 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -146.34 90.58 1.96 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.926 1.69 . . . . 0.34999999999999998 108.187 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -155.55 -33.36 0.09 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.056 0.762 . . . . 0.34999999999999998 113.056 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.6 t -76.22 98.7 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.975 0.91 . . . . 0.34999999999999998 111.216 -176.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -86.97 170.09 11.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.317 0.647 . . . . 0.34999999999999998 110.141 167.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -155.41 131.1 5.47 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.269 -1.011 . . . . 0.33000000000000002 108.269 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.48 121.84 8.8 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.815 2.343 . . . . 0.34999999999999998 109.059 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.0 tt -57.53 133.85 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.32 1.048 . . . . 0.34999999999999998 112.856 -168.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -142.77 98.39 5.77 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 125.565 1.546 . . . . 0.33000000000000002 107.495 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.77 173.66 13.76 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.247 2.631 . . . . 0.34999999999999998 111.288 -174.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.42 -26.48 24.17 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.013 0.816 . . . . 0.34999999999999998 112.159 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.1 t -66.32 151.51 46.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.889 0.844 . . . . 0.34999999999999998 110.796 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -62.46 148.62 45.07 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.959 0.903 . . . . 0.34999999999999998 110.118 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.51 101.23 2.64 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.368 -0.975 . . . . 0.34999999999999998 108.368 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 t -144.89 -171.07 3.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.165 1.386 . . . . 0.34999999999999998 108.752 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -58.19 -57.41 12.99 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.34999999999999998 110.674 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -61.96 -29.03 69.96 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.518 0.562 . . . . 0.34999999999999998 112.518 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -62.39 -54.01 46.54 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.547 -0.538 . . . . 0.34999999999999998 109.547 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 mm -51.14 -55.38 7.76 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 124.526 1.13 . . . . 0.34999999999999998 109.786 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -45.98 -63.75 0.91 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.675 1.19 . . . . 0.34999999999999998 112.406 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -63.62 -38.46 91.19 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.465 0.575 . . . . 0.34999999999999998 111.894 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.1 -49.15 62.97 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.491 0.716 . . . . 0.34999999999999998 110.644 -173.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.61 -37.22 79.46 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 118.454 0.57 . . . . 0.34999999999999998 111.551 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -58.83 -44.37 90.88 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.357 0.663 . . . . 0.34999999999999998 110.589 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -67.57 -34.8 77.79 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.568 0.347 . . . . 0.34999999999999998 110.85 176.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.04 -64.78 0.83 Allowed 'General case' 0 C--N 1.343 0.287 0 CA-C-O 118.605 -0.712 . . . . 0.34999999999999998 111.502 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -66.43 -35.32 79.99 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.647 0.658 . . . . 0.34999999999999998 112.368 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -90.14 49.39 1.69 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.489 0.715 . . . . 0.34999999999999998 110.578 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.0 -51.99 2.88 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.328 1.451 . . . . 0.34999999999999998 107.362 164.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.5 p -79.56 -45.76 18.6 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.566 1.146 . . . . 0.34999999999999998 110.291 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.18 -93.22 0.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.633 0.773 . . . . 0.34999999999999998 110.695 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 62.28 -151.14 0.36 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.978 1.311 . . . . 0.34999999999999998 110.674 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? 66.38 -80.45 0.03 OUTLIER 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.678 1.991 . . . . 0.34999999999999998 111.549 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -84.28 -115.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.05 -1.093 . . . . 0.34999999999999998 108.05 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 59.3 82.39 0.15 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.248 1.419 . . . . 0.34999999999999998 111.455 171.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.5 ttm105 -66.14 -55.23 17.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.698 0.799 . . . . 0.34999999999999998 109.98 172.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 t 60.89 78.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 125.189 1.396 . . . . 0.34999999999999998 109.11 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.38 -43.71 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.083 0.953 . . . . 0.34999999999999998 112.232 -171.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -138.44 170.53 15.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.247 1.019 . . . . 0.34999999999999998 110.552 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 pp -153.5 159.84 42.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.359 1.464 . . . . 0.34999999999999998 109.159 171.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.05 120.57 82.19 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 109.222 -0.658 . . . . 0.33000000000000002 109.222 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -70.72 -33.0 13.62 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.186 2.591 . . . . 0.34999999999999998 110.97 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -82.7 70.49 9.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.52 1.128 . . . . 0.34999999999999998 109.384 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.0 160.66 30.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.642 0.777 . . . . 0.34999999999999998 109.951 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.7 145.47 34.93 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.899 0.48 . . . . 0.34999999999999998 111.818 -171.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mp -122.84 99.4 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 126.728 2.011 . . . . 0.34999999999999998 106.294 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -88.93 72.53 8.46 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.175 0.99 . . . . 0.34999999999999998 109.34 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.83 115.14 5.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.401 0.68 . . . . 0.34999999999999998 110.3 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.1 m -103.01 91.6 4.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.862 1.265 . . . . 0.34999999999999998 108.303 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -81.19 94.35 6.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.306 0.642 . . . . 0.34999999999999998 109.89 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -105.68 129.7 53.85 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.056 1.342 . . . . 0.34999999999999998 110.505 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -161.37 94.4 0.98 Allowed 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 106.429 -1.693 . . . . 0.34999999999999998 106.429 172.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -56.12 -28.23 57.06 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.409 0.892 . . . . 0.34999999999999998 113.409 -169.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -56.34 -41.79 76.64 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.93 1.292 . . . . 0.35999999999999999 112.133 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -144.18 -56.12 0.36 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 112.852 0.686 . . . . 0.34999999999999998 112.852 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.61 -61.2 1.92 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.65 0.659 . . . . 0.34999999999999998 111.069 -171.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 80.41 149.26 0.1 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.503 1.921 . . . . 0.34999999999999998 110.905 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -49.38 126.43 13.12 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.983 1.713 . . . . 0.34999999999999998 112.153 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -155.24 101.42 2.22 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.148 0.979 . . . . 0.34999999999999998 109.04 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.7 m -77.23 97.86 4.95 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.939 1.296 . . . . 0.34999999999999998 109.708 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -91.66 108.38 19.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.569 1.148 . . . . 0.34999999999999998 108.39 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.0 p -82.68 77.95 9.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.51 1.124 . . . . 0.34999999999999998 111.44 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -72.33 131.9 84.53 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 108.567 -0.901 . . . . 0.33000000000000002 108.567 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.89 -125.03 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.653 2.902 . . . . 0.34999999999999998 109.03 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.51 154.12 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 119.268 0.94 . . . . 0.34999999999999998 110.013 173.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.7 p -108.01 123.21 48.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.366 1.067 . . . . 0.34999999999999998 108.558 169.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -61.23 -36.56 80.27 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.531 1.132 . . . . 0.34999999999999998 110.658 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -56.01 -56.55 19.45 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.426 1.091 . . . . 0.34999999999999998 111.238 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.51 139.42 2.71 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 112.26 -0.336 . . . . 0.34999999999999998 112.26 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -155.39 165.9 35.19 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.571 1.548 . . . . 0.34999999999999998 108.783 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -137.19 146.1 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.264 1.426 . . . . 0.34999999999999998 108.71 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.33 116.95 29.24 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.348 -0.982 . . . . 0.33000000000000002 108.348 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.83 175.52 10.43 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.094 2.53 . . . . 0.34999999999999998 111.504 -171.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.8 -166.01 0.26 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.616 1.166 . . . . 0.34999999999999998 110.356 171.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.26 28.65 1.67 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.581 0.752 . . . . 0.34999999999999998 112.536 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.6 t 53.1 -113.4 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.984 1.314 . . . . 0.34999999999999998 111.796 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -158.09 -33.44 0.07 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.428 1.091 . . . . 0.34999999999999998 111.595 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -60.45 -39.24 86.84 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.057 0.943 . . . . 0.34999999999999998 111.227 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.6 tp -102.13 137.09 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.247 1.419 . . . . 0.34999999999999998 108.13 171.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -137.28 13.47 3.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.494 1.117 . . . . 0.34999999999999998 111.211 175.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -159.66 63.86 2.27 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.056 0.942 . . . . 0.35999999999999999 109.995 -173.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.89 -176.22 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.65 2.9 . . . . 0.34999999999999998 111.914 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.76 78.18 0.25 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 109.608 -1.397 . . . . 0.34999999999999998 109.608 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -66.43 118.09 9.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.981 0.912 . . . . 0.34999999999999998 109.441 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -121.06 90.99 3.43 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.812 1.245 . . . . 0.35999999999999999 108.803 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.73 69.84 10.35 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.743 0.817 . . . . 0.34999999999999998 109.178 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.3 mt -97.25 89.84 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.553 1.141 . . . . 0.34999999999999998 108.678 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 57.7 m -92.07 169.13 10.88 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.306 1.442 . . . . 0.34999999999999998 108.621 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -116.92 132.86 56.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.592 1.157 . . . . 0.34999999999999998 108.934 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.9 m -124.66 138.58 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.509 1.124 . . . . 0.34999999999999998 109.956 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -92.45 96.3 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.283 -1.006 . . . . 0.34999999999999998 108.283 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.7 mt -80.86 110.21 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 123.311 0.644 . . . . 0.34999999999999998 110.03 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -98.09 155.88 16.92 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.703 -1.221 . . . . 0.34999999999999998 107.703 153.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -107.97 132.67 53.26 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.314 1.046 . . . . 0.34999999999999998 109.134 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 N--CA 1.453 -0.311 0 C-N-CA 124.541 1.136 . . . . 0.25 110.291 -174.03 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 97.6 p . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 110.637 -0.135 . . . . 0.34999999999999998 110.637 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.7 m -81.18 -113.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.885 1.274 . . . . 0.34999999999999998 109.225 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.9 t -113.83 45.22 1.49 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.561 1.144 . . . . 0.34999999999999998 108.877 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 p90 35.88 58.71 0.91 Allowed 'General case' 0 C--N 1.344 0.355 0 C-N-CA 127.113 2.165 . . . . 0.34999999999999998 112.548 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -40.09 88.72 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.13 2.172 . . . . 0.34999999999999998 114.438 -163.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt 156.72 143.5 0.0 OUTLIER 'General case' 0 C--N 1.344 0.328 0 C-N-CA 130.097 3.359 . . . . 0.34999999999999998 108.539 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.48 87.27 1.5 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.06 -1.216 . . . . 0.34999999999999998 110.06 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 59.59 -96.59 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.751 1.621 . . . . 0.34999999999999998 110.423 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.8 t80 52.75 76.44 0.19 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.086 1.354 . . . . 0.34999999999999998 109.897 -172.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -81.64 65.09 6.63 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.753 1.221 . . . . 0.34999999999999998 110.67 -171.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? 71.66 -71.5 0.13 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.68 2.392 . . . . 0.34999999999999998 112.798 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.86 -19.86 0.29 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.725 1.155 . . . . 0.34999999999999998 111.515 -167.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.68 138.61 17.86 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.667 1.587 . . . . 0.34999999999999998 111.357 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -87.44 81.4 7.83 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.189 0.996 . . . . 0.34999999999999998 109.806 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.83 158.43 18.74 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.506 1.123 . . . . 0.34999999999999998 109.545 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -159.96 170.61 20.99 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.092 0.557 . . . . 0.34999999999999998 111.184 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -122.36 43.43 2.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.11 1.364 . . . . 0.34999999999999998 107.451 164.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -173.52 107.14 0.14 Allowed 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.051 1.34 . . . . 0.34999999999999998 108.529 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 71.02 153.86 0.15 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 126.544 1.938 . . . . 0.33000000000000002 111.655 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.62 85.59 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.987 2.458 . . . . 0.34999999999999998 110.121 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.8 p -77.32 -56.79 4.25 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.021 0.929 . . . . 0.34999999999999998 110.401 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.43 158.34 23.67 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 111.736 -0.546 . . . . 0.33000000000000002 111.736 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -80.56 172.12 13.83 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.243 3.295 . . . . 0.34999999999999998 111.815 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -163.62 175.48 10.59 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.597 1.159 . . . . 0.34999999999999998 110.111 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 tt -144.55 92.41 2.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.071 -1.455 . . . . 0.34999999999999998 107.071 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -78.7 129.26 34.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.08 1.352 . . . . 0.34999999999999998 109.595 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.68 91.19 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.295 0 C-N-CA 124.813 1.245 . . . . 0.34999999999999998 108.658 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -152.53 161.98 41.84 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.255 1.022 . . . . 0.35999999999999999 109.9 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.5 m -121.4 155.3 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.784 1.234 . . . . 0.34999999999999998 111.329 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.8 m -87.96 77.83 8.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.156 -1.424 . . . . 0.34999999999999998 107.156 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.1 126.84 26.63 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 109.039 -1.625 . . . . 0.34999999999999998 109.039 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.46 168.75 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 124.534 1.134 . . . . 0.34999999999999998 110.172 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.08 -177.55 2.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.767 0.827 . . . . 0.34999999999999998 109.326 164.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 t -83.09 42.71 0.82 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.939 0.496 . . . . 0.34999999999999998 110.415 172.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.2 -59.07 0.49 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.833 2.053 . . . . 0.34999999999999998 107.86 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.33 -9.43 0.81 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.21 0.91 . . . . 0.34999999999999998 113.058 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -71.01 124.23 23.89 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.526 1.163 . . . . 0.35999999999999999 110.143 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.38 125.19 25.67 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.559 0.743 . . . . 0.34999999999999998 111.766 -171.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.7 mt -92.81 -45.53 7.96 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.859 1.664 . . . . 0.34999999999999998 109.487 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.87 151.5 44.35 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.822 0.849 . . . . 0.34999999999999998 111.753 175.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.5 t -89.48 149.56 42.77 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 126.078 1.751 . . . . 0.33000000000000002 111.077 -169.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.17 47.16 1.98 Allowed 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.414 2.743 . . . . 0.34999999999999998 111.848 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -174.52 116.78 0.2 Allowed 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.155 0.982 . . . . 0.34999999999999998 110.09 173.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -170.93 -11.24 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.19 1.396 . . . . 0.34999999999999998 113.127 173.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.03 143.47 26.61 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 C-N-CA 124.671 1.188 . . . . 0.34999999999999998 109.278 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -152.79 142.59 22.04 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.327 1.051 . . . . 0.34999999999999998 109.946 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.65 145.82 32.42 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 124.236 1.015 . . . . 0.33000000000000002 110.156 -168.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.9 118.67 5.69 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.739 2.293 . . . . 0.34999999999999998 108.385 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 tt -60.93 140.86 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.413 0.685 . . . . 0.34999999999999998 112.654 -164.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -127.58 103.61 22.04 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 106.356 -1.72 . . . . 0.33000000000000002 106.356 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.22 159.54 29.82 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.993 2.462 . . . . 0.34999999999999998 111.002 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.99 66.37 1.58 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.291 -1.524 . . . . 0.34999999999999998 109.291 -175.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.8 t -152.28 145.87 24.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.492 1.117 . . . . 0.34999999999999998 109.705 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 87.9 m -70.2 115.46 9.42 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.346 1.058 . . . . 0.34999999999999998 110.499 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -119.52 102.77 8.88 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.885 1.674 . . . . 0.34999999999999998 108.217 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t -148.72 167.79 24.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.153 0.981 . . . . 0.34999999999999998 109.092 173.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -56.13 -49.27 74.39 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.072 0.949 . . . . 0.34999999999999998 111.102 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -73.04 -9.78 59.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.139 0.792 . . . . 0.34999999999999998 113.139 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.15 37.46 3.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.259 1.424 . . . . 0.34999999999999998 109.667 172.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mm -141.44 -40.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.243 0 C-N-CA 125.698 1.599 . . . . 0.34999999999999998 109.472 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -52.19 -37.51 55.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.644 1.178 . . . . 0.34999999999999998 113.128 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.06 -32.89 26.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.588 1.155 . . . . 0.34999999999999998 111.835 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -71.09 -41.12 71.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.594 1.158 . . . . 0.34999999999999998 111.84 -170.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.03 -35.59 75.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 C-N-CA 123.481 0.713 . . . . 0.34999999999999998 111.482 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.89 -35.38 79.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.098 0.559 . . . . 0.34999999999999998 110.944 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.77 -34.24 69.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.245 0.618 . . . . 0.34999999999999998 111.496 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.97 -46.77 70.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.661 0.385 . . . . 0.34999999999999998 111.153 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -73.04 -26.02 61.14 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 118.845 -0.598 . . . . 0.34999999999999998 112.462 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.4 -41.33 76.11 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 123.84 0.856 . . . . 0.34999999999999998 110.939 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -48.65 -51.17 29.62 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.042 1.337 . . . . 0.34999999999999998 112.346 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.6 p -72.48 -49.64 31.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.205 0.602 . . . . 0.34999999999999998 111.257 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.02 146.47 17.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.594 0.758 . . . . 0.34999999999999998 110.197 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -149.11 45.66 0.99 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.751 0.82 . . . . 0.34999999999999998 111.201 -171.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -132.64 -59.57 0.9 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.755 0.822 . . . . 0.34999999999999998 110.684 -173.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -93.39 70.77 4.35 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.715 0.806 . . . . 0.34999999999999998 110.948 -164.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.98 161.05 40.54 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.016 0.926 . . . . 0.34999999999999998 112.999 -175.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.93 77.98 0.45 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.803 -1.925 . . . . 0.34999999999999998 105.803 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.27 100.47 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.059 0.944 . . . . 0.34999999999999998 109.803 -167.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.33 -61.72 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.88 1.272 . . . . 0.34999999999999998 110.583 -175.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -156.25 117.29 3.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.186 0.594 . . . . 0.34999999999999998 110.192 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -78.21 144.98 35.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.906 0.882 . . . . 0.34999999999999998 109.782 168.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.52 131.61 67.8 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.181 -0.674 . . . . 0.33000000000000002 109.181 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.73 -24.02 22.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.474 2.783 . . . . 0.34999999999999998 111.566 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.9 m -85.21 60.05 6.01 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 124.396 1.078 . . . . 0.34999999999999998 110.442 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.56 162.44 29.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.189 0.996 . . . . 0.34999999999999998 109.459 169.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -153.74 147.68 25.51 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.46 0.541 . . . . 0.34999999999999998 112.46 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 mp -90.44 135.47 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.388 -1.708 . . . . 0.34999999999999998 106.388 165.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.2 66.67 1.53 Allowed 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.303 -0.999 . . . . 0.34999999999999998 108.303 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.77 125.22 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.061 0.944 . . . . 0.34999999999999998 110.751 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 m -123.89 109.72 13.94 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.346 1.058 . . . . 0.34999999999999998 109.429 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.52 110.58 22.91 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 125.128 1.371 . . . . 0.34999999999999998 108.878 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.44 52.97 2.58 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.612 1.565 . . . . 0.34999999999999998 110.14 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.65 84.44 5.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.072 0.949 . . . . 0.34999999999999998 110.186 -172.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -61.19 -11.94 11.05 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.667 1.187 . . . . 0.34999999999999998 113.376 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -55.62 -50.78 69.25 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.153 0.981 . . . . 0.35999999999999999 111.145 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.52 -42.14 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.98 0.733 . . . . 0.34999999999999998 112.98 176.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -65.84 -40.76 92.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.319 0.509 . . . . 0.34999999999999998 112.101 -172.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? 77.7 160.32 0.21 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.482 1.913 . . . . 0.34999999999999998 111.181 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -50.7 121.33 5.7 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.821 1.248 . . . . 0.34999999999999998 110.109 171.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -154.19 107.08 2.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.092 0.957 . . . . 0.34999999999999998 108.446 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.2 m -78.98 89.82 4.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.969 0.908 . . . . 0.34999999999999998 108.555 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -77.35 97.27 4.85 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.107 0.963 . . . . 0.34999999999999998 108.6 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.2 p -88.72 139.91 29.98 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.308 1.043 . . . . 0.34999999999999998 110.358 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.96 140.28 8.7 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 123.891 0.877 . . . . 0.33000000000000002 109.63 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.46 140.71 33.69 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.221 2.614 . . . . 0.34999999999999998 109.788 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tt -72.42 148.92 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.05 0.54 . . . . 0.34999999999999998 110.099 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.7 p -73.1 160.26 32.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.307 0.643 . . . . 0.34999999999999998 110.739 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -88.3 -21.68 24.29 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.377 1.071 . . . . 0.34999999999999998 111.026 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -86.85 -79.61 0.26 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.278 1.031 . . . . 0.34999999999999998 110.932 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -177.42 74.4 0.07 OUTLIER Glycine 0 CA--C 1.528 0.844 0 CA-C-N 118.215 0.461 . . . . 0.34999999999999998 112.448 -170.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -77.47 154.51 32.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.866 -0.79 . . . . 0.34999999999999998 108.866 165.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.0 t -131.88 140.73 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.367 1.067 . . . . 0.34999999999999998 108.719 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.9 t -67.94 122.02 82.12 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 108.502 -0.925 . . . . 0.33000000000000002 108.502 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.27 158.16 41.28 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.069 2.513 . . . . 0.34999999999999998 111.052 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.74 80.35 2.69 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.627 1.171 . . . . 0.34999999999999998 109.296 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.405 HD11 HG13 ' A' ' 120' ' ' ILE . 2.1 tm? -84.96 99.93 11.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.998 1.319 . . . . 0.34999999999999998 109.071 -169.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.9 t -167.57 79.14 0.18 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.253 1.021 . . . . 0.34999999999999998 108.998 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.39 -99.23 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.651 0.78 . . . . 0.34999999999999998 110.035 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -70.23 -16.65 63.08 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.512 1.051 . . . . 0.34999999999999998 112.304 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.405 HG13 HD11 ' A' ' 116' ' ' LEU . 9.6 pt -142.21 160.45 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 125.701 1.6 . . . . 0.34999999999999998 109.22 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 29.56 0.37 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.89 0.7 . . . . 0.34999999999999998 112.89 -175.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.35 46.51 0.69 Allowed Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.403 0.519 . . . . 0.35999999999999999 112.403 172.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.39 135.13 41.47 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.094 2.53 . . . . 0.34999999999999998 111.339 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -116.05 74.14 0.26 Allowed Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.959 -1.256 . . . . 0.34999999999999998 109.959 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -60.74 95.99 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.625 1.57 . . . . 0.34999999999999998 111.109 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -91.24 99.16 12.2 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.784 0.834 . . . . 0.35999999999999999 109.694 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.2 80.35 9.09 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 108.366 -0.976 . . . . 0.34999999999999998 108.366 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 94.5 mt -94.82 121.11 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.442 -1.318 . . . . 0.34999999999999998 107.442 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.8 m -141.17 136.77 32.15 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.431 1.092 . . . . 0.34999999999999998 109.005 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.21 131.78 34.09 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.387 1.075 . . . . 0.34999999999999998 108.593 -178.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.05 141.06 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.48 0.712 . . . . 0.34999999999999998 110.422 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 51.0 t -93.81 140.52 16.36 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 124.477 1.111 . . . . 0.34999999999999998 108.843 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.5 mt -139.64 154.5 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.825 1.65 . . . . 0.34999999999999998 107.742 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -143.07 23.78 1.85 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.67 0.989 . . . . 0.34999999999999998 113.67 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.61 134.58 0.05 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.936 1.294 . . . . 0.34999999999999998 111.474 169.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? . . . . . 0 C--N 1.342 0.251 0 C-N-CA 124.703 1.201 . . . . 0.25 110.637 177.878 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.1 m . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 119.648 -0.215 . . . . 0.34999999999999998 110.599 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.8 p 51.39 -129.24 2.31 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.788 1.635 . . . . 0.34999999999999998 111.878 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 t 67.8 2.06 2.91 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.609 1.563 . . . . 0.34999999999999998 113.677 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 50.21 67.98 0.83 Allowed 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.213 1.405 . . . . 0.34999999999999998 110.061 -169.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -83.9 68.38 9.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.415 1.086 . . . . 0.34999999999999998 108.894 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -134.73 -24.48 1.51 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.879 1.672 . . . . 0.34999999999999998 110.736 -172.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.05 26.78 30.34 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.537 1.065 . . . . 0.34999999999999998 112.166 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 49.92 51.37 16.71 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.699 1.6 . . . . 0.34999999999999998 111.566 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -103.85 94.33 5.37 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.966 0.906 . . . . 0.34999999999999998 110.603 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.32 36.94 0.71 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.526 1.13 . . . . 0.34999999999999998 111.075 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? 54.04 -95.3 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.206 1.802 . . . . 0.34999999999999998 110.903 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.14 56.42 0.26 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.549 -1.82 . . . . 0.34999999999999998 108.549 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -130.17 67.11 1.48 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.981 1.312 . . . . 0.34999999999999998 108.888 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -167.71 113.95 0.72 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.174 0.989 . . . . 0.34999999999999998 109.645 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.75 -65.96 0.97 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.029 0.932 . . . . 0.34999999999999998 110.339 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.3 t 69.63 -73.4 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.923 2.089 . . . . 0.34999999999999998 111.654 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -140.03 75.67 1.52 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.766 -1.198 . . . . 0.34999999999999998 107.766 162.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -145.73 33.03 1.04 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.041 0.937 . . . . 0.34999999999999998 110.054 173.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 66.62 168.71 0.11 Allowed Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.534 1.934 . . . . 0.33000000000000002 112.101 171.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -69.12 99.95 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.121 2.548 . . . . 0.34999999999999998 111.361 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.3 p -110.34 -40.93 4.51 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.589 1.556 . . . . 0.34999999999999998 109.602 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.87 155.03 9.73 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.538 -1.025 . . . . 0.33000000000000002 110.538 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.13 161.16 29.57 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.072 3.181 . . . . 0.34999999999999998 111.024 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -156.58 164.62 37.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.611 0.764 . . . . 0.34999999999999998 111.135 -170.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.5 tt -149.13 132.03 16.13 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.146 1.378 . . . . 0.34999999999999998 108.012 -177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.2 mtp -125.31 133.11 52.74 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.889 1.275 . . . . 0.34999999999999998 109.453 -171.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.54 95.29 2.89 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 C-N-CA 124.075 0.95 . . . . 0.34999999999999998 110.409 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -149.31 178.35 8.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.568 0.747 . . . . 0.35999999999999999 111.278 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.08 146.35 26.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 124.802 1.241 . . . . 0.34999999999999998 110.948 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.1 m -84.06 86.31 7.22 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.918 -1.141 . . . . 0.34999999999999998 107.918 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.64 119.7 6.63 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.527 -1.029 . . . . 0.34999999999999998 110.527 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.81 170.43 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.496 1.118 . . . . 0.34999999999999998 110.962 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -84.45 177.62 8.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.357 1.063 . . . . 0.34999999999999998 109.639 166.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -58.67 -38.29 77.87 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.805 0.842 . . . . 0.34999999999999998 110.649 171.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -57.38 -49.06 77.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.666 1.186 . . . . 0.34999999999999998 110.719 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.96 5.98 7.91 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.142 1.353 . . . . 0.34999999999999998 111.869 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.11 123.2 24.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.081 0.941 . . . . 0.35999999999999999 109.19 -176.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.96 107.15 3.0 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.383 0.673 . . . . 0.34999999999999998 111.414 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.93 -42.26 70.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.536 1.134 . . . . 0.34999999999999998 109.781 170.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -152.06 150.06 29.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.998 0.919 . . . . 0.34999999999999998 111.184 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.7 m -84.52 159.54 58.33 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 124.955 1.302 . . . . 0.33000000000000002 110.463 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -84.75 53.99 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.52 2.813 . . . . 0.34999999999999998 111.079 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -158.75 111.56 2.29 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.587 0.755 . . . . 0.34999999999999998 110.991 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -160.81 -54.88 0.05 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.206 0.603 . . . . 0.34999999999999998 111.461 152.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.47 147.17 5.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.48 0.582 . . . . 0.34999999999999998 110.822 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.26 174.61 7.59 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.323 1.849 . . . . 0.34999999999999998 110.156 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -161.98 131.81 3.35 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.756 0.822 . . . . 0.33000000000000002 109.286 -176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -73.63 124.03 9.0 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.658 2.239 . . . . 0.34999999999999998 108.722 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.5 tp -48.19 132.52 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.115 1.366 . . . . 0.34999999999999998 112.391 -174.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -140.66 104.05 6.39 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 124.927 1.291 . . . . 0.33000000000000002 108.009 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -81.11 -171.37 1.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.573 2.849 . . . . 0.34999999999999998 110.467 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.26 -37.49 3.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.342 -0.703 . . . . 0.34999999999999998 111.342 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.3 t -62.68 146.77 51.41 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.099 0.959 . . . . 0.34999999999999998 111.007 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.8 m -73.6 149.83 41.82 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.628 0.771 . . . . 0.34999999999999998 109.271 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.6 108.67 12.85 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.808 1.243 . . . . 0.34999999999999998 107.794 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.0 t -154.94 162.06 41.21 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.72 1.208 . . . . 0.34999999999999998 109.677 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -48.51 -54.7 13.33 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.694 1.198 . . . . 0.34999999999999998 111.276 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -61.7 -32.27 72.46 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.837 0.681 . . . . 0.34999999999999998 112.837 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -62.9 -56.85 13.62 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.438 0.563 . . . . 0.34999999999999998 109.906 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.1 mm -53.95 -43.96 59.8 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.761 1.224 . . . . 0.34999999999999998 111.761 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -51.24 -63.11 1.24 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.642 0.777 . . . . 0.34999999999999998 111.674 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -67.66 -33.65 75.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.195 0.452 . . . . 0.34999999999999998 112.053 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -62.55 -50.0 73.08 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.713 0.805 . . . . 0.34999999999999998 111.637 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.54 -37.29 78.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 118.931 -0.557 . . . . 0.34999999999999998 111.417 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.31 -45.94 92.34 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.911 0.884 . . . . 0.34999999999999998 111.295 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -41.33 99.38 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.314 0.646 . . . . 0.34999999999999998 110.941 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.95 91.85 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.841 0.857 . . . . 0.34999999999999998 111.597 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.3 -12.3 60.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.103 1.149 . . . . 0.34999999999999998 114.103 -177.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -73.01 3.09 5.78 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.347 0.976 . . . . 0.34999999999999998 113.513 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.79 15.12 6.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.153 0.888 . . . . 0.34999999999999998 111.947 169.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.0 t -161.47 -45.62 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.774 1.23 . . . . 0.34999999999999998 110.552 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.95 79.78 1.36 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.61 1.564 . . . . 0.34999999999999998 109.952 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -132.88 -43.41 0.89 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.737 1.615 . . . . 0.34999999999999998 109.422 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -60.11 -57.32 13.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.468 1.507 . . . . 0.34999999999999998 110.379 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.32 72.93 0.86 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.666 1.186 . . . . 0.34999999999999998 108.633 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -157.62 76.97 0.83 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.019 0.528 . . . . 0.34999999999999998 110.161 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -84.66 -53.15 5.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.929 1.292 . . . . 0.34999999999999998 109.949 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 t 71.03 114.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.093 1.757 . . . . 0.34999999999999998 111.226 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.73 -49.3 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.384 0.674 . . . . 0.34999999999999998 110.556 174.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.68 172.94 12.29 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.693 1.197 . . . . 0.34999999999999998 110.86 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.62 163.23 38.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.358 1.463 . . . . 0.34999999999999998 110.34 172.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.08 122.69 87.96 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.364 0.666 . . . . 0.33000000000000002 109.718 -176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.0 -32.49 11.01 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.956 2.437 . . . . 0.34999999999999998 110.451 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.3 m -80.88 74.75 7.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.434 1.094 . . . . 0.34999999999999998 109.339 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.71 162.78 17.87 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.307 1.043 . . . . 0.34999999999999998 110.53 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 142.54 23.94 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.344 0.657 . . . . 0.34999999999999998 111.118 -173.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -127.3 113.38 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.86 1.664 . . . . 0.34999999999999998 107.623 -174.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -94.62 75.03 3.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.858 0.863 . . . . 0.34999999999999998 109.151 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.94 108.21 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.768 -1.197 . . . . 0.34999999999999998 107.768 168.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.2 m -86.88 67.75 9.9 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.463 1.105 . . . . 0.34999999999999998 108.35 -170.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -60.64 99.79 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.846 1.258 . . . . 0.34999999999999998 111.772 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -130.7 134.79 47.21 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.604 1.961 . . . . 0.34999999999999998 109.86 -166.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -160.32 121.27 3.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.15 0.98 . . . . 0.34999999999999998 109.067 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -89.9 65.71 6.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.966 0.907 . . . . 0.34999999999999998 110.341 -172.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -142.8 -47.47 0.32 Allowed 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.078 1.351 . . . . 0.35999999999999999 109.134 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.16 -31.46 0.54 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.39 1.076 . . . . 0.34999999999999998 112.046 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -80.99 -42.8 20.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.852 0.686 . . . . 0.34999999999999998 112.852 -161.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? 70.01 173.25 0.3 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.543 1.537 . . . . 0.34999999999999998 110.118 -169.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -77.28 93.87 4.07 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.719 -0.474 . . . . 0.34999999999999998 109.719 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -96.64 158.26 15.51 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.616 1.167 . . . . 0.34999999999999998 108.16 170.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.9 m -136.62 110.41 8.14 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.526 0.731 . . . . 0.34999999999999998 109.686 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -95.57 100.58 12.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.582 1.153 . . . . 0.34999999999999998 108.332 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.7 p -86.92 65.29 8.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.198 0.999 . . . . 0.34999999999999998 110.051 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -65.92 136.64 95.72 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.217 1.007 . . . . 0.33000000000000002 109.388 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.23 -113.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.46 2.773 . . . . 0.34999999999999998 109.701 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.4 tp -160.46 153.69 4.45 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 CA-C-N 119.032 0.833 . . . . 0.34999999999999998 109.694 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.6 p -130.74 128.36 40.64 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.366 1.067 . . . . 0.34999999999999998 108.955 173.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -64.94 -25.68 67.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.212 1.005 . . . . 0.34999999999999998 111.47 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.16 -65.18 0.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.26 1.424 . . . . 0.34999999999999998 111.486 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 125.24 143.8 6.14 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 124.139 0.876 . . . . 0.34999999999999998 111.391 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.1 131.69 7.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.366 1.066 . . . . 0.34999999999999998 109.068 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.76 141.61 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.54 0.736 . . . . 0.34999999999999998 109.387 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 83.2 t -61.99 117.35 28.38 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 108.341 -0.985 . . . . 0.33000000000000002 108.341 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.83 -21.59 24.62 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.425 2.75 . . . . 0.34999999999999998 112.32 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.0 t70 68.77 77.21 0.23 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.721 1.608 . . . . 0.34999999999999998 111.008 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 35.64 70.58 0.14 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.203 2.201 . . . . 0.34999999999999998 114.713 166.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.7 t 25.65 -103.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.951 2.5 . . . . 0.34999999999999998 113.716 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.88 -33.72 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.684 1.194 . . . . 0.34999999999999998 111.491 172.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -83.2 43.91 0.91 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.46 1.504 . . . . 0.34999999999999998 111.526 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.6 tt -167.82 155.28 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.958 1.703 . . . . 0.34999999999999998 108.136 -172.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -146.17 -13.41 0.47 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.2 0.815 . . . . 0.34999999999999998 113.2 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.26 78.39 8.65 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 119.661 1.119 . . . . 0.35999999999999999 112.447 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.49 -84.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.548 2.832 . . . . 0.34999999999999998 111.433 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.17 74.7 0.67 Allowed Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.285 -1.126 . . . . 0.34999999999999998 110.285 -168.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -68.91 95.02 0.67 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.937 1.295 . . . . 0.34999999999999998 109.3 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -99.04 95.34 7.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.973 0.509 . . . . 0.35999999999999999 109.829 -173.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.32 98.46 3.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.844 -1.169 . . . . 0.34999999999999998 107.844 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.4 mt -125.54 109.76 22.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 124.983 1.313 . . . . 0.34999999999999998 107.588 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.2 m -133.98 125.48 28.28 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.281 1.032 . . . . 0.34999999999999998 108.807 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -67.31 128.12 35.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.583 0.753 . . . . 0.34999999999999998 110.141 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.28 138.31 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.305 1.042 . . . . 0.34999999999999998 108.6 169.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -90.68 94.69 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.158 -1.423 . . . . 0.34999999999999998 107.158 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 44.9 mt -71.43 131.46 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.259 0.624 . . . . 0.34999999999999998 109.83 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -106.36 133.92 50.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.344 -1.725 . . . . 0.34999999999999998 106.344 163.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -84.38 118.38 24.2 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.175 0.59 . . . . 0.34999999999999998 109.465 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? . . . . . 0 N--CA 1.455 -0.203 0 C-N-CA 123.285 0.634 . . . . 0.25 109.784 178.545 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 111.873 0.323 . . . . 0.34999999999999998 111.873 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -129.27 169.97 14.18 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.798 1.239 . . . . 0.34999999999999998 110.699 -175.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.2 m -87.68 67.41 9.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.494 1.118 . . . . 0.34999999999999998 108.991 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 p90 42.91 92.28 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.508 2.323 . . . . 0.34999999999999998 113.822 -175.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -66.67 168.89 8.63 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.332 0.653 . . . . 0.34999999999999998 110.2 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mptt 78.36 -38.25 0.23 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.163 2.185 . . . . 0.34999999999999998 111.71 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.7 53.55 11.81 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 110.959 -0.856 . . . . 0.34999999999999998 110.959 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 56.31 59.24 3.76 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.125 1.37 . . . . 0.34999999999999998 111.442 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -117.18 119.12 34.24 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.952 1.301 . . . . 0.34999999999999998 108.391 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.13 40.67 3.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.002 1.321 . . . . 0.34999999999999998 109.768 -171.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 59.2 -93.05 0.04 OUTLIER 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.175 1.39 . . . . 0.34999999999999998 109.817 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.06 48.03 0.4 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.562 -1.415 . . . . 0.34999999999999998 109.562 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 26.38 55.73 0.05 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 128.84 2.856 . . . . 0.34999999999999998 114.136 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 44.35 71.0 0.28 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.513 1.525 . . . . 0.34999999999999998 111.38 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.34 71.64 0.56 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.985 1.314 . . . . 0.34999999999999998 110.55 -172.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.3 t -66.62 112.26 4.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.845 1.258 . . . . 0.34999999999999998 109.01 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 62.38 -174.23 0.15 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.65 1.18 . . . . 0.34999999999999998 112.087 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 76.8 t80 65.02 88.39 0.11 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.346 1.859 . . . . 0.34999999999999998 111.697 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 67.58 167.33 0.12 Allowed Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.198 1.799 . . . . 0.33000000000000002 113.018 166.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.67 105.65 0.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.227 2.618 . . . . 0.34999999999999998 111.134 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.0 p -141.95 -54.02 0.44 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.996 0.919 . . . . 0.34999999999999998 111.403 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.44 122.22 1.03 Allowed Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.98 -0.9 . . . . 0.33000000000000002 112.261 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.99 170.62 2.02 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.542 3.495 . . . . 0.34999999999999998 114.041 170.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -161.34 165.17 29.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.286 1.034 . . . . 0.34999999999999998 110.844 171.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -160.55 93.0 0.99 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.327 1.451 . . . . 0.34999999999999998 107.235 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.5 mtm -87.54 105.23 17.17 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.477 0.711 . . . . 0.34999999999999998 111.151 -170.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -101.51 96.6 4.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 124.792 1.237 . . . . 0.34999999999999998 110.578 -174.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -163.64 171.59 15.49 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.502 1.121 . . . . 0.35999999999999999 110.809 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.1 m -100.7 -177.52 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.145 1.378 . . . . 0.34999999999999998 111.45 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.2 m -130.8 104.07 6.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.863 1.665 . . . . 0.34999999999999998 106.686 167.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.31 121.52 6.5 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.626 -0.59 . . . . 0.34999999999999998 111.626 -173.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.28 166.26 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.863 0.865 . . . . 0.34999999999999998 110.657 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -72.79 174.64 7.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.958 1.303 . . . . 0.34999999999999998 110.576 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -79.32 31.38 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.236 1.014 . . . . 0.34999999999999998 112.181 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -138.04 -55.96 0.66 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.104 1.762 . . . . 0.34999999999999998 107.669 170.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.89 65.61 0.02 OUTLIER Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.697 -1.361 . . . . 0.34999999999999998 109.697 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -139.09 122.63 17.33 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.445 1.098 . . . . 0.35999999999999999 108.493 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.58 106.03 0.51 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.218 1.007 . . . . 0.34999999999999998 111.49 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.74 -57.23 3.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.166 0.986 . . . . 0.34999999999999998 108.706 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.4 mt -124.51 167.69 14.11 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.785 1.234 . . . . 0.34999999999999998 110.13 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -146.02 73.48 13.41 Favored Pre-proline 0 N--CA 1.455 -0.199 0 N-CA-C 106.817 -1.549 . . . . 0.33000000000000002 106.817 167.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -87.25 58.75 3.5 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.844 3.029 . . . . 0.34999999999999998 110.208 -168.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -107.58 54.58 0.66 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.779 1.232 . . . . 0.34999999999999998 109.443 -172.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -114.45 15.46 17.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.2 1.4 . . . . 0.34999999999999998 113.478 -169.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.51 165.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 CA-C-N 118.849 0.749 . . . . 0.34999999999999998 110.275 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.42 177.54 10.19 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.269 1.027 . . . . 0.34999999999999998 110.843 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -134.57 141.34 38.5 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.574 1.55 . . . . 0.33000000000000002 108.027 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -84.81 26.24 0.66 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.14 2.56 . . . . 0.34999999999999998 113.86 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 69.97 136.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.765 2.026 . . . . 0.34999999999999998 111.717 -176.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.05 128.52 5.01 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.647 -0.872 . . . . 0.33000000000000002 108.647 157.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.15 165.51 21.4 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.209 2.606 . . . . 0.34999999999999998 110.49 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.64 63.57 1.75 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.681 -0.968 . . . . 0.34999999999999998 110.681 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -153.05 138.78 17.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.733 1.213 . . . . 0.34999999999999998 108.738 173.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 m -73.47 87.45 1.58 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.374 1.069 . . . . 0.34999999999999998 109.748 -173.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 106.13 9.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.06 1.344 . . . . 0.34999999999999998 109.012 -174.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -140.09 177.65 7.83 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 125.742 1.617 . . . . 0.34999999999999998 109.411 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -41.2 88.54 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.933 -0.395 . . . . 0.34999999999999998 109.933 170.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.43 -45.83 78.54 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.428 0.691 . . . . 0.34999999999999998 111.936 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -86.26 31.04 0.66 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.779 0.718 . . . . 0.34999999999999998 112.293 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 mm -133.34 -44.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 125.396 1.478 . . . . 0.34999999999999998 108.61 172.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -53.44 -50.98 64.09 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.196 0.998 . . . . 0.34999999999999998 112.052 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -70.81 -34.31 71.6 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.598 0.636 . . . . 0.34999999999999998 111.615 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -64.5 -51.82 61.03 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.999 0.92 . . . . 0.34999999999999998 111.069 -172.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.8 m -63.5 -32.14 55.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 124.098 0.959 . . . . 0.34999999999999998 111.937 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -65.43 -38.19 89.15 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.97 0.508 . . . . 0.34999999999999998 111.059 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -70.82 -31.18 67.83 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.068 0.547 . . . . 0.34999999999999998 111.363 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.58 -49.08 67.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.653 0.781 . . . . 0.34999999999999998 111.047 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.18 -13.3 60.44 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.772 0.829 . . . . 0.34999999999999998 113.145 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -74.62 89.24 2.21 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.442 0.697 . . . . 0.34999999999999998 109.992 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.56 -52.44 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.533 1.533 . . . . 0.34999999999999998 108.846 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 66.1 p -98.19 -52.46 3.67 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.315 1.046 . . . . 0.34999999999999998 110.517 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.59 95.41 5.13 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.178 1.391 . . . . 0.34999999999999998 108.487 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -147.38 4.71 0.8 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.953 0.901 . . . . 0.34999999999999998 112.806 -173.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -148.39 -46.27 0.15 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.981 0.912 . . . . 0.34999999999999998 109.651 -169.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -54.4 -48.53 71.48 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.385 1.474 . . . . 0.34999999999999998 110.611 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.78 176.92 9.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.046 0.938 . . . . 0.34999999999999998 112.094 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -155.78 105.16 2.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.519 -0.919 . . . . 0.34999999999999998 108.519 168.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.62 131.5 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.153 0.981 . . . . 0.34999999999999998 109.74 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.56 -60.65 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.318 -0.993 . . . . 0.34999999999999998 108.318 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -133.34 154.29 50.85 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.136 1.374 . . . . 0.34999999999999998 110.185 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.4 mt -99.68 124.94 45.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.175 -1.417 . . . . 0.34999999999999998 107.175 165.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -73.64 127.66 88.24 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.299 -0.63 . . . . 0.33000000000000002 109.299 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.78 -21.69 18.57 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.44 2.76 . . . . 0.34999999999999998 111.672 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.8 m -85.21 66.44 9.73 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.052 0.941 . . . . 0.34999999999999998 110.604 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.32 165.91 23.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.361 0.665 . . . . 0.34999999999999998 109.446 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -136.81 117.9 14.38 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.06 0.544 . . . . 0.34999999999999998 111.344 -170.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.0 mm -86.95 90.79 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.762 1.625 . . . . 0.34999999999999998 108.017 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.37 72.88 8.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.633 -0.877 . . . . 0.34999999999999998 108.633 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.66 94.57 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 CA-C-O 121.6 0.714 . . . . 0.34999999999999998 110.052 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.5 m -79.74 108.91 13.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.982 -1.118 . . . . 0.34999999999999998 107.982 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -78.41 70.37 4.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.808 -0.812 . . . . 0.34999999999999998 108.808 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -71.06 124.21 23.88 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.107 0.479 . . . . 0.34999999999999998 110.133 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -153.21 163.99 38.89 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.385 1.474 . . . . 0.34999999999999998 107.839 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.65 61.83 1.08 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.36 -0.978 . . . . 0.34999999999999998 108.36 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -149.64 -54.37 0.17 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.686 1.194 . . . . 0.35999999999999999 109.78 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 -42.41 0.12 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.842 0.857 . . . . 0.34999999999999998 112.281 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -73.5 -46.55 47.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.1 0.96 . . . . 0.34999999999999998 110.955 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 81.7 tttt 71.0 163.48 0.26 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.076 1.35 . . . . 0.34999999999999998 110.984 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -47.77 124.1 6.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.561 1.144 . . . . 0.34999999999999998 110.408 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -149.46 86.43 1.47 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.922 -0.77 . . . . 0.34999999999999998 108.922 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.4 m -69.41 94.34 0.72 Allowed 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.008 1.323 . . . . 0.34999999999999998 109.581 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -89.01 95.16 10.21 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.108 -1.071 . . . . 0.34999999999999998 108.108 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p -72.53 133.47 44.79 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.688 0.795 . . . . 0.34999999999999998 110.34 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -151.02 139.05 12.58 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 125.058 1.343 . . . . 0.33000000000000002 107.627 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.76 -139.34 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.766 2.977 . . . . 0.34999999999999998 109.986 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.8 tp -158.75 156.41 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 119.272 0.942 . . . . 0.34999999999999998 109.616 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -130.29 166.63 19.96 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.397 1.079 . . . . 0.34999999999999998 110.335 176.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.6 -51.27 70.53 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.791 1.236 . . . . 0.34999999999999998 111.328 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -80.17 -33.89 37.98 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.856 0.863 . . . . 0.34999999999999998 110.992 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.85 -127.57 45.35 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.238 0.923 . . . . 0.34999999999999998 112.38 170.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -165.46 149.11 8.19 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.019 0.928 . . . . 0.34999999999999998 110.126 -173.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.1 t -78.45 132.3 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.565 -1.272 . . . . 0.34999999999999998 107.565 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.4 t -52.95 113.28 4.39 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.0 0.92 . . . . 0.33000000000000002 109.769 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -84.31 -174.2 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.516 2.811 . . . . 0.34999999999999998 110.833 -171.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -63.81 143.45 57.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.564 0.746 . . . . 0.34999999999999998 109.792 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.45 61.2 2.31 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.724 1.209 . . . . 0.34999999999999998 109.169 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.0 t 55.97 -122.65 1.8 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.936 1.694 . . . . 0.34999999999999998 111.207 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -159.25 -48.51 0.06 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.252 1.021 . . . . 0.34999999999999998 109.687 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -75.01 7.89 2.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.981 1.312 . . . . 0.34999999999999998 113.596 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.6 tt -142.35 141.3 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.305 1.442 . . . . 0.34999999999999998 108.821 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.37 29.11 2.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.287 1.035 . . . . 0.34999999999999998 111.427 174.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.402 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 16.0 p-10 -151.89 60.6 3.72 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.997 0.919 . . . . 0.35999999999999999 112.38 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 122' ' ' ASN . 24.1 Cg_exo -71.76 -166.87 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.56 2.173 . . . . 0.34999999999999998 112.655 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.81 78.38 0.21 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 108.718 -1.753 . . . . 0.34999999999999998 108.718 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -72.7 76.6 1.11 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.546 1.538 . . . . 0.34999999999999998 109.658 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -86.17 102.49 13.95 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.004 0.522 . . . . 0.35999999999999999 110.14 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.48 81.62 7.53 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.909 1.284 . . . . 0.34999999999999998 108.494 174.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.8 mt -94.91 76.19 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 107.203 -1.406 . . . . 0.34999999999999998 107.203 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.6 m -75.37 172.64 12.12 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.984 1.313 . . . . 0.34999999999999998 109.542 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.28 138.78 31.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.769 1.228 . . . . 0.34999999999999998 108.389 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.95 150.72 26.78 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 C-N-CA 123.936 0.894 . . . . 0.34999999999999998 110.987 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.42 132.85 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.842 1.257 . . . . 0.34999999999999998 108.811 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 68.2 mt -134.58 150.5 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.438 1.495 . . . . 0.34999999999999998 109.551 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -120.62 113.3 20.05 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.141 1.376 . . . . 0.34999999999999998 107.731 162.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.19 166.03 17.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.03 0.932 . . . . 0.34999999999999998 111.861 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt . . . . . 0 C--N 1.34 0.164 0 C-N-CA 124.611 1.165 . . . . 0.25 109.288 179.454 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 111.669 0.248 . . . . 0.34999999999999998 111.669 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.9 p -158.81 -26.74 0.07 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.217 0.821 . . . . 0.34999999999999998 113.217 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 p -152.13 -69.44 0.16 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.521 0.6 . . . . 0.34999999999999998 111.685 -170.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -160.44 145.59 14.69 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.092 0.557 . . . . 0.34999999999999998 110.144 -164.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -158.97 174.06 15.54 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.357 1.063 . . . . 0.34999999999999998 110.41 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.64 25.24 7.89 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 128.282 2.633 . . . . 0.34999999999999998 116.128 168.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.42 -164.42 37.64 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 118.617 0.644 . . . . 0.34999999999999998 111.569 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -93.6 56.65 2.42 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.55 0.74 . . . . 0.34999999999999998 109.232 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -85.29 89.4 7.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.589 1.156 . . . . 0.34999999999999998 109.497 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -77.27 46.14 0.49 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.349 1.459 . . . . 0.34999999999999998 113.21 -172.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.41 -75.05 0.08 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.923 2.489 . . . . 0.34999999999999998 111.969 175.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.6 -38.44 0.09 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.79 -1.324 . . . . 0.34999999999999998 109.79 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -49.99 117.83 2.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.528 1.531 . . . . 0.34999999999999998 110.0 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -170.32 133.38 1.08 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.166 0.986 . . . . 0.34999999999999998 109.392 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.5 148.64 7.95 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.4 1.08 . . . . 0.34999999999999998 109.958 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.4 t -161.34 115.86 2.03 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.062 0.945 . . . . 0.34999999999999998 109.073 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 61.19 172.66 0.11 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.354 1.862 . . . . 0.34999999999999998 113.426 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 60.07 89.18 0.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.421 1.888 . . . . 0.34999999999999998 112.186 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 71.23 154.38 0.15 Allowed Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 126.211 1.804 . . . . 0.33000000000000002 112.738 165.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.11 97.92 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.388 2.725 . . . . 0.34999999999999998 110.009 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -104.05 -58.76 1.83 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.628 1.171 . . . . 0.34999999999999998 110.987 -173.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.97 110.75 0.43 Allowed Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.896 -0.947 . . . . 0.33000000000000002 111.767 -171.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -80.3 169.42 17.35 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.472 2.781 . . . . 0.34999999999999998 111.294 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -162.41 170.04 19.45 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 113.281 0.845 . . . . 0.34999999999999998 113.281 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.07 94.88 3.01 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.825 2.05 . . . . 0.34999999999999998 107.955 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 31.7 ttp -87.5 104.37 16.41 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.027 0.531 . . . . 0.34999999999999998 110.545 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.72 97.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 125.16 1.384 . . . . 0.34999999999999998 108.832 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.35 170.3 21.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.366 1.066 . . . . 0.35999999999999999 109.158 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.44 139.45 32.3 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 C-N-CA 124.004 0.922 . . . . 0.34999999999999998 110.555 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.1 m -73.2 101.02 3.24 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.188 0.995 . . . . 0.34999999999999998 108.723 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.92 82.44 1.63 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 123.933 0.778 . . . . 0.34999999999999998 111.757 -170.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 m -85.18 157.69 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 C-N-CA 123.512 0.725 . . . . 0.34999999999999998 110.566 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.47 -69.56 0.45 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.464 -0.569 . . . . 0.34999999999999998 109.464 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.4 m -156.07 -56.21 0.09 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.104 1.362 . . . . 0.34999999999999998 109.299 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -91.56 42.05 1.09 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.759 1.223 . . . . 0.34999999999999998 110.819 -175.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.03 35.62 87.87 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.032 0.825 . . . . 0.34999999999999998 112.491 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -102.6 96.36 6.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.448 1.099 . . . . 0.35999999999999999 108.563 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.49 101.54 0.09 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.76 1.224 . . . . 0.34999999999999998 111.169 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.32 -63.47 1.23 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.426 -0.953 . . . . 0.34999999999999998 108.426 171.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -89.97 121.08 31.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.399 -0.963 . . . . 0.34999999999999998 108.399 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.5 m -87.07 108.13 17.49 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.335 1.054 . . . . 0.33000000000000002 108.399 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.96 -172.87 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.695 2.93 . . . . 0.34999999999999998 112.717 -164.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.5 m170 72.13 54.63 0.18 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.077 1.751 . . . . 0.34999999999999998 111.47 172.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -120.64 -2.4 9.91 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.725 1.21 . . . . 0.34999999999999998 112.575 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.12 142.17 40.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 125.042 1.337 . . . . 0.34999999999999998 108.284 170.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -141.14 -84.82 0.2 Allowed 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.312 -0.852 . . . . 0.34999999999999998 110.463 -177.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.1 t80 74.81 140.0 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.561 1.544 . . . . 0.33000000000000002 110.381 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.74 159.36 51.66 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.777 2.318 . . . . 0.34999999999999998 112.668 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 tp -61.33 137.36 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.886 1.274 . . . . 0.34999999999999998 112.007 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -138.57 102.76 7.84 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.414 1.486 . . . . 0.33000000000000002 107.404 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.11 175.55 11.01 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.306 2.671 . . . . 0.34999999999999998 110.709 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.26 -29.47 8.72 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.996 0.808 . . . . 0.34999999999999998 112.248 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 t -67.43 142.0 56.82 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.704 0.752 . . . . 0.34999999999999998 111.311 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.8 m -71.11 144.35 50.3 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.938 0.895 . . . . 0.34999999999999998 108.876 172.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.03 75.27 1.59 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.755 0.822 . . . . 0.34999999999999998 109.302 -166.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.1 p -104.99 173.57 6.25 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 125.57 1.548 . . . . 0.34999999999999998 110.265 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -57.83 -50.99 71.42 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.431 1.092 . . . . 0.34999999999999998 109.579 171.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.75 -28.3 67.51 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.58 0.956 . . . . 0.34999999999999998 113.58 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -68.6 -53.27 23.75 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.056 0.844 . . . . 0.34999999999999998 109.68 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.3 mm -55.3 -40.93 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.931 1.292 . . . . 0.34999999999999998 111.39 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -47.51 -64.45 0.78 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.241 1.416 . . . . 0.34999999999999998 111.908 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -69.56 -32.59 71.46 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.856 0.317 . . . . 0.34999999999999998 111.856 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -65.25 -49.86 68.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.629 0.772 . . . . 0.34999999999999998 111.543 -172.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 m -67.35 -34.31 68.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.011 0.524 . . . . 0.34999999999999998 111.474 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.32 -48.24 80.74 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 122.862 0.465 . . . . 0.34999999999999998 110.397 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -40.86 97.47 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.204 0.456 . . . . 0.34999999999999998 110.967 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.03 -50.3 73.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.167 0.987 . . . . 0.34999999999999998 111.129 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 pp -71.59 -29.43 64.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.076 0.55 . . . . 0.34999999999999998 111.605 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -70.32 -1.13 9.57 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 113.302 0.853 . . . . 0.34999999999999998 113.302 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.16 -43.47 61.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.719 0.691 . . . . 0.34999999999999998 110.28 164.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.5 p -86.37 -47.93 8.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.053 0.941 . . . . 0.34999999999999998 110.935 173.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.85 -105.84 0.03 OUTLIER 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.319 0.509 . . . . 0.34999999999999998 112.135 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 71.4 144.68 0.06 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.907 1.683 . . . . 0.34999999999999998 111.114 -171.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 70.17 -82.59 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.799 2.039 . . . . 0.34999999999999998 110.853 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -72.8 171.7 12.17 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.44 0.696 . . . . 0.34999999999999998 109.123 172.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 70.8 146.66 0.07 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.5 1.52 . . . . 0.34999999999999998 110.108 -162.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -158.18 133.82 8.97 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.911 0.884 . . . . 0.34999999999999998 109.162 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -85.22 128.64 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.037 0.935 . . . . 0.34999999999999998 108.915 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.3 t -69.78 -65.06 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.41 -1.33 . . . . 0.34999999999999998 107.41 167.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.57 139.14 5.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.795 0.838 . . . . 0.34999999999999998 109.135 170.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.16 170.22 16.97 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.63 0.772 . . . . 0.34999999999999998 109.777 170.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -67.81 129.47 93.28 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 108.927 -0.768 . . . . 0.33000000000000002 108.927 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.53 -36.07 35.59 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.503 2.135 . . . . 0.34999999999999998 109.697 172.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -89.78 69.46 7.62 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.798 1.239 . . . . 0.34999999999999998 109.163 170.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.08 172.73 4.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.629 0.772 . . . . 0.34999999999999998 109.99 168.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -152.17 151.46 31.04 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.359 0.503 . . . . 0.34999999999999998 112.359 -167.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.26 101.15 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 126.205 1.802 . . . . 0.34999999999999998 107.375 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -96.27 63.18 2.17 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.42 1.088 . . . . 0.34999999999999998 110.203 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.67 122.22 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 122.763 0.425 . . . . 0.34999999999999998 110.246 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.4 m -118.03 106.31 12.78 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.408 1.483 . . . . 0.34999999999999998 107.413 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -124.32 119.0 28.03 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.698 1.199 . . . . 0.34999999999999998 109.726 -167.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -132.38 55.66 1.87 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.979 1.311 . . . . 0.34999999999999998 112.246 -158.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -74.34 137.47 42.85 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 122.067 -0.396 . . . . 0.34999999999999998 110.996 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -93.92 70.3 3.99 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.821 -1.177 . . . . 0.34999999999999998 107.821 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -143.3 -50.57 0.33 Allowed 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.44 1.096 . . . . 0.35999999999999999 109.533 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.76 -40.65 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.163 0.585 . . . . 0.34999999999999998 112.359 -170.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -53.53 4.61 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.069 0.547 . . . . 0.34999999999999998 112.033 -168.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt 71.02 -177.82 0.21 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.846 1.258 . . . . 0.34999999999999998 110.064 -167.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -69.25 127.66 33.85 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.465 0.706 . . . . 0.34999999999999998 111.756 -170.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -142.65 104.29 4.35 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.619 1.168 . . . . 0.34999999999999998 109.459 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.7 m -80.75 108.8 14.71 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.66 -0.867 . . . . 0.34999999999999998 108.66 173.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -109.91 102.6 11.34 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.627 1.171 . . . . 0.34999999999999998 108.46 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.8 p -90.62 64.64 5.78 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.976 1.311 . . . . 0.34999999999999998 110.779 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -77.08 141.67 67.67 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.033 0.533 . . . . 0.33000000000000002 109.67 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.84 170.96 18.11 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.581 2.854 . . . . 0.34999999999999998 112.136 -171.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.4 tp -77.01 161.44 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.844 1.258 . . . . 0.34999999999999998 109.86 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 73.4 p -132.01 129.0 39.54 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.091 0.957 . . . . 0.34999999999999998 108.966 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.83 -29.29 70.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.489 0.716 . . . . 0.34999999999999998 111.487 172.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.4 -50.02 75.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.172 0.989 . . . . 0.34999999999999998 109.635 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.98 170.95 24.23 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 124.328 0.966 . . . . 0.34999999999999998 112.562 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -158.35 136.03 10.39 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.112 0.965 . . . . 0.34999999999999998 109.204 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.8 t -70.48 130.96 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.465 -1.309 . . . . 0.34999999999999998 107.465 166.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.6 t -57.51 112.51 4.8 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 107.311 -1.366 . . . . 0.33000000000000002 107.311 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.05 -95.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.597 2.198 . . . . 0.34999999999999998 112.193 -158.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -158.38 150.22 21.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.009 0.924 . . . . 0.34999999999999998 109.737 -173.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.85 56.7 0.7 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.528 1.531 . . . . 0.34999999999999998 109.552 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.4 t 34.5 -103.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.754 2.422 . . . . 0.34999999999999998 113.436 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -161.93 -51.7 0.04 OUTLIER 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.649 1.18 . . . . 0.34999999999999998 109.396 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -61.78 -44.39 96.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.062 0.945 . . . . 0.34999999999999998 111.264 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.9 tp -83.74 111.74 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.933 0.893 . . . . 0.34999999999999998 109.494 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -134.94 43.85 2.67 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.446 1.098 . . . . 0.34999999999999998 110.154 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -151.76 47.33 0.41 Allowed Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 114.0 1.111 . . . . 0.35999999999999999 114.0 163.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -55.86 145.44 72.9 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.839 1.693 . . . . 0.34999999999999998 113.31 168.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.47 76.72 0.38 Allowed Glycine 0 C--N 1.338 0.657 0 N-CA-C 108.641 -1.783 . . . . 0.34999999999999998 108.641 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -69.59 96.74 0.96 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.675 1.19 . . . . 0.34999999999999998 110.781 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -87.93 109.93 20.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.131 -1.063 . . . . 0.35999999999999999 108.131 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -94.82 52.69 1.51 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.245 -1.02 . . . . 0.34999999999999998 108.245 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -94.3 130.93 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.838 1.255 . . . . 0.34999999999999998 108.783 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 81.6 m -149.05 140.6 23.41 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.163 1.385 . . . . 0.34999999999999998 108.016 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 135.47 45.01 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.292 0.637 . . . . 0.34999999999999998 109.348 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.4 m -133.37 136.0 55.4 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 123.341 0.656 . . . . 0.34999999999999998 110.454 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.5 t -84.75 130.19 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.921 1.288 . . . . 0.34999999999999998 107.779 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 55.4 mt -123.14 131.79 72.58 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 124.122 0.969 . . . . 0.34999999999999998 110.588 -171.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -87.96 103.4 15.65 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.74 1.616 . . . . 0.34999999999999998 107.273 165.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -70.61 140.88 51.76 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.083 0.553 . . . . 0.34999999999999998 110.584 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt . . . . . 0 N--CA 1.456 -0.161 0 C-N-CA 125.474 1.51 . . . . 0.25 108.385 -175.109 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 119.049 -0.501 . . . . 0.34999999999999998 111.767 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.1 p 45.77 -131.5 1.07 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.079 1.351 . . . . 0.34999999999999998 111.038 -172.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.8 m 75.68 -54.52 0.63 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.076 2.151 . . . . 0.34999999999999998 114.218 167.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 55.46 60.38 3.39 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.236 -1.394 . . . . 0.34999999999999998 107.236 -153.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -51.54 -47.44 63.4 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 127.244 2.218 . . . . 0.34999999999999998 112.661 -167.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -66.35 107.66 2.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.668 -1.234 . . . . 0.34999999999999998 107.668 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.55 82.37 1.68 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.304 -1.119 . . . . 0.34999999999999998 110.304 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt 56.61 60.34 3.14 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.108 1.363 . . . . 0.34999999999999998 110.853 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -82.75 -64.16 1.23 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.616 1.167 . . . . 0.34999999999999998 110.089 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.95 25.47 0.31 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.002 2.521 . . . . 0.34999999999999998 114.772 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 57.27 -87.57 0.02 OUTLIER 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.847 1.659 . . . . 0.34999999999999998 111.06 -170.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.53 -55.98 0.13 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 107.83 -2.108 . . . . 0.34999999999999998 107.83 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 t0 57.54 38.13 27.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.669 1.588 . . . . 0.34999999999999998 111.396 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 42.95 63.33 1.51 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.948 1.699 . . . . 0.34999999999999998 111.438 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.82 -175.67 4.9 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.082 0.553 . . . . 0.34999999999999998 112.282 -170.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 m 65.63 79.21 0.25 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.988 1.715 . . . . 0.34999999999999998 110.195 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 54.64 65.56 1.47 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.521 1.528 . . . . 0.34999999999999998 111.03 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -145.8 34.3 1.03 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.182 1.393 . . . . 0.34999999999999998 109.716 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.52 162.99 0.12 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.005 1.722 . . . . 0.33000000000000002 112.805 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -65.68 94.48 0.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.257 2.638 . . . . 0.34999999999999998 110.224 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.3 p -138.98 -46.64 0.48 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.247 1.419 . . . . 0.34999999999999998 110.088 -171.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.04 86.89 0.26 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.883 0.754 . . . . 0.33000000000000002 111.931 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.65 153.75 10.45 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.341 3.361 . . . . 0.34999999999999998 112.718 166.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -146.48 173.64 12.11 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.447 0.699 . . . . 0.34999999999999998 110.992 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 tt -151.11 93.36 1.91 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.774 -1.195 . . . . 0.34999999999999998 107.774 176.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.4 mtp -78.71 141.99 37.45 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.941 1.296 . . . . 0.34999999999999998 109.996 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 37.0 t -136.18 94.99 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 124.861 1.265 . . . . 0.34999999999999998 108.85 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -148.28 174.6 11.85 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.179 0.992 . . . . 0.35999999999999999 110.391 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.01 -170.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 125.323 1.449 . . . . 0.34999999999999998 109.231 174.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.6 m -121.24 103.5 9.03 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.603 -1.628 . . . . 0.34999999999999998 106.603 162.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.78 85.11 1.45 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.986 -0.846 . . . . 0.34999999999999998 110.986 -173.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.6 m -102.23 172.08 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.258 1.023 . . . . 0.34999999999999998 111.321 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -63.99 -52.69 58.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.792 1.237 . . . . 0.34999999999999998 110.709 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 m -178.88 -56.07 0.01 OUTLIER 'General case' 0 C--N 1.339 0.144 0 C-N-CA 128.189 2.596 . . . . 0.34999999999999998 107.197 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.52 -61.37 1.8 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.752 1.221 . . . . 0.34999999999999998 110.748 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.0 -19.82 0.04 OUTLIER Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.168 -0.795 . . . . 0.34999999999999998 113.351 -170.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -64.33 111.07 2.47 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.155 0.978 . . . . 0.35999999999999999 109.693 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -76.64 123.51 26.24 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.385 1.074 . . . . 0.34999999999999998 111.142 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.88 -65.2 1.04 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.61 -0.885 . . . . 0.34999999999999998 108.61 170.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.5 mt -98.65 136.02 39.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.464 1.106 . . . . 0.34999999999999998 109.95 -168.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.9 m -85.04 102.42 2.32 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.657 1.583 . . . . 0.33000000000000002 110.926 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.78 -165.4 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.25 2.633 . . . . 0.34999999999999998 111.677 -169.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 75.0 57.57 0.07 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.651 1.58 . . . . 0.34999999999999998 111.036 166.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -138.16 -5.13 1.66 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.053 1.131 . . . . 0.34999999999999998 114.053 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -130.26 143.78 39.97 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 123.739 0.816 . . . . 0.34999999999999998 109.582 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.23 177.07 11.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.541 0.736 . . . . 0.34999999999999998 112.284 -173.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -137.34 154.13 75.22 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 126.497 1.919 . . . . 0.33000000000000002 107.555 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -84.12 34.79 0.53 Allowed 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.235 2.623 . . . . 0.34999999999999998 112.323 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.257 13.8 tt 54.21 149.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 129.603 3.161 . . . . 0.34999999999999998 115.732 176.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -158.18 123.35 2.31 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.172 0.989 . . . . 0.33000000000000002 109.321 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -80.12 179.18 6.41 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.32 2.68 . . . . 0.34999999999999998 110.949 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.21 -33.72 4.95 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.774 0.702 . . . . 0.34999999999999998 111.527 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 t -63.87 144.83 56.75 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.24 1.016 . . . . 0.34999999999999998 110.948 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.9 m -73.72 145.1 45.43 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.909 -0.774 . . . . 0.34999999999999998 108.909 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.6 104.51 7.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.171 -1.418 . . . . 0.34999999999999998 107.171 177.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -143.53 157.58 44.32 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.402 1.081 . . . . 0.34999999999999998 110.4 -173.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.31 -57.55 10.18 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.493 1.117 . . . . 0.34999999999999998 111.57 -174.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -58.72 -29.11 66.44 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.01 0.744 . . . . 0.34999999999999998 113.01 -175.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -72.1 -48.34 44.69 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.714 0.806 . . . . 0.34999999999999998 110.684 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.8 mm -56.21 -39.09 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.66 1.184 . . . . 0.34999999999999998 111.944 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -47.87 -57.98 4.97 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.425 1.09 . . . . 0.34999999999999998 112.397 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -78.83 -29.7 44.87 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.061 0.544 . . . . 0.34999999999999998 112.347 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -64.01 -45.95 86.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.187 0.595 . . . . 0.34999999999999998 111.636 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.4 m -68.83 -31.81 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 122.916 0.487 . . . . 0.34999999999999998 111.406 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.46 -36.94 85.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.616 0.767 . . . . 0.34999999999999998 111.053 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -74.8 -36.09 62.48 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.801 0.841 . . . . 0.34999999999999998 111.134 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.92 78.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.125 0.57 . . . . 0.34999999999999998 111.026 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.02 -17.72 62.01 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.983 0.735 . . . . 0.34999999999999998 112.983 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -58.0 -33.61 69.11 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.492 0.717 . . . . 0.34999999999999998 112.095 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -41.57 -47.66 3.86 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 125.547 1.539 . . . . 0.34999999999999998 112.573 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 65.1 p -97.21 -51.54 4.16 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.95 1.3 . . . . 0.34999999999999998 110.797 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.21 82.17 2.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.221 1.408 . . . . 0.34999999999999998 110.288 -171.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -109.96 -36.53 5.85 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.34 1.456 . . . . 0.34999999999999998 110.965 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -87.9 -73.11 0.5 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.611 0.765 . . . . 0.34999999999999998 110.643 -173.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -96.09 62.08 2.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.24 0.616 . . . . 0.34999999999999998 111.085 -165.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.42 153.02 32.72 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.817 0.447 . . . . 0.34999999999999998 110.568 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -158.27 105.97 1.94 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.34999999999999998 108.675 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -75.05 97.98 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.541 -0.911 . . . . 0.34999999999999998 108.541 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.41 -42.64 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.302 0.641 . . . . 0.34999999999999998 110.712 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -140.94 161.22 38.34 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.738 1.215 . . . . 0.34999999999999998 109.634 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.58 163.38 32.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.773 1.229 . . . . 0.34999999999999998 109.942 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -90.32 126.79 55.49 Favored Pre-proline 0 N--CA 1.455 -0.199 0 N-CA-C 108.078 -1.082 . . . . 0.33000000000000002 108.078 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.68 -20.39 30.53 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.682 2.255 . . . . 0.34999999999999998 110.915 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.7 m -84.64 70.71 10.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.707 1.203 . . . . 0.34999999999999998 110.476 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.64 162.18 18.91 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.556 0.742 . . . . 0.34999999999999998 109.746 165.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -151.86 107.58 3.35 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.979 0.419 . . . . 0.34999999999999998 111.935 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.26 130.23 30.27 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 125.34 1.456 . . . . 0.34999999999999998 107.481 168.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -131.13 80.96 1.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.119 -1.067 . . . . 0.34999999999999998 108.119 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.56 98.25 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.833 0.853 . . . . 0.34999999999999998 110.205 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 62.1 m -93.52 97.67 10.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.074 1.35 . . . . 0.34999999999999998 107.931 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -103.63 93.46 4.94 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.989 0.916 . . . . 0.34999999999999998 111.24 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -73.07 52.48 0.33 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.648 2.379 . . . . 0.34999999999999998 111.336 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -82.06 102.1 10.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.289 1.035 . . . . 0.34999999999999998 110.605 -171.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -87.78 71.7 9.53 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.164 0.986 . . . . 0.34999999999999998 108.617 174.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -148.88 -58.51 0.22 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.056 1.343 . . . . 0.35999999999999999 109.478 172.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.13 -38.39 0.16 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.242 0.83 . . . . 0.34999999999999998 113.242 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -84.08 -45.7 12.75 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.893 0.477 . . . . 0.34999999999999998 112.128 -164.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt 73.54 162.43 0.26 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.713 1.605 . . . . 0.34999999999999998 112.264 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.76 109.93 1.58 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.548 1.139 . . . . 0.34999999999999998 111.823 -175.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.5 102.71 5.02 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.003 -1.48 . . . . 0.34999999999999998 107.003 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.2 m -79.43 93.16 5.32 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.644 0.777 . . . . 0.34999999999999998 109.181 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -83.31 106.36 15.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.766 -0.827 . . . . 0.34999999999999998 108.766 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.4 p -84.5 69.64 10.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.829 1.252 . . . . 0.34999999999999998 111.192 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -64.99 137.19 97.07 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 108.595 -0.891 . . . . 0.33000000000000002 108.595 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.09 -115.76 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.409 2.739 . . . . 0.34999999999999998 110.579 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 tp -168.42 158.24 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.609 1.164 . . . . 0.34999999999999998 108.828 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.4 p -136.41 137.69 40.74 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.835 0.854 . . . . 0.34999999999999998 109.744 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -71.88 -22.6 61.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.987 0.915 . . . . 0.34999999999999998 111.039 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -58.76 -50.18 74.91 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.792 0.837 . . . . 0.34999999999999998 109.558 168.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.62 169.95 26.61 Favored Glycine 0 C--N 1.341 0.835 0 C-N-CA 124.056 0.836 . . . . 0.34999999999999998 112.769 171.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -163.37 137.35 5.92 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.995 1.318 . . . . 0.34999999999999998 109.124 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.5 138.29 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.75 0.82 . . . . 0.34999999999999998 109.512 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.32 118.01 55.23 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 107.712 -1.218 . . . . 0.33000000000000002 107.712 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.27 -66.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.616 2.211 . . . . 0.34999999999999998 111.486 -170.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 t70 173.09 -66.4 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 126.506 1.922 . . . . 0.34999999999999998 107.544 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 55.35 60.07 3.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.633 1.573 . . . . 0.34999999999999998 110.201 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.0 m -138.17 45.64 2.09 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.589 1.156 . . . . 0.34999999999999998 108.791 174.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -104.89 -62.67 1.31 Allowed 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.046 1.339 . . . . 0.34999999999999998 109.974 -170.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -101.57 -55.65 2.47 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.934 1.293 . . . . 0.34999999999999998 109.298 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.8 pt -93.95 158.03 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.724 0.81 . . . . 0.34999999999999998 108.83 167.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -135.56 60.55 1.68 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.223 1.009 . . . . 0.34999999999999998 108.303 173.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -170.34 58.75 0.3 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.847 1.259 . . . . 0.35999999999999999 111.093 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -57.21 -51.54 8.44 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.738 2.292 . . . . 0.34999999999999998 111.4 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.82 66.0 2.31 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.539 -0.625 . . . . 0.34999999999999998 111.539 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -69.11 100.09 1.21 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.129 1.372 . . . . 0.34999999999999998 111.081 -175.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -88.61 92.96 9.4 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.294 -0.632 . . . . 0.35999999999999999 109.294 172.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.49 109.67 8.16 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 107.802 -1.184 . . . . 0.34999999999999998 107.802 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.7 mt -127.38 133.74 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.913 1.285 . . . . 0.34999999999999998 107.915 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.2 m -146.46 116.09 7.18 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.811 1.244 . . . . 0.34999999999999998 107.775 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -69.09 132.62 46.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.859 -0.423 . . . . 0.34999999999999998 109.859 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.34 153.86 36.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 123.799 0.84 . . . . 0.34999999999999998 110.976 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.5 t -93.82 103.82 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.258 1.423 . . . . 0.34999999999999998 108.058 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.8 mt -94.92 132.67 38.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.508 0.723 . . . . 0.34999999999999998 109.225 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -113.82 98.19 6.87 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.042 1.337 . . . . 0.34999999999999998 107.774 170.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -72.15 131.28 42.58 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.484 -0.562 . . . . 0.34999999999999998 109.484 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt . . . . . 0 N--CA 1.456 -0.163 0 C-N-CA 124.336 1.054 . . . . 0.25 109.566 -176.225 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 CA--C 1.534 0.337 0 CA-C-O 119.234 -0.412 . . . . 0.34999999999999998 112.059 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m 62.13 50.12 4.14 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 125.153 1.381 . . . . 0.34999999999999998 110.739 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.2 t -164.68 -38.03 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.546 0.738 . . . . 0.34999999999999998 111.688 -171.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 67.96 120.83 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.202 2.201 . . . . 0.34999999999999998 110.908 -168.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.4 148.92 44.77 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.835 0.854 . . . . 0.34999999999999998 110.494 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? 78.14 156.35 0.16 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.896 2.078 . . . . 0.34999999999999998 110.856 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.59 80.89 0.66 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 124.401 1.0 . . . . 0.34999999999999998 110.706 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? 57.56 44.15 21.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.974 1.31 . . . . 0.34999999999999998 110.744 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -93.41 87.32 5.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.637 0.775 . . . . 0.34999999999999998 109.627 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -84.02 52.52 2.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.88 1.272 . . . . 0.34999999999999998 111.096 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm 68.68 -72.41 0.1 Allowed 'General case' 0 C--N 1.342 0.277 0 C-N-CA 127.15 2.18 . . . . 0.34999999999999998 111.993 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.24 -40.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.611 -0.996 . . . . 0.34999999999999998 110.611 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -57.96 136.61 57.11 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.385 1.074 . . . . 0.34999999999999998 110.623 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -157.97 59.91 0.47 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.873 -0.788 . . . . 0.34999999999999998 108.873 174.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.11 78.71 6.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.649 1.18 . . . . 0.34999999999999998 108.476 173.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.6 m -113.46 -42.12 3.53 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.949 1.3 . . . . 0.34999999999999998 111.05 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.96 170.04 19.24 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.581 0.753 . . . . 0.34999999999999998 111.712 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.7 t80 64.76 91.23 0.08 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 126.73 2.012 . . . . 0.34999999999999998 111.241 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 70.84 150.56 0.13 Allowed Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.559 1.944 . . . . 0.33000000000000002 111.676 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.42 80.58 2.23 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.443 2.762 . . . . 0.34999999999999998 110.03 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.3 p -71.32 -48.27 51.5 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.992 0.917 . . . . 0.34999999999999998 110.641 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.83 -179.01 44.58 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 117.994 0.361 . . . . 0.33000000000000002 112.887 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -76.63 177.2 9.13 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.217 3.278 . . . . 0.34999999999999998 112.715 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -160.05 -177.5 6.35 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.165 1.386 . . . . 0.34999999999999998 109.524 157.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -153.81 99.32 2.27 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.23 -0.656 . . . . 0.34999999999999998 109.23 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 77.6 mtm -84.44 111.82 19.81 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.552 1.141 . . . . 0.34999999999999998 110.587 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.7 t -101.0 90.66 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 125.43 1.492 . . . . 0.34999999999999998 108.064 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -146.21 178.01 8.56 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.371 0.668 . . . . 0.35999999999999999 111.962 -173.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.77 142.53 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.222 1.409 . . . . 0.34999999999999998 109.835 -172.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.6 m -93.34 81.6 4.44 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.204 -1.406 . . . . 0.34999999999999998 107.204 168.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.74 113.86 3.78 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.915 -0.874 . . . . 0.34999999999999998 110.915 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.41 164.42 15.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.849 1.259 . . . . 0.34999999999999998 111.179 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -77.3 174.07 11.19 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.784 0.833 . . . . 0.34999999999999998 110.703 172.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -55.81 -40.37 72.66 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.248 1.019 . . . . 0.34999999999999998 110.41 167.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -59.13 -59.05 6.08 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.287 1.035 . . . . 0.34999999999999998 109.94 171.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 140.17 -0.99 2.13 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.26 0.933 . . . . 0.34999999999999998 112.924 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -72.63 128.06 34.42 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.478 1.139 . . . . 0.35999999999999999 109.839 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -70.01 106.49 3.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.46 0.704 . . . . 0.34999999999999998 110.89 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.8 mt -67.37 -47.16 71.2 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.591 1.156 . . . . 0.34999999999999998 110.553 174.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -142.98 152.77 42.32 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.479 0.712 . . . . 0.34999999999999998 111.316 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.0 m -108.0 152.23 41.63 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 125.389 1.476 . . . . 0.33000000000000002 109.993 -175.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.8 -173.02 1.58 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.656 2.904 . . . . 0.34999999999999998 112.304 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.1 m170 74.19 66.76 0.09 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 127.055 2.142 . . . . 0.34999999999999998 111.306 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -153.55 -2.55 0.21 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.863 0.865 . . . . 0.34999999999999998 113.041 177.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.6 t -135.39 115.73 18.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 N-CA-C 106.426 -1.694 . . . . 0.34999999999999998 106.426 170.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -143.82 148.8 36.05 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.317 1.047 . . . . 0.34999999999999998 109.503 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -139.61 148.64 56.82 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 124.284 1.034 . . . . 0.33000000000000002 109.889 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.64 135.89 34.53 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.648 2.232 . . . . 0.34999999999999998 108.544 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.4 tt -66.61 144.35 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 122.927 0.491 . . . . 0.34999999999999998 112.161 -168.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -137.97 87.31 16.71 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 125.401 1.48 . . . . 0.33000000000000002 107.5 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.55 155.5 31.76 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.38 2.72 . . . . 0.34999999999999998 110.878 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.41 -32.41 2.48 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.077 0.846 . . . . 0.34999999999999998 111.698 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.3 t -70.39 155.22 40.98 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.983 0.913 . . . . 0.34999999999999998 111.357 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.1 m -72.53 145.46 47.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.741 0.816 . . . . 0.34999999999999998 109.069 172.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.42 76.74 1.69 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.416 1.086 . . . . 0.34999999999999998 108.901 -172.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t -114.86 171.22 7.78 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.171 1.788 . . . . 0.34999999999999998 109.88 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -56.61 -44.79 81.5 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.693 1.197 . . . . 0.34999999999999998 111.63 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.79 -27.79 67.05 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.931 0.715 . . . . 0.34999999999999998 112.931 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -73.82 -25.58 60.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.37 1.068 . . . . 0.34999999999999998 112.065 174.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.8 mm -90.51 -51.4 11.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-N 118.564 0.62 . . . . 0.34999999999999998 110.94 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.36 -41.01 75.45 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.691 0.626 . . . . 0.34999999999999998 112.691 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.36 -30.37 57.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.032 0.533 . . . . 0.34999999999999998 111.697 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -76.11 -42.18 47.89 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.411 1.084 . . . . 0.34999999999999998 111.02 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.3 m -72.32 -23.76 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.001 0.52 . . . . 0.34999999999999998 111.329 173.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -68.9 -34.39 75.32 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.242 0.474 . . . . 0.34999999999999998 110.579 171.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -24.52 63.2 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.07 -0.491 . . . . 0.34999999999999998 111.732 174.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.3 -38.6 75.03 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.513 0.597 . . . . 0.34999999999999998 110.925 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.7 -45.42 92.86 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.38 0.672 . . . . 0.34999999999999998 110.366 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -64.67 153.55 39.21 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.006 0.366 . . . . 0.34999999999999998 110.279 172.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 82.51 -47.54 0.17 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.801 2.04 . . . . 0.34999999999999998 110.94 -167.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.3 p -91.69 -99.28 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.095 0.958 . . . . 0.34999999999999998 110.087 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.15 96.44 9.62 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.994 1.318 . . . . 0.34999999999999998 111.228 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -153.89 6.73 0.33 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.537 1.135 . . . . 0.34999999999999998 111.724 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -74.33 -60.56 2.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.265 1.026 . . . . 0.34999999999999998 109.612 -173.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -104.5 -21.96 13.37 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.665 1.586 . . . . 0.34999999999999998 110.542 171.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -70.28 133.79 47.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.279 1.432 . . . . 0.34999999999999998 109.921 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -152.43 114.49 4.42 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.792 0.837 . . . . 0.34999999999999998 110.078 -175.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -70.05 117.24 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.272 1.029 . . . . 0.34999999999999998 109.861 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.6 -46.7 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.976 0.911 . . . . 0.34999999999999998 110.698 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -136.94 163.18 31.31 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.651 1.181 . . . . 0.34999999999999998 109.623 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -137.04 153.06 50.72 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.766 1.226 . . . . 0.34999999999999998 110.135 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.59 126.36 71.37 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 108.437 -0.949 . . . . 0.33000000000000002 108.437 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.25 -30.79 15.33 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.917 2.411 . . . . 0.34999999999999998 111.028 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.6 t -87.13 72.7 9.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.553 1.141 . . . . 0.34999999999999998 110.502 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.03 168.69 14.93 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.112 0.965 . . . . 0.34999999999999998 110.335 168.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -139.13 152.85 47.79 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.696 0.798 . . . . 0.34999999999999998 111.735 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.92 87.55 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 126.128 1.771 . . . . 0.34999999999999998 106.923 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -86.15 93.74 9.1 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 108.86 -0.793 . . . . 0.34999999999999998 108.86 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.2 m -73.56 85.02 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 108.09 -1.078 . . . . 0.34999999999999998 108.09 171.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.7 m -87.72 78.71 8.39 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.659 1.183 . . . . 0.34999999999999998 108.521 -174.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -88.3 165.28 15.11 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.935 0.894 . . . . 0.34999999999999998 110.102 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -154.16 28.87 0.45 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.682 1.593 . . . . 0.34999999999999998 109.647 -168.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.95 125.49 20.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.318 1.447 . . . . 0.34999999999999998 112.02 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -85.49 63.02 7.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.206 -1.035 . . . . 0.34999999999999998 108.206 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -144.17 -60.76 0.39 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.715 1.206 . . . . 0.35999999999999999 109.933 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -152.68 -56.32 0.13 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.013 0.746 . . . . 0.34999999999999998 113.013 -172.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -80.02 -41.93 24.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.114 0.87 . . . . 0.34999999999999998 112.044 -171.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt 69.57 -148.77 0.11 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.918 1.287 . . . . 0.34999999999999998 111.341 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -75.66 115.92 15.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.754 0.822 . . . . 0.34999999999999998 111.442 -167.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.17 113.32 6.87 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.365 1.066 . . . . 0.34999999999999998 109.206 173.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.8 m -79.47 81.93 5.66 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 107.4 -1.333 . . . . 0.34999999999999998 107.4 169.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -86.74 86.25 7.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.279 1.032 . . . . 0.34999999999999998 109.415 -169.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.5 p -77.08 84.03 3.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.023 1.329 . . . . 0.34999999999999998 111.387 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -83.38 127.62 67.75 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 123.915 0.886 . . . . 0.33000000000000002 108.95 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.89 163.55 28.48 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.198 2.598 . . . . 0.34999999999999998 111.908 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 tp -78.84 163.83 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.714 1.206 . . . . 0.34999999999999998 110.355 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.6 p -124.34 165.3 17.93 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.849 1.26 . . . . 0.34999999999999998 110.358 176.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.37 -28.46 14.94 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.875 1.27 . . . . 0.34999999999999998 110.715 171.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -70.0 -60.25 2.41 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.012 0.925 . . . . 0.34999999999999998 109.848 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.14 98.65 2.28 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 123.993 0.806 . . . . 0.34999999999999998 111.587 174.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -78.23 136.97 37.89 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.099 -0.704 . . . . 0.34999999999999998 109.099 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.36 136.67 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.708 -0.849 . . . . 0.34999999999999998 108.708 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.83 118.22 46.43 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.469 -0.937 . . . . 0.33000000000000002 108.469 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -84.58 162.06 12.56 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.065 2.51 . . . . 0.34999999999999998 111.184 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -83.67 168.05 16.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.898 0.879 . . . . 0.34999999999999998 109.458 166.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -158.44 130.98 7.03 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.22 0.608 . . . . 0.34999999999999998 111.02 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.1 t -163.21 69.84 0.23 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.436 1.095 . . . . 0.34999999999999998 108.581 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -158.22 -63.89 0.09 Allowed 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.851 0.86 . . . . 0.34999999999999998 108.996 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -89.39 -47.29 8.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.353 1.061 . . . . 0.34999999999999998 111.382 -175.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.7 pt -136.65 169.1 20.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 C-N-CA 123.879 0.872 . . . . 0.34999999999999998 111.633 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -144.03 38.79 1.32 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.995 1.718 . . . . 0.34999999999999998 108.162 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -169.77 58.52 0.32 Allowed Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.906 0.882 . . . . 0.35999999999999999 110.502 -172.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -63.69 -57.1 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.512 2.808 . . . . 0.34999999999999998 111.993 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.38 72.91 0.86 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.457 -1.057 . . . . 0.34999999999999998 110.457 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -68.99 97.79 0.89 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.311 1.444 . . . . 0.34999999999999998 110.46 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -87.41 96.2 10.29 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.595 -0.52 . . . . 0.35999999999999999 109.595 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -88.27 62.96 6.95 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.278 -1.008 . . . . 0.34999999999999998 108.278 170.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -94.72 104.36 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.501 -2.037 . . . . 0.34999999999999998 105.501 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 68.5 p -97.94 -162.89 0.99 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.288 1.035 . . . . 0.34999999999999998 109.244 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.53 121.77 4.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.232 -1.395 . . . . 0.34999999999999998 107.232 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.36 157.02 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.224 0.61 . . . . 0.34999999999999998 110.223 175.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.81 143.85 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.942 1.297 . . . . 0.34999999999999998 108.364 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.6 mp -130.82 145.06 36.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 C-N-CA 124.767 1.227 . . . . 0.34999999999999998 110.383 -175.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.84 157.17 34.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.161 1.385 . . . . 0.34999999999999998 108.255 160.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -90.2 126.02 35.67 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.29 -0.633 . . . . 0.34999999999999998 109.29 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 C--N 1.34 0.192 0 C-N-CA 123.834 0.854 . . . . 0.25 110.635 -175.895 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 110.146 -0.316 . . . . 0.34999999999999998 110.146 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.2 m 67.42 127.15 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.659 1.984 . . . . 0.34999999999999998 112.658 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 m 54.35 42.27 31.52 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.879 1.271 . . . . 0.34999999999999998 112.256 172.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 73.29 128.73 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.312 1.845 . . . . 0.34999999999999998 109.751 -176.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -77.46 70.04 3.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.505 1.122 . . . . 0.34999999999999998 110.067 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -175.81 173.5 2.32 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.373 1.869 . . . . 0.34999999999999998 109.454 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.77 -155.4 8.65 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.859 0.742 . . . . 0.34999999999999998 111.775 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -71.17 109.74 5.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.811 0.844 . . . . 0.34999999999999998 109.059 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -138.94 80.51 1.79 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.056 0.943 . . . . 0.34999999999999998 109.004 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -89.47 35.1 0.81 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.633 1.173 . . . . 0.34999999999999998 112.013 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.6 -82.77 0.03 OUTLIER 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.849 1.66 . . . . 0.34999999999999998 110.43 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 13' ' ' ASP . . . -176.17 2.94 0.03 OUTLIER Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.389 1.471 . . . . 0.34999999999999998 112.752 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.414 ' H ' ' H ' ' A' ' 12' ' ' GLY . 3.3 p30 50.02 26.93 2.24 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 127.351 2.261 . . . . 0.34999999999999998 115.799 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 49.35 38.17 13.29 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.807 1.643 . . . . 0.34999999999999998 112.572 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.74 -44.41 0.01 OUTLIER 'General case' 0 C--N 1.339 0.11 0 C-N-CA 125.044 1.337 . . . . 0.34999999999999998 109.511 -171.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.7 t 68.64 45.72 1.04 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.294 1.838 . . . . 0.34999999999999998 110.51 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.2 t80 49.21 61.74 2.98 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.287 1.435 . . . . 0.34999999999999998 110.325 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -160.49 92.89 0.99 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.237 0.615 . . . . 0.34999999999999998 109.899 -170.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 66.5 166.21 0.12 Allowed Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 126.117 1.767 . . . . 0.33000000000000002 113.595 165.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.85 96.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.365 3.377 . . . . 0.34999999999999998 111.811 169.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.8 p -144.38 -38.49 0.29 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.917 1.287 . . . . 0.34999999999999998 110.496 -174.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.82 143.88 6.82 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 110.921 -0.872 . . . . 0.33000000000000002 110.921 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -86.44 168.32 8.68 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.052 3.168 . . . . 0.34999999999999998 112.087 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -165.08 160.03 18.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.163 0.985 . . . . 0.34999999999999998 111.215 -172.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.9 tt -158.27 113.2 2.61 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.09 1.356 . . . . 0.34999999999999998 108.748 -170.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -96.73 152.12 18.98 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.55 1.14 . . . . 0.34999999999999998 110.774 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.01 89.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.301 0 C-N-CA 124.654 1.182 . . . . 0.34999999999999998 108.709 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -144.66 -162.93 1.59 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.711 0.805 . . . . 0.35999999999999999 110.3 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.5 m -137.91 148.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 124.675 1.19 . . . . 0.34999999999999998 110.024 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.4 m -85.54 93.38 8.78 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.088 -1.449 . . . . 0.34999999999999998 107.088 169.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.89 89.32 1.43 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.819 0.723 . . . . 0.34999999999999998 111.758 -169.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.4 m -101.74 170.61 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.749 1.22 . . . . 0.34999999999999998 112.627 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.06 179.09 7.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.961 1.304 . . . . 0.34999999999999998 109.438 165.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.3 t -58.36 -40.41 82.17 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.03 0.932 . . . . 0.34999999999999998 110.786 172.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.53 -54.98 40.34 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.265 1.026 . . . . 0.34999999999999998 110.423 175.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.84 26.79 0.56 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.726 1.155 . . . . 0.34999999999999998 111.905 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -100.11 115.54 30.02 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.187 0.995 . . . . 0.35999999999999999 109.21 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.84 114.23 4.36 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.463 0.705 . . . . 0.34999999999999998 110.552 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.417 HD12 ' H ' ' A' ' 39' ' ' LEU . 4.4 mp -77.75 -51.01 11.23 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.987 -0.746 . . . . 0.34999999999999998 108.987 173.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.0 mt -91.99 -149.45 0.24 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.997 1.319 . . . . 0.34999999999999998 110.189 -167.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.4 m -154.87 123.54 3.02 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.474 1.11 . . . . 0.33000000000000002 109.126 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.16 -171.29 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.257 2.638 . . . . 0.34999999999999998 110.311 171.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.2 m170 64.14 75.63 0.37 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.696 1.199 . . . . 0.34999999999999998 111.171 174.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -145.44 -61.44 0.34 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.328 0.651 . . . . 0.34999999999999998 110.646 174.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.59 124.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 107.926 -1.139 . . . . 0.34999999999999998 107.926 166.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -149.9 151.32 33.24 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.67 1.188 . . . . 0.34999999999999998 109.541 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -140.17 146.15 44.86 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.812 1.245 . . . . 0.33000000000000002 109.333 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.71 128.76 17.51 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.329 2.019 . . . . 0.34999999999999998 107.713 166.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.4 tt -59.82 142.62 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.418 0.525 . . . . 0.34999999999999998 112.418 -167.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -128.72 97.9 26.21 Favored Pre-proline 0 N--CA 1.453 -0.287 0 N-CA-C 107.31 -1.367 . . . . 0.33000000000000002 107.31 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.29 157.47 49.88 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.454 2.103 . . . . 0.34999999999999998 109.811 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.02 58.32 1.8 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.146 -1.182 . . . . 0.34999999999999998 110.146 -174.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.3 t -152.56 147.26 25.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.979 1.311 . . . . 0.34999999999999998 108.981 174.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.1 m -61.2 138.77 58.22 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.236 0.614 . . . . 0.34999999999999998 110.379 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.89 80.95 1.71 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.446 1.098 . . . . 0.34999999999999998 108.722 -173.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.3 p -133.39 178.66 6.74 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.869 1.268 . . . . 0.34999999999999998 109.288 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -54.75 -54.37 42.86 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.109 0.564 . . . . 0.34999999999999998 111.208 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.54 -42.93 67.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.383 1.073 . . . . 0.34999999999999998 112.603 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.8 -60.24 4.11 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.231 0.612 . . . . 0.34999999999999998 110.609 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.2 mm -57.54 -42.23 80.65 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 C-N-CA 124.61 1.164 . . . . 0.34999999999999998 111.603 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -49.77 -59.24 4.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.75 1.22 . . . . 0.34999999999999998 111.999 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -73.65 -29.61 62.43 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.497 0.555 . . . . 0.34999999999999998 112.497 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -69.87 -40.03 75.99 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.518 0.727 . . . . 0.34999999999999998 111.898 -170.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.34 -30.79 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.017 0.527 . . . . 0.34999999999999998 111.512 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.3 -33.67 74.76 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.223 0.609 . . . . 0.34999999999999998 111.019 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -31.56 67.52 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.332 0.653 . . . . 0.34999999999999998 111.337 176.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 -55.4 22.23 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.228 0.611 . . . . 0.34999999999999998 110.994 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 pp -64.12 -27.33 69.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.171 0.988 . . . . 0.34999999999999998 112.811 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.62 -43.56 63.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.281 0.632 . . . . 0.34999999999999998 110.32 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.51 50.47 1.89 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.64 1.176 . . . . 0.34999999999999998 111.401 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.0 t -168.07 -42.69 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.358 1.463 . . . . 0.34999999999999998 109.945 173.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.94 88.58 0.83 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.74 0.816 . . . . 0.34999999999999998 110.023 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -107.71 46.81 0.92 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.278 1.031 . . . . 0.34999999999999998 108.717 167.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -84.89 -57.64 3.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.771 1.228 . . . . 0.34999999999999998 109.038 -175.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.74 -139.25 0.33 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.601 1.561 . . . . 0.34999999999999998 108.42 176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 82.56 109.82 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.284 1.433 . . . . 0.34999999999999998 111.436 162.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -41.86 9.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.907 1.283 . . . . 0.34999999999999998 111.209 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.1 t 69.11 92.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 126.219 1.808 . . . . 0.34999999999999998 109.463 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.6 t -67.95 -63.72 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.419 0.688 . . . . 0.34999999999999998 109.767 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -160.33 117.82 2.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.15 0.58 . . . . 0.34999999999999998 109.742 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.04 145.95 44.11 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.195 0.598 . . . . 0.34999999999999998 110.019 172.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.99 123.07 85.16 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.518 -0.919 . . . . 0.33000000000000002 108.518 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.31 -32.96 19.33 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.232 2.621 . . . . 0.34999999999999998 111.045 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.3 m -79.67 76.25 6.32 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.976 0.911 . . . . 0.34999999999999998 109.184 173.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.01 154.23 23.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.242 1.017 . . . . 0.34999999999999998 110.07 172.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -133.93 134.42 42.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.109 0.964 . . . . 0.34999999999999998 109.952 -171.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.4 mp -122.5 111.76 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 125.669 1.587 . . . . 0.34999999999999998 107.964 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -99.04 63.39 1.33 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.117 0.967 . . . . 0.34999999999999998 108.648 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.01 99.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.358 0.599 . . . . 0.34999999999999998 109.896 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.6 m -80.39 150.46 29.82 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.532 1.133 . . . . 0.34999999999999998 108.94 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -139.1 66.42 1.42 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.322 1.049 . . . . 0.34999999999999998 108.726 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -91.55 121.59 33.37 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 127.396 2.278 . . . . 0.34999999999999998 109.863 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.3 p-10 -131.29 -165.06 1.51 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.687 0.795 . . . . 0.34999999999999998 110.56 169.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -144.51 63.8 1.31 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.826 -1.176 . . . . 0.34999999999999998 107.826 169.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -134.04 -53.35 0.85 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 125.468 1.507 . . . . 0.35999999999999999 109.21 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -155.88 -41.3 0.08 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.063 0.945 . . . . 0.34999999999999998 111.679 -172.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.6 tppt? -83.67 -59.54 2.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.88 0.872 . . . . 0.34999999999999998 111.467 -166.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? 68.03 177.84 0.25 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.933 1.693 . . . . 0.34999999999999998 111.401 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -63.47 110.91 2.11 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 112.514 0.561 . . . . 0.34999999999999998 112.514 -165.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -132.93 137.25 46.55 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.229 1.811 . . . . 0.34999999999999998 106.66 170.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.5 m -116.01 102.12 9.36 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.894 0.878 . . . . 0.34999999999999998 109.35 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -79.59 101.32 8.24 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.678 -0.86 . . . . 0.34999999999999998 108.678 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.4 m -90.16 67.52 6.92 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.211 1.005 . . . . 0.34999999999999998 110.07 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -71.01 134.34 85.56 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.103 0.961 . . . . 0.33000000000000002 109.398 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.15 -113.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.474 2.783 . . . . 0.34999999999999998 109.622 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.1 tp -163.05 158.43 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.245 0 CA-C-N 119.156 0.889 . . . . 0.34999999999999998 110.087 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.8 p -133.69 151.82 51.73 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.798 1.239 . . . . 0.34999999999999998 109.183 169.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.13 -35.16 66.8 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.957 1.303 . . . . 0.34999999999999998 112.965 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -141.58 74.26 1.45 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.961 1.304 . . . . 0.34999999999999998 107.883 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.69 -92.03 0.41 Allowed Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.141 0.877 . . . . 0.34999999999999998 112.184 -175.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -162.03 171.01 18.26 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.304 0.573 . . . . 0.34999999999999998 112.076 -163.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 99.3 t -90.21 145.35 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.204 1.802 . . . . 0.34999999999999998 107.73 169.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.5 t -52.92 115.14 6.83 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 123.846 0.859 . . . . 0.33000000000000002 109.371 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -82.6 -178.67 4.08 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.275 2.65 . . . . 0.34999999999999998 110.931 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -72.38 -178.45 2.54 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.873 0.869 . . . . 0.34999999999999998 109.922 170.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.31 61.11 1.53 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.912 0.885 . . . . 0.34999999999999998 110.388 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t 56.84 -103.0 0.17 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.97 1.708 . . . . 0.34999999999999998 112.129 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -163.49 -58.12 0.04 OUTLIER 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.557 1.143 . . . . 0.34999999999999998 108.623 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -57.92 -47.55 82.53 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.257 1.423 . . . . 0.34999999999999998 112.124 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.3 tp -81.39 133.54 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.692 0.797 . . . . 0.34999999999999998 110.684 -176.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.39 29.61 0.49 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.272 1.029 . . . . 0.34999999999999998 111.643 166.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -142.49 60.56 10.23 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.227 1.411 . . . . 0.35999999999999999 108.988 167.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.92 -73.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.743 2.962 . . . . 0.34999999999999998 113.074 -168.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.71 78.36 1.4 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.927 -1.669 . . . . 0.34999999999999998 108.927 -164.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -80.03 95.99 6.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.904 -1.147 . . . . 0.34999999999999998 107.904 171.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -83.16 101.27 11.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.748 -0.834 . . . . 0.35999999999999999 108.748 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.07 49.98 1.71 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.148 -1.056 . . . . 0.34999999999999998 108.148 166.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.85 109.79 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.205 -1.776 . . . . 0.34999999999999998 106.205 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 67.1 p -94.09 -133.69 0.17 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.226 1.011 . . . . 0.34999999999999998 109.109 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -162.33 133.69 5.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.601 1.16 . . . . 0.34999999999999998 108.065 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 m -142.34 143.45 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.718 0.807 . . . . 0.34999999999999998 110.031 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.38 134.03 28.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.838 -1.171 . . . . 0.34999999999999998 107.838 173.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.7 mt -123.5 143.58 36.12 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 C-N-CA 124.47 1.108 . . . . 0.34999999999999998 110.652 -169.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -128.69 102.77 6.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.686 1.595 . . . . 0.34999999999999998 106.76 166.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -60.85 128.26 35.64 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.2 0.6 . . . . 0.34999999999999998 109.392 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.184 0 C-N-CA 123.79 0.836 . . . . 0.25 109.383 -164.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.965 -0.383 . . . . 0.34999999999999998 109.965 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 t -82.77 177.09 8.84 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.11 0.964 . . . . 0.34999999999999998 110.584 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.0 p -81.71 51.57 1.73 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.568 1.147 . . . . 0.34999999999999998 110.011 172.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 58.62 23.57 11.1 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.608 1.563 . . . . 0.34999999999999998 111.833 -171.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.8 t70 60.79 171.07 0.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.155 1.382 . . . . 0.34999999999999998 110.994 -167.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.3 pttt 47.57 -106.16 0.15 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.373 1.469 . . . . 0.34999999999999998 112.396 171.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.1 -136.49 2.03 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.546 -1.022 . . . . 0.34999999999999998 110.546 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -85.7 71.46 10.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.941 -1.133 . . . . 0.34999999999999998 107.941 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -67.15 -56.88 8.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.065 0.946 . . . . 0.34999999999999998 113.061 -162.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 44' ' ' TYR . 47.3 mmtm 76.84 110.58 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.921 2.088 . . . . 0.34999999999999998 108.297 -170.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -55.41 -61.54 2.27 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.365 1.066 . . . . 0.34999999999999998 111.817 -167.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.58 80.28 0.1 OUTLIER Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.516 -1.434 . . . . 0.34999999999999998 109.516 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -127.82 41.18 3.55 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.251 1.021 . . . . 0.34999999999999998 109.914 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.7 t0 50.71 55.25 9.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.185 1.394 . . . . 0.34999999999999998 109.552 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -129.58 -168.62 1.97 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.77 1.228 . . . . 0.34999999999999998 111.454 -155.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.5 m 63.65 69.64 0.55 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.952 1.701 . . . . 0.34999999999999998 111.025 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 60.65 -145.43 0.47 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.242 1.417 . . . . 0.34999999999999998 110.169 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 77.0 t80 57.8 73.87 0.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.468 1.507 . . . . 0.34999999999999998 111.867 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 65.43 168.09 0.11 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.992 1.717 . . . . 0.33000000000000002 113.28 168.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.32 113.53 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.981 2.454 . . . . 0.34999999999999998 110.557 168.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 p -142.36 -73.32 0.31 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.558 0.743 . . . . 0.34999999999999998 111.564 -170.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.43 112.97 0.53 Allowed Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.892 -0.949 . . . . 0.33000000000000002 111.088 -170.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.97 175.61 10.61 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.816 3.011 . . . . 0.34999999999999998 112.758 -171.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -155.28 166.98 31.88 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.835 0.68 . . . . 0.34999999999999998 112.835 -172.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.2 tp -139.0 80.94 1.81 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.469 1.908 . . . . 0.34999999999999998 107.743 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.1 mtm -74.45 100.89 3.96 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 122.674 0.39 . . . . 0.34999999999999998 111.196 -172.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 t -84.57 76.72 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.521 -1.289 . . . . 0.34999999999999998 107.521 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -149.02 148.18 29.42 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.618 1.167 . . . . 0.35999999999999999 109.708 -171.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.6 m -140.37 144.36 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.266 1.026 . . . . 0.34999999999999998 111.249 -170.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.1 m -70.2 105.49 2.97 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.731 1.212 . . . . 0.34999999999999998 109.34 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.49 81.04 1.48 Allowed Glycine 0 C--N 1.34 0.776 0 C-N-CA 124.204 0.907 . . . . 0.34999999999999998 111.711 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.9 m -87.16 170.27 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.154 0.982 . . . . 0.34999999999999998 111.909 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -77.1 -44.56 30.06 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.928 0.891 . . . . 0.34999999999999998 110.571 173.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.8 t 169.72 -59.8 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.097 2.559 . . . . 0.34999999999999998 107.077 -171.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.9 43.66 1.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.115 1.366 . . . . 0.34999999999999998 111.915 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.04 32.39 63.32 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.784 -1.009 . . . . 0.34999999999999998 114.297 167.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -103.43 90.77 3.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.483 1.141 . . . . 0.35999999999999999 108.132 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.89 109.5 1.47 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.848 0.859 . . . . 0.34999999999999998 110.077 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mp -77.52 -53.8 7.18 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.38 0.672 . . . . 0.34999999999999998 109.845 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.9 mt -86.07 -169.43 2.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.406 1.082 . . . . 0.34999999999999998 110.247 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.3 m -126.48 68.51 67.79 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.553 0.741 . . . . 0.33000000000000002 111.051 -174.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.99 164.29 35.32 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.909 3.073 . . . . 0.34999999999999998 112.893 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.1 m170 79.1 80.67 0.06 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 127.222 2.209 . . . . 0.34999999999999998 108.357 -172.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.403 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 31.2 p90 -147.31 -48.64 0.18 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.352 0.661 . . . . 0.34999999999999998 111.957 -176.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -83.86 77.51 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 108.568 -0.901 . . . . 0.34999999999999998 108.568 169.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -72.2 -38.06 69.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.897 -0.573 . . . . 0.34999999999999998 111.924 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 64.67 154.26 0.12 Allowed Pre-proline 0 C--N 1.345 0.399 0 C-N-CA 126.634 1.974 . . . . 0.33000000000000002 113.454 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.87 134.57 8.44 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.085 2.523 . . . . 0.34999999999999998 108.378 165.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.5 tt -70.51 148.57 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.505 0.322 . . . . 0.34999999999999998 111.196 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -135.08 107.39 10.4 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 107.287 -1.375 . . . . 0.33000000000000002 107.287 172.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.63 161.69 27.71 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.12 2.547 . . . . 0.34999999999999998 110.563 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.32 61.61 1.98 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.711 -1.356 . . . . 0.34999999999999998 109.711 -173.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 t -151.9 142.98 23.18 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.55 1.14 . . . . 0.34999999999999998 109.431 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.5 m -62.79 121.03 12.44 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.699 0.799 . . . . 0.34999999999999998 110.034 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.85 78.63 1.64 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.893 1.277 . . . . 0.34999999999999998 108.621 -173.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.3 p -116.02 172.1 7.37 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.746 1.618 . . . . 0.34999999999999998 109.59 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.87 -49.78 75.52 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.69 1.196 . . . . 0.34999999999999998 110.531 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -65.06 -28.94 69.81 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.61 0.764 . . . . 0.34999999999999998 112.926 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -74.36 4.02 6.51 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.471 -0.775 . . . . 0.34999999999999998 112.844 172.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.2 mm -100.36 -49.51 11.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 CA-C-N 119.324 0.965 . . . . 0.34999999999999998 109.039 168.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -43.75 -64.78 0.59 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.691 1.597 . . . . 0.34999999999999998 113.607 -167.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -82.11 -28.65 32.14 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.779 0.832 . . . . 0.34999999999999998 111.795 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -60.18 -49.41 77.75 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.626 1.17 . . . . 0.34999999999999998 111.691 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.0 m -66.9 -38.19 80.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 C-N-CA 123.371 0.668 . . . . 0.34999999999999998 110.983 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.89 -39.22 84.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.779 0.832 . . . . 0.34999999999999998 111.127 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -72.46 -40.8 66.73 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.0 0.92 . . . . 0.34999999999999998 111.466 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.74 95.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.358 0.663 . . . . 0.34999999999999998 111.218 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -85.95 -22.38 27.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.963 0.905 . . . . 0.34999999999999998 113.025 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.7 -41.77 91.51 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.512 0.725 . . . . 0.34999999999999998 110.573 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.85 64.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.0 0.92 . . . . 0.34999999999999998 112.091 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.7 p -83.58 -62.03 1.68 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.857 0.863 . . . . 0.34999999999999998 112.276 -173.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.01 -67.85 0.39 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-N 118.495 0.588 . . . . 0.34999999999999998 110.076 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 71.48 149.42 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.966 1.707 . . . . 0.34999999999999998 113.202 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? 68.59 -90.18 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.101 1.76 . . . . 0.34999999999999998 112.775 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -84.5 72.35 10.64 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 123.901 0.88 . . . . 0.34999999999999998 111.078 -169.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -167.74 147.96 5.12 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.256 1.422 . . . . 0.34999999999999998 108.248 173.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.3 tpt85 -114.1 -60.04 1.94 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.591 0.757 . . . . 0.34999999999999998 111.473 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.3 t 71.76 82.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 125.304 1.442 . . . . 0.34999999999999998 107.963 -160.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.5 t -69.38 -57.33 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.623 1.169 . . . . 0.34999999999999998 109.99 -172.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -131.11 169.52 15.78 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.627 1.171 . . . . 0.34999999999999998 110.842 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -153.68 156.4 37.78 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.712 1.605 . . . . 0.34999999999999998 109.013 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -87.33 138.27 32.25 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.276 -0.639 . . . . 0.33000000000000002 109.276 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.06 -17.92 24.43 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.436 2.758 . . . . 0.34999999999999998 111.856 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.4 m -59.01 -31.87 69.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.436 1.095 . . . . 0.34999999999999998 112.291 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 15.69 74.38 0.01 OUTLIER 'General case' 0 C--N 1.348 0.511 0 C-N-CA 128.813 2.845 . . . . 0.34999999999999998 113.728 172.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -78.9 128.77 33.75 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.122 0.969 . . . . 0.34999999999999998 113.092 -161.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.8 124.03 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 125.988 1.715 . . . . 0.34999999999999998 107.354 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -122.57 90.26 3.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.377 1.071 . . . . 0.34999999999999998 108.601 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 m -78.8 92.19 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.786 1.234 . . . . 0.34999999999999998 110.548 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.1 m -85.5 94.37 9.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.616 1.167 . . . . 0.34999999999999998 108.645 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.74 84.1 4.94 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.509 0.724 . . . . 0.34999999999999998 110.38 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -76.11 91.74 3.16 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.878 1.671 . . . . 0.34999999999999998 110.003 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -134.19 78.95 1.78 Allowed 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.896 -0.779 . . . . 0.34999999999999998 108.896 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -75.67 83.31 2.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.724 1.21 . . . . 0.34999999999999998 108.667 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -155.19 -37.86 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.857 1.663 . . . . 0.35999999999999999 110.018 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -154.7 -41.35 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.93 1.292 . . . . 0.34999999999999998 110.624 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -79.85 -63.2 1.47 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 123.246 0.618 . . . . 0.34999999999999998 110.699 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.48 125.49 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.322 1.849 . . . . 0.34999999999999998 109.84 -177.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -10.17 108.18 0.01 OUTLIER 'General case' 0 C--N 1.344 0.369 0 C-N-CA 129.516 3.126 . . . . 0.34999999999999998 115.261 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -140.86 123.33 15.95 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.03 1.332 . . . . 0.34999999999999998 107.989 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.7 m -102.32 103.9 14.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.748 1.219 . . . . 0.34999999999999998 109.726 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.86 109.15 14.01 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.491 -0.929 . . . . 0.34999999999999998 108.491 173.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.8 p -89.29 75.24 7.77 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.607 1.163 . . . . 0.34999999999999998 111.151 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -81.21 142.57 51.2 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.679 1.192 . . . . 0.33000000000000002 109.52 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -77.33 -129.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.79 2.993 . . . . 0.34999999999999998 110.157 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.8 tp -167.43 159.92 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 119.663 1.12 . . . . 0.34999999999999998 110.211 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.9 p -136.42 151.89 50.01 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.687 1.195 . . . . 0.34999999999999998 109.84 170.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.5 -11.26 60.68 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.722 1.209 . . . . 0.34999999999999998 114.062 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -142.05 59.15 1.47 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.973 -1.121 . . . . 0.34999999999999998 107.973 172.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.38 -82.67 1.0 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.183 0.897 . . . . 0.34999999999999998 111.558 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -163.54 159.83 22.41 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.193 0.521 . . . . 0.34999999999999998 112.013 -163.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.4 t -91.08 144.85 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.005 1.722 . . . . 0.34999999999999998 106.998 166.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 80.7 t -57.28 117.2 16.74 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 108.522 -0.918 . . . . 0.33000000000000002 108.522 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.55 -109.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.009 2.473 . . . . 0.34999999999999998 109.349 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -156.33 -137.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.591 -1.263 . . . . 0.34999999999999998 107.591 173.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 mp -137.27 151.54 48.81 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.821 1.248 . . . . 0.34999999999999998 109.595 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.3 t -77.11 -71.05 0.43 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.569 0.748 . . . . 0.34999999999999998 109.74 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -168.02 -46.21 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.593 1.157 . . . . 0.34999999999999998 109.799 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -39.4 -45.56 1.51 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.213 2.205 . . . . 0.34999999999999998 115.151 -169.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.39 161.15 41.06 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 C-N-CA 123.444 0.698 . . . . 0.34999999999999998 111.386 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -91.21 -68.18 0.81 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.209 1.404 . . . . 0.34999999999999998 110.092 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.473 HD22 ' H ' ' A' ' 122' ' ' ASN . 0.1 OUTLIER -107.94 103.34 49.46 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.234 1.014 . . . . 0.35999999999999999 112.407 -165.671 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.43 -177.68 3.72 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.926 2.417 . . . . 0.34999999999999998 111.174 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -153.3 68.0 0.31 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.876 -1.289 . . . . 0.34999999999999998 109.876 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -57.71 129.11 40.38 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.787 1.235 . . . . 0.34999999999999998 109.376 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -131.89 116.0 16.62 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.523 -0.918 . . . . 0.35999999999999999 108.523 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -88.5 60.13 5.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.257 1.023 . . . . 0.34999999999999998 109.628 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.8 mt -78.66 130.9 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.408 1.083 . . . . 0.34999999999999998 109.542 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.4 m -143.85 139.23 29.16 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.174 1.39 . . . . 0.34999999999999998 108.354 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.76 93.52 9.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.187 0.995 . . . . 0.34999999999999998 108.467 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.73 138.29 30.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 C-N-CA 124.198 0.999 . . . . 0.34999999999999998 111.222 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.79 100.62 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.427 1.491 . . . . 0.34999999999999998 108.751 -175.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 18.5 mt -90.98 145.84 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.089 0.956 . . . . 0.34999999999999998 110.234 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -138.59 127.05 23.15 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.845 1.258 . . . . 0.34999999999999998 109.208 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -66.71 125.71 26.7 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.316 1.046 . . . . 0.34999999999999998 109.579 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? . . . . . 0 C--N 1.34 0.183 0 C-N-CA 123.128 0.571 . . . . 0.25 109.745 176.586 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.413 ' H3 ' ' H ' ' A' ' 73' ' ' TYR . 19.8 m . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 118.595 -0.717 . . . . 0.34999999999999998 112.654 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.5 m 71.53 -74.05 0.09 Allowed 'General case' 0 C--N 1.344 0.365 0 C-N-CA 126.543 1.937 . . . . 0.34999999999999998 112.261 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 82.2 p -91.89 138.39 31.59 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.414 1.086 . . . . 0.34999999999999998 109.723 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -69.13 139.43 54.7 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.887 0.875 . . . . 0.34999999999999998 109.697 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -79.83 -171.74 3.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.402 0.681 . . . . 0.34999999999999998 110.596 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 17.8 pttm 47.75 -134.34 1.15 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.464 1.506 . . . . 0.34999999999999998 111.816 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.02 74.95 0.07 OUTLIER Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.339 0.972 . . . . 0.34999999999999998 111.842 -175.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt 52.56 62.56 2.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.537 1.135 . . . . 0.34999999999999998 110.344 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -135.86 133.43 37.77 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.317 1.047 . . . . 0.34999999999999998 110.512 -170.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.33 45.2 0.64 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.962 1.305 . . . . 0.34999999999999998 109.016 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt 64.17 -89.54 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.401 1.48 . . . . 0.34999999999999998 108.929 -168.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.33 32.58 0.12 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.338 -1.105 . . . . 0.34999999999999998 110.338 168.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 55.3 20.08 3.33 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.014 1.726 . . . . 0.34999999999999998 113.016 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 47.78 40.47 12.44 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.518 1.527 . . . . 0.34999999999999998 111.618 -173.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.05 85.35 0.15 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.373 0.669 . . . . 0.34999999999999998 109.904 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -86.86 -112.54 0.05 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.794 0.838 . . . . 0.34999999999999998 109.452 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -149.11 67.68 1.04 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.268 1.027 . . . . 0.34999999999999998 110.355 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -154.28 91.56 1.43 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.324 1.05 . . . . 0.34999999999999998 108.363 166.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 69.49 150.36 0.12 Allowed Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.875 1.67 . . . . 0.33000000000000002 111.661 173.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.45 93.14 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.0 2.467 . . . . 0.34999999999999998 111.187 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 p -74.41 -52.57 11.69 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.155 0.982 . . . . 0.34999999999999998 109.162 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.4 163.42 29.31 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.147 -0.781 . . . . 0.33000000000000002 111.147 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -80.85 -174.44 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.482 3.455 . . . . 0.34999999999999998 112.092 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -163.15 -178.45 6.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.077 1.751 . . . . 0.34999999999999998 108.807 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 tt -155.05 83.63 1.08 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.712 -1.218 . . . . 0.34999999999999998 107.712 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.1 ttp -82.27 118.63 23.27 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.324 0.65 . . . . 0.34999999999999998 110.56 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.0 t -107.78 101.11 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 126.019 1.728 . . . . 0.34999999999999998 108.281 -174.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -156.82 -177.4 6.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.582 1.153 . . . . 0.35999999999999999 110.71 -172.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.85 -164.63 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.268 1.427 . . . . 0.34999999999999998 109.162 172.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 m -133.2 99.76 4.65 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.382 -1.34 . . . . 0.34999999999999998 107.382 169.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.35 87.57 1.21 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.823 1.201 . . . . 0.34999999999999998 111.857 -171.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -104.44 166.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 124.15 0.98 . . . . 0.34999999999999998 111.943 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.32 176.46 9.3 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.638 1.575 . . . . 0.34999999999999998 109.288 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 t -53.55 -41.52 66.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.708 0.803 . . . . 0.34999999999999998 110.755 166.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -91.86 18.87 7.16 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.612 1.165 . . . . 0.34999999999999998 112.459 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 -5.7 76.79 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.926 -0.93 . . . . 0.34999999999999998 114.921 168.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -75.07 123.57 25.44 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.921 1.361 . . . . 0.35999999999999999 110.09 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.14 102.24 0.48 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.162 0.985 . . . . 0.34999999999999998 110.841 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.68 -72.32 0.3 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.845 0.858 . . . . 0.34999999999999998 108.828 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 mt -93.63 156.37 16.75 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.23 -1.026 . . . . 0.34999999999999998 108.23 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.1 t -119.43 71.33 13.02 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 124.021 0.928 . . . . 0.33000000000000002 109.652 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.61 91.84 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 124.539 3.493 . . . . 0.34999999999999998 109.893 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -156.73 55.15 0.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.713 1.205 . . . . 0.34999999999999998 109.032 -172.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -154.92 15.22 0.42 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.732 1.012 . . . . 0.34999999999999998 113.732 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.8 t -125.94 119.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 C-N-CA 123.842 0.857 . . . . 0.34999999999999998 108.859 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.68 169.52 17.64 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.291 0.636 . . . . 0.34999999999999998 111.9 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.94 157.93 53.48 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 125.907 1.683 . . . . 0.33000000000000002 108.486 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.98 168.62 22.64 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.858 2.372 . . . . 0.34999999999999998 110.413 171.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 tp -65.21 118.79 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.628 0.771 . . . . 0.34999999999999998 110.419 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -144.64 83.63 9.57 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.622 1.169 . . . . 0.33000000000000002 108.636 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -84.58 -168.53 0.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.014 3.143 . . . . 0.34999999999999998 109.907 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.17 -15.7 61.41 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.665 0.65 . . . . 0.34999999999999998 112.356 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.0 t -75.36 148.03 39.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.799 0.84 . . . . 0.34999999999999998 110.491 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.7 m -66.77 148.51 51.83 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.056 0.942 . . . . 0.34999999999999998 108.94 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.99 116.03 7.88 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.401 -0.592 . . . . 0.34999999999999998 109.401 -172.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -164.05 171.29 15.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.281 1.832 . . . . 0.34999999999999998 108.099 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -52.69 -41.37 63.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.138 0.975 . . . . 0.34999999999999998 112.143 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -83.98 -2.54 56.77 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.661 0.784 . . . . 0.34999999999999998 113.042 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.42 50.81 2.2 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.503 1.121 . . . . 0.34999999999999998 110.196 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -159.68 -48.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.378 1.071 . . . . 0.34999999999999998 109.234 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.16 -47.34 62.16 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.044 1.338 . . . . 0.34999999999999998 112.996 -174.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -63.77 -41.27 98.0 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.996 0.362 . . . . 0.34999999999999998 111.79 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -65.09 -44.97 87.13 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.037 0.935 . . . . 0.34999999999999998 111.745 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 m -69.2 -29.38 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.417 0.687 . . . . 0.34999999999999998 112.497 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -72.21 -36.88 69.29 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 122.813 0.445 . . . . 0.34999999999999998 111.08 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.21 -28.19 65.08 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.055 0.542 . . . . 0.34999999999999998 111.394 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.01 -60.05 3.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.42 0.688 . . . . 0.34999999999999998 110.618 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.69 -23.81 67.37 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.661 0.615 . . . . 0.34999999999999998 112.661 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.15 -22.62 64.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.516 0.726 . . . . 0.34999999999999998 112.252 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.62 -54.07 42.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.944 0.898 . . . . 0.34999999999999998 111.802 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.7 p -75.23 -70.14 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.441 0.696 . . . . 0.34999999999999998 110.832 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.8 148.56 25.96 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.102 1.361 . . . . 0.34999999999999998 109.841 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.413 ' H ' ' H3 ' ' A' ' 1' ' ' SER . 29.8 p90 -167.08 44.01 0.05 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.543 0.737 . . . . 0.34999999999999998 111.221 -173.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -139.26 -71.39 0.4 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.026 0.531 . . . . 0.34999999999999998 111.206 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -62.99 -57.28 11.24 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.065 0.946 . . . . 0.34999999999999998 112.215 -167.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -62.72 145.15 55.46 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.746 0.418 . . . . 0.34999999999999998 111.802 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.36 -41.5 2.04 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.498 1.919 . . . . 0.34999999999999998 109.059 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t 79.33 126.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.283 0 C-N-CA 126.569 1.948 . . . . 0.34999999999999998 111.539 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.14 -60.57 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 124.98 1.312 . . . . 0.34999999999999998 108.982 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -153.81 128.73 9.53 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.868 0.867 . . . . 0.34999999999999998 109.93 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.4 mt -78.49 118.7 20.88 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.801 -1.555 . . . . 0.34999999999999998 106.801 164.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.15 137.09 95.67 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.979 -0.378 . . . . 0.33000000000000002 109.979 -172.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -66.22 -33.93 37.94 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.41 2.74 . . . . 0.34999999999999998 111.088 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -83.87 75.27 10.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.537 1.135 . . . . 0.34999999999999998 110.165 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.89 165.05 13.74 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.654 0.782 . . . . 0.34999999999999998 109.884 167.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -153.48 121.27 6.01 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.177 0.513 . . . . 0.34999999999999998 111.794 -167.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.61 122.32 44.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 126.673 1.989 . . . . 0.34999999999999998 107.093 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -111.96 77.73 1.07 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.415 -1.328 . . . . 0.34999999999999998 107.415 173.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -72.79 86.94 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.591 0.71 . . . . 0.34999999999999998 109.555 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.4 m -94.36 92.52 7.21 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.395 1.478 . . . . 0.34999999999999998 108.816 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -91.37 169.22 10.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.648 1.179 . . . . 0.34999999999999998 109.757 172.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -149.66 63.01 1.0 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.604 1.162 . . . . 0.34999999999999998 108.033 173.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.87 86.69 4.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.525 1.13 . . . . 0.34999999999999998 108.803 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -78.98 71.92 5.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.047 1.339 . . . . 0.34999999999999998 109.214 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -149.31 -57.5 0.2 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.34 1.456 . . . . 0.35999999999999999 109.168 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.84 35.56 0.4 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.658 0.783 . . . . 0.34999999999999998 111.57 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.6 -51.06 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.937 0.495 . . . . 0.34999999999999998 110.47 -170.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt 69.26 -153.18 0.14 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.689 1.596 . . . . 0.34999999999999998 110.229 -173.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -95.18 130.91 41.72 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.503 1.121 . . . . 0.34999999999999998 110.857 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -141.74 121.17 13.21 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.466 1.106 . . . . 0.34999999999999998 108.463 171.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.6 m -81.29 85.4 6.4 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.304 -1.369 . . . . 0.34999999999999998 107.304 170.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -79.75 95.75 6.08 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.058 0.943 . . . . 0.34999999999999998 109.266 -173.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.5 p -88.17 70.1 9.24 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.667 1.187 . . . . 0.34999999999999998 111.642 -171.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -68.12 136.48 91.66 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.709 0.804 . . . . 0.33000000000000002 108.985 171.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -79.73 -111.76 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.338 2.692 . . . . 0.34999999999999998 110.275 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.5 tp -163.21 153.37 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.987 1.315 . . . . 0.34999999999999998 108.478 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.8 p -129.69 156.17 44.7 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.759 0.823 . . . . 0.34999999999999998 109.928 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.2 -26.08 52.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.311 1.444 . . . . 0.34999999999999998 112.017 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.83 -44.0 94.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.436 1.095 . . . . 0.34999999999999998 113.099 -165.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.71 64.97 0.62 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.031 -1.228 . . . . 0.34999999999999998 110.031 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -73.95 126.08 29.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.617 -0.512 . . . . 0.34999999999999998 109.617 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.9 t -76.27 130.56 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.263 -1.014 . . . . 0.34999999999999998 108.263 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.23 120.89 77.8 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 107.712 -1.218 . . . . 0.33000000000000002 107.712 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.35 -94.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.977 2.451 . . . . 0.34999999999999998 109.312 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -169.81 -82.69 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.395 1.478 . . . . 0.34999999999999998 107.275 166.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.7 mt -150.81 160.6 43.76 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.051 1.34 . . . . 0.34999999999999998 110.444 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.3 t -100.6 -72.7 0.66 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.658 1.183 . . . . 0.34999999999999998 108.992 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -166.77 -48.39 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.191 0.996 . . . . 0.34999999999999998 110.066 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.17 -35.63 12.06 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.675 1.99 . . . . 0.34999999999999998 115.385 -168.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.2 pt -132.23 171.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 124.163 0.985 . . . . 0.34999999999999998 110.963 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.09 42.34 0.59 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.277 1.031 . . . . 0.34999999999999998 111.064 172.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.01 54.47 0.56 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.785 1.234 . . . . 0.35999999999999999 110.214 170.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -44.09 -55.27 3.23 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 125.027 3.818 . . . . 0.34999999999999998 113.759 -173.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.39 67.95 1.83 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.162 -0.775 . . . . 0.34999999999999998 111.162 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -67.21 139.17 57.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.143 0.977 . . . . 0.34999999999999998 111.12 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -127.58 87.9 2.7 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.767 1.227 . . . . 0.35999999999999999 108.292 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -75.25 98.76 3.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.939 -1.504 . . . . 0.34999999999999998 106.939 174.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.53 96.67 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.679 1.192 . . . . 0.34999999999999998 108.398 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.3 m -84.88 146.8 27.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.185 0.994 . . . . 0.34999999999999998 109.783 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.14 122.82 29.36 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.776 -1.194 . . . . 0.34999999999999998 107.776 173.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.71 137.2 57.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 123.211 0.604 . . . . 0.34999999999999998 110.517 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.9 t -97.48 103.23 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.674 1.189 . . . . 0.34999999999999998 108.361 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.3 mt -82.05 126.13 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.231 1.012 . . . . 0.34999999999999998 109.977 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -100.44 140.63 34.42 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 107.84 -1.17 . . . . 0.34999999999999998 107.84 155.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.75 138.22 45.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.518 1.127 . . . . 0.34999999999999998 110.381 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 124.101 0.96 . . . . 0.25 109.013 178.358 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.459 ' H2 ' ' H ' ' A' ' 75' ' ' GLU . 35.6 t . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 110.385 -0.228 . . . . 0.34999999999999998 110.385 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.4 p -162.4 -173.96 3.82 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.048 0.939 . . . . 0.34999999999999998 110.158 -172.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.5 p -63.92 104.12 0.66 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.45 1.1 . . . . 0.34999999999999998 110.446 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -74.16 100.25 3.61 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.893 -1.151 . . . . 0.34999999999999998 107.893 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.77 92.76 0.16 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.953 1.301 . . . . 0.34999999999999998 111.967 -163.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -146.46 80.39 1.55 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.081 1.753 . . . . 0.34999999999999998 107.146 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.14 98.79 1.5 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.996 0.808 . . . . 0.34999999999999998 111.298 -175.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 54.65 63.48 2.13 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.204 1.402 . . . . 0.34999999999999998 109.744 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -109.61 -69.55 0.86 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.513 1.525 . . . . 0.34999999999999998 109.525 -174.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 65.17 165.64 0.17 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.686 1.594 . . . . 0.34999999999999998 111.83 -170.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -46.36 -53.45 10.88 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.368 1.467 . . . . 0.34999999999999998 112.054 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.61 -23.65 0.56 Allowed Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.952 0.787 . . . . 0.34999999999999998 111.648 -175.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.11 -22.6 65.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.929 1.292 . . . . 0.34999999999999998 112.604 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.67 130.0 44.69 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 123.625 0.77 . . . . 0.34999999999999998 110.865 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.43 52.7 0.73 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.831 0.852 . . . . 0.34999999999999998 109.103 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -61.85 140.37 58.27 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.307 1.043 . . . . 0.34999999999999998 111.104 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 64.73 174.27 0.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.352 1.461 . . . . 0.34999999999999998 113.156 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.5 t80 56.59 88.56 0.05 OUTLIER 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.85 2.06 . . . . 0.34999999999999998 112.028 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 70.43 154.72 0.15 Allowed Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.431 1.892 . . . . 0.33000000000000002 111.474 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -63.61 100.65 0.29 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.146 2.564 . . . . 0.34999999999999998 109.58 163.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -107.35 -70.79 0.78 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.931 0.892 . . . . 0.34999999999999998 111.263 -172.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.23 111.5 0.45 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.884 -0.953 . . . . 0.33000000000000002 110.801 -169.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.5 -179.29 4.33 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.403 2.735 . . . . 0.34999999999999998 112.294 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -165.65 178.84 6.38 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.145 0.978 . . . . 0.34999999999999998 110.549 -166.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -153.02 92.63 1.65 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.059 1.344 . . . . 0.34999999999999998 107.586 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 68.3 mtp -88.05 101.42 13.76 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.402 1.481 . . . . 0.34999999999999998 110.409 -168.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.2 t -98.78 112.32 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.187 0.995 . . . . 0.34999999999999998 109.591 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -175.46 171.44 2.83 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.502 1.121 . . . . 0.35999999999999999 109.964 174.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.87 140.33 36.15 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.11 0.964 . . . . 0.34999999999999998 111.785 -178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.6 m -70.55 101.25 1.97 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.448 1.899 . . . . 0.34999999999999998 108.947 175.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.08 87.0 1.33 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.04 0.829 . . . . 0.34999999999999998 111.654 -172.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.2 m -85.04 166.46 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 123.895 0.878 . . . . 0.34999999999999998 110.477 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.23 -42.8 30.13 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.804 -0.443 . . . . 0.34999999999999998 109.804 166.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 t -173.11 -53.72 0.02 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 125.246 1.418 . . . . 0.34999999999999998 110.022 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -92.6 41.87 1.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.484 1.114 . . . . 0.34999999999999998 113.92 -159.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.81 60.47 8.4 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.494 -0.642 . . . . 0.34999999999999998 111.494 172.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -157.19 98.67 1.74 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.163 0.985 . . . . 0.35999999999999999 109.42 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.65 118.64 7.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.805 1.242 . . . . 0.34999999999999998 111.01 -173.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.89 -48.07 26.68 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.941 0.896 . . . . 0.34999999999999998 110.036 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.5 mt -86.62 -169.37 2.61 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.405 1.082 . . . . 0.34999999999999998 111.053 -171.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.8 p -130.32 78.62 74.09 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 106.87 -1.53 . . . . 0.33000000000000002 106.87 163.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -85.49 77.14 2.8 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 124.804 3.669 . . . . 0.34999999999999998 109.636 -166.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -150.12 85.67 1.41 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.132 0.973 . . . . 0.34999999999999998 108.602 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -155.55 -48.42 0.08 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.249 0.62 . . . . 0.34999999999999998 112.273 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.55 119.88 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.009 0.822 . . . . 0.34999999999999998 110.048 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -156.43 151.84 26.73 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.541 1.137 . . . . 0.34999999999999998 109.788 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -129.93 153.32 80.95 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 125.502 1.521 . . . . 0.33000000000000002 108.742 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.39 60.9 7.51 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.711 2.94 . . . . 0.34999999999999998 110.345 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 tp 39.97 89.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.689 1.996 . . . . 0.34999999999999998 112.578 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -107.87 92.24 8.73 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.879 1.272 . . . . 0.33000000000000002 108.633 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.87 155.96 48.31 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.127 2.551 . . . . 0.34999999999999998 110.804 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.08 -50.4 0.7 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.573 -1.011 . . . . 0.34999999999999998 110.573 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.4 t -63.01 146.48 53.11 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.905 0.882 . . . . 0.34999999999999998 110.729 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 m -77.97 116.88 18.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.622 -0.51 . . . . 0.34999999999999998 109.622 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -77.08 86.19 3.58 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.021 1.328 . . . . 0.34999999999999998 108.572 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 p -150.0 151.85 33.97 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.682 1.193 . . . . 0.34999999999999998 110.558 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -52.51 -53.06 50.93 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.178 1.391 . . . . 0.34999999999999998 111.208 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -49.78 -45.32 49.61 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.677 1.191 . . . . 0.34999999999999998 112.978 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -76.52 -50.01 15.05 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.018 0.372 . . . . 0.34999999999999998 111.506 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.7 mm -54.22 -38.18 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.646 1.178 . . . . 0.34999999999999998 112.402 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -52.9 -61.01 2.57 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.957 0.799 . . . . 0.34999999999999998 112.015 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -71.41 -36.83 71.47 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.697 0.258 . . . . 0.34999999999999998 111.697 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -64.77 -47.99 76.14 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.759 0.824 . . . . 0.34999999999999998 111.786 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 p -71.89 -28.19 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.497 0.719 . . . . 0.34999999999999998 111.322 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.69 -44.5 90.09 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 123.019 0.528 . . . . 0.34999999999999998 109.643 172.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -66.18 -20.86 66.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.45 0.7 . . . . 0.34999999999999998 112.369 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.33 -47.3 64.82 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.886 0.766 . . . . 0.34999999999999998 110.914 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -39.36 84.98 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 109.936 -0.394 . . . . 0.34999999999999998 109.936 173.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -93.42 52.12 1.7 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.876 1.271 . . . . 0.34999999999999998 110.033 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.96 -58.84 2.01 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.019 1.328 . . . . 0.34999999999999998 108.541 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.1 p -80.87 -50.16 10.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.622 1.169 . . . . 0.34999999999999998 110.658 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.46 -97.61 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.971 0.908 . . . . 0.34999999999999998 109.917 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.3 t80 54.98 87.63 0.05 OUTLIER 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.914 1.686 . . . . 0.34999999999999998 113.072 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -161.23 -49.33 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.237 0.615 . . . . 0.34999999999999998 109.954 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.459 ' H ' ' H2 ' ' A' ' 1' ' ' SER . 47.0 mt-10 -120.75 50.73 1.3 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.026 1.33 . . . . 0.34999999999999998 109.521 -175.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -139.04 92.0 2.56 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.371 1.068 . . . . 0.34999999999999998 109.855 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -73.43 -40.0 64.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.463 1.105 . . . . 0.34999999999999998 111.35 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.5 t 74.24 115.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 126.169 1.788 . . . . 0.34999999999999998 110.798 -175.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.05 -67.37 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 108.13 -1.063 . . . . 0.34999999999999998 108.13 172.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -145.12 165.02 29.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.844 1.658 . . . . 0.34999999999999998 109.116 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -130.67 129.17 42.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.058 1.343 . . . . 0.34999999999999998 107.431 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.91 132.28 84.97 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.946 -0.39 . . . . 0.33000000000000002 109.946 -168.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.99 -22.71 22.68 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.505 2.803 . . . . 0.34999999999999998 111.517 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.2 m -82.61 68.04 8.91 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.371 1.068 . . . . 0.34999999999999998 110.328 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.99 165.09 25.76 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.864 0.865 . . . . 0.34999999999999998 110.267 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -148.71 132.62 17.1 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.219 0.533 . . . . 0.34999999999999998 112.119 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.2 114.69 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.877 -1.897 . . . . 0.34999999999999998 105.877 171.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -107.94 58.1 0.62 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.957 0.903 . . . . 0.34999999999999998 108.628 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.77 103.69 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.953 0.901 . . . . 0.34999999999999998 110.372 -174.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 89.9 m -99.61 100.76 11.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.399 1.48 . . . . 0.34999999999999998 108.114 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -98.87 84.89 3.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.015 0.926 . . . . 0.34999999999999998 110.314 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -69.92 75.95 0.47 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.373 1.869 . . . . 0.34999999999999998 109.769 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -120.5 65.53 0.84 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.14 1.376 . . . . 0.34999999999999998 108.677 -170.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.7 110.35 6.19 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.35 0.66 . . . . 0.34999999999999998 110.269 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -178.68 -47.6 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.293 1.837 . . . . 0.35999999999999999 108.801 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -37.48 0.11 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.367 1.067 . . . . 0.34999999999999998 110.883 172.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -78.06 -52.6 8.5 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.612 0.765 . . . . 0.34999999999999998 110.651 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt 72.95 170.46 0.31 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.799 1.639 . . . . 0.34999999999999998 111.382 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.16 125.23 24.33 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.663 0.785 . . . . 0.34999999999999998 111.157 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -140.51 108.74 5.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.579 -1.267 . . . . 0.34999999999999998 107.579 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.4 m -76.0 86.54 2.92 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.026 -1.102 . . . . 0.34999999999999998 108.026 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -80.47 98.29 7.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.066 0.946 . . . . 0.34999999999999998 108.553 -175.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.6 p -87.29 64.54 8.33 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.719 1.208 . . . . 0.34999999999999998 111.116 -174.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -65.9 134.73 95.15 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.727 -0.842 . . . . 0.33000000000000002 108.727 170.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.35 -114.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.24 2.627 . . . . 0.34999999999999998 109.511 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 tp -161.67 151.57 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.973 0.806 . . . . 0.34999999999999998 109.74 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.9 p -127.16 150.05 49.68 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.057 1.343 . . . . 0.34999999999999998 109.678 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -67.37 0.48 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.477 0.711 . . . . 0.34999999999999998 110.023 -176.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -108.78 101.71 10.81 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 106.607 -1.627 . . . . 0.34999999999999998 106.607 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.15 -97.91 0.87 Allowed Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.332 0.968 . . . . 0.34999999999999998 111.86 -168.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -159.37 177.54 10.89 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.261 0.624 . . . . 0.34999999999999998 111.443 -163.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.1 t -102.71 150.63 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.982 1.713 . . . . 0.34999999999999998 110.142 -175.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.3 t -54.52 114.91 7.5 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.308 1.043 . . . . 0.33000000000000002 108.88 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.08 148.81 19.55 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.791 2.327 . . . . 0.34999999999999998 111.016 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -94.18 -178.19 4.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.956 1.303 . . . . 0.34999999999999998 110.132 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.85 165.35 25.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.725 0.81 . . . . 0.34999999999999998 111.518 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.3 t -142.22 -68.42 0.37 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.464 1.106 . . . . 0.34999999999999998 109.57 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -163.87 -52.71 0.03 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.208 1.003 . . . . 0.34999999999999998 109.497 -174.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -42.08 -43.81 3.38 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.872 2.069 . . . . 0.34999999999999998 114.068 -173.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.1 pt -133.82 173.9 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.606 0.762 . . . . 0.34999999999999998 111.398 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -107.06 -44.92 4.27 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 126.203 1.801 . . . . 0.34999999999999998 108.685 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -120.4 101.56 46.39 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.907 1.283 . . . . 0.35999999999999999 110.865 -170.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -57.83 -59.51 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.452 2.768 . . . . 0.34999999999999998 111.926 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 64.92 66.89 2.25 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.759 -0.937 . . . . 0.34999999999999998 110.759 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -70.72 144.67 50.89 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.392 1.077 . . . . 0.34999999999999998 111.162 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -132.16 92.93 3.18 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.371 1.068 . . . . 0.35999999999999999 108.995 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.74 62.92 7.76 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.442 1.097 . . . . 0.34999999999999998 108.628 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.98 125.14 54.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 125.465 1.506 . . . . 0.34999999999999998 107.141 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.9 m -141.88 172.65 12.39 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.251 1.82 . . . . 0.34999999999999998 107.631 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.69 131.55 56.92 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.556 1.142 . . . . 0.34999999999999998 109.49 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.4 m -130.24 155.21 41.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 C-N-CA 124.677 1.191 . . . . 0.34999999999999998 110.371 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.63 103.51 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.977 1.311 . . . . 0.34999999999999998 108.716 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 29.1 mt -81.37 139.05 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.122 0.969 . . . . 0.34999999999999998 110.772 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -102.66 128.99 49.13 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.417 -1.697 . . . . 0.34999999999999998 106.417 162.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -84.33 74.2 10.37 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.497 -0.927 . . . . 0.34999999999999998 108.497 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.341 0.228 0 C-N-CA 125.735 1.614 . . . . 0.25 109.475 -173.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.8 m . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 109.829 -0.434 . . . . 0.34999999999999998 109.829 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 t 50.0 50.33 18.7 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.359 1.464 . . . . 0.34999999999999998 111.407 -172.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 t -102.93 109.27 20.77 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.56 1.144 . . . . 0.34999999999999998 108.722 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -73.16 104.72 4.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.674 0.79 . . . . 0.34999999999999998 109.441 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -124.96 53.37 1.5 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.335 1.054 . . . . 0.34999999999999998 110.392 -174.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -122.52 -51.78 1.94 Allowed 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.497 1.119 . . . . 0.34999999999999998 108.573 173.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.61 78.85 0.8 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.648 . . . . 0.34999999999999998 112.331 169.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp 58.21 73.4 0.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.686 1.194 . . . . 0.34999999999999998 111.484 166.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -111.84 60.55 0.62 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.44 1.096 . . . . 0.34999999999999998 109.802 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.19 177.89 8.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.756 0.823 . . . . 0.34999999999999998 112.482 -168.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.7 tttm 60.48 52.86 4.44 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 127.111 2.165 . . . . 0.34999999999999998 110.447 -172.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.42 -86.38 0.46 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 106.828 -2.509 . . . . 0.34999999999999998 106.828 172.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t0 53.28 61.96 2.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.259 1.024 . . . . 0.34999999999999998 109.499 176.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 64.87 53.92 1.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.425 1.49 . . . . 0.34999999999999998 110.953 -171.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.74 91.06 0.05 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.936 1.694 . . . . 0.34999999999999998 112.362 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -55.23 -53.86 50.76 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.503 1.121 . . . . 0.34999999999999998 111.44 -176.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -77.12 175.84 9.26 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.11 0.964 . . . . 0.34999999999999998 111.851 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.3 t80 60.12 84.86 0.11 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 126.38 1.872 . . . . 0.34999999999999998 111.107 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 66.37 158.92 0.13 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 126.491 1.916 . . . . 0.33000000000000002 112.144 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.06 129.97 35.82 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.157 2.572 . . . . 0.34999999999999998 111.592 167.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.5 p -121.92 -57.54 1.79 Allowed 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.506 1.123 . . . . 0.34999999999999998 109.122 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.69 172.96 43.61 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 112.343 -0.303 . . . . 0.33000000000000002 112.343 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.48 166.47 19.52 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 124.223 3.282 . . . . 0.34999999999999998 113.835 -173.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -154.75 161.52 41.48 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.811 1.244 . . . . 0.34999999999999998 109.668 167.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 tt -157.32 99.15 1.76 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.446 -0.946 . . . . 0.34999999999999998 108.446 -170.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.9 mtp -92.14 146.34 23.8 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.396 1.479 . . . . 0.34999999999999998 110.329 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.6 t -146.05 90.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.4 0 C-N-CA 124.046 0.939 . . . . 0.34999999999999998 110.458 -167.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -156.01 -179.7 8.39 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.356 1.062 . . . . 0.35999999999999999 110.949 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.7 m -129.33 150.61 34.79 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 125.028 1.331 . . . . 0.34999999999999998 111.494 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.1 m -80.62 91.77 5.88 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.014 -1.476 . . . . 0.34999999999999998 107.014 169.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.31 73.05 2.71 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.071 -0.812 . . . . 0.34999999999999998 111.071 -172.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.89 147.29 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 122.944 0.498 . . . . 0.34999999999999998 110.679 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.99 178.88 5.95 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.598 1.159 . . . . 0.34999999999999998 109.323 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -47.31 -45.31 24.25 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.202 1.001 . . . . 0.34999999999999998 110.599 164.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -105.95 34.36 3.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.723 1.209 . . . . 0.34999999999999998 111.562 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.62 -25.14 8.7 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.111 -0.827 . . . . 0.34999999999999998 115.032 167.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -61.32 124.93 21.99 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.344 1.072 . . . . 0.35999999999999999 111.64 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.62 101.01 0.95 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.581 0.752 . . . . 0.34999999999999998 110.205 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.74 -50.09 39.85 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.384 1.074 . . . . 0.34999999999999998 110.007 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 pp -130.47 150.76 51.53 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.663 1.185 . . . . 0.34999999999999998 110.224 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 t -82.8 147.49 55.13 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.044 0.937 . . . . 0.33000000000000002 111.604 -164.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.03 27.58 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.31 3.34 . . . . 0.34999999999999998 112.588 171.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -169.09 132.44 1.33 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.931 0.893 . . . . 0.34999999999999998 109.652 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -165.28 -72.47 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.381 1.073 . . . . 0.34999999999999998 109.481 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.07 147.05 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.702 0.801 . . . . 0.34999999999999998 109.716 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -142.94 166.79 23.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.723 0.809 . . . . 0.34999999999999998 111.142 174.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -141.04 144.82 36.53 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 125.049 1.339 . . . . 0.33000000000000002 108.576 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.06 64.77 8.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.948 3.099 . . . . 0.34999999999999998 110.655 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.258 9.0 tt 39.42 110.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 129.567 3.147 . . . . 0.34999999999999998 114.608 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -119.83 82.32 27.48 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.263 1.025 . . . . 0.33000000000000002 108.528 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -82.9 -170.31 0.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.952 3.101 . . . . 0.34999999999999998 110.576 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.41 -41.57 2.1 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.739 -0.945 . . . . 0.34999999999999998 110.739 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.9 t -66.32 152.61 44.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.604 0.762 . . . . 0.34999999999999998 110.347 174.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.5 m -69.18 150.31 47.64 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.779 -0.823 . . . . 0.34999999999999998 108.779 171.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.3 tp -127.41 102.93 7.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.912 -1.144 . . . . 0.34999999999999998 107.912 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -151.61 176.07 11.72 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.505 1.522 . . . . 0.34999999999999998 109.43 -170.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -63.13 -47.49 82.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.738 0.415 . . . . 0.34999999999999998 111.46 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.93 -30.73 70.95 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.012 0.745 . . . . 0.34999999999999998 113.012 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -64.39 -54.61 30.17 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.205 0.602 . . . . 0.34999999999999998 109.377 171.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mm -51.55 -49.88 31.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 125.143 1.377 . . . . 0.34999999999999998 111.18 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -45.49 -56.71 4.77 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.665 1.186 . . . . 0.34999999999999998 112.518 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -75.31 -37.14 60.96 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.969 0.359 . . . . 0.34999999999999998 111.969 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -67.11 -48.65 67.48 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.669 0.787 . . . . 0.34999999999999998 111.958 -169.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.4 m -67.99 -33.0 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.884 0.473 . . . . 0.34999999999999998 111.266 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -65.13 -41.17 95.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.541 0.737 . . . . 0.34999999999999998 110.678 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -35.12 75.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.453 0.701 . . . . 0.34999999999999998 111.148 176.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.77 -48.58 76.39 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.592 0.757 . . . . 0.34999999999999998 111.334 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.8 -19.98 61.24 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.386 0.675 . . . . 0.34999999999999998 112.423 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -77.29 13.41 1.18 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.448 0.699 . . . . 0.34999999999999998 112.197 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.57 -41.4 65.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.375 -0.602 . . . . 0.34999999999999998 109.375 160.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 70.2 p -103.35 -49.4 3.73 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.208 1.403 . . . . 0.34999999999999998 111.748 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.75 -85.67 0.09 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.8 0.84 . . . . 0.34999999999999998 111.32 -170.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.8 p90 51.62 18.17 0.68 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.3 2.24 . . . . 0.34999999999999998 116.016 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -131.99 -81.02 0.51 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.31 0.959 . . . . 0.34999999999999998 112.097 -164.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -97.26 -54.46 3.15 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.577 0.751 . . . . 0.34999999999999998 111.943 -158.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -45.37 145.57 1.16 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.433 2.293 . . . . 0.34999999999999998 114.378 -173.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -85.69 -63.08 1.38 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.872 1.269 . . . . 0.34999999999999998 111.348 -172.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.3 t 72.1 97.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 126.071 1.748 . . . . 0.34999999999999998 108.984 -164.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.69 -65.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.085 0.954 . . . . 0.34999999999999998 109.305 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -162.51 135.78 6.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.879 0.872 . . . . 0.34999999999999998 109.186 -174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.67 152.83 24.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.838 0.855 . . . . 0.34999999999999998 110.927 177.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.87 145.53 50.25 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.948 -0.76 . . . . 0.33000000000000002 108.948 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.12 -17.12 40.64 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.47 2.78 . . . . 0.34999999999999998 111.993 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -83.39 61.51 6.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.509 1.124 . . . . 0.34999999999999998 111.069 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.98 141.24 45.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.223 -1.399 . . . . 0.34999999999999998 107.223 159.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -148.61 131.57 16.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.191 0.52 . . . . 0.34999999999999998 112.4 -171.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 mp -75.88 116.41 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.439 -1.689 . . . . 0.34999999999999998 106.439 168.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -107.68 68.82 0.72 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.343 -1.354 . . . . 0.34999999999999998 107.343 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.98 115.01 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.924 0.89 . . . . 0.34999999999999998 110.519 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.0 m -110.16 87.33 2.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.47 1.508 . . . . 0.34999999999999998 108.496 -172.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.62 87.12 3.99 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.018 1.327 . . . . 0.34999999999999998 111.22 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -74.77 85.5 2.17 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.961 1.305 . . . . 0.34999999999999998 109.674 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -132.81 71.77 1.48 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.376 -0.972 . . . . 0.34999999999999998 108.376 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -53.12 -22.43 6.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.646 1.578 . . . . 0.34999999999999998 113.834 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -58.14 -31.41 67.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.73 1.212 . . . . 0.35999999999999999 112.438 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.7 -52.48 0.34 Allowed 'General case' 0 C--N 1.344 0.367 0 N-CA-C 112.662 0.615 . . . . 0.34999999999999998 112.662 173.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -87.4 -58.45 2.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.647 0.658 . . . . 0.34999999999999998 111.644 -168.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt 85.65 160.99 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.975 2.11 . . . . 0.34999999999999998 110.492 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.41 97.9 0.6 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.791 1.236 . . . . 0.34999999999999998 111.506 -174.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -119.18 123.63 44.82 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 107.729 -1.211 . . . . 0.34999999999999998 107.729 168.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.1 m -87.99 83.14 7.07 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.453 1.101 . . . . 0.34999999999999998 108.179 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -75.16 119.81 19.81 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.344 1.057 . . . . 0.34999999999999998 109.916 -170.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.6 m -83.09 74.75 9.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.101 1.361 . . . . 0.34999999999999998 111.488 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -80.52 132.99 56.93 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.75 -1.204 . . . . 0.33000000000000002 107.75 165.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.72 -118.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.309 2.673 . . . . 0.34999999999999998 110.178 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.4 tp -159.87 155.38 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.462 1.105 . . . . 0.34999999999999998 108.777 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.8 p -124.01 136.8 54.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.147 0.979 . . . . 0.34999999999999998 109.058 174.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -73.17 -33.1 65.26 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.945 0.898 . . . . 0.34999999999999998 110.776 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -21.13 65.1 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.424 0.69 . . . . 0.34999999999999998 112.205 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.96 174.96 43.56 Favored Glycine 0 C--N 1.341 0.85 0 C-N-CA 123.904 0.764 . . . . 0.34999999999999998 114.223 166.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -161.43 136.16 7.25 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.406 1.083 . . . . 0.34999999999999998 109.867 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.16 126.48 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.653 -0.869 . . . . 0.34999999999999998 108.653 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.2 t -73.02 121.62 85.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 107.475 -1.305 . . . . 0.33000000000000002 107.475 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.43 -102.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.246 2.63 . . . . 0.34999999999999998 110.432 -173.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -163.52 111.44 1.2 Allowed 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.497 1.119 . . . . 0.34999999999999998 108.271 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.413 HD12 ' HD3' ' A' ' 123' ' ' PRO . 2.9 tm? -87.9 97.22 10.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.157 0.983 . . . . 0.34999999999999998 108.587 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.5 t -170.76 86.68 0.11 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.951 1.3 . . . . 0.34999999999999998 108.391 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -153.34 -71.48 0.14 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.329 0.652 . . . . 0.34999999999999998 109.485 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -92.76 -52.29 4.69 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.469 1.108 . . . . 0.34999999999999998 109.355 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.5 pt -109.51 169.13 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.392 1.477 . . . . 0.34999999999999998 108.934 170.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.89 19.63 0.26 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.372 1.249 . . . . 0.34999999999999998 114.372 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -137.96 61.52 28.68 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.093 0.86 . . . . 0.35999999999999999 111.85 175.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.413 ' HD3' HD12 ' A' ' 116' ' ' LEU . 94.7 Cg_endo -73.53 172.73 15.13 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.219 3.279 . . . . 0.34999999999999998 111.36 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.38 68.49 0.43 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.051 -1.219 . . . . 0.34999999999999998 110.051 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -64.02 88.93 0.05 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.353 1.461 . . . . 0.34999999999999998 110.407 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -99.51 100.65 11.7 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.641 -0.874 . . . . 0.35999999999999999 108.641 -174.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.6 93.47 8.38 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.385 1.074 . . . . 0.34999999999999998 109.055 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.17 134.49 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.504 -1.295 . . . . 0.34999999999999998 107.504 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 44.7 m -142.67 116.58 9.34 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 107.269 -1.382 . . . . 0.34999999999999998 107.269 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -73.42 133.17 43.67 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.421 -0.585 . . . . 0.34999999999999998 109.421 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.9 m -134.36 136.7 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.111 0.965 . . . . 0.34999999999999998 109.604 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 77.6 t -82.58 137.35 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.406 -0.961 . . . . 0.34999999999999998 108.406 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 47.2 mt -137.26 133.45 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.697 1.199 . . . . 0.34999999999999998 108.978 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -97.44 130.26 44.57 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.324 -1.361 . . . . 0.34999999999999998 107.324 161.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -72.2 96.26 1.78 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.724 -0.843 . . . . 0.34999999999999998 108.724 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.34 0.168 0 C-N-CA 125.538 1.535 . . . . 0.25 109.325 -167.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.8 m . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 109.166 -0.679 . . . . 0.34999999999999998 109.166 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 t 61.26 48.23 6.35 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.551 1.14 . . . . 0.34999999999999998 111.404 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.4 t 66.07 159.88 0.13 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.922 1.689 . . . . 0.34999999999999998 111.367 -171.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.1 t80 57.69 65.37 1.34 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.005 1.322 . . . . 0.34999999999999998 110.885 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -112.57 42.03 1.91 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.405 1.082 . . . . 0.34999999999999998 109.101 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.63 -47.7 0.69 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.029 1.732 . . . . 0.34999999999999998 109.523 -177.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.67 56.16 1.92 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.766 -0.934 . . . . 0.34999999999999998 110.766 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 56.99 70.72 0.63 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.295 1.438 . . . . 0.34999999999999998 111.458 176.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -90.58 0.41 57.37 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.178 1.391 . . . . 0.34999999999999998 112.449 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -175.59 3.24 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.268 1.027 . . . . 0.34999999999999998 112.009 -176.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.5 tttp 93.94 -22.41 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.601 2.36 . . . . 0.34999999999999998 112.456 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.6 81.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.859 1.219 . . . . 0.34999999999999998 114.523 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -84.55 56.02 3.65 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.227 1.013 . . . . 0.34999999999999998 111.068 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 48.99 45.05 22.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.494 1.517 . . . . 0.34999999999999998 111.758 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.46 53.08 0.89 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.401 1.081 . . . . 0.34999999999999998 109.679 -172.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 m -87.47 -122.26 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.762 0.825 . . . . 0.34999999999999998 110.526 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -163.41 145.11 9.58 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.043 1.337 . . . . 0.34999999999999998 108.11 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.1 t80 66.85 119.22 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.828 1.651 . . . . 0.34999999999999998 111.369 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 68.55 151.85 0.13 Allowed Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 126.454 1.902 . . . . 0.33000000000000002 111.699 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.71 92.08 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.335 2.69 . . . . 0.34999999999999998 110.82 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.5 p -75.47 -42.96 51.82 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.807 0.843 . . . . 0.34999999999999998 109.938 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.78 166.06 26.22 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.468 -0.653 . . . . 0.33000000000000002 111.468 172.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.93 168.43 19.1 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.186 3.258 . . . . 0.34999999999999998 111.09 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -163.34 176.62 9.69 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.389 1.076 . . . . 0.34999999999999998 110.628 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 tt -156.59 94.14 1.44 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.079 0.951 . . . . 0.34999999999999998 108.706 -175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -89.1 143.28 26.95 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.327 0.651 . . . . 0.34999999999999998 109.923 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.9 t -144.67 91.41 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.244 1.017 . . . . 0.34999999999999998 108.585 -172.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -153.31 162.49 41.24 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.607 1.163 . . . . 0.35999999999999999 110.709 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -95.85 153.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 124.963 1.305 . . . . 0.34999999999999998 110.097 174.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -88.91 93.84 9.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.412 -1.699 . . . . 0.34999999999999998 106.412 169.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.77 105.77 1.63 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.505 -1.038 . . . . 0.34999999999999998 110.505 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.49 169.64 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.927 1.291 . . . . 0.34999999999999998 109.996 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -87.3 -179.78 6.47 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.829 0.852 . . . . 0.34999999999999998 109.128 166.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 t -60.54 -38.79 85.6 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.663 0.785 . . . . 0.34999999999999998 110.869 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -76.78 -0.91 25.59 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.427 1.091 . . . . 0.34999999999999998 112.571 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.59 52.13 6.15 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 110.968 -0.853 . . . . 0.34999999999999998 110.968 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -120.45 108.35 14.0 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.623 1.169 . . . . 0.35999999999999999 108.416 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -65.96 118.29 9.54 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.793 0.837 . . . . 0.34999999999999998 111.79 -172.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.34 -40.22 30.79 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.5 1.12 . . . . 0.34999999999999998 109.875 169.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 pp -151.89 154.42 36.09 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.358 1.063 . . . . 0.34999999999999998 112.304 -164.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.7 m -88.5 154.31 50.98 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.151 1.38 . . . . 0.33000000000000002 110.353 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -86.14 49.79 2.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.314 3.342 . . . . 0.34999999999999998 110.47 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -149.13 97.2 2.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.685 0.794 . . . . 0.34999999999999998 109.523 -166.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -162.15 -55.73 0.04 OUTLIER 'General case' 0 C--N 1.344 0.352 0 CA-C-O 118.85 -0.595 . . . . 0.34999999999999998 112.451 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 m -82.66 141.06 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.328 0.967 . . . . 0.34999999999999998 109.304 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -146.49 109.83 4.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.297 1.039 . . . . 0.34999999999999998 109.089 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -94.28 154.4 40.41 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 125.366 1.466 . . . . 0.33000000000000002 109.72 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.77 147.46 44.7 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.189 2.593 . . . . 0.34999999999999998 109.844 169.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.81 137.0 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 122.977 0.511 . . . . 0.34999999999999998 110.404 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -142.49 114.09 6.14 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.801 1.24 . . . . 0.33000000000000002 107.837 171.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.74 179.87 6.1 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.61 2.874 . . . . 0.34999999999999998 110.903 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.56 -26.66 18.92 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.424 -0.653 . . . . 0.34999999999999998 112.643 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 t -67.07 141.36 57.52 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.801 0.8 . . . . 0.34999999999999998 111.021 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.5 m -72.62 139.12 47.18 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.606 -0.887 . . . . 0.34999999999999998 108.606 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.67 117.24 16.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.978 0.911 . . . . 0.34999999999999998 108.963 -171.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.5 t -167.44 176.07 6.81 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.151 1.781 . . . . 0.34999999999999998 108.458 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -57.76 -52.38 65.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.933 0.893 . . . . 0.34999999999999998 110.796 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -64.56 -32.43 74.07 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.934 0.716 . . . . 0.34999999999999998 112.934 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -65.98 -57.69 7.22 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.567 0.621 . . . . 0.34999999999999998 110.369 175.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.79 -23.37 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.166 0.986 . . . . 0.34999999999999998 111.805 -172.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.54 -58.35 8.93 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.174 0.99 . . . . 0.34999999999999998 111.067 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -66.04 -37.85 86.88 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.14 0.427 . . . . 0.34999999999999998 111.2 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -62.96 -48.7 77.75 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.559 0.744 . . . . 0.34999999999999998 111.795 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.9 -36.77 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 118.256 0.48 . . . . 0.34999999999999998 111.585 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -63.53 -37.1 86.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.807 0.843 . . . . 0.34999999999999998 111.111 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -74.12 -37.8 64.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.872 0.469 . . . . 0.34999999999999998 111.041 176.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.16 -44.03 97.52 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.297 1.039 . . . . 0.34999999999999998 111.485 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.19 -41.49 63.78 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.904 0.482 . . . . 0.34999999999999998 111.644 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -76.83 -3.4 38.23 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.436 0.694 . . . . 0.34999999999999998 112.758 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.71 -42.45 83.77 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.866 0.757 . . . . 0.34999999999999998 110.33 173.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.9 t -103.2 -38.93 7.06 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.105 1.362 . . . . 0.34999999999999998 111.579 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.89 -101.18 0.03 OUTLIER 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.676 -0.678 . . . . 0.34999999999999998 110.795 -173.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.1 t80 75.74 -43.33 0.48 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 126.572 1.949 . . . . 0.34999999999999998 113.751 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -55.27 -67.1 0.3 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.345 1.458 . . . . 0.34999999999999998 112.593 -169.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -107.11 24.22 13.16 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.235 0.614 . . . . 0.34999999999999998 112.189 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -92.63 136.75 32.96 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.243 0.617 . . . . 0.34999999999999998 111.431 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -164.05 109.24 1.02 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.962 1.305 . . . . 0.34999999999999998 108.485 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 p -77.61 148.63 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.299 0.64 . . . . 0.34999999999999998 109.87 171.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.47 -44.48 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.699 1.2 . . . . 0.34999999999999998 109.888 173.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -129.39 151.54 49.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.269 1.428 . . . . 0.34999999999999998 108.853 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.75 143.52 32.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.313 1.045 . . . . 0.34999999999999998 109.909 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -72.39 117.24 57.04 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.787 0.835 . . . . 0.33000000000000002 108.978 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.89 -27.4 21.12 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.867 2.378 . . . . 0.34999999999999998 111.118 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.1 m -87.87 58.03 4.64 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.513 1.125 . . . . 0.34999999999999998 110.358 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.97 167.08 5.05 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.26 0.624 . . . . 0.34999999999999998 109.624 169.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -155.85 142.32 18.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.531 0.681 . . . . 0.34999999999999998 112.352 -171.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 mp -85.74 111.73 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 106.144 -1.798 . . . . 0.34999999999999998 106.144 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -100.99 70.78 1.38 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.614 -1.254 . . . . 0.34999999999999998 107.614 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.16 99.16 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.333 0.653 . . . . 0.34999999999999998 109.819 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 94.0 m -98.83 125.19 44.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.195 1.398 . . . . 0.34999999999999998 109.012 -173.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -139.43 132.84 30.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.255 1.022 . . . . 0.34999999999999998 109.484 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -101.26 60.34 0.91 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.451 1.5 . . . . 0.34999999999999998 108.669 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -81.71 82.29 7.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.226 0.61 . . . . 0.34999999999999998 109.665 -177.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -83.19 67.43 9.19 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.423 -0.955 . . . . 0.34999999999999998 108.423 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -143.77 -49.14 0.3 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.905 1.682 . . . . 0.35999999999999999 108.729 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 pttt -159.03 -54.93 0.06 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.512 0.725 . . . . 0.34999999999999998 111.856 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -74.97 -22.24 58.67 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.884 0.698 . . . . 0.34999999999999998 112.884 -172.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 81.0 tttt 75.5 164.18 0.26 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.785 1.634 . . . . 0.34999999999999998 111.973 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -56.62 106.18 0.27 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.332 1.453 . . . . 0.34999999999999998 110.528 172.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -145.17 145.28 31.29 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.414 1.086 . . . . 0.34999999999999998 109.637 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 94.0 m -119.6 95.84 4.95 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 125.182 1.393 . . . . 0.34999999999999998 108.056 176.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -70.64 125.44 26.83 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.253 -0.647 . . . . 0.34999999999999998 109.253 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -96.18 63.16 2.2 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.886 1.274 . . . . 0.34999999999999998 110.094 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -75.35 124.64 89.21 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 109.337 -0.616 . . . . 0.33000000000000002 109.337 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.76 162.47 26.93 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.205 2.604 . . . . 0.34999999999999998 111.454 -175.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.3 tp -76.97 152.68 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.017 0.927 . . . . 0.34999999999999998 109.866 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.1 p -105.24 -179.41 3.94 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.137 0.975 . . . . 0.34999999999999998 110.419 178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.57 -11.3 14.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.694 1.597 . . . . 0.34999999999999998 110.81 166.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -78.06 -87.69 0.05 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.625 1.17 . . . . 0.34999999999999998 110.506 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.15 63.79 0.01 OUTLIER Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.475 -1.05 . . . . 0.34999999999999998 110.475 -172.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -73.56 126.03 29.33 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.285 -0.635 . . . . 0.34999999999999998 109.285 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.67 135.25 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.663 -0.866 . . . . 0.34999999999999998 108.663 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.9 112.05 6.02 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 107.592 -1.262 . . . . 0.33000000000000002 107.592 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -89.32 14.66 2.16 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.927 2.418 . . . . 0.34999999999999998 112.673 -165.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.3 t70 60.11 -157.44 0.33 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.266 1.027 . . . . 0.34999999999999998 109.572 -168.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.5 tt -163.6 146.31 9.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.64 0.655 . . . . 0.34999999999999998 110.396 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.5 t -154.33 164.72 38.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.299 1.04 . . . . 0.34999999999999998 110.025 172.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 82.42 -76.7 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.172 1.789 . . . . 0.34999999999999998 112.635 165.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -69.15 -41.14 77.69 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.886 0.875 . . . . 0.34999999999999998 113.039 -168.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.1 pt -135.17 -173.35 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.699 0.8 . . . . 0.34999999999999998 109.367 169.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -158.81 28.86 0.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.176 0.59 . . . . 0.34999999999999998 112.113 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.1 50.13 0.45 Allowed Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.783 0.66 . . . . 0.35999999999999999 112.783 175.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -66.57 120.82 7.98 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.163 2.575 . . . . 0.34999999999999998 111.32 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.11 75.84 0.22 Allowed Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.91 1.243 . . . . 0.34999999999999998 110.419 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -64.05 85.79 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.515 1.926 . . . . 0.34999999999999998 112.157 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -92.41 99.49 12.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.24 0.616 . . . . 0.35999999999999999 109.603 -176.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.83 95.16 3.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.618 -0.882 . . . . 0.34999999999999998 108.618 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.6 mt -108.8 121.76 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 124.838 1.255 . . . . 0.34999999999999998 108.22 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.4 m -119.36 175.27 5.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.918 1.687 . . . . 0.34999999999999998 107.402 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -136.06 114.47 11.7 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.133 0.973 . . . . 0.34999999999999998 108.442 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.5 146.12 32.89 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 C-N-CA 123.462 0.705 . . . . 0.34999999999999998 110.841 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.1 t -81.22 111.63 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.297 1.039 . . . . 0.34999999999999998 108.318 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mt -101.09 110.39 27.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 108.219 -1.03 . . . . 0.34999999999999998 108.219 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -85.85 97.52 10.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.914 -1.143 . . . . 0.34999999999999998 107.914 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -61.57 126.75 28.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.427 0.691 . . . . 0.34999999999999998 110.832 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt . . . . . 0 N--CA 1.455 -0.185 0 C-N-CA 123.53 0.732 . . . . 0.25 109.915 179.171 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 112.163 0.431 . . . . 0.34999999999999998 112.163 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 t 55.03 49.64 17.16 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.369 1.468 . . . . 0.34999999999999998 110.792 -173.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.7 p -164.78 3.3 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.875 0.87 . . . . 0.34999999999999998 112.716 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 t80 55.15 69.09 0.77 Allowed 'General case' 0 C--N 1.344 0.336 0 C-N-CA 124.651 1.181 . . . . 0.34999999999999998 109.914 -173.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -89.13 75.78 7.83 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.43 1.092 . . . . 0.34999999999999998 110.111 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -162.19 -62.88 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.441 1.096 . . . . 0.34999999999999998 108.881 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.43 92.88 0.21 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.538 0.59 . . . . 0.34999999999999998 112.536 169.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt 58.8 51.69 7.31 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.764 1.225 . . . . 0.34999999999999998 111.674 164.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -85.17 -64.9 1.08 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.589 0.756 . . . . 0.34999999999999998 111.499 -174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp 75.96 118.82 0.05 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 127.143 2.177 . . . . 0.34999999999999998 109.664 -165.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -50.11 -47.94 53.71 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.024 1.329 . . . . 0.34999999999999998 110.418 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.33 -92.79 0.22 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.283 -1.527 . . . . 0.34999999999999998 109.283 175.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t70 52.51 66.62 1.16 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.218 1.407 . . . . 0.34999999999999998 110.688 -173.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -93.64 47.3 1.23 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.135 -1.061 . . . . 0.34999999999999998 108.135 170.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.05 70.13 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.152 1.781 . . . . 0.34999999999999998 107.083 -170.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 t -67.72 -71.29 0.21 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.308 0.643 . . . . 0.34999999999999998 111.523 -168.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -162.31 39.64 0.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 117.622 0.192 . . . . 0.34999999999999998 111.325 -167.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -157.36 115.67 3.19 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.032 0.533 . . . . 0.34999999999999998 110.726 -173.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 65.74 164.67 0.12 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.91 2.084 . . . . 0.33000000000000002 112.951 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -63.19 74.48 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.577 3.518 . . . . 0.34999999999999998 112.84 172.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 p -100.71 -39.91 7.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.063 1.745 . . . . 0.34999999999999998 109.077 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.84 157.43 10.03 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 112.02 -0.432 . . . . 0.33000000000000002 112.02 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -82.24 -178.62 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.504 3.469 . . . . 0.34999999999999998 110.827 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -157.46 169.4 24.78 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.115 0.966 . . . . 0.34999999999999998 110.39 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.1 tp -142.81 86.24 1.92 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.355 1.462 . . . . 0.34999999999999998 107.806 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.7 mtp -82.56 89.56 6.7 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.605 1.162 . . . . 0.34999999999999998 110.59 -176.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.49 91.95 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.362 1.065 . . . . 0.34999999999999998 109.059 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -149.18 172.58 14.6 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.492 1.117 . . . . 0.35999999999999999 109.985 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.58 153.45 19.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 123.993 0.917 . . . . 0.34999999999999998 111.204 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.5 m -94.39 94.66 8.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.885 1.274 . . . . 0.34999999999999998 107.909 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.78 116.26 7.64 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 109.479 -1.448 . . . . 0.34999999999999998 109.479 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -122.98 157.15 28.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 C-N-CA 125.661 1.584 . . . . 0.34999999999999998 109.191 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -79.43 178.33 8.19 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.581 -0.525 . . . . 0.34999999999999998 109.581 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 t -60.04 -46.11 90.61 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.533 0.733 . . . . 0.34999999999999998 110.304 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -68.98 -16.77 63.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.382 1.073 . . . . 0.34999999999999998 112.91 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.05 29.09 7.38 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.314 0.959 . . . . 0.34999999999999998 113.09 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -91.17 114.25 26.72 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 117.818 0.809 . . . . 0.35999999999999999 108.9 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.15 123.77 21.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.327 0.651 . . . . 0.34999999999999998 110.817 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 mp -93.63 -38.66 11.23 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.844 1.258 . . . . 0.34999999999999998 109.957 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -144.52 152.59 40.8 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.254 1.022 . . . . 0.34999999999999998 111.549 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.2 t -99.26 148.75 35.07 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.002 1.721 . . . . 0.33000000000000002 109.664 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -84.33 70.45 5.86 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.624 2.883 . . . . 0.34999999999999998 111.456 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -148.74 -177.74 5.96 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.783 0.833 . . . . 0.34999999999999998 110.508 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . 0.314 0.0 OUTLIER 100.02 -44.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.597 2.759 . . . . 0.34999999999999998 112.854 173.361 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.74 136.62 23.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 109.553 -0.536 . . . . 0.34999999999999998 109.553 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.04 171.98 15.5 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.091 0.956 . . . . 0.34999999999999998 109.35 164.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -161.12 132.9 4.1 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.657 -0.687 . . . . 0.33000000000000002 109.731 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.31 111.78 1.91 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.654 2.236 . . . . 0.34999999999999998 108.66 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 tt -60.92 144.8 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.147 0.979 . . . . 0.34999999999999998 112.944 -162.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -130.54 87.16 50.91 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.593 1.557 . . . . 0.33000000000000002 107.372 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.97 159.66 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.492 2.795 . . . . 0.34999999999999998 111.263 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.03 -33.4 2.46 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.268 0.937 . . . . 0.34999999999999998 111.364 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.7 t -71.58 157.43 38.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.211 1.004 . . . . 0.34999999999999998 111.321 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.4 p -72.81 167.24 21.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.191 0.996 . . . . 0.34999999999999998 110.953 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.29 119.64 3.5 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.754 0.822 . . . . 0.34999999999999998 108.888 -174.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -167.4 178.66 5.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.191 1.796 . . . . 0.34999999999999998 108.015 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -57.08 -46.92 82.16 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.56 -0.712 . . . . 0.34999999999999998 111.343 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.47 -34.25 77.76 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.197 0.599 . . . . 0.34999999999999998 111.967 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -104.06 53.66 0.74 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.788 1.235 . . . . 0.34999999999999998 109.97 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -159.18 -41.94 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.655 1.182 . . . . 0.34999999999999998 108.674 170.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.02 -44.38 82.78 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.11 0.964 . . . . 0.34999999999999998 111.765 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -59.33 -39.41 83.07 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.612 0.765 . . . . 0.34999999999999998 111.029 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -50.29 62.95 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.295 1.438 . . . . 0.34999999999999998 110.18 -171.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.28 -32.33 42.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 124.565 1.146 . . . . 0.34999999999999998 112.121 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -60.29 -49.18 78.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.531 -0.544 . . . . 0.34999999999999998 109.531 172.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -33.29 75.68 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.791 0.437 . . . . 0.34999999999999998 111.517 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.77 -55.23 32.36 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.564 0.746 . . . . 0.34999999999999998 110.965 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 pp -74.69 -15.76 60.78 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.956 0.724 . . . . 0.34999999999999998 112.956 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -79.41 71.39 5.97 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 123.878 0.871 . . . . 0.34999999999999998 110.033 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -168.68 -53.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.372 1.869 . . . . 0.34999999999999998 107.723 172.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.2 p -88.08 -35.11 17.68 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.656 1.583 . . . . 0.34999999999999998 111.202 -178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.19 74.76 1.32 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.273 1.429 . . . . 0.34999999999999998 108.436 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -133.3 -19.14 2.2 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.987 1.106 . . . . 0.34999999999999998 113.987 -165.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -59.58 -41.19 89.7 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.676 0.791 . . . . 0.34999999999999998 112.542 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -141.65 -66.62 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.151 1.38 . . . . 0.34999999999999998 109.311 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.9 p90 34.85 88.45 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.172 2.589 . . . . 0.34999999999999998 114.193 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -73.63 106.73 5.52 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 109.322 -0.622 . . . . 0.34999999999999998 109.322 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.21 120.4 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.332 -0.988 . . . . 0.34999999999999998 108.332 174.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.3 t -75.92 -73.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.587 -1.264 . . . . 0.34999999999999998 107.587 171.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -167.78 146.58 4.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.381 1.073 . . . . 0.34999999999999998 109.446 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.85 156.84 29.53 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.546 0.738 . . . . 0.34999999999999998 111.262 173.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.49 135.56 81.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 108.136 -1.061 . . . . 0.33000000000000002 108.136 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.62 -33.02 29.53 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.318 2.679 . . . . 0.34999999999999998 111.774 -176.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.0 m -86.77 70.21 10.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.337 1.055 . . . . 0.34999999999999998 110.263 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.61 169.99 16.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.379 0.672 . . . . 0.34999999999999998 109.746 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -159.41 143.43 14.95 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.512 0.56 . . . . 0.34999999999999998 112.512 -167.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.74 122.53 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 126.855 2.062 . . . . 0.34999999999999998 106.133 172.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -118.1 64.73 0.75 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.97 0.908 . . . . 0.34999999999999998 109.183 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.04 118.33 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.416 0.686 . . . . 0.34999999999999998 110.942 -176.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.2 m -111.57 100.59 9.11 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.509 1.123 . . . . 0.34999999999999998 109.529 -173.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.29 99.4 12.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.154 0.982 . . . . 0.34999999999999998 109.851 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -94.38 47.89 1.21 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.596 1.558 . . . . 0.34999999999999998 111.099 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -69.68 106.92 3.24 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.03 0.932 . . . . 0.34999999999999998 109.628 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -32.6 73.13 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.07 1.348 . . . . 0.34999999999999998 111.635 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -55.06 -50.15 69.85 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.702 1.201 . . . . 0.35999999999999999 113.017 -170.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 -41.44 0.09 Allowed 'General case' 0 C--N 1.342 0.279 0 N-CA-C 113.347 0.869 . . . . 0.34999999999999998 113.347 -175.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -70.56 -47.84 58.33 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.326 0.512 . . . . 0.34999999999999998 112.016 -168.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt 80.56 155.9 0.14 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.328 1.851 . . . . 0.34999999999999998 110.741 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -43.8 124.4 3.68 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 126.719 2.008 . . . . 0.34999999999999998 111.265 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.35 106.53 2.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.216 -1.031 . . . . 0.34999999999999998 108.216 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.3 m -78.15 97.96 5.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.454 1.102 . . . . 0.34999999999999998 109.171 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -82.13 96.94 7.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.785 0.834 . . . . 0.34999999999999998 108.957 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.8 m -76.07 120.01 20.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.671 0.789 . . . . 0.34999999999999998 109.272 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -134.79 125.33 17.3 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 125.351 1.46 . . . . 0.33000000000000002 108.527 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.51 162.36 33.31 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.063 2.509 . . . . 0.34999999999999998 111.559 -175.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.7 tp -73.88 159.96 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.574 1.149 . . . . 0.34999999999999998 110.13 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 p -116.21 177.79 4.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.221 1.009 . . . . 0.34999999999999998 110.202 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -103.11 -12.3 17.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.111 1.364 . . . . 0.34999999999999998 110.924 165.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -76.31 -76.34 0.16 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.606 1.163 . . . . 0.34999999999999998 111.116 -171.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 139.43 61.91 0.04 OUTLIER Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.846 -0.902 . . . . 0.34999999999999998 110.846 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -71.53 132.91 45.36 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 117.351 0.575 . . . . 0.34999999999999998 109.918 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.5 t -73.13 136.18 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.073 -0.714 . . . . 0.34999999999999998 109.073 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.98 118.49 43.05 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 107.33 -1.359 . . . . 0.33000000000000002 107.33 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.24 165.98 27.02 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.019 2.479 . . . . 0.34999999999999998 112.37 -165.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.42 165.85 22.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.6 1.16 . . . . 0.34999999999999998 110.866 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.1 mp -94.86 30.99 1.93 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.993 0.917 . . . . 0.34999999999999998 111.412 -173.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.0 t 46.71 -102.34 0.07 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.092 1.757 . . . . 0.34999999999999998 112.468 175.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -162.24 -44.22 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.986 1.315 . . . . 0.34999999999999998 109.653 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -83.1 22.17 1.0 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.244 1.418 . . . . 0.34999999999999998 113.186 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.4 tp -160.53 129.61 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.514 0.726 . . . . 0.34999999999999998 110.082 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -140.7 27.73 2.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.831 1.252 . . . . 0.34999999999999998 111.61 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -150.2 51.05 0.82 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 113.221 0.822 . . . . 0.35999999999999999 113.221 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -70.45 115.02 4.0 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.856 2.371 . . . . 0.34999999999999998 109.291 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -92.79 79.22 1.13 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.866 -1.294 . . . . 0.34999999999999998 109.866 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -62.4 107.15 0.86 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.003 0.921 . . . . 0.34999999999999998 110.387 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -99.79 94.56 6.39 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.34 1.056 . . . . 0.35999999999999999 108.743 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.75 74.72 10.14 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.554 -1.276 . . . . 0.34999999999999998 107.554 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.67 126.54 71.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 126.041 1.736 . . . . 0.34999999999999998 107.948 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.8 m -148.94 142.47 25.36 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.917 0.887 . . . . 0.34999999999999998 110.26 -173.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -72.85 140.35 47.54 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.264 1.026 . . . . 0.34999999999999998 109.96 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.1 m -142.36 144.52 24.75 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 123.891 0.876 . . . . 0.34999999999999998 109.661 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.05 100.23 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.876 -0.787 . . . . 0.34999999999999998 108.876 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 75.3 mt -119.67 144.14 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.46 1.504 . . . . 0.34999999999999998 109.062 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -131.29 80.79 1.95 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.556 1.542 . . . . 0.34999999999999998 107.773 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -58.41 150.2 22.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.731 0.812 . . . . 0.34999999999999998 111.954 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.196 -1.039 . . . . 0.25 108.196 178.62 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.485 ' H1 ' ' HB3' ' A' ' 74' ' ' LYS . 33.1 t . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 119.31 -0.376 . . . . 0.34999999999999998 110.902 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 p 65.33 146.21 0.03 OUTLIER 'General case' 0 C--N 1.344 0.339 0 C-N-CA 127.355 2.262 . . . . 0.34999999999999998 111.823 -170.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 p 69.34 -6.33 0.98 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.372 1.869 . . . . 0.34999999999999998 113.845 -170.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.6 p90 48.44 19.02 0.2 Allowed 'General case' 0 C--N 1.346 0.455 0 C-N-CA 127.686 2.394 . . . . 0.34999999999999998 114.966 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 53.42 -141.45 0.86 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.046 0.938 . . . . 0.34999999999999998 109.73 -171.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.4 pttt 11.29 76.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.631 2.772 . . . . 0.34999999999999998 114.922 169.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.53 113.02 5.28 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 124.683 1.135 . . . . 0.34999999999999998 111.663 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt 56.64 69.64 0.72 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.251 1.42 . . . . 0.34999999999999998 110.278 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -70.82 -45.9 63.73 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.611 0.764 . . . . 0.34999999999999998 111.143 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 66.34 5.31 3.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.165 1.786 . . . . 0.34999999999999998 114.006 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 tttm 54.07 -92.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.898 1.279 . . . . 0.34999999999999998 110.808 -172.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.86 58.72 0.07 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.393 -1.483 . . . . 0.34999999999999998 109.393 173.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -132.55 66.58 1.55 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.382 1.073 . . . . 0.34999999999999998 109.254 -176.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 64.47 -176.74 0.17 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.267 1.427 . . . . 0.34999999999999998 112.12 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.88 178.23 9.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.294 1.037 . . . . 0.34999999999999998 110.696 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.7 m -76.55 147.76 37.49 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.614 1.166 . . . . 0.34999999999999998 111.234 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 65.31 175.98 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.014 1.726 . . . . 0.34999999999999998 113.421 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.4 t80 59.35 90.56 0.05 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 126.448 1.899 . . . . 0.34999999999999998 111.257 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 66.96 161.33 0.14 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 125.573 1.549 . . . . 0.33000000000000002 111.131 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.28 90.52 1.0 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.359 2.039 . . . . 0.34999999999999998 108.619 173.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.2 p -63.86 -60.52 3.18 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.234 1.014 . . . . 0.34999999999999998 111.724 -166.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.68 172.0 32.55 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.962 -0.855 . . . . 0.33000000000000002 110.962 174.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -66.53 149.0 84.46 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.469 2.779 . . . . 0.34999999999999998 112.212 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -163.04 168.48 20.92 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.508 0.723 . . . . 0.34999999999999998 111.292 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tt -145.11 100.86 3.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.737 1.215 . . . . 0.34999999999999998 108.304 -173.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.6 mtp -88.16 134.06 33.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.722 1.609 . . . . 0.34999999999999998 109.541 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.1 t -137.01 87.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.346 0 C-N-CA 124.075 0.95 . . . . 0.34999999999999998 110.485 -168.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -159.35 165.64 32.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.958 1.303 . . . . 0.35999999999999999 110.395 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -94.02 153.17 3.44 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 124.627 1.171 . . . . 0.34999999999999998 112.267 -172.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -82.68 92.65 7.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.755 -1.572 . . . . 0.34999999999999998 106.755 163.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.88 80.79 1.64 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.95 -0.86 . . . . 0.34999999999999998 110.95 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 m -92.56 165.58 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.447 1.099 . . . . 0.34999999999999998 110.318 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -82.4 -162.1 0.53 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.877 0.871 . . . . 0.34999999999999998 110.41 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -53.28 -50.42 64.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.753 1.221 . . . . 0.34999999999999998 111.598 175.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -75.37 -84.11 0.05 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.368 1.067 . . . . 0.34999999999999998 110.33 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.76 46.89 0.06 OUTLIER Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.049 -0.82 . . . . 0.34999999999999998 111.049 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -112.37 108.09 17.14 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.152 1.381 . . . . 0.35999999999999999 108.257 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -70.49 112.34 6.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.886 0.874 . . . . 0.34999999999999998 111.433 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.1 mp -73.88 -45.87 48.23 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.749 0.82 . . . . 0.34999999999999998 109.442 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.2 147.3 36.33 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.858 0.863 . . . . 0.34999999999999998 111.413 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.0 m -91.75 159.45 38.32 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.282 1.433 . . . . 0.33000000000000002 111.29 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -87.27 49.86 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.507 2.805 . . . . 0.34999999999999998 111.914 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -168.72 120.49 0.78 Allowed 'General case' 0 C--N 1.343 0.293 0 N-CA-C 112.915 0.709 . . . . 0.34999999999999998 112.915 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -162.26 -45.09 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.528 1.531 . . . . 0.34999999999999998 109.223 159.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.98 130.87 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.522 -0.918 . . . . 0.34999999999999998 108.522 169.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -144.77 154.09 42.35 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.364 1.066 . . . . 0.34999999999999998 109.05 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -131.77 155.1 81.83 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 125.31 1.444 . . . . 0.33000000000000002 108.735 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.71 34.75 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.554 2.836 . . . . 0.34999999999999998 111.945 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.25 2.8 tt 59.45 134.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 128.679 2.792 . . . . 0.34999999999999998 114.372 -175.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -142.61 98.24 5.9 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.815 1.246 . . . . 0.33000000000000002 107.793 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.61 177.96 8.12 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.533 2.822 . . . . 0.34999999999999998 110.999 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.07 -32.99 6.95 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.977 0.799 . . . . 0.34999999999999998 111.695 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.6 t -67.18 148.71 51.44 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.471 0.708 . . . . 0.34999999999999998 110.682 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.2 m -76.63 109.93 10.79 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.892 -0.781 . . . . 0.34999999999999998 108.892 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.08 96.58 7.81 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.573 -1.269 . . . . 0.34999999999999998 107.573 176.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.3 t -147.31 160.56 42.37 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.502 1.121 . . . . 0.34999999999999998 109.924 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -60.29 -42.84 96.33 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 119.5 -0.286 . . . . 0.34999999999999998 111.576 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.06 -22.4 66.42 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.86 0.689 . . . . 0.34999999999999998 112.86 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -75.31 -58.85 3.03 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 123.401 0.68 . . . . 0.34999999999999998 109.895 167.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.4 mm -63.15 -39.42 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.457 1.103 . . . . 0.34999999999999998 112.813 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -52.25 -48.1 65.4 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.881 0.872 . . . . 0.34999999999999998 112.037 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -76.52 -39.84 51.78 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.063 0.392 . . . . 0.34999999999999998 111.526 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -69.89 -39.3 76.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.45 0.7 . . . . 0.34999999999999998 112.407 -169.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.89 -35.77 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.626 0.771 . . . . 0.34999999999999998 110.752 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -72.4 -34.64 68.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.303 1.041 . . . . 0.34999999999999998 111.071 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -47.08 73.86 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.746 0.819 . . . . 0.34999999999999998 110.051 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.8 -39.96 75.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.276 1.03 . . . . 0.34999999999999998 111.237 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.9 tp -69.1 -50.67 46.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.28 1.032 . . . . 0.34999999999999998 111.467 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -74.43 8.29 2.36 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.727 1.01 . . . . 0.34999999999999998 113.727 -174.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.84 -46.41 89.61 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.51 0.724 . . . . 0.34999999999999998 109.959 166.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 m -118.58 -51.93 2.37 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.679 1.192 . . . . 0.34999999999999998 110.352 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.96 82.38 6.7 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.164 0.985 . . . . 0.34999999999999998 110.866 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -128.89 -43.87 1.34 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.057 1.343 . . . . 0.34999999999999998 111.437 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.485 ' HB3' ' H1 ' ' A' ' 1' ' ' SER . 32.1 ttmt -59.08 -71.31 0.12 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.212 1.405 . . . . 0.34999999999999998 110.576 -173.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.08 -35.74 74.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.378 1.071 . . . . 0.34999999999999998 110.771 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -58.32 146.41 34.52 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.833 1.253 . . . . 0.34999999999999998 111.629 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -156.13 141.24 17.37 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.564 1.146 . . . . 0.34999999999999998 109.562 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.6 t -88.06 137.16 21.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 124.317 1.047 . . . . 0.34999999999999998 109.449 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.95 -56.87 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.067 1.347 . . . . 0.34999999999999998 107.666 167.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -156.96 110.42 2.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.198 0.999 . . . . 0.34999999999999998 108.395 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 pp -87.82 132.22 34.25 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.36 0.664 . . . . 0.34999999999999998 109.823 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.77 124.46 90.77 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 108.322 -0.992 . . . . 0.33000000000000002 108.322 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.91 -54.1 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.829 2.353 . . . . 0.34999999999999998 111.793 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.7 m -74.5 96.14 2.87 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.989 0.916 . . . . 0.34999999999999998 109.969 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.44 133.58 49.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.871 0.868 . . . . 0.34999999999999998 110.132 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -95.81 108.77 21.14 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.166 0.987 . . . . 0.34999999999999998 110.26 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.04 113.04 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.694 -1.595 . . . . 0.34999999999999998 106.694 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.7 64.73 0.65 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.417 1.087 . . . . 0.34999999999999998 108.984 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.3 p -67.86 115.33 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.347 0.659 . . . . 0.34999999999999998 110.627 -176.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 m -111.32 101.38 9.86 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.418 1.087 . . . . 0.34999999999999998 108.985 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -92.92 102.91 15.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.748 1.219 . . . . 0.34999999999999998 108.962 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -81.03 61.65 4.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.647 1.179 . . . . 0.34999999999999998 109.611 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -99.03 85.66 3.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.391 1.477 . . . . 0.34999999999999998 108.453 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -82.59 52.19 2.03 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.763 0.825 . . . . 0.34999999999999998 110.706 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -137.36 -44.53 0.55 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.839 1.256 . . . . 0.35999999999999999 109.828 -170.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -140.64 -66.46 0.43 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.23 1.012 . . . . 0.34999999999999998 110.1 -173.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -89.58 -22.0 22.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.487 0.921 . . . . 0.34999999999999998 113.487 -164.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 tttm 74.92 159.43 0.22 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.855 1.662 . . . . 0.34999999999999998 111.494 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -53.8 117.63 3.32 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.506 1.122 . . . . 0.34999999999999998 109.951 168.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -141.33 111.74 6.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.827 -1.175 . . . . 0.34999999999999998 107.827 171.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.2 m -75.76 86.17 2.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.828 -1.175 . . . . 0.34999999999999998 107.828 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -80.42 97.17 6.96 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.051 0.94 . . . . 0.34999999999999998 108.957 -171.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.9 m -90.24 132.7 35.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.083 1.353 . . . . 0.34999999999999998 110.348 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -163.71 141.2 5.77 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 123.625 0.77 . . . . 0.33000000000000002 110.377 176.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.24 178.91 6.36 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 124.256 3.304 . . . . 0.34999999999999998 110.952 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.0 tp -138.02 143.44 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.228 0.611 . . . . 0.34999999999999998 110.56 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.2 p -100.27 -179.97 4.29 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.999 1.32 . . . . 0.34999999999999998 111.376 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.99 -36.36 72.52 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.738 1.615 . . . . 0.34999999999999998 112.805 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -88.54 -50.73 6.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.269 1.028 . . . . 0.34999999999999998 109.895 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.67 -144.27 45.17 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.156 -0.777 . . . . 0.34999999999999998 111.156 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -161.0 152.57 19.34 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.74 0.816 . . . . 0.34999999999999998 110.756 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.9 t -78.35 133.08 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.097 0.959 . . . . 0.34999999999999998 109.677 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.71 126.22 91.95 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 108.479 -0.934 . . . . 0.33000000000000002 108.479 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.21 -80.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.782 2.322 . . . . 0.34999999999999998 110.77 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -169.05 -56.55 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.902 1.281 . . . . 0.34999999999999998 109.205 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.461 HD11 HG13 ' A' ' 120' ' ' ILE . 2.6 tm? 69.48 99.08 0.06 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.491 1.916 . . . . 0.34999999999999998 110.434 -179.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.8 t -171.12 78.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.092 1.357 . . . . 0.34999999999999998 108.273 173.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -153.86 -77.35 0.11 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 122.782 0.433 . . . . 0.34999999999999998 110.146 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -88.24 -50.15 6.54 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.265 1.026 . . . . 0.34999999999999998 110.282 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.461 HG13 HD11 ' A' ' 116' ' ' LEU . 10.7 pt -103.51 169.37 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.38 1.072 . . . . 0.34999999999999998 109.333 166.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -137.53 -26.95 0.96 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.027 0.931 . . . . 0.34999999999999998 112.631 -166.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.05 58.1 27.38 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 123.702 0.801 . . . . 0.35999999999999999 112.92 -169.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.09 119.64 6.45 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.178 2.585 . . . . 0.34999999999999998 110.65 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.9 77.72 0.69 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 109.574 -1.411 . . . . 0.34999999999999998 109.574 177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -62.67 96.69 0.09 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.163 1.385 . . . . 0.34999999999999998 110.65 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -92.62 98.69 11.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.629 -0.878 . . . . 0.35999999999999999 108.629 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.36 76.97 8.28 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 108.075 -1.083 . . . . 0.34999999999999998 108.075 176.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.9 mt -90.24 122.34 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.181 -1.415 . . . . 0.34999999999999998 107.181 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.3 m -131.0 111.67 12.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.97 -1.122 . . . . 0.34999999999999998 107.97 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -62.99 137.01 58.15 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.365 0.666 . . . . 0.34999999999999998 110.299 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.7 149.67 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.869 0.867 . . . . 0.34999999999999998 109.517 169.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.96 142.54 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.857 1.263 . . . . 0.34999999999999998 108.214 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.6 mt -129.96 147.7 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.698 1.199 . . . . 0.34999999999999998 109.569 -171.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -126.28 -23.85 3.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.326 1.45 . . . . 0.34999999999999998 112.487 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? 93.08 134.88 0.02 OUTLIER 'General case' 0 C--N 1.345 0.395 0 C-N-CA 127.834 2.454 . . . . 0.34999999999999998 110.418 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? . . . . . 0 N--CA 1.455 -0.213 0 C-N-CA 125.007 1.323 . . . . 0.25 109.956 178.655 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 110.137 -0.32 . . . . 0.34999999999999998 110.137 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -80.71 95.91 6.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.86 1.264 . . . . 0.34999999999999998 109.283 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.8 p -80.7 75.81 7.6 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.212 1.005 . . . . 0.34999999999999998 110.991 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -71.39 153.82 42.02 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.028 0.931 . . . . 0.34999999999999998 109.082 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -155.22 65.42 0.63 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.292 1.037 . . . . 0.34999999999999998 108.83 -174.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -95.34 57.3 1.96 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.251 1.02 . . . . 0.34999999999999998 110.186 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 49.9 26.33 8.29 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.275 1.893 . . . . 0.34999999999999998 114.922 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 47.16 49.01 15.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.645 1.578 . . . . 0.34999999999999998 112.582 -176.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -86.23 105.13 16.39 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.649 0.78 . . . . 0.34999999999999998 109.958 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -77.6 72.34 4.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.307 1.443 . . . . 0.34999999999999998 110.608 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 42.57 -91.05 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.029 2.532 . . . . 0.34999999999999998 112.721 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.39 -111.04 0.89 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 108.718 -1.753 . . . . 0.34999999999999998 108.718 175.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 50.73 65.25 1.52 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 125.038 1.335 . . . . 0.34999999999999998 110.938 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -84.02 75.8 10.11 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.938 0.895 . . . . 0.34999999999999998 109.158 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -128.36 73.15 1.46 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.374 1.47 . . . . 0.34999999999999998 108.776 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 t -74.71 175.39 7.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.24 1.016 . . . . 0.34999999999999998 110.996 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -80.94 76.71 7.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.566 1.147 . . . . 0.34999999999999998 109.771 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -154.07 76.82 1.07 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.013 1.325 . . . . 0.34999999999999998 107.559 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 68.04 169.65 0.11 Allowed Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.378 1.471 . . . . 0.33000000000000002 111.108 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.46 108.01 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.56 2.84 . . . . 0.34999999999999998 113.051 170.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.0 p -106.0 -60.32 1.66 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.408 1.483 . . . . 0.34999999999999998 108.695 175.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.7 150.24 7.65 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 110.451 -1.06 . . . . 0.33000000000000002 110.451 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.76 162.78 27.08 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.81 2.34 . . . . 0.34999999999999998 113.332 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -158.68 164.46 35.92 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.331 1.052 . . . . 0.34999999999999998 110.085 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 tt -148.51 103.28 3.4 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.295 -1.002 . . . . 0.34999999999999998 108.295 -173.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 41.9 mtm -82.17 120.68 25.64 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.985 0.914 . . . . 0.34999999999999998 111.128 -176.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -114.87 96.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 124.824 1.249 . . . . 0.34999999999999998 110.092 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -156.33 -176.01 5.73 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.529 0.732 . . . . 0.35999999999999999 110.998 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.2 m -140.27 -170.62 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.767 1.227 . . . . 0.34999999999999998 110.248 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.2 m -135.89 94.12 3.02 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.897 -1.52 . . . . 0.34999999999999998 106.897 168.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.09 98.33 2.39 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 124.649 1.119 . . . . 0.34999999999999998 111.885 -169.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.12 162.64 3.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 124.466 1.106 . . . . 0.34999999999999998 111.731 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -74.03 -52.25 13.31 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.468 -0.938 . . . . 0.34999999999999998 108.468 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 m -157.58 -64.37 0.09 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.989 1.316 . . . . 0.34999999999999998 109.474 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -106.7 63.78 0.64 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.2 1.0 . . . . 0.34999999999999998 111.264 -165.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.75 -40.62 3.04 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 119.758 -0.468 . . . . 0.34999999999999998 113.012 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -49.41 103.77 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.751 2.02 . . . . 0.35999999999999999 112.509 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.81 136.43 34.14 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.489 1.115 . . . . 0.34999999999999998 110.731 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 mp -79.09 -62.3 1.74 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.456 0.703 . . . . 0.34999999999999998 109.457 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mt -94.88 -148.28 0.28 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.695 1.198 . . . . 0.34999999999999998 108.879 -170.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.9 m -143.07 68.11 17.65 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 108.036 -1.098 . . . . 0.33000000000000002 108.036 164.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -83.18 75.58 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.567 2.845 . . . . 0.34999999999999998 110.006 -166.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -152.86 54.22 0.77 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.58 1.552 . . . . 0.34999999999999998 108.016 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.99 48.38 0.44 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.272 0.842 . . . . 0.34999999999999998 113.272 -171.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -169.71 136.74 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.722 0.809 . . . . 0.34999999999999998 109.875 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -161.27 178.18 9.48 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.632 0.773 . . . . 0.34999999999999998 111.378 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -145.39 157.81 52.0 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.627 1.571 . . . . 0.33000000000000002 108.848 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.17 168.76 18.32 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.0 2.467 . . . . 0.34999999999999998 110.866 171.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 tp -61.41 144.64 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.707 0.803 . . . . 0.34999999999999998 111.33 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -156.68 94.75 2.28 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.823 -1.177 . . . . 0.33000000000000002 107.823 173.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.96 -179.03 4.94 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.393 2.729 . . . . 0.34999999999999998 110.585 -175.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.96 -37.47 3.7 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.748 0.69 . . . . 0.34999999999999998 111.555 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.1 t -62.85 142.87 58.07 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.847 0.859 . . . . 0.34999999999999998 111.459 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.6 m -82.29 135.94 35.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.475 1.11 . . . . 0.34999999999999998 109.187 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 mp -117.03 131.37 56.96 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.232 1.413 . . . . 0.34999999999999998 109.794 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 t -172.59 172.05 4.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.073 2.549 . . . . 0.34999999999999998 106.808 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -61.06 -29.54 69.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.366 0.876 . . . . 0.34999999999999998 113.366 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -83.7 -13.08 54.92 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.863 0.69 . . . . 0.34999999999999998 112.863 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -98.27 -27.54 14.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.6 1.16 . . . . 0.34999999999999998 111.913 173.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -39.71 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.219 -0.66 . . . . 0.34999999999999998 109.219 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -67.92 -54.99 14.53 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.401 1.081 . . . . 0.34999999999999998 113.198 -169.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -66.27 -35.02 79.32 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.78 0.718 . . . . 0.34999999999999998 111.226 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -64.09 -53.81 43.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.954 1.302 . . . . 0.34999999999999998 111.5 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.1 m -69.32 -36.36 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 123.007 0.523 . . . . 0.34999999999999998 111.656 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.79 -41.37 95.46 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.824 0.85 . . . . 0.34999999999999998 111.254 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -33.53 68.78 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.806 0.443 . . . . 0.34999999999999998 111.201 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.64 -53.83 35.95 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.357 0.663 . . . . 0.34999999999999998 110.861 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.3 -27.87 67.53 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.225 0.61 . . . . 0.34999999999999998 112.01 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -67.78 -33.43 74.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.264 0.484 . . . . 0.34999999999999998 110.439 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.9 28.58 0.35 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.456 0.702 . . . . 0.34999999999999998 112.15 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 88.5 m -146.27 -65.36 0.3 Allowed 'General case' 0 C--N 1.344 0.336 0 C-N-CA 125.063 1.345 . . . . 0.34999999999999998 108.229 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.85 -52.25 13.62 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.741 1.216 . . . . 0.34999999999999998 111.207 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 73.42 150.86 0.11 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.532 1.933 . . . . 0.34999999999999998 113.776 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.4 tttm 100.72 37.05 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 129.17 2.988 . . . . 0.34999999999999998 111.29 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 62.21 -74.43 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.176 2.19 . . . . 0.34999999999999998 114.308 166.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 87.75 159.26 0.07 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 128.459 2.703 . . . . 0.34999999999999998 110.689 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -54.69 -59.96 4.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.128 0.971 . . . . 0.34999999999999998 110.209 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t 56.25 76.64 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.952 1.301 . . . . 0.34999999999999998 108.736 -171.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.9 t -56.99 -60.92 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 124.612 1.165 . . . . 0.34999999999999998 109.984 -177.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -162.76 126.93 3.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.773 0.829 . . . . 0.34999999999999998 109.0 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.507 HD13 ' H ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -81.0 157.36 25.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.342 0.657 . . . . 0.34999999999999998 110.206 172.7 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.63 123.73 89.13 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.457 -0.942 . . . . 0.33000000000000002 108.457 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.86 -31.81 30.68 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.171 2.581 . . . . 0.34999999999999998 110.67 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 52.8 m -89.64 60.91 5.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.763 1.225 . . . . 0.34999999999999998 109.536 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.34 170.1 7.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.249 1.02 . . . . 0.34999999999999998 110.458 171.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -150.74 148.36 28.45 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 113.137 0.791 . . . . 0.34999999999999998 113.137 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.5 mp -119.68 105.33 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.692 1.597 . . . . 0.34999999999999998 107.19 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.88 76.83 9.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.607 -0.886 . . . . 0.34999999999999998 108.607 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.31 94.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.065 -1.087 . . . . 0.34999999999999998 108.065 172.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.8 m -88.14 75.51 8.64 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.202 -1.036 . . . . 0.34999999999999998 108.202 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -68.92 121.09 15.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.035 -0.53 . . . . 0.34999999999999998 110.951 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -138.94 146.71 41.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.9 1.68 . . . . 0.34999999999999998 109.785 -172.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -154.2 -177.54 6.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.108 1.363 . . . . 0.34999999999999998 109.48 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -133.45 59.29 1.74 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.571 -1.27 . . . . 0.34999999999999998 107.571 167.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -143.78 -66.62 0.35 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.498 1.119 . . . . 0.35999999999999999 109.71 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 56.54 0.23 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.827 0.451 . . . . 0.34999999999999998 111.998 -171.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -159.84 -55.85 0.06 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-O 119.118 -0.468 . . . . 0.34999999999999998 111.761 169.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt 80.52 160.18 0.16 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.34999999999999998 110.122 -168.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.34 136.66 58.04 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.139 0.976 . . . . 0.34999999999999998 110.969 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -151.85 113.25 4.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.468 1.107 . . . . 0.34999999999999998 108.272 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.1 m -79.89 82.92 5.9 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.672 1.189 . . . . 0.34999999999999998 109.05 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -82.66 108.27 15.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.674 -0.861 . . . . 0.34999999999999998 108.674 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.6 p -85.86 63.66 8.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.743 1.217 . . . . 0.34999999999999998 110.504 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -61.51 111.85 5.04 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.262 1.425 . . . . 0.33000000000000002 107.904 172.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.67 -109.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.661 2.241 . . . . 0.34999999999999998 111.461 -160.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.3 tp -160.64 155.84 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.893 0.877 . . . . 0.34999999999999998 109.132 -177.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.7 p -106.87 173.02 6.5 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.3 1.04 . . . . 0.34999999999999998 110.073 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.07 51.12 0.98 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.337 -1.357 . . . . 0.34999999999999998 107.337 167.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -156.37 -76.65 0.09 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.308 1.043 . . . . 0.34999999999999998 109.29 -169.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 152.07 143.46 3.7 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.85 -0.9 . . . . 0.34999999999999998 110.85 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -153.17 128.01 9.54 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.694 0.798 . . . . 0.34999999999999998 109.757 167.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.06 130.62 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.201 1.0 . . . . 0.34999999999999998 108.983 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.76 122.69 86.71 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.727 -1.212 . . . . 0.33000000000000002 107.727 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.02 -98.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.152 2.568 . . . . 0.34999999999999998 111.059 -172.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -169.25 172.0 7.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.607 1.163 . . . . 0.34999999999999998 110.08 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.26 137.3 13.62 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.646 1.178 . . . . 0.34999999999999998 109.767 176.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.9 t -167.69 -174.81 2.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.65 0.78 . . . . 0.34999999999999998 110.706 -171.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 74.05 -82.03 0.03 OUTLIER 'General case' 0 C--N 1.342 0.245 0 C-N-CA 127.055 2.142 . . . . 0.34999999999999998 111.366 170.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -104.57 -50.27 3.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.983 1.313 . . . . 0.34999999999999998 109.162 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.0 tp -78.67 104.77 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.238 1.015 . . . . 0.34999999999999998 109.207 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -143.47 10.03 1.63 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.275 1.03 . . . . 0.34999999999999998 112.502 -170.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.32 63.48 4.62 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.31 0.959 . . . . 0.35999999999999999 111.817 170.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.2 -90.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.941 3.094 . . . . 0.34999999999999998 112.974 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.96 78.75 0.52 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 109.338 -1.505 . . . . 0.34999999999999998 109.338 -168.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -75.02 95.18 2.98 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.909 1.284 . . . . 0.34999999999999998 108.894 176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -91.6 91.4 8.02 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.634 0.374 . . . . 0.35999999999999999 110.683 -168.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.96 61.39 1.95 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.274 1.429 . . . . 0.34999999999999998 109.027 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.58 127.91 58.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.143 1.777 . . . . 0.34999999999999998 106.748 174.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 51.6 m -147.42 131.58 17.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.376 1.07 . . . . 0.34999999999999998 109.371 -171.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -64.38 131.55 47.53 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.493 0.717 . . . . 0.34999999999999998 109.56 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.5 m -136.98 159.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.159 0 C-N-CA 123.922 0.889 . . . . 0.34999999999999998 109.655 174.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.2 124.84 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 124.369 1.067 . . . . 0.34999999999999998 108.203 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.5 mt -129.43 145.49 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.854 1.261 . . . . 0.34999999999999998 109.548 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -127.22 156.28 42.1 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.567 1.547 . . . . 0.34999999999999998 108.822 168.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -77.02 140.79 40.47 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.561 -0.533 . . . . 0.34999999999999998 109.561 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.147 0 C-N-CA 124.307 1.043 . . . . 0.25 110.667 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.1 p90 . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 114.882 1.438 . . . . 0.35 114.882 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -149.86 32.21 0.69 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.141 0.976 . . . . 0.35 110.443 165.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -131.27 -58.93 0.99 Allowed 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.717 1.607 . . . . 0.35 108.555 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.89 90.49 0.33 Allowed Glycine 0 C--N 1.341 0.834 0 C-N-CA 123.82 0.724 . . . . 0.35 111.902 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 56.82 42.46 26.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.193 1.397 . . . . 0.35 111.852 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -88.97 -40.83 12.75 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.681 1.193 . . . . 0.35 111.703 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.35 48.88 10.47 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 126.584 1.953 . . . . 0.35 112.699 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.2 pttp 67.47 -12.31 0.27 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.173 2.189 . . . . 0.35 115.015 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.68 -36.92 2.86 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.923 1.249 . . . . 0.35 110.46 -170.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.27 85.55 4.41 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.689 1.195 . . . . 0.35 110.094 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -99.64 73.48 1.82 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.918 1.287 . . . . 0.35 108.579 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.83 79.81 9.49 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.208 1.003 . . . . 0.35 109.178 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.3 p -70.65 -59.01 3.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.666 0.786 . . . . 0.35 111.58 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -158.99 -143.33 0.1 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.612 -0.885 . . . . 0.35 108.612 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.5 t80 56.97 88.14 0.05 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.256 1.822 . . . . 0.35 112.207 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 68.27 162.95 0.14 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 126.054 1.742 . . . . 0.33 112.09 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.08 99.9 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.131 2.554 . . . . 0.35 110.251 171.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.1 p -90.12 -76.66 0.42 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.447 1.099 . . . . 0.35 110.25 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.82 149.02 10.96 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 110.593 -1.003 . . . . 0.33 110.593 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.11 169.97 21.0 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 124.133 3.222 . . . . 0.35 112.506 -170.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -163.53 162.6 24.62 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.558 1.143 . . . . 0.35 110.673 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 tt -138.66 97.43 3.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.979 1.312 . . . . 0.35 107.583 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.8 ttm -98.96 108.25 20.89 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.069 1.748 . . . . 0.35 110.781 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.2 t -110.14 99.82 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.793 1.237 . . . . 0.35 110.867 -167.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -150.14 -163.92 1.9 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.89 1.276 . . . . 0.36 109.948 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.0 150.69 24.98 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 C-N-CA 124.648 1.179 . . . . 0.35 110.923 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 83.8 m -84.09 79.96 9.34 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.431 -1.692 . . . . 0.35 106.431 163.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.84 100.43 1.85 Allowed Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.481 -1.048 . . . . 0.35 110.481 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.79 169.55 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 124.893 1.277 . . . . 0.35 110.348 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -63.8 -49.34 73.29 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.942 0.897 . . . . 0.35 110.757 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.2 p -178.47 -58.48 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.598 1.959 . . . . 0.35 108.624 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.5 tttp -75.7 -73.7 0.25 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.791 0.836 . . . . 0.35 109.622 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.25 28.32 0.07 OUTLIER Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.219 -0.767 . . . . 0.35 112.976 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -90.46 94.25 9.65 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 107.252 -1.388 . . . . 0.36 107.252 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.38 110.22 3.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.06 0.944 . . . . 0.35 111.562 -168.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.6 mt -70.65 -41.51 72.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.759 1.223 . . . . 0.35 110.09 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 pp -143.98 138.24 28.3 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.727 0.811 . . . . 0.35 111.205 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.7 m -88.36 141.99 31.1 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 124.494 1.118 . . . . 0.33 110.039 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.47 -171.57 0.86 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.976 3.117 . . . . 0.35 111.688 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.7 m170 87.16 17.77 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.482 2.313 . . . . 0.35 114.087 168.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -94.0 -38.95 10.9 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.778 0.717 . . . . 0.35 112.417 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.3 t -99.08 137.96 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.204 1.002 . . . . 0.35 109.237 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -157.85 135.32 10.38 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.104 0.962 . . . . 0.35 109.431 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -120.31 143.69 36.42 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 125.362 1.465 . . . . 0.33 108.941 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.33 137.53 40.25 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.543 2.162 . . . . 0.35 109.106 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.5 tt -64.21 135.26 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 122.845 0.458 . . . . 0.35 111.999 -170.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -142.56 97.38 6.06 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 106.828 -1.545 . . . . 0.33 106.828 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.61 135.61 24.32 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.82 2.347 . . . . 0.35 110.325 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 162.95 -41.73 0.34 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.925 -0.87 . . . . 0.35 110.925 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.4 t -61.21 145.65 50.44 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.97 0.908 . . . . 0.35 110.952 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.7 m -78.77 97.49 5.93 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.877 0.871 . . . . 0.35 108.895 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -74.32 81.17 1.86 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.29 1.436 . . . . 0.35 109.56 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.5 p -150.42 165.6 32.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.56 1.544 . . . . 0.35 109.152 -171.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -54.39 -43.49 71.47 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.87 1.268 . . . . 0.35 111.69 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -50.82 -50.57 56.14 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.832 0.853 . . . . 0.35 112.381 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -102.83 38.04 1.81 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.638 0.775 . . . . 0.35 111.565 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.27 -38.06 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.488 1.515 . . . . 0.35 107.94 165.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -54.55 -67.7 0.24 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 127.053 2.141 . . . . 0.35 110.988 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -81.71 -18.13 45.44 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.078 0.551 . . . . 0.35 112.471 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -66.65 -49.46 66.14 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.142 0.577 . . . . 0.35 111.224 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.8 m -68.47 -31.12 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.391 0.676 . . . . 0.35 111.373 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.05 -40.96 97.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.745 0.818 . . . . 0.35 110.748 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.84 -33.3 72.12 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.491 0.716 . . . . 0.35 111.532 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.29 -52.92 51.1 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.122 0.569 . . . . 0.35 111.207 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.74 -33.73 76.28 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.672 0.389 . . . . 0.35 111.642 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -67.62 -30.49 70.08 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 122.699 0.4 . . . . 0.35 111.256 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.87 38.67 0.53 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.718 0.807 . . . . 0.35 110.967 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.3 m -150.83 -53.17 0.14 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.946 1.698 . . . . 0.35 107.992 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.46 -94.09 0.4 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.098 1.359 . . . . 0.35 110.505 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.4 t80 55.04 64.06 1.92 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.714 1.606 . . . . 0.35 111.623 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -137.8 -54.2 0.66 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.835 1.254 . . . . 0.35 108.797 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -125.25 78.2 1.7 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.107 1.363 . . . . 0.35 108.07 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -159.45 126.81 4.73 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.099 0.96 . . . . 0.35 108.972 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -146.37 -38.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.575 1.15 . . . . 0.35 111.537 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 t 76.65 119.55 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 126.408 1.883 . . . . 0.35 111.492 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 55.6 t -68.46 -59.16 3.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 N-CA-C 108.088 -1.079 . . . . 0.35 108.088 166.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -153.24 154.17 34.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.48 1.512 . . . . 0.35 109.023 -175.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 pp -118.6 140.74 49.41 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.472 1.109 . . . . 0.35 108.782 170.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.47 137.29 67.58 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 109.721 -0.474 . . . . 0.33 109.721 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.81 -33.77 15.74 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.449 2.766 . . . . 0.35 111.361 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -85.14 65.64 9.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.495 1.118 . . . . 0.35 109.966 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.65 158.67 35.8 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.325 0.65 . . . . 0.35 109.346 170.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -142.07 155.06 45.37 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 121.204 0.526 . . . . 0.35 112.217 -171.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mp -129.88 117.62 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.687 1.595 . . . . 0.35 107.159 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -103.72 67.41 0.89 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.357 1.063 . . . . 0.35 109.615 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.68 119.09 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 122.921 0.489 . . . . 0.35 109.883 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 m -119.42 117.46 28.53 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.508 1.123 . . . . 0.35 108.816 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.0 110.68 20.43 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.839 1.256 . . . . 0.35 109.983 -168.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -101.63 56.95 0.83 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.94 1.296 . . . . 0.35 112.316 -164.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.48 87.4 6.39 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.289 0.636 . . . . 0.35 109.404 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -77.41 65.69 3.01 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.177 0.591 . . . . 0.35 110.384 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -152.6 -48.93 0.1 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.203 1.801 . . . . 0.36 108.893 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -140.42 -66.14 0.44 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.465 1.106 . . . . 0.35 110.63 -173.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -78.72 -51.16 10.21 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.877 0.471 . . . . 0.35 111.501 -167.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 75.63 167.04 0.27 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.901 1.681 . . . . 0.35 113.013 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.84 111.98 0.94 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.333 1.853 . . . . 0.35 111.297 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -141.31 104.82 4.68 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.131 1.373 . . . . 0.35 107.656 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.5 m -77.53 88.57 3.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.617 -0.883 . . . . 0.35 108.617 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -80.26 95.81 6.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.427 -0.953 . . . . 0.35 108.427 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.6 p -90.54 61.19 4.83 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.85 1.26 . . . . 0.35 110.617 -175.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -71.12 145.13 90.83 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.582 -0.525 . . . . 0.33 109.582 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.81 -118.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.519 2.813 . . . . 0.35 109.732 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.4 tp -162.89 159.15 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.62 0.768 . . . . 0.35 110.176 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.4 p -133.97 155.7 49.49 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.873 1.269 . . . . 0.35 109.538 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -64.35 -48.82 74.07 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.074 0.95 . . . . 0.35 112.425 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -138.77 62.81 1.54 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.064 0.946 . . . . 0.35 108.915 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.3 -84.22 0.5 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.6 1.095 . . . . 0.35 112.755 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -158.0 159.17 36.13 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.421 0.526 . . . . 0.35 112.421 -158.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.6 t -82.83 154.02 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.947 1.699 . . . . 0.35 109.135 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.0 t -48.83 115.08 4.18 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.763 1.225 . . . . 0.33 109.647 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.17 165.21 26.15 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.003 2.469 . . . . 0.35 110.797 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -68.88 158.46 34.49 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.504 0.721 . . . . 0.35 110.417 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 116' ' ' LEU . 2.1 pt? -84.09 48.68 1.51 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.546 1.138 . . . . 0.35 112.845 -175.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.9 t 53.35 -99.78 0.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.658 1.583 . . . . 0.35 112.319 173.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -165.16 -53.83 0.03 OUTLIER 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.571 1.148 . . . . 0.35 109.305 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -90.32 44.46 1.2 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.074 1.749 . . . . 0.35 112.247 -170.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.3 tp -164.15 138.34 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.642 0.777 . . . . 0.35 110.244 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -99.54 -43.85 6.36 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.095 1.758 . . . . 0.35 110.515 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.449 HD22 ' H ' ' A' ' 122' ' ' ASN . 0.1 OUTLIER -123.25 71.17 44.73 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 115.182 1.549 . . . . 0.36 115.182 -164.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.87 140.39 92.85 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.756 2.304 . . . . 0.35 110.848 163.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.32 67.21 0.32 Allowed Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.648 -1.381 . . . . 0.35 109.648 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -58.02 103.24 0.13 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 125.047 1.339 . . . . 0.35 110.48 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -99.09 86.36 3.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.89 0.876 . . . . 0.36 109.225 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.86 86.23 0.34 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.717 1.607 . . . . 0.35 108.046 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.4 mt -134.14 115.83 21.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 124.792 1.237 . . . . 0.35 108.316 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 40.5 m -116.48 130.41 56.74 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.832 1.253 . . . . 0.35 109.566 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -75.87 128.05 34.29 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.667 -0.864 . . . . 0.35 108.667 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.38 153.54 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.116 0.966 . . . . 0.35 111.057 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.6 t -96.84 97.08 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.781 1.633 . . . . 0.35 107.555 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.5 mt -83.02 138.42 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.299 0.639 . . . . 0.35 110.865 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -103.28 113.44 26.93 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 107.537 -1.283 . . . . 0.35 107.537 164.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -91.64 91.5 8.04 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.881 0.872 . . . . 0.35 108.865 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 C--N 1.342 0.263 0 CA-C-O 121.51 0.671 . . . . 0.25 109.362 177.057 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.5 p90 . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 112.97 0.73 . . . . 0.35 112.97 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -61.8 165.21 5.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.854 1.261 . . . . 0.35 110.062 172.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.32 60.73 2.68 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.479 1.512 . . . . 0.35 110.797 -175.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.07 109.8 3.1 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.859 1.219 . . . . 0.35 112.102 -168.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt 58.48 53.01 6.53 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.326 1.45 . . . . 0.35 110.572 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -127.56 72.28 1.38 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.352 1.061 . . . . 0.35 108.836 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.34 66.94 9.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.671 1.188 . . . . 0.35 108.681 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.4 mptt 51.47 -107.33 0.3 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.29 1.836 . . . . 0.35 110.022 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.01 52.82 0.55 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 108.244 -1.942 . . . . 0.35 108.244 168.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -132.31 75.63 1.65 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.364 1.466 . . . . 0.35 108.156 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -157.93 44.58 0.33 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.823 1.249 . . . . 0.35 109.718 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.42 95.05 2.65 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.471 1.108 . . . . 0.35 108.587 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 t -53.73 -51.24 63.95 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.301 1.04 . . . . 0.35 112.118 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -154.17 57.72 0.71 Allowed 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.547 0.739 . . . . 0.35 110.462 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -138.58 69.29 1.38 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 122.722 0.409 . . . . 0.35 111.522 -170.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 68.42 163.89 0.13 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.93 1.692 . . . . 0.33 113.663 161.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -54.29 104.64 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.791 2.994 . . . . 0.35 111.047 164.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.9 p -143.35 -51.56 0.35 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.601 1.16 . . . . 0.35 109.938 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.97 81.01 0.06 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.182 -1.167 . . . . 0.33 110.182 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -70.85 170.84 16.9 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.714 2.942 . . . . 0.35 111.44 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -154.77 168.26 27.46 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.51 0.671 . . . . 0.35 112.46 -161.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -147.32 93.28 2.22 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.275 -1.75 . . . . 0.35 106.275 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 62.6 mtm -85.16 96.65 9.53 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.518 0.727 . . . . 0.35 111.339 -169.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.54 89.11 2.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 125.128 1.371 . . . . 0.35 108.359 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -151.41 176.55 11.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.429 1.092 . . . . 0.36 109.954 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.417 HG11 HG22 ' A' ' 131' ' ' VAL . 6.8 t -136.46 145.7 30.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 C-N-CA 123.873 0.869 . . . . 0.35 110.958 -171.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.6 m -82.69 84.38 7.33 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.564 -1.643 . . . . 0.35 106.564 164.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.33 83.14 1.58 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.462 -0.655 . . . . 0.35 111.462 -169.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.93 164.43 3.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 C-N-CA 123.575 0.75 . . . . 0.35 111.37 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -72.43 -45.82 57.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.069 0.948 . . . . 0.35 110.96 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.9 t 169.54 -58.02 0.01 OUTLIER 'General case' 0 C--N 1.341 0.226 0 C-N-CA 127.984 2.514 . . . . 0.35 107.586 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -71.6 -66.75 0.59 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.22 1.008 . . . . 0.35 109.891 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.73 62.91 0.02 OUTLIER Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.001 -1.239 . . . . 0.35 110.001 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -133.04 97.23 3.95 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 107.645 -1.242 . . . . 0.36 107.645 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.22 119.68 9.48 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.78 1.232 . . . . 0.35 111.276 -173.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.0 mp -84.75 -39.41 18.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.153 0.981 . . . . 0.35 110.006 170.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 pp -141.88 149.04 39.72 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.535 0.734 . . . . 0.35 112.467 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.7 m -89.33 155.26 49.03 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.558 1.143 . . . . 0.33 111.544 -167.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -83.7 44.71 1.64 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.811 3.007 . . . . 0.35 111.952 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -177.71 111.39 0.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.421 1.089 . . . . 0.35 109.936 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -163.83 -51.8 0.03 OUTLIER 'General case' 0 C--N 1.341 0.236 0 CA-C-O 118.668 -0.682 . . . . 0.35 112.518 170.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.28 -57.13 6.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 CA-C-N 119.134 0.879 . . . . 0.35 110.594 -173.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 65.9 155.08 0.08 Allowed 'General case' 0 C--N 1.343 0.292 0 C-N-CA 126.19 1.796 . . . . 0.35 113.061 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -138.55 147.02 53.32 Favored Pre-proline 0 N--CA 1.454 -0.275 0 C-N-CA 125.603 1.561 . . . . 0.33 107.521 171.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.63 144.54 55.07 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.582 2.188 . . . . 0.35 109.985 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.97 116.85 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.679 0.792 . . . . 0.35 109.437 -177.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -137.88 116.16 9.68 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.841 1.256 . . . . 0.33 108.484 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.09 178.56 7.36 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.438 2.759 . . . . 0.35 110.881 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.23 -30.29 10.67 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.9 0.762 . . . . 0.35 112.55 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.4 t -68.13 144.65 54.92 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.797 0.798 . . . . 0.35 111.088 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.6 m -71.89 145.65 48.39 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.746 -0.835 . . . . 0.35 108.746 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.98 113.89 7.63 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.443 0.697 . . . . 0.35 109.531 -167.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 t -162.22 175.25 11.85 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.686 1.594 . . . . 0.35 108.898 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -47.97 -60.45 2.6 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.359 1.463 . . . . 0.35 111.054 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -59.77 -35.24 74.22 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.375 0.88 . . . . 0.35 113.375 -174.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.42 -55.41 28.1 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 118.676 0.671 . . . . 0.35 110.62 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.3 mm -60.43 -39.33 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.281 1.033 . . . . 0.35 111.754 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -55.65 -59.19 5.2 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.645 0.657 . . . . 0.35 111.936 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -66.56 -38.1 86.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.942 0.792 . . . . 0.35 111.751 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -66.07 -45.52 81.0 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.516 0.727 . . . . 0.35 111.363 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.79 -26.17 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.61 0.764 . . . . 0.35 111.736 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -62.92 -35.55 80.45 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.11 0.564 . . . . 0.35 110.878 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -71.11 -32.53 69.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.329 0.652 . . . . 0.35 111.308 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.58 -36.44 82.72 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.066 0.546 . . . . 0.35 111.335 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.0 mt -72.76 -41.49 65.01 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 122.884 0.474 . . . . 0.35 111.065 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.49 67.6 6.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.66 0.784 . . . . 0.35 109.641 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.57 -60.48 0.1 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.783 1.233 . . . . 0.35 108.796 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.0 p -96.79 -56.42 2.58 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.617 1.167 . . . . 0.35 109.671 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.79 63.7 7.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.695 -1.224 . . . . 0.35 107.695 169.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -72.77 -57.47 4.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.282 0.633 . . . . 0.35 112.058 -164.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -93.99 -52.3 4.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.438 0.695 . . . . 0.35 111.109 -164.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.52 68.43 10.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.032 0.933 . . . . 0.35 110.235 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -163.18 155.35 18.1 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.115 0.966 . . . . 0.35 109.575 169.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -163.28 111.21 1.23 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.985 -1.117 . . . . 0.35 107.985 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.92 92.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.17 -0.678 . . . . 0.35 109.17 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.51 -40.93 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.596 1.158 . . . . 0.35 111.332 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -149.15 160.5 43.3 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.615 0.766 . . . . 0.35 110.268 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 81' ' ' LEU . 1.7 pt? -137.61 142.54 41.24 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.901 1.28 . . . . 0.35 110.441 -175.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.77 132.76 82.87 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 109.398 -0.593 . . . . 0.33 109.398 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.74 -34.96 13.6 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.194 2.596 . . . . 0.35 110.751 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -81.53 78.83 8.24 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.152 0.981 . . . . 0.35 110.473 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.85 166.07 16.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.37 0.668 . . . . 0.35 109.269 164.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -153.7 122.06 6.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.73 0.3 . . . . 0.35 111.637 -168.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.0 mp -94.28 124.27 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.546 1.538 . . . . 0.35 107.325 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -111.25 84.29 1.91 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.486 -1.301 . . . . 0.35 107.486 174.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.95 96.86 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 108.975 -0.75 . . . . 0.35 108.975 171.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -86.57 87.45 7.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.273 -1.751 . . . . 0.35 106.273 171.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -86.78 80.63 8.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.234 0.54 . . . . 0.35 110.168 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -91.11 144.09 26.0 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.883 1.273 . . . . 0.35 111.034 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -166.38 89.8 0.4 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.039 -1.467 . . . . 0.35 107.039 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -77.54 74.36 4.1 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.142 0.977 . . . . 0.35 108.636 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -154.67 -48.98 0.09 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.581 1.952 . . . . 0.36 108.339 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.23 -45.99 0.1 Allowed 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.554 0.742 . . . . 0.35 112.561 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -73.64 -57.37 4.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.614 0.643 . . . . 0.35 111.495 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt 82.96 158.05 0.12 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.974 1.71 . . . . 0.35 111.7 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.91 135.26 20.2 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 126.438 1.895 . . . . 0.35 113.243 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -150.05 103.67 3.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.743 1.217 . . . . 0.35 107.997 170.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.2 m -77.19 87.43 3.65 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.408 1.083 . . . . 0.35 108.757 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -97.88 103.64 15.6 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.572 1.149 . . . . 0.35 108.32 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.6 p -83.32 143.16 30.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.276 1.03 . . . . 0.35 111.266 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -151.45 152.97 31.71 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.422 1.089 . . . . 0.33 108.856 169.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.43 -117.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.357 2.705 . . . . 0.35 110.897 -171.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tp -158.76 150.16 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.901 0.88 . . . . 0.35 109.559 -173.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.3 p -91.85 172.68 8.3 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.025 0.93 . . . . 0.35 110.807 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -102.9 -28.39 12.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.324 1.45 . . . . 0.35 109.386 165.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -62.63 -76.04 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.0 1.32 . . . . 0.35 111.777 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 133.93 73.73 0.09 OUTLIER Glycine 0 C--N 1.341 0.86 0 N-CA-C 110.354 -1.099 . . . . 0.35 110.354 -172.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -77.21 131.1 38.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.336 0.568 . . . . 0.35 109.685 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.63 127.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.678 -1.23 . . . . 0.35 107.678 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.16 115.35 12.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.698 -1.223 . . . . 0.33 107.698 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -82.84 -174.04 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.115 2.543 . . . . 0.35 110.866 -170.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -69.37 -171.57 0.37 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.858 0.863 . . . . 0.35 110.109 167.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.27 1.76 2.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.663 0.785 . . . . 0.35 113.094 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 t 65.08 -154.62 0.28 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.177 0.991 . . . . 0.35 111.516 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -96.6 -50.14 4.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.715 1.206 . . . . 0.35 111.483 -166.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -50.45 -41.77 53.24 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.965 1.306 . . . . 0.35 112.896 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.3 tp -105.36 144.23 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.783 1.233 . . . . 0.35 108.488 168.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -149.93 17.4 0.87 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.553 1.141 . . . . 0.35 111.405 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.81 70.16 2.02 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.359 1.064 . . . . 0.36 110.074 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -87.98 -172.69 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.434 3.423 . . . . 0.35 112.26 -170.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.88 84.26 0.17 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.596 -1.402 . . . . 0.35 109.596 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -74.88 81.24 2.14 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.31 1.444 . . . . 0.35 109.917 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -90.58 104.31 16.9 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.048 0.539 . . . . 0.36 110.437 -169.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.88 90.59 4.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.005 -1.109 . . . . 0.35 108.005 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.2 mt -96.59 74.76 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 106.97 -1.493 . . . . 0.35 106.97 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.1 m -78.67 170.73 16.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.641 1.176 . . . . 0.35 109.127 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -141.94 133.81 27.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.43 1.092 . . . . 0.35 108.861 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.417 HG22 HG11 ' A' ' 29' ' ' VAL . 5.3 m -142.52 159.62 19.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 123.652 0.781 . . . . 0.35 110.803 173.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.4 t -90.85 126.83 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.117 1.367 . . . . 0.35 108.205 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 34.9 mt -116.65 120.35 64.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.295 1.038 . . . . 0.35 110.159 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -80.29 120.43 24.34 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.267 1.427 . . . . 0.35 108.073 164.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -89.07 -3.51 58.65 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.414 1.086 . . . . 0.35 112.997 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? . . . . . 0 C--N 1.343 0.323 0 C-N-CA 125.52 1.528 . . . . 0.25 110.333 -164.267 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 115.274 1.583 . . . . 0.35 115.274 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -93.59 71.78 4.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.803 0.841 . . . . 0.35 108.917 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -157.47 -51.39 0.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.409 1.083 . . . . 0.35 110.163 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.49 67.45 0.89 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.825 -0.91 . . . . 0.35 110.825 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt 56.14 -121.45 1.62 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.431 1.492 . . . . 0.35 110.904 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.9 t80 61.71 99.64 0.03 OUTLIER 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.499 1.92 . . . . 0.35 112.181 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.81 52.43 0.94 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.685 1.194 . . . . 0.35 110.678 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.6 mttt 79.55 -65.18 0.2 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 126.915 2.086 . . . . 0.35 111.866 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 147.09 -47.8 0.67 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 108.387 -1.885 . . . . 0.35 108.387 -168.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 48.4 51.15 15.66 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.881 2.073 . . . . 0.35 113.809 167.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 56.66 54.39 7.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.901 1.281 . . . . 0.35 111.778 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.16 -158.33 0.32 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.553 1.141 . . . . 0.35 112.984 171.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 p -162.79 -35.6 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.482 1.113 . . . . 0.35 111.812 -171.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -133.8 39.44 3.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.705 1.202 . . . . 0.35 109.944 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -147.37 73.05 1.27 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 122.775 0.43 . . . . 0.35 110.788 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 65.8 177.99 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.191 1.396 . . . . 0.33 112.886 162.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -74.89 60.41 5.34 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.596 2.864 . . . . 0.35 113.742 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.2 p -68.01 -40.97 82.9 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.566 0.746 . . . . 0.35 109.915 170.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.96 166.79 22.36 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 111.881 -0.488 . . . . 0.33 111.881 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.03 -177.45 3.72 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.875 3.717 . . . . 0.35 111.807 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -156.46 171.8 19.65 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.594 1.157 . . . . 0.35 110.452 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tt -149.16 82.61 1.43 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.957 -1.127 . . . . 0.35 107.957 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -67.42 133.14 49.01 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.378 0.671 . . . . 0.35 110.166 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.8 t -128.67 86.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 125.076 1.35 . . . . 0.35 108.423 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -146.93 177.97 8.72 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.989 1.315 . . . . 0.36 109.254 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.3 m -137.71 144.05 32.21 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 C-N-CA 124.348 1.059 . . . . 0.35 110.34 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.7 m -75.99 97.35 3.99 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.305 -0.998 . . . . 0.35 108.305 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.92 84.01 1.57 Allowed Glycine 0 C--N 1.338 0.686 0 C-N-CA 123.988 0.804 . . . . 0.35 111.535 -172.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.8 m -77.14 165.5 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.25 0.62 . . . . 0.35 110.315 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.4 -66.53 0.89 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.884 0.474 . . . . 0.35 109.862 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.6 m -158.42 -56.0 0.07 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.61 1.564 . . . . 0.35 108.249 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.25 45.42 1.02 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.763 1.225 . . . . 0.35 110.17 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.59 29.03 73.45 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.161 0.886 . . . . 0.35 113.419 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -96.75 97.71 9.56 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 117.933 0.866 . . . . 0.36 108.887 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.08 116.26 4.39 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.506 1.123 . . . . 0.35 111.541 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.7 mp -73.16 -45.82 54.34 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.327 0.651 . . . . 0.35 109.386 168.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 pp -138.58 138.82 38.29 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.308 1.043 . . . . 0.35 111.978 -171.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.7 t -82.32 138.08 45.27 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 124.658 1.183 . . . . 0.33 109.107 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -86.31 61.36 4.73 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.648 2.899 . . . . 0.35 111.825 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -149.11 65.31 1.03 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.609 0.764 . . . . 0.35 109.845 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -128.61 -52.74 1.25 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.159 0.984 . . . . 0.35 111.261 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.1 t -101.47 140.49 20.02 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 123.214 0.606 . . . . 0.35 109.893 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.7 170.06 19.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.643 0.777 . . . . 0.35 110.109 164.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -140.13 147.94 52.49 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.133 0.973 . . . . 0.33 109.373 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.38 126.89 14.86 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.346 2.031 . . . . 0.35 107.911 168.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.3 tt -57.83 137.57 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.36 0.664 . . . . 0.35 112.585 -168.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 86.62 8.99 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.961 1.705 . . . . 0.33 107.765 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.16 168.47 23.94 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.193 2.595 . . . . 0.35 111.371 -170.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.51 -28.64 14.14 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.025 0.821 . . . . 0.35 111.802 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.0 t -65.58 148.03 52.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.722 0.809 . . . . 0.35 110.879 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -74.61 124.27 26.36 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.419 0.688 . . . . 0.35 109.702 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.96 102.28 7.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.34 1.456 . . . . 0.35 107.435 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.2 t -139.8 -175.99 4.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.596 1.158 . . . . 0.35 108.882 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -55.71 -60.16 3.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.668 0.787 . . . . 0.35 110.672 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.6 -33.19 74.5 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.376 0.88 . . . . 0.35 113.376 -173.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -61.23 2.5 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.246 0.93 . . . . 0.35 110.055 175.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.13 -31.78 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.35 1.06 . . . . 0.35 111.342 -170.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.74 -62.46 1.64 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.653 1.181 . . . . 0.35 111.572 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.04 -34.97 78.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.166 0.439 . . . . 0.35 111.539 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -63.6 -46.8 84.11 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.621 0.768 . . . . 0.35 111.663 -175.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.8 p -73.66 -31.93 33.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 122.809 0.443 . . . . 0.35 111.724 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -58.95 -31.89 69.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.279 0.632 . . . . 0.35 111.512 173.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -76.54 -38.33 55.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.922 0.489 . . . . 0.35 110.771 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.31 -62.27 1.96 Allowed 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.335 1.054 . . . . 0.35 111.942 -174.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.13 -23.88 67.48 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.048 0.758 . . . . 0.35 113.048 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -80.43 66.66 6.01 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.813 1.245 . . . . 0.35 110.972 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.07 49.86 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.798 1.639 . . . . 0.35 108.672 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.2 p -140.08 -62.41 0.51 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.047 1.339 . . . . 0.35 108.873 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.29 -64.93 1.01 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.118 1.367 . . . . 0.35 108.686 172.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.62 68.99 0.78 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.873 1.669 . . . . 0.35 110.802 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -132.8 47.7 2.48 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.993 1.317 . . . . 0.35 108.53 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 63.6 111.51 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.065 2.146 . . . . 0.35 112.36 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -111.57 99.52 8.25 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.271 1.428 . . . . 0.35 108.107 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -81.28 98.49 8.15 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.369 -0.604 . . . . 0.35 109.369 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.5 96.83 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.907 -0.775 . . . . 0.35 108.907 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.53 -46.02 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.652 0.781 . . . . 0.35 111.035 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -137.96 164.41 29.11 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.71 1.204 . . . . 0.35 110.225 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 pp -157.66 158.29 35.17 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.861 1.264 . . . . 0.35 110.316 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.23 121.22 68.86 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 108.533 -0.914 . . . . 0.33 108.533 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.77 -39.46 3.4 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.019 2.479 . . . . 0.35 110.938 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -79.49 83.48 5.49 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.006 0.923 . . . . 0.35 109.291 176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.07 129.75 41.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.628 0.771 . . . . 0.35 109.778 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -100.23 136.38 40.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.575 1.15 . . . . 0.35 110.82 -172.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.43 120.27 58.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 125.633 1.573 . . . . 0.35 108.492 -173.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -117.9 90.56 3.36 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.819 1.248 . . . . 0.35 108.647 -172.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 m -77.06 94.08 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.261 1.024 . . . . 0.35 110.544 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 88.1 m -91.88 90.62 7.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.634 1.574 . . . . 0.35 108.532 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.75 93.9 7.78 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.823 0.849 . . . . 0.35 110.534 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -86.09 62.55 7.51 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.71 1.604 . . . . 0.35 109.615 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -98.99 78.63 2.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.996 1.319 . . . . 0.35 107.469 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.12 80.28 4.55 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.656 1.182 . . . . 0.35 109.376 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -150.75 -41.43 0.12 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.784 2.034 . . . . 0.36 108.442 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.65 -39.75 0.18 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.817 1.647 . . . . 0.35 110.894 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -85.77 -54.75 4.34 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.0 0.92 . . . . 0.35 111.439 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 83.3 tttt 69.52 158.51 0.17 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.877 1.671 . . . . 0.35 110.856 -172.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.73 123.62 14.74 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.105 0.562 . . . . 0.35 111.446 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -145.0 105.64 4.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.91 1.284 . . . . 0.35 107.841 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.7 m -82.62 86.85 6.75 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.949 1.299 . . . . 0.35 108.968 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.3 101.61 14.28 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.014 0.926 . . . . 0.35 108.85 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.8 p -80.35 144.21 32.92 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.415 1.086 . . . . 0.35 111.266 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -158.95 137.0 7.46 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 123.282 0.633 . . . . 0.33 110.719 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.6 161.73 27.77 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.858 3.039 . . . . 0.35 110.525 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.0 tp -95.42 151.66 3.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 123.788 0.835 . . . . 0.35 110.339 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 67.6 p -86.67 112.18 21.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.835 -1.172 . . . . 0.35 107.835 169.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.15 -21.76 66.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.478 1.111 . . . . 0.35 113.596 -173.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.05 -44.05 97.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.899 0.88 . . . . 0.35 111.713 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.32 135.15 1.77 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.519 -1.033 . . . . 0.35 110.519 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -159.27 166.86 30.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.372 1.069 . . . . 0.35 109.555 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.67 144.6 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.283 1.433 . . . . 0.35 109.229 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.19 116.33 15.58 Favored Pre-proline 0 C--N 1.345 0.405 0 N-CA-C 108.156 -1.053 . . . . 0.33 108.156 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.42 -101.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.921 2.414 . . . . 0.35 110.902 -167.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -166.17 169.04 14.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.098 0.959 . . . . 0.35 109.376 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.53 17.54 0.86 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.767 1.227 . . . . 0.35 112.635 172.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.8 t 63.04 -95.13 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.647 1.579 . . . . 0.35 111.024 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -167.36 -48.76 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.167 0.987 . . . . 0.35 109.855 -174.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -70.76 -0.34 8.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.495 1.518 . . . . 0.35 114.943 -168.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.7 pt -133.24 -172.98 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.411 1.084 . . . . 0.35 110.188 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -130.6 -45.32 1.08 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.414 1.486 . . . . 0.35 110.62 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -119.92 74.49 19.71 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 0.36 112.772 -162.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -69.27 141.27 46.74 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.17 1.913 . . . . 0.35 109.935 171.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.24 79.7 0.28 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.405 -1.478 . . . . 0.35 109.405 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -66.67 92.92 0.23 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.713 1.205 . . . . 0.35 110.713 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -85.37 98.68 10.69 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.877 -1.157 . . . . 0.36 107.877 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.93 53.82 2.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.171 0.988 . . . . 0.35 109.196 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.0 mt -99.03 99.29 8.31 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 124.462 1.105 . . . . 0.35 108.681 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 96.3 m -105.63 140.53 38.56 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.102 1.361 . . . . 0.35 109.231 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 126.46 31.63 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.525 0.73 . . . . 0.35 109.326 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.34 148.33 32.77 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 C-N-CA 123.888 0.875 . . . . 0.35 110.299 172.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 t -96.51 130.83 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.689 1.196 . . . . 0.35 108.364 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mt -126.97 105.95 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.829 1.251 . . . . 0.35 109.222 -173.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -71.58 132.07 44.13 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.79 -1.189 . . . . 0.35 107.79 159.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 94.83 4.4 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.403 0.681 . . . . 0.35 109.497 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.344 0.337 0 C-N-CA 124.969 1.307 . . . . 0.25 109.438 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 t80 . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 110.102 -0.333 . . . . 0.35 110.102 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -164.96 99.07 0.76 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.752 0.821 . . . . 0.35 110.077 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -157.89 37.68 0.26 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.257 1.023 . . . . 0.35 109.946 168.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.43 159.93 9.74 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.017 0.818 . . . . 0.35 111.18 -174.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -74.76 96.95 3.15 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.985 0.514 . . . . 0.35 110.189 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -85.88 79.12 9.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.305 1.042 . . . . 0.35 110.609 -174.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -137.84 -158.12 0.83 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.913 0.885 . . . . 0.35 109.187 170.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.9 tttt 62.61 46.86 5.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.197 0.999 . . . . 0.35 109.542 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.11 -42.88 1.85 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.046 1.308 . . . . 0.35 111.653 -172.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -85.47 56.52 3.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.588 1.155 . . . . 0.35 110.558 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 54.85 28.71 10.78 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.682 1.993 . . . . 0.35 113.693 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.17 140.63 29.3 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.384 0.674 . . . . 0.35 110.889 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -166.32 -130.13 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.154 0.982 . . . . 0.35 109.511 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -138.82 164.83 28.61 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.306 1.842 . . . . 0.35 108.951 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.7 t80 66.72 103.62 0.04 OUTLIER 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.763 1.625 . . . . 0.35 110.673 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 75.66 144.65 0.1 Allowed Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 126.109 1.764 . . . . 0.33 110.079 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.62 96.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.443 2.762 . . . . 0.35 111.847 171.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.1 p -94.33 -44.3 8.0 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.008 0.923 . . . . 0.35 110.291 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.21 150.38 8.64 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 112.032 -0.427 . . . . 0.33 112.032 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -92.21 -170.12 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.939 3.093 . . . . 0.35 111.098 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -168.75 165.32 11.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.006 0.922 . . . . 0.35 111.73 172.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.0 tp -134.42 88.54 2.46 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.94 1.696 . . . . 0.35 107.731 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -78.41 125.57 29.55 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.883 1.273 . . . . 0.35 108.312 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -135.65 91.09 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.882 0.873 . . . . 0.35 109.382 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -149.28 157.68 43.55 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.465 1.506 . . . . 0.36 109.169 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.13 161.09 42.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 123.806 0.843 . . . . 0.35 112.146 -168.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.3 m -87.91 91.15 8.66 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.841 1.257 . . . . 0.35 108.438 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.06 104.24 2.66 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.653 -0.979 . . . . 0.35 110.653 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.35 174.0 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.224 1.01 . . . . 0.35 111.033 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -71.62 -55.82 7.03 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.065 0.546 . . . . 0.35 109.675 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.2 p -150.1 -71.04 0.18 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.067 0.947 . . . . 0.35 110.559 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -85.45 -73.33 0.45 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.862 0.865 . . . . 0.35 110.541 -171.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.49 50.77 0.41 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.341 -1.104 . . . . 0.35 110.341 -176.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -115.82 79.99 1.38 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.338 1.455 . . . . 0.36 108.714 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.46 138.76 58.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.036 1.334 . . . . 0.35 112.256 -173.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mp -113.96 -24.84 8.85 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.311 1.445 . . . . 0.35 110.666 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.51 146.0 32.16 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.355 1.062 . . . . 0.35 111.738 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.8 m -81.33 153.6 71.51 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.367 1.067 . . . . 0.33 110.331 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.99 50.44 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.78 2.987 . . . . 0.35 111.521 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -173.21 103.96 0.13 Allowed 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.09 0.556 . . . . 0.35 111.038 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -164.88 14.02 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.5 0.926 . . . . 0.35 113.5 172.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.6 t -149.16 135.22 12.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 C-N-CA 125.241 1.416 . . . . 0.35 107.441 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -139.46 171.05 14.82 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.128 0.571 . . . . 0.35 111.295 169.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -140.81 151.7 63.61 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.765 1.226 . . . . 0.33 109.967 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.04 100.61 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.487 2.791 . . . . 0.35 109.397 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.77 138.17 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.262 1.025 . . . . 0.35 111.508 -171.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -138.53 137.11 19.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.717 1.207 . . . . 0.33 108.733 171.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.24 169.36 22.67 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.647 2.898 . . . . 0.35 110.864 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 110.63 -31.21 7.51 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.108 0.861 . . . . 0.35 111.841 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 t -66.13 146.27 54.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.559 0.744 . . . . 0.35 111.146 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.7 m -74.21 152.91 39.67 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.455 1.102 . . . . 0.35 109.282 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.04 121.13 8.28 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.4 0.68 . . . . 0.35 109.482 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 t -166.09 174.53 9.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.689 1.996 . . . . 0.35 107.846 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.62 -52.18 64.67 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.692 0.797 . . . . 0.35 111.23 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.75 -24.72 67.88 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.184 0.809 . . . . 0.35 113.184 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -71.85 -51.66 21.3 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.371 0.668 . . . . 0.35 110.582 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.2 -33.25 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.51 1.124 . . . . 0.35 111.886 -172.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -55.29 -55.23 33.82 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.463 1.105 . . . . 0.35 111.714 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -66.99 -30.29 70.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.073 0.397 . . . . 0.35 111.867 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -52.88 61.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.483 0.713 . . . . 0.35 110.209 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -61.13 -38.95 80.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 CA-C-O 119.038 -0.506 . . . . 0.35 111.343 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.92 -36.16 76.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.586 0.755 . . . . 0.35 111.875 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -70.2 -48.04 58.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.93 0.492 . . . . 0.35 110.844 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.95 97.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.427 0.691 . . . . 0.35 111.52 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 mt -54.51 -58.78 6.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.22 1.408 . . . . 0.35 110.304 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -61.38 -59.62 4.99 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.01 0.924 . . . . 0.35 111.652 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -41.23 -48.8 3.58 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 126.131 1.772 . . . . 0.35 113.429 -171.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.5 m -74.13 -63.61 1.19 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.348 0.659 . . . . 0.35 109.924 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.56 96.08 5.69 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.01 1.324 . . . . 0.35 109.915 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -112.18 70.67 0.72 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.196 1.399 . . . . 0.35 109.571 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -137.95 -113.17 0.17 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.745 0.818 . . . . 0.35 109.906 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.42 83.22 6.86 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.414 1.086 . . . . 0.35 110.81 -173.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -152.43 162.87 40.58 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.317 0.647 . . . . 0.35 111.469 176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -173.98 125.05 0.35 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.549 1.94 . . . . 0.35 106.789 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.96 91.74 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.297 -1.001 . . . . 0.35 108.297 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 p -61.2 -43.92 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.885 0.874 . . . . 0.35 110.985 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -151.1 169.16 22.52 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.943 0.897 . . . . 0.35 110.12 169.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 pp -144.64 149.56 35.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.285 1.034 . . . . 0.35 109.992 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.86 135.73 55.35 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.578 -0.897 . . . . 0.33 108.578 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.46 -24.44 22.46 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.162 2.575 . . . . 0.35 111.923 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 m -86.21 70.03 10.51 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.57 1.148 . . . . 0.35 110.855 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.39 164.35 26.49 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.767 0.827 . . . . 0.35 109.965 168.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -150.02 121.72 8.07 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.134 0.493 . . . . 0.35 112.313 -174.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 mp -77.74 114.69 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.663 -1.606 . . . . 0.35 106.663 165.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -110.23 63.42 0.61 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.34 -0.985 . . . . 0.35 108.34 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.09 111.11 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.405 0.682 . . . . 0.35 110.945 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.5 m -98.45 81.85 2.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.49 1.516 . . . . 0.35 108.263 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -87.27 112.56 22.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.245 1.018 . . . . 0.35 108.577 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -104.67 117.49 34.23 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.547 1.139 . . . . 0.35 110.578 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.411 ' HB2' HD12 ' A' ' 120' ' ' ILE . 27.1 t70 -128.37 89.34 2.89 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.597 1.159 . . . . 0.35 110.236 -172.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -82.82 67.83 9.06 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.04 -0.726 . . . . 0.35 109.04 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -149.0 -54.17 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.225 1.41 . . . . 0.36 109.134 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.74 -48.11 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.634 0.773 . . . . 0.35 112.823 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -71.94 -34.32 68.94 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.884 0.874 . . . . 0.35 112.17 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt 72.68 174.9 0.29 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.118 1.367 . . . . 0.35 110.945 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -79.16 132.23 36.48 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.209 0.604 . . . . 0.35 110.876 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -139.87 113.4 8.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.585 1.154 . . . . 0.35 108.562 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.6 m -80.2 84.88 5.81 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.658 -1.238 . . . . 0.35 107.658 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -78.82 105.66 10.29 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.898 0.879 . . . . 0.35 109.35 -173.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.5 m -87.95 67.79 9.08 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.585 1.154 . . . . 0.35 111.163 -172.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -69.56 140.87 89.97 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.216 1.006 . . . . 0.33 108.74 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -78.78 -116.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.265 2.644 . . . . 0.35 110.335 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.1 tp -160.52 150.83 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.17 0.988 . . . . 0.35 108.862 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.0 p -103.4 175.7 5.39 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.036 0.934 . . . . 0.35 110.611 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.83 -10.79 15.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.592 1.557 . . . . 0.35 110.573 164.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -77.31 -82.97 0.08 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 124.813 1.245 . . . . 0.35 110.713 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 145.4 63.85 0.02 OUTLIER Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.155 -1.178 . . . . 0.35 110.155 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -72.27 129.71 39.07 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 117.508 0.654 . . . . 0.35 109.728 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.71 130.99 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.395 -0.965 . . . . 0.35 108.395 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.6 117.24 29.51 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 107.918 -1.141 . . . . 0.33 107.918 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.27 172.02 16.05 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.199 2.6 . . . . 0.35 110.898 -173.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.11 34.53 0.62 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.146 0.978 . . . . 0.35 110.932 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 32.66 54.0 0.36 Allowed 'General case' 0 C--N 1.346 0.43 0 C-N-CA 128.041 2.536 . . . . 0.35 113.878 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.1 t 56.47 -105.84 0.29 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.893 1.677 . . . . 0.35 111.467 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -163.22 -38.17 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.233 1.013 . . . . 0.35 110.654 -172.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -55.22 -13.6 1.37 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.26 1.824 . . . . 0.35 115.169 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 93' ' ' ASP . 1.0 OUTLIER -153.14 148.23 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.574 1.15 . . . . 0.35 108.978 171.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.49 34.77 3.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.37 1.868 . . . . 0.35 111.337 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -153.37 79.48 5.48 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.318 0.647 . . . . 0.36 111.378 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.59 167.67 25.1 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.022 2.482 . . . . 0.35 111.527 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.0 68.2 0.47 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.194 -1.163 . . . . 0.35 110.194 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -59.73 103.05 0.18 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.165 1.386 . . . . 0.35 111.26 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -100.39 98.41 9.05 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.072 0.949 . . . . 0.36 109.449 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.96 73.83 10.24 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.116 0.966 . . . . 0.35 108.535 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.6 mt -91.05 91.29 3.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.093 -1.447 . . . . 0.35 107.093 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.1 m -111.58 150.48 29.98 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.688 1.195 . . . . 0.35 109.468 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -91.75 130.3 37.56 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.151 1.38 . . . . 0.35 109.053 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 m -137.5 169.46 19.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 123.753 0.821 . . . . 0.35 110.351 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 37.9 t -119.73 139.75 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.035 1.334 . . . . 0.35 108.111 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.7 mt -130.54 119.35 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.232 1.013 . . . . 0.35 109.503 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -78.71 127.2 31.76 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.923 -1.14 . . . . 0.35 107.923 161.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -95.24 60.32 2.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.241 1.017 . . . . 0.35 111.252 -168.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.186 0 C-N-CA 124.004 0.921 . . . . 0.25 110.021 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.7 p90 . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 110.817 -0.068 . . . . 0.35 110.817 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -95.02 162.29 13.79 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.125 0.97 . . . . 0.35 110.33 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 pttm 50.51 83.36 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.557 1.943 . . . . 0.35 112.57 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.22 103.32 0.33 Allowed Glycine 0 C--N 1.341 0.845 0 C-N-CA 126.387 1.946 . . . . 0.35 112.621 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt 75.1 -33.68 0.24 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 126.688 1.995 . . . . 0.35 113.743 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -55.1 123.13 12.65 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.138 0.975 . . . . 0.35 110.173 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -101.43 27.85 5.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.491 -0.766 . . . . 0.35 112.996 -159.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? 69.53 -63.95 0.36 Allowed 'General case' 0 C--N 1.346 0.435 0 C-N-CA 126.21 1.804 . . . . 0.35 109.907 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.59 -151.49 6.7 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.605 -1.798 . . . . 0.35 108.605 172.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 57.62 37.73 27.54 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.371 1.068 . . . . 0.35 111.753 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.91 64.63 0.96 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.507 1.123 . . . . 0.35 109.335 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.51 -41.53 60.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.009 0.924 . . . . 0.35 110.345 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.6 t 74.26 -74.67 0.08 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.779 2.032 . . . . 0.35 112.064 175.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -155.22 171.56 19.62 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.332 0.653 . . . . 0.35 111.257 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 70.11 121.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.709 2.004 . . . . 0.35 112.633 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 73.93 137.81 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 126.17 1.788 . . . . 0.33 112.223 168.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.79 109.62 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.19 3.26 . . . . 0.35 111.922 160.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 p -138.06 -62.54 0.58 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.847 1.259 . . . . 0.35 109.588 -174.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.0 113.08 0.31 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.46 -1.056 . . . . 0.33 110.46 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.24 176.58 9.87 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.003 2.469 . . . . 0.35 111.803 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -159.06 163.09 36.61 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.207 1.003 . . . . 0.35 110.344 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.8 tt -145.11 94.61 2.55 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.458 -1.312 . . . . 0.35 107.458 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.3 ptp -88.74 139.06 30.85 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.884 0.874 . . . . 0.35 110.357 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.6 91.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.205 0 C-N-CA 124.636 1.174 . . . . 0.35 107.874 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -153.59 166.1 33.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.699 1.2 . . . . 0.36 110.139 -171.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -144.94 170.59 6.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 123.147 0.579 . . . . 0.35 112.352 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -107.0 121.46 44.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.155 1.382 . . . . 0.35 108.264 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.55 92.41 1.72 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.15 0.881 . . . . 0.35 111.624 -174.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.0 m -99.08 168.63 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 124.316 1.046 . . . . 0.35 112.852 -174.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -83.09 172.72 12.41 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.626 1.17 . . . . 0.35 109.563 166.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -57.18 -40.94 78.33 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.722 0.809 . . . . 0.35 110.39 170.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -62.02 -55.29 30.67 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.061 0.945 . . . . 0.35 110.186 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.1 4.29 0.59 Allowed Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.938 -0.923 . . . . 0.35 114.017 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -79.32 123.18 27.22 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.774 1.287 . . . . 0.36 110.217 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -65.21 104.11 0.87 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.912 0.885 . . . . 0.35 110.976 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 mp -69.65 -56.77 6.34 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.751 -1.203 . . . . 0.35 107.751 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.5 mt -120.65 164.91 15.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.188 1.795 . . . . 0.35 108.789 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.8 m -142.74 68.26 19.17 Favored Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 124.522 1.129 . . . . 0.33 108.015 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.08 106.29 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.578 2.852 . . . . 0.35 110.073 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -146.34 90.58 1.96 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.926 1.69 . . . . 0.35 108.187 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -155.55 -33.36 0.09 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.056 0.762 . . . . 0.35 113.056 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.6 t -76.22 98.7 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.975 0.91 . . . . 0.35 111.216 -176.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -86.97 170.09 11.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.317 0.647 . . . . 0.35 110.141 167.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -155.41 131.1 5.47 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.269 -1.011 . . . . 0.33 108.269 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.48 121.84 8.8 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.815 2.343 . . . . 0.35 109.059 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.0 tt -57.53 133.85 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.32 1.048 . . . . 0.35 112.856 -168.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -142.77 98.39 5.77 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 125.565 1.546 . . . . 0.33 107.495 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.77 173.66 13.76 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.247 2.631 . . . . 0.35 111.288 -174.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.42 -26.48 24.17 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.013 0.816 . . . . 0.35 112.159 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.1 t -66.32 151.51 46.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.889 0.844 . . . . 0.35 110.796 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -62.46 148.62 45.07 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.959 0.903 . . . . 0.35 110.118 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.51 101.23 2.64 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.368 -0.975 . . . . 0.35 108.368 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 t -144.89 -171.07 3.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.165 1.386 . . . . 0.35 108.752 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -58.19 -57.41 12.99 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.35 110.674 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -61.96 -29.03 69.96 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.518 0.562 . . . . 0.35 112.518 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -62.39 -54.01 46.54 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.547 -0.538 . . . . 0.35 109.547 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 mm -51.14 -55.38 7.76 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 124.526 1.13 . . . . 0.35 109.786 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -45.98 -63.75 0.91 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.675 1.19 . . . . 0.35 112.406 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -63.62 -38.46 91.19 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.465 0.575 . . . . 0.35 111.894 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.1 -49.15 62.97 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.491 0.716 . . . . 0.35 110.644 -173.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.61 -37.22 79.46 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 118.454 0.57 . . . . 0.35 111.551 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -58.83 -44.37 90.88 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.357 0.663 . . . . 0.35 110.589 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -67.57 -34.8 77.79 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.568 0.347 . . . . 0.35 110.85 176.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.04 -64.78 0.83 Allowed 'General case' 0 C--N 1.343 0.287 0 CA-C-O 118.605 -0.712 . . . . 0.35 111.502 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -66.43 -35.32 79.99 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.647 0.658 . . . . 0.35 112.368 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -90.14 49.39 1.69 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.489 0.715 . . . . 0.35 110.578 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.0 -51.99 2.88 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.328 1.451 . . . . 0.35 107.362 164.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.5 p -79.56 -45.76 18.6 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.566 1.146 . . . . 0.35 110.291 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.18 -93.22 0.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.633 0.773 . . . . 0.35 110.695 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 62.28 -151.14 0.36 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.978 1.311 . . . . 0.35 110.674 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? 66.38 -80.45 0.03 OUTLIER 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.678 1.991 . . . . 0.35 111.549 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -84.28 -115.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.05 -1.093 . . . . 0.35 108.05 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 59.3 82.39 0.15 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.248 1.419 . . . . 0.35 111.455 171.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.5 ttm105 -66.14 -55.23 17.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.698 0.799 . . . . 0.35 109.98 172.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 t 60.89 78.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 125.189 1.396 . . . . 0.35 109.11 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.38 -43.71 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.083 0.953 . . . . 0.35 112.232 -171.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -138.44 170.53 15.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.247 1.019 . . . . 0.35 110.552 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 pp -153.5 159.84 42.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.359 1.464 . . . . 0.35 109.159 171.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.05 120.57 82.19 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 109.222 -0.658 . . . . 0.33 109.222 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -70.72 -33.0 13.62 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.186 2.591 . . . . 0.35 110.97 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -82.7 70.49 9.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.52 1.128 . . . . 0.35 109.384 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.0 160.66 30.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.642 0.777 . . . . 0.35 109.951 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.7 145.47 34.93 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.899 0.48 . . . . 0.35 111.818 -171.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mp -122.84 99.4 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 126.728 2.011 . . . . 0.35 106.294 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -88.93 72.53 8.46 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.175 0.99 . . . . 0.35 109.34 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.83 115.14 5.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.401 0.68 . . . . 0.35 110.3 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.1 m -103.01 91.6 4.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.862 1.265 . . . . 0.35 108.303 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -81.19 94.35 6.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.306 0.642 . . . . 0.35 109.89 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -105.68 129.7 53.85 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.056 1.342 . . . . 0.35 110.505 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -161.37 94.4 0.98 Allowed 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 106.429 -1.693 . . . . 0.35 106.429 172.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -56.12 -28.23 57.06 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.409 0.892 . . . . 0.35 113.409 -169.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -56.34 -41.79 76.64 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.93 1.292 . . . . 0.36 112.133 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -144.18 -56.12 0.36 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 112.852 0.686 . . . . 0.35 112.852 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.61 -61.2 1.92 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.65 0.659 . . . . 0.35 111.069 -171.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 80.41 149.26 0.1 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.503 1.921 . . . . 0.35 110.905 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -49.38 126.43 13.12 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.983 1.713 . . . . 0.35 112.153 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -155.24 101.42 2.22 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.148 0.979 . . . . 0.35 109.04 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.7 m -77.23 97.86 4.95 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.939 1.296 . . . . 0.35 109.708 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -91.66 108.38 19.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.569 1.148 . . . . 0.35 108.39 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.0 p -82.68 77.95 9.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.51 1.124 . . . . 0.35 111.44 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -72.33 131.9 84.53 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 108.567 -0.901 . . . . 0.33 108.567 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.89 -125.03 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.653 2.902 . . . . 0.35 109.03 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.51 154.12 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 119.268 0.94 . . . . 0.35 110.013 173.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.7 p -108.01 123.21 48.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.366 1.067 . . . . 0.35 108.558 169.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -61.23 -36.56 80.27 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.531 1.132 . . . . 0.35 110.658 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -56.01 -56.55 19.45 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.426 1.091 . . . . 0.35 111.238 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.51 139.42 2.71 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 112.26 -0.336 . . . . 0.35 112.26 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -155.39 165.9 35.19 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.571 1.548 . . . . 0.35 108.783 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -137.19 146.1 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.264 1.426 . . . . 0.35 108.71 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.33 116.95 29.24 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.348 -0.982 . . . . 0.33 108.348 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.83 175.52 10.43 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.094 2.53 . . . . 0.35 111.504 -171.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.8 -166.01 0.26 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.616 1.166 . . . . 0.35 110.356 171.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.26 28.65 1.67 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.581 0.752 . . . . 0.35 112.536 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.6 t 53.1 -113.4 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.984 1.314 . . . . 0.35 111.796 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -158.09 -33.44 0.07 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.428 1.091 . . . . 0.35 111.595 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -60.45 -39.24 86.84 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.057 0.943 . . . . 0.35 111.227 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.6 tp -102.13 137.09 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.247 1.419 . . . . 0.35 108.13 171.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -137.28 13.47 3.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.494 1.117 . . . . 0.35 111.211 175.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.66 63.86 2.27 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.056 0.942 . . . . 0.36 109.995 -173.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.89 -176.22 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.65 2.9 . . . . 0.35 111.914 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.76 78.18 0.25 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 109.608 -1.397 . . . . 0.35 109.608 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -66.43 118.09 9.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.981 0.912 . . . . 0.35 109.441 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -121.06 90.99 3.43 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.812 1.245 . . . . 0.36 108.803 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.73 69.84 10.35 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.743 0.817 . . . . 0.35 109.178 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.3 mt -97.25 89.84 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.553 1.141 . . . . 0.35 108.678 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 57.7 m -92.07 169.13 10.88 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.306 1.442 . . . . 0.35 108.621 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -116.92 132.86 56.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.592 1.157 . . . . 0.35 108.934 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.9 m -124.66 138.58 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.509 1.124 . . . . 0.35 109.956 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -92.45 96.3 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.283 -1.006 . . . . 0.35 108.283 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.7 mt -80.86 110.21 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 123.311 0.644 . . . . 0.35 110.03 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -98.09 155.88 16.92 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.703 -1.221 . . . . 0.35 107.703 153.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -107.97 132.67 53.26 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.314 1.046 . . . . 0.35 109.134 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 N--CA 1.453 -0.311 0 C-N-CA 124.541 1.136 . . . . 0.25 110.291 -174.03 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 p90 . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 112.548 0.573 . . . . 0.35 112.548 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -40.09 88.72 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.13 2.172 . . . . 0.35 114.438 -163.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt 156.72 143.5 0.0 OUTLIER 'General case' 0 C--N 1.344 0.328 0 C-N-CA 130.097 3.359 . . . . 0.35 108.539 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.48 87.27 1.5 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.06 -1.216 . . . . 0.35 110.06 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 59.59 -96.59 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.751 1.621 . . . . 0.35 110.423 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.8 t80 52.75 76.44 0.19 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.086 1.354 . . . . 0.35 109.897 -172.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -81.64 65.09 6.63 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.753 1.221 . . . . 0.35 110.67 -171.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? 71.66 -71.5 0.13 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.68 2.392 . . . . 0.35 112.798 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.86 -19.86 0.29 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.725 1.155 . . . . 0.35 111.515 -167.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.68 138.61 17.86 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.667 1.587 . . . . 0.35 111.357 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -87.44 81.4 7.83 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.189 0.996 . . . . 0.35 109.806 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.83 158.43 18.74 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.506 1.123 . . . . 0.35 109.545 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -159.96 170.61 20.99 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.092 0.557 . . . . 0.35 111.184 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -122.36 43.43 2.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.11 1.364 . . . . 0.35 107.451 164.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -173.52 107.14 0.14 Allowed 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.051 1.34 . . . . 0.35 108.529 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 71.02 153.86 0.15 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 126.544 1.938 . . . . 0.33 111.655 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.62 85.59 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.987 2.458 . . . . 0.35 110.121 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.8 p -77.32 -56.79 4.25 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.021 0.929 . . . . 0.35 110.401 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.43 158.34 23.67 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 111.736 -0.546 . . . . 0.33 111.736 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -80.56 172.12 13.83 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.243 3.295 . . . . 0.35 111.815 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -163.62 175.48 10.59 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.597 1.159 . . . . 0.35 110.111 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 tt -144.55 92.41 2.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.071 -1.455 . . . . 0.35 107.071 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -78.7 129.26 34.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.08 1.352 . . . . 0.35 109.595 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.68 91.19 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.295 0 C-N-CA 124.813 1.245 . . . . 0.35 108.658 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -152.53 161.98 41.84 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.255 1.022 . . . . 0.36 109.9 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.5 m -121.4 155.3 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.784 1.234 . . . . 0.35 111.329 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.8 m -87.96 77.83 8.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.156 -1.424 . . . . 0.35 107.156 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.1 126.84 26.63 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 109.039 -1.625 . . . . 0.35 109.039 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.46 168.75 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 124.534 1.134 . . . . 0.35 110.172 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.08 -177.55 2.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.767 0.827 . . . . 0.35 109.326 164.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 t -83.09 42.71 0.82 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.939 0.496 . . . . 0.35 110.415 172.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.2 -59.07 0.49 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.833 2.053 . . . . 0.35 107.86 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.33 -9.43 0.81 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.21 0.91 . . . . 0.35 113.058 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -71.01 124.23 23.89 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.526 1.163 . . . . 0.36 110.143 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.38 125.19 25.67 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.559 0.743 . . . . 0.35 111.766 -171.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.7 mt -92.81 -45.53 7.96 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.859 1.664 . . . . 0.35 109.487 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.87 151.5 44.35 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.822 0.849 . . . . 0.35 111.753 175.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.5 t -89.48 149.56 42.77 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 126.078 1.751 . . . . 0.33 111.077 -169.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.17 47.16 1.98 Allowed 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.414 2.743 . . . . 0.35 111.848 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -174.52 116.78 0.2 Allowed 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.155 0.982 . . . . 0.35 110.09 173.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -170.93 -11.24 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.19 1.396 . . . . 0.35 113.127 173.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.03 143.47 26.61 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 C-N-CA 124.671 1.188 . . . . 0.35 109.278 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -152.79 142.59 22.04 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.327 1.051 . . . . 0.35 109.946 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.65 145.82 32.42 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 124.236 1.015 . . . . 0.33 110.156 -168.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.9 118.67 5.69 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.739 2.293 . . . . 0.35 108.385 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 tt -60.93 140.86 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.413 0.685 . . . . 0.35 112.654 -164.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -127.58 103.61 22.04 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 106.356 -1.72 . . . . 0.33 106.356 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.22 159.54 29.82 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.993 2.462 . . . . 0.35 111.002 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.99 66.37 1.58 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.291 -1.524 . . . . 0.35 109.291 -175.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.8 t -152.28 145.87 24.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.492 1.117 . . . . 0.35 109.705 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 87.9 m -70.2 115.46 9.42 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.346 1.058 . . . . 0.35 110.499 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -119.52 102.77 8.88 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.885 1.674 . . . . 0.35 108.217 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t -148.72 167.79 24.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.153 0.981 . . . . 0.35 109.092 173.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -56.13 -49.27 74.39 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.072 0.949 . . . . 0.35 111.102 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -73.04 -9.78 59.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.139 0.792 . . . . 0.35 113.139 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.15 37.46 3.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.259 1.424 . . . . 0.35 109.667 172.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mm -141.44 -40.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.243 0 C-N-CA 125.698 1.599 . . . . 0.35 109.472 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -52.19 -37.51 55.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.644 1.178 . . . . 0.35 113.128 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.06 -32.89 26.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.588 1.155 . . . . 0.35 111.835 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -71.09 -41.12 71.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.594 1.158 . . . . 0.35 111.84 -170.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.03 -35.59 75.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 C-N-CA 123.481 0.713 . . . . 0.35 111.482 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.89 -35.38 79.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.098 0.559 . . . . 0.35 110.944 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.77 -34.24 69.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.245 0.618 . . . . 0.35 111.496 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.97 -46.77 70.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.661 0.385 . . . . 0.35 111.153 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -73.04 -26.02 61.14 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 118.845 -0.598 . . . . 0.35 112.462 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.4 -41.33 76.11 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 123.84 0.856 . . . . 0.35 110.939 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -48.65 -51.17 29.62 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.042 1.337 . . . . 0.35 112.346 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.6 p -72.48 -49.64 31.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.205 0.602 . . . . 0.35 111.257 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.02 146.47 17.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.594 0.758 . . . . 0.35 110.197 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -149.11 45.66 0.99 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.751 0.82 . . . . 0.35 111.201 -171.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -132.64 -59.57 0.9 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.755 0.822 . . . . 0.35 110.684 -173.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -93.39 70.77 4.35 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.715 0.806 . . . . 0.35 110.948 -164.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.98 161.05 40.54 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.016 0.926 . . . . 0.35 112.999 -175.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.93 77.98 0.45 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.803 -1.925 . . . . 0.35 105.803 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.27 100.47 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.059 0.944 . . . . 0.35 109.803 -167.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.33 -61.72 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.88 1.272 . . . . 0.35 110.583 -175.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -156.25 117.29 3.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.186 0.594 . . . . 0.35 110.192 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -78.21 144.98 35.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.906 0.882 . . . . 0.35 109.782 168.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.52 131.61 67.8 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.181 -0.674 . . . . 0.33 109.181 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.73 -24.02 22.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.474 2.783 . . . . 0.35 111.566 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.9 m -85.21 60.05 6.01 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 124.396 1.078 . . . . 0.35 110.442 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.56 162.44 29.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.189 0.996 . . . . 0.35 109.459 169.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -153.74 147.68 25.51 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.46 0.541 . . . . 0.35 112.46 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 mp -90.44 135.47 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.388 -1.708 . . . . 0.35 106.388 165.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.2 66.67 1.53 Allowed 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.303 -0.999 . . . . 0.35 108.303 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.77 125.22 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.061 0.944 . . . . 0.35 110.751 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 m -123.89 109.72 13.94 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.346 1.058 . . . . 0.35 109.429 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.52 110.58 22.91 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 125.128 1.371 . . . . 0.35 108.878 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.44 52.97 2.58 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.612 1.565 . . . . 0.35 110.14 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.65 84.44 5.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.072 0.949 . . . . 0.35 110.186 -172.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -61.19 -11.94 11.05 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.667 1.187 . . . . 0.35 113.376 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -55.62 -50.78 69.25 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.153 0.981 . . . . 0.36 111.145 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.52 -42.14 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.98 0.733 . . . . 0.35 112.98 176.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -65.84 -40.76 92.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.319 0.509 . . . . 0.35 112.101 -172.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? 77.7 160.32 0.21 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.482 1.913 . . . . 0.35 111.181 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -50.7 121.33 5.7 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.821 1.248 . . . . 0.35 110.109 171.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -154.19 107.08 2.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.092 0.957 . . . . 0.35 108.446 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.2 m -78.98 89.82 4.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.969 0.908 . . . . 0.35 108.555 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -77.35 97.27 4.85 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.107 0.963 . . . . 0.35 108.6 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.2 p -88.72 139.91 29.98 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.308 1.043 . . . . 0.35 110.358 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.96 140.28 8.7 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 123.891 0.877 . . . . 0.33 109.63 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.46 140.71 33.69 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.221 2.614 . . . . 0.35 109.788 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tt -72.42 148.92 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.05 0.54 . . . . 0.35 110.099 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.7 p -73.1 160.26 32.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.307 0.643 . . . . 0.35 110.739 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -88.3 -21.68 24.29 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.377 1.071 . . . . 0.35 111.026 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -86.85 -79.61 0.26 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.278 1.031 . . . . 0.35 110.932 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -177.42 74.4 0.07 OUTLIER Glycine 0 CA--C 1.528 0.844 0 CA-C-N 118.215 0.461 . . . . 0.35 112.448 -170.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -77.47 154.51 32.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.866 -0.79 . . . . 0.35 108.866 165.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.0 t -131.88 140.73 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.367 1.067 . . . . 0.35 108.719 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.9 t -67.94 122.02 82.12 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 108.502 -0.925 . . . . 0.33 108.502 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.27 158.16 41.28 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.069 2.513 . . . . 0.35 111.052 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.74 80.35 2.69 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.627 1.171 . . . . 0.35 109.296 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.405 HD11 HG13 ' A' ' 120' ' ' ILE . 2.1 tm? -84.96 99.93 11.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.998 1.319 . . . . 0.35 109.071 -169.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.9 t -167.57 79.14 0.18 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.253 1.021 . . . . 0.35 108.998 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.39 -99.23 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.651 0.78 . . . . 0.35 110.035 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -70.23 -16.65 63.08 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.512 1.051 . . . . 0.35 112.304 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.405 HG13 HD11 ' A' ' 116' ' ' LEU . 9.6 pt -142.21 160.45 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 125.701 1.6 . . . . 0.35 109.22 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 29.56 0.37 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.89 0.7 . . . . 0.35 112.89 -175.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.35 46.51 0.69 Allowed Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.403 0.519 . . . . 0.36 112.403 172.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.39 135.13 41.47 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.094 2.53 . . . . 0.35 111.339 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -116.05 74.14 0.26 Allowed Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.959 -1.256 . . . . 0.35 109.959 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -60.74 95.99 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.625 1.57 . . . . 0.35 111.109 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -91.24 99.16 12.2 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.784 0.834 . . . . 0.36 109.694 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.2 80.35 9.09 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 108.366 -0.976 . . . . 0.35 108.366 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 94.5 mt -94.82 121.11 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.442 -1.318 . . . . 0.35 107.442 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.8 m -141.17 136.77 32.15 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.431 1.092 . . . . 0.35 109.005 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.21 131.78 34.09 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.387 1.075 . . . . 0.35 108.593 -178.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.05 141.06 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.48 0.712 . . . . 0.35 110.422 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 51.0 t -93.81 140.52 16.36 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 124.477 1.111 . . . . 0.35 108.843 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.5 mt -139.64 154.5 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.825 1.65 . . . . 0.35 107.742 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -143.07 23.78 1.85 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.67 0.989 . . . . 0.35 113.67 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.61 134.58 0.05 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.936 1.294 . . . . 0.35 111.474 169.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? . . . . . 0 C--N 1.342 0.251 0 C-N-CA 124.703 1.201 . . . . 0.25 110.637 177.878 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 110.061 -0.348 . . . . 0.35 110.061 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -83.9 68.38 9.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.415 1.086 . . . . 0.35 108.894 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -134.73 -24.48 1.51 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.879 1.672 . . . . 0.35 110.736 -172.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.05 26.78 30.34 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.537 1.065 . . . . 0.35 112.166 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 49.92 51.37 16.71 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.699 1.6 . . . . 0.35 111.566 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -103.85 94.33 5.37 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.966 0.906 . . . . 0.35 110.603 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.32 36.94 0.71 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.526 1.13 . . . . 0.35 111.075 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? 54.04 -95.3 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.206 1.802 . . . . 0.35 110.903 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.14 56.42 0.26 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.549 -1.82 . . . . 0.35 108.549 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -130.17 67.11 1.48 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.981 1.312 . . . . 0.35 108.888 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -167.71 113.95 0.72 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.174 0.989 . . . . 0.35 109.645 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.75 -65.96 0.97 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.029 0.932 . . . . 0.35 110.339 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.3 t 69.63 -73.4 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.923 2.089 . . . . 0.35 111.654 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -140.03 75.67 1.52 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.766 -1.198 . . . . 0.35 107.766 162.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -145.73 33.03 1.04 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.041 0.937 . . . . 0.35 110.054 173.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 66.62 168.71 0.11 Allowed Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.534 1.934 . . . . 0.33 112.101 171.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -69.12 99.95 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.121 2.548 . . . . 0.35 111.361 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.3 p -110.34 -40.93 4.51 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.589 1.556 . . . . 0.35 109.602 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.87 155.03 9.73 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.538 -1.025 . . . . 0.33 110.538 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.13 161.16 29.57 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.072 3.181 . . . . 0.35 111.024 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -156.58 164.62 37.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.611 0.764 . . . . 0.35 111.135 -170.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.5 tt -149.13 132.03 16.13 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.146 1.378 . . . . 0.35 108.012 -177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.2 mtp -125.31 133.11 52.74 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.889 1.275 . . . . 0.35 109.453 -171.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.54 95.29 2.89 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 C-N-CA 124.075 0.95 . . . . 0.35 110.409 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -149.31 178.35 8.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.568 0.747 . . . . 0.36 111.278 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.08 146.35 26.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 124.802 1.241 . . . . 0.35 110.948 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.1 m -84.06 86.31 7.22 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.918 -1.141 . . . . 0.35 107.918 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.64 119.7 6.63 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.527 -1.029 . . . . 0.35 110.527 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.81 170.43 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.496 1.118 . . . . 0.35 110.962 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -84.45 177.62 8.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.357 1.063 . . . . 0.35 109.639 166.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -58.67 -38.29 77.87 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.805 0.842 . . . . 0.35 110.649 171.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -57.38 -49.06 77.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.666 1.186 . . . . 0.35 110.719 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.96 5.98 7.91 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.142 1.353 . . . . 0.35 111.869 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.11 123.2 24.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.081 0.941 . . . . 0.36 109.19 -176.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.96 107.15 3.0 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.383 0.673 . . . . 0.35 111.414 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.93 -42.26 70.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.536 1.134 . . . . 0.35 109.781 170.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -152.06 150.06 29.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.998 0.919 . . . . 0.35 111.184 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.7 m -84.52 159.54 58.33 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 124.955 1.302 . . . . 0.33 110.463 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -84.75 53.99 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.52 2.813 . . . . 0.35 111.079 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -158.75 111.56 2.29 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.587 0.755 . . . . 0.35 110.991 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -160.81 -54.88 0.05 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.206 0.603 . . . . 0.35 111.461 152.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.47 147.17 5.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.48 0.582 . . . . 0.35 110.822 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.26 174.61 7.59 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.323 1.849 . . . . 0.35 110.156 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -161.98 131.81 3.35 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.756 0.822 . . . . 0.33 109.286 -176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -73.63 124.03 9.0 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.658 2.239 . . . . 0.35 108.722 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.5 tp -48.19 132.52 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.115 1.366 . . . . 0.35 112.391 -174.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -140.66 104.05 6.39 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 124.927 1.291 . . . . 0.33 108.009 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -81.11 -171.37 1.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.573 2.849 . . . . 0.35 110.467 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.26 -37.49 3.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.342 -0.703 . . . . 0.35 111.342 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.3 t -62.68 146.77 51.41 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.099 0.959 . . . . 0.35 111.007 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.8 m -73.6 149.83 41.82 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.628 0.771 . . . . 0.35 109.271 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.6 108.67 12.85 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.808 1.243 . . . . 0.35 107.794 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.0 t -154.94 162.06 41.21 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.72 1.208 . . . . 0.35 109.677 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -48.51 -54.7 13.33 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.694 1.198 . . . . 0.35 111.276 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -61.7 -32.27 72.46 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.837 0.681 . . . . 0.35 112.837 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -62.9 -56.85 13.62 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.438 0.563 . . . . 0.35 109.906 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.1 mm -53.95 -43.96 59.8 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.761 1.224 . . . . 0.35 111.761 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -51.24 -63.11 1.24 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.642 0.777 . . . . 0.35 111.674 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -67.66 -33.65 75.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.195 0.452 . . . . 0.35 112.053 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -62.55 -50.0 73.08 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.713 0.805 . . . . 0.35 111.637 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.54 -37.29 78.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 118.931 -0.557 . . . . 0.35 111.417 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.31 -45.94 92.34 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.911 0.884 . . . . 0.35 111.295 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -41.33 99.38 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.314 0.646 . . . . 0.35 110.941 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.95 91.85 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.841 0.857 . . . . 0.35 111.597 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.3 -12.3 60.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.103 1.149 . . . . 0.35 114.103 -177.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -73.01 3.09 5.78 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.347 0.976 . . . . 0.35 113.513 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.79 15.12 6.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.153 0.888 . . . . 0.35 111.947 169.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.0 t -161.47 -45.62 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.774 1.23 . . . . 0.35 110.552 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.95 79.78 1.36 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.61 1.564 . . . . 0.35 109.952 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -132.88 -43.41 0.89 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.737 1.615 . . . . 0.35 109.422 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -60.11 -57.32 13.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.468 1.507 . . . . 0.35 110.379 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.32 72.93 0.86 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.666 1.186 . . . . 0.35 108.633 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -157.62 76.97 0.83 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.019 0.528 . . . . 0.35 110.161 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -84.66 -53.15 5.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.929 1.292 . . . . 0.35 109.949 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 t 71.03 114.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.093 1.757 . . . . 0.35 111.226 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.73 -49.3 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.384 0.674 . . . . 0.35 110.556 174.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.68 172.94 12.29 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.693 1.197 . . . . 0.35 110.86 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.62 163.23 38.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.358 1.463 . . . . 0.35 110.34 172.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.08 122.69 87.96 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.364 0.666 . . . . 0.33 109.718 -176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.0 -32.49 11.01 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.956 2.437 . . . . 0.35 110.451 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.3 m -80.88 74.75 7.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.434 1.094 . . . . 0.35 109.339 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.71 162.78 17.87 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.307 1.043 . . . . 0.35 110.53 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 142.54 23.94 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.344 0.657 . . . . 0.35 111.118 -173.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -127.3 113.38 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.86 1.664 . . . . 0.35 107.623 -174.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -94.62 75.03 3.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.858 0.863 . . . . 0.35 109.151 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.94 108.21 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.768 -1.197 . . . . 0.35 107.768 168.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.2 m -86.88 67.75 9.9 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.463 1.105 . . . . 0.35 108.35 -170.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -60.64 99.79 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.846 1.258 . . . . 0.35 111.772 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -130.7 134.79 47.21 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.604 1.961 . . . . 0.35 109.86 -166.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -160.32 121.27 3.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.15 0.98 . . . . 0.35 109.067 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -89.9 65.71 6.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.966 0.907 . . . . 0.35 110.341 -172.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -142.8 -47.47 0.32 Allowed 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.078 1.351 . . . . 0.36 109.134 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.16 -31.46 0.54 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.39 1.076 . . . . 0.35 112.046 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -80.99 -42.8 20.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.852 0.686 . . . . 0.35 112.852 -161.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? 70.01 173.25 0.3 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.543 1.537 . . . . 0.35 110.118 -169.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -77.28 93.87 4.07 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.719 -0.474 . . . . 0.35 109.719 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -96.64 158.26 15.51 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.616 1.167 . . . . 0.35 108.16 170.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.9 m -136.62 110.41 8.14 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.526 0.731 . . . . 0.35 109.686 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -95.57 100.58 12.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.582 1.153 . . . . 0.35 108.332 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.7 p -86.92 65.29 8.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.198 0.999 . . . . 0.35 110.051 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -65.92 136.64 95.72 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.217 1.007 . . . . 0.33 109.388 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.23 -113.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.46 2.773 . . . . 0.35 109.701 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.4 tp -160.46 153.69 4.45 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 CA-C-N 119.032 0.833 . . . . 0.35 109.694 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.6 p -130.74 128.36 40.64 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.366 1.067 . . . . 0.35 108.955 173.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -64.94 -25.68 67.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.212 1.005 . . . . 0.35 111.47 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.16 -65.18 0.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.26 1.424 . . . . 0.35 111.486 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 125.24 143.8 6.14 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 124.139 0.876 . . . . 0.35 111.391 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.1 131.69 7.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.366 1.066 . . . . 0.35 109.068 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.76 141.61 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.54 0.736 . . . . 0.35 109.387 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 83.2 t -61.99 117.35 28.38 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 108.341 -0.985 . . . . 0.33 108.341 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.83 -21.59 24.62 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.425 2.75 . . . . 0.35 112.32 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.0 t70 68.77 77.21 0.23 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.721 1.608 . . . . 0.35 111.008 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 35.64 70.58 0.14 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.203 2.201 . . . . 0.35 114.713 166.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.7 t 25.65 -103.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.951 2.5 . . . . 0.35 113.716 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.88 -33.72 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.684 1.194 . . . . 0.35 111.491 172.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -83.2 43.91 0.91 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.46 1.504 . . . . 0.35 111.526 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.6 tt -167.82 155.28 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.958 1.703 . . . . 0.35 108.136 -172.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -146.17 -13.41 0.47 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.2 0.815 . . . . 0.35 113.2 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.26 78.39 8.65 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 119.661 1.119 . . . . 0.36 112.447 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.49 -84.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.548 2.832 . . . . 0.35 111.433 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.17 74.7 0.67 Allowed Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.285 -1.126 . . . . 0.35 110.285 -168.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -68.91 95.02 0.67 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.937 1.295 . . . . 0.35 109.3 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -99.04 95.34 7.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.973 0.509 . . . . 0.36 109.829 -173.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.32 98.46 3.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.844 -1.169 . . . . 0.35 107.844 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.4 mt -125.54 109.76 22.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 124.983 1.313 . . . . 0.35 107.588 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.2 m -133.98 125.48 28.28 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.281 1.032 . . . . 0.35 108.807 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -67.31 128.12 35.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.583 0.753 . . . . 0.35 110.141 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.28 138.31 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.305 1.042 . . . . 0.35 108.6 169.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -90.68 94.69 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.158 -1.423 . . . . 0.35 107.158 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 44.9 mt -71.43 131.46 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.259 0.624 . . . . 0.35 109.83 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -106.36 133.92 50.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.344 -1.725 . . . . 0.35 106.344 163.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -84.38 118.38 24.2 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.175 0.59 . . . . 0.35 109.465 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? . . . . . 0 N--CA 1.455 -0.203 0 C-N-CA 123.285 0.634 . . . . 0.25 109.784 178.545 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 p90 . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 113.822 1.045 . . . . 0.35 113.822 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -66.67 168.89 8.63 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.332 0.653 . . . . 0.35 110.2 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mptt 78.36 -38.25 0.23 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.163 2.185 . . . . 0.35 111.71 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.7 53.55 11.81 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 110.959 -0.856 . . . . 0.35 110.959 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 56.31 59.24 3.76 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.125 1.37 . . . . 0.35 111.442 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -117.18 119.12 34.24 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.952 1.301 . . . . 0.35 108.391 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.13 40.67 3.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.002 1.321 . . . . 0.35 109.768 -171.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 59.2 -93.05 0.04 OUTLIER 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.175 1.39 . . . . 0.35 109.817 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.06 48.03 0.4 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.562 -1.415 . . . . 0.35 109.562 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 26.38 55.73 0.05 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 128.84 2.856 . . . . 0.35 114.136 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 44.35 71.0 0.28 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.513 1.525 . . . . 0.35 111.38 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.34 71.64 0.56 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.985 1.314 . . . . 0.35 110.55 -172.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.3 t -66.62 112.26 4.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.845 1.258 . . . . 0.35 109.01 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 62.38 -174.23 0.15 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.65 1.18 . . . . 0.35 112.087 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 76.8 t80 65.02 88.39 0.11 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.346 1.859 . . . . 0.35 111.697 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 67.58 167.33 0.12 Allowed Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.198 1.799 . . . . 0.33 113.018 166.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.67 105.65 0.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.227 2.618 . . . . 0.35 111.134 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.0 p -141.95 -54.02 0.44 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.996 0.919 . . . . 0.35 111.403 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.44 122.22 1.03 Allowed Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.98 -0.9 . . . . 0.33 112.261 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.99 170.62 2.02 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.542 3.495 . . . . 0.35 114.041 170.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -161.34 165.17 29.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.286 1.034 . . . . 0.35 110.844 171.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -160.55 93.0 0.99 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.327 1.451 . . . . 0.35 107.235 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.5 mtm -87.54 105.23 17.17 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.477 0.711 . . . . 0.35 111.151 -170.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -101.51 96.6 4.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 124.792 1.237 . . . . 0.35 110.578 -174.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -163.64 171.59 15.49 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.502 1.121 . . . . 0.36 110.809 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.1 m -100.7 -177.52 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.145 1.378 . . . . 0.35 111.45 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.2 m -130.8 104.07 6.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.863 1.665 . . . . 0.35 106.686 167.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.31 121.52 6.5 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.626 -0.59 . . . . 0.35 111.626 -173.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.28 166.26 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.863 0.865 . . . . 0.35 110.657 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -72.79 174.64 7.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.958 1.303 . . . . 0.35 110.576 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -79.32 31.38 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.236 1.014 . . . . 0.35 112.181 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -138.04 -55.96 0.66 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.104 1.762 . . . . 0.35 107.669 170.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.89 65.61 0.02 OUTLIER Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.697 -1.361 . . . . 0.35 109.697 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -139.09 122.63 17.33 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.445 1.098 . . . . 0.36 108.493 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.58 106.03 0.51 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.218 1.007 . . . . 0.35 111.49 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.74 -57.23 3.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.166 0.986 . . . . 0.35 108.706 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.4 mt -124.51 167.69 14.11 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.785 1.234 . . . . 0.35 110.13 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -146.02 73.48 13.41 Favored Pre-proline 0 N--CA 1.455 -0.199 0 N-CA-C 106.817 -1.549 . . . . 0.33 106.817 167.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -87.25 58.75 3.5 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.844 3.029 . . . . 0.35 110.208 -168.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -107.58 54.58 0.66 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.779 1.232 . . . . 0.35 109.443 -172.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -114.45 15.46 17.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.2 1.4 . . . . 0.35 113.478 -169.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.51 165.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 CA-C-N 118.849 0.749 . . . . 0.35 110.275 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.42 177.54 10.19 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.269 1.027 . . . . 0.35 110.843 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -134.57 141.34 38.5 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.574 1.55 . . . . 0.33 108.027 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -84.81 26.24 0.66 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.14 2.56 . . . . 0.35 113.86 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 69.97 136.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.765 2.026 . . . . 0.35 111.717 -176.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.05 128.52 5.01 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.647 -0.872 . . . . 0.33 108.647 157.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.15 165.51 21.4 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.209 2.606 . . . . 0.35 110.49 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.64 63.57 1.75 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.681 -0.968 . . . . 0.35 110.681 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -153.05 138.78 17.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.733 1.213 . . . . 0.35 108.738 173.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 m -73.47 87.45 1.58 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.374 1.069 . . . . 0.35 109.748 -173.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 106.13 9.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.06 1.344 . . . . 0.35 109.012 -174.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -140.09 177.65 7.83 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 125.742 1.617 . . . . 0.35 109.411 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -41.2 88.54 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.933 -0.395 . . . . 0.35 109.933 170.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.43 -45.83 78.54 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.428 0.691 . . . . 0.35 111.936 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -86.26 31.04 0.66 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.779 0.718 . . . . 0.35 112.293 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 mm -133.34 -44.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 125.396 1.478 . . . . 0.35 108.61 172.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -53.44 -50.98 64.09 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.196 0.998 . . . . 0.35 112.052 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -70.81 -34.31 71.6 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.598 0.636 . . . . 0.35 111.615 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -64.5 -51.82 61.03 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.999 0.92 . . . . 0.35 111.069 -172.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.8 m -63.5 -32.14 55.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 124.098 0.959 . . . . 0.35 111.937 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -65.43 -38.19 89.15 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.97 0.508 . . . . 0.35 111.059 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -70.82 -31.18 67.83 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.068 0.547 . . . . 0.35 111.363 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.58 -49.08 67.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.653 0.781 . . . . 0.35 111.047 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.18 -13.3 60.44 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.772 0.829 . . . . 0.35 113.145 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -74.62 89.24 2.21 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.442 0.697 . . . . 0.35 109.992 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.56 -52.44 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.533 1.533 . . . . 0.35 108.846 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 66.1 p -98.19 -52.46 3.67 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.315 1.046 . . . . 0.35 110.517 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.59 95.41 5.13 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.178 1.391 . . . . 0.35 108.487 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -147.38 4.71 0.8 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.953 0.901 . . . . 0.35 112.806 -173.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -148.39 -46.27 0.15 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.981 0.912 . . . . 0.35 109.651 -169.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -54.4 -48.53 71.48 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.385 1.474 . . . . 0.35 110.611 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.78 176.92 9.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.046 0.938 . . . . 0.35 112.094 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -155.78 105.16 2.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.519 -0.919 . . . . 0.35 108.519 168.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.62 131.5 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.153 0.981 . . . . 0.35 109.74 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.56 -60.65 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.318 -0.993 . . . . 0.35 108.318 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -133.34 154.29 50.85 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.136 1.374 . . . . 0.35 110.185 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.4 mt -99.68 124.94 45.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.175 -1.417 . . . . 0.35 107.175 165.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -73.64 127.66 88.24 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.299 -0.63 . . . . 0.33 109.299 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.78 -21.69 18.57 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.44 2.76 . . . . 0.35 111.672 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.8 m -85.21 66.44 9.73 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.052 0.941 . . . . 0.35 110.604 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.32 165.91 23.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.361 0.665 . . . . 0.35 109.446 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -136.81 117.9 14.38 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.06 0.544 . . . . 0.35 111.344 -170.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.0 mm -86.95 90.79 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.762 1.625 . . . . 0.35 108.017 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.37 72.88 8.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.633 -0.877 . . . . 0.35 108.633 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.66 94.57 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 CA-C-O 121.6 0.714 . . . . 0.35 110.052 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.5 m -79.74 108.91 13.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.982 -1.118 . . . . 0.35 107.982 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -78.41 70.37 4.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.808 -0.812 . . . . 0.35 108.808 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -71.06 124.21 23.88 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.107 0.479 . . . . 0.35 110.133 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -153.21 163.99 38.89 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.385 1.474 . . . . 0.35 107.839 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.65 61.83 1.08 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.36 -0.978 . . . . 0.35 108.36 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -149.64 -54.37 0.17 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.686 1.194 . . . . 0.36 109.78 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 -42.41 0.12 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.842 0.857 . . . . 0.35 112.281 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -73.5 -46.55 47.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.1 0.96 . . . . 0.35 110.955 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 81.7 tttt 71.0 163.48 0.26 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.076 1.35 . . . . 0.35 110.984 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -47.77 124.1 6.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.561 1.144 . . . . 0.35 110.408 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -149.46 86.43 1.47 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.922 -0.77 . . . . 0.35 108.922 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.4 m -69.41 94.34 0.72 Allowed 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.008 1.323 . . . . 0.35 109.581 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -89.01 95.16 10.21 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.108 -1.071 . . . . 0.35 108.108 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p -72.53 133.47 44.79 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.688 0.795 . . . . 0.35 110.34 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -151.02 139.05 12.58 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 125.058 1.343 . . . . 0.33 107.627 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.76 -139.34 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.766 2.977 . . . . 0.35 109.986 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.8 tp -158.75 156.41 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 119.272 0.942 . . . . 0.35 109.616 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -130.29 166.63 19.96 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.397 1.079 . . . . 0.35 110.335 176.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.6 -51.27 70.53 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.791 1.236 . . . . 0.35 111.328 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -80.17 -33.89 37.98 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.856 0.863 . . . . 0.35 110.992 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.85 -127.57 45.35 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.238 0.923 . . . . 0.35 112.38 170.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -165.46 149.11 8.19 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.019 0.928 . . . . 0.35 110.126 -173.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.1 t -78.45 132.3 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.565 -1.272 . . . . 0.35 107.565 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.4 t -52.95 113.28 4.39 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.0 0.92 . . . . 0.33 109.769 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -84.31 -174.2 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.516 2.811 . . . . 0.35 110.833 -171.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -63.81 143.45 57.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.564 0.746 . . . . 0.35 109.792 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.45 61.2 2.31 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.724 1.209 . . . . 0.35 109.169 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.0 t 55.97 -122.65 1.8 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.936 1.694 . . . . 0.35 111.207 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -159.25 -48.51 0.06 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.252 1.021 . . . . 0.35 109.687 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -75.01 7.89 2.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.981 1.312 . . . . 0.35 113.596 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.6 tt -142.35 141.3 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.305 1.442 . . . . 0.35 108.821 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.37 29.11 2.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.287 1.035 . . . . 0.35 111.427 174.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.402 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -151.89 60.6 3.72 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.997 0.919 . . . . 0.36 112.38 176.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 122' ' ' ASN . 24.1 Cg_exo -71.76 -166.87 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.56 2.173 . . . . 0.35 112.655 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.81 78.38 0.21 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 108.718 -1.753 . . . . 0.35 108.718 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -72.7 76.6 1.11 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.546 1.538 . . . . 0.35 109.658 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -86.17 102.49 13.95 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.004 0.522 . . . . 0.36 110.14 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.48 81.62 7.53 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.909 1.284 . . . . 0.35 108.494 174.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.8 mt -94.91 76.19 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 107.203 -1.406 . . . . 0.35 107.203 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.6 m -75.37 172.64 12.12 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.984 1.313 . . . . 0.35 109.542 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.28 138.78 31.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.769 1.228 . . . . 0.35 108.389 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.95 150.72 26.78 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 C-N-CA 123.936 0.894 . . . . 0.35 110.987 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.42 132.85 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.842 1.257 . . . . 0.35 108.811 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 68.2 mt -134.58 150.5 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.438 1.495 . . . . 0.35 109.551 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -120.62 113.3 20.05 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.141 1.376 . . . . 0.35 107.731 162.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.19 166.03 17.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.03 0.932 . . . . 0.35 111.861 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt . . . . . 0 C--N 1.34 0.164 0 C-N-CA 124.611 1.165 . . . . 0.25 109.288 179.454 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 t80 . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 110.144 -0.317 . . . . 0.35 110.144 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -158.97 174.06 15.54 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.357 1.063 . . . . 0.35 110.41 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.64 25.24 7.89 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 128.282 2.633 . . . . 0.35 116.128 168.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.42 -164.42 37.64 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 118.617 0.644 . . . . 0.35 111.569 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -93.6 56.65 2.42 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.55 0.74 . . . . 0.35 109.232 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -85.29 89.4 7.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.589 1.156 . . . . 0.35 109.497 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -77.27 46.14 0.49 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.349 1.459 . . . . 0.35 113.21 -172.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.41 -75.05 0.08 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.923 2.489 . . . . 0.35 111.969 175.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.6 -38.44 0.09 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.79 -1.324 . . . . 0.35 109.79 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -49.99 117.83 2.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.528 1.531 . . . . 0.35 110.0 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -170.32 133.38 1.08 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.166 0.986 . . . . 0.35 109.392 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.5 148.64 7.95 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.4 1.08 . . . . 0.35 109.958 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.4 t -161.34 115.86 2.03 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.062 0.945 . . . . 0.35 109.073 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 61.19 172.66 0.11 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.354 1.862 . . . . 0.35 113.426 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 60.07 89.18 0.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.421 1.888 . . . . 0.35 112.186 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 71.23 154.38 0.15 Allowed Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 126.211 1.804 . . . . 0.33 112.738 165.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.11 97.92 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.388 2.725 . . . . 0.35 110.009 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -104.05 -58.76 1.83 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.628 1.171 . . . . 0.35 110.987 -173.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.97 110.75 0.43 Allowed Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.896 -0.947 . . . . 0.33 111.767 -171.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -80.3 169.42 17.35 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.472 2.781 . . . . 0.35 111.294 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -162.41 170.04 19.45 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 113.281 0.845 . . . . 0.35 113.281 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.07 94.88 3.01 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.825 2.05 . . . . 0.35 107.955 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 31.7 ttp -87.5 104.37 16.41 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.027 0.531 . . . . 0.35 110.545 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.72 97.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 125.16 1.384 . . . . 0.35 108.832 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.35 170.3 21.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.366 1.066 . . . . 0.36 109.158 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.44 139.45 32.3 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 C-N-CA 124.004 0.922 . . . . 0.35 110.555 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.1 m -73.2 101.02 3.24 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.188 0.995 . . . . 0.35 108.723 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.92 82.44 1.63 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 123.933 0.778 . . . . 0.35 111.757 -170.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 m -85.18 157.69 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 C-N-CA 123.512 0.725 . . . . 0.35 110.566 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.47 -69.56 0.45 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.464 -0.569 . . . . 0.35 109.464 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.4 m -156.07 -56.21 0.09 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.104 1.362 . . . . 0.35 109.299 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -91.56 42.05 1.09 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.759 1.223 . . . . 0.35 110.819 -175.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.03 35.62 87.87 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.032 0.825 . . . . 0.35 112.491 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -102.6 96.36 6.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.448 1.099 . . . . 0.36 108.563 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.49 101.54 0.09 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.76 1.224 . . . . 0.35 111.169 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.32 -63.47 1.23 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.426 -0.953 . . . . 0.35 108.426 171.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -89.97 121.08 31.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.399 -0.963 . . . . 0.35 108.399 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.5 m -87.07 108.13 17.49 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.335 1.054 . . . . 0.33 108.399 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.96 -172.87 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.695 2.93 . . . . 0.35 112.717 -164.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.5 m170 72.13 54.63 0.18 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.077 1.751 . . . . 0.35 111.47 172.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -120.64 -2.4 9.91 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.725 1.21 . . . . 0.35 112.575 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.12 142.17 40.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 125.042 1.337 . . . . 0.35 108.284 170.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -141.14 -84.82 0.2 Allowed 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.312 -0.852 . . . . 0.35 110.463 -177.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.1 t80 74.81 140.0 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.561 1.544 . . . . 0.33 110.381 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.74 159.36 51.66 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.777 2.318 . . . . 0.35 112.668 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 tp -61.33 137.36 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.886 1.274 . . . . 0.35 112.007 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -138.57 102.76 7.84 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.414 1.486 . . . . 0.33 107.404 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.11 175.55 11.01 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.306 2.671 . . . . 0.35 110.709 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.26 -29.47 8.72 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.996 0.808 . . . . 0.35 112.248 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 t -67.43 142.0 56.82 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.704 0.752 . . . . 0.35 111.311 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.8 m -71.11 144.35 50.3 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.938 0.895 . . . . 0.35 108.876 172.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.03 75.27 1.59 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.755 0.822 . . . . 0.35 109.302 -166.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.1 p -104.99 173.57 6.25 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 125.57 1.548 . . . . 0.35 110.265 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -57.83 -50.99 71.42 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.431 1.092 . . . . 0.35 109.579 171.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.75 -28.3 67.51 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.58 0.956 . . . . 0.35 113.58 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -68.6 -53.27 23.75 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.056 0.844 . . . . 0.35 109.68 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.3 mm -55.3 -40.93 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.931 1.292 . . . . 0.35 111.39 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -47.51 -64.45 0.78 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.241 1.416 . . . . 0.35 111.908 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -69.56 -32.59 71.46 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.856 0.317 . . . . 0.35 111.856 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -65.25 -49.86 68.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.629 0.772 . . . . 0.35 111.543 -172.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 m -67.35 -34.31 68.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.011 0.524 . . . . 0.35 111.474 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.32 -48.24 80.74 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 122.862 0.465 . . . . 0.35 110.397 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -40.86 97.47 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.204 0.456 . . . . 0.35 110.967 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.03 -50.3 73.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.167 0.987 . . . . 0.35 111.129 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 pp -71.59 -29.43 64.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.076 0.55 . . . . 0.35 111.605 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -70.32 -1.13 9.57 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 113.302 0.853 . . . . 0.35 113.302 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.16 -43.47 61.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.719 0.691 . . . . 0.35 110.28 164.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.5 p -86.37 -47.93 8.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.053 0.941 . . . . 0.35 110.935 173.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.85 -105.84 0.03 OUTLIER 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.319 0.509 . . . . 0.35 112.135 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 71.4 144.68 0.06 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.907 1.683 . . . . 0.35 111.114 -171.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 70.17 -82.59 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.799 2.039 . . . . 0.35 110.853 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -72.8 171.7 12.17 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.44 0.696 . . . . 0.35 109.123 172.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 70.8 146.66 0.07 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.5 1.52 . . . . 0.35 110.108 -162.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -158.18 133.82 8.97 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.911 0.884 . . . . 0.35 109.162 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -85.22 128.64 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.037 0.935 . . . . 0.35 108.915 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.3 t -69.78 -65.06 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.41 -1.33 . . . . 0.35 107.41 167.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.57 139.14 5.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.795 0.838 . . . . 0.35 109.135 170.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.16 170.22 16.97 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.63 0.772 . . . . 0.35 109.777 170.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -67.81 129.47 93.28 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 108.927 -0.768 . . . . 0.33 108.927 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.53 -36.07 35.59 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.503 2.135 . . . . 0.35 109.697 172.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -89.78 69.46 7.62 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.798 1.239 . . . . 0.35 109.163 170.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.08 172.73 4.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.629 0.772 . . . . 0.35 109.99 168.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -152.17 151.46 31.04 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.359 0.503 . . . . 0.35 112.359 -167.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.26 101.15 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 126.205 1.802 . . . . 0.35 107.375 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -96.27 63.18 2.17 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.42 1.088 . . . . 0.35 110.203 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.67 122.22 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 122.763 0.425 . . . . 0.35 110.246 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.4 m -118.03 106.31 12.78 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.408 1.483 . . . . 0.35 107.413 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -124.32 119.0 28.03 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.698 1.199 . . . . 0.35 109.726 -167.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -132.38 55.66 1.87 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.979 1.311 . . . . 0.35 112.246 -158.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -74.34 137.47 42.85 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 122.067 -0.396 . . . . 0.35 110.996 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -93.92 70.3 3.99 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.821 -1.177 . . . . 0.35 107.821 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -143.3 -50.57 0.33 Allowed 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.44 1.096 . . . . 0.36 109.533 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.76 -40.65 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.163 0.585 . . . . 0.35 112.359 -170.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -53.53 4.61 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.069 0.547 . . . . 0.35 112.033 -168.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt 71.02 -177.82 0.21 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.846 1.258 . . . . 0.35 110.064 -167.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -69.25 127.66 33.85 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.465 0.706 . . . . 0.35 111.756 -170.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -142.65 104.29 4.35 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.619 1.168 . . . . 0.35 109.459 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.7 m -80.75 108.8 14.71 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.66 -0.867 . . . . 0.35 108.66 173.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -109.91 102.6 11.34 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.627 1.171 . . . . 0.35 108.46 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.8 p -90.62 64.64 5.78 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.976 1.311 . . . . 0.35 110.779 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -77.08 141.67 67.67 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.033 0.533 . . . . 0.33 109.67 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.84 170.96 18.11 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.581 2.854 . . . . 0.35 112.136 -171.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.4 tp -77.01 161.44 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.844 1.258 . . . . 0.35 109.86 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 73.4 p -132.01 129.0 39.54 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.091 0.957 . . . . 0.35 108.966 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.83 -29.29 70.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.489 0.716 . . . . 0.35 111.487 172.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.4 -50.02 75.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.172 0.989 . . . . 0.35 109.635 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.98 170.95 24.23 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 124.328 0.966 . . . . 0.35 112.562 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -158.35 136.03 10.39 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.112 0.965 . . . . 0.35 109.204 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.8 t -70.48 130.96 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.465 -1.309 . . . . 0.35 107.465 166.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.6 t -57.51 112.51 4.8 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 107.311 -1.366 . . . . 0.33 107.311 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.05 -95.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.597 2.198 . . . . 0.35 112.193 -158.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -158.38 150.22 21.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.009 0.924 . . . . 0.35 109.737 -173.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.85 56.7 0.7 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.528 1.531 . . . . 0.35 109.552 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.4 t 34.5 -103.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.754 2.422 . . . . 0.35 113.436 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -161.93 -51.7 0.04 OUTLIER 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.649 1.18 . . . . 0.35 109.396 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -61.78 -44.39 96.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.062 0.945 . . . . 0.35 111.264 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.9 tp -83.74 111.74 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.933 0.893 . . . . 0.35 109.494 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -134.94 43.85 2.67 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.446 1.098 . . . . 0.35 110.154 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -151.76 47.33 0.41 Allowed Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 114.0 1.111 . . . . 0.36 114.0 163.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -55.86 145.44 72.9 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.839 1.693 . . . . 0.35 113.31 168.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.47 76.72 0.38 Allowed Glycine 0 C--N 1.338 0.657 0 N-CA-C 108.641 -1.783 . . . . 0.35 108.641 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -69.59 96.74 0.96 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.675 1.19 . . . . 0.35 110.781 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -87.93 109.93 20.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.131 -1.063 . . . . 0.36 108.131 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -94.82 52.69 1.51 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.245 -1.02 . . . . 0.35 108.245 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -94.3 130.93 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.838 1.255 . . . . 0.35 108.783 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 81.6 m -149.05 140.6 23.41 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.163 1.385 . . . . 0.35 108.016 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 135.47 45.01 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.292 0.637 . . . . 0.35 109.348 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.4 m -133.37 136.0 55.4 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 123.341 0.656 . . . . 0.35 110.454 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.5 t -84.75 130.19 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.921 1.288 . . . . 0.35 107.779 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 55.4 mt -123.14 131.79 72.58 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 124.122 0.969 . . . . 0.35 110.588 -171.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -87.96 103.4 15.65 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.74 1.616 . . . . 0.35 107.273 165.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -70.61 140.88 51.76 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.083 0.553 . . . . 0.35 110.584 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt . . . . . 0 N--CA 1.456 -0.161 0 C-N-CA 125.474 1.51 . . . . 0.25 108.385 -175.109 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 107.236 -1.394 . . . . 0.35 107.236 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -51.54 -47.44 63.4 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 127.244 2.218 . . . . 0.35 112.661 -167.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -66.35 107.66 2.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.668 -1.234 . . . . 0.35 107.668 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.55 82.37 1.68 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.304 -1.119 . . . . 0.35 110.304 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt 56.61 60.34 3.14 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.108 1.363 . . . . 0.35 110.853 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -82.75 -64.16 1.23 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.616 1.167 . . . . 0.35 110.089 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.95 25.47 0.31 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.002 2.521 . . . . 0.35 114.772 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 57.27 -87.57 0.02 OUTLIER 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.847 1.659 . . . . 0.35 111.06 -170.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.53 -55.98 0.13 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 107.83 -2.108 . . . . 0.35 107.83 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 t0 57.54 38.13 27.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.669 1.588 . . . . 0.35 111.396 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 42.95 63.33 1.51 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.948 1.699 . . . . 0.35 111.438 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.82 -175.67 4.9 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.082 0.553 . . . . 0.35 112.282 -170.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 m 65.63 79.21 0.25 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.988 1.715 . . . . 0.35 110.195 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 54.64 65.56 1.47 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.521 1.528 . . . . 0.35 111.03 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -145.8 34.3 1.03 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.182 1.393 . . . . 0.35 109.716 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.52 162.99 0.12 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.005 1.722 . . . . 0.33 112.805 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -65.68 94.48 0.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.257 2.638 . . . . 0.35 110.224 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.3 p -138.98 -46.64 0.48 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.247 1.419 . . . . 0.35 110.088 -171.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.04 86.89 0.26 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.883 0.754 . . . . 0.33 111.931 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.65 153.75 10.45 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.341 3.361 . . . . 0.35 112.718 166.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -146.48 173.64 12.11 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.447 0.699 . . . . 0.35 110.992 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 tt -151.11 93.36 1.91 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.774 -1.195 . . . . 0.35 107.774 176.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.4 mtp -78.71 141.99 37.45 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.941 1.296 . . . . 0.35 109.996 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 37.0 t -136.18 94.99 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 124.861 1.265 . . . . 0.35 108.85 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -148.28 174.6 11.85 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.179 0.992 . . . . 0.36 110.391 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.01 -170.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 125.323 1.449 . . . . 0.35 109.231 174.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.6 m -121.24 103.5 9.03 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.603 -1.628 . . . . 0.35 106.603 162.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.78 85.11 1.45 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.986 -0.846 . . . . 0.35 110.986 -173.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.6 m -102.23 172.08 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.258 1.023 . . . . 0.35 111.321 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -63.99 -52.69 58.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.792 1.237 . . . . 0.35 110.709 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 m -178.88 -56.07 0.01 OUTLIER 'General case' 0 C--N 1.339 0.144 0 C-N-CA 128.189 2.596 . . . . 0.35 107.197 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.52 -61.37 1.8 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.752 1.221 . . . . 0.35 110.748 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.0 -19.82 0.04 OUTLIER Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.168 -0.795 . . . . 0.35 113.351 -170.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -64.33 111.07 2.47 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.155 0.978 . . . . 0.36 109.693 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -76.64 123.51 26.24 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.385 1.074 . . . . 0.35 111.142 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.88 -65.2 1.04 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.61 -0.885 . . . . 0.35 108.61 170.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.5 mt -98.65 136.02 39.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.464 1.106 . . . . 0.35 109.95 -168.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.9 m -85.04 102.42 2.32 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.657 1.583 . . . . 0.33 110.926 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.78 -165.4 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.25 2.633 . . . . 0.35 111.677 -169.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 75.0 57.57 0.07 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.651 1.58 . . . . 0.35 111.036 166.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -138.16 -5.13 1.66 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.053 1.131 . . . . 0.35 114.053 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -130.26 143.78 39.97 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 123.739 0.816 . . . . 0.35 109.582 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.23 177.07 11.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.541 0.736 . . . . 0.35 112.284 -173.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -137.34 154.13 75.22 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 126.497 1.919 . . . . 0.33 107.555 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -84.12 34.79 0.53 Allowed 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.235 2.623 . . . . 0.35 112.323 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.257 13.8 tt 54.21 149.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 129.603 3.161 . . . . 0.35 115.732 176.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -158.18 123.35 2.31 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.172 0.989 . . . . 0.33 109.321 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -80.12 179.18 6.41 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.32 2.68 . . . . 0.35 110.949 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.21 -33.72 4.95 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.774 0.702 . . . . 0.35 111.527 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 t -63.87 144.83 56.75 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.24 1.016 . . . . 0.35 110.948 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.9 m -73.72 145.1 45.43 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.909 -0.774 . . . . 0.35 108.909 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.6 104.51 7.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.171 -1.418 . . . . 0.35 107.171 177.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -143.53 157.58 44.32 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.402 1.081 . . . . 0.35 110.4 -173.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.31 -57.55 10.18 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.493 1.117 . . . . 0.35 111.57 -174.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -58.72 -29.11 66.44 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.01 0.744 . . . . 0.35 113.01 -175.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -72.1 -48.34 44.69 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.714 0.806 . . . . 0.35 110.684 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.8 mm -56.21 -39.09 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.66 1.184 . . . . 0.35 111.944 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -47.87 -57.98 4.97 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.425 1.09 . . . . 0.35 112.397 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -78.83 -29.7 44.87 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.061 0.544 . . . . 0.35 112.347 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -64.01 -45.95 86.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.187 0.595 . . . . 0.35 111.636 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.4 m -68.83 -31.81 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 122.916 0.487 . . . . 0.35 111.406 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.46 -36.94 85.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.616 0.767 . . . . 0.35 111.053 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -74.8 -36.09 62.48 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.801 0.841 . . . . 0.35 111.134 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.92 78.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.125 0.57 . . . . 0.35 111.026 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.02 -17.72 62.01 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.983 0.735 . . . . 0.35 112.983 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -58.0 -33.61 69.11 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.492 0.717 . . . . 0.35 112.095 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -41.57 -47.66 3.86 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 125.547 1.539 . . . . 0.35 112.573 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 65.1 p -97.21 -51.54 4.16 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.95 1.3 . . . . 0.35 110.797 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.21 82.17 2.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.221 1.408 . . . . 0.35 110.288 -171.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -109.96 -36.53 5.85 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.34 1.456 . . . . 0.35 110.965 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -87.9 -73.11 0.5 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.611 0.765 . . . . 0.35 110.643 -173.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -96.09 62.08 2.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.24 0.616 . . . . 0.35 111.085 -165.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.42 153.02 32.72 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.817 0.447 . . . . 0.35 110.568 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -158.27 105.97 1.94 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.35 108.675 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -75.05 97.98 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.541 -0.911 . . . . 0.35 108.541 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.41 -42.64 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.302 0.641 . . . . 0.35 110.712 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -140.94 161.22 38.34 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.738 1.215 . . . . 0.35 109.634 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.58 163.38 32.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.773 1.229 . . . . 0.35 109.942 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -90.32 126.79 55.49 Favored Pre-proline 0 N--CA 1.455 -0.199 0 N-CA-C 108.078 -1.082 . . . . 0.33 108.078 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.68 -20.39 30.53 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.682 2.255 . . . . 0.35 110.915 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.7 m -84.64 70.71 10.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.707 1.203 . . . . 0.35 110.476 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.64 162.18 18.91 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.556 0.742 . . . . 0.35 109.746 165.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -151.86 107.58 3.35 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.979 0.419 . . . . 0.35 111.935 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.26 130.23 30.27 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 125.34 1.456 . . . . 0.35 107.481 168.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -131.13 80.96 1.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.119 -1.067 . . . . 0.35 108.119 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.56 98.25 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.833 0.853 . . . . 0.35 110.205 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 62.1 m -93.52 97.67 10.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.074 1.35 . . . . 0.35 107.931 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -103.63 93.46 4.94 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.989 0.916 . . . . 0.35 111.24 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -73.07 52.48 0.33 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.648 2.379 . . . . 0.35 111.336 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -82.06 102.1 10.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.289 1.035 . . . . 0.35 110.605 -171.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -87.78 71.7 9.53 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.164 0.986 . . . . 0.35 108.617 174.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -148.88 -58.51 0.22 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.056 1.343 . . . . 0.36 109.478 172.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.13 -38.39 0.16 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.242 0.83 . . . . 0.35 113.242 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -84.08 -45.7 12.75 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.893 0.477 . . . . 0.35 112.128 -164.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt 73.54 162.43 0.26 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.713 1.605 . . . . 0.35 112.264 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.76 109.93 1.58 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.548 1.139 . . . . 0.35 111.823 -175.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.5 102.71 5.02 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.003 -1.48 . . . . 0.35 107.003 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.2 m -79.43 93.16 5.32 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.644 0.777 . . . . 0.35 109.181 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -83.31 106.36 15.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.766 -0.827 . . . . 0.35 108.766 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.4 p -84.5 69.64 10.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.829 1.252 . . . . 0.35 111.192 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -64.99 137.19 97.07 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 108.595 -0.891 . . . . 0.33 108.595 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.09 -115.76 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.409 2.739 . . . . 0.35 110.579 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 tp -168.42 158.24 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.609 1.164 . . . . 0.35 108.828 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.4 p -136.41 137.69 40.74 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.835 0.854 . . . . 0.35 109.744 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -71.88 -22.6 61.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.987 0.915 . . . . 0.35 111.039 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -58.76 -50.18 74.91 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.792 0.837 . . . . 0.35 109.558 168.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.62 169.95 26.61 Favored Glycine 0 C--N 1.341 0.835 0 C-N-CA 124.056 0.836 . . . . 0.35 112.769 171.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -163.37 137.35 5.92 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.995 1.318 . . . . 0.35 109.124 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.5 138.29 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.75 0.82 . . . . 0.35 109.512 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.32 118.01 55.23 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 107.712 -1.218 . . . . 0.33 107.712 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.27 -66.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.616 2.211 . . . . 0.35 111.486 -170.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 t70 173.09 -66.4 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 126.506 1.922 . . . . 0.35 107.544 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 55.35 60.07 3.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.633 1.573 . . . . 0.35 110.201 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.0 m -138.17 45.64 2.09 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.589 1.156 . . . . 0.35 108.791 174.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -104.89 -62.67 1.31 Allowed 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.046 1.339 . . . . 0.35 109.974 -170.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -101.57 -55.65 2.47 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.934 1.293 . . . . 0.35 109.298 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.8 pt -93.95 158.03 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.724 0.81 . . . . 0.35 108.83 167.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -135.56 60.55 1.68 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.223 1.009 . . . . 0.35 108.303 173.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -170.34 58.75 0.3 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.847 1.259 . . . . 0.36 111.093 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -57.21 -51.54 8.44 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.738 2.292 . . . . 0.35 111.4 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.82 66.0 2.31 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.539 -0.625 . . . . 0.35 111.539 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -69.11 100.09 1.21 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.129 1.372 . . . . 0.35 111.081 -175.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -88.61 92.96 9.4 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.294 -0.632 . . . . 0.36 109.294 172.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.49 109.67 8.16 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 107.802 -1.184 . . . . 0.35 107.802 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.7 mt -127.38 133.74 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.913 1.285 . . . . 0.35 107.915 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.2 m -146.46 116.09 7.18 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.811 1.244 . . . . 0.35 107.775 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -69.09 132.62 46.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.859 -0.423 . . . . 0.35 109.859 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.34 153.86 36.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 123.799 0.84 . . . . 0.35 110.976 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.5 t -93.82 103.82 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.258 1.423 . . . . 0.35 108.058 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.8 mt -94.92 132.67 38.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.508 0.723 . . . . 0.35 109.225 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -113.82 98.19 6.87 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.042 1.337 . . . . 0.35 107.774 170.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -72.15 131.28 42.58 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.484 -0.562 . . . . 0.35 109.484 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt . . . . . 0 N--CA 1.456 -0.163 0 C-N-CA 124.336 1.054 . . . . 0.25 109.566 -176.225 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.331 0 CA-C-O 120.748 0.309 . . . . 0.35 110.908 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.4 148.92 44.77 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.835 0.854 . . . . 0.35 110.494 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? 78.14 156.35 0.16 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.896 2.078 . . . . 0.35 110.856 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.59 80.89 0.66 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 124.401 1.0 . . . . 0.35 110.706 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? 57.56 44.15 21.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.974 1.31 . . . . 0.35 110.744 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -93.41 87.32 5.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.637 0.775 . . . . 0.35 109.627 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -84.02 52.52 2.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.88 1.272 . . . . 0.35 111.096 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm 68.68 -72.41 0.1 Allowed 'General case' 0 C--N 1.342 0.277 0 C-N-CA 127.15 2.18 . . . . 0.35 111.993 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.24 -40.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.611 -0.996 . . . . 0.35 110.611 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -57.96 136.61 57.11 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.385 1.074 . . . . 0.35 110.623 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -157.97 59.91 0.47 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.873 -0.788 . . . . 0.35 108.873 174.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.11 78.71 6.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.649 1.18 . . . . 0.35 108.476 173.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.6 m -113.46 -42.12 3.53 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.949 1.3 . . . . 0.35 111.05 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.96 170.04 19.24 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.581 0.753 . . . . 0.35 111.712 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.7 t80 64.76 91.23 0.08 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 126.73 2.012 . . . . 0.35 111.241 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 70.84 150.56 0.13 Allowed Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.559 1.944 . . . . 0.33 111.676 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.42 80.58 2.23 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.443 2.762 . . . . 0.35 110.03 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.3 p -71.32 -48.27 51.5 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.992 0.917 . . . . 0.35 110.641 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.83 -179.01 44.58 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 117.994 0.361 . . . . 0.33 112.887 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -76.63 177.2 9.13 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.217 3.278 . . . . 0.35 112.715 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -160.05 -177.5 6.35 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.165 1.386 . . . . 0.35 109.524 157.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -153.81 99.32 2.27 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.23 -0.656 . . . . 0.35 109.23 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 77.6 mtm -84.44 111.82 19.81 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.552 1.141 . . . . 0.35 110.587 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.7 t -101.0 90.66 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 125.43 1.492 . . . . 0.35 108.064 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -146.21 178.01 8.56 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.371 0.668 . . . . 0.36 111.962 -173.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.77 142.53 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.222 1.409 . . . . 0.35 109.835 -172.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.6 m -93.34 81.6 4.44 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.204 -1.406 . . . . 0.35 107.204 168.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.74 113.86 3.78 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.915 -0.874 . . . . 0.35 110.915 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.41 164.42 15.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.849 1.259 . . . . 0.35 111.179 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -77.3 174.07 11.19 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.784 0.833 . . . . 0.35 110.703 172.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -55.81 -40.37 72.66 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.248 1.019 . . . . 0.35 110.41 167.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -59.13 -59.05 6.08 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.287 1.035 . . . . 0.35 109.94 171.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 140.17 -0.99 2.13 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.26 0.933 . . . . 0.35 112.924 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -72.63 128.06 34.42 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.478 1.139 . . . . 0.36 109.839 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -70.01 106.49 3.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.46 0.704 . . . . 0.35 110.89 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.8 mt -67.37 -47.16 71.2 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.591 1.156 . . . . 0.35 110.553 174.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -142.98 152.77 42.32 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.479 0.712 . . . . 0.35 111.316 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.0 m -108.0 152.23 41.63 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 125.389 1.476 . . . . 0.33 109.993 -175.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.8 -173.02 1.58 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.656 2.904 . . . . 0.35 112.304 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.1 m170 74.19 66.76 0.09 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 127.055 2.142 . . . . 0.35 111.306 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -153.55 -2.55 0.21 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.863 0.865 . . . . 0.35 113.041 177.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.6 t -135.39 115.73 18.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 N-CA-C 106.426 -1.694 . . . . 0.35 106.426 170.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -143.82 148.8 36.05 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.317 1.047 . . . . 0.35 109.503 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -139.61 148.64 56.82 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 124.284 1.034 . . . . 0.33 109.889 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.64 135.89 34.53 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.648 2.232 . . . . 0.35 108.544 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.4 tt -66.61 144.35 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 122.927 0.491 . . . . 0.35 112.161 -168.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -137.97 87.31 16.71 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 125.401 1.48 . . . . 0.33 107.5 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.55 155.5 31.76 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.38 2.72 . . . . 0.35 110.878 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.41 -32.41 2.48 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.077 0.846 . . . . 0.35 111.698 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.3 t -70.39 155.22 40.98 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.983 0.913 . . . . 0.35 111.357 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.1 m -72.53 145.46 47.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.741 0.816 . . . . 0.35 109.069 172.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.42 76.74 1.69 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.416 1.086 . . . . 0.35 108.901 -172.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t -114.86 171.22 7.78 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.171 1.788 . . . . 0.35 109.88 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -56.61 -44.79 81.5 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.693 1.197 . . . . 0.35 111.63 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.79 -27.79 67.05 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.931 0.715 . . . . 0.35 112.931 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -73.82 -25.58 60.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.37 1.068 . . . . 0.35 112.065 174.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.8 mm -90.51 -51.4 11.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-N 118.564 0.62 . . . . 0.35 110.94 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.36 -41.01 75.45 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.691 0.626 . . . . 0.35 112.691 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.36 -30.37 57.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.032 0.533 . . . . 0.35 111.697 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -76.11 -42.18 47.89 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.411 1.084 . . . . 0.35 111.02 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.3 m -72.32 -23.76 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.001 0.52 . . . . 0.35 111.329 173.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -68.9 -34.39 75.32 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.242 0.474 . . . . 0.35 110.579 171.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -24.52 63.2 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.07 -0.491 . . . . 0.35 111.732 174.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.3 -38.6 75.03 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.513 0.597 . . . . 0.35 110.925 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.7 -45.42 92.86 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.38 0.672 . . . . 0.35 110.366 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -64.67 153.55 39.21 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.006 0.366 . . . . 0.35 110.279 172.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 82.51 -47.54 0.17 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.801 2.04 . . . . 0.35 110.94 -167.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.3 p -91.69 -99.28 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.095 0.958 . . . . 0.35 110.087 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.15 96.44 9.62 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.994 1.318 . . . . 0.35 111.228 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -153.89 6.73 0.33 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.537 1.135 . . . . 0.35 111.724 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -74.33 -60.56 2.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.265 1.026 . . . . 0.35 109.612 -173.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -104.5 -21.96 13.37 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.665 1.586 . . . . 0.35 110.542 171.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -70.28 133.79 47.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.279 1.432 . . . . 0.35 109.921 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -152.43 114.49 4.42 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.792 0.837 . . . . 0.35 110.078 -175.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -70.05 117.24 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.272 1.029 . . . . 0.35 109.861 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.6 -46.7 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.976 0.911 . . . . 0.35 110.698 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -136.94 163.18 31.31 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.651 1.181 . . . . 0.35 109.623 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -137.04 153.06 50.72 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.766 1.226 . . . . 0.35 110.135 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.59 126.36 71.37 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 108.437 -0.949 . . . . 0.33 108.437 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.25 -30.79 15.33 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.917 2.411 . . . . 0.35 111.028 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.6 t -87.13 72.7 9.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.553 1.141 . . . . 0.35 110.502 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.03 168.69 14.93 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.112 0.965 . . . . 0.35 110.335 168.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -139.13 152.85 47.79 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.696 0.798 . . . . 0.35 111.735 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.92 87.55 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 126.128 1.771 . . . . 0.35 106.923 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -86.15 93.74 9.1 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 108.86 -0.793 . . . . 0.35 108.86 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.2 m -73.56 85.02 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 108.09 -1.078 . . . . 0.35 108.09 171.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.7 m -87.72 78.71 8.39 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.659 1.183 . . . . 0.35 108.521 -174.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -88.3 165.28 15.11 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.935 0.894 . . . . 0.35 110.102 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -154.16 28.87 0.45 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.682 1.593 . . . . 0.35 109.647 -168.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.95 125.49 20.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.318 1.447 . . . . 0.35 112.02 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -85.49 63.02 7.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.206 -1.035 . . . . 0.35 108.206 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -144.17 -60.76 0.39 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.715 1.206 . . . . 0.36 109.933 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -152.68 -56.32 0.13 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.013 0.746 . . . . 0.35 113.013 -172.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -80.02 -41.93 24.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.114 0.87 . . . . 0.35 112.044 -171.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt 69.57 -148.77 0.11 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.918 1.287 . . . . 0.35 111.341 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -75.66 115.92 15.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.754 0.822 . . . . 0.35 111.442 -167.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.17 113.32 6.87 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.365 1.066 . . . . 0.35 109.206 173.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.8 m -79.47 81.93 5.66 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 107.4 -1.333 . . . . 0.35 107.4 169.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -86.74 86.25 7.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.279 1.032 . . . . 0.35 109.415 -169.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.5 p -77.08 84.03 3.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.023 1.329 . . . . 0.35 111.387 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -83.38 127.62 67.75 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 123.915 0.886 . . . . 0.33 108.95 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.89 163.55 28.48 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.198 2.598 . . . . 0.35 111.908 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 tp -78.84 163.83 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.714 1.206 . . . . 0.35 110.355 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.6 p -124.34 165.3 17.93 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.849 1.26 . . . . 0.35 110.358 176.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.37 -28.46 14.94 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.875 1.27 . . . . 0.35 110.715 171.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -70.0 -60.25 2.41 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.012 0.925 . . . . 0.35 109.848 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.14 98.65 2.28 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 123.993 0.806 . . . . 0.35 111.587 174.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -78.23 136.97 37.89 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.099 -0.704 . . . . 0.35 109.099 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.36 136.67 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.708 -0.849 . . . . 0.35 108.708 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.83 118.22 46.43 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.469 -0.937 . . . . 0.33 108.469 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -84.58 162.06 12.56 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.065 2.51 . . . . 0.35 111.184 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -83.67 168.05 16.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.898 0.879 . . . . 0.35 109.458 166.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -158.44 130.98 7.03 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.22 0.608 . . . . 0.35 111.02 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.1 t -163.21 69.84 0.23 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.436 1.095 . . . . 0.35 108.581 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -158.22 -63.89 0.09 Allowed 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.851 0.86 . . . . 0.35 108.996 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -89.39 -47.29 8.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.353 1.061 . . . . 0.35 111.382 -175.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.7 pt -136.65 169.1 20.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 C-N-CA 123.879 0.872 . . . . 0.35 111.633 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -144.03 38.79 1.32 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.995 1.718 . . . . 0.35 108.162 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -169.77 58.52 0.32 Allowed Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.906 0.882 . . . . 0.36 110.502 -172.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -63.69 -57.1 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.512 2.808 . . . . 0.35 111.993 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.38 72.91 0.86 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.457 -1.057 . . . . 0.35 110.457 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -68.99 97.79 0.89 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.311 1.444 . . . . 0.35 110.46 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -87.41 96.2 10.29 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.595 -0.52 . . . . 0.36 109.595 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -88.27 62.96 6.95 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.278 -1.008 . . . . 0.35 108.278 170.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -94.72 104.36 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.501 -2.037 . . . . 0.35 105.501 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 68.5 p -97.94 -162.89 0.99 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.288 1.035 . . . . 0.35 109.244 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.53 121.77 4.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.232 -1.395 . . . . 0.35 107.232 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.36 157.02 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.224 0.61 . . . . 0.35 110.223 175.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.81 143.85 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.942 1.297 . . . . 0.35 108.364 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.6 mp -130.82 145.06 36.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 C-N-CA 124.767 1.227 . . . . 0.35 110.383 -175.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.84 157.17 34.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.161 1.385 . . . . 0.35 108.255 160.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -90.2 126.02 35.67 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.29 -0.633 . . . . 0.35 109.29 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 C--N 1.34 0.192 0 C-N-CA 123.834 0.854 . . . . 0.25 110.635 -175.895 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 109.751 -0.463 . . . . 0.35 109.751 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -77.46 70.04 3.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.505 1.122 . . . . 0.35 110.067 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -175.81 173.5 2.32 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.373 1.869 . . . . 0.35 109.454 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.77 -155.4 8.65 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.859 0.742 . . . . 0.35 111.775 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -71.17 109.74 5.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.811 0.844 . . . . 0.35 109.059 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -138.94 80.51 1.79 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.056 0.943 . . . . 0.35 109.004 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -89.47 35.1 0.81 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.633 1.173 . . . . 0.35 112.013 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.6 -82.77 0.03 OUTLIER 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.849 1.66 . . . . 0.35 110.43 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 13' ' ' ASP . . . -176.17 2.94 0.03 OUTLIER Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.389 1.471 . . . . 0.35 112.752 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.414 ' H ' ' H ' ' A' ' 12' ' ' GLY . 3.3 p30 50.02 26.93 2.24 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 127.351 2.261 . . . . 0.35 115.799 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 49.35 38.17 13.29 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.807 1.643 . . . . 0.35 112.572 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.74 -44.41 0.01 OUTLIER 'General case' 0 C--N 1.339 0.11 0 C-N-CA 125.044 1.337 . . . . 0.35 109.511 -171.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.7 t 68.64 45.72 1.04 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.294 1.838 . . . . 0.35 110.51 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.2 t80 49.21 61.74 2.98 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.287 1.435 . . . . 0.35 110.325 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -160.49 92.89 0.99 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.237 0.615 . . . . 0.35 109.899 -170.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 66.5 166.21 0.12 Allowed Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 126.117 1.767 . . . . 0.33 113.595 165.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.85 96.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.365 3.377 . . . . 0.35 111.811 169.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.8 p -144.38 -38.49 0.29 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.917 1.287 . . . . 0.35 110.496 -174.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.82 143.88 6.82 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 110.921 -0.872 . . . . 0.33 110.921 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -86.44 168.32 8.68 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.052 3.168 . . . . 0.35 112.087 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -165.08 160.03 18.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.163 0.985 . . . . 0.35 111.215 -172.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.9 tt -158.27 113.2 2.61 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.09 1.356 . . . . 0.35 108.748 -170.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -96.73 152.12 18.98 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.55 1.14 . . . . 0.35 110.774 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.01 89.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.301 0 C-N-CA 124.654 1.182 . . . . 0.35 108.709 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -144.66 -162.93 1.59 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.711 0.805 . . . . 0.36 110.3 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.5 m -137.91 148.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 124.675 1.19 . . . . 0.35 110.024 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.4 m -85.54 93.38 8.78 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.088 -1.449 . . . . 0.35 107.088 169.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.89 89.32 1.43 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.819 0.723 . . . . 0.35 111.758 -169.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.4 m -101.74 170.61 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.749 1.22 . . . . 0.35 112.627 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.06 179.09 7.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.961 1.304 . . . . 0.35 109.438 165.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.3 t -58.36 -40.41 82.17 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.03 0.932 . . . . 0.35 110.786 172.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.53 -54.98 40.34 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.265 1.026 . . . . 0.35 110.423 175.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.84 26.79 0.56 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.726 1.155 . . . . 0.35 111.905 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -100.11 115.54 30.02 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.187 0.995 . . . . 0.36 109.21 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.84 114.23 4.36 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.463 0.705 . . . . 0.35 110.552 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.417 HD12 ' H ' ' A' ' 39' ' ' LEU . 4.4 mp -77.75 -51.01 11.23 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.987 -0.746 . . . . 0.35 108.987 173.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.0 mt -91.99 -149.45 0.24 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.997 1.319 . . . . 0.35 110.189 -167.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.4 m -154.87 123.54 3.02 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.474 1.11 . . . . 0.33 109.126 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.16 -171.29 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.257 2.638 . . . . 0.35 110.311 171.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.2 m170 64.14 75.63 0.37 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.696 1.199 . . . . 0.35 111.171 174.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -145.44 -61.44 0.34 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.328 0.651 . . . . 0.35 110.646 174.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.59 124.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 107.926 -1.139 . . . . 0.35 107.926 166.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -149.9 151.32 33.24 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.67 1.188 . . . . 0.35 109.541 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -140.17 146.15 44.86 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.812 1.245 . . . . 0.33 109.333 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.71 128.76 17.51 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.329 2.019 . . . . 0.35 107.713 166.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.4 tt -59.82 142.62 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.418 0.525 . . . . 0.35 112.418 -167.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -128.72 97.9 26.21 Favored Pre-proline 0 N--CA 1.453 -0.287 0 N-CA-C 107.31 -1.367 . . . . 0.33 107.31 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.29 157.47 49.88 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.454 2.103 . . . . 0.35 109.811 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.02 58.32 1.8 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.146 -1.182 . . . . 0.35 110.146 -174.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.3 t -152.56 147.26 25.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.979 1.311 . . . . 0.35 108.981 174.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.1 m -61.2 138.77 58.22 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.236 0.614 . . . . 0.35 110.379 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.89 80.95 1.71 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.446 1.098 . . . . 0.35 108.722 -173.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.3 p -133.39 178.66 6.74 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.869 1.268 . . . . 0.35 109.288 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -54.75 -54.37 42.86 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.109 0.564 . . . . 0.35 111.208 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.54 -42.93 67.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.383 1.073 . . . . 0.35 112.603 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.8 -60.24 4.11 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.231 0.612 . . . . 0.35 110.609 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.2 mm -57.54 -42.23 80.65 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 C-N-CA 124.61 1.164 . . . . 0.35 111.603 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -49.77 -59.24 4.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.75 1.22 . . . . 0.35 111.999 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -73.65 -29.61 62.43 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.497 0.555 . . . . 0.35 112.497 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -69.87 -40.03 75.99 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.518 0.727 . . . . 0.35 111.898 -170.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.34 -30.79 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.017 0.527 . . . . 0.35 111.512 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.3 -33.67 74.76 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.223 0.609 . . . . 0.35 111.019 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -31.56 67.52 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.332 0.653 . . . . 0.35 111.337 176.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 -55.4 22.23 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.228 0.611 . . . . 0.35 110.994 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 pp -64.12 -27.33 69.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.171 0.988 . . . . 0.35 112.811 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.62 -43.56 63.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.281 0.632 . . . . 0.35 110.32 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.51 50.47 1.89 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.64 1.176 . . . . 0.35 111.401 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.0 t -168.07 -42.69 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.358 1.463 . . . . 0.35 109.945 173.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.94 88.58 0.83 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.74 0.816 . . . . 0.35 110.023 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -107.71 46.81 0.92 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.278 1.031 . . . . 0.35 108.717 167.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -84.89 -57.64 3.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.771 1.228 . . . . 0.35 109.038 -175.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.74 -139.25 0.33 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.601 1.561 . . . . 0.35 108.42 176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 82.56 109.82 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.284 1.433 . . . . 0.35 111.436 162.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -41.86 9.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.907 1.283 . . . . 0.35 111.209 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.1 t 69.11 92.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 126.219 1.808 . . . . 0.35 109.463 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.6 t -67.95 -63.72 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.419 0.688 . . . . 0.35 109.767 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -160.33 117.82 2.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.15 0.58 . . . . 0.35 109.742 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.04 145.95 44.11 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.195 0.598 . . . . 0.35 110.019 172.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.99 123.07 85.16 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.518 -0.919 . . . . 0.33 108.518 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.31 -32.96 19.33 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.232 2.621 . . . . 0.35 111.045 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.3 m -79.67 76.25 6.32 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.976 0.911 . . . . 0.35 109.184 173.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.01 154.23 23.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.242 1.017 . . . . 0.35 110.07 172.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -133.93 134.42 42.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.109 0.964 . . . . 0.35 109.952 -171.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.4 mp -122.5 111.76 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 125.669 1.587 . . . . 0.35 107.964 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -99.04 63.39 1.33 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.117 0.967 . . . . 0.35 108.648 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.01 99.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.358 0.599 . . . . 0.35 109.896 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.6 m -80.39 150.46 29.82 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.532 1.133 . . . . 0.35 108.94 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -139.1 66.42 1.42 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.322 1.049 . . . . 0.35 108.726 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -91.55 121.59 33.37 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 127.396 2.278 . . . . 0.35 109.863 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.3 p-10 -131.29 -165.06 1.51 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.687 0.795 . . . . 0.35 110.56 169.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -144.51 63.8 1.31 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.826 -1.176 . . . . 0.35 107.826 169.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -134.04 -53.35 0.85 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 125.468 1.507 . . . . 0.36 109.21 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -155.88 -41.3 0.08 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.063 0.945 . . . . 0.35 111.679 -172.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.6 tppt? -83.67 -59.54 2.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.88 0.872 . . . . 0.35 111.467 -166.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? 68.03 177.84 0.25 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.933 1.693 . . . . 0.35 111.401 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -63.47 110.91 2.11 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 112.514 0.561 . . . . 0.35 112.514 -165.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -132.93 137.25 46.55 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.229 1.811 . . . . 0.35 106.66 170.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.5 m -116.01 102.12 9.36 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.894 0.878 . . . . 0.35 109.35 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -79.59 101.32 8.24 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.678 -0.86 . . . . 0.35 108.678 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.4 m -90.16 67.52 6.92 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.211 1.005 . . . . 0.35 110.07 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -71.01 134.34 85.56 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.103 0.961 . . . . 0.33 109.398 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.15 -113.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.474 2.783 . . . . 0.35 109.622 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.1 tp -163.05 158.43 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.245 0 CA-C-N 119.156 0.889 . . . . 0.35 110.087 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.8 p -133.69 151.82 51.73 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.798 1.239 . . . . 0.35 109.183 169.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.13 -35.16 66.8 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.957 1.303 . . . . 0.35 112.965 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -141.58 74.26 1.45 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.961 1.304 . . . . 0.35 107.883 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.69 -92.03 0.41 Allowed Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.141 0.877 . . . . 0.35 112.184 -175.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -162.03 171.01 18.26 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.304 0.573 . . . . 0.35 112.076 -163.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 99.3 t -90.21 145.35 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.204 1.802 . . . . 0.35 107.73 169.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.5 t -52.92 115.14 6.83 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 123.846 0.859 . . . . 0.33 109.371 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -82.6 -178.67 4.08 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.275 2.65 . . . . 0.35 110.931 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -72.38 -178.45 2.54 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.873 0.869 . . . . 0.35 109.922 170.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.31 61.11 1.53 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.912 0.885 . . . . 0.35 110.388 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t 56.84 -103.0 0.17 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.97 1.708 . . . . 0.35 112.129 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -163.49 -58.12 0.04 OUTLIER 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.557 1.143 . . . . 0.35 108.623 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -57.92 -47.55 82.53 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.257 1.423 . . . . 0.35 112.124 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.3 tp -81.39 133.54 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.692 0.797 . . . . 0.35 110.684 -176.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.39 29.61 0.49 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.272 1.029 . . . . 0.35 111.643 166.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.49 60.56 10.23 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.227 1.411 . . . . 0.36 108.988 167.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.92 -73.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.743 2.962 . . . . 0.35 113.074 -168.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.71 78.36 1.4 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.927 -1.669 . . . . 0.35 108.927 -164.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -80.03 95.99 6.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.904 -1.147 . . . . 0.35 107.904 171.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -83.16 101.27 11.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.748 -0.834 . . . . 0.36 108.748 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.07 49.98 1.71 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.148 -1.056 . . . . 0.35 108.148 166.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.85 109.79 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.205 -1.776 . . . . 0.35 106.205 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 67.1 p -94.09 -133.69 0.17 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.226 1.011 . . . . 0.35 109.109 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -162.33 133.69 5.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.601 1.16 . . . . 0.35 108.065 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 m -142.34 143.45 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.718 0.807 . . . . 0.35 110.031 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.38 134.03 28.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.838 -1.171 . . . . 0.35 107.838 173.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.7 mt -123.5 143.58 36.12 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 C-N-CA 124.47 1.108 . . . . 0.35 110.652 -169.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -128.69 102.77 6.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.686 1.595 . . . . 0.35 106.76 166.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -60.85 128.26 35.64 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.2 0.6 . . . . 0.35 109.392 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.184 0 C-N-CA 123.79 0.836 . . . . 0.25 109.383 -164.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 111.833 0.309 . . . . 0.35 111.833 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.8 t70 60.79 171.07 0.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.155 1.382 . . . . 0.35 110.994 -167.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.3 pttt 47.57 -106.16 0.15 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.373 1.469 . . . . 0.35 112.396 171.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.1 -136.49 2.03 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.546 -1.022 . . . . 0.35 110.546 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -85.7 71.46 10.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.941 -1.133 . . . . 0.35 107.941 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -67.15 -56.88 8.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.065 0.946 . . . . 0.35 113.061 -162.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 44' ' ' TYR . 47.3 mmtm 76.84 110.58 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.921 2.088 . . . . 0.35 108.297 -170.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -55.41 -61.54 2.27 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.365 1.066 . . . . 0.35 111.817 -167.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.58 80.28 0.1 OUTLIER Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.516 -1.434 . . . . 0.35 109.516 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -127.82 41.18 3.55 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.251 1.021 . . . . 0.35 109.914 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.7 t0 50.71 55.25 9.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.185 1.394 . . . . 0.35 109.552 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -129.58 -168.62 1.97 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.77 1.228 . . . . 0.35 111.454 -155.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.5 m 63.65 69.64 0.55 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.952 1.701 . . . . 0.35 111.025 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 60.65 -145.43 0.47 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.242 1.417 . . . . 0.35 110.169 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 77.0 t80 57.8 73.87 0.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.468 1.507 . . . . 0.35 111.867 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 65.43 168.09 0.11 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.992 1.717 . . . . 0.33 113.28 168.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.32 113.53 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.981 2.454 . . . . 0.35 110.557 168.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 p -142.36 -73.32 0.31 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.558 0.743 . . . . 0.35 111.564 -170.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.43 112.97 0.53 Allowed Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.892 -0.949 . . . . 0.33 111.088 -170.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.97 175.61 10.61 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.816 3.011 . . . . 0.35 112.758 -171.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -155.28 166.98 31.88 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.835 0.68 . . . . 0.35 112.835 -172.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.2 tp -139.0 80.94 1.81 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.469 1.908 . . . . 0.35 107.743 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.1 mtm -74.45 100.89 3.96 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 122.674 0.39 . . . . 0.35 111.196 -172.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 t -84.57 76.72 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.521 -1.289 . . . . 0.35 107.521 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -149.02 148.18 29.42 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.618 1.167 . . . . 0.36 109.708 -171.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.6 m -140.37 144.36 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.266 1.026 . . . . 0.35 111.249 -170.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.1 m -70.2 105.49 2.97 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.731 1.212 . . . . 0.35 109.34 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.49 81.04 1.48 Allowed Glycine 0 C--N 1.34 0.776 0 C-N-CA 124.204 0.907 . . . . 0.35 111.711 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.9 m -87.16 170.27 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.154 0.982 . . . . 0.35 111.909 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -77.1 -44.56 30.06 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.928 0.891 . . . . 0.35 110.571 173.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.8 t 169.72 -59.8 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.097 2.559 . . . . 0.35 107.077 -171.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.9 43.66 1.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.115 1.366 . . . . 0.35 111.915 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.04 32.39 63.32 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.784 -1.009 . . . . 0.35 114.297 167.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -103.43 90.77 3.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.483 1.141 . . . . 0.36 108.132 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.89 109.5 1.47 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.848 0.859 . . . . 0.35 110.077 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mp -77.52 -53.8 7.18 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.38 0.672 . . . . 0.35 109.845 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.9 mt -86.07 -169.43 2.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.406 1.082 . . . . 0.35 110.247 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.3 m -126.48 68.51 67.79 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.553 0.741 . . . . 0.33 111.051 -174.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.99 164.29 35.32 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.909 3.073 . . . . 0.35 112.893 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.1 m170 79.1 80.67 0.06 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 127.222 2.209 . . . . 0.35 108.357 -172.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.403 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 31.2 p90 -147.31 -48.64 0.18 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.352 0.661 . . . . 0.35 111.957 -176.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -83.86 77.51 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 108.568 -0.901 . . . . 0.35 108.568 169.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -72.2 -38.06 69.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.897 -0.573 . . . . 0.35 111.924 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 64.67 154.26 0.12 Allowed Pre-proline 0 C--N 1.345 0.399 0 C-N-CA 126.634 1.974 . . . . 0.33 113.454 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.87 134.57 8.44 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.085 2.523 . . . . 0.35 108.378 165.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.5 tt -70.51 148.57 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.505 0.322 . . . . 0.35 111.196 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -135.08 107.39 10.4 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 107.287 -1.375 . . . . 0.33 107.287 172.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.63 161.69 27.71 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.12 2.547 . . . . 0.35 110.563 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.32 61.61 1.98 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.711 -1.356 . . . . 0.35 109.711 -173.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 t -151.9 142.98 23.18 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.55 1.14 . . . . 0.35 109.431 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.5 m -62.79 121.03 12.44 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.699 0.799 . . . . 0.35 110.034 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.85 78.63 1.64 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.893 1.277 . . . . 0.35 108.621 -173.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.3 p -116.02 172.1 7.37 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.746 1.618 . . . . 0.35 109.59 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.87 -49.78 75.52 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.69 1.196 . . . . 0.35 110.531 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -65.06 -28.94 69.81 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.61 0.764 . . . . 0.35 112.926 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -74.36 4.02 6.51 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.471 -0.775 . . . . 0.35 112.844 172.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.2 mm -100.36 -49.51 11.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 CA-C-N 119.324 0.965 . . . . 0.35 109.039 168.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -43.75 -64.78 0.59 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.691 1.597 . . . . 0.35 113.607 -167.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -82.11 -28.65 32.14 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.779 0.832 . . . . 0.35 111.795 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -60.18 -49.41 77.75 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.626 1.17 . . . . 0.35 111.691 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.0 m -66.9 -38.19 80.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 C-N-CA 123.371 0.668 . . . . 0.35 110.983 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.89 -39.22 84.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.779 0.832 . . . . 0.35 111.127 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -72.46 -40.8 66.73 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.0 0.92 . . . . 0.35 111.466 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.74 95.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.358 0.663 . . . . 0.35 111.218 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -85.95 -22.38 27.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.963 0.905 . . . . 0.35 113.025 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.7 -41.77 91.51 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.512 0.725 . . . . 0.35 110.573 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.85 64.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.0 0.92 . . . . 0.35 112.091 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.7 p -83.58 -62.03 1.68 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.857 0.863 . . . . 0.35 112.276 -173.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.01 -67.85 0.39 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-N 118.495 0.588 . . . . 0.35 110.076 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 71.48 149.42 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.966 1.707 . . . . 0.35 113.202 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? 68.59 -90.18 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.101 1.76 . . . . 0.35 112.775 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -84.5 72.35 10.64 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 123.901 0.88 . . . . 0.35 111.078 -169.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -167.74 147.96 5.12 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.256 1.422 . . . . 0.35 108.248 173.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.3 tpt85 -114.1 -60.04 1.94 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.591 0.757 . . . . 0.35 111.473 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.3 t 71.76 82.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 125.304 1.442 . . . . 0.35 107.963 -160.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.5 t -69.38 -57.33 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.623 1.169 . . . . 0.35 109.99 -172.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -131.11 169.52 15.78 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.627 1.171 . . . . 0.35 110.842 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -153.68 156.4 37.78 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.712 1.605 . . . . 0.35 109.013 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -87.33 138.27 32.25 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.276 -0.639 . . . . 0.33 109.276 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.06 -17.92 24.43 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.436 2.758 . . . . 0.35 111.856 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.4 m -59.01 -31.87 69.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.436 1.095 . . . . 0.35 112.291 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 15.69 74.38 0.01 OUTLIER 'General case' 0 C--N 1.348 0.511 0 C-N-CA 128.813 2.845 . . . . 0.35 113.728 172.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -78.9 128.77 33.75 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.122 0.969 . . . . 0.35 113.092 -161.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.8 124.03 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 125.988 1.715 . . . . 0.35 107.354 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -122.57 90.26 3.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.377 1.071 . . . . 0.35 108.601 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 m -78.8 92.19 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.786 1.234 . . . . 0.35 110.548 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.1 m -85.5 94.37 9.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.616 1.167 . . . . 0.35 108.645 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.74 84.1 4.94 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.509 0.724 . . . . 0.35 110.38 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -76.11 91.74 3.16 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.878 1.671 . . . . 0.35 110.003 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -134.19 78.95 1.78 Allowed 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.896 -0.779 . . . . 0.35 108.896 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -75.67 83.31 2.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.724 1.21 . . . . 0.35 108.667 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -155.19 -37.86 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.857 1.663 . . . . 0.36 110.018 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -154.7 -41.35 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.93 1.292 . . . . 0.35 110.624 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -79.85 -63.2 1.47 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 123.246 0.618 . . . . 0.35 110.699 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.48 125.49 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.322 1.849 . . . . 0.35 109.84 -177.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -10.17 108.18 0.01 OUTLIER 'General case' 0 C--N 1.344 0.369 0 C-N-CA 129.516 3.126 . . . . 0.35 115.261 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -140.86 123.33 15.95 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.03 1.332 . . . . 0.35 107.989 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.7 m -102.32 103.9 14.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.748 1.219 . . . . 0.35 109.726 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.86 109.15 14.01 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.491 -0.929 . . . . 0.35 108.491 173.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.8 p -89.29 75.24 7.77 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.607 1.163 . . . . 0.35 111.151 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -81.21 142.57 51.2 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.679 1.192 . . . . 0.33 109.52 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -77.33 -129.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.79 2.993 . . . . 0.35 110.157 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.8 tp -167.43 159.92 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 119.663 1.12 . . . . 0.35 110.211 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.9 p -136.42 151.89 50.01 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.687 1.195 . . . . 0.35 109.84 170.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.5 -11.26 60.68 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.722 1.209 . . . . 0.35 114.062 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -142.05 59.15 1.47 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.973 -1.121 . . . . 0.35 107.973 172.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.38 -82.67 1.0 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.183 0.897 . . . . 0.35 111.558 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -163.54 159.83 22.41 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.193 0.521 . . . . 0.35 112.013 -163.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.4 t -91.08 144.85 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.005 1.722 . . . . 0.35 106.998 166.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 80.7 t -57.28 117.2 16.74 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 108.522 -0.918 . . . . 0.33 108.522 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.55 -109.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.009 2.473 . . . . 0.35 109.349 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -156.33 -137.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.591 -1.263 . . . . 0.35 107.591 173.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 mp -137.27 151.54 48.81 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.821 1.248 . . . . 0.35 109.595 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.3 t -77.11 -71.05 0.43 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.569 0.748 . . . . 0.35 109.74 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -168.02 -46.21 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.593 1.157 . . . . 0.35 109.799 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -39.4 -45.56 1.51 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.213 2.205 . . . . 0.35 115.151 -169.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.39 161.15 41.06 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 C-N-CA 123.444 0.698 . . . . 0.35 111.386 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -91.21 -68.18 0.81 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.209 1.404 . . . . 0.35 110.092 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.473 HD22 ' H ' ' A' ' 122' ' ' ASN . 0.1 OUTLIER -107.94 103.34 49.46 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.234 1.014 . . . . 0.36 112.407 -165.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.43 -177.68 3.72 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.926 2.417 . . . . 0.35 111.174 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -153.3 68.0 0.31 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.876 -1.289 . . . . 0.35 109.876 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -57.71 129.11 40.38 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.787 1.235 . . . . 0.35 109.376 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -131.89 116.0 16.62 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.523 -0.918 . . . . 0.36 108.523 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -88.5 60.13 5.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.257 1.023 . . . . 0.35 109.628 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.8 mt -78.66 130.9 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.408 1.083 . . . . 0.35 109.542 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.4 m -143.85 139.23 29.16 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.174 1.39 . . . . 0.35 108.354 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.76 93.52 9.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.187 0.995 . . . . 0.35 108.467 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.73 138.29 30.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 C-N-CA 124.198 0.999 . . . . 0.35 111.222 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.79 100.62 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.427 1.491 . . . . 0.35 108.751 -175.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 18.5 mt -90.98 145.84 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.089 0.956 . . . . 0.35 110.234 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -138.59 127.05 23.15 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.845 1.258 . . . . 0.35 109.208 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -66.71 125.71 26.7 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.316 1.046 . . . . 0.35 109.579 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? . . . . . 0 C--N 1.34 0.183 0 C-N-CA 123.128 0.571 . . . . 0.25 109.745 176.586 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.7 p90 . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 109.697 -0.483 . . . . 0.35 109.697 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -79.83 -171.74 3.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.402 0.681 . . . . 0.35 110.596 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 17.8 pttm 47.75 -134.34 1.15 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.464 1.506 . . . . 0.35 111.816 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.02 74.95 0.07 OUTLIER Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.339 0.972 . . . . 0.35 111.842 -175.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt 52.56 62.56 2.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.537 1.135 . . . . 0.35 110.344 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -135.86 133.43 37.77 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.317 1.047 . . . . 0.35 110.512 -170.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.33 45.2 0.64 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.962 1.305 . . . . 0.35 109.016 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt 64.17 -89.54 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.401 1.48 . . . . 0.35 108.929 -168.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.33 32.58 0.12 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.338 -1.105 . . . . 0.35 110.338 168.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 55.3 20.08 3.33 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.014 1.726 . . . . 0.35 113.016 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 47.78 40.47 12.44 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.518 1.527 . . . . 0.35 111.618 -173.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.05 85.35 0.15 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.373 0.669 . . . . 0.35 109.904 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -86.86 -112.54 0.05 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.794 0.838 . . . . 0.35 109.452 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -149.11 67.68 1.04 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.268 1.027 . . . . 0.35 110.355 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -154.28 91.56 1.43 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.324 1.05 . . . . 0.35 108.363 166.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 69.49 150.36 0.12 Allowed Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.875 1.67 . . . . 0.33 111.661 173.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.45 93.14 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.0 2.467 . . . . 0.35 111.187 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 p -74.41 -52.57 11.69 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.155 0.982 . . . . 0.35 109.162 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.4 163.42 29.31 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.147 -0.781 . . . . 0.33 111.147 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -80.85 -174.44 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.482 3.455 . . . . 0.35 112.092 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -163.15 -178.45 6.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.077 1.751 . . . . 0.35 108.807 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 tt -155.05 83.63 1.08 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.712 -1.218 . . . . 0.35 107.712 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.1 ttp -82.27 118.63 23.27 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.324 0.65 . . . . 0.35 110.56 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.0 t -107.78 101.11 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 126.019 1.728 . . . . 0.35 108.281 -174.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -156.82 -177.4 6.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.582 1.153 . . . . 0.36 110.71 -172.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.85 -164.63 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.268 1.427 . . . . 0.35 109.162 172.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 m -133.2 99.76 4.65 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.382 -1.34 . . . . 0.35 107.382 169.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.35 87.57 1.21 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.823 1.201 . . . . 0.35 111.857 -171.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -104.44 166.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 124.15 0.98 . . . . 0.35 111.943 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.32 176.46 9.3 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.638 1.575 . . . . 0.35 109.288 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 t -53.55 -41.52 66.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.708 0.803 . . . . 0.35 110.755 166.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -91.86 18.87 7.16 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.612 1.165 . . . . 0.35 112.459 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 -5.7 76.79 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.926 -0.93 . . . . 0.35 114.921 168.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -75.07 123.57 25.44 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.921 1.361 . . . . 0.36 110.09 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.14 102.24 0.48 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.162 0.985 . . . . 0.35 110.841 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.68 -72.32 0.3 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.845 0.858 . . . . 0.35 108.828 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 mt -93.63 156.37 16.75 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.23 -1.026 . . . . 0.35 108.23 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.1 t -119.43 71.33 13.02 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 124.021 0.928 . . . . 0.33 109.652 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.61 91.84 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 124.539 3.493 . . . . 0.35 109.893 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -156.73 55.15 0.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.713 1.205 . . . . 0.35 109.032 -172.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -154.92 15.22 0.42 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.732 1.012 . . . . 0.35 113.732 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.8 t -125.94 119.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 C-N-CA 123.842 0.857 . . . . 0.35 108.859 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.68 169.52 17.64 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.291 0.636 . . . . 0.35 111.9 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.94 157.93 53.48 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 125.907 1.683 . . . . 0.33 108.486 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.98 168.62 22.64 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.858 2.372 . . . . 0.35 110.413 171.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 tp -65.21 118.79 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.628 0.771 . . . . 0.35 110.419 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -144.64 83.63 9.57 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.622 1.169 . . . . 0.33 108.636 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -84.58 -168.53 0.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.014 3.143 . . . . 0.35 109.907 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.17 -15.7 61.41 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.665 0.65 . . . . 0.35 112.356 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.0 t -75.36 148.03 39.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.799 0.84 . . . . 0.35 110.491 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.7 m -66.77 148.51 51.83 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.056 0.942 . . . . 0.35 108.94 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.99 116.03 7.88 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.401 -0.592 . . . . 0.35 109.401 -172.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -164.05 171.29 15.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.281 1.832 . . . . 0.35 108.099 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -52.69 -41.37 63.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.138 0.975 . . . . 0.35 112.143 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -83.98 -2.54 56.77 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.661 0.784 . . . . 0.35 113.042 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.42 50.81 2.2 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.503 1.121 . . . . 0.35 110.196 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -159.68 -48.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.378 1.071 . . . . 0.35 109.234 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.16 -47.34 62.16 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.044 1.338 . . . . 0.35 112.996 -174.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -63.77 -41.27 98.0 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.996 0.362 . . . . 0.35 111.79 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -65.09 -44.97 87.13 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.037 0.935 . . . . 0.35 111.745 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 m -69.2 -29.38 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.417 0.687 . . . . 0.35 112.497 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -72.21 -36.88 69.29 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 122.813 0.445 . . . . 0.35 111.08 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.21 -28.19 65.08 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.055 0.542 . . . . 0.35 111.394 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.01 -60.05 3.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.42 0.688 . . . . 0.35 110.618 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.69 -23.81 67.37 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.661 0.615 . . . . 0.35 112.661 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.15 -22.62 64.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.516 0.726 . . . . 0.35 112.252 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.62 -54.07 42.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.944 0.898 . . . . 0.35 111.802 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.7 p -75.23 -70.14 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.441 0.696 . . . . 0.35 110.832 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.8 148.56 25.96 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.102 1.361 . . . . 0.35 109.841 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -167.08 44.01 0.05 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.543 0.737 . . . . 0.35 111.221 -173.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -139.26 -71.39 0.4 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.026 0.531 . . . . 0.35 111.206 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -62.99 -57.28 11.24 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.065 0.946 . . . . 0.35 112.215 -167.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -62.72 145.15 55.46 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.746 0.418 . . . . 0.35 111.802 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.36 -41.5 2.04 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.498 1.919 . . . . 0.35 109.059 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t 79.33 126.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.283 0 C-N-CA 126.569 1.948 . . . . 0.35 111.539 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.14 -60.57 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 124.98 1.312 . . . . 0.35 108.982 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -153.81 128.73 9.53 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.868 0.867 . . . . 0.35 109.93 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.4 mt -78.49 118.7 20.88 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.801 -1.555 . . . . 0.35 106.801 164.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.15 137.09 95.67 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.979 -0.378 . . . . 0.33 109.979 -172.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -66.22 -33.93 37.94 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.41 2.74 . . . . 0.35 111.088 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -83.87 75.27 10.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.537 1.135 . . . . 0.35 110.165 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.89 165.05 13.74 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.654 0.782 . . . . 0.35 109.884 167.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -153.48 121.27 6.01 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.177 0.513 . . . . 0.35 111.794 -167.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.61 122.32 44.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 126.673 1.989 . . . . 0.35 107.093 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -111.96 77.73 1.07 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.415 -1.328 . . . . 0.35 107.415 173.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -72.79 86.94 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.591 0.71 . . . . 0.35 109.555 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.4 m -94.36 92.52 7.21 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.395 1.478 . . . . 0.35 108.816 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -91.37 169.22 10.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.648 1.179 . . . . 0.35 109.757 172.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -149.66 63.01 1.0 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.604 1.162 . . . . 0.35 108.033 173.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.87 86.69 4.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.525 1.13 . . . . 0.35 108.803 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -78.98 71.92 5.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.047 1.339 . . . . 0.35 109.214 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -149.31 -57.5 0.2 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.34 1.456 . . . . 0.36 109.168 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.84 35.56 0.4 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.658 0.783 . . . . 0.35 111.57 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.6 -51.06 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.937 0.495 . . . . 0.35 110.47 -170.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt 69.26 -153.18 0.14 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.689 1.596 . . . . 0.35 110.229 -173.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -95.18 130.91 41.72 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.503 1.121 . . . . 0.35 110.857 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -141.74 121.17 13.21 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.466 1.106 . . . . 0.35 108.463 171.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.6 m -81.29 85.4 6.4 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.304 -1.369 . . . . 0.35 107.304 170.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -79.75 95.75 6.08 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.058 0.943 . . . . 0.35 109.266 -173.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.5 p -88.17 70.1 9.24 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.667 1.187 . . . . 0.35 111.642 -171.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -68.12 136.48 91.66 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.709 0.804 . . . . 0.33 108.985 171.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -79.73 -111.76 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.338 2.692 . . . . 0.35 110.275 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.5 tp -163.21 153.37 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.987 1.315 . . . . 0.35 108.478 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.8 p -129.69 156.17 44.7 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.759 0.823 . . . . 0.35 109.928 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.2 -26.08 52.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.311 1.444 . . . . 0.35 112.017 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.83 -44.0 94.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.436 1.095 . . . . 0.35 113.099 -165.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.71 64.97 0.62 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.031 -1.228 . . . . 0.35 110.031 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -73.95 126.08 29.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.617 -0.512 . . . . 0.35 109.617 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.9 t -76.27 130.56 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.263 -1.014 . . . . 0.35 108.263 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.23 120.89 77.8 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 107.712 -1.218 . . . . 0.33 107.712 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.35 -94.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.977 2.451 . . . . 0.35 109.312 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -169.81 -82.69 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.395 1.478 . . . . 0.35 107.275 166.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.7 mt -150.81 160.6 43.76 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.051 1.34 . . . . 0.35 110.444 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.3 t -100.6 -72.7 0.66 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.658 1.183 . . . . 0.35 108.992 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -166.77 -48.39 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.191 0.996 . . . . 0.35 110.066 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.17 -35.63 12.06 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.675 1.99 . . . . 0.35 115.385 -168.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.2 pt -132.23 171.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 124.163 0.985 . . . . 0.35 110.963 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.09 42.34 0.59 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.277 1.031 . . . . 0.35 111.064 172.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.01 54.47 0.56 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.785 1.234 . . . . 0.36 110.214 170.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -44.09 -55.27 3.23 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 125.027 3.818 . . . . 0.35 113.759 -173.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.39 67.95 1.83 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.162 -0.775 . . . . 0.35 111.162 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -67.21 139.17 57.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.143 0.977 . . . . 0.35 111.12 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -127.58 87.9 2.7 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.767 1.227 . . . . 0.36 108.292 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -75.25 98.76 3.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.939 -1.504 . . . . 0.35 106.939 174.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.53 96.67 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.679 1.192 . . . . 0.35 108.398 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.3 m -84.88 146.8 27.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.185 0.994 . . . . 0.35 109.783 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.14 122.82 29.36 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.776 -1.194 . . . . 0.35 107.776 173.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.71 137.2 57.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 123.211 0.604 . . . . 0.35 110.517 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.9 t -97.48 103.23 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.674 1.189 . . . . 0.35 108.361 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.3 mt -82.05 126.13 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.231 1.012 . . . . 0.35 109.977 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -100.44 140.63 34.42 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 107.84 -1.17 . . . . 0.35 107.84 155.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.75 138.22 45.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.518 1.127 . . . . 0.35 110.381 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 124.101 0.96 . . . . 0.25 109.013 178.358 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.9 t80 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 107.893 -1.151 . . . . 0.35 107.893 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.77 92.76 0.16 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.953 1.301 . . . . 0.35 111.967 -163.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -146.46 80.39 1.55 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.081 1.753 . . . . 0.35 107.146 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.14 98.79 1.5 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.996 0.808 . . . . 0.35 111.298 -175.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 54.65 63.48 2.13 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.204 1.402 . . . . 0.35 109.744 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -109.61 -69.55 0.86 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.513 1.525 . . . . 0.35 109.525 -174.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 65.17 165.64 0.17 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.686 1.594 . . . . 0.35 111.83 -170.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -46.36 -53.45 10.88 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.368 1.467 . . . . 0.35 112.054 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.61 -23.65 0.56 Allowed Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.952 0.787 . . . . 0.35 111.648 -175.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.11 -22.6 65.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.929 1.292 . . . . 0.35 112.604 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.67 130.0 44.69 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 123.625 0.77 . . . . 0.35 110.865 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.43 52.7 0.73 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.831 0.852 . . . . 0.35 109.103 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -61.85 140.37 58.27 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.307 1.043 . . . . 0.35 111.104 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 64.73 174.27 0.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.352 1.461 . . . . 0.35 113.156 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.5 t80 56.59 88.56 0.05 OUTLIER 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.85 2.06 . . . . 0.35 112.028 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 70.43 154.72 0.15 Allowed Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.431 1.892 . . . . 0.33 111.474 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -63.61 100.65 0.29 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.146 2.564 . . . . 0.35 109.58 163.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -107.35 -70.79 0.78 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.931 0.892 . . . . 0.35 111.263 -172.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.23 111.5 0.45 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.884 -0.953 . . . . 0.33 110.801 -169.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.5 -179.29 4.33 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.403 2.735 . . . . 0.35 112.294 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -165.65 178.84 6.38 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.145 0.978 . . . . 0.35 110.549 -166.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -153.02 92.63 1.65 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.059 1.344 . . . . 0.35 107.586 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 68.3 mtp -88.05 101.42 13.76 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.402 1.481 . . . . 0.35 110.409 -168.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.2 t -98.78 112.32 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.187 0.995 . . . . 0.35 109.591 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -175.46 171.44 2.83 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.502 1.121 . . . . 0.36 109.964 174.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.87 140.33 36.15 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.11 0.964 . . . . 0.35 111.785 -178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.6 m -70.55 101.25 1.97 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.448 1.899 . . . . 0.35 108.947 175.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.08 87.0 1.33 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.04 0.829 . . . . 0.35 111.654 -172.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.2 m -85.04 166.46 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 123.895 0.878 . . . . 0.35 110.477 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.23 -42.8 30.13 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.804 -0.443 . . . . 0.35 109.804 166.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 t -173.11 -53.72 0.02 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 125.246 1.418 . . . . 0.35 110.022 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -92.6 41.87 1.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.484 1.114 . . . . 0.35 113.92 -159.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.81 60.47 8.4 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.494 -0.642 . . . . 0.35 111.494 172.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -157.19 98.67 1.74 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.163 0.985 . . . . 0.36 109.42 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.65 118.64 7.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.805 1.242 . . . . 0.35 111.01 -173.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.89 -48.07 26.68 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.941 0.896 . . . . 0.35 110.036 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.5 mt -86.62 -169.37 2.61 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.405 1.082 . . . . 0.35 111.053 -171.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.8 p -130.32 78.62 74.09 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 106.87 -1.53 . . . . 0.33 106.87 163.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -85.49 77.14 2.8 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 124.804 3.669 . . . . 0.35 109.636 -166.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -150.12 85.67 1.41 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.132 0.973 . . . . 0.35 108.602 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -155.55 -48.42 0.08 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.249 0.62 . . . . 0.35 112.273 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.55 119.88 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.009 0.822 . . . . 0.35 110.048 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -156.43 151.84 26.73 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.541 1.137 . . . . 0.35 109.788 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -129.93 153.32 80.95 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 125.502 1.521 . . . . 0.33 108.742 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.39 60.9 7.51 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.711 2.94 . . . . 0.35 110.345 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 tp 39.97 89.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.689 1.996 . . . . 0.35 112.578 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -107.87 92.24 8.73 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.879 1.272 . . . . 0.33 108.633 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.87 155.96 48.31 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.127 2.551 . . . . 0.35 110.804 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.08 -50.4 0.7 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.573 -1.011 . . . . 0.35 110.573 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.4 t -63.01 146.48 53.11 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.905 0.882 . . . . 0.35 110.729 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 m -77.97 116.88 18.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.622 -0.51 . . . . 0.35 109.622 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -77.08 86.19 3.58 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.021 1.328 . . . . 0.35 108.572 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 p -150.0 151.85 33.97 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.682 1.193 . . . . 0.35 110.558 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -52.51 -53.06 50.93 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.178 1.391 . . . . 0.35 111.208 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -49.78 -45.32 49.61 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.677 1.191 . . . . 0.35 112.978 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -76.52 -50.01 15.05 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.018 0.372 . . . . 0.35 111.506 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.7 mm -54.22 -38.18 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.646 1.178 . . . . 0.35 112.402 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -52.9 -61.01 2.57 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.957 0.799 . . . . 0.35 112.015 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -71.41 -36.83 71.47 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.697 0.258 . . . . 0.35 111.697 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -64.77 -47.99 76.14 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.759 0.824 . . . . 0.35 111.786 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 p -71.89 -28.19 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.497 0.719 . . . . 0.35 111.322 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.69 -44.5 90.09 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 123.019 0.528 . . . . 0.35 109.643 172.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -66.18 -20.86 66.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.45 0.7 . . . . 0.35 112.369 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.33 -47.3 64.82 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.886 0.766 . . . . 0.35 110.914 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -39.36 84.98 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 109.936 -0.394 . . . . 0.35 109.936 173.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -93.42 52.12 1.7 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.876 1.271 . . . . 0.35 110.033 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.96 -58.84 2.01 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.019 1.328 . . . . 0.35 108.541 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.1 p -80.87 -50.16 10.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.622 1.169 . . . . 0.35 110.658 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.46 -97.61 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.971 0.908 . . . . 0.35 109.917 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.3 t80 54.98 87.63 0.05 OUTLIER 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.914 1.686 . . . . 0.35 113.072 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -161.23 -49.33 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.237 0.615 . . . . 0.35 109.954 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -120.75 50.73 1.3 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.026 1.33 . . . . 0.35 109.521 -175.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -139.04 92.0 2.56 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.371 1.068 . . . . 0.35 109.855 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -73.43 -40.0 64.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.463 1.105 . . . . 0.35 111.35 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.5 t 74.24 115.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 126.169 1.788 . . . . 0.35 110.798 -175.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.05 -67.37 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 108.13 -1.063 . . . . 0.35 108.13 172.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -145.12 165.02 29.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.844 1.658 . . . . 0.35 109.116 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -130.67 129.17 42.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.058 1.343 . . . . 0.35 107.431 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.91 132.28 84.97 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.946 -0.39 . . . . 0.33 109.946 -168.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.99 -22.71 22.68 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.505 2.803 . . . . 0.35 111.517 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.2 m -82.61 68.04 8.91 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.371 1.068 . . . . 0.35 110.328 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.99 165.09 25.76 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.864 0.865 . . . . 0.35 110.267 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -148.71 132.62 17.1 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.219 0.533 . . . . 0.35 112.119 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.2 114.69 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.877 -1.897 . . . . 0.35 105.877 171.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -107.94 58.1 0.62 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.957 0.903 . . . . 0.35 108.628 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.77 103.69 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.953 0.901 . . . . 0.35 110.372 -174.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 89.9 m -99.61 100.76 11.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.399 1.48 . . . . 0.35 108.114 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -98.87 84.89 3.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.015 0.926 . . . . 0.35 110.314 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -69.92 75.95 0.47 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.373 1.869 . . . . 0.35 109.769 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -120.5 65.53 0.84 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.14 1.376 . . . . 0.35 108.677 -170.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.7 110.35 6.19 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.35 0.66 . . . . 0.35 110.269 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -178.68 -47.6 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.293 1.837 . . . . 0.36 108.801 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -37.48 0.11 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.367 1.067 . . . . 0.35 110.883 172.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -78.06 -52.6 8.5 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.612 0.765 . . . . 0.35 110.651 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt 72.95 170.46 0.31 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.799 1.639 . . . . 0.35 111.382 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.16 125.23 24.33 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.663 0.785 . . . . 0.35 111.157 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -140.51 108.74 5.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.579 -1.267 . . . . 0.35 107.579 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.4 m -76.0 86.54 2.92 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.026 -1.102 . . . . 0.35 108.026 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -80.47 98.29 7.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.066 0.946 . . . . 0.35 108.553 -175.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.6 p -87.29 64.54 8.33 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.719 1.208 . . . . 0.35 111.116 -174.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -65.9 134.73 95.15 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.727 -0.842 . . . . 0.33 108.727 170.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.35 -114.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.24 2.627 . . . . 0.35 109.511 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 tp -161.67 151.57 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.973 0.806 . . . . 0.35 109.74 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.9 p -127.16 150.05 49.68 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.057 1.343 . . . . 0.35 109.678 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -67.37 0.48 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.477 0.711 . . . . 0.35 110.023 -176.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -108.78 101.71 10.81 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 106.607 -1.627 . . . . 0.35 106.607 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.15 -97.91 0.87 Allowed Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.332 0.968 . . . . 0.35 111.86 -168.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -159.37 177.54 10.89 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.261 0.624 . . . . 0.35 111.443 -163.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.1 t -102.71 150.63 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.982 1.713 . . . . 0.35 110.142 -175.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.3 t -54.52 114.91 7.5 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.308 1.043 . . . . 0.33 108.88 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.08 148.81 19.55 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.791 2.327 . . . . 0.35 111.016 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -94.18 -178.19 4.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.956 1.303 . . . . 0.35 110.132 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.85 165.35 25.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.725 0.81 . . . . 0.35 111.518 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.3 t -142.22 -68.42 0.37 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.464 1.106 . . . . 0.35 109.57 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -163.87 -52.71 0.03 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.208 1.003 . . . . 0.35 109.497 -174.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -42.08 -43.81 3.38 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.872 2.069 . . . . 0.35 114.068 -173.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.1 pt -133.82 173.9 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.606 0.762 . . . . 0.35 111.398 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -107.06 -44.92 4.27 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 126.203 1.801 . . . . 0.35 108.685 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -120.4 101.56 46.39 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.907 1.283 . . . . 0.36 110.865 -170.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -57.83 -59.51 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.452 2.768 . . . . 0.35 111.926 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 64.92 66.89 2.25 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.759 -0.937 . . . . 0.35 110.759 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -70.72 144.67 50.89 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.392 1.077 . . . . 0.35 111.162 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -132.16 92.93 3.18 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.371 1.068 . . . . 0.36 108.995 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.74 62.92 7.76 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.442 1.097 . . . . 0.35 108.628 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.98 125.14 54.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 125.465 1.506 . . . . 0.35 107.141 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.9 m -141.88 172.65 12.39 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.251 1.82 . . . . 0.35 107.631 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.69 131.55 56.92 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.556 1.142 . . . . 0.35 109.49 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.4 m -130.24 155.21 41.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 C-N-CA 124.677 1.191 . . . . 0.35 110.371 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.63 103.51 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.977 1.311 . . . . 0.35 108.716 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 29.1 mt -81.37 139.05 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.122 0.969 . . . . 0.35 110.772 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -102.66 128.99 49.13 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.417 -1.697 . . . . 0.35 106.417 162.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -84.33 74.2 10.37 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.497 -0.927 . . . . 0.35 108.497 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.341 0.228 0 C-N-CA 125.735 1.614 . . . . 0.25 109.475 -173.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 t80 . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.441 -0.577 . . . . 0.35 109.441 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -124.96 53.37 1.5 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.335 1.054 . . . . 0.35 110.392 -174.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -122.52 -51.78 1.94 Allowed 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.497 1.119 . . . . 0.35 108.573 173.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.61 78.85 0.8 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.648 . . . . 0.35 112.331 169.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp 58.21 73.4 0.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.686 1.194 . . . . 0.35 111.484 166.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -111.84 60.55 0.62 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.44 1.096 . . . . 0.35 109.802 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.19 177.89 8.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.756 0.823 . . . . 0.35 112.482 -168.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.7 tttm 60.48 52.86 4.44 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 127.111 2.165 . . . . 0.35 110.447 -172.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.42 -86.38 0.46 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 106.828 -2.509 . . . . 0.35 106.828 172.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t0 53.28 61.96 2.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.259 1.024 . . . . 0.35 109.499 176.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 64.87 53.92 1.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.425 1.49 . . . . 0.35 110.953 -171.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.74 91.06 0.05 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.936 1.694 . . . . 0.35 112.362 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -55.23 -53.86 50.76 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.503 1.121 . . . . 0.35 111.44 -176.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -77.12 175.84 9.26 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.11 0.964 . . . . 0.35 111.851 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.3 t80 60.12 84.86 0.11 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 126.38 1.872 . . . . 0.35 111.107 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 66.37 158.92 0.13 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 126.491 1.916 . . . . 0.33 112.144 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.06 129.97 35.82 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.157 2.572 . . . . 0.35 111.592 167.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.5 p -121.92 -57.54 1.79 Allowed 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.506 1.123 . . . . 0.35 109.122 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.69 172.96 43.61 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 112.343 -0.303 . . . . 0.33 112.343 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.48 166.47 19.52 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 124.223 3.282 . . . . 0.35 113.835 -173.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -154.75 161.52 41.48 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.811 1.244 . . . . 0.35 109.668 167.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 tt -157.32 99.15 1.76 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.446 -0.946 . . . . 0.35 108.446 -170.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.9 mtp -92.14 146.34 23.8 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.396 1.479 . . . . 0.35 110.329 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.6 t -146.05 90.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.4 0 C-N-CA 124.046 0.939 . . . . 0.35 110.458 -167.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -156.01 -179.7 8.39 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.356 1.062 . . . . 0.36 110.949 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.7 m -129.33 150.61 34.79 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 125.028 1.331 . . . . 0.35 111.494 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.1 m -80.62 91.77 5.88 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.014 -1.476 . . . . 0.35 107.014 169.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.31 73.05 2.71 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.071 -0.812 . . . . 0.35 111.071 -172.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.89 147.29 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 122.944 0.498 . . . . 0.35 110.679 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.99 178.88 5.95 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.598 1.159 . . . . 0.35 109.323 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -47.31 -45.31 24.25 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.202 1.001 . . . . 0.35 110.599 164.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -105.95 34.36 3.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.723 1.209 . . . . 0.35 111.562 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.62 -25.14 8.7 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.111 -0.827 . . . . 0.35 115.032 167.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -61.32 124.93 21.99 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.344 1.072 . . . . 0.36 111.64 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.62 101.01 0.95 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.581 0.752 . . . . 0.35 110.205 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.74 -50.09 39.85 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.384 1.074 . . . . 0.35 110.007 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 pp -130.47 150.76 51.53 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.663 1.185 . . . . 0.35 110.224 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 t -82.8 147.49 55.13 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.044 0.937 . . . . 0.33 111.604 -164.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.03 27.58 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.31 3.34 . . . . 0.35 112.588 171.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -169.09 132.44 1.33 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.931 0.893 . . . . 0.35 109.652 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -165.28 -72.47 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.381 1.073 . . . . 0.35 109.481 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.07 147.05 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.702 0.801 . . . . 0.35 109.716 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -142.94 166.79 23.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.723 0.809 . . . . 0.35 111.142 174.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -141.04 144.82 36.53 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 125.049 1.339 . . . . 0.33 108.576 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.06 64.77 8.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.948 3.099 . . . . 0.35 110.655 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.258 9.0 tt 39.42 110.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 129.567 3.147 . . . . 0.35 114.608 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -119.83 82.32 27.48 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.263 1.025 . . . . 0.33 108.528 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -82.9 -170.31 0.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.952 3.101 . . . . 0.35 110.576 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.41 -41.57 2.1 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.739 -0.945 . . . . 0.35 110.739 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.9 t -66.32 152.61 44.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.604 0.762 . . . . 0.35 110.347 174.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.5 m -69.18 150.31 47.64 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.779 -0.823 . . . . 0.35 108.779 171.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.3 tp -127.41 102.93 7.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.912 -1.144 . . . . 0.35 107.912 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -151.61 176.07 11.72 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.505 1.522 . . . . 0.35 109.43 -170.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -63.13 -47.49 82.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.738 0.415 . . . . 0.35 111.46 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.93 -30.73 70.95 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.012 0.745 . . . . 0.35 113.012 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -64.39 -54.61 30.17 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.205 0.602 . . . . 0.35 109.377 171.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mm -51.55 -49.88 31.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 125.143 1.377 . . . . 0.35 111.18 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -45.49 -56.71 4.77 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.665 1.186 . . . . 0.35 112.518 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -75.31 -37.14 60.96 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.969 0.359 . . . . 0.35 111.969 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -67.11 -48.65 67.48 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.669 0.787 . . . . 0.35 111.958 -169.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.4 m -67.99 -33.0 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.884 0.473 . . . . 0.35 111.266 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -65.13 -41.17 95.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.541 0.737 . . . . 0.35 110.678 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -35.12 75.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.453 0.701 . . . . 0.35 111.148 176.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.77 -48.58 76.39 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.592 0.757 . . . . 0.35 111.334 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.8 -19.98 61.24 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.386 0.675 . . . . 0.35 112.423 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -77.29 13.41 1.18 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.448 0.699 . . . . 0.35 112.197 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.57 -41.4 65.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.375 -0.602 . . . . 0.35 109.375 160.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 70.2 p -103.35 -49.4 3.73 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.208 1.403 . . . . 0.35 111.748 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.75 -85.67 0.09 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.8 0.84 . . . . 0.35 111.32 -170.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.8 p90 51.62 18.17 0.68 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.3 2.24 . . . . 0.35 116.016 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -131.99 -81.02 0.51 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.31 0.959 . . . . 0.35 112.097 -164.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -97.26 -54.46 3.15 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.577 0.751 . . . . 0.35 111.943 -158.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -45.37 145.57 1.16 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.433 2.293 . . . . 0.35 114.378 -173.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -85.69 -63.08 1.38 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.872 1.269 . . . . 0.35 111.348 -172.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.3 t 72.1 97.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 126.071 1.748 . . . . 0.35 108.984 -164.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.69 -65.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.085 0.954 . . . . 0.35 109.305 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -162.51 135.78 6.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.879 0.872 . . . . 0.35 109.186 -174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.67 152.83 24.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.838 0.855 . . . . 0.35 110.927 177.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.87 145.53 50.25 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.948 -0.76 . . . . 0.33 108.948 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.12 -17.12 40.64 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.47 2.78 . . . . 0.35 111.993 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -83.39 61.51 6.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.509 1.124 . . . . 0.35 111.069 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.98 141.24 45.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.223 -1.399 . . . . 0.35 107.223 159.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -148.61 131.57 16.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.191 0.52 . . . . 0.35 112.4 -171.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 mp -75.88 116.41 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.439 -1.689 . . . . 0.35 106.439 168.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -107.68 68.82 0.72 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.343 -1.354 . . . . 0.35 107.343 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.98 115.01 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.924 0.89 . . . . 0.35 110.519 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.0 m -110.16 87.33 2.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.47 1.508 . . . . 0.35 108.496 -172.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.62 87.12 3.99 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.018 1.327 . . . . 0.35 111.22 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -74.77 85.5 2.17 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.961 1.305 . . . . 0.35 109.674 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -132.81 71.77 1.48 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.376 -0.972 . . . . 0.35 108.376 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -53.12 -22.43 6.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.646 1.578 . . . . 0.35 113.834 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -58.14 -31.41 67.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.73 1.212 . . . . 0.36 112.438 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.7 -52.48 0.34 Allowed 'General case' 0 C--N 1.344 0.367 0 N-CA-C 112.662 0.615 . . . . 0.35 112.662 173.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -87.4 -58.45 2.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.647 0.658 . . . . 0.35 111.644 -168.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt 85.65 160.99 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.975 2.11 . . . . 0.35 110.492 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.41 97.9 0.6 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.791 1.236 . . . . 0.35 111.506 -174.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -119.18 123.63 44.82 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 107.729 -1.211 . . . . 0.35 107.729 168.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.1 m -87.99 83.14 7.07 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.453 1.101 . . . . 0.35 108.179 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -75.16 119.81 19.81 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.344 1.057 . . . . 0.35 109.916 -170.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.6 m -83.09 74.75 9.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.101 1.361 . . . . 0.35 111.488 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -80.52 132.99 56.93 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.75 -1.204 . . . . 0.33 107.75 165.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.72 -118.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.309 2.673 . . . . 0.35 110.178 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.4 tp -159.87 155.38 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.462 1.105 . . . . 0.35 108.777 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.8 p -124.01 136.8 54.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.147 0.979 . . . . 0.35 109.058 174.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -73.17 -33.1 65.26 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.945 0.898 . . . . 0.35 110.776 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -21.13 65.1 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.424 0.69 . . . . 0.35 112.205 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.96 174.96 43.56 Favored Glycine 0 C--N 1.341 0.85 0 C-N-CA 123.904 0.764 . . . . 0.35 114.223 166.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -161.43 136.16 7.25 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.406 1.083 . . . . 0.35 109.867 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.16 126.48 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.653 -0.869 . . . . 0.35 108.653 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.2 t -73.02 121.62 85.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 107.475 -1.305 . . . . 0.33 107.475 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.43 -102.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.246 2.63 . . . . 0.35 110.432 -173.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -163.52 111.44 1.2 Allowed 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.497 1.119 . . . . 0.35 108.271 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.413 HD12 ' HD3' ' A' ' 123' ' ' PRO . 2.9 tm? -87.9 97.22 10.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.157 0.983 . . . . 0.35 108.587 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.5 t -170.76 86.68 0.11 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.951 1.3 . . . . 0.35 108.391 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -153.34 -71.48 0.14 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.329 0.652 . . . . 0.35 109.485 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -92.76 -52.29 4.69 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.469 1.108 . . . . 0.35 109.355 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.5 pt -109.51 169.13 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.392 1.477 . . . . 0.35 108.934 170.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.89 19.63 0.26 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.372 1.249 . . . . 0.35 114.372 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.96 61.52 28.68 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.093 0.86 . . . . 0.36 111.85 175.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.413 ' HD3' HD12 ' A' ' 116' ' ' LEU . 94.7 Cg_endo -73.53 172.73 15.13 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.219 3.279 . . . . 0.35 111.36 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.38 68.49 0.43 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.051 -1.219 . . . . 0.35 110.051 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -64.02 88.93 0.05 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.353 1.461 . . . . 0.35 110.407 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -99.51 100.65 11.7 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.641 -0.874 . . . . 0.36 108.641 -174.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.6 93.47 8.38 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.385 1.074 . . . . 0.35 109.055 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.17 134.49 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.504 -1.295 . . . . 0.35 107.504 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 44.7 m -142.67 116.58 9.34 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 107.269 -1.382 . . . . 0.35 107.269 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -73.42 133.17 43.67 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.421 -0.585 . . . . 0.35 109.421 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.9 m -134.36 136.7 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.111 0.965 . . . . 0.35 109.604 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 77.6 t -82.58 137.35 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.406 -0.961 . . . . 0.35 108.406 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 47.2 mt -137.26 133.45 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.697 1.199 . . . . 0.35 108.978 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -97.44 130.26 44.57 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.324 -1.361 . . . . 0.35 107.324 161.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -72.2 96.26 1.78 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.724 -0.843 . . . . 0.35 108.724 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.34 0.168 0 C-N-CA 125.538 1.535 . . . . 0.25 109.325 -167.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.465 ' N ' ' HH ' ' A' ' 44' ' ' TYR . 47.1 t80 . . . . . 0 CA--C 1.531 0.237 0 CA-C-O 120.655 0.264 . . . . 0.35 110.885 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -112.57 42.03 1.91 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.405 1.082 . . . . 0.35 109.101 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.63 -47.7 0.69 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.029 1.732 . . . . 0.35 109.523 -177.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.67 56.16 1.92 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.766 -0.934 . . . . 0.35 110.766 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 56.99 70.72 0.63 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.295 1.438 . . . . 0.35 111.458 176.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -90.58 0.41 57.37 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.178 1.391 . . . . 0.35 112.449 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -175.59 3.24 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.268 1.027 . . . . 0.35 112.009 -176.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.5 tttp 93.94 -22.41 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.601 2.36 . . . . 0.35 112.456 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.6 81.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.859 1.219 . . . . 0.35 114.523 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -84.55 56.02 3.65 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.227 1.013 . . . . 0.35 111.068 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 48.99 45.05 22.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.494 1.517 . . . . 0.35 111.758 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.46 53.08 0.89 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.401 1.081 . . . . 0.35 109.679 -172.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 m -87.47 -122.26 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.762 0.825 . . . . 0.35 110.526 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -163.41 145.11 9.58 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.043 1.337 . . . . 0.35 108.11 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.1 t80 66.85 119.22 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.828 1.651 . . . . 0.35 111.369 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 68.55 151.85 0.13 Allowed Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 126.454 1.902 . . . . 0.33 111.699 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.71 92.08 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.335 2.69 . . . . 0.35 110.82 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.5 p -75.47 -42.96 51.82 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.807 0.843 . . . . 0.35 109.938 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.78 166.06 26.22 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.468 -0.653 . . . . 0.33 111.468 172.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.93 168.43 19.1 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.186 3.258 . . . . 0.35 111.09 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -163.34 176.62 9.69 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.389 1.076 . . . . 0.35 110.628 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 tt -156.59 94.14 1.44 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.079 0.951 . . . . 0.35 108.706 -175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -89.1 143.28 26.95 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.327 0.651 . . . . 0.35 109.923 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.9 t -144.67 91.41 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.244 1.017 . . . . 0.35 108.585 -172.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -153.31 162.49 41.24 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.607 1.163 . . . . 0.36 110.709 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -95.85 153.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 124.963 1.305 . . . . 0.35 110.097 174.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -88.91 93.84 9.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.412 -1.699 . . . . 0.35 106.412 169.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.77 105.77 1.63 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.505 -1.038 . . . . 0.35 110.505 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.49 169.64 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.927 1.291 . . . . 0.35 109.996 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -87.3 -179.78 6.47 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.829 0.852 . . . . 0.35 109.128 166.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 t -60.54 -38.79 85.6 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.663 0.785 . . . . 0.35 110.869 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -76.78 -0.91 25.59 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.427 1.091 . . . . 0.35 112.571 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.59 52.13 6.15 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 110.968 -0.853 . . . . 0.35 110.968 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -120.45 108.35 14.0 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.623 1.169 . . . . 0.36 108.416 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -65.96 118.29 9.54 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.793 0.837 . . . . 0.35 111.79 -172.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.34 -40.22 30.79 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.5 1.12 . . . . 0.35 109.875 169.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 pp -151.89 154.42 36.09 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.358 1.063 . . . . 0.35 112.304 -164.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.7 m -88.5 154.31 50.98 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.151 1.38 . . . . 0.33 110.353 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -86.14 49.79 2.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.314 3.342 . . . . 0.35 110.47 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -149.13 97.2 2.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.685 0.794 . . . . 0.35 109.523 -166.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.465 ' HH ' ' N ' ' A' ' 4' ' ' PHE . 42.8 p90 -162.15 -55.73 0.04 OUTLIER 'General case' 0 C--N 1.344 0.352 0 CA-C-O 118.85 -0.595 . . . . 0.35 112.451 171.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 m -82.66 141.06 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.328 0.967 . . . . 0.35 109.304 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -146.49 109.83 4.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.297 1.039 . . . . 0.35 109.089 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -94.28 154.4 40.41 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 125.366 1.466 . . . . 0.33 109.72 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.77 147.46 44.7 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.189 2.593 . . . . 0.35 109.844 169.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.81 137.0 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 122.977 0.511 . . . . 0.35 110.404 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -142.49 114.09 6.14 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.801 1.24 . . . . 0.33 107.837 171.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.74 179.87 6.1 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.61 2.874 . . . . 0.35 110.903 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.56 -26.66 18.92 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.424 -0.653 . . . . 0.35 112.643 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 t -67.07 141.36 57.52 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.801 0.8 . . . . 0.35 111.021 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.5 m -72.62 139.12 47.18 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.606 -0.887 . . . . 0.35 108.606 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.67 117.24 16.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.978 0.911 . . . . 0.35 108.963 -171.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.5 t -167.44 176.07 6.81 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.151 1.781 . . . . 0.35 108.458 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -57.76 -52.38 65.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.933 0.893 . . . . 0.35 110.796 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -64.56 -32.43 74.07 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.934 0.716 . . . . 0.35 112.934 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -65.98 -57.69 7.22 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.567 0.621 . . . . 0.35 110.369 175.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.79 -23.37 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.166 0.986 . . . . 0.35 111.805 -172.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.54 -58.35 8.93 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.174 0.99 . . . . 0.35 111.067 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -66.04 -37.85 86.88 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.14 0.427 . . . . 0.35 111.2 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -62.96 -48.7 77.75 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.559 0.744 . . . . 0.35 111.795 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.9 -36.77 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 118.256 0.48 . . . . 0.35 111.585 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -63.53 -37.1 86.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.807 0.843 . . . . 0.35 111.111 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -74.12 -37.8 64.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.872 0.469 . . . . 0.35 111.041 176.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.16 -44.03 97.52 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.297 1.039 . . . . 0.35 111.485 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.19 -41.49 63.78 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.904 0.482 . . . . 0.35 111.644 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -76.83 -3.4 38.23 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.436 0.694 . . . . 0.35 112.758 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.71 -42.45 83.77 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.866 0.757 . . . . 0.35 110.33 173.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.9 t -103.2 -38.93 7.06 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.105 1.362 . . . . 0.35 111.579 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.89 -101.18 0.03 OUTLIER 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.676 -0.678 . . . . 0.35 110.795 -173.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.1 t80 75.74 -43.33 0.48 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 126.572 1.949 . . . . 0.35 113.751 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -55.27 -67.1 0.3 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.345 1.458 . . . . 0.35 112.593 -169.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -107.11 24.22 13.16 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.235 0.614 . . . . 0.35 112.189 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -92.63 136.75 32.96 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.243 0.617 . . . . 0.35 111.431 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -164.05 109.24 1.02 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.962 1.305 . . . . 0.35 108.485 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 p -77.61 148.63 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.299 0.64 . . . . 0.35 109.87 171.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.47 -44.48 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.699 1.2 . . . . 0.35 109.888 173.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -129.39 151.54 49.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.269 1.428 . . . . 0.35 108.853 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.75 143.52 32.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.313 1.045 . . . . 0.35 109.909 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -72.39 117.24 57.04 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.787 0.835 . . . . 0.33 108.978 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.89 -27.4 21.12 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.867 2.378 . . . . 0.35 111.118 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.1 m -87.87 58.03 4.64 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.513 1.125 . . . . 0.35 110.358 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.97 167.08 5.05 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.26 0.624 . . . . 0.35 109.624 169.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -155.85 142.32 18.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.531 0.681 . . . . 0.35 112.352 -171.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 mp -85.74 111.73 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 106.144 -1.798 . . . . 0.35 106.144 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -100.99 70.78 1.38 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.614 -1.254 . . . . 0.35 107.614 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.16 99.16 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.333 0.653 . . . . 0.35 109.819 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 94.0 m -98.83 125.19 44.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.195 1.398 . . . . 0.35 109.012 -173.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -139.43 132.84 30.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.255 1.022 . . . . 0.35 109.484 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -101.26 60.34 0.91 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.451 1.5 . . . . 0.35 108.669 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -81.71 82.29 7.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.226 0.61 . . . . 0.35 109.665 -177.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -83.19 67.43 9.19 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.423 -0.955 . . . . 0.35 108.423 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -143.77 -49.14 0.3 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.905 1.682 . . . . 0.36 108.729 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 pttt -159.03 -54.93 0.06 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.512 0.725 . . . . 0.35 111.856 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -74.97 -22.24 58.67 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.884 0.698 . . . . 0.35 112.884 -172.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 81.0 tttt 75.5 164.18 0.26 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.785 1.634 . . . . 0.35 111.973 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -56.62 106.18 0.27 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.332 1.453 . . . . 0.35 110.528 172.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -145.17 145.28 31.29 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.414 1.086 . . . . 0.35 109.637 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 94.0 m -119.6 95.84 4.95 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 125.182 1.393 . . . . 0.35 108.056 176.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -70.64 125.44 26.83 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.253 -0.647 . . . . 0.35 109.253 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -96.18 63.16 2.2 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.886 1.274 . . . . 0.35 110.094 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -75.35 124.64 89.21 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 109.337 -0.616 . . . . 0.33 109.337 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.76 162.47 26.93 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.205 2.604 . . . . 0.35 111.454 -175.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.3 tp -76.97 152.68 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.017 0.927 . . . . 0.35 109.866 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.1 p -105.24 -179.41 3.94 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.137 0.975 . . . . 0.35 110.419 178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.57 -11.3 14.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.694 1.597 . . . . 0.35 110.81 166.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -78.06 -87.69 0.05 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.625 1.17 . . . . 0.35 110.506 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.15 63.79 0.01 OUTLIER Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.475 -1.05 . . . . 0.35 110.475 -172.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -73.56 126.03 29.33 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.285 -0.635 . . . . 0.35 109.285 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.67 135.25 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.663 -0.866 . . . . 0.35 108.663 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.9 112.05 6.02 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 107.592 -1.262 . . . . 0.33 107.592 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -89.32 14.66 2.16 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.927 2.418 . . . . 0.35 112.673 -165.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.3 t70 60.11 -157.44 0.33 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.266 1.027 . . . . 0.35 109.572 -168.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.5 tt -163.6 146.31 9.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.64 0.655 . . . . 0.35 110.396 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.5 t -154.33 164.72 38.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.299 1.04 . . . . 0.35 110.025 172.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 82.42 -76.7 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.172 1.789 . . . . 0.35 112.635 165.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -69.15 -41.14 77.69 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.886 0.875 . . . . 0.35 113.039 -168.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.1 pt -135.17 -173.35 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.699 0.8 . . . . 0.35 109.367 169.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -158.81 28.86 0.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.176 0.59 . . . . 0.35 112.113 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.1 50.13 0.45 Allowed Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.783 0.66 . . . . 0.36 112.783 175.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -66.57 120.82 7.98 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.163 2.575 . . . . 0.35 111.32 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.11 75.84 0.22 Allowed Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.91 1.243 . . . . 0.35 110.419 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -64.05 85.79 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.515 1.926 . . . . 0.35 112.157 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -92.41 99.49 12.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.24 0.616 . . . . 0.36 109.603 -176.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.83 95.16 3.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.618 -0.882 . . . . 0.35 108.618 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.6 mt -108.8 121.76 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 124.838 1.255 . . . . 0.35 108.22 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.4 m -119.36 175.27 5.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.918 1.687 . . . . 0.35 107.402 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -136.06 114.47 11.7 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.133 0.973 . . . . 0.35 108.442 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.5 146.12 32.89 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 C-N-CA 123.462 0.705 . . . . 0.35 110.841 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.1 t -81.22 111.63 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.297 1.039 . . . . 0.35 108.318 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mt -101.09 110.39 27.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 108.219 -1.03 . . . . 0.35 108.219 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -85.85 97.52 10.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.914 -1.143 . . . . 0.35 107.914 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -61.57 126.75 28.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.427 0.691 . . . . 0.35 110.832 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt . . . . . 0 N--CA 1.455 -0.185 0 C-N-CA 123.53 0.732 . . . . 0.25 109.915 179.171 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 t80 . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 120.962 0.41 . . . . 0.35 109.914 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -89.13 75.78 7.83 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.43 1.092 . . . . 0.35 110.111 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -162.19 -62.88 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.441 1.096 . . . . 0.35 108.881 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.43 92.88 0.21 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.538 0.59 . . . . 0.35 112.536 169.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt 58.8 51.69 7.31 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.764 1.225 . . . . 0.35 111.674 164.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -85.17 -64.9 1.08 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.589 0.756 . . . . 0.35 111.499 -174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp 75.96 118.82 0.05 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 127.143 2.177 . . . . 0.35 109.664 -165.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -50.11 -47.94 53.71 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.024 1.329 . . . . 0.35 110.418 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.33 -92.79 0.22 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.283 -1.527 . . . . 0.35 109.283 175.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t70 52.51 66.62 1.16 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.218 1.407 . . . . 0.35 110.688 -173.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -93.64 47.3 1.23 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.135 -1.061 . . . . 0.35 108.135 170.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.05 70.13 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.152 1.781 . . . . 0.35 107.083 -170.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 t -67.72 -71.29 0.21 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.308 0.643 . . . . 0.35 111.523 -168.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -162.31 39.64 0.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 117.622 0.192 . . . . 0.35 111.325 -167.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -157.36 115.67 3.19 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.032 0.533 . . . . 0.35 110.726 -173.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 65.74 164.67 0.12 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.91 2.084 . . . . 0.33 112.951 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -63.19 74.48 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.577 3.518 . . . . 0.35 112.84 172.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 p -100.71 -39.91 7.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.063 1.745 . . . . 0.35 109.077 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.84 157.43 10.03 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 112.02 -0.432 . . . . 0.33 112.02 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -82.24 -178.62 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.504 3.469 . . . . 0.35 110.827 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -157.46 169.4 24.78 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.115 0.966 . . . . 0.35 110.39 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.1 tp -142.81 86.24 1.92 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.355 1.462 . . . . 0.35 107.806 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.7 mtp -82.56 89.56 6.7 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.605 1.162 . . . . 0.35 110.59 -176.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.49 91.95 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.362 1.065 . . . . 0.35 109.059 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -149.18 172.58 14.6 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.492 1.117 . . . . 0.36 109.985 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.58 153.45 19.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 123.993 0.917 . . . . 0.35 111.204 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.5 m -94.39 94.66 8.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.885 1.274 . . . . 0.35 107.909 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.78 116.26 7.64 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 109.479 -1.448 . . . . 0.35 109.479 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -122.98 157.15 28.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 C-N-CA 125.661 1.584 . . . . 0.35 109.191 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -79.43 178.33 8.19 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.581 -0.525 . . . . 0.35 109.581 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 t -60.04 -46.11 90.61 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.533 0.733 . . . . 0.35 110.304 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -68.98 -16.77 63.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.382 1.073 . . . . 0.35 112.91 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.05 29.09 7.38 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.314 0.959 . . . . 0.35 113.09 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -91.17 114.25 26.72 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 117.818 0.809 . . . . 0.36 108.9 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.15 123.77 21.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.327 0.651 . . . . 0.35 110.817 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 mp -93.63 -38.66 11.23 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.844 1.258 . . . . 0.35 109.957 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -144.52 152.59 40.8 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.254 1.022 . . . . 0.35 111.549 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.2 t -99.26 148.75 35.07 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.002 1.721 . . . . 0.33 109.664 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -84.33 70.45 5.86 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.624 2.883 . . . . 0.35 111.456 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -148.74 -177.74 5.96 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.783 0.833 . . . . 0.35 110.508 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . 0.314 0.0 OUTLIER 100.02 -44.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.597 2.759 . . . . 0.35 112.854 173.361 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.74 136.62 23.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 109.553 -0.536 . . . . 0.35 109.553 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.04 171.98 15.5 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.091 0.956 . . . . 0.35 109.35 164.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -161.12 132.9 4.1 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.657 -0.687 . . . . 0.33 109.731 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.31 111.78 1.91 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.654 2.236 . . . . 0.35 108.66 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 tt -60.92 144.8 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.147 0.979 . . . . 0.35 112.944 -162.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -130.54 87.16 50.91 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.593 1.557 . . . . 0.33 107.372 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.97 159.66 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.492 2.795 . . . . 0.35 111.263 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.03 -33.4 2.46 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.268 0.937 . . . . 0.35 111.364 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.7 t -71.58 157.43 38.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.211 1.004 . . . . 0.35 111.321 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.4 p -72.81 167.24 21.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.191 0.996 . . . . 0.35 110.953 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.29 119.64 3.5 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.754 0.822 . . . . 0.35 108.888 -174.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -167.4 178.66 5.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.191 1.796 . . . . 0.35 108.015 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -57.08 -46.92 82.16 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.56 -0.712 . . . . 0.35 111.343 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.47 -34.25 77.76 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.197 0.599 . . . . 0.35 111.967 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -104.06 53.66 0.74 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.788 1.235 . . . . 0.35 109.97 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -159.18 -41.94 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.655 1.182 . . . . 0.35 108.674 170.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.02 -44.38 82.78 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.11 0.964 . . . . 0.35 111.765 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -59.33 -39.41 83.07 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.612 0.765 . . . . 0.35 111.029 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -50.29 62.95 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.295 1.438 . . . . 0.35 110.18 -171.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.28 -32.33 42.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 124.565 1.146 . . . . 0.35 112.121 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -60.29 -49.18 78.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.531 -0.544 . . . . 0.35 109.531 172.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -33.29 75.68 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.791 0.437 . . . . 0.35 111.517 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.77 -55.23 32.36 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.564 0.746 . . . . 0.35 110.965 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 pp -74.69 -15.76 60.78 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.956 0.724 . . . . 0.35 112.956 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -79.41 71.39 5.97 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 123.878 0.871 . . . . 0.35 110.033 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -168.68 -53.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.372 1.869 . . . . 0.35 107.723 172.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.2 p -88.08 -35.11 17.68 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.656 1.583 . . . . 0.35 111.202 -178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.19 74.76 1.32 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.273 1.429 . . . . 0.35 108.436 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -133.3 -19.14 2.2 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.987 1.106 . . . . 0.35 113.987 -165.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -59.58 -41.19 89.7 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.676 0.791 . . . . 0.35 112.542 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -141.65 -66.62 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.151 1.38 . . . . 0.35 109.311 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.9 p90 34.85 88.45 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.172 2.589 . . . . 0.35 114.193 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -73.63 106.73 5.52 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 109.322 -0.622 . . . . 0.35 109.322 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.21 120.4 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.332 -0.988 . . . . 0.35 108.332 174.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.3 t -75.92 -73.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.587 -1.264 . . . . 0.35 107.587 171.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -167.78 146.58 4.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.381 1.073 . . . . 0.35 109.446 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.85 156.84 29.53 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.546 0.738 . . . . 0.35 111.262 173.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.49 135.56 81.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 108.136 -1.061 . . . . 0.33 108.136 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.62 -33.02 29.53 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.318 2.679 . . . . 0.35 111.774 -176.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.0 m -86.77 70.21 10.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.337 1.055 . . . . 0.35 110.263 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.61 169.99 16.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.379 0.672 . . . . 0.35 109.746 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -159.41 143.43 14.95 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.512 0.56 . . . . 0.35 112.512 -167.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.74 122.53 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 126.855 2.062 . . . . 0.35 106.133 172.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -118.1 64.73 0.75 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.97 0.908 . . . . 0.35 109.183 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.04 118.33 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.416 0.686 . . . . 0.35 110.942 -176.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.2 m -111.57 100.59 9.11 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.509 1.123 . . . . 0.35 109.529 -173.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.29 99.4 12.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.154 0.982 . . . . 0.35 109.851 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -94.38 47.89 1.21 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.596 1.558 . . . . 0.35 111.099 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -69.68 106.92 3.24 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.03 0.932 . . . . 0.35 109.628 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -32.6 73.13 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.07 1.348 . . . . 0.35 111.635 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -55.06 -50.15 69.85 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.702 1.201 . . . . 0.36 113.017 -170.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 -41.44 0.09 Allowed 'General case' 0 C--N 1.342 0.279 0 N-CA-C 113.347 0.869 . . . . 0.35 113.347 -175.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -70.56 -47.84 58.33 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.326 0.512 . . . . 0.35 112.016 -168.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt 80.56 155.9 0.14 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.328 1.851 . . . . 0.35 110.741 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -43.8 124.4 3.68 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 126.719 2.008 . . . . 0.35 111.265 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.35 106.53 2.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.216 -1.031 . . . . 0.35 108.216 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.3 m -78.15 97.96 5.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.454 1.102 . . . . 0.35 109.171 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -82.13 96.94 7.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.785 0.834 . . . . 0.35 108.957 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.8 m -76.07 120.01 20.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.671 0.789 . . . . 0.35 109.272 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -134.79 125.33 17.3 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 125.351 1.46 . . . . 0.33 108.527 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.51 162.36 33.31 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.063 2.509 . . . . 0.35 111.559 -175.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.7 tp -73.88 159.96 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.574 1.149 . . . . 0.35 110.13 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 p -116.21 177.79 4.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.221 1.009 . . . . 0.35 110.202 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -103.11 -12.3 17.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.111 1.364 . . . . 0.35 110.924 165.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -76.31 -76.34 0.16 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.606 1.163 . . . . 0.35 111.116 -171.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 139.43 61.91 0.04 OUTLIER Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.846 -0.902 . . . . 0.35 110.846 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -71.53 132.91 45.36 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 117.351 0.575 . . . . 0.35 109.918 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.5 t -73.13 136.18 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.073 -0.714 . . . . 0.35 109.073 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.98 118.49 43.05 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 107.33 -1.359 . . . . 0.33 107.33 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.24 165.98 27.02 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.019 2.479 . . . . 0.35 112.37 -165.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.42 165.85 22.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.6 1.16 . . . . 0.35 110.866 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.1 mp -94.86 30.99 1.93 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.993 0.917 . . . . 0.35 111.412 -173.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.0 t 46.71 -102.34 0.07 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.092 1.757 . . . . 0.35 112.468 175.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -162.24 -44.22 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.986 1.315 . . . . 0.35 109.653 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -83.1 22.17 1.0 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.244 1.418 . . . . 0.35 113.186 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.4 tp -160.53 129.61 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.514 0.726 . . . . 0.35 110.082 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -140.7 27.73 2.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.831 1.252 . . . . 0.35 111.61 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -150.2 51.05 0.82 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 113.221 0.822 . . . . 0.36 113.221 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -70.45 115.02 4.0 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.856 2.371 . . . . 0.35 109.291 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -92.79 79.22 1.13 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.866 -1.294 . . . . 0.35 109.866 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -62.4 107.15 0.86 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.003 0.921 . . . . 0.35 110.387 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -99.79 94.56 6.39 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.34 1.056 . . . . 0.36 108.743 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.75 74.72 10.14 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.554 -1.276 . . . . 0.35 107.554 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.67 126.54 71.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 126.041 1.736 . . . . 0.35 107.948 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.8 m -148.94 142.47 25.36 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.917 0.887 . . . . 0.35 110.26 -173.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -72.85 140.35 47.54 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.264 1.026 . . . . 0.35 109.96 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.1 m -142.36 144.52 24.75 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 123.891 0.876 . . . . 0.35 109.661 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.05 100.23 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.876 -0.787 . . . . 0.35 108.876 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 75.3 mt -119.67 144.14 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.46 1.504 . . . . 0.35 109.062 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -131.29 80.79 1.95 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.556 1.542 . . . . 0.35 107.773 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -58.41 150.2 22.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.731 0.812 . . . . 0.35 111.954 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.196 -1.039 . . . . 0.25 108.196 178.62 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.6 p90 . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 114.966 1.469 . . . . 0.35 114.966 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 53.42 -141.45 0.86 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.046 0.938 . . . . 0.35 109.73 -171.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.4 pttt 11.29 76.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.631 2.772 . . . . 0.35 114.922 169.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.53 113.02 5.28 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 124.683 1.135 . . . . 0.35 111.663 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt 56.64 69.64 0.72 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.251 1.42 . . . . 0.35 110.278 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -70.82 -45.9 63.73 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.611 0.764 . . . . 0.35 111.143 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 66.34 5.31 3.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.165 1.786 . . . . 0.35 114.006 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 tttm 54.07 -92.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.898 1.279 . . . . 0.35 110.808 -172.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.86 58.72 0.07 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.393 -1.483 . . . . 0.35 109.393 173.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -132.55 66.58 1.55 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.382 1.073 . . . . 0.35 109.254 -176.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 64.47 -176.74 0.17 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.267 1.427 . . . . 0.35 112.12 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.88 178.23 9.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.294 1.037 . . . . 0.35 110.696 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.7 m -76.55 147.76 37.49 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.614 1.166 . . . . 0.35 111.234 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 65.31 175.98 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.014 1.726 . . . . 0.35 113.421 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.4 t80 59.35 90.56 0.05 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 126.448 1.899 . . . . 0.35 111.257 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 66.96 161.33 0.14 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 125.573 1.549 . . . . 0.33 111.131 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.28 90.52 1.0 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.359 2.039 . . . . 0.35 108.619 173.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.2 p -63.86 -60.52 3.18 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.234 1.014 . . . . 0.35 111.724 -166.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.68 172.0 32.55 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.962 -0.855 . . . . 0.33 110.962 174.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -66.53 149.0 84.46 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.469 2.779 . . . . 0.35 112.212 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -163.04 168.48 20.92 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.508 0.723 . . . . 0.35 111.292 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tt -145.11 100.86 3.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.737 1.215 . . . . 0.35 108.304 -173.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.6 mtp -88.16 134.06 33.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.722 1.609 . . . . 0.35 109.541 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.1 t -137.01 87.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.346 0 C-N-CA 124.075 0.95 . . . . 0.35 110.485 -168.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -159.35 165.64 32.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.958 1.303 . . . . 0.36 110.395 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -94.02 153.17 3.44 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 124.627 1.171 . . . . 0.35 112.267 -172.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -82.68 92.65 7.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.755 -1.572 . . . . 0.35 106.755 163.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.88 80.79 1.64 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.95 -0.86 . . . . 0.35 110.95 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 m -92.56 165.58 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.447 1.099 . . . . 0.35 110.318 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -82.4 -162.1 0.53 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.877 0.871 . . . . 0.35 110.41 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -53.28 -50.42 64.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.753 1.221 . . . . 0.35 111.598 175.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -75.37 -84.11 0.05 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.368 1.067 . . . . 0.35 110.33 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.76 46.89 0.06 OUTLIER Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.049 -0.82 . . . . 0.35 111.049 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -112.37 108.09 17.14 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.152 1.381 . . . . 0.36 108.257 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -70.49 112.34 6.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.886 0.874 . . . . 0.35 111.433 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.1 mp -73.88 -45.87 48.23 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.749 0.82 . . . . 0.35 109.442 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.2 147.3 36.33 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.858 0.863 . . . . 0.35 111.413 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.0 m -91.75 159.45 38.32 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.282 1.433 . . . . 0.33 111.29 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -87.27 49.86 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.507 2.805 . . . . 0.35 111.914 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -168.72 120.49 0.78 Allowed 'General case' 0 C--N 1.343 0.293 0 N-CA-C 112.915 0.709 . . . . 0.35 112.915 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -162.26 -45.09 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.528 1.531 . . . . 0.35 109.223 159.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.98 130.87 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.522 -0.918 . . . . 0.35 108.522 169.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -144.77 154.09 42.35 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.364 1.066 . . . . 0.35 109.05 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -131.77 155.1 81.83 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 125.31 1.444 . . . . 0.33 108.735 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.71 34.75 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.554 2.836 . . . . 0.35 111.945 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.25 2.8 tt 59.45 134.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 128.679 2.792 . . . . 0.35 114.372 -175.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -142.61 98.24 5.9 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.815 1.246 . . . . 0.33 107.793 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.61 177.96 8.12 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.533 2.822 . . . . 0.35 110.999 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.07 -32.99 6.95 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.977 0.799 . . . . 0.35 111.695 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.6 t -67.18 148.71 51.44 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.471 0.708 . . . . 0.35 110.682 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.2 m -76.63 109.93 10.79 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.892 -0.781 . . . . 0.35 108.892 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.08 96.58 7.81 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.573 -1.269 . . . . 0.35 107.573 176.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.3 t -147.31 160.56 42.37 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.502 1.121 . . . . 0.35 109.924 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -60.29 -42.84 96.33 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 119.5 -0.286 . . . . 0.35 111.576 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.06 -22.4 66.42 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.86 0.689 . . . . 0.35 112.86 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -75.31 -58.85 3.03 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 123.401 0.68 . . . . 0.35 109.895 167.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.4 mm -63.15 -39.42 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.457 1.103 . . . . 0.35 112.813 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -52.25 -48.1 65.4 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.881 0.872 . . . . 0.35 112.037 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -76.52 -39.84 51.78 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.063 0.392 . . . . 0.35 111.526 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -69.89 -39.3 76.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.45 0.7 . . . . 0.35 112.407 -169.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.89 -35.77 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.626 0.771 . . . . 0.35 110.752 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -72.4 -34.64 68.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.303 1.041 . . . . 0.35 111.071 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -47.08 73.86 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.746 0.819 . . . . 0.35 110.051 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.8 -39.96 75.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.276 1.03 . . . . 0.35 111.237 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.9 tp -69.1 -50.67 46.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.28 1.032 . . . . 0.35 111.467 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -74.43 8.29 2.36 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.727 1.01 . . . . 0.35 113.727 -174.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.84 -46.41 89.61 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.51 0.724 . . . . 0.35 109.959 166.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 m -118.58 -51.93 2.37 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.679 1.192 . . . . 0.35 110.352 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.96 82.38 6.7 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.164 0.985 . . . . 0.35 110.866 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -128.89 -43.87 1.34 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.057 1.343 . . . . 0.35 111.437 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -59.08 -71.31 0.12 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.212 1.405 . . . . 0.35 110.576 -173.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.08 -35.74 74.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.378 1.071 . . . . 0.35 110.771 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -58.32 146.41 34.52 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.833 1.253 . . . . 0.35 111.629 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -156.13 141.24 17.37 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.564 1.146 . . . . 0.35 109.562 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.6 t -88.06 137.16 21.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 124.317 1.047 . . . . 0.35 109.449 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.95 -56.87 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.067 1.347 . . . . 0.35 107.666 167.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -156.96 110.42 2.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.198 0.999 . . . . 0.35 108.395 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 pp -87.82 132.22 34.25 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.36 0.664 . . . . 0.35 109.823 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.77 124.46 90.77 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 108.322 -0.992 . . . . 0.33 108.322 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.91 -54.1 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.829 2.353 . . . . 0.35 111.793 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.7 m -74.5 96.14 2.87 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.989 0.916 . . . . 0.35 109.969 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.44 133.58 49.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.871 0.868 . . . . 0.35 110.132 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -95.81 108.77 21.14 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.166 0.987 . . . . 0.35 110.26 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.04 113.04 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.694 -1.595 . . . . 0.35 106.694 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.7 64.73 0.65 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.417 1.087 . . . . 0.35 108.984 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.3 p -67.86 115.33 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.347 0.659 . . . . 0.35 110.627 -176.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 m -111.32 101.38 9.86 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.418 1.087 . . . . 0.35 108.985 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -92.92 102.91 15.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.748 1.219 . . . . 0.35 108.962 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -81.03 61.65 4.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.647 1.179 . . . . 0.35 109.611 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -99.03 85.66 3.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.391 1.477 . . . . 0.35 108.453 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -82.59 52.19 2.03 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.763 0.825 . . . . 0.35 110.706 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -137.36 -44.53 0.55 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.839 1.256 . . . . 0.36 109.828 -170.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -140.64 -66.46 0.43 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.23 1.012 . . . . 0.35 110.1 -173.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -89.58 -22.0 22.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.487 0.921 . . . . 0.35 113.487 -164.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 tttm 74.92 159.43 0.22 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.855 1.662 . . . . 0.35 111.494 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -53.8 117.63 3.32 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.506 1.122 . . . . 0.35 109.951 168.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -141.33 111.74 6.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.827 -1.175 . . . . 0.35 107.827 171.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.2 m -75.76 86.17 2.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.828 -1.175 . . . . 0.35 107.828 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -80.42 97.17 6.96 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.051 0.94 . . . . 0.35 108.957 -171.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.9 m -90.24 132.7 35.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.083 1.353 . . . . 0.35 110.348 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -163.71 141.2 5.77 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 123.625 0.77 . . . . 0.33 110.377 176.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.24 178.91 6.36 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 124.256 3.304 . . . . 0.35 110.952 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.0 tp -138.02 143.44 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.228 0.611 . . . . 0.35 110.56 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.2 p -100.27 -179.97 4.29 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.999 1.32 . . . . 0.35 111.376 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.99 -36.36 72.52 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.738 1.615 . . . . 0.35 112.805 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -88.54 -50.73 6.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.269 1.028 . . . . 0.35 109.895 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.67 -144.27 45.17 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.156 -0.777 . . . . 0.35 111.156 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -161.0 152.57 19.34 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.74 0.816 . . . . 0.35 110.756 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.9 t -78.35 133.08 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.097 0.959 . . . . 0.35 109.677 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.71 126.22 91.95 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 108.479 -0.934 . . . . 0.33 108.479 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.21 -80.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.782 2.322 . . . . 0.35 110.77 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -169.05 -56.55 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.902 1.281 . . . . 0.35 109.205 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.461 HD11 HG13 ' A' ' 120' ' ' ILE . 2.6 tm? 69.48 99.08 0.06 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.491 1.916 . . . . 0.35 110.434 -179.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.8 t -171.12 78.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.092 1.357 . . . . 0.35 108.273 173.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -153.86 -77.35 0.11 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 122.782 0.433 . . . . 0.35 110.146 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -88.24 -50.15 6.54 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.265 1.026 . . . . 0.35 110.282 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.461 HG13 HD11 ' A' ' 116' ' ' LEU . 10.7 pt -103.51 169.37 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.38 1.072 . . . . 0.35 109.333 166.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -137.53 -26.95 0.96 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.027 0.931 . . . . 0.35 112.631 -166.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.05 58.1 27.38 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 123.702 0.801 . . . . 0.36 112.92 -169.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.09 119.64 6.45 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.178 2.585 . . . . 0.35 110.65 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.9 77.72 0.69 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 109.574 -1.411 . . . . 0.35 109.574 177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -62.67 96.69 0.09 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.163 1.385 . . . . 0.35 110.65 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -92.62 98.69 11.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.629 -0.878 . . . . 0.36 108.629 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.36 76.97 8.28 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 108.075 -1.083 . . . . 0.35 108.075 176.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.9 mt -90.24 122.34 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.181 -1.415 . . . . 0.35 107.181 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.3 m -131.0 111.67 12.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.97 -1.122 . . . . 0.35 107.97 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -62.99 137.01 58.15 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.365 0.666 . . . . 0.35 110.299 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.7 149.67 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.869 0.867 . . . . 0.35 109.517 169.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.96 142.54 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.857 1.263 . . . . 0.35 108.214 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.6 mt -129.96 147.7 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.698 1.199 . . . . 0.35 109.569 -171.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -126.28 -23.85 3.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.326 1.45 . . . . 0.35 112.487 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? 93.08 134.88 0.02 OUTLIER 'General case' 0 C--N 1.345 0.395 0 C-N-CA 127.834 2.454 . . . . 0.35 110.418 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? . . . . . 0 N--CA 1.455 -0.213 0 C-N-CA 125.007 1.323 . . . . 0.25 109.956 178.655 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 109.082 -0.71 . . . . 0.35 109.082 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -155.22 65.42 0.63 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.292 1.037 . . . . 0.35 108.83 -174.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -95.34 57.3 1.96 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.251 1.02 . . . . 0.35 110.186 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 49.9 26.33 8.29 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.275 1.893 . . . . 0.35 114.922 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 47.16 49.01 15.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.645 1.578 . . . . 0.35 112.582 -176.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -86.23 105.13 16.39 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.649 0.78 . . . . 0.35 109.958 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -77.6 72.34 4.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.307 1.443 . . . . 0.35 110.608 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 42.57 -91.05 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.029 2.532 . . . . 0.35 112.721 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.39 -111.04 0.89 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 108.718 -1.753 . . . . 0.35 108.718 175.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 50.73 65.25 1.52 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 125.038 1.335 . . . . 0.35 110.938 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -84.02 75.8 10.11 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.938 0.895 . . . . 0.35 109.158 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -128.36 73.15 1.46 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.374 1.47 . . . . 0.35 108.776 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 t -74.71 175.39 7.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.24 1.016 . . . . 0.35 110.996 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -80.94 76.71 7.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.566 1.147 . . . . 0.35 109.771 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -154.07 76.82 1.07 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.013 1.325 . . . . 0.35 107.559 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 68.04 169.65 0.11 Allowed Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.378 1.471 . . . . 0.33 111.108 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.46 108.01 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.56 2.84 . . . . 0.35 113.051 170.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.0 p -106.0 -60.32 1.66 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.408 1.483 . . . . 0.35 108.695 175.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.7 150.24 7.65 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 110.451 -1.06 . . . . 0.33 110.451 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.76 162.78 27.08 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.81 2.34 . . . . 0.35 113.332 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -158.68 164.46 35.92 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.331 1.052 . . . . 0.35 110.085 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 tt -148.51 103.28 3.4 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.295 -1.002 . . . . 0.35 108.295 -173.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 41.9 mtm -82.17 120.68 25.64 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.985 0.914 . . . . 0.35 111.128 -176.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -114.87 96.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 124.824 1.249 . . . . 0.35 110.092 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -156.33 -176.01 5.73 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.529 0.732 . . . . 0.36 110.998 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.2 m -140.27 -170.62 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.767 1.227 . . . . 0.35 110.248 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.2 m -135.89 94.12 3.02 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.897 -1.52 . . . . 0.35 106.897 168.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.09 98.33 2.39 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 124.649 1.119 . . . . 0.35 111.885 -169.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.12 162.64 3.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 124.466 1.106 . . . . 0.35 111.731 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -74.03 -52.25 13.31 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.468 -0.938 . . . . 0.35 108.468 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 m -157.58 -64.37 0.09 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.989 1.316 . . . . 0.35 109.474 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -106.7 63.78 0.64 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.2 1.0 . . . . 0.35 111.264 -165.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.75 -40.62 3.04 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 119.758 -0.468 . . . . 0.35 113.012 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -49.41 103.77 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.751 2.02 . . . . 0.36 112.509 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.81 136.43 34.14 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.489 1.115 . . . . 0.35 110.731 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 mp -79.09 -62.3 1.74 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.456 0.703 . . . . 0.35 109.457 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mt -94.88 -148.28 0.28 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.695 1.198 . . . . 0.35 108.879 -170.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.9 m -143.07 68.11 17.65 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 108.036 -1.098 . . . . 0.33 108.036 164.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -83.18 75.58 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.567 2.845 . . . . 0.35 110.006 -166.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -152.86 54.22 0.77 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.58 1.552 . . . . 0.35 108.016 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.99 48.38 0.44 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.272 0.842 . . . . 0.35 113.272 -171.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -169.71 136.74 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.722 0.809 . . . . 0.35 109.875 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -161.27 178.18 9.48 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.632 0.773 . . . . 0.35 111.378 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -145.39 157.81 52.0 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.627 1.571 . . . . 0.33 108.848 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.17 168.76 18.32 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.0 2.467 . . . . 0.35 110.866 171.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 tp -61.41 144.64 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.707 0.803 . . . . 0.35 111.33 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -156.68 94.75 2.28 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.823 -1.177 . . . . 0.33 107.823 173.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.96 -179.03 4.94 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.393 2.729 . . . . 0.35 110.585 -175.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.96 -37.47 3.7 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.748 0.69 . . . . 0.35 111.555 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.1 t -62.85 142.87 58.07 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.847 0.859 . . . . 0.35 111.459 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.6 m -82.29 135.94 35.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.475 1.11 . . . . 0.35 109.187 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 mp -117.03 131.37 56.96 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.232 1.413 . . . . 0.35 109.794 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 t -172.59 172.05 4.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.073 2.549 . . . . 0.35 106.808 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -61.06 -29.54 69.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.366 0.876 . . . . 0.35 113.366 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -83.7 -13.08 54.92 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.863 0.69 . . . . 0.35 112.863 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -98.27 -27.54 14.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.6 1.16 . . . . 0.35 111.913 173.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -39.71 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.219 -0.66 . . . . 0.35 109.219 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -67.92 -54.99 14.53 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.401 1.081 . . . . 0.35 113.198 -169.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -66.27 -35.02 79.32 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.78 0.718 . . . . 0.35 111.226 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -64.09 -53.81 43.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.954 1.302 . . . . 0.35 111.5 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.1 m -69.32 -36.36 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 123.007 0.523 . . . . 0.35 111.656 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.79 -41.37 95.46 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.824 0.85 . . . . 0.35 111.254 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -33.53 68.78 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.806 0.443 . . . . 0.35 111.201 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.64 -53.83 35.95 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.357 0.663 . . . . 0.35 110.861 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.3 -27.87 67.53 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.225 0.61 . . . . 0.35 112.01 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -67.78 -33.43 74.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.264 0.484 . . . . 0.35 110.439 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.9 28.58 0.35 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.456 0.702 . . . . 0.35 112.15 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 88.5 m -146.27 -65.36 0.3 Allowed 'General case' 0 C--N 1.344 0.336 0 C-N-CA 125.063 1.345 . . . . 0.35 108.229 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.85 -52.25 13.62 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.741 1.216 . . . . 0.35 111.207 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 73.42 150.86 0.11 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.532 1.933 . . . . 0.35 113.776 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.4 tttm 100.72 37.05 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 129.17 2.988 . . . . 0.35 111.29 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 62.21 -74.43 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.176 2.19 . . . . 0.35 114.308 166.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 87.75 159.26 0.07 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 128.459 2.703 . . . . 0.35 110.689 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -54.69 -59.96 4.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.128 0.971 . . . . 0.35 110.209 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t 56.25 76.64 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.952 1.301 . . . . 0.35 108.736 -171.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.9 t -56.99 -60.92 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 124.612 1.165 . . . . 0.35 109.984 -177.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -162.76 126.93 3.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.773 0.829 . . . . 0.35 109.0 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.507 ' H ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -81.0 157.36 25.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.342 0.657 . . . . 0.35 110.206 172.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.63 123.73 89.13 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.457 -0.942 . . . . 0.33 108.457 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.86 -31.81 30.68 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.171 2.581 . . . . 0.35 110.67 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 52.8 m -89.64 60.91 5.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.763 1.225 . . . . 0.35 109.536 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.34 170.1 7.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.249 1.02 . . . . 0.35 110.458 171.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -150.74 148.36 28.45 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 113.137 0.791 . . . . 0.35 113.137 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.5 mp -119.68 105.33 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.692 1.597 . . . . 0.35 107.19 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.88 76.83 9.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.607 -0.886 . . . . 0.35 108.607 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.31 94.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.065 -1.087 . . . . 0.35 108.065 172.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.8 m -88.14 75.51 8.64 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.202 -1.036 . . . . 0.35 108.202 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -68.92 121.09 15.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.035 -0.53 . . . . 0.35 110.951 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -138.94 146.71 41.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.9 1.68 . . . . 0.35 109.785 -172.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -154.2 -177.54 6.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.108 1.363 . . . . 0.35 109.48 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -133.45 59.29 1.74 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.571 -1.27 . . . . 0.35 107.571 167.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -143.78 -66.62 0.35 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.498 1.119 . . . . 0.36 109.71 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 56.54 0.23 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.827 0.451 . . . . 0.35 111.998 -171.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -159.84 -55.85 0.06 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-O 119.118 -0.468 . . . . 0.35 111.761 169.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt 80.52 160.18 0.16 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.35 110.122 -168.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.34 136.66 58.04 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.139 0.976 . . . . 0.35 110.969 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -151.85 113.25 4.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.468 1.107 . . . . 0.35 108.272 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.1 m -79.89 82.92 5.9 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.672 1.189 . . . . 0.35 109.05 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -82.66 108.27 15.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.674 -0.861 . . . . 0.35 108.674 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.6 p -85.86 63.66 8.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.743 1.217 . . . . 0.35 110.504 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -61.51 111.85 5.04 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.262 1.425 . . . . 0.33 107.904 172.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.67 -109.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.661 2.241 . . . . 0.35 111.461 -160.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.3 tp -160.64 155.84 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.893 0.877 . . . . 0.35 109.132 -177.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.7 p -106.87 173.02 6.5 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.3 1.04 . . . . 0.35 110.073 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.07 51.12 0.98 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.337 -1.357 . . . . 0.35 107.337 167.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -156.37 -76.65 0.09 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.308 1.043 . . . . 0.35 109.29 -169.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 152.07 143.46 3.7 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.85 -0.9 . . . . 0.35 110.85 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -153.17 128.01 9.54 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.694 0.798 . . . . 0.35 109.757 167.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.06 130.62 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.201 1.0 . . . . 0.35 108.983 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.76 122.69 86.71 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.727 -1.212 . . . . 0.33 107.727 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.02 -98.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.152 2.568 . . . . 0.35 111.059 -172.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -169.25 172.0 7.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.607 1.163 . . . . 0.35 110.08 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.26 137.3 13.62 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.646 1.178 . . . . 0.35 109.767 176.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.9 t -167.69 -174.81 2.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.65 0.78 . . . . 0.35 110.706 -171.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 74.05 -82.03 0.03 OUTLIER 'General case' 0 C--N 1.342 0.245 0 C-N-CA 127.055 2.142 . . . . 0.35 111.366 170.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -104.57 -50.27 3.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.983 1.313 . . . . 0.35 109.162 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.0 tp -78.67 104.77 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.238 1.015 . . . . 0.35 109.207 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -143.47 10.03 1.63 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.275 1.03 . . . . 0.35 112.502 -170.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.32 63.48 4.62 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.31 0.959 . . . . 0.36 111.817 170.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.2 -90.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.941 3.094 . . . . 0.35 112.974 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.96 78.75 0.52 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 109.338 -1.505 . . . . 0.35 109.338 -168.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -75.02 95.18 2.98 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.909 1.284 . . . . 0.35 108.894 176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -91.6 91.4 8.02 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.634 0.374 . . . . 0.36 110.683 -168.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.96 61.39 1.95 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.274 1.429 . . . . 0.35 109.027 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.58 127.91 58.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.143 1.777 . . . . 0.35 106.748 174.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 51.6 m -147.42 131.58 17.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.376 1.07 . . . . 0.35 109.371 -171.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -64.38 131.55 47.53 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.493 0.717 . . . . 0.35 109.56 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.5 m -136.98 159.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.159 0 C-N-CA 123.922 0.889 . . . . 0.35 109.655 174.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.2 124.84 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 124.369 1.067 . . . . 0.35 108.203 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.5 mt -129.43 145.49 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.854 1.261 . . . . 0.35 109.548 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -127.22 156.28 42.1 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.567 1.547 . . . . 0.35 108.822 168.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -77.02 140.79 40.47 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.561 -0.533 . . . . 0.35 109.561 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.147 0 C-N-CA 124.307 1.043 . . . . 0.25 110.667 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.028 -0.36 . . . . 0.35 110.028 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.8 t -158.31 -54.32 0.07 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.67 0.788 . . . . 0.35 109.227 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t -86.1 69.35 10.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.438 1.095 . . . . 0.35 110.88 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.1 p90 51.91 -174.35 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.389 2.275 . . . . 0.35 114.882 170.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -149.86 32.21 0.69 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.141 0.976 . . . . 0.35 110.443 165.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -131.27 -58.93 0.99 Allowed 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.717 1.607 . . . . 0.35 108.555 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.89 90.49 0.33 Allowed Glycine 0 C--N 1.341 0.834 0 C-N-CA 123.82 0.724 . . . . 0.35 111.902 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 56.82 42.46 26.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.193 1.397 . . . . 0.35 111.852 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -88.97 -40.83 12.75 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.681 1.193 . . . . 0.35 111.703 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.35 48.88 10.47 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 126.584 1.953 . . . . 0.35 112.699 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.2 pttp 67.47 -12.31 0.27 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.173 2.189 . . . . 0.35 115.015 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.68 -36.92 2.86 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.923 1.249 . . . . 0.35 110.46 -170.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.27 85.55 4.41 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.689 1.195 . . . . 0.35 110.094 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -99.64 73.48 1.82 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.918 1.287 . . . . 0.35 108.579 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.83 79.81 9.49 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.208 1.003 . . . . 0.35 109.178 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.3 p -70.65 -59.01 3.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.666 0.786 . . . . 0.35 111.58 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -158.99 -143.33 0.1 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.612 -0.885 . . . . 0.35 108.612 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.5 t80 56.97 88.14 0.05 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.256 1.822 . . . . 0.35 112.207 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 68.27 162.95 0.14 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 126.054 1.742 . . . . 0.33 112.09 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.08 99.9 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.131 2.554 . . . . 0.35 110.251 171.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.1 p -90.12 -76.66 0.42 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.447 1.099 . . . . 0.35 110.25 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.82 149.02 10.96 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 110.593 -1.003 . . . . 0.33 110.593 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.11 169.97 21.0 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 124.133 3.222 . . . . 0.35 112.506 -170.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -163.53 162.6 24.62 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.558 1.143 . . . . 0.35 110.673 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 tt -138.66 97.43 3.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.979 1.312 . . . . 0.35 107.583 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.8 ttm -98.96 108.25 20.89 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.069 1.748 . . . . 0.35 110.781 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.2 t -110.14 99.82 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.793 1.237 . . . . 0.35 110.867 -167.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -150.14 -163.92 1.9 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.89 1.276 . . . . 0.36 109.948 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.0 150.69 24.98 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 C-N-CA 124.648 1.179 . . . . 0.35 110.923 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 83.8 m -84.09 79.96 9.34 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.431 -1.692 . . . . 0.35 106.431 163.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.84 100.43 1.85 Allowed Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.481 -1.048 . . . . 0.35 110.481 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.79 169.55 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 124.893 1.277 . . . . 0.35 110.348 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -63.8 -49.34 73.29 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.942 0.897 . . . . 0.35 110.757 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.2 p -178.47 -58.48 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.598 1.959 . . . . 0.35 108.624 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.5 tttp -75.7 -73.7 0.25 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.791 0.836 . . . . 0.35 109.622 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.25 28.32 0.07 OUTLIER Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.219 -0.767 . . . . 0.35 112.976 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -90.46 94.25 9.65 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 107.252 -1.388 . . . . 0.36 107.252 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.38 110.22 3.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.06 0.944 . . . . 0.35 111.562 -168.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.6 mt -70.65 -41.51 72.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.759 1.223 . . . . 0.35 110.09 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 pp -143.98 138.24 28.3 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.727 0.811 . . . . 0.35 111.205 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.7 m -88.36 141.99 31.1 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 124.494 1.118 . . . . 0.33 110.039 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.47 -171.57 0.86 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.976 3.117 . . . . 0.35 111.688 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.7 m170 87.16 17.77 0.08 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.482 2.313 . . . . 0.35 114.087 168.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -94.0 -38.95 10.9 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.778 0.717 . . . . 0.35 112.417 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.3 t -99.08 137.96 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.204 1.002 . . . . 0.35 109.237 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -157.85 135.32 10.38 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.104 0.962 . . . . 0.35 109.431 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -120.31 143.69 36.42 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 125.362 1.465 . . . . 0.33 108.941 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.33 137.53 40.25 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.543 2.162 . . . . 0.35 109.106 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.5 tt -64.21 135.26 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 122.845 0.458 . . . . 0.35 111.999 -170.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -142.56 97.38 6.06 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 106.828 -1.545 . . . . 0.33 106.828 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.61 135.61 24.32 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.82 2.347 . . . . 0.35 110.325 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 162.95 -41.73 0.34 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.925 -0.87 . . . . 0.35 110.925 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.4 t -61.21 145.65 50.44 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.97 0.908 . . . . 0.35 110.952 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.7 m -78.77 97.49 5.93 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.877 0.871 . . . . 0.35 108.895 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -74.32 81.17 1.86 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.29 1.436 . . . . 0.35 109.56 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.5 p -150.42 165.6 32.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.56 1.544 . . . . 0.35 109.152 -171.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -54.39 -43.49 71.47 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.87 1.268 . . . . 0.35 111.69 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -50.82 -50.57 56.14 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.832 0.853 . . . . 0.35 112.381 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -102.83 38.04 1.81 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.638 0.775 . . . . 0.35 111.565 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.27 -38.06 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.488 1.515 . . . . 0.35 107.94 165.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -54.55 -67.7 0.24 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 127.053 2.141 . . . . 0.35 110.988 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -81.71 -18.13 45.44 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.078 0.551 . . . . 0.35 112.471 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -66.65 -49.46 66.14 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.142 0.577 . . . . 0.35 111.224 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.8 m -68.47 -31.12 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.391 0.676 . . . . 0.35 111.373 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.05 -40.96 97.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.745 0.818 . . . . 0.35 110.748 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -69.84 -33.3 72.12 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.491 0.716 . . . . 0.35 111.532 177.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.29 -52.92 51.1 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.122 0.569 . . . . 0.35 111.207 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.74 -33.73 76.28 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.672 0.389 . . . . 0.35 111.642 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -67.62 -30.49 70.08 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 122.699 0.4 . . . . 0.35 111.256 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.87 38.67 0.53 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.718 0.807 . . . . 0.35 110.967 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.3 m -150.83 -53.17 0.14 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.946 1.698 . . . . 0.35 107.992 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.46 -94.09 0.4 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.098 1.359 . . . . 0.35 110.505 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.4 t80 55.04 64.06 1.92 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.714 1.606 . . . . 0.35 111.623 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -137.8 -54.2 0.66 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.835 1.254 . . . . 0.35 108.797 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -125.25 78.2 1.7 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.107 1.363 . . . . 0.35 108.07 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -159.45 126.81 4.73 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.099 0.96 . . . . 0.35 108.972 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -146.37 -38.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.575 1.15 . . . . 0.35 111.537 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 t 76.65 119.55 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 126.408 1.883 . . . . 0.35 111.492 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 55.6 t -68.46 -59.16 3.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 N-CA-C 108.088 -1.079 . . . . 0.35 108.088 166.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -153.24 154.17 34.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.48 1.512 . . . . 0.35 109.023 -175.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 pp -118.6 140.74 49.41 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.472 1.109 . . . . 0.35 108.782 170.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.47 137.29 67.58 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 109.721 -0.474 . . . . 0.33 109.721 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.81 -33.77 15.74 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.449 2.766 . . . . 0.35 111.361 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -85.14 65.64 9.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.495 1.118 . . . . 0.35 109.966 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.65 158.67 35.8 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.325 0.65 . . . . 0.35 109.346 170.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -142.07 155.06 45.37 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 121.204 0.526 . . . . 0.35 112.217 -171.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mp -129.88 117.62 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.687 1.595 . . . . 0.35 107.159 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -103.72 67.41 0.89 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.357 1.063 . . . . 0.35 109.615 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.68 119.09 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 122.921 0.489 . . . . 0.35 109.883 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 m -119.42 117.46 28.53 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.508 1.123 . . . . 0.35 108.816 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.0 110.68 20.43 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.839 1.256 . . . . 0.35 109.983 -168.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -101.63 56.95 0.83 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.94 1.296 . . . . 0.35 112.316 -164.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.48 87.4 6.39 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.289 0.636 . . . . 0.35 109.404 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -77.41 65.69 3.01 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.177 0.591 . . . . 0.35 110.384 177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -152.6 -48.93 0.1 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.203 1.801 . . . . 0.36 108.893 -176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -140.42 -66.14 0.44 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.465 1.106 . . . . 0.35 110.63 -173.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -78.72 -51.16 10.21 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.877 0.471 . . . . 0.35 111.501 -167.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 75.63 167.04 0.27 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.901 1.681 . . . . 0.35 113.013 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.84 111.98 0.94 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.333 1.853 . . . . 0.35 111.297 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -141.31 104.82 4.68 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.131 1.373 . . . . 0.35 107.656 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.5 m -77.53 88.57 3.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.617 -0.883 . . . . 0.35 108.617 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -80.26 95.81 6.42 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.427 -0.953 . . . . 0.35 108.427 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.6 p -90.54 61.19 4.83 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.85 1.26 . . . . 0.35 110.617 -175.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -71.12 145.13 90.83 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.582 -0.525 . . . . 0.33 109.582 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.81 -118.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.519 2.813 . . . . 0.35 109.732 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.4 tp -162.89 159.15 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.62 0.768 . . . . 0.35 110.176 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.4 p -133.97 155.7 49.49 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.873 1.269 . . . . 0.35 109.538 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -64.35 -48.82 74.07 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.074 0.95 . . . . 0.35 112.425 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -138.77 62.81 1.54 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.064 0.946 . . . . 0.35 108.915 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.3 -84.22 0.5 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.6 1.095 . . . . 0.35 112.755 -178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -158.0 159.17 36.13 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.421 0.526 . . . . 0.35 112.421 -158.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 50.6 t -82.83 154.02 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.947 1.699 . . . . 0.35 109.135 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.0 t -48.83 115.08 4.18 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.763 1.225 . . . . 0.33 109.647 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.17 165.21 26.15 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.003 2.469 . . . . 0.35 110.797 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -68.88 158.46 34.49 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.504 0.721 . . . . 0.35 110.417 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 116' ' ' LEU . 2.1 pt? -84.09 48.68 1.51 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.546 1.138 . . . . 0.35 112.845 -175.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.9 t 53.35 -99.78 0.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.658 1.583 . . . . 0.35 112.319 173.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -165.16 -53.83 0.03 OUTLIER 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.571 1.148 . . . . 0.35 109.305 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -90.32 44.46 1.2 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.074 1.749 . . . . 0.35 112.247 -170.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.3 tp -164.15 138.34 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.642 0.777 . . . . 0.35 110.244 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -99.54 -43.85 6.36 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.095 1.758 . . . . 0.35 110.515 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.449 HD22 ' H ' ' A' ' 122' ' ' ASN . 0.1 OUTLIER -123.25 71.17 44.73 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 115.182 1.549 . . . . 0.36 115.182 -164.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.87 140.39 92.85 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.756 2.304 . . . . 0.35 110.848 163.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.32 67.21 0.32 Allowed Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.648 -1.381 . . . . 0.35 109.648 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -58.02 103.24 0.13 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 125.047 1.339 . . . . 0.35 110.48 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -99.09 86.36 3.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.89 0.876 . . . . 0.36 109.225 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.86 86.23 0.34 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.717 1.607 . . . . 0.35 108.046 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 61.4 mt -134.14 115.83 21.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 124.792 1.237 . . . . 0.35 108.316 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 40.5 m -116.48 130.41 56.74 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.832 1.253 . . . . 0.35 109.566 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -75.87 128.05 34.29 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.667 -0.864 . . . . 0.35 108.667 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.1 m -139.38 153.54 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.116 0.966 . . . . 0.35 111.057 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.6 t -96.84 97.08 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.781 1.633 . . . . 0.35 107.555 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.5 mt -83.02 138.42 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.299 0.639 . . . . 0.35 110.865 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -103.28 113.44 26.93 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 107.537 -1.283 . . . . 0.35 107.537 164.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -91.64 91.5 8.04 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.881 0.872 . . . . 0.35 108.865 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 C--N 1.342 0.263 0 CA-C-O 121.51 0.671 . . . . 0.25 109.362 177.057 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 118.716 -0.659 . . . . 0.35 112.212 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t 74.62 -71.89 0.12 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 126.829 2.052 . . . . 0.35 110.617 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.4 p -71.87 95.15 1.5 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.256 -1.016 . . . . 0.35 108.256 171.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -41.65 117.05 0.86 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.882 2.073 . . . . 0.35 112.97 -175.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -61.8 165.21 5.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.854 1.261 . . . . 0.35 110.062 172.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.32 60.73 2.68 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.479 1.512 . . . . 0.35 110.797 -175.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.07 109.8 3.1 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.859 1.219 . . . . 0.35 112.102 -168.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt 58.48 53.01 6.53 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.326 1.45 . . . . 0.35 110.572 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -127.56 72.28 1.38 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.352 1.061 . . . . 0.35 108.836 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.34 66.94 9.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.671 1.188 . . . . 0.35 108.681 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.4 mptt 51.47 -107.33 0.3 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.29 1.836 . . . . 0.35 110.022 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.01 52.82 0.55 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 108.244 -1.942 . . . . 0.35 108.244 168.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -132.31 75.63 1.65 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.364 1.466 . . . . 0.35 108.156 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -157.93 44.58 0.33 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.823 1.249 . . . . 0.35 109.718 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.42 95.05 2.65 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.471 1.108 . . . . 0.35 108.587 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 t -53.73 -51.24 63.95 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.301 1.04 . . . . 0.35 112.118 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -154.17 57.72 0.71 Allowed 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.547 0.739 . . . . 0.35 110.462 175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -138.58 69.29 1.38 Allowed 'General case' 0 C--N 1.341 0.229 0 C-N-CA 122.722 0.409 . . . . 0.35 111.522 -170.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 68.42 163.89 0.13 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 125.93 1.692 . . . . 0.33 113.663 161.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -54.29 104.64 0.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.791 2.994 . . . . 0.35 111.047 164.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.9 p -143.35 -51.56 0.35 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.601 1.16 . . . . 0.35 109.938 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.97 81.01 0.06 OUTLIER Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.182 -1.167 . . . . 0.33 110.182 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -70.85 170.84 16.9 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.714 2.942 . . . . 0.35 111.44 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -154.77 168.26 27.46 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.51 0.671 . . . . 0.35 112.46 -161.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -147.32 93.28 2.22 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.275 -1.75 . . . . 0.35 106.275 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 62.6 mtm -85.16 96.65 9.53 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.518 0.727 . . . . 0.35 111.339 -169.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -86.54 89.11 2.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 125.128 1.371 . . . . 0.35 108.359 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -151.41 176.55 11.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.429 1.092 . . . . 0.36 109.954 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.417 HG11 HG22 ' A' ' 131' ' ' VAL . 6.8 t -136.46 145.7 30.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 C-N-CA 123.873 0.869 . . . . 0.35 110.958 -171.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.6 m -82.69 84.38 7.33 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.564 -1.643 . . . . 0.35 106.564 164.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -82.33 83.14 1.58 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.462 -0.655 . . . . 0.35 111.462 -169.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.93 164.43 3.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 C-N-CA 123.575 0.75 . . . . 0.35 111.37 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -72.43 -45.82 57.88 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.069 0.948 . . . . 0.35 110.96 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.9 t 169.54 -58.02 0.01 OUTLIER 'General case' 0 C--N 1.341 0.226 0 C-N-CA 127.984 2.514 . . . . 0.35 107.586 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -71.6 -66.75 0.59 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.22 1.008 . . . . 0.35 109.891 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.73 62.91 0.02 OUTLIER Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.001 -1.239 . . . . 0.35 110.001 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -133.04 97.23 3.95 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 107.645 -1.242 . . . . 0.36 107.645 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.22 119.68 9.48 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.78 1.232 . . . . 0.35 111.276 -173.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.0 mp -84.75 -39.41 18.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.153 0.981 . . . . 0.35 110.006 170.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 pp -141.88 149.04 39.72 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.535 0.734 . . . . 0.35 112.467 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.7 m -89.33 155.26 49.03 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.558 1.143 . . . . 0.33 111.544 -167.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -83.7 44.71 1.64 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.811 3.007 . . . . 0.35 111.952 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -177.71 111.39 0.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.421 1.089 . . . . 0.35 109.936 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -163.83 -51.8 0.03 OUTLIER 'General case' 0 C--N 1.341 0.236 0 CA-C-O 118.668 -0.682 . . . . 0.35 112.518 170.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.28 -57.13 6.26 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 CA-C-N 119.134 0.879 . . . . 0.35 110.594 -173.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 65.9 155.08 0.08 Allowed 'General case' 0 C--N 1.343 0.292 0 C-N-CA 126.19 1.796 . . . . 0.35 113.061 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -138.55 147.02 53.32 Favored Pre-proline 0 N--CA 1.454 -0.275 0 C-N-CA 125.603 1.561 . . . . 0.33 107.521 171.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.63 144.54 55.07 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.582 2.188 . . . . 0.35 109.985 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.97 116.85 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.679 0.792 . . . . 0.35 109.437 -177.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -137.88 116.16 9.68 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.841 1.256 . . . . 0.33 108.484 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.09 178.56 7.36 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.438 2.759 . . . . 0.35 110.881 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.23 -30.29 10.67 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.9 0.762 . . . . 0.35 112.55 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.4 t -68.13 144.65 54.92 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.797 0.798 . . . . 0.35 111.088 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.6 m -71.89 145.65 48.39 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.746 -0.835 . . . . 0.35 108.746 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.98 113.89 7.63 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.443 0.697 . . . . 0.35 109.531 -167.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 t -162.22 175.25 11.85 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.686 1.594 . . . . 0.35 108.898 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -47.97 -60.45 2.6 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.359 1.463 . . . . 0.35 111.054 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -59.77 -35.24 74.22 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.375 0.88 . . . . 0.35 113.375 -174.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.42 -55.41 28.1 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 118.676 0.671 . . . . 0.35 110.62 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.3 mm -60.43 -39.33 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.281 1.033 . . . . 0.35 111.754 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -55.65 -59.19 5.2 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.645 0.657 . . . . 0.35 111.936 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -66.56 -38.1 86.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.942 0.792 . . . . 0.35 111.751 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -66.07 -45.52 81.0 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.516 0.727 . . . . 0.35 111.363 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.79 -26.17 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.61 0.764 . . . . 0.35 111.736 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -62.92 -35.55 80.45 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.11 0.564 . . . . 0.35 110.878 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -71.11 -32.53 69.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.329 0.652 . . . . 0.35 111.308 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.58 -36.44 82.72 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.066 0.546 . . . . 0.35 111.335 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.0 mt -72.76 -41.49 65.01 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 122.884 0.474 . . . . 0.35 111.065 173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -80.49 67.6 6.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.66 0.784 . . . . 0.35 109.641 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.57 -60.48 0.1 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.783 1.233 . . . . 0.35 108.796 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.0 p -96.79 -56.42 2.58 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.617 1.167 . . . . 0.35 109.671 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.79 63.7 7.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.695 -1.224 . . . . 0.35 107.695 169.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -72.77 -57.47 4.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.282 0.633 . . . . 0.35 112.058 -164.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -93.99 -52.3 4.47 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.438 0.695 . . . . 0.35 111.109 -164.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.52 68.43 10.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.032 0.933 . . . . 0.35 110.235 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -163.18 155.35 18.1 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.115 0.966 . . . . 0.35 109.575 169.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -163.28 111.21 1.23 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.985 -1.117 . . . . 0.35 107.985 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.92 92.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.17 -0.678 . . . . 0.35 109.17 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.51 -40.93 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.596 1.158 . . . . 0.35 111.332 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -149.15 160.5 43.3 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.615 0.766 . . . . 0.35 110.268 169.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 81' ' ' LEU . 1.7 pt? -137.61 142.54 41.24 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.901 1.28 . . . . 0.35 110.441 -175.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.77 132.76 82.87 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 109.398 -0.593 . . . . 0.33 109.398 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.74 -34.96 13.6 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.194 2.596 . . . . 0.35 110.751 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -81.53 78.83 8.24 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.152 0.981 . . . . 0.35 110.473 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.85 166.07 16.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.37 0.668 . . . . 0.35 109.269 164.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -153.7 122.06 6.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.73 0.3 . . . . 0.35 111.637 -168.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.0 mp -94.28 124.27 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.546 1.538 . . . . 0.35 107.325 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -111.25 84.29 1.91 Allowed 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.486 -1.301 . . . . 0.35 107.486 174.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.95 96.86 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 108.975 -0.75 . . . . 0.35 108.975 171.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -86.57 87.45 7.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.273 -1.751 . . . . 0.35 106.273 171.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -86.78 80.63 8.45 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.234 0.54 . . . . 0.35 110.168 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -91.11 144.09 26.0 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.883 1.273 . . . . 0.35 111.034 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -166.38 89.8 0.4 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.039 -1.467 . . . . 0.35 107.039 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -77.54 74.36 4.1 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.142 0.977 . . . . 0.35 108.636 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -154.67 -48.98 0.09 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.581 1.952 . . . . 0.36 108.339 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.23 -45.99 0.1 Allowed 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.554 0.742 . . . . 0.35 112.561 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -73.64 -57.37 4.04 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.614 0.643 . . . . 0.35 111.495 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt 82.96 158.05 0.12 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.974 1.71 . . . . 0.35 111.7 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.91 135.26 20.2 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 126.438 1.895 . . . . 0.35 113.243 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -150.05 103.67 3.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.743 1.217 . . . . 0.35 107.997 170.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.2 m -77.19 87.43 3.65 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.408 1.083 . . . . 0.35 108.757 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -97.88 103.64 15.6 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.572 1.149 . . . . 0.35 108.32 -175.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.6 p -83.32 143.16 30.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.276 1.03 . . . . 0.35 111.266 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -151.45 152.97 31.71 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.422 1.089 . . . . 0.33 108.856 169.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.43 -117.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.357 2.705 . . . . 0.35 110.897 -171.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tp -158.76 150.16 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.901 0.88 . . . . 0.35 109.559 -173.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.3 p -91.85 172.68 8.3 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.025 0.93 . . . . 0.35 110.807 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -102.9 -28.39 12.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.324 1.45 . . . . 0.35 109.386 165.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -62.63 -76.04 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.0 1.32 . . . . 0.35 111.777 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 133.93 73.73 0.09 OUTLIER Glycine 0 C--N 1.341 0.86 0 N-CA-C 110.354 -1.099 . . . . 0.35 110.354 -172.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -77.21 131.1 38.06 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.336 0.568 . . . . 0.35 109.685 175.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.63 127.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.678 -1.23 . . . . 0.35 107.678 170.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.16 115.35 12.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.698 -1.223 . . . . 0.33 107.698 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -82.84 -174.04 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.115 2.543 . . . . 0.35 110.866 -170.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -69.37 -171.57 0.37 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.858 0.863 . . . . 0.35 110.109 167.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.27 1.76 2.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.663 0.785 . . . . 0.35 113.094 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 t 65.08 -154.62 0.28 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.177 0.991 . . . . 0.35 111.516 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -96.6 -50.14 4.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.715 1.206 . . . . 0.35 111.483 -166.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -50.45 -41.77 53.24 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.965 1.306 . . . . 0.35 112.896 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.3 tp -105.36 144.23 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.783 1.233 . . . . 0.35 108.488 168.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -149.93 17.4 0.87 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.553 1.141 . . . . 0.35 111.405 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.81 70.16 2.02 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.359 1.064 . . . . 0.36 110.074 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -87.98 -172.69 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.434 3.423 . . . . 0.35 112.26 -170.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.88 84.26 0.17 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.596 -1.402 . . . . 0.35 109.596 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -74.88 81.24 2.14 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.31 1.444 . . . . 0.35 109.917 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -90.58 104.31 16.9 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.048 0.539 . . . . 0.36 110.437 -169.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.88 90.59 4.72 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.005 -1.109 . . . . 0.35 108.005 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.2 mt -96.59 74.76 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 106.97 -1.493 . . . . 0.35 106.97 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.1 m -78.67 170.73 16.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.641 1.176 . . . . 0.35 109.127 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -141.94 133.81 27.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.43 1.092 . . . . 0.35 108.861 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.417 HG22 HG11 ' A' ' 29' ' ' VAL . 5.3 m -142.52 159.62 19.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 123.652 0.781 . . . . 0.35 110.803 173.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.4 t -90.85 126.83 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.117 1.367 . . . . 0.35 108.205 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 34.9 mt -116.65 120.35 64.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.295 1.038 . . . . 0.35 110.159 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -80.29 120.43 24.34 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.267 1.427 . . . . 0.35 108.073 164.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -89.07 -3.51 58.65 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.414 1.086 . . . . 0.35 112.997 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? . . . . . 0 C--N 1.343 0.323 0 C-N-CA 125.52 1.528 . . . . 0.25 110.333 -164.267 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 119.04 -0.505 . . . . 0.35 110.408 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m -14.15 -78.0 0.01 OUTLIER 'General case' 0 C--N 1.344 0.347 0 C-N-CA 129.317 3.047 . . . . 0.35 114.61 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.5 p -133.73 63.36 1.63 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.406 1.083 . . . . 0.35 108.746 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -9.22 96.55 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 129.445 3.098 . . . . 0.35 115.274 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -93.59 71.78 4.29 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.803 0.841 . . . . 0.35 108.917 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -157.47 -51.39 0.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.409 1.083 . . . . 0.35 110.163 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.49 67.45 0.89 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.825 -0.91 . . . . 0.35 110.825 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt 56.14 -121.45 1.62 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.431 1.492 . . . . 0.35 110.904 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.9 t80 61.71 99.64 0.03 OUTLIER 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.499 1.92 . . . . 0.35 112.181 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.81 52.43 0.94 Allowed 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.685 1.194 . . . . 0.35 110.678 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.6 mttt 79.55 -65.18 0.2 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 126.915 2.086 . . . . 0.35 111.866 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 147.09 -47.8 0.67 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 108.387 -1.885 . . . . 0.35 108.387 -168.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 48.4 51.15 15.66 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.881 2.073 . . . . 0.35 113.809 167.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 56.66 54.39 7.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.901 1.281 . . . . 0.35 111.778 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.16 -158.33 0.32 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.553 1.141 . . . . 0.35 112.984 171.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.0 p -162.79 -35.6 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.482 1.113 . . . . 0.35 111.812 -171.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -133.8 39.44 3.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.705 1.202 . . . . 0.35 109.944 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -147.37 73.05 1.27 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 122.775 0.43 . . . . 0.35 110.788 -174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 65.8 177.99 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.191 1.396 . . . . 0.33 112.886 162.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -74.89 60.41 5.34 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.596 2.864 . . . . 0.35 113.742 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.2 p -68.01 -40.97 82.9 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.566 0.746 . . . . 0.35 109.915 170.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.96 166.79 22.36 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 111.881 -0.488 . . . . 0.33 111.881 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.03 -177.45 3.72 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.875 3.717 . . . . 0.35 111.807 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -156.46 171.8 19.65 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.594 1.157 . . . . 0.35 110.452 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tt -149.16 82.61 1.43 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.957 -1.127 . . . . 0.35 107.957 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -67.42 133.14 49.01 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.378 0.671 . . . . 0.35 110.166 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.8 t -128.67 86.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 125.076 1.35 . . . . 0.35 108.423 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -146.93 177.97 8.72 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.989 1.315 . . . . 0.36 109.254 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.3 m -137.71 144.05 32.21 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 C-N-CA 124.348 1.059 . . . . 0.35 110.34 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.7 m -75.99 97.35 3.99 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.305 -0.998 . . . . 0.35 108.305 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.92 84.01 1.57 Allowed Glycine 0 C--N 1.338 0.686 0 C-N-CA 123.988 0.804 . . . . 0.35 111.535 -172.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.8 m -77.14 165.5 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.25 0.62 . . . . 0.35 110.315 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.4 -66.53 0.89 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.884 0.474 . . . . 0.35 109.862 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.6 m -158.42 -56.0 0.07 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.61 1.564 . . . . 0.35 108.249 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.25 45.42 1.02 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.763 1.225 . . . . 0.35 110.17 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.59 29.03 73.45 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.161 0.886 . . . . 0.35 113.419 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -96.75 97.71 9.56 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 117.933 0.866 . . . . 0.36 108.887 -177.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.08 116.26 4.39 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.506 1.123 . . . . 0.35 111.541 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.7 mp -73.16 -45.82 54.34 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.327 0.651 . . . . 0.35 109.386 168.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 pp -138.58 138.82 38.29 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.308 1.043 . . . . 0.35 111.978 -171.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.7 t -82.32 138.08 45.27 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 124.658 1.183 . . . . 0.33 109.107 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -86.31 61.36 4.73 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.648 2.899 . . . . 0.35 111.825 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -149.11 65.31 1.03 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.609 0.764 . . . . 0.35 109.845 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -128.61 -52.74 1.25 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.159 0.984 . . . . 0.35 111.261 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.1 t -101.47 140.49 20.02 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 123.214 0.606 . . . . 0.35 109.893 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.7 170.06 19.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.643 0.777 . . . . 0.35 110.109 164.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -140.13 147.94 52.49 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.133 0.973 . . . . 0.33 109.373 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.38 126.89 14.86 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.346 2.031 . . . . 0.35 107.911 168.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.3 tt -57.83 137.57 19.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.36 0.664 . . . . 0.35 112.585 -168.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 86.62 8.99 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.961 1.705 . . . . 0.33 107.765 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.16 168.47 23.94 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.193 2.595 . . . . 0.35 111.371 -170.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.51 -28.64 14.14 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.025 0.821 . . . . 0.35 111.802 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.0 t -65.58 148.03 52.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.722 0.809 . . . . 0.35 110.879 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.9 m -74.61 124.27 26.36 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.419 0.688 . . . . 0.35 109.702 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.96 102.28 7.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.34 1.456 . . . . 0.35 107.435 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.2 t -139.8 -175.99 4.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.596 1.158 . . . . 0.35 108.882 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -55.71 -60.16 3.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.668 0.787 . . . . 0.35 110.672 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.6 -33.19 74.5 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.376 0.88 . . . . 0.35 113.376 -173.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -61.23 2.5 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.246 0.93 . . . . 0.35 110.055 175.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.13 -31.78 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.35 1.06 . . . . 0.35 111.342 -170.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.74 -62.46 1.64 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.653 1.181 . . . . 0.35 111.572 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.04 -34.97 78.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.166 0.439 . . . . 0.35 111.539 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -63.6 -46.8 84.11 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.621 0.768 . . . . 0.35 111.663 -175.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.8 p -73.66 -31.93 33.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 122.809 0.443 . . . . 0.35 111.724 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -58.95 -31.89 69.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.279 0.632 . . . . 0.35 111.512 173.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -76.54 -38.33 55.25 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.922 0.489 . . . . 0.35 110.771 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.31 -62.27 1.96 Allowed 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.335 1.054 . . . . 0.35 111.942 -174.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.13 -23.88 67.48 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.048 0.758 . . . . 0.35 113.048 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -80.43 66.66 6.01 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.813 1.245 . . . . 0.35 110.972 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.07 49.86 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.798 1.639 . . . . 0.35 108.672 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.2 p -140.08 -62.41 0.51 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.047 1.339 . . . . 0.35 108.873 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.29 -64.93 1.01 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.118 1.367 . . . . 0.35 108.686 172.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.7 t80 56.62 68.99 0.78 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.873 1.669 . . . . 0.35 110.802 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -132.8 47.7 2.48 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.993 1.317 . . . . 0.35 108.53 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 63.6 111.51 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.065 2.146 . . . . 0.35 112.36 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -111.57 99.52 8.25 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.271 1.428 . . . . 0.35 108.107 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -81.28 98.49 8.15 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.369 -0.604 . . . . 0.35 109.369 -174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.5 96.83 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.907 -0.775 . . . . 0.35 108.907 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.53 -46.02 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.652 0.781 . . . . 0.35 111.035 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -137.96 164.41 29.11 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.71 1.204 . . . . 0.35 110.225 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 pp -157.66 158.29 35.17 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.861 1.264 . . . . 0.35 110.316 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -90.23 121.22 68.86 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 108.533 -0.914 . . . . 0.33 108.533 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.77 -39.46 3.4 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.019 2.479 . . . . 0.35 110.938 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -79.49 83.48 5.49 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.006 0.923 . . . . 0.35 109.291 176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.07 129.75 41.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.628 0.771 . . . . 0.35 109.778 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -100.23 136.38 40.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.575 1.15 . . . . 0.35 110.82 -172.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.43 120.27 58.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.286 0 C-N-CA 125.633 1.573 . . . . 0.35 108.492 -173.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -117.9 90.56 3.36 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.819 1.248 . . . . 0.35 108.647 -172.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 m -77.06 94.08 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.261 1.024 . . . . 0.35 110.544 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 88.1 m -91.88 90.62 7.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.634 1.574 . . . . 0.35 108.532 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.75 93.9 7.78 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.823 0.849 . . . . 0.35 110.534 -177.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -86.09 62.55 7.51 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.71 1.604 . . . . 0.35 109.615 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -98.99 78.63 2.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.996 1.319 . . . . 0.35 107.469 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.12 80.28 4.55 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.656 1.182 . . . . 0.35 109.376 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -150.75 -41.43 0.12 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.784 2.034 . . . . 0.36 108.442 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.65 -39.75 0.18 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.817 1.647 . . . . 0.35 110.894 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -85.77 -54.75 4.34 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.0 0.92 . . . . 0.35 111.439 -171.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 83.3 tttt 69.52 158.51 0.17 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.877 1.671 . . . . 0.35 110.856 -172.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.73 123.62 14.74 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.105 0.562 . . . . 0.35 111.446 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -145.0 105.64 4.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.91 1.284 . . . . 0.35 107.841 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.7 m -82.62 86.85 6.75 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.949 1.299 . . . . 0.35 108.968 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -89.3 101.61 14.28 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.014 0.926 . . . . 0.35 108.85 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.8 p -80.35 144.21 32.92 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.415 1.086 . . . . 0.35 111.266 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -158.95 137.0 7.46 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 123.282 0.633 . . . . 0.33 110.719 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.6 161.73 27.77 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.858 3.039 . . . . 0.35 110.525 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.0 tp -95.42 151.66 3.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 123.788 0.835 . . . . 0.35 110.339 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 67.6 p -86.67 112.18 21.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.835 -1.172 . . . . 0.35 107.835 169.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.15 -21.76 66.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.478 1.111 . . . . 0.35 113.596 -173.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.05 -44.05 97.52 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.899 0.88 . . . . 0.35 111.713 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.32 135.15 1.77 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.519 -1.033 . . . . 0.35 110.519 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -159.27 166.86 30.37 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.372 1.069 . . . . 0.35 109.555 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.67 144.6 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.283 1.433 . . . . 0.35 109.229 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.19 116.33 15.58 Favored Pre-proline 0 C--N 1.345 0.405 0 N-CA-C 108.156 -1.053 . . . . 0.33 108.156 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.42 -101.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.921 2.414 . . . . 0.35 110.902 -167.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -166.17 169.04 14.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.098 0.959 . . . . 0.35 109.376 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.53 17.54 0.86 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.767 1.227 . . . . 0.35 112.635 172.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.8 t 63.04 -95.13 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.647 1.579 . . . . 0.35 111.024 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -167.36 -48.76 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.167 0.987 . . . . 0.35 109.855 -174.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -70.76 -0.34 8.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.495 1.518 . . . . 0.35 114.943 -168.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.7 pt -133.24 -172.98 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.411 1.084 . . . . 0.35 110.188 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -130.6 -45.32 1.08 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.414 1.486 . . . . 0.35 110.62 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -119.92 74.49 19.71 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 0.36 112.772 -162.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -69.27 141.27 46.74 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.17 1.913 . . . . 0.35 109.935 171.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.24 79.7 0.28 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.405 -1.478 . . . . 0.35 109.405 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -66.67 92.92 0.23 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.713 1.205 . . . . 0.35 110.713 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -85.37 98.68 10.69 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.877 -1.157 . . . . 0.36 107.877 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.93 53.82 2.89 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.171 0.988 . . . . 0.35 109.196 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.0 mt -99.03 99.29 8.31 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 124.462 1.105 . . . . 0.35 108.681 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 96.3 m -105.63 140.53 38.56 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.102 1.361 . . . . 0.35 109.231 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 126.46 31.63 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.525 0.73 . . . . 0.35 109.326 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.34 148.33 32.77 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 C-N-CA 123.888 0.875 . . . . 0.35 110.299 172.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 t -96.51 130.83 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.689 1.196 . . . . 0.35 108.364 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mt -126.97 105.95 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.829 1.251 . . . . 0.35 109.222 -173.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -71.58 132.07 44.13 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.79 -1.189 . . . . 0.35 107.79 159.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 94.83 4.4 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.403 0.681 . . . . 0.35 109.497 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.344 0.337 0 C-N-CA 124.969 1.307 . . . . 0.25 109.438 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 110.162 -0.31 . . . . 0.35 110.162 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.0 m -89.13 57.24 3.99 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.458 1.103 . . . . 0.35 108.263 172.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t 55.23 64.87 1.64 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.356 1.463 . . . . 0.35 110.648 -169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -60.66 135.48 57.78 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.878 0.871 . . . . 0.35 110.102 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -164.96 99.07 0.76 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.752 0.821 . . . . 0.35 110.077 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -157.89 37.68 0.26 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.257 1.023 . . . . 0.35 109.946 168.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.43 159.93 9.74 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.017 0.818 . . . . 0.35 111.18 -174.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -74.76 96.95 3.15 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.985 0.514 . . . . 0.35 110.189 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -85.88 79.12 9.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.305 1.042 . . . . 0.35 110.609 -174.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -137.84 -158.12 0.83 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.913 0.885 . . . . 0.35 109.187 170.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.9 tttt 62.61 46.86 5.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.197 0.999 . . . . 0.35 109.542 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.11 -42.88 1.85 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.046 1.308 . . . . 0.35 111.653 -172.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -85.47 56.52 3.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.588 1.155 . . . . 0.35 110.558 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 54.85 28.71 10.78 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.682 1.993 . . . . 0.35 113.693 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.17 140.63 29.3 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.384 0.674 . . . . 0.35 110.889 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -166.32 -130.13 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.154 0.982 . . . . 0.35 109.511 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -138.82 164.83 28.61 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.306 1.842 . . . . 0.35 108.951 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.7 t80 66.72 103.62 0.04 OUTLIER 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.763 1.625 . . . . 0.35 110.673 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 75.66 144.65 0.1 Allowed Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 126.109 1.764 . . . . 0.33 110.079 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -57.62 96.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.443 2.762 . . . . 0.35 111.847 171.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.1 p -94.33 -44.3 8.0 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.008 0.923 . . . . 0.35 110.291 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.21 150.38 8.64 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 112.032 -0.427 . . . . 0.33 112.032 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -92.21 -170.12 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.939 3.093 . . . . 0.35 111.098 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -168.75 165.32 11.96 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.006 0.922 . . . . 0.35 111.73 172.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.0 tp -134.42 88.54 2.46 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.94 1.696 . . . . 0.35 107.731 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -78.41 125.57 29.55 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.883 1.273 . . . . 0.35 108.312 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.1 t -135.65 91.09 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.882 0.873 . . . . 0.35 109.382 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -149.28 157.68 43.55 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.465 1.506 . . . . 0.36 109.169 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.13 161.09 42.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 123.806 0.843 . . . . 0.35 112.146 -168.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.3 m -87.91 91.15 8.66 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.841 1.257 . . . . 0.35 108.438 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.06 104.24 2.66 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.653 -0.979 . . . . 0.35 110.653 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.35 174.0 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.224 1.01 . . . . 0.35 111.033 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -71.62 -55.82 7.03 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.065 0.546 . . . . 0.35 109.675 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.2 p -150.1 -71.04 0.18 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.067 0.947 . . . . 0.35 110.559 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -85.45 -73.33 0.45 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.862 0.865 . . . . 0.35 110.541 -171.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.49 50.77 0.41 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.341 -1.104 . . . . 0.35 110.341 -176.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -115.82 79.99 1.38 Allowed 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.338 1.455 . . . . 0.36 108.714 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.46 138.76 58.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.036 1.334 . . . . 0.35 112.256 -173.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mp -113.96 -24.84 8.85 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.311 1.445 . . . . 0.35 110.666 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.51 146.0 32.16 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 124.355 1.062 . . . . 0.35 111.738 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.8 m -81.33 153.6 71.51 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.367 1.067 . . . . 0.33 110.331 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.99 50.44 1.81 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.78 2.987 . . . . 0.35 111.521 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -173.21 103.96 0.13 Allowed 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.09 0.556 . . . . 0.35 111.038 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -164.88 14.02 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.5 0.926 . . . . 0.35 113.5 172.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.6 t -149.16 135.22 12.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 C-N-CA 125.241 1.416 . . . . 0.35 107.441 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -139.46 171.05 14.82 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.128 0.571 . . . . 0.35 111.295 169.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -140.81 151.7 63.61 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.765 1.226 . . . . 0.33 109.967 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.04 100.61 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.487 2.791 . . . . 0.35 109.397 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.77 138.17 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.262 1.025 . . . . 0.35 111.508 -171.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -138.53 137.11 19.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.717 1.207 . . . . 0.33 108.733 171.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.24 169.36 22.67 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.647 2.898 . . . . 0.35 110.864 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 110.63 -31.21 7.51 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.108 0.861 . . . . 0.35 111.841 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 t -66.13 146.27 54.84 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.559 0.744 . . . . 0.35 111.146 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.7 m -74.21 152.91 39.67 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.455 1.102 . . . . 0.35 109.282 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.04 121.13 8.28 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.4 0.68 . . . . 0.35 109.482 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 t -166.09 174.53 9.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.689 1.996 . . . . 0.35 107.846 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -55.62 -52.18 64.67 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.692 0.797 . . . . 0.35 111.23 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.75 -24.72 67.88 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.184 0.809 . . . . 0.35 113.184 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -71.85 -51.66 21.3 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.371 0.668 . . . . 0.35 110.582 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.2 -33.25 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.51 1.124 . . . . 0.35 111.886 -172.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -55.29 -55.23 33.82 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.463 1.105 . . . . 0.35 111.714 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -66.99 -30.29 70.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.073 0.397 . . . . 0.35 111.867 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -52.88 61.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.483 0.713 . . . . 0.35 110.209 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -61.13 -38.95 80.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 CA-C-O 119.038 -0.506 . . . . 0.35 111.343 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.92 -36.16 76.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.586 0.755 . . . . 0.35 111.875 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -70.2 -48.04 58.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.93 0.492 . . . . 0.35 110.844 177.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.95 97.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.427 0.691 . . . . 0.35 111.52 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 mt -54.51 -58.78 6.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.22 1.408 . . . . 0.35 110.304 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -61.38 -59.62 4.99 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.01 0.924 . . . . 0.35 111.652 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -41.23 -48.8 3.58 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 126.131 1.772 . . . . 0.35 113.429 -171.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.5 m -74.13 -63.61 1.19 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.348 0.659 . . . . 0.35 109.924 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.56 96.08 5.69 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.01 1.324 . . . . 0.35 109.915 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -112.18 70.67 0.72 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.196 1.399 . . . . 0.35 109.571 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -137.95 -113.17 0.17 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.745 0.818 . . . . 0.35 109.906 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.42 83.22 6.86 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.414 1.086 . . . . 0.35 110.81 -173.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -152.43 162.87 40.58 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.317 0.647 . . . . 0.35 111.469 176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -173.98 125.05 0.35 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.549 1.94 . . . . 0.35 106.789 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.96 91.74 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.297 -1.001 . . . . 0.35 108.297 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 p -61.2 -43.92 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.885 0.874 . . . . 0.35 110.985 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -151.1 169.16 22.52 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.943 0.897 . . . . 0.35 110.12 169.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 pp -144.64 149.56 35.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.285 1.034 . . . . 0.35 109.992 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.86 135.73 55.35 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.578 -0.897 . . . . 0.33 108.578 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.46 -24.44 22.46 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.162 2.575 . . . . 0.35 111.923 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 m -86.21 70.03 10.51 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.57 1.148 . . . . 0.35 110.855 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.39 164.35 26.49 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.767 0.827 . . . . 0.35 109.965 168.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -150.02 121.72 8.07 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.134 0.493 . . . . 0.35 112.313 -174.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 mp -77.74 114.69 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.663 -1.606 . . . . 0.35 106.663 165.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -110.23 63.42 0.61 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.34 -0.985 . . . . 0.35 108.34 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.09 111.11 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.405 0.682 . . . . 0.35 110.945 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.5 m -98.45 81.85 2.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.49 1.516 . . . . 0.35 108.263 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -87.27 112.56 22.16 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.245 1.018 . . . . 0.35 108.577 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -104.67 117.49 34.23 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.547 1.139 . . . . 0.35 110.578 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.411 ' HB2' HD12 ' A' ' 120' ' ' ILE . 27.1 t70 -128.37 89.34 2.89 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.597 1.159 . . . . 0.35 110.236 -172.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -82.82 67.83 9.06 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.04 -0.726 . . . . 0.35 109.04 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -149.0 -54.17 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.225 1.41 . . . . 0.36 109.134 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.74 -48.11 0.09 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.634 0.773 . . . . 0.35 112.823 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -71.94 -34.32 68.94 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.884 0.874 . . . . 0.35 112.17 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 ttmt 72.68 174.9 0.29 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.118 1.367 . . . . 0.35 110.945 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -79.16 132.23 36.48 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.209 0.604 . . . . 0.35 110.876 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -139.87 113.4 8.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.585 1.154 . . . . 0.35 108.562 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.6 m -80.2 84.88 5.81 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.658 -1.238 . . . . 0.35 107.658 172.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -78.82 105.66 10.29 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.898 0.879 . . . . 0.35 109.35 -173.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.5 m -87.95 67.79 9.08 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.585 1.154 . . . . 0.35 111.163 -172.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -69.56 140.87 89.97 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.216 1.006 . . . . 0.33 108.74 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -78.78 -116.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.265 2.644 . . . . 0.35 110.335 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.1 tp -160.52 150.83 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.17 0.988 . . . . 0.35 108.862 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.0 p -103.4 175.7 5.39 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.036 0.934 . . . . 0.35 110.611 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.83 -10.79 15.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.592 1.557 . . . . 0.35 110.573 164.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -77.31 -82.97 0.08 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 124.813 1.245 . . . . 0.35 110.713 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 145.4 63.85 0.02 OUTLIER Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.155 -1.178 . . . . 0.35 110.155 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -72.27 129.71 39.07 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 117.508 0.654 . . . . 0.35 109.728 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.71 130.99 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.395 -0.965 . . . . 0.35 108.395 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 91.7 t -62.6 117.24 29.51 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 107.918 -1.141 . . . . 0.33 107.918 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.27 172.02 16.05 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.199 2.6 . . . . 0.35 110.898 -173.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.11 34.53 0.62 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.146 0.978 . . . . 0.35 110.932 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 32.66 54.0 0.36 Allowed 'General case' 0 C--N 1.346 0.43 0 C-N-CA 128.041 2.536 . . . . 0.35 113.878 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.1 t 56.47 -105.84 0.29 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.893 1.677 . . . . 0.35 111.467 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -163.22 -38.17 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.233 1.013 . . . . 0.35 110.654 -172.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -55.22 -13.6 1.37 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.26 1.824 . . . . 0.35 115.169 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 93' ' ' ASP . 1.0 OUTLIER -153.14 148.23 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.574 1.15 . . . . 0.35 108.978 171.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.49 34.77 3.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.37 1.868 . . . . 0.35 111.337 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -153.37 79.48 5.48 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.318 0.647 . . . . 0.36 111.378 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.59 167.67 25.1 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.022 2.482 . . . . 0.35 111.527 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.0 68.2 0.47 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.194 -1.163 . . . . 0.35 110.194 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -59.73 103.05 0.18 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.165 1.386 . . . . 0.35 111.26 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -100.39 98.41 9.05 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.072 0.949 . . . . 0.36 109.449 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.96 73.83 10.24 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.116 0.966 . . . . 0.35 108.535 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.6 mt -91.05 91.29 3.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.093 -1.447 . . . . 0.35 107.093 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.1 m -111.58 150.48 29.98 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.688 1.195 . . . . 0.35 109.468 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -91.75 130.3 37.56 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.151 1.38 . . . . 0.35 109.053 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 m -137.5 169.46 19.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 123.753 0.821 . . . . 0.35 110.351 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 37.9 t -119.73 139.75 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.035 1.334 . . . . 0.35 108.111 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.7 mt -130.54 119.35 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.232 1.013 . . . . 0.35 109.503 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -78.71 127.2 31.76 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.923 -1.14 . . . . 0.35 107.923 161.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -95.24 60.32 2.3 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.241 1.017 . . . . 0.35 111.252 -168.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.186 0 C-N-CA 124.004 0.921 . . . . 0.25 110.021 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 110.713 -0.106 . . . . 0.35 110.713 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -68.66 176.11 3.15 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.619 1.167 . . . . 0.35 112.094 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.9 p -137.13 166.45 23.7 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.294 1.438 . . . . 0.35 109.919 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -82.45 145.66 29.71 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.82 0.448 . . . . 0.35 110.817 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -95.02 162.29 13.79 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.125 0.97 . . . . 0.35 110.33 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 pttm 50.51 83.36 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.557 1.943 . . . . 0.35 112.57 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.22 103.32 0.33 Allowed Glycine 0 C--N 1.341 0.845 0 C-N-CA 126.387 1.946 . . . . 0.35 112.621 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt 75.1 -33.68 0.24 Allowed 'General case' 0 C--N 1.343 0.315 0 C-N-CA 126.688 1.995 . . . . 0.35 113.743 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -55.1 123.13 12.65 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.138 0.975 . . . . 0.35 110.173 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -101.43 27.85 5.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.491 -0.766 . . . . 0.35 112.996 -159.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? 69.53 -63.95 0.36 Allowed 'General case' 0 C--N 1.346 0.435 0 C-N-CA 126.21 1.804 . . . . 0.35 109.907 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.59 -151.49 6.7 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.605 -1.798 . . . . 0.35 108.605 172.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 57.62 37.73 27.54 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.371 1.068 . . . . 0.35 111.753 173.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.91 64.63 0.96 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.507 1.123 . . . . 0.35 109.335 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.51 -41.53 60.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.009 0.924 . . . . 0.35 110.345 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.6 t 74.26 -74.67 0.08 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.779 2.032 . . . . 0.35 112.064 175.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -155.22 171.56 19.62 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.332 0.653 . . . . 0.35 111.257 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 70.11 121.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.709 2.004 . . . . 0.35 112.633 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 73.93 137.81 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 126.17 1.788 . . . . 0.33 112.223 168.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.79 109.62 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.19 3.26 . . . . 0.35 111.922 160.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 p -138.06 -62.54 0.58 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.847 1.259 . . . . 0.35 109.588 -174.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.0 113.08 0.31 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.46 -1.056 . . . . 0.33 110.46 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.24 176.58 9.87 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.003 2.469 . . . . 0.35 111.803 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -159.06 163.09 36.61 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.207 1.003 . . . . 0.35 110.344 -174.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.8 tt -145.11 94.61 2.55 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.458 -1.312 . . . . 0.35 107.458 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.3 ptp -88.74 139.06 30.85 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.884 0.874 . . . . 0.35 110.357 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.6 91.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.205 0 C-N-CA 124.636 1.174 . . . . 0.35 107.874 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -153.59 166.1 33.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.699 1.2 . . . . 0.36 110.139 -171.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -144.94 170.59 6.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 123.147 0.579 . . . . 0.35 112.352 -167.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 m -107.0 121.46 44.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.155 1.382 . . . . 0.35 108.264 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.55 92.41 1.72 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.15 0.881 . . . . 0.35 111.624 -174.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.0 m -99.08 168.63 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 124.316 1.046 . . . . 0.35 112.852 -174.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -83.09 172.72 12.41 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.626 1.17 . . . . 0.35 109.563 166.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -57.18 -40.94 78.33 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.722 0.809 . . . . 0.35 110.39 170.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -62.02 -55.29 30.67 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.061 0.945 . . . . 0.35 110.186 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.1 4.29 0.59 Allowed Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.938 -0.923 . . . . 0.35 114.017 172.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -79.32 123.18 27.22 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.774 1.287 . . . . 0.36 110.217 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -65.21 104.11 0.87 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.912 0.885 . . . . 0.35 110.976 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 mp -69.65 -56.77 6.34 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.751 -1.203 . . . . 0.35 107.751 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.5 mt -120.65 164.91 15.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.188 1.795 . . . . 0.35 108.789 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.8 m -142.74 68.26 19.17 Favored Pre-proline 0 N--CA 1.454 -0.258 0 C-N-CA 124.522 1.129 . . . . 0.33 108.015 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.08 106.29 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.578 2.852 . . . . 0.35 110.073 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -146.34 90.58 1.96 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.926 1.69 . . . . 0.35 108.187 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -155.55 -33.36 0.09 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.056 0.762 . . . . 0.35 113.056 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.6 t -76.22 98.7 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.975 0.91 . . . . 0.35 111.216 -176.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -86.97 170.09 11.88 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.317 0.647 . . . . 0.35 110.141 167.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -155.41 131.1 5.47 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.269 -1.011 . . . . 0.33 108.269 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.48 121.84 8.8 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.815 2.343 . . . . 0.35 109.059 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.0 tt -57.53 133.85 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.32 1.048 . . . . 0.35 112.856 -168.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -142.77 98.39 5.77 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 125.565 1.546 . . . . 0.33 107.495 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.77 173.66 13.76 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.247 2.631 . . . . 0.35 111.288 -174.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.42 -26.48 24.17 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.013 0.816 . . . . 0.35 112.159 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.1 t -66.32 151.51 46.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.889 0.844 . . . . 0.35 110.796 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -62.46 148.62 45.07 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.959 0.903 . . . . 0.35 110.118 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.51 101.23 2.64 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.368 -0.975 . . . . 0.35 108.368 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 t -144.89 -171.07 3.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.165 1.386 . . . . 0.35 108.752 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -58.19 -57.41 12.99 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.35 110.674 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -61.96 -29.03 69.96 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.518 0.562 . . . . 0.35 112.518 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -62.39 -54.01 46.54 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.547 -0.538 . . . . 0.35 109.547 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 mm -51.14 -55.38 7.76 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 124.526 1.13 . . . . 0.35 109.786 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -45.98 -63.75 0.91 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.675 1.19 . . . . 0.35 112.406 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -63.62 -38.46 91.19 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.465 0.575 . . . . 0.35 111.894 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.1 -49.15 62.97 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.491 0.716 . . . . 0.35 110.644 -173.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.61 -37.22 79.46 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 118.454 0.57 . . . . 0.35 111.551 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -58.83 -44.37 90.88 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.357 0.663 . . . . 0.35 110.589 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -67.57 -34.8 77.79 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.568 0.347 . . . . 0.35 110.85 176.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.04 -64.78 0.83 Allowed 'General case' 0 C--N 1.343 0.287 0 CA-C-O 118.605 -0.712 . . . . 0.35 111.502 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -66.43 -35.32 79.99 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.647 0.658 . . . . 0.35 112.368 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -90.14 49.39 1.69 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.489 0.715 . . . . 0.35 110.578 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.0 -51.99 2.88 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.328 1.451 . . . . 0.35 107.362 164.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.5 p -79.56 -45.76 18.6 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.566 1.146 . . . . 0.35 110.291 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.18 -93.22 0.07 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.633 0.773 . . . . 0.35 110.695 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 62.28 -151.14 0.36 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.978 1.311 . . . . 0.35 110.674 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? 66.38 -80.45 0.03 OUTLIER 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.678 1.991 . . . . 0.35 111.549 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -84.28 -115.41 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.05 -1.093 . . . . 0.35 108.05 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 59.3 82.39 0.15 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.248 1.419 . . . . 0.35 111.455 171.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.5 ttm105 -66.14 -55.23 17.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.698 0.799 . . . . 0.35 109.98 172.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 t 60.89 78.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 125.189 1.396 . . . . 0.35 109.11 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.38 -43.71 97.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.083 0.953 . . . . 0.35 112.232 -171.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -138.44 170.53 15.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.247 1.019 . . . . 0.35 110.552 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 pp -153.5 159.84 42.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.359 1.464 . . . . 0.35 109.159 171.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.05 120.57 82.19 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 109.222 -0.658 . . . . 0.33 109.222 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -70.72 -33.0 13.62 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.186 2.591 . . . . 0.35 110.97 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -82.7 70.49 9.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.52 1.128 . . . . 0.35 109.384 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.0 160.66 30.52 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.642 0.777 . . . . 0.35 109.951 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.7 145.47 34.93 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.899 0.48 . . . . 0.35 111.818 -171.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 mp -122.84 99.4 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 126.728 2.011 . . . . 0.35 106.294 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -88.93 72.53 8.46 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.175 0.99 . . . . 0.35 109.34 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.83 115.14 5.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.401 0.68 . . . . 0.35 110.3 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.1 m -103.01 91.6 4.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.862 1.265 . . . . 0.35 108.303 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -81.19 94.35 6.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.306 0.642 . . . . 0.35 109.89 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -105.68 129.7 53.85 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.056 1.342 . . . . 0.35 110.505 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -161.37 94.4 0.98 Allowed 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 106.429 -1.693 . . . . 0.35 106.429 172.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -56.12 -28.23 57.06 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.409 0.892 . . . . 0.35 113.409 -169.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -56.34 -41.79 76.64 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.93 1.292 . . . . 0.36 112.133 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -144.18 -56.12 0.36 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 112.852 0.686 . . . . 0.35 112.852 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.61 -61.2 1.92 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.65 0.659 . . . . 0.35 111.069 -171.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 79.9 tttt 80.41 149.26 0.1 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.503 1.921 . . . . 0.35 110.905 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -49.38 126.43 13.12 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.983 1.713 . . . . 0.35 112.153 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -155.24 101.42 2.22 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.148 0.979 . . . . 0.35 109.04 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.7 m -77.23 97.86 4.95 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.939 1.296 . . . . 0.35 109.708 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -91.66 108.38 19.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.569 1.148 . . . . 0.35 108.39 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 65.0 p -82.68 77.95 9.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.51 1.124 . . . . 0.35 111.44 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -72.33 131.9 84.53 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 108.567 -0.901 . . . . 0.33 108.567 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.89 -125.03 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.653 2.902 . . . . 0.35 109.03 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.51 154.12 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 119.268 0.94 . . . . 0.35 110.013 173.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.7 p -108.01 123.21 48.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.366 1.067 . . . . 0.35 108.558 169.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -61.23 -36.56 80.27 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.531 1.132 . . . . 0.35 110.658 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -56.01 -56.55 19.45 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.426 1.091 . . . . 0.35 111.238 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.51 139.42 2.71 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 112.26 -0.336 . . . . 0.35 112.26 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -155.39 165.9 35.19 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.571 1.548 . . . . 0.35 108.783 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -137.19 146.1 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.264 1.426 . . . . 0.35 108.71 -174.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.33 116.95 29.24 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.348 -0.982 . . . . 0.33 108.348 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.83 175.52 10.43 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.094 2.53 . . . . 0.35 111.504 -171.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.8 -166.01 0.26 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.616 1.166 . . . . 0.35 110.356 171.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.26 28.65 1.67 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.581 0.752 . . . . 0.35 112.536 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.6 t 53.1 -113.4 0.77 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.984 1.314 . . . . 0.35 111.796 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -158.09 -33.44 0.07 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.428 1.091 . . . . 0.35 111.595 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -60.45 -39.24 86.84 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.057 0.943 . . . . 0.35 111.227 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.6 tp -102.13 137.09 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.247 1.419 . . . . 0.35 108.13 171.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -137.28 13.47 3.03 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.494 1.117 . . . . 0.35 111.211 175.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.66 63.86 2.27 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.056 0.942 . . . . 0.36 109.995 -173.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.89 -176.22 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.65 2.9 . . . . 0.35 111.914 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.76 78.18 0.25 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 109.608 -1.397 . . . . 0.35 109.608 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -66.43 118.09 9.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.981 0.912 . . . . 0.35 109.441 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -121.06 90.99 3.43 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.812 1.245 . . . . 0.36 108.803 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.73 69.84 10.35 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.743 0.817 . . . . 0.35 109.178 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.3 mt -97.25 89.84 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.553 1.141 . . . . 0.35 108.678 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 57.7 m -92.07 169.13 10.88 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.306 1.442 . . . . 0.35 108.621 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -116.92 132.86 56.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.592 1.157 . . . . 0.35 108.934 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.9 m -124.66 138.58 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.509 1.124 . . . . 0.35 109.956 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -92.45 96.3 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.283 -1.006 . . . . 0.35 108.283 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.7 mt -80.86 110.21 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 123.311 0.644 . . . . 0.35 110.03 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -98.09 155.88 16.92 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.703 -1.221 . . . . 0.35 107.703 153.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -107.97 132.67 53.26 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.314 1.046 . . . . 0.35 109.134 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 N--CA 1.453 -0.311 0 C-N-CA 124.541 1.136 . . . . 0.25 110.291 -174.03 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 97.6 p . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 110.637 -0.135 . . . . 0.35 110.637 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.7 m -81.18 -113.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.885 1.274 . . . . 0.35 109.225 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.9 t -113.83 45.22 1.49 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.561 1.144 . . . . 0.35 108.877 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 p90 35.88 58.71 0.91 Allowed 'General case' 0 C--N 1.344 0.355 0 C-N-CA 127.113 2.165 . . . . 0.35 112.548 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -40.09 88.72 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.13 2.172 . . . . 0.35 114.438 -163.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt 156.72 143.5 0.0 OUTLIER 'General case' 0 C--N 1.344 0.328 0 C-N-CA 130.097 3.359 . . . . 0.35 108.539 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.48 87.27 1.5 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.06 -1.216 . . . . 0.35 110.06 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 59.59 -96.59 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.751 1.621 . . . . 0.35 110.423 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.8 t80 52.75 76.44 0.19 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.086 1.354 . . . . 0.35 109.897 -172.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -81.64 65.09 6.63 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.753 1.221 . . . . 0.35 110.67 -171.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? 71.66 -71.5 0.13 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.68 2.392 . . . . 0.35 112.798 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.86 -19.86 0.29 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.725 1.155 . . . . 0.35 111.515 -167.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.68 138.61 17.86 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.667 1.587 . . . . 0.35 111.357 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -87.44 81.4 7.83 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.189 0.996 . . . . 0.35 109.806 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.83 158.43 18.74 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.506 1.123 . . . . 0.35 109.545 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -159.96 170.61 20.99 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.092 0.557 . . . . 0.35 111.184 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -122.36 43.43 2.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.11 1.364 . . . . 0.35 107.451 164.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -173.52 107.14 0.14 Allowed 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.051 1.34 . . . . 0.35 108.529 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 71.02 153.86 0.15 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 126.544 1.938 . . . . 0.33 111.655 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.62 85.59 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.987 2.458 . . . . 0.35 110.121 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.8 p -77.32 -56.79 4.25 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.021 0.929 . . . . 0.35 110.401 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.43 158.34 23.67 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 111.736 -0.546 . . . . 0.33 111.736 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -80.56 172.12 13.83 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.243 3.295 . . . . 0.35 111.815 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -163.62 175.48 10.59 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.597 1.159 . . . . 0.35 110.111 172.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 tt -144.55 92.41 2.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.071 -1.455 . . . . 0.35 107.071 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -78.7 129.26 34.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.08 1.352 . . . . 0.35 109.595 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.68 91.19 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.295 0 C-N-CA 124.813 1.245 . . . . 0.35 108.658 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -152.53 161.98 41.84 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.255 1.022 . . . . 0.36 109.9 172.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.5 m -121.4 155.3 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.784 1.234 . . . . 0.35 111.329 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.8 m -87.96 77.83 8.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.156 -1.424 . . . . 0.35 107.156 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.1 126.84 26.63 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 109.039 -1.625 . . . . 0.35 109.039 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.2 m -132.46 168.75 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 124.534 1.134 . . . . 0.35 110.172 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.08 -177.55 2.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.767 0.827 . . . . 0.35 109.326 164.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 t -83.09 42.71 0.82 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.939 0.496 . . . . 0.35 110.415 172.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.2 -59.07 0.49 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.833 2.053 . . . . 0.35 107.86 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.33 -9.43 0.81 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.21 0.91 . . . . 0.35 113.058 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -71.01 124.23 23.89 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.526 1.163 . . . . 0.36 110.143 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.38 125.19 25.67 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.559 0.743 . . . . 0.35 111.766 -171.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.7 mt -92.81 -45.53 7.96 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.859 1.664 . . . . 0.35 109.487 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.87 151.5 44.35 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.822 0.849 . . . . 0.35 111.753 175.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.5 t -89.48 149.56 42.77 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 126.078 1.751 . . . . 0.33 111.077 -169.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.17 47.16 1.98 Allowed 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.414 2.743 . . . . 0.35 111.848 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -174.52 116.78 0.2 Allowed 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.155 0.982 . . . . 0.35 110.09 173.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -170.93 -11.24 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.19 1.396 . . . . 0.35 113.127 173.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.03 143.47 26.61 Favored 'Isoleucine or valine' 0 C--N 1.342 0.246 0 C-N-CA 124.671 1.188 . . . . 0.35 109.278 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -152.79 142.59 22.04 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.327 1.051 . . . . 0.35 109.946 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -108.65 145.82 32.42 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 124.236 1.015 . . . . 0.33 110.156 -168.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.9 118.67 5.69 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.739 2.293 . . . . 0.35 108.385 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 tt -60.93 140.86 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.413 0.685 . . . . 0.35 112.654 -164.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -127.58 103.61 22.04 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 106.356 -1.72 . . . . 0.33 106.356 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.22 159.54 29.82 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.993 2.462 . . . . 0.35 111.002 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.99 66.37 1.58 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.291 -1.524 . . . . 0.35 109.291 -175.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.8 t -152.28 145.87 24.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.492 1.117 . . . . 0.35 109.705 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 87.9 m -70.2 115.46 9.42 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.346 1.058 . . . . 0.35 110.499 -172.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -119.52 102.77 8.88 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.885 1.674 . . . . 0.35 108.217 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t -148.72 167.79 24.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.153 0.981 . . . . 0.35 109.092 173.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -56.13 -49.27 74.39 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.072 0.949 . . . . 0.35 111.102 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -73.04 -9.78 59.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.139 0.792 . . . . 0.35 113.139 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.15 37.46 3.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.259 1.424 . . . . 0.35 109.667 172.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mm -141.44 -40.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.243 0 C-N-CA 125.698 1.599 . . . . 0.35 109.472 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -52.19 -37.51 55.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.644 1.178 . . . . 0.35 113.128 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.06 -32.89 26.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.588 1.155 . . . . 0.35 111.835 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -71.09 -41.12 71.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.594 1.158 . . . . 0.35 111.84 -170.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.03 -35.59 75.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 C-N-CA 123.481 0.713 . . . . 0.35 111.482 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.89 -35.38 79.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.098 0.559 . . . . 0.35 110.944 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -71.77 -34.24 69.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.245 0.618 . . . . 0.35 111.496 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.97 -46.77 70.43 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.661 0.385 . . . . 0.35 111.153 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -73.04 -26.02 61.14 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 118.845 -0.598 . . . . 0.35 112.462 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.4 -41.33 76.11 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 123.84 0.856 . . . . 0.35 110.939 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -48.65 -51.17 29.62 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.042 1.337 . . . . 0.35 112.346 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.6 p -72.48 -49.64 31.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.205 0.602 . . . . 0.35 111.257 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.02 146.47 17.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.594 0.758 . . . . 0.35 110.197 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -149.11 45.66 0.99 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.751 0.82 . . . . 0.35 111.201 -171.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -132.64 -59.57 0.9 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.755 0.822 . . . . 0.35 110.684 -173.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -93.39 70.77 4.35 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.715 0.806 . . . . 0.35 110.948 -164.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.98 161.05 40.54 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.016 0.926 . . . . 0.35 112.999 -175.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.93 77.98 0.45 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.803 -1.925 . . . . 0.35 105.803 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.27 100.47 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.059 0.944 . . . . 0.35 109.803 -167.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.33 -61.72 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.88 1.272 . . . . 0.35 110.583 -175.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -156.25 117.29 3.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.186 0.594 . . . . 0.35 110.192 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -78.21 144.98 35.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.906 0.882 . . . . 0.35 109.782 168.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.52 131.61 67.8 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.181 -0.674 . . . . 0.33 109.181 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.73 -24.02 22.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.474 2.783 . . . . 0.35 111.566 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.9 m -85.21 60.05 6.01 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 124.396 1.078 . . . . 0.35 110.442 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.56 162.44 29.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.189 0.996 . . . . 0.35 109.459 169.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -153.74 147.68 25.51 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.46 0.541 . . . . 0.35 112.46 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 mp -90.44 135.47 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.388 -1.708 . . . . 0.35 106.388 165.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.2 66.67 1.53 Allowed 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.303 -0.999 . . . . 0.35 108.303 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.2 p -69.77 125.22 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.061 0.944 . . . . 0.35 110.751 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 m -123.89 109.72 13.94 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.346 1.058 . . . . 0.35 109.429 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.52 110.58 22.91 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 125.128 1.371 . . . . 0.35 108.878 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.44 52.97 2.58 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.612 1.565 . . . . 0.35 110.14 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.65 84.44 5.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.072 0.949 . . . . 0.35 110.186 -172.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -61.19 -11.94 11.05 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.667 1.187 . . . . 0.35 113.376 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -55.62 -50.78 69.25 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.153 0.981 . . . . 0.36 111.145 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.52 -42.14 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.98 0.733 . . . . 0.35 112.98 176.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -65.84 -40.76 92.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.319 0.509 . . . . 0.35 112.101 -172.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? 77.7 160.32 0.21 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.482 1.913 . . . . 0.35 111.181 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -50.7 121.33 5.7 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.821 1.248 . . . . 0.35 110.109 171.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -154.19 107.08 2.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.092 0.957 . . . . 0.35 108.446 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.2 m -78.98 89.82 4.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.969 0.908 . . . . 0.35 108.555 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -77.35 97.27 4.85 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.107 0.963 . . . . 0.35 108.6 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.2 p -88.72 139.91 29.98 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.308 1.043 . . . . 0.35 110.358 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.96 140.28 8.7 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 123.891 0.877 . . . . 0.33 109.63 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.46 140.71 33.69 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.221 2.614 . . . . 0.35 109.788 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tt -72.42 148.92 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.05 0.54 . . . . 0.35 110.099 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 60.7 p -73.1 160.26 32.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.307 0.643 . . . . 0.35 110.739 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -88.3 -21.68 24.29 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.377 1.071 . . . . 0.35 111.026 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -86.85 -79.61 0.26 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.278 1.031 . . . . 0.35 110.932 -174.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -177.42 74.4 0.07 OUTLIER Glycine 0 CA--C 1.528 0.844 0 CA-C-N 118.215 0.461 . . . . 0.35 112.448 -170.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -77.47 154.51 32.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.866 -0.79 . . . . 0.35 108.866 165.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.0 t -131.88 140.73 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.367 1.067 . . . . 0.35 108.719 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.9 t -67.94 122.02 82.12 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 108.502 -0.925 . . . . 0.33 108.502 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.27 158.16 41.28 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.069 2.513 . . . . 0.35 111.052 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.74 80.35 2.69 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.627 1.171 . . . . 0.35 109.296 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.405 HD11 HG13 ' A' ' 120' ' ' ILE . 2.1 tm? -84.96 99.93 11.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.998 1.319 . . . . 0.35 109.071 -169.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.9 t -167.57 79.14 0.18 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.253 1.021 . . . . 0.35 108.998 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.39 -99.23 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.651 0.78 . . . . 0.35 110.035 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -70.23 -16.65 63.08 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.512 1.051 . . . . 0.35 112.304 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.405 HG13 HD11 ' A' ' 116' ' ' LEU . 9.6 pt -142.21 160.45 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 125.701 1.6 . . . . 0.35 109.22 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 29.56 0.37 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.89 0.7 . . . . 0.35 112.89 -175.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.35 46.51 0.69 Allowed Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.403 0.519 . . . . 0.36 112.403 172.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.39 135.13 41.47 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.094 2.53 . . . . 0.35 111.339 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -116.05 74.14 0.26 Allowed Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.959 -1.256 . . . . 0.35 109.959 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -60.74 95.99 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.625 1.57 . . . . 0.35 111.109 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -91.24 99.16 12.2 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.784 0.834 . . . . 0.36 109.694 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.2 80.35 9.09 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 108.366 -0.976 . . . . 0.35 108.366 173.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 94.5 mt -94.82 121.11 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.442 -1.318 . . . . 0.35 107.442 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.8 m -141.17 136.77 32.15 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.431 1.092 . . . . 0.35 109.005 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.21 131.78 34.09 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.387 1.075 . . . . 0.35 108.593 -178.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.05 141.06 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.48 0.712 . . . . 0.35 110.422 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 51.0 t -93.81 140.52 16.36 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 124.477 1.111 . . . . 0.35 108.843 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.5 mt -139.64 154.5 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.825 1.65 . . . . 0.35 107.742 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -143.07 23.78 1.85 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.67 0.989 . . . . 0.35 113.67 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.61 134.58 0.05 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.936 1.294 . . . . 0.35 111.474 169.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? . . . . . 0 C--N 1.342 0.251 0 C-N-CA 124.703 1.201 . . . . 0.25 110.637 177.878 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.1 m . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 119.648 -0.215 . . . . 0.35 110.599 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.8 p 51.39 -129.24 2.31 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.788 1.635 . . . . 0.35 111.878 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 t 67.8 2.06 2.91 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.609 1.563 . . . . 0.35 113.677 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 50.21 67.98 0.83 Allowed 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.213 1.405 . . . . 0.35 110.061 -169.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -83.9 68.38 9.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.415 1.086 . . . . 0.35 108.894 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -134.73 -24.48 1.51 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.879 1.672 . . . . 0.35 110.736 -172.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.05 26.78 30.34 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.537 1.065 . . . . 0.35 112.166 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 49.92 51.37 16.71 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.699 1.6 . . . . 0.35 111.566 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -103.85 94.33 5.37 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.966 0.906 . . . . 0.35 110.603 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.32 36.94 0.71 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.526 1.13 . . . . 0.35 111.075 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? 54.04 -95.3 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.206 1.802 . . . . 0.35 110.903 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.14 56.42 0.26 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.549 -1.82 . . . . 0.35 108.549 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -130.17 67.11 1.48 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.981 1.312 . . . . 0.35 108.888 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -167.71 113.95 0.72 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.174 0.989 . . . . 0.35 109.645 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.75 -65.96 0.97 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.029 0.932 . . . . 0.35 110.339 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.3 t 69.63 -73.4 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.923 2.089 . . . . 0.35 111.654 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -140.03 75.67 1.52 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.766 -1.198 . . . . 0.35 107.766 162.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -145.73 33.03 1.04 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.041 0.937 . . . . 0.35 110.054 173.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 66.62 168.71 0.11 Allowed Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.534 1.934 . . . . 0.33 112.101 171.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -69.12 99.95 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.121 2.548 . . . . 0.35 111.361 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.3 p -110.34 -40.93 4.51 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.589 1.556 . . . . 0.35 109.602 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.87 155.03 9.73 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.538 -1.025 . . . . 0.33 110.538 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.13 161.16 29.57 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.072 3.181 . . . . 0.35 111.024 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -156.58 164.62 37.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.611 0.764 . . . . 0.35 111.135 -170.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.5 tt -149.13 132.03 16.13 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.146 1.378 . . . . 0.35 108.012 -177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 58.2 mtp -125.31 133.11 52.74 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.889 1.275 . . . . 0.35 109.453 -171.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.54 95.29 2.89 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 C-N-CA 124.075 0.95 . . . . 0.35 110.409 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -149.31 178.35 8.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.568 0.747 . . . . 0.36 111.278 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.08 146.35 26.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 124.802 1.241 . . . . 0.35 110.948 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.1 m -84.06 86.31 7.22 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.918 -1.141 . . . . 0.35 107.918 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.64 119.7 6.63 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.527 -1.029 . . . . 0.35 110.527 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.81 170.43 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.496 1.118 . . . . 0.35 110.962 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -84.45 177.62 8.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.357 1.063 . . . . 0.35 109.639 166.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t -58.67 -38.29 77.87 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.805 0.842 . . . . 0.35 110.649 171.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -57.38 -49.06 77.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.666 1.186 . . . . 0.35 110.719 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.96 5.98 7.91 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.142 1.353 . . . . 0.35 111.869 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.11 123.2 24.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.081 0.941 . . . . 0.36 109.19 -176.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.96 107.15 3.0 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.383 0.673 . . . . 0.35 111.414 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.93 -42.26 70.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.536 1.134 . . . . 0.35 109.781 170.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 pp -152.06 150.06 29.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.998 0.919 . . . . 0.35 111.184 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.7 m -84.52 159.54 58.33 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 124.955 1.302 . . . . 0.33 110.463 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -84.75 53.99 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.52 2.813 . . . . 0.35 111.079 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -158.75 111.56 2.29 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.587 0.755 . . . . 0.35 110.991 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -160.81 -54.88 0.05 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.206 0.603 . . . . 0.35 111.461 152.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.47 147.17 5.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.48 0.582 . . . . 0.35 110.822 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.26 174.61 7.59 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.323 1.849 . . . . 0.35 110.156 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -161.98 131.81 3.35 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.756 0.822 . . . . 0.33 109.286 -176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -73.63 124.03 9.0 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.658 2.239 . . . . 0.35 108.722 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.5 tp -48.19 132.52 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.115 1.366 . . . . 0.35 112.391 -174.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -140.66 104.05 6.39 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 124.927 1.291 . . . . 0.33 108.009 172.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -81.11 -171.37 1.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.573 2.849 . . . . 0.35 110.467 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.26 -37.49 3.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.342 -0.703 . . . . 0.35 111.342 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.3 t -62.68 146.77 51.41 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.099 0.959 . . . . 0.35 111.007 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.8 m -73.6 149.83 41.82 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.628 0.771 . . . . 0.35 109.271 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.6 108.67 12.85 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.808 1.243 . . . . 0.35 107.794 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.0 t -154.94 162.06 41.21 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.72 1.208 . . . . 0.35 109.677 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -48.51 -54.7 13.33 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.694 1.198 . . . . 0.35 111.276 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -61.7 -32.27 72.46 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.837 0.681 . . . . 0.35 112.837 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -62.9 -56.85 13.62 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.438 0.563 . . . . 0.35 109.906 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.1 mm -53.95 -43.96 59.8 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 C-N-CA 124.761 1.224 . . . . 0.35 111.761 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -51.24 -63.11 1.24 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.642 0.777 . . . . 0.35 111.674 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -67.66 -33.65 75.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.195 0.452 . . . . 0.35 112.053 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -62.55 -50.0 73.08 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.713 0.805 . . . . 0.35 111.637 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 m -67.54 -37.29 78.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 118.931 -0.557 . . . . 0.35 111.417 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.31 -45.94 92.34 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.911 0.884 . . . . 0.35 111.295 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -41.33 99.38 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.314 0.646 . . . . 0.35 110.941 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.95 91.85 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.841 0.857 . . . . 0.35 111.597 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.3 -12.3 60.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.103 1.149 . . . . 0.35 114.103 -177.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -73.01 3.09 5.78 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.347 0.976 . . . . 0.35 113.513 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.79 15.12 6.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.153 0.888 . . . . 0.35 111.947 169.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.0 t -161.47 -45.62 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.774 1.23 . . . . 0.35 110.552 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.95 79.78 1.36 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.61 1.564 . . . . 0.35 109.952 -175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -132.88 -43.41 0.89 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.737 1.615 . . . . 0.35 109.422 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -60.11 -57.32 13.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.468 1.507 . . . . 0.35 110.379 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -108.32 72.93 0.86 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.666 1.186 . . . . 0.35 108.633 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -157.62 76.97 0.83 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.019 0.528 . . . . 0.35 110.161 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.6 tpt85 -84.66 -53.15 5.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.929 1.292 . . . . 0.35 109.949 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 t 71.03 114.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.093 1.757 . . . . 0.35 111.226 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.73 -49.3 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.384 0.674 . . . . 0.35 110.556 174.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.68 172.94 12.29 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.693 1.197 . . . . 0.35 110.86 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -157.62 163.23 38.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.358 1.463 . . . . 0.35 110.34 172.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.08 122.69 87.96 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.364 0.666 . . . . 0.33 109.718 -176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.0 -32.49 11.01 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.956 2.437 . . . . 0.35 110.451 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.3 m -80.88 74.75 7.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.434 1.094 . . . . 0.35 109.339 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.71 162.78 17.87 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.307 1.043 . . . . 0.35 110.53 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 142.54 23.94 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.344 0.657 . . . . 0.35 111.118 -173.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.9 mp -127.3 113.38 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 125.86 1.664 . . . . 0.35 107.623 -174.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -94.62 75.03 3.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.858 0.863 . . . . 0.35 109.151 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.94 108.21 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.768 -1.197 . . . . 0.35 107.768 168.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.2 m -86.88 67.75 9.9 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.463 1.105 . . . . 0.35 108.35 -170.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -60.64 99.79 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.846 1.258 . . . . 0.35 111.772 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -130.7 134.79 47.21 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.604 1.961 . . . . 0.35 109.86 -166.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -160.32 121.27 3.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.15 0.98 . . . . 0.35 109.067 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -89.9 65.71 6.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.966 0.907 . . . . 0.35 110.341 -172.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -142.8 -47.47 0.32 Allowed 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.078 1.351 . . . . 0.36 109.134 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.16 -31.46 0.54 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.39 1.076 . . . . 0.35 112.046 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -80.99 -42.8 20.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.852 0.686 . . . . 0.35 112.852 -161.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? 70.01 173.25 0.3 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.543 1.537 . . . . 0.35 110.118 -169.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -77.28 93.87 4.07 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 109.719 -0.474 . . . . 0.35 109.719 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -96.64 158.26 15.51 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.616 1.167 . . . . 0.35 108.16 170.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.9 m -136.62 110.41 8.14 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.526 0.731 . . . . 0.35 109.686 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -95.57 100.58 12.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.582 1.153 . . . . 0.35 108.332 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.7 p -86.92 65.29 8.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.198 0.999 . . . . 0.35 110.051 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -65.92 136.64 95.72 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.217 1.007 . . . . 0.33 109.388 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.23 -113.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.46 2.773 . . . . 0.35 109.701 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.4 tp -160.46 153.69 4.45 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 CA-C-N 119.032 0.833 . . . . 0.35 109.694 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.6 p -130.74 128.36 40.64 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.366 1.067 . . . . 0.35 108.955 173.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -64.94 -25.68 67.98 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.212 1.005 . . . . 0.35 111.47 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.16 -65.18 0.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.26 1.424 . . . . 0.35 111.486 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 125.24 143.8 6.14 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 124.139 0.876 . . . . 0.35 111.391 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.1 131.69 7.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.366 1.066 . . . . 0.35 109.068 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.9 t -68.76 141.61 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.54 0.736 . . . . 0.35 109.387 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 83.2 t -61.99 117.35 28.38 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 108.341 -0.985 . . . . 0.33 108.341 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.83 -21.59 24.62 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.425 2.75 . . . . 0.35 112.32 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.0 t70 68.77 77.21 0.23 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.721 1.608 . . . . 0.35 111.008 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 35.64 70.58 0.14 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.203 2.201 . . . . 0.35 114.713 166.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.7 t 25.65 -103.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.951 2.5 . . . . 0.35 113.716 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.88 -33.72 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.684 1.194 . . . . 0.35 111.491 172.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -83.2 43.91 0.91 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.46 1.504 . . . . 0.35 111.526 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.6 tt -167.82 155.28 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.958 1.703 . . . . 0.35 108.136 -172.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -146.17 -13.41 0.47 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.2 0.815 . . . . 0.35 113.2 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.26 78.39 8.65 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 119.661 1.119 . . . . 0.36 112.447 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.49 -84.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.548 2.832 . . . . 0.35 111.433 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.17 74.7 0.67 Allowed Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.285 -1.126 . . . . 0.35 110.285 -168.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -68.91 95.02 0.67 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.937 1.295 . . . . 0.35 109.3 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -99.04 95.34 7.07 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.973 0.509 . . . . 0.36 109.829 -173.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -74.32 98.46 3.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.844 -1.169 . . . . 0.35 107.844 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.4 mt -125.54 109.76 22.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 124.983 1.313 . . . . 0.35 107.588 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 95.2 m -133.98 125.48 28.28 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.281 1.032 . . . . 0.35 108.807 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -67.31 128.12 35.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.583 0.753 . . . . 0.35 110.141 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.28 138.31 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.305 1.042 . . . . 0.35 108.6 169.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.7 t -90.68 94.69 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.158 -1.423 . . . . 0.35 107.158 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 44.9 mt -71.43 131.46 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.259 0.624 . . . . 0.35 109.83 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -106.36 133.92 50.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.344 -1.725 . . . . 0.35 106.344 163.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -84.38 118.38 24.2 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.175 0.59 . . . . 0.35 109.465 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? . . . . . 0 N--CA 1.455 -0.203 0 C-N-CA 123.285 0.634 . . . . 0.25 109.784 178.545 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.8 p . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 111.873 0.323 . . . . 0.35 111.873 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -129.27 169.97 14.18 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.798 1.239 . . . . 0.35 110.699 -175.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.2 m -87.68 67.41 9.21 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.494 1.118 . . . . 0.35 108.991 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 p90 42.91 92.28 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.508 2.323 . . . . 0.35 113.822 -175.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -66.67 168.89 8.63 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.332 0.653 . . . . 0.35 110.2 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mptt 78.36 -38.25 0.23 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.163 2.185 . . . . 0.35 111.71 -176.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.7 53.55 11.81 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 110.959 -0.856 . . . . 0.35 110.959 174.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 56.31 59.24 3.76 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.125 1.37 . . . . 0.35 111.442 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -117.18 119.12 34.24 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.952 1.301 . . . . 0.35 108.391 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.13 40.67 3.68 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.002 1.321 . . . . 0.35 109.768 -171.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 59.2 -93.05 0.04 OUTLIER 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.175 1.39 . . . . 0.35 109.817 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.06 48.03 0.4 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.562 -1.415 . . . . 0.35 109.562 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 26.38 55.73 0.05 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 128.84 2.856 . . . . 0.35 114.136 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 44.35 71.0 0.28 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.513 1.525 . . . . 0.35 111.38 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 60.34 71.64 0.56 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.985 1.314 . . . . 0.35 110.55 -172.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.3 t -66.62 112.26 4.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.845 1.258 . . . . 0.35 109.01 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 62.38 -174.23 0.15 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.65 1.18 . . . . 0.35 112.087 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 76.8 t80 65.02 88.39 0.11 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.346 1.859 . . . . 0.35 111.697 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 67.58 167.33 0.12 Allowed Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.198 1.799 . . . . 0.33 113.018 166.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.67 105.65 0.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.227 2.618 . . . . 0.35 111.134 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.0 p -141.95 -54.02 0.44 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.996 0.919 . . . . 0.35 111.403 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.44 122.22 1.03 Allowed Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.98 -0.9 . . . . 0.33 112.261 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.99 170.62 2.02 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.542 3.495 . . . . 0.35 114.041 170.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -161.34 165.17 29.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.286 1.034 . . . . 0.35 110.844 171.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 tt -160.55 93.0 0.99 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.327 1.451 . . . . 0.35 107.235 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 73.5 mtm -87.54 105.23 17.17 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.477 0.711 . . . . 0.35 111.151 -170.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -101.51 96.6 4.85 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 124.792 1.237 . . . . 0.35 110.578 -174.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -163.64 171.59 15.49 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.502 1.121 . . . . 0.36 110.809 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.1 m -100.7 -177.52 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.145 1.378 . . . . 0.35 111.45 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.2 m -130.8 104.07 6.95 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.863 1.665 . . . . 0.35 106.686 167.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.31 121.52 6.5 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.626 -0.59 . . . . 0.35 111.626 -173.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.28 166.26 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.863 0.865 . . . . 0.35 110.657 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -72.79 174.64 7.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.958 1.303 . . . . 0.35 110.576 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -79.32 31.38 0.22 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.236 1.014 . . . . 0.35 112.181 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -138.04 -55.96 0.66 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.104 1.762 . . . . 0.35 107.669 170.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 143.89 65.61 0.02 OUTLIER Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.697 -1.361 . . . . 0.35 109.697 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -139.09 122.63 17.33 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.445 1.098 . . . . 0.36 108.493 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.58 106.03 0.51 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.218 1.007 . . . . 0.35 111.49 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.74 -57.23 3.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.166 0.986 . . . . 0.35 108.706 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.4 mt -124.51 167.69 14.11 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.785 1.234 . . . . 0.35 110.13 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -146.02 73.48 13.41 Favored Pre-proline 0 N--CA 1.455 -0.199 0 N-CA-C 106.817 -1.549 . . . . 0.33 106.817 167.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -87.25 58.75 3.5 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.844 3.029 . . . . 0.35 110.208 -168.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -107.58 54.58 0.66 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.779 1.232 . . . . 0.35 109.443 -172.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -114.45 15.46 17.88 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.2 1.4 . . . . 0.35 113.478 -169.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.51 165.48 22.7 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 CA-C-N 118.849 0.749 . . . . 0.35 110.275 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.42 177.54 10.19 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.269 1.027 . . . . 0.35 110.843 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -134.57 141.34 38.5 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.574 1.55 . . . . 0.33 108.027 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -84.81 26.24 0.66 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.14 2.56 . . . . 0.35 113.86 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 69.97 136.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.765 2.026 . . . . 0.35 111.717 -176.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.05 128.52 5.01 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.647 -0.872 . . . . 0.33 108.647 157.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.15 165.51 21.4 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 123.209 2.606 . . . . 0.35 110.49 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.64 63.57 1.75 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.681 -0.968 . . . . 0.35 110.681 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -153.05 138.78 17.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.733 1.213 . . . . 0.35 108.738 173.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 m -73.47 87.45 1.58 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.374 1.069 . . . . 0.35 109.748 -173.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 106.13 9.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.06 1.344 . . . . 0.35 109.012 -174.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -140.09 177.65 7.83 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 125.742 1.617 . . . . 0.35 109.411 -173.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -41.2 88.54 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.933 -0.395 . . . . 0.35 109.933 170.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -66.43 -45.83 78.54 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.428 0.691 . . . . 0.35 111.936 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -86.26 31.04 0.66 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.779 0.718 . . . . 0.35 112.293 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.8 mm -133.34 -44.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 125.396 1.478 . . . . 0.35 108.61 172.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -53.44 -50.98 64.09 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.196 0.998 . . . . 0.35 112.052 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -70.81 -34.31 71.6 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.598 0.636 . . . . 0.35 111.615 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -64.5 -51.82 61.03 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.999 0.92 . . . . 0.35 111.069 -172.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.8 m -63.5 -32.14 55.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 124.098 0.959 . . . . 0.35 111.937 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -65.43 -38.19 89.15 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.97 0.508 . . . . 0.35 111.059 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -70.82 -31.18 67.83 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.068 0.547 . . . . 0.35 111.363 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.58 -49.08 67.54 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.653 0.781 . . . . 0.35 111.047 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.18 -13.3 60.44 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.772 0.829 . . . . 0.35 113.145 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -74.62 89.24 2.21 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.442 0.697 . . . . 0.35 109.992 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.56 -52.44 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.533 1.533 . . . . 0.35 108.846 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 66.1 p -98.19 -52.46 3.67 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.315 1.046 . . . . 0.35 110.517 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.59 95.41 5.13 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.178 1.391 . . . . 0.35 108.487 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -147.38 4.71 0.8 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.953 0.901 . . . . 0.35 112.806 -173.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -148.39 -46.27 0.15 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.981 0.912 . . . . 0.35 109.651 -169.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -54.4 -48.53 71.48 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.385 1.474 . . . . 0.35 110.611 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.78 176.92 9.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.046 0.938 . . . . 0.35 112.094 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -155.78 105.16 2.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.519 -0.919 . . . . 0.35 108.519 168.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.4 t -65.62 131.5 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 124.153 0.981 . . . . 0.35 109.74 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.56 -60.65 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.318 -0.993 . . . . 0.35 108.318 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -133.34 154.29 50.85 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.136 1.374 . . . . 0.35 110.185 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.4 mt -99.68 124.94 45.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.175 -1.417 . . . . 0.35 107.175 165.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -73.64 127.66 88.24 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.299 -0.63 . . . . 0.33 109.299 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.78 -21.69 18.57 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.44 2.76 . . . . 0.35 111.672 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.8 m -85.21 66.44 9.73 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.052 0.941 . . . . 0.35 110.604 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.32 165.91 23.55 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.361 0.665 . . . . 0.35 109.446 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -136.81 117.9 14.38 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.06 0.544 . . . . 0.35 111.344 -170.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.0 mm -86.95 90.79 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.762 1.625 . . . . 0.35 108.017 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.37 72.88 8.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.633 -0.877 . . . . 0.35 108.633 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.66 94.57 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 CA-C-O 121.6 0.714 . . . . 0.35 110.052 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.5 m -79.74 108.91 13.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.982 -1.118 . . . . 0.35 107.982 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -78.41 70.37 4.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.808 -0.812 . . . . 0.35 108.808 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -71.06 124.21 23.88 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.107 0.479 . . . . 0.35 110.133 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -153.21 163.99 38.89 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.385 1.474 . . . . 0.35 107.839 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.65 61.83 1.08 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.36 -0.978 . . . . 0.35 108.36 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -149.64 -54.37 0.17 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.686 1.194 . . . . 0.36 109.78 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 -42.41 0.12 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.842 0.857 . . . . 0.35 112.281 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -73.5 -46.55 47.29 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.1 0.96 . . . . 0.35 110.955 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 81.7 tttt 71.0 163.48 0.26 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.076 1.35 . . . . 0.35 110.984 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -47.77 124.1 6.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.561 1.144 . . . . 0.35 110.408 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -149.46 86.43 1.47 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.922 -0.77 . . . . 0.35 108.922 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.4 m -69.41 94.34 0.72 Allowed 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.008 1.323 . . . . 0.35 109.581 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -89.01 95.16 10.21 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.108 -1.071 . . . . 0.35 108.108 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.7 p -72.53 133.47 44.79 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.688 0.795 . . . . 0.35 110.34 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -151.02 139.05 12.58 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 125.058 1.343 . . . . 0.33 107.627 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.76 -139.34 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.766 2.977 . . . . 0.35 109.986 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.8 tp -158.75 156.41 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 119.272 0.942 . . . . 0.35 109.616 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -130.29 166.63 19.96 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.397 1.079 . . . . 0.35 110.335 176.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.6 -51.27 70.53 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.791 1.236 . . . . 0.35 111.328 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -80.17 -33.89 37.98 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.856 0.863 . . . . 0.35 110.992 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.85 -127.57 45.35 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.238 0.923 . . . . 0.35 112.38 170.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -165.46 149.11 8.19 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.019 0.928 . . . . 0.35 110.126 -173.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.1 t -78.45 132.3 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.565 -1.272 . . . . 0.35 107.565 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.4 t -52.95 113.28 4.39 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.0 0.92 . . . . 0.33 109.769 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -84.31 -174.2 1.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.516 2.811 . . . . 0.35 110.833 -171.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -63.81 143.45 57.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.564 0.746 . . . . 0.35 109.792 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.45 61.2 2.31 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.724 1.209 . . . . 0.35 109.169 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 17.0 t 55.97 -122.65 1.8 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.936 1.694 . . . . 0.35 111.207 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -159.25 -48.51 0.06 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.252 1.021 . . . . 0.35 109.687 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -75.01 7.89 2.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.981 1.312 . . . . 0.35 113.596 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.6 tt -142.35 141.3 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.305 1.442 . . . . 0.35 108.821 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.37 29.11 2.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.287 1.035 . . . . 0.35 111.427 174.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.402 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -151.89 60.6 3.72 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.997 0.919 . . . . 0.36 112.38 176.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 122' ' ' ASN . 24.1 Cg_exo -71.76 -166.87 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.56 2.173 . . . . 0.35 112.655 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.81 78.38 0.21 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 108.718 -1.753 . . . . 0.35 108.718 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -72.7 76.6 1.11 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.546 1.538 . . . . 0.35 109.658 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -86.17 102.49 13.95 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.004 0.522 . . . . 0.36 110.14 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.48 81.62 7.53 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.909 1.284 . . . . 0.35 108.494 174.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.8 mt -94.91 76.19 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 107.203 -1.406 . . . . 0.35 107.203 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.6 m -75.37 172.64 12.12 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.984 1.313 . . . . 0.35 109.542 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.28 138.78 31.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.769 1.228 . . . . 0.35 108.389 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.95 150.72 26.78 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 C-N-CA 123.936 0.894 . . . . 0.35 110.987 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.42 132.85 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.842 1.257 . . . . 0.35 108.811 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 68.2 mt -134.58 150.5 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 125.438 1.495 . . . . 0.35 109.551 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -120.62 113.3 20.05 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.141 1.376 . . . . 0.35 107.731 162.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.19 166.03 17.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.03 0.932 . . . . 0.35 111.861 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt . . . . . 0 C--N 1.34 0.164 0 C-N-CA 124.611 1.165 . . . . 0.25 109.288 179.454 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 111.669 0.248 . . . . 0.35 111.669 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.9 p -158.81 -26.74 0.07 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.217 0.821 . . . . 0.35 113.217 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 p -152.13 -69.44 0.16 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.521 0.6 . . . . 0.35 111.685 -170.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -160.44 145.59 14.69 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.092 0.557 . . . . 0.35 110.144 -164.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -158.97 174.06 15.54 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.357 1.063 . . . . 0.35 110.41 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.64 25.24 7.89 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 128.282 2.633 . . . . 0.35 116.128 168.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.42 -164.42 37.64 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 118.617 0.644 . . . . 0.35 111.569 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -93.6 56.65 2.42 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.55 0.74 . . . . 0.35 109.232 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -85.29 89.4 7.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.589 1.156 . . . . 0.35 109.497 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -77.27 46.14 0.49 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.349 1.459 . . . . 0.35 113.21 -172.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.41 -75.05 0.08 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.923 2.489 . . . . 0.35 111.969 175.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.6 -38.44 0.09 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.79 -1.324 . . . . 0.35 109.79 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -49.99 117.83 2.55 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.528 1.531 . . . . 0.35 110.0 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -170.32 133.38 1.08 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.166 0.986 . . . . 0.35 109.392 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.5 148.64 7.95 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.4 1.08 . . . . 0.35 109.958 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.4 t -161.34 115.86 2.03 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.062 0.945 . . . . 0.35 109.073 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 61.19 172.66 0.11 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.354 1.862 . . . . 0.35 113.426 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 60.07 89.18 0.07 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.421 1.888 . . . . 0.35 112.186 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 71.23 154.38 0.15 Allowed Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 126.211 1.804 . . . . 0.33 112.738 165.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.11 97.92 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.388 2.725 . . . . 0.35 110.009 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -104.05 -58.76 1.83 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.628 1.171 . . . . 0.35 110.987 -173.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.97 110.75 0.43 Allowed Glycine 0 CA--C 1.532 1.097 0 CA-C-O 118.896 -0.947 . . . . 0.33 111.767 -171.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -80.3 169.42 17.35 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.472 2.781 . . . . 0.35 111.294 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -162.41 170.04 19.45 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 113.281 0.845 . . . . 0.35 113.281 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 tp -137.07 94.88 3.01 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.825 2.05 . . . . 0.35 107.955 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 31.7 ttp -87.5 104.37 16.41 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 123.027 0.531 . . . . 0.35 110.545 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.72 97.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 125.16 1.384 . . . . 0.35 108.832 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.35 170.3 21.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.366 1.066 . . . . 0.36 109.158 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.44 139.45 32.3 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 C-N-CA 124.004 0.922 . . . . 0.35 110.555 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.1 m -73.2 101.02 3.24 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.188 0.995 . . . . 0.35 108.723 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.92 82.44 1.63 Allowed Glycine 0 C--N 1.337 0.602 0 C-N-CA 123.933 0.778 . . . . 0.35 111.757 -170.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 m -85.18 157.69 3.45 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 C-N-CA 123.512 0.725 . . . . 0.35 110.566 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.47 -69.56 0.45 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.464 -0.569 . . . . 0.35 109.464 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.4 m -156.07 -56.21 0.09 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.104 1.362 . . . . 0.35 109.299 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -91.56 42.05 1.09 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.759 1.223 . . . . 0.35 110.819 -175.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.03 35.62 87.87 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.032 0.825 . . . . 0.35 112.491 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -102.6 96.36 6.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.448 1.099 . . . . 0.36 108.563 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.49 101.54 0.09 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.76 1.224 . . . . 0.35 111.169 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.1 mt -74.32 -63.47 1.23 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.426 -0.953 . . . . 0.35 108.426 171.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -89.97 121.08 31.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.399 -0.963 . . . . 0.35 108.399 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.5 m -87.07 108.13 17.49 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.335 1.054 . . . . 0.33 108.399 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.96 -172.87 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.695 2.93 . . . . 0.35 112.717 -164.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.5 m170 72.13 54.63 0.18 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.077 1.751 . . . . 0.35 111.47 172.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -120.64 -2.4 9.91 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.725 1.21 . . . . 0.35 112.575 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.12 142.17 40.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 125.042 1.337 . . . . 0.35 108.284 170.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -141.14 -84.82 0.2 Allowed 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.312 -0.852 . . . . 0.35 110.463 -177.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.1 t80 74.81 140.0 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.561 1.544 . . . . 0.33 110.381 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.74 159.36 51.66 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.777 2.318 . . . . 0.35 112.668 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 tp -61.33 137.36 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.886 1.274 . . . . 0.35 112.007 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -138.57 102.76 7.84 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.414 1.486 . . . . 0.33 107.404 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.11 175.55 11.01 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.306 2.671 . . . . 0.35 110.709 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 111.26 -29.47 8.72 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.996 0.808 . . . . 0.35 112.248 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 t -67.43 142.0 56.82 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.704 0.752 . . . . 0.35 111.311 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.8 m -71.11 144.35 50.3 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.938 0.895 . . . . 0.35 108.876 172.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.03 75.27 1.59 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.755 0.822 . . . . 0.35 109.302 -166.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.1 p -104.99 173.57 6.25 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 125.57 1.548 . . . . 0.35 110.265 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -57.83 -50.99 71.42 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.431 1.092 . . . . 0.35 109.579 171.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.75 -28.3 67.51 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.58 0.956 . . . . 0.35 113.58 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -68.6 -53.27 23.75 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.056 0.844 . . . . 0.35 109.68 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.3 mm -55.3 -40.93 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.931 1.292 . . . . 0.35 111.39 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -47.51 -64.45 0.78 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.241 1.416 . . . . 0.35 111.908 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -69.56 -32.59 71.46 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.856 0.317 . . . . 0.35 111.856 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -65.25 -49.86 68.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.629 0.772 . . . . 0.35 111.543 -172.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 m -67.35 -34.31 68.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.011 0.524 . . . . 0.35 111.474 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.32 -48.24 80.74 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 122.862 0.465 . . . . 0.35 110.397 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -40.86 97.47 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.204 0.456 . . . . 0.35 110.967 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.03 -50.3 73.92 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.167 0.987 . . . . 0.35 111.129 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 pp -71.59 -29.43 64.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.076 0.55 . . . . 0.35 111.605 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -70.32 -1.13 9.57 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 113.302 0.853 . . . . 0.35 113.302 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.16 -43.47 61.28 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.719 0.691 . . . . 0.35 110.28 164.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.5 p -86.37 -47.93 8.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.053 0.941 . . . . 0.35 110.935 173.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.85 -105.84 0.03 OUTLIER 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.319 0.509 . . . . 0.35 112.135 -172.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 71.4 144.68 0.06 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.907 1.683 . . . . 0.35 111.114 -171.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 70.17 -82.59 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.799 2.039 . . . . 0.35 110.853 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -72.8 171.7 12.17 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.44 0.696 . . . . 0.35 109.123 172.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 70.8 146.66 0.07 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.5 1.52 . . . . 0.35 110.108 -162.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -158.18 133.82 8.97 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.911 0.884 . . . . 0.35 109.162 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -85.22 128.64 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 124.037 0.935 . . . . 0.35 108.915 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.3 t -69.78 -65.06 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.41 -1.33 . . . . 0.35 107.41 167.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.57 139.14 5.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.795 0.838 . . . . 0.35 109.135 170.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.16 170.22 16.97 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.63 0.772 . . . . 0.35 109.777 170.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -67.81 129.47 93.28 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 108.927 -0.768 . . . . 0.33 108.927 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.53 -36.07 35.59 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.503 2.135 . . . . 0.35 109.697 172.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -89.78 69.46 7.62 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.798 1.239 . . . . 0.35 109.163 170.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.08 172.73 4.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.629 0.772 . . . . 0.35 109.99 168.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -152.17 151.46 31.04 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.359 0.503 . . . . 0.35 112.359 -167.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.26 101.15 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 126.205 1.802 . . . . 0.35 107.375 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -96.27 63.18 2.17 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.42 1.088 . . . . 0.35 110.203 -174.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.4 p -65.67 122.22 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 122.763 0.425 . . . . 0.35 110.246 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.4 m -118.03 106.31 12.78 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.408 1.483 . . . . 0.35 107.413 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -124.32 119.0 28.03 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.698 1.199 . . . . 0.35 109.726 -167.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -132.38 55.66 1.87 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.979 1.311 . . . . 0.35 112.246 -158.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -74.34 137.47 42.85 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 122.067 -0.396 . . . . 0.35 110.996 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -93.92 70.3 3.99 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.821 -1.177 . . . . 0.35 107.821 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -143.3 -50.57 0.33 Allowed 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.44 1.096 . . . . 0.36 109.533 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.76 -40.65 0.08 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.163 0.585 . . . . 0.35 112.359 -170.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -53.53 4.61 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.069 0.547 . . . . 0.35 112.033 -168.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt 71.02 -177.82 0.21 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.846 1.258 . . . . 0.35 110.064 -167.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -69.25 127.66 33.85 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.465 0.706 . . . . 0.35 111.756 -170.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -142.65 104.29 4.35 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.619 1.168 . . . . 0.35 109.459 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.7 m -80.75 108.8 14.71 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.66 -0.867 . . . . 0.35 108.66 173.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -109.91 102.6 11.34 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.627 1.171 . . . . 0.35 108.46 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.8 p -90.62 64.64 5.78 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.976 1.311 . . . . 0.35 110.779 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -77.08 141.67 67.67 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 123.033 0.533 . . . . 0.33 109.67 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.84 170.96 18.11 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.581 2.854 . . . . 0.35 112.136 -171.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.4 tp -77.01 161.44 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.844 1.258 . . . . 0.35 109.86 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 73.4 p -132.01 129.0 39.54 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.091 0.957 . . . . 0.35 108.966 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.83 -29.29 70.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.489 0.716 . . . . 0.35 111.487 172.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.4 -50.02 75.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.172 0.989 . . . . 0.35 109.635 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.98 170.95 24.23 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 124.328 0.966 . . . . 0.35 112.562 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -158.35 136.03 10.39 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.112 0.965 . . . . 0.35 109.204 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.8 t -70.48 130.96 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.465 -1.309 . . . . 0.35 107.465 166.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.6 t -57.51 112.51 4.8 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 107.311 -1.366 . . . . 0.33 107.311 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.05 -95.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.597 2.198 . . . . 0.35 112.193 -158.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -158.38 150.22 21.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.009 0.924 . . . . 0.35 109.737 -173.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.85 56.7 0.7 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.528 1.531 . . . . 0.35 109.552 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.4 t 34.5 -103.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.754 2.422 . . . . 0.35 113.436 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -161.93 -51.7 0.04 OUTLIER 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.649 1.18 . . . . 0.35 109.396 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -61.78 -44.39 96.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.062 0.945 . . . . 0.35 111.264 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.9 tp -83.74 111.74 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.933 0.893 . . . . 0.35 109.494 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -134.94 43.85 2.67 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.446 1.098 . . . . 0.35 110.154 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -151.76 47.33 0.41 Allowed Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 114.0 1.111 . . . . 0.36 114.0 163.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -55.86 145.44 72.9 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.839 1.693 . . . . 0.35 113.31 168.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.47 76.72 0.38 Allowed Glycine 0 C--N 1.338 0.657 0 N-CA-C 108.641 -1.783 . . . . 0.35 108.641 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -69.59 96.74 0.96 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.675 1.19 . . . . 0.35 110.781 -177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -87.93 109.93 20.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.131 -1.063 . . . . 0.36 108.131 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -94.82 52.69 1.51 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.245 -1.02 . . . . 0.35 108.245 173.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 mp -94.3 130.93 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.838 1.255 . . . . 0.35 108.783 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 81.6 m -149.05 140.6 23.41 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.163 1.385 . . . . 0.35 108.016 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.96 135.47 45.01 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.292 0.637 . . . . 0.35 109.348 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.4 m -133.37 136.0 55.4 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 123.341 0.656 . . . . 0.35 110.454 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.5 t -84.75 130.19 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.921 1.288 . . . . 0.35 107.779 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 55.4 mt -123.14 131.79 72.58 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 124.122 0.969 . . . . 0.35 110.588 -171.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -87.96 103.4 15.65 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.74 1.616 . . . . 0.35 107.273 165.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -70.61 140.88 51.76 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.083 0.553 . . . . 0.35 110.584 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt . . . . . 0 N--CA 1.456 -0.161 0 C-N-CA 125.474 1.51 . . . . 0.25 108.385 -175.109 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 119.049 -0.501 . . . . 0.35 111.767 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.1 p 45.77 -131.5 1.07 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.079 1.351 . . . . 0.35 111.038 -172.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.8 m 75.68 -54.52 0.63 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.076 2.151 . . . . 0.35 114.218 167.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 55.46 60.38 3.39 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.236 -1.394 . . . . 0.35 107.236 -153.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -51.54 -47.44 63.4 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 127.244 2.218 . . . . 0.35 112.661 -167.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -66.35 107.66 2.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.668 -1.234 . . . . 0.35 107.668 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.55 82.37 1.68 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.304 -1.119 . . . . 0.35 110.304 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt 56.61 60.34 3.14 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.108 1.363 . . . . 0.35 110.853 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -82.75 -64.16 1.23 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.616 1.167 . . . . 0.35 110.089 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.95 25.47 0.31 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.002 2.521 . . . . 0.35 114.772 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 57.27 -87.57 0.02 OUTLIER 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.847 1.659 . . . . 0.35 111.06 -170.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.53 -55.98 0.13 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 107.83 -2.108 . . . . 0.35 107.83 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 t0 57.54 38.13 27.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.669 1.588 . . . . 0.35 111.396 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 42.95 63.33 1.51 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.948 1.699 . . . . 0.35 111.438 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.82 -175.67 4.9 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.082 0.553 . . . . 0.35 112.282 -170.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 m 65.63 79.21 0.25 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.988 1.715 . . . . 0.35 110.195 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 54.64 65.56 1.47 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.521 1.528 . . . . 0.35 111.03 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -145.8 34.3 1.03 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.182 1.393 . . . . 0.35 109.716 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.52 162.99 0.12 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.005 1.722 . . . . 0.33 112.805 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -65.68 94.48 0.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.257 2.638 . . . . 0.35 110.224 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.3 p -138.98 -46.64 0.48 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.247 1.419 . . . . 0.35 110.088 -171.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.04 86.89 0.26 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.883 0.754 . . . . 0.33 111.931 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.65 153.75 10.45 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.341 3.361 . . . . 0.35 112.718 166.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -146.48 173.64 12.11 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.447 0.699 . . . . 0.35 110.992 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 tt -151.11 93.36 1.91 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.774 -1.195 . . . . 0.35 107.774 176.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 66.4 mtp -78.71 141.99 37.45 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.941 1.296 . . . . 0.35 109.996 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 37.0 t -136.18 94.99 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 124.861 1.265 . . . . 0.35 108.85 -172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -148.28 174.6 11.85 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.179 0.992 . . . . 0.36 110.391 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -113.01 -170.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 125.323 1.449 . . . . 0.35 109.231 174.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.6 m -121.24 103.5 9.03 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.603 -1.628 . . . . 0.35 106.603 162.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.78 85.11 1.45 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.986 -0.846 . . . . 0.35 110.986 -173.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.6 m -102.23 172.08 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.258 1.023 . . . . 0.35 111.321 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -63.99 -52.69 58.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.792 1.237 . . . . 0.35 110.709 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 m -178.88 -56.07 0.01 OUTLIER 'General case' 0 C--N 1.339 0.144 0 C-N-CA 128.189 2.596 . . . . 0.35 107.197 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.52 -61.37 1.8 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.752 1.221 . . . . 0.35 110.748 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.0 -19.82 0.04 OUTLIER Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.168 -0.795 . . . . 0.35 113.351 -170.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -64.33 111.07 2.47 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.155 0.978 . . . . 0.36 109.693 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -76.64 123.51 26.24 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.385 1.074 . . . . 0.35 111.142 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.88 -65.2 1.04 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.61 -0.885 . . . . 0.35 108.61 170.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.5 mt -98.65 136.02 39.32 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.464 1.106 . . . . 0.35 109.95 -168.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.9 m -85.04 102.42 2.32 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.657 1.583 . . . . 0.33 110.926 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.78 -165.4 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.25 2.633 . . . . 0.35 111.677 -169.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 75.0 57.57 0.07 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.651 1.58 . . . . 0.35 111.036 166.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -138.16 -5.13 1.66 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.053 1.131 . . . . 0.35 114.053 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -130.26 143.78 39.97 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 123.739 0.816 . . . . 0.35 109.582 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.23 177.07 11.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.541 0.736 . . . . 0.35 112.284 -173.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -137.34 154.13 75.22 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 126.497 1.919 . . . . 0.33 107.555 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -84.12 34.79 0.53 Allowed 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.235 2.623 . . . . 0.35 112.323 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.257 13.8 tt 54.21 149.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 129.603 3.161 . . . . 0.35 115.732 176.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -158.18 123.35 2.31 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.172 0.989 . . . . 0.33 109.321 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -80.12 179.18 6.41 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.32 2.68 . . . . 0.35 110.949 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.21 -33.72 4.95 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.774 0.702 . . . . 0.35 111.527 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.8 t -63.87 144.83 56.75 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.24 1.016 . . . . 0.35 110.948 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.9 m -73.72 145.1 45.43 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.909 -0.774 . . . . 0.35 108.909 173.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.6 104.51 7.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.171 -1.418 . . . . 0.35 107.171 177.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -143.53 157.58 44.32 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.402 1.081 . . . . 0.35 110.4 -173.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.31 -57.55 10.18 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.493 1.117 . . . . 0.35 111.57 -174.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -58.72 -29.11 66.44 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.01 0.744 . . . . 0.35 113.01 -175.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -72.1 -48.34 44.69 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.714 0.806 . . . . 0.35 110.684 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.8 mm -56.21 -39.09 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.66 1.184 . . . . 0.35 111.944 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -47.87 -57.98 4.97 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.425 1.09 . . . . 0.35 112.397 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -78.83 -29.7 44.87 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.061 0.544 . . . . 0.35 112.347 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -64.01 -45.95 86.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.187 0.595 . . . . 0.35 111.636 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.4 m -68.83 -31.81 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 122.916 0.487 . . . . 0.35 111.406 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -63.46 -36.94 85.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.616 0.767 . . . . 0.35 111.053 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -74.8 -36.09 62.48 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.801 0.841 . . . . 0.35 111.134 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.92 78.61 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.125 0.57 . . . . 0.35 111.026 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.02 -17.72 62.01 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.983 0.735 . . . . 0.35 112.983 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -58.0 -33.61 69.11 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.492 0.717 . . . . 0.35 112.095 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -41.57 -47.66 3.86 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 125.547 1.539 . . . . 0.35 112.573 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 65.1 p -97.21 -51.54 4.16 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.95 1.3 . . . . 0.35 110.797 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.21 82.17 2.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.221 1.408 . . . . 0.35 110.288 -171.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -109.96 -36.53 5.85 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.34 1.456 . . . . 0.35 110.965 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -87.9 -73.11 0.5 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.611 0.765 . . . . 0.35 110.643 -173.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -96.09 62.08 2.15 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.24 0.616 . . . . 0.35 111.085 -165.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -152.42 153.02 32.72 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.817 0.447 . . . . 0.35 110.568 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -158.27 105.97 1.94 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.35 108.675 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -75.05 97.98 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.541 -0.911 . . . . 0.35 108.541 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.41 -42.64 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 123.302 0.641 . . . . 0.35 110.712 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -140.94 161.22 38.34 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.738 1.215 . . . . 0.35 109.634 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.6 pp -138.58 163.38 32.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.773 1.229 . . . . 0.35 109.942 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -90.32 126.79 55.49 Favored Pre-proline 0 N--CA 1.455 -0.199 0 N-CA-C 108.078 -1.082 . . . . 0.33 108.078 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.68 -20.39 30.53 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.682 2.255 . . . . 0.35 110.915 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.7 m -84.64 70.71 10.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.707 1.203 . . . . 0.35 110.476 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.64 162.18 18.91 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.556 0.742 . . . . 0.35 109.746 165.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.2 ptmm? -151.86 107.58 3.35 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.979 0.419 . . . . 0.35 111.935 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.26 130.23 30.27 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 125.34 1.456 . . . . 0.35 107.481 168.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -131.13 80.96 1.96 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.119 -1.067 . . . . 0.35 108.119 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.56 98.25 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.833 0.853 . . . . 0.35 110.205 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 62.1 m -93.52 97.67 10.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.074 1.35 . . . . 0.35 107.931 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -103.63 93.46 4.94 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.989 0.916 . . . . 0.35 111.24 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -73.07 52.48 0.33 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.648 2.379 . . . . 0.35 111.336 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -82.06 102.1 10.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.289 1.035 . . . . 0.35 110.605 -171.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -87.78 71.7 9.53 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.164 0.986 . . . . 0.35 108.617 174.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -148.88 -58.51 0.22 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.056 1.343 . . . . 0.36 109.478 172.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.13 -38.39 0.16 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.242 0.83 . . . . 0.35 113.242 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -84.08 -45.7 12.75 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.893 0.477 . . . . 0.35 112.128 -164.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt 73.54 162.43 0.26 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.713 1.605 . . . . 0.35 112.264 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.76 109.93 1.58 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.548 1.139 . . . . 0.35 111.823 -175.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.5 102.71 5.02 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.003 -1.48 . . . . 0.35 107.003 175.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.2 m -79.43 93.16 5.32 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.644 0.777 . . . . 0.35 109.181 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -83.31 106.36 15.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.766 -0.827 . . . . 0.35 108.766 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.4 p -84.5 69.64 10.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.829 1.252 . . . . 0.35 111.192 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -64.99 137.19 97.07 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 108.595 -0.891 . . . . 0.33 108.595 170.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -78.09 -115.76 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.409 2.739 . . . . 0.35 110.579 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 tp -168.42 158.24 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.609 1.164 . . . . 0.35 108.828 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.4 p -136.41 137.69 40.74 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.835 0.854 . . . . 0.35 109.744 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -71.88 -22.6 61.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.987 0.915 . . . . 0.35 111.039 172.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -58.76 -50.18 74.91 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.792 0.837 . . . . 0.35 109.558 168.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.62 169.95 26.61 Favored Glycine 0 C--N 1.341 0.835 0 C-N-CA 124.056 0.836 . . . . 0.35 112.769 171.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -163.37 137.35 5.92 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.995 1.318 . . . . 0.35 109.124 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.5 138.29 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.75 0.82 . . . . 0.35 109.512 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.32 118.01 55.23 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 107.712 -1.218 . . . . 0.33 107.712 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -70.27 -66.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.616 2.211 . . . . 0.35 111.486 -170.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 t70 173.09 -66.4 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 126.506 1.922 . . . . 0.35 107.544 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 55.35 60.07 3.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.633 1.573 . . . . 0.35 110.201 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.0 m -138.17 45.64 2.09 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.589 1.156 . . . . 0.35 108.791 174.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -104.89 -62.67 1.31 Allowed 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.046 1.339 . . . . 0.35 109.974 -170.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -101.57 -55.65 2.47 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.934 1.293 . . . . 0.35 109.298 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.8 pt -93.95 158.03 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.724 0.81 . . . . 0.35 108.83 167.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -135.56 60.55 1.68 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.223 1.009 . . . . 0.35 108.303 173.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -170.34 58.75 0.3 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.847 1.259 . . . . 0.36 111.093 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -57.21 -51.54 8.44 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.738 2.292 . . . . 0.35 111.4 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.82 66.0 2.31 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.539 -0.625 . . . . 0.35 111.539 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -69.11 100.09 1.21 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.129 1.372 . . . . 0.35 111.081 -175.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -88.61 92.96 9.4 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.294 -0.632 . . . . 0.36 109.294 172.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.49 109.67 8.16 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 107.802 -1.184 . . . . 0.35 107.802 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 60.7 mt -127.38 133.74 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.913 1.285 . . . . 0.35 107.915 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.2 m -146.46 116.09 7.18 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.811 1.244 . . . . 0.35 107.775 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -69.09 132.62 46.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.859 -0.423 . . . . 0.35 109.859 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.34 153.86 36.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 123.799 0.84 . . . . 0.35 110.976 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.5 t -93.82 103.82 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.258 1.423 . . . . 0.35 108.058 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.8 mt -94.92 132.67 38.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 C-N-CA 123.508 0.723 . . . . 0.35 109.225 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -113.82 98.19 6.87 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.042 1.337 . . . . 0.35 107.774 170.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -72.15 131.28 42.58 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.484 -0.562 . . . . 0.35 109.484 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt . . . . . 0 N--CA 1.456 -0.163 0 C-N-CA 124.336 1.054 . . . . 0.25 109.566 -176.225 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 CA--C 1.534 0.337 0 CA-C-O 119.234 -0.412 . . . . 0.35 112.059 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m 62.13 50.12 4.14 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 125.153 1.381 . . . . 0.35 110.739 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.2 t -164.68 -38.03 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.546 0.738 . . . . 0.35 111.688 -171.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 67.96 120.83 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.202 2.201 . . . . 0.35 110.908 -168.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.4 148.92 44.77 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.835 0.854 . . . . 0.35 110.494 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? 78.14 156.35 0.16 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.896 2.078 . . . . 0.35 110.856 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.59 80.89 0.66 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 124.401 1.0 . . . . 0.35 110.706 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? 57.56 44.15 21.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.974 1.31 . . . . 0.35 110.744 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -93.41 87.32 5.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.637 0.775 . . . . 0.35 109.627 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -84.02 52.52 2.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.88 1.272 . . . . 0.35 111.096 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm 68.68 -72.41 0.1 Allowed 'General case' 0 C--N 1.342 0.277 0 C-N-CA 127.15 2.18 . . . . 0.35 111.993 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.24 -40.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.611 -0.996 . . . . 0.35 110.611 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -57.96 136.61 57.11 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.385 1.074 . . . . 0.35 110.623 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -157.97 59.91 0.47 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.873 -0.788 . . . . 0.35 108.873 174.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.11 78.71 6.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.649 1.18 . . . . 0.35 108.476 173.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.6 m -113.46 -42.12 3.53 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.949 1.3 . . . . 0.35 111.05 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.96 170.04 19.24 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.581 0.753 . . . . 0.35 111.712 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.7 t80 64.76 91.23 0.08 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 126.73 2.012 . . . . 0.35 111.241 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 70.84 150.56 0.13 Allowed Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 126.559 1.944 . . . . 0.33 111.676 174.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.42 80.58 2.23 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.443 2.762 . . . . 0.35 110.03 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.3 p -71.32 -48.27 51.5 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.992 0.917 . . . . 0.35 110.641 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.83 -179.01 44.58 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 117.994 0.361 . . . . 0.33 112.887 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -76.63 177.2 9.13 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 124.217 3.278 . . . . 0.35 112.715 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -160.05 -177.5 6.35 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.165 1.386 . . . . 0.35 109.524 157.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 tt -153.81 99.32 2.27 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.23 -0.656 . . . . 0.35 109.23 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 77.6 mtm -84.44 111.82 19.81 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.552 1.141 . . . . 0.35 110.587 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.7 t -101.0 90.66 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 125.43 1.492 . . . . 0.35 108.064 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -146.21 178.01 8.56 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.371 0.668 . . . . 0.36 111.962 -173.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.77 142.53 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.222 1.409 . . . . 0.35 109.835 -172.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.6 m -93.34 81.6 4.44 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.204 -1.406 . . . . 0.35 107.204 168.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.74 113.86 3.78 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.915 -0.874 . . . . 0.35 110.915 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.41 164.42 15.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.849 1.259 . . . . 0.35 111.179 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -77.3 174.07 11.19 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.784 0.833 . . . . 0.35 110.703 172.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -55.81 -40.37 72.66 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.248 1.019 . . . . 0.35 110.41 167.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -59.13 -59.05 6.08 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.287 1.035 . . . . 0.35 109.94 171.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 140.17 -0.99 2.13 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.26 0.933 . . . . 0.35 112.924 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -72.63 128.06 34.42 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.478 1.139 . . . . 0.36 109.839 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -70.01 106.49 3.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.46 0.704 . . . . 0.35 110.89 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.8 mt -67.37 -47.16 71.2 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.591 1.156 . . . . 0.35 110.553 174.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 pp -142.98 152.77 42.32 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.479 0.712 . . . . 0.35 111.316 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.0 m -108.0 152.23 41.63 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 125.389 1.476 . . . . 0.33 109.993 -175.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.8 -173.02 1.58 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.656 2.904 . . . . 0.35 112.304 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.1 m170 74.19 66.76 0.09 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 127.055 2.142 . . . . 0.35 111.306 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -153.55 -2.55 0.21 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.863 0.865 . . . . 0.35 113.041 177.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.6 t -135.39 115.73 18.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 N-CA-C 106.426 -1.694 . . . . 0.35 106.426 170.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -143.82 148.8 36.05 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.317 1.047 . . . . 0.35 109.503 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -139.61 148.64 56.82 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 124.284 1.034 . . . . 0.33 109.889 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.64 135.89 34.53 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.648 2.232 . . . . 0.35 108.544 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.4 tt -66.61 144.35 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 122.927 0.491 . . . . 0.35 112.161 -168.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -137.97 87.31 16.71 Favored Pre-proline 0 CA--C 1.534 0.337 0 C-N-CA 125.401 1.48 . . . . 0.33 107.5 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.55 155.5 31.76 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.38 2.72 . . . . 0.35 110.878 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.41 -32.41 2.48 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.077 0.846 . . . . 0.35 111.698 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.3 t -70.39 155.22 40.98 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.983 0.913 . . . . 0.35 111.357 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.1 m -72.53 145.46 47.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.741 0.816 . . . . 0.35 109.069 172.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.42 76.74 1.69 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.416 1.086 . . . . 0.35 108.901 -172.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t -114.86 171.22 7.78 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.171 1.788 . . . . 0.35 109.88 176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -56.61 -44.79 81.5 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.693 1.197 . . . . 0.35 111.63 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.79 -27.79 67.05 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.931 0.715 . . . . 0.35 112.931 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -73.82 -25.58 60.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.37 1.068 . . . . 0.35 112.065 174.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.8 mm -90.51 -51.4 11.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-N 118.564 0.62 . . . . 0.35 110.94 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.36 -41.01 75.45 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.691 0.626 . . . . 0.35 112.691 -170.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.36 -30.37 57.55 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.032 0.533 . . . . 0.35 111.697 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -76.11 -42.18 47.89 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.411 1.084 . . . . 0.35 111.02 -175.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.3 m -72.32 -23.76 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.001 0.52 . . . . 0.35 111.329 173.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -68.9 -34.39 75.32 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.242 0.474 . . . . 0.35 110.579 171.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -24.52 63.2 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.07 -0.491 . . . . 0.35 111.732 174.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.3 -38.6 75.03 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.513 0.597 . . . . 0.35 110.925 171.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.7 -45.42 92.86 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.38 0.672 . . . . 0.35 110.366 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -64.67 153.55 39.21 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.006 0.366 . . . . 0.35 110.279 172.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 82.51 -47.54 0.17 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.801 2.04 . . . . 0.35 110.94 -167.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.3 p -91.69 -99.28 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.095 0.958 . . . . 0.35 110.087 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.15 96.44 9.62 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.994 1.318 . . . . 0.35 111.228 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -153.89 6.73 0.33 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.537 1.135 . . . . 0.35 111.724 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -74.33 -60.56 2.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.265 1.026 . . . . 0.35 109.612 -173.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -104.5 -21.96 13.37 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.665 1.586 . . . . 0.35 110.542 171.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -70.28 133.79 47.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.279 1.432 . . . . 0.35 109.921 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -152.43 114.49 4.42 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 123.792 0.837 . . . . 0.35 110.078 -175.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.5 t -70.05 117.24 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.272 1.029 . . . . 0.35 109.861 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.6 -46.7 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.976 0.911 . . . . 0.35 110.698 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -136.94 163.18 31.31 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.651 1.181 . . . . 0.35 109.623 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -137.04 153.06 50.72 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.766 1.226 . . . . 0.35 110.135 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -83.59 126.36 71.37 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 108.437 -0.949 . . . . 0.33 108.437 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.25 -30.79 15.33 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.917 2.411 . . . . 0.35 111.028 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.6 t -87.13 72.7 9.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.553 1.141 . . . . 0.35 110.502 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.03 168.69 14.93 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.112 0.965 . . . . 0.35 110.335 168.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -139.13 152.85 47.79 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.696 0.798 . . . . 0.35 111.735 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.92 87.55 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 126.128 1.771 . . . . 0.35 106.923 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -86.15 93.74 9.1 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 108.86 -0.793 . . . . 0.35 108.86 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.2 m -73.56 85.02 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 108.09 -1.078 . . . . 0.35 108.09 171.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.7 m -87.72 78.71 8.39 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.659 1.183 . . . . 0.35 108.521 -174.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -88.3 165.28 15.11 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.935 0.894 . . . . 0.35 110.102 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -154.16 28.87 0.45 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.682 1.593 . . . . 0.35 109.647 -168.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.95 125.49 20.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.318 1.447 . . . . 0.35 112.02 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -85.49 63.02 7.84 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.206 -1.035 . . . . 0.35 108.206 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -144.17 -60.76 0.39 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.715 1.206 . . . . 0.36 109.933 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -152.68 -56.32 0.13 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.013 0.746 . . . . 0.35 113.013 -172.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -80.02 -41.93 24.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.114 0.87 . . . . 0.35 112.044 -171.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt 69.57 -148.77 0.11 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.918 1.287 . . . . 0.35 111.341 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -75.66 115.92 15.84 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.754 0.822 . . . . 0.35 111.442 -167.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.17 113.32 6.87 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.365 1.066 . . . . 0.35 109.206 173.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.8 m -79.47 81.93 5.66 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 107.4 -1.333 . . . . 0.35 107.4 169.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -86.74 86.25 7.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.279 1.032 . . . . 0.35 109.415 -169.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.5 p -77.08 84.03 3.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.023 1.329 . . . . 0.35 111.387 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -83.38 127.62 67.75 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 123.915 0.886 . . . . 0.33 108.95 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.89 163.55 28.48 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.198 2.598 . . . . 0.35 111.908 -173.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.0 tp -78.84 163.83 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.714 1.206 . . . . 0.35 110.355 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 81.6 p -124.34 165.3 17.93 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.849 1.26 . . . . 0.35 110.358 176.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.37 -28.46 14.94 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.875 1.27 . . . . 0.35 110.715 171.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -70.0 -60.25 2.41 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.012 0.925 . . . . 0.35 109.848 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.14 98.65 2.28 Favored Glycine 0 C--N 1.342 0.87 0 C-N-CA 123.993 0.806 . . . . 0.35 111.587 174.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -78.23 136.97 37.89 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.099 -0.704 . . . . 0.35 109.099 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.36 136.67 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.708 -0.849 . . . . 0.35 108.708 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.2 t -64.83 118.22 46.43 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.469 -0.937 . . . . 0.33 108.469 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -84.58 162.06 12.56 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.065 2.51 . . . . 0.35 111.184 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -83.67 168.05 16.66 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.898 0.879 . . . . 0.35 109.458 166.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -158.44 130.98 7.03 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.22 0.608 . . . . 0.35 111.02 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.1 t -163.21 69.84 0.23 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.436 1.095 . . . . 0.35 108.581 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -158.22 -63.89 0.09 Allowed 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.851 0.86 . . . . 0.35 108.996 -177.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -89.39 -47.29 8.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.353 1.061 . . . . 0.35 111.382 -175.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.7 pt -136.65 169.1 20.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 C-N-CA 123.879 0.872 . . . . 0.35 111.633 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -144.03 38.79 1.32 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.995 1.718 . . . . 0.35 108.162 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -169.77 58.52 0.32 Allowed Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.906 0.882 . . . . 0.36 110.502 -172.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -63.69 -57.1 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.512 2.808 . . . . 0.35 111.993 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.38 72.91 0.86 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.457 -1.057 . . . . 0.35 110.457 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -68.99 97.79 0.89 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.311 1.444 . . . . 0.35 110.46 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -87.41 96.2 10.29 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.595 -0.52 . . . . 0.36 109.595 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -88.27 62.96 6.95 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.278 -1.008 . . . . 0.35 108.278 170.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -94.72 104.36 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.501 -2.037 . . . . 0.35 105.501 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 68.5 p -97.94 -162.89 0.99 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.288 1.035 . . . . 0.35 109.244 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.53 121.77 4.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.232 -1.395 . . . . 0.35 107.232 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.36 157.02 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 123.224 0.61 . . . . 0.35 110.223 175.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.81 143.85 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.942 1.297 . . . . 0.35 108.364 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.6 mp -130.82 145.06 36.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 C-N-CA 124.767 1.227 . . . . 0.35 110.383 -175.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.84 157.17 34.76 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.161 1.385 . . . . 0.35 108.255 160.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -90.2 126.02 35.67 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.29 -0.633 . . . . 0.35 109.29 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 C--N 1.34 0.192 0 C-N-CA 123.834 0.854 . . . . 0.25 110.635 -175.895 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 110.146 -0.316 . . . . 0.35 110.146 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.2 m 67.42 127.15 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.659 1.984 . . . . 0.35 112.658 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 m 54.35 42.27 31.52 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.879 1.271 . . . . 0.35 112.256 172.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 73.29 128.73 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.312 1.845 . . . . 0.35 109.751 -176.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -77.46 70.04 3.79 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.505 1.122 . . . . 0.35 110.067 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -175.81 173.5 2.32 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.373 1.869 . . . . 0.35 109.454 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.77 -155.4 8.65 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.859 0.742 . . . . 0.35 111.775 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -71.17 109.74 5.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.811 0.844 . . . . 0.35 109.059 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -138.94 80.51 1.79 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.056 0.943 . . . . 0.35 109.004 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -89.47 35.1 0.81 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.633 1.173 . . . . 0.35 112.013 -179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.6 -82.77 0.03 OUTLIER 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.849 1.66 . . . . 0.35 110.43 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 13' ' ' ASP . . . -176.17 2.94 0.03 OUTLIER Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.389 1.471 . . . . 0.35 112.752 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.414 ' H ' ' H ' ' A' ' 12' ' ' GLY . 3.3 p30 50.02 26.93 2.24 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 127.351 2.261 . . . . 0.35 115.799 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 49.35 38.17 13.29 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.807 1.643 . . . . 0.35 112.572 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.74 -44.41 0.01 OUTLIER 'General case' 0 C--N 1.339 0.11 0 C-N-CA 125.044 1.337 . . . . 0.35 109.511 -171.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.7 t 68.64 45.72 1.04 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.294 1.838 . . . . 0.35 110.51 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.2 t80 49.21 61.74 2.98 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.287 1.435 . . . . 0.35 110.325 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -160.49 92.89 0.99 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.237 0.615 . . . . 0.35 109.899 -170.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 66.5 166.21 0.12 Allowed Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 126.117 1.767 . . . . 0.33 113.595 165.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.85 96.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.365 3.377 . . . . 0.35 111.811 169.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.8 p -144.38 -38.49 0.29 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.917 1.287 . . . . 0.35 110.496 -174.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.82 143.88 6.82 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 110.921 -0.872 . . . . 0.33 110.921 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -86.44 168.32 8.68 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.052 3.168 . . . . 0.35 112.087 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -165.08 160.03 18.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.163 0.985 . . . . 0.35 111.215 -172.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.9 tt -158.27 113.2 2.61 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.09 1.356 . . . . 0.35 108.748 -170.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -96.73 152.12 18.98 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.55 1.14 . . . . 0.35 110.774 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -141.01 89.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.301 0 C-N-CA 124.654 1.182 . . . . 0.35 108.709 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -144.66 -162.93 1.59 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.711 0.805 . . . . 0.36 110.3 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.5 m -137.91 148.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 124.675 1.19 . . . . 0.35 110.024 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.4 m -85.54 93.38 8.78 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.088 -1.449 . . . . 0.35 107.088 169.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.89 89.32 1.43 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.819 0.723 . . . . 0.35 111.758 -169.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.4 m -101.74 170.61 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.749 1.22 . . . . 0.35 112.627 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.06 179.09 7.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.961 1.304 . . . . 0.35 109.438 165.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.3 t -58.36 -40.41 82.17 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.03 0.932 . . . . 0.35 110.786 172.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.53 -54.98 40.34 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.265 1.026 . . . . 0.35 110.423 175.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.84 26.79 0.56 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.726 1.155 . . . . 0.35 111.905 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -100.11 115.54 30.02 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.187 0.995 . . . . 0.36 109.21 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -64.84 114.23 4.36 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.463 0.705 . . . . 0.35 110.552 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.417 HD12 ' H ' ' A' ' 39' ' ' LEU . 4.4 mp -77.75 -51.01 11.23 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.987 -0.746 . . . . 0.35 108.987 173.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.0 mt -91.99 -149.45 0.24 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.997 1.319 . . . . 0.35 110.189 -167.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.4 m -154.87 123.54 3.02 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.474 1.11 . . . . 0.33 109.126 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.16 -171.29 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.257 2.638 . . . . 0.35 110.311 171.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.2 m170 64.14 75.63 0.37 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.696 1.199 . . . . 0.35 111.171 174.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -145.44 -61.44 0.34 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.328 0.651 . . . . 0.35 110.646 174.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.59 124.06 20.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 107.926 -1.139 . . . . 0.35 107.926 166.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -149.9 151.32 33.24 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.67 1.188 . . . . 0.35 109.541 -175.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -140.17 146.15 44.86 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 124.812 1.245 . . . . 0.33 109.333 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.71 128.76 17.51 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.329 2.019 . . . . 0.35 107.713 166.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.4 tt -59.82 142.62 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.418 0.525 . . . . 0.35 112.418 -167.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -128.72 97.9 26.21 Favored Pre-proline 0 N--CA 1.453 -0.287 0 N-CA-C 107.31 -1.367 . . . . 0.33 107.31 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.29 157.47 49.88 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.454 2.103 . . . . 0.35 109.811 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.02 58.32 1.8 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.146 -1.182 . . . . 0.35 110.146 -174.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.3 t -152.56 147.26 25.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.979 1.311 . . . . 0.35 108.981 174.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.1 m -61.2 138.77 58.22 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.236 0.614 . . . . 0.35 110.379 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.89 80.95 1.71 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.446 1.098 . . . . 0.35 108.722 -173.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.3 p -133.39 178.66 6.74 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.869 1.268 . . . . 0.35 109.288 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -54.75 -54.37 42.86 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.109 0.564 . . . . 0.35 111.208 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.54 -42.93 67.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.383 1.073 . . . . 0.35 112.603 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.8 -60.24 4.11 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.231 0.612 . . . . 0.35 110.609 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.2 mm -57.54 -42.23 80.65 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 C-N-CA 124.61 1.164 . . . . 0.35 111.603 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -49.77 -59.24 4.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.75 1.22 . . . . 0.35 111.999 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -73.65 -29.61 62.43 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.497 0.555 . . . . 0.35 112.497 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -69.87 -40.03 75.99 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.518 0.727 . . . . 0.35 111.898 -170.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.34 -30.79 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.017 0.527 . . . . 0.35 111.512 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.3 -33.67 74.76 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.223 0.609 . . . . 0.35 111.019 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -31.56 67.52 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.332 0.653 . . . . 0.35 111.337 176.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 -55.4 22.23 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.228 0.611 . . . . 0.35 110.994 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 pp -64.12 -27.33 69.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.171 0.988 . . . . 0.35 112.811 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.62 -43.56 63.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.281 0.632 . . . . 0.35 110.32 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.51 50.47 1.89 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.64 1.176 . . . . 0.35 111.401 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.0 t -168.07 -42.69 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.358 1.463 . . . . 0.35 109.945 173.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.94 88.58 0.83 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.74 0.816 . . . . 0.35 110.023 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -107.71 46.81 0.92 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.278 1.031 . . . . 0.35 108.717 167.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -84.89 -57.64 3.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.771 1.228 . . . . 0.35 109.038 -175.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -100.74 -139.25 0.33 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.601 1.561 . . . . 0.35 108.42 176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 82.56 109.82 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.284 1.433 . . . . 0.35 111.436 162.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -41.86 9.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.907 1.283 . . . . 0.35 111.209 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.1 t 69.11 92.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 126.219 1.808 . . . . 0.35 109.463 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.6 t -67.95 -63.72 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.419 0.688 . . . . 0.35 109.767 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -160.33 117.82 2.52 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.15 0.58 . . . . 0.35 109.742 -176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.04 145.95 44.11 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.195 0.598 . . . . 0.35 110.019 172.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.99 123.07 85.16 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 108.518 -0.919 . . . . 0.33 108.518 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.31 -32.96 19.33 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.232 2.621 . . . . 0.35 111.045 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.3 m -79.67 76.25 6.32 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.976 0.911 . . . . 0.35 109.184 173.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.01 154.23 23.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.242 1.017 . . . . 0.35 110.07 172.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -133.93 134.42 42.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.109 0.964 . . . . 0.35 109.952 -171.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.4 mp -122.5 111.76 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 125.669 1.587 . . . . 0.35 107.964 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -99.04 63.39 1.33 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.117 0.967 . . . . 0.35 108.648 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.01 99.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.358 0.599 . . . . 0.35 109.896 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.6 m -80.39 150.46 29.82 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.532 1.133 . . . . 0.35 108.94 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -139.1 66.42 1.42 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.322 1.049 . . . . 0.35 108.726 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -91.55 121.59 33.37 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 127.396 2.278 . . . . 0.35 109.863 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.3 p-10 -131.29 -165.06 1.51 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.687 0.795 . . . . 0.35 110.56 169.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -144.51 63.8 1.31 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.826 -1.176 . . . . 0.35 107.826 169.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -134.04 -53.35 0.85 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 125.468 1.507 . . . . 0.36 109.21 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -155.88 -41.3 0.08 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.063 0.945 . . . . 0.35 111.679 -172.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.6 tppt? -83.67 -59.54 2.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.88 0.872 . . . . 0.35 111.467 -166.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? 68.03 177.84 0.25 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.933 1.693 . . . . 0.35 111.401 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -63.47 110.91 2.11 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 112.514 0.561 . . . . 0.35 112.514 -165.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -132.93 137.25 46.55 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.229 1.811 . . . . 0.35 106.66 170.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 87.5 m -116.01 102.12 9.36 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 123.894 0.878 . . . . 0.35 109.35 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -79.59 101.32 8.24 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.678 -0.86 . . . . 0.35 108.678 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.4 m -90.16 67.52 6.92 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.211 1.005 . . . . 0.35 110.07 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -71.01 134.34 85.56 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.103 0.961 . . . . 0.33 109.398 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.15 -113.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.474 2.783 . . . . 0.35 109.622 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.1 tp -163.05 158.43 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.245 0 CA-C-N 119.156 0.889 . . . . 0.35 110.087 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.8 p -133.69 151.82 51.73 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.798 1.239 . . . . 0.35 109.183 169.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.13 -35.16 66.8 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.957 1.303 . . . . 0.35 112.965 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -141.58 74.26 1.45 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.961 1.304 . . . . 0.35 107.883 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.69 -92.03 0.41 Allowed Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.141 0.877 . . . . 0.35 112.184 -175.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -162.03 171.01 18.26 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.304 0.573 . . . . 0.35 112.076 -163.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 99.3 t -90.21 145.35 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 126.204 1.802 . . . . 0.35 107.73 169.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.5 t -52.92 115.14 6.83 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 123.846 0.859 . . . . 0.33 109.371 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -82.6 -178.67 4.08 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.275 2.65 . . . . 0.35 110.931 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -72.38 -178.45 2.54 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.873 0.869 . . . . 0.35 109.922 170.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -140.31 61.11 1.53 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.912 0.885 . . . . 0.35 110.388 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 t 56.84 -103.0 0.17 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.97 1.708 . . . . 0.35 112.129 172.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -163.49 -58.12 0.04 OUTLIER 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.557 1.143 . . . . 0.35 108.623 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -57.92 -47.55 82.53 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.257 1.423 . . . . 0.35 112.124 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.3 tp -81.39 133.54 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.692 0.797 . . . . 0.35 110.684 -176.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.39 29.61 0.49 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.272 1.029 . . . . 0.35 111.643 166.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.49 60.56 10.23 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.227 1.411 . . . . 0.36 108.988 167.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.92 -73.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.743 2.962 . . . . 0.35 113.074 -168.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.71 78.36 1.4 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 108.927 -1.669 . . . . 0.35 108.927 -164.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -80.03 95.99 6.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.904 -1.147 . . . . 0.35 107.904 171.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -83.16 101.27 11.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.748 -0.834 . . . . 0.36 108.748 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.07 49.98 1.71 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.148 -1.056 . . . . 0.35 108.148 166.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.85 109.79 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.205 -1.776 . . . . 0.35 106.205 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 67.1 p -94.09 -133.69 0.17 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.226 1.011 . . . . 0.35 109.109 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -162.33 133.69 5.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.601 1.16 . . . . 0.35 108.065 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 m -142.34 143.45 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.718 0.807 . . . . 0.35 110.031 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.38 134.03 28.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.838 -1.171 . . . . 0.35 107.838 173.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 10.7 mt -123.5 143.58 36.12 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 C-N-CA 124.47 1.108 . . . . 0.35 110.652 -169.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -128.69 102.77 6.73 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.686 1.595 . . . . 0.35 106.76 166.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -60.85 128.26 35.64 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.2 0.6 . . . . 0.35 109.392 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.34 0.184 0 C-N-CA 123.79 0.836 . . . . 0.25 109.383 -164.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.965 -0.383 . . . . 0.35 109.965 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 t -82.77 177.09 8.84 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.11 0.964 . . . . 0.35 110.584 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.0 p -81.71 51.57 1.73 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.568 1.147 . . . . 0.35 110.011 172.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 58.62 23.57 11.1 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.608 1.563 . . . . 0.35 111.833 -171.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.8 t70 60.79 171.07 0.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.155 1.382 . . . . 0.35 110.994 -167.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.3 pttt 47.57 -106.16 0.15 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.373 1.469 . . . . 0.35 112.396 171.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.1 -136.49 2.03 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.546 -1.022 . . . . 0.35 110.546 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -85.7 71.46 10.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.941 -1.133 . . . . 0.35 107.941 173.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -67.15 -56.88 8.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.065 0.946 . . . . 0.35 113.061 -162.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 44' ' ' TYR . 47.3 mmtm 76.84 110.58 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.921 2.088 . . . . 0.35 108.297 -170.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -55.41 -61.54 2.27 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.365 1.066 . . . . 0.35 111.817 -167.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.58 80.28 0.1 OUTLIER Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.516 -1.434 . . . . 0.35 109.516 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -127.82 41.18 3.55 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.251 1.021 . . . . 0.35 109.914 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.7 t0 50.71 55.25 9.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.185 1.394 . . . . 0.35 109.552 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -129.58 -168.62 1.97 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.77 1.228 . . . . 0.35 111.454 -155.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.5 m 63.65 69.64 0.55 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.952 1.701 . . . . 0.35 111.025 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 60.65 -145.43 0.47 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.242 1.417 . . . . 0.35 110.169 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 77.0 t80 57.8 73.87 0.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.468 1.507 . . . . 0.35 111.867 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 65.43 168.09 0.11 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.992 1.717 . . . . 0.33 113.28 168.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.32 113.53 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.981 2.454 . . . . 0.35 110.557 168.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 p -142.36 -73.32 0.31 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.558 0.743 . . . . 0.35 111.564 -170.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.43 112.97 0.53 Allowed Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.892 -0.949 . . . . 0.33 111.088 -170.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.97 175.61 10.61 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.816 3.011 . . . . 0.35 112.758 -171.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -155.28 166.98 31.88 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.835 0.68 . . . . 0.35 112.835 -172.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.2 tp -139.0 80.94 1.81 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.469 1.908 . . . . 0.35 107.743 -175.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.1 mtm -74.45 100.89 3.96 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 122.674 0.39 . . . . 0.35 111.196 -172.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.5 t -84.57 76.72 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.521 -1.289 . . . . 0.35 107.521 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -149.02 148.18 29.42 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.618 1.167 . . . . 0.36 109.708 -171.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.6 m -140.37 144.36 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.266 1.026 . . . . 0.35 111.249 -170.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.1 m -70.2 105.49 2.97 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.731 1.212 . . . . 0.35 109.34 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.49 81.04 1.48 Allowed Glycine 0 C--N 1.34 0.776 0 C-N-CA 124.204 0.907 . . . . 0.35 111.711 -172.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.9 m -87.16 170.27 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.154 0.982 . . . . 0.35 111.909 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -77.1 -44.56 30.06 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.928 0.891 . . . . 0.35 110.571 173.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.8 t 169.72 -59.8 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 128.097 2.559 . . . . 0.35 107.077 -171.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.9 43.66 1.06 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.115 1.366 . . . . 0.35 111.915 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.04 32.39 63.32 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 118.784 -1.009 . . . . 0.35 114.297 167.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -103.43 90.77 3.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.483 1.141 . . . . 0.36 108.132 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.89 109.5 1.47 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.848 0.859 . . . . 0.35 110.077 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mp -77.52 -53.8 7.18 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.38 0.672 . . . . 0.35 109.845 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.9 mt -86.07 -169.43 2.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.406 1.082 . . . . 0.35 110.247 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.3 m -126.48 68.51 67.79 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.553 0.741 . . . . 0.33 111.051 -174.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.99 164.29 35.32 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.909 3.073 . . . . 0.35 112.893 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.1 m170 79.1 80.67 0.06 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 127.222 2.209 . . . . 0.35 108.357 -172.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.403 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 31.2 p90 -147.31 -48.64 0.18 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.352 0.661 . . . . 0.35 111.957 -176.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -83.86 77.51 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 108.568 -0.901 . . . . 0.35 108.568 169.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -72.2 -38.06 69.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.897 -0.573 . . . . 0.35 111.924 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 64.67 154.26 0.12 Allowed Pre-proline 0 C--N 1.345 0.399 0 C-N-CA 126.634 1.974 . . . . 0.33 113.454 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.87 134.57 8.44 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.085 2.523 . . . . 0.35 108.378 165.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.5 tt -70.51 148.57 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.505 0.322 . . . . 0.35 111.196 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -135.08 107.39 10.4 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 107.287 -1.375 . . . . 0.33 107.287 172.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.63 161.69 27.71 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.12 2.547 . . . . 0.35 110.563 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.32 61.61 1.98 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.711 -1.356 . . . . 0.35 109.711 -173.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 t -151.9 142.98 23.18 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.55 1.14 . . . . 0.35 109.431 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.5 m -62.79 121.03 12.44 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.699 0.799 . . . . 0.35 110.034 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.85 78.63 1.64 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.893 1.277 . . . . 0.35 108.621 -173.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.3 p -116.02 172.1 7.37 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.746 1.618 . . . . 0.35 109.59 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.87 -49.78 75.52 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.69 1.196 . . . . 0.35 110.531 177.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -65.06 -28.94 69.81 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.61 0.764 . . . . 0.35 112.926 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -74.36 4.02 6.51 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.471 -0.775 . . . . 0.35 112.844 172.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.2 mm -100.36 -49.51 11.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 CA-C-N 119.324 0.965 . . . . 0.35 109.039 168.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -43.75 -64.78 0.59 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.691 1.597 . . . . 0.35 113.607 -167.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -82.11 -28.65 32.14 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.779 0.832 . . . . 0.35 111.795 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -60.18 -49.41 77.75 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.626 1.17 . . . . 0.35 111.691 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.0 m -66.9 -38.19 80.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 C-N-CA 123.371 0.668 . . . . 0.35 110.983 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.89 -39.22 84.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.779 0.832 . . . . 0.35 111.127 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -72.46 -40.8 66.73 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.0 0.92 . . . . 0.35 111.466 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.74 95.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.358 0.663 . . . . 0.35 111.218 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -85.95 -22.38 27.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.963 0.905 . . . . 0.35 113.025 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -59.7 -41.77 91.51 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.512 0.725 . . . . 0.35 110.573 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.85 64.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.0 0.92 . . . . 0.35 112.091 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.7 p -83.58 -62.03 1.68 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.857 0.863 . . . . 0.35 112.276 -173.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.01 -67.85 0.39 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-N 118.495 0.588 . . . . 0.35 110.076 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.1 t80 71.48 149.42 0.09 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.966 1.707 . . . . 0.35 113.202 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? 68.59 -90.18 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.101 1.76 . . . . 0.35 112.775 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -84.5 72.35 10.64 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 123.901 0.88 . . . . 0.35 111.078 -169.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -167.74 147.96 5.12 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.256 1.422 . . . . 0.35 108.248 173.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.3 tpt85 -114.1 -60.04 1.94 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.591 0.757 . . . . 0.35 111.473 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.3 t 71.76 82.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 125.304 1.442 . . . . 0.35 107.963 -160.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.5 t -69.38 -57.33 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.623 1.169 . . . . 0.35 109.99 -172.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -131.11 169.52 15.78 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.627 1.171 . . . . 0.35 110.842 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 pp -153.68 156.4 37.78 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.712 1.605 . . . . 0.35 109.013 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -87.33 138.27 32.25 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 109.276 -0.639 . . . . 0.33 109.276 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.06 -17.92 24.43 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.436 2.758 . . . . 0.35 111.856 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.4 m -59.01 -31.87 69.2 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.436 1.095 . . . . 0.35 112.291 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 15.69 74.38 0.01 OUTLIER 'General case' 0 C--N 1.348 0.511 0 C-N-CA 128.813 2.845 . . . . 0.35 113.728 172.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -78.9 128.77 33.75 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.122 0.969 . . . . 0.35 113.092 -161.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.8 124.03 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 125.988 1.715 . . . . 0.35 107.354 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -122.57 90.26 3.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.377 1.071 . . . . 0.35 108.601 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 m -78.8 92.19 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.786 1.234 . . . . 0.35 110.548 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.1 m -85.5 94.37 9.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.616 1.167 . . . . 0.35 108.645 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.74 84.1 4.94 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.509 0.724 . . . . 0.35 110.38 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -76.11 91.74 3.16 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.878 1.671 . . . . 0.35 110.003 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -134.19 78.95 1.78 Allowed 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.896 -0.779 . . . . 0.35 108.896 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -75.67 83.31 2.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.724 1.21 . . . . 0.35 108.667 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -155.19 -37.86 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.857 1.663 . . . . 0.36 110.018 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -154.7 -41.35 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.93 1.292 . . . . 0.35 110.624 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -79.85 -63.2 1.47 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 123.246 0.618 . . . . 0.35 110.699 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.48 125.49 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.322 1.849 . . . . 0.35 109.84 -177.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -10.17 108.18 0.01 OUTLIER 'General case' 0 C--N 1.344 0.369 0 C-N-CA 129.516 3.126 . . . . 0.35 115.261 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -140.86 123.33 15.95 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.03 1.332 . . . . 0.35 107.989 177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.7 m -102.32 103.9 14.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.748 1.219 . . . . 0.35 109.726 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.86 109.15 14.01 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.491 -0.929 . . . . 0.35 108.491 173.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.8 p -89.29 75.24 7.77 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.607 1.163 . . . . 0.35 111.151 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -81.21 142.57 51.2 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.679 1.192 . . . . 0.33 109.52 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -77.33 -129.02 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.79 2.993 . . . . 0.35 110.157 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.8 tp -167.43 159.92 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 119.663 1.12 . . . . 0.35 110.211 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.9 p -136.42 151.89 50.01 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.687 1.195 . . . . 0.35 109.84 170.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.5 -11.26 60.68 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.722 1.209 . . . . 0.35 114.062 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -142.05 59.15 1.47 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.973 -1.121 . . . . 0.35 107.973 172.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.38 -82.67 1.0 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.183 0.897 . . . . 0.35 111.558 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -163.54 159.83 22.41 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.193 0.521 . . . . 0.35 112.013 -163.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.4 t -91.08 144.85 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.005 1.722 . . . . 0.35 106.998 166.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 80.7 t -57.28 117.2 16.74 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 108.522 -0.918 . . . . 0.33 108.522 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.55 -109.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.009 2.473 . . . . 0.35 109.349 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -156.33 -137.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.591 -1.263 . . . . 0.35 107.591 173.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 mp -137.27 151.54 48.81 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.821 1.248 . . . . 0.35 109.595 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.3 t -77.11 -71.05 0.43 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.569 0.748 . . . . 0.35 109.74 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -168.02 -46.21 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.593 1.157 . . . . 0.35 109.799 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -39.4 -45.56 1.51 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.213 2.205 . . . . 0.35 115.151 -169.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.39 161.15 41.06 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 C-N-CA 123.444 0.698 . . . . 0.35 111.386 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -91.21 -68.18 0.81 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.209 1.404 . . . . 0.35 110.092 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.473 HD22 ' H ' ' A' ' 122' ' ' ASN . 0.1 OUTLIER -107.94 103.34 49.46 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.234 1.014 . . . . 0.36 112.407 -165.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.43 -177.68 3.72 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.926 2.417 . . . . 0.35 111.174 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -153.3 68.0 0.31 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.876 -1.289 . . . . 0.35 109.876 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -57.71 129.11 40.38 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.787 1.235 . . . . 0.35 109.376 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -131.89 116.0 16.62 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.523 -0.918 . . . . 0.36 108.523 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -88.5 60.13 5.5 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.257 1.023 . . . . 0.35 109.628 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.8 mt -78.66 130.9 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.408 1.083 . . . . 0.35 109.542 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.4 m -143.85 139.23 29.16 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.174 1.39 . . . . 0.35 108.354 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.76 93.52 9.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.187 0.995 . . . . 0.35 108.467 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.73 138.29 30.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 C-N-CA 124.198 0.999 . . . . 0.35 111.222 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.79 100.62 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.427 1.491 . . . . 0.35 108.751 -175.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 18.5 mt -90.98 145.84 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.089 0.956 . . . . 0.35 110.234 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -138.59 127.05 23.15 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.845 1.258 . . . . 0.35 109.208 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -66.71 125.71 26.7 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.316 1.046 . . . . 0.35 109.579 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? . . . . . 0 C--N 1.34 0.183 0 C-N-CA 123.128 0.571 . . . . 0.25 109.745 176.586 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.413 ' H3 ' ' H ' ' A' ' 73' ' ' TYR . 19.8 m . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 118.595 -0.717 . . . . 0.35 112.654 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.5 m 71.53 -74.05 0.09 Allowed 'General case' 0 C--N 1.344 0.365 0 C-N-CA 126.543 1.937 . . . . 0.35 112.261 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 82.2 p -91.89 138.39 31.59 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.414 1.086 . . . . 0.35 109.723 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -69.13 139.43 54.7 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.887 0.875 . . . . 0.35 109.697 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -79.83 -171.74 3.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.402 0.681 . . . . 0.35 110.596 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 17.8 pttm 47.75 -134.34 1.15 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.464 1.506 . . . . 0.35 111.816 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.02 74.95 0.07 OUTLIER Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.339 0.972 . . . . 0.35 111.842 -175.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt 52.56 62.56 2.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.537 1.135 . . . . 0.35 110.344 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -135.86 133.43 37.77 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.317 1.047 . . . . 0.35 110.512 -170.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.33 45.2 0.64 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.962 1.305 . . . . 0.35 109.016 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt 64.17 -89.54 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.401 1.48 . . . . 0.35 108.929 -168.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.33 32.58 0.12 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.338 -1.105 . . . . 0.35 110.338 168.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 55.3 20.08 3.33 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.014 1.726 . . . . 0.35 113.016 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 47.78 40.47 12.44 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.518 1.527 . . . . 0.35 111.618 -173.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.05 85.35 0.15 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.373 0.669 . . . . 0.35 109.904 -169.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -86.86 -112.54 0.05 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.794 0.838 . . . . 0.35 109.452 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -149.11 67.68 1.04 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.268 1.027 . . . . 0.35 110.355 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -154.28 91.56 1.43 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.324 1.05 . . . . 0.35 108.363 166.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 69.49 150.36 0.12 Allowed Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.875 1.67 . . . . 0.33 111.661 173.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.45 93.14 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.0 2.467 . . . . 0.35 111.187 -177.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 p -74.41 -52.57 11.69 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.155 0.982 . . . . 0.35 109.162 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.4 163.42 29.31 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.147 -0.781 . . . . 0.33 111.147 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -80.85 -174.44 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.482 3.455 . . . . 0.35 112.092 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -163.15 -178.45 6.01 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.077 1.751 . . . . 0.35 108.807 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 tt -155.05 83.63 1.08 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.712 -1.218 . . . . 0.35 107.712 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 24.1 ttp -82.27 118.63 23.27 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.324 0.65 . . . . 0.35 110.56 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.0 t -107.78 101.11 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 126.019 1.728 . . . . 0.35 108.281 -174.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -156.82 -177.4 6.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.582 1.153 . . . . 0.36 110.71 -172.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.85 -164.63 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.268 1.427 . . . . 0.35 109.162 172.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.0 m -133.2 99.76 4.65 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.382 -1.34 . . . . 0.35 107.382 169.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.35 87.57 1.21 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.823 1.201 . . . . 0.35 111.857 -171.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -104.44 166.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 124.15 0.98 . . . . 0.35 111.943 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.32 176.46 9.3 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.638 1.575 . . . . 0.35 109.288 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 t -53.55 -41.52 66.56 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.708 0.803 . . . . 0.35 110.755 166.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -91.86 18.87 7.16 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.612 1.165 . . . . 0.35 112.459 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 -5.7 76.79 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.926 -0.93 . . . . 0.35 114.921 168.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -75.07 123.57 25.44 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.921 1.361 . . . . 0.36 110.09 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.14 102.24 0.48 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.162 0.985 . . . . 0.35 110.841 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.68 -72.32 0.3 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.845 0.858 . . . . 0.35 108.828 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 mt -93.63 156.37 16.75 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.23 -1.026 . . . . 0.35 108.23 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.1 t -119.43 71.33 13.02 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 124.021 0.928 . . . . 0.33 109.652 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.61 91.84 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 124.539 3.493 . . . . 0.35 109.893 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -156.73 55.15 0.54 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.713 1.205 . . . . 0.35 109.032 -172.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -154.92 15.22 0.42 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.732 1.012 . . . . 0.35 113.732 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.8 t -125.94 119.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 C-N-CA 123.842 0.857 . . . . 0.35 108.859 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -138.68 169.52 17.64 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.291 0.636 . . . . 0.35 111.9 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.94 157.93 53.48 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 125.907 1.683 . . . . 0.33 108.486 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.98 168.62 22.64 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.858 2.372 . . . . 0.35 110.413 171.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 tp -65.21 118.79 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.628 0.771 . . . . 0.35 110.419 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -144.64 83.63 9.57 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.622 1.169 . . . . 0.33 108.636 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -84.58 -168.53 0.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.014 3.143 . . . . 0.35 109.907 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.17 -15.7 61.41 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.665 0.65 . . . . 0.35 112.356 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.0 t -75.36 148.03 39.57 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.799 0.84 . . . . 0.35 110.491 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.7 m -66.77 148.51 51.83 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.056 0.942 . . . . 0.35 108.94 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.99 116.03 7.88 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.401 -0.592 . . . . 0.35 109.401 -172.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -164.05 171.29 15.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.281 1.832 . . . . 0.35 108.099 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -52.69 -41.37 63.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.138 0.975 . . . . 0.35 112.143 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -83.98 -2.54 56.77 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.661 0.784 . . . . 0.35 113.042 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.42 50.81 2.2 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.503 1.121 . . . . 0.35 110.196 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -159.68 -48.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.378 1.071 . . . . 0.35 109.234 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.16 -47.34 62.16 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.044 1.338 . . . . 0.35 112.996 -174.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -63.77 -41.27 98.0 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.996 0.362 . . . . 0.35 111.79 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -65.09 -44.97 87.13 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.037 0.935 . . . . 0.35 111.745 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 m -69.2 -29.38 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.417 0.687 . . . . 0.35 112.497 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -72.21 -36.88 69.29 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 122.813 0.445 . . . . 0.35 111.08 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -70.21 -28.19 65.08 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.055 0.542 . . . . 0.35 111.394 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.01 -60.05 3.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.42 0.688 . . . . 0.35 110.618 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.69 -23.81 67.37 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.661 0.615 . . . . 0.35 112.661 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -61.15 -22.62 64.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.516 0.726 . . . . 0.35 112.252 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.62 -54.07 42.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.944 0.898 . . . . 0.35 111.802 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.7 p -75.23 -70.14 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.441 0.696 . . . . 0.35 110.832 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.8 148.56 25.96 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.102 1.361 . . . . 0.35 109.841 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.413 ' H ' ' H3 ' ' A' ' 1' ' ' SER . 29.8 p90 -167.08 44.01 0.05 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.543 0.737 . . . . 0.35 111.221 -173.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -139.26 -71.39 0.4 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.026 0.531 . . . . 0.35 111.206 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -62.99 -57.28 11.24 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.065 0.946 . . . . 0.35 112.215 -167.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -62.72 145.15 55.46 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.746 0.418 . . . . 0.35 111.802 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.36 -41.5 2.04 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.498 1.919 . . . . 0.35 109.059 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t 79.33 126.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.283 0 C-N-CA 126.569 1.948 . . . . 0.35 111.539 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.14 -60.57 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 124.98 1.312 . . . . 0.35 108.982 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -153.81 128.73 9.53 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.868 0.867 . . . . 0.35 109.93 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.4 mt -78.49 118.7 20.88 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.801 -1.555 . . . . 0.35 106.801 164.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.15 137.09 95.67 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.979 -0.378 . . . . 0.33 109.979 -172.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -66.22 -33.93 37.94 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.41 2.74 . . . . 0.35 111.088 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -83.87 75.27 10.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.537 1.135 . . . . 0.35 110.165 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.89 165.05 13.74 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.654 0.782 . . . . 0.35 109.884 167.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -153.48 121.27 6.01 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.177 0.513 . . . . 0.35 111.794 -167.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.61 122.32 44.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 C-N-CA 126.673 1.989 . . . . 0.35 107.093 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -111.96 77.73 1.07 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 107.415 -1.328 . . . . 0.35 107.415 173.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 p -72.79 86.94 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.591 0.71 . . . . 0.35 109.555 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 55.4 m -94.36 92.52 7.21 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.395 1.478 . . . . 0.35 108.816 -170.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -91.37 169.22 10.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.648 1.179 . . . . 0.35 109.757 172.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -149.66 63.01 1.0 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.604 1.162 . . . . 0.35 108.033 173.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.87 86.69 4.09 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.525 1.13 . . . . 0.35 108.803 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -78.98 71.92 5.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.047 1.339 . . . . 0.35 109.214 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -149.31 -57.5 0.2 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.34 1.456 . . . . 0.36 109.168 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.84 35.56 0.4 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.658 0.783 . . . . 0.35 111.57 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.6 -51.06 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.937 0.495 . . . . 0.35 110.47 -170.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt 69.26 -153.18 0.14 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.689 1.596 . . . . 0.35 110.229 -173.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -95.18 130.91 41.72 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.503 1.121 . . . . 0.35 110.857 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -141.74 121.17 13.21 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.466 1.106 . . . . 0.35 108.463 171.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.6 m -81.29 85.4 6.4 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.304 -1.369 . . . . 0.35 107.304 170.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -79.75 95.75 6.08 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.058 0.943 . . . . 0.35 109.266 -173.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.5 p -88.17 70.1 9.24 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.667 1.187 . . . . 0.35 111.642 -171.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -68.12 136.48 91.66 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.709 0.804 . . . . 0.33 108.985 171.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -79.73 -111.76 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.338 2.692 . . . . 0.35 110.275 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.5 tp -163.21 153.37 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.987 1.315 . . . . 0.35 108.478 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.8 p -129.69 156.17 44.7 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.759 0.823 . . . . 0.35 109.928 172.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.2 -26.08 52.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.311 1.444 . . . . 0.35 112.017 -173.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.83 -44.0 94.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.436 1.095 . . . . 0.35 113.099 -165.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.71 64.97 0.62 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.031 -1.228 . . . . 0.35 110.031 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -73.95 126.08 29.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.617 -0.512 . . . . 0.35 109.617 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.9 t -76.27 130.56 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.263 -1.014 . . . . 0.35 108.263 174.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.23 120.89 77.8 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 107.712 -1.218 . . . . 0.33 107.712 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.35 -94.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.977 2.451 . . . . 0.35 109.312 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -169.81 -82.69 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.395 1.478 . . . . 0.35 107.275 166.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.7 mt -150.81 160.6 43.76 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.051 1.34 . . . . 0.35 110.444 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.3 t -100.6 -72.7 0.66 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.658 1.183 . . . . 0.35 108.992 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -166.77 -48.39 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.191 0.996 . . . . 0.35 110.066 -173.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.17 -35.63 12.06 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.675 1.99 . . . . 0.35 115.385 -168.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.2 pt -132.23 171.87 17.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 C-N-CA 124.163 0.985 . . . . 0.35 110.963 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.09 42.34 0.59 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.277 1.031 . . . . 0.35 111.064 172.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.01 54.47 0.56 Allowed Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.785 1.234 . . . . 0.36 110.214 170.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -44.09 -55.27 3.23 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 125.027 3.818 . . . . 0.35 113.759 -173.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.39 67.95 1.83 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.162 -0.775 . . . . 0.35 111.162 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -67.21 139.17 57.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.143 0.977 . . . . 0.35 111.12 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -127.58 87.9 2.7 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.767 1.227 . . . . 0.36 108.292 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -75.25 98.76 3.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.939 -1.504 . . . . 0.35 106.939 174.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.53 96.67 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.679 1.192 . . . . 0.35 108.398 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.3 m -84.88 146.8 27.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.185 0.994 . . . . 0.35 109.783 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.14 122.82 29.36 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.776 -1.194 . . . . 0.35 107.776 173.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.71 137.2 57.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 C-N-CA 123.211 0.604 . . . . 0.35 110.517 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.9 t -97.48 103.23 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.674 1.189 . . . . 0.35 108.361 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.3 mt -82.05 126.13 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.231 1.012 . . . . 0.35 109.977 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -100.44 140.63 34.42 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 107.84 -1.17 . . . . 0.35 107.84 155.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.75 138.22 45.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.518 1.127 . . . . 0.35 110.381 -174.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 124.101 0.96 . . . . 0.25 109.013 178.358 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.459 ' H2 ' ' H ' ' A' ' 75' ' ' GLU . 35.6 t . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 110.385 -0.228 . . . . 0.35 110.385 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.4 p -162.4 -173.96 3.82 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.048 0.939 . . . . 0.35 110.158 -172.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.5 p -63.92 104.12 0.66 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.45 1.1 . . . . 0.35 110.446 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -74.16 100.25 3.61 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.893 -1.151 . . . . 0.35 107.893 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.77 92.76 0.16 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.953 1.301 . . . . 0.35 111.967 -163.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -146.46 80.39 1.55 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.081 1.753 . . . . 0.35 107.146 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.14 98.79 1.5 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.996 0.808 . . . . 0.35 111.298 -175.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 54.65 63.48 2.13 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.204 1.402 . . . . 0.35 109.744 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -109.61 -69.55 0.86 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.513 1.525 . . . . 0.35 109.525 -174.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 65.17 165.64 0.17 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.686 1.594 . . . . 0.35 111.83 -170.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -46.36 -53.45 10.88 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.368 1.467 . . . . 0.35 112.054 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.61 -23.65 0.56 Allowed Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.952 0.787 . . . . 0.35 111.648 -175.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.11 -22.6 65.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.929 1.292 . . . . 0.35 112.604 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.67 130.0 44.69 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 123.625 0.77 . . . . 0.35 110.865 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.43 52.7 0.73 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.831 0.852 . . . . 0.35 109.103 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -61.85 140.37 58.27 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.307 1.043 . . . . 0.35 111.104 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 64.73 174.27 0.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.352 1.461 . . . . 0.35 113.156 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.5 t80 56.59 88.56 0.05 OUTLIER 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.85 2.06 . . . . 0.35 112.028 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 70.43 154.72 0.15 Allowed Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.431 1.892 . . . . 0.33 111.474 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -63.61 100.65 0.29 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.146 2.564 . . . . 0.35 109.58 163.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -107.35 -70.79 0.78 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 123.931 0.892 . . . . 0.35 111.263 -172.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.23 111.5 0.45 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.884 -0.953 . . . . 0.33 110.801 -169.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.5 -179.29 4.33 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.403 2.735 . . . . 0.35 112.294 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -165.65 178.84 6.38 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.145 0.978 . . . . 0.35 110.549 -166.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tt -153.02 92.63 1.65 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.059 1.344 . . . . 0.35 107.586 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 68.3 mtp -88.05 101.42 13.76 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.402 1.481 . . . . 0.35 110.409 -168.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.2 t -98.78 112.32 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.187 0.995 . . . . 0.35 109.591 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -175.46 171.44 2.83 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.502 1.121 . . . . 0.36 109.964 174.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.87 140.33 36.15 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 C-N-CA 124.11 0.964 . . . . 0.35 111.785 -178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.6 m -70.55 101.25 1.97 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.448 1.899 . . . . 0.35 108.947 175.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.08 87.0 1.33 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.04 0.829 . . . . 0.35 111.654 -172.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.2 m -85.04 166.46 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 123.895 0.878 . . . . 0.35 110.477 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.23 -42.8 30.13 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.804 -0.443 . . . . 0.35 109.804 166.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 t -173.11 -53.72 0.02 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 125.246 1.418 . . . . 0.35 110.022 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -92.6 41.87 1.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.484 1.114 . . . . 0.35 113.92 -159.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.81 60.47 8.4 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.494 -0.642 . . . . 0.35 111.494 172.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -157.19 98.67 1.74 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.163 0.985 . . . . 0.36 109.42 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.65 118.64 7.36 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.805 1.242 . . . . 0.35 111.01 -173.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.89 -48.07 26.68 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.941 0.896 . . . . 0.35 110.036 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.5 mt -86.62 -169.37 2.61 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.405 1.082 . . . . 0.35 111.053 -171.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.8 p -130.32 78.62 74.09 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 106.87 -1.53 . . . . 0.33 106.87 163.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -85.49 77.14 2.8 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 124.804 3.669 . . . . 0.35 109.636 -166.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -150.12 85.67 1.41 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.132 0.973 . . . . 0.35 108.602 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -155.55 -48.42 0.08 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.249 0.62 . . . . 0.35 112.273 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.55 119.88 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 119.009 0.822 . . . . 0.35 110.048 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -156.43 151.84 26.73 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.541 1.137 . . . . 0.35 109.788 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -129.93 153.32 80.95 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 125.502 1.521 . . . . 0.33 108.742 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -82.39 60.9 7.51 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.711 2.94 . . . . 0.35 110.345 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.3 tp 39.97 89.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.689 1.996 . . . . 0.35 112.578 -173.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -107.87 92.24 8.73 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.879 1.272 . . . . 0.33 108.633 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.87 155.96 48.31 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.127 2.551 . . . . 0.35 110.804 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.08 -50.4 0.7 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.573 -1.011 . . . . 0.35 110.573 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.4 t -63.01 146.48 53.11 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.905 0.882 . . . . 0.35 110.729 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 m -77.97 116.88 18.79 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.622 -0.51 . . . . 0.35 109.622 -175.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -77.08 86.19 3.58 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.021 1.328 . . . . 0.35 108.572 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 p -150.0 151.85 33.97 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.682 1.193 . . . . 0.35 110.558 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -52.51 -53.06 50.93 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.178 1.391 . . . . 0.35 111.208 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -49.78 -45.32 49.61 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.677 1.191 . . . . 0.35 112.978 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -76.52 -50.01 15.05 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.018 0.372 . . . . 0.35 111.506 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.7 mm -54.22 -38.18 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.646 1.178 . . . . 0.35 112.402 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -52.9 -61.01 2.57 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.957 0.799 . . . . 0.35 112.015 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -71.41 -36.83 71.47 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.697 0.258 . . . . 0.35 111.697 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -64.77 -47.99 76.14 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.759 0.824 . . . . 0.35 111.786 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 p -71.89 -28.19 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.497 0.719 . . . . 0.35 111.322 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.69 -44.5 90.09 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 123.019 0.528 . . . . 0.35 109.643 172.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -66.18 -20.86 66.26 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.45 0.7 . . . . 0.35 112.369 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.33 -47.3 64.82 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.886 0.766 . . . . 0.35 110.914 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -39.36 84.98 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 109.936 -0.394 . . . . 0.35 109.936 173.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -93.42 52.12 1.7 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.876 1.271 . . . . 0.35 110.033 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.96 -58.84 2.01 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.019 1.328 . . . . 0.35 108.541 174.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 75.1 p -80.87 -50.16 10.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.622 1.169 . . . . 0.35 110.658 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.46 -97.61 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.971 0.908 . . . . 0.35 109.917 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.3 t80 54.98 87.63 0.05 OUTLIER 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.914 1.686 . . . . 0.35 113.072 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -161.23 -49.33 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.237 0.615 . . . . 0.35 109.954 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.459 ' H ' ' H2 ' ' A' ' 1' ' ' SER . 47.0 mt-10 -120.75 50.73 1.3 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.026 1.33 . . . . 0.35 109.521 -175.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -139.04 92.0 2.56 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.371 1.068 . . . . 0.35 109.855 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -73.43 -40.0 64.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.463 1.105 . . . . 0.35 111.35 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.5 t 74.24 115.62 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 126.169 1.788 . . . . 0.35 110.798 -175.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.05 -67.37 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 108.13 -1.063 . . . . 0.35 108.13 172.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -145.12 165.02 29.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.844 1.658 . . . . 0.35 109.116 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 pp -130.67 129.17 42.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.058 1.343 . . . . 0.35 107.431 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.91 132.28 84.97 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.946 -0.39 . . . . 0.33 109.946 -168.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.99 -22.71 22.68 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.505 2.803 . . . . 0.35 111.517 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.2 m -82.61 68.04 8.91 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.371 1.068 . . . . 0.35 110.328 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.99 165.09 25.76 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.864 0.865 . . . . 0.35 110.267 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -148.71 132.62 17.1 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.219 0.533 . . . . 0.35 112.119 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.2 114.69 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.877 -1.897 . . . . 0.35 105.877 171.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -107.94 58.1 0.62 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.957 0.903 . . . . 0.35 108.628 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.77 103.69 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.953 0.901 . . . . 0.35 110.372 -174.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 89.9 m -99.61 100.76 11.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.399 1.48 . . . . 0.35 108.114 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -98.87 84.89 3.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.015 0.926 . . . . 0.35 110.314 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -69.92 75.95 0.47 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.373 1.869 . . . . 0.35 109.769 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -120.5 65.53 0.84 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.14 1.376 . . . . 0.35 108.677 -170.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.7 110.35 6.19 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.35 0.66 . . . . 0.35 110.269 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -178.68 -47.6 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.293 1.837 . . . . 0.36 108.801 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -37.48 0.11 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.367 1.067 . . . . 0.35 110.883 172.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -78.06 -52.6 8.5 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.612 0.765 . . . . 0.35 110.651 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt 72.95 170.46 0.31 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.799 1.639 . . . . 0.35 111.382 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.16 125.23 24.33 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.663 0.785 . . . . 0.35 111.157 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -140.51 108.74 5.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.579 -1.267 . . . . 0.35 107.579 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.4 m -76.0 86.54 2.92 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.026 -1.102 . . . . 0.35 108.026 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -80.47 98.29 7.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.066 0.946 . . . . 0.35 108.553 -175.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.6 p -87.29 64.54 8.33 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.719 1.208 . . . . 0.35 111.116 -174.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -65.9 134.73 95.15 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.727 -0.842 . . . . 0.33 108.727 170.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.35 -114.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.24 2.627 . . . . 0.35 109.511 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.2 tp -161.67 151.57 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 118.973 0.806 . . . . 0.35 109.74 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.9 p -127.16 150.05 49.68 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.057 1.343 . . . . 0.35 109.678 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -67.37 0.48 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.477 0.711 . . . . 0.35 110.023 -176.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -108.78 101.71 10.81 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 106.607 -1.627 . . . . 0.35 106.607 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.15 -97.91 0.87 Allowed Glycine 0 C--N 1.34 0.774 0 C-N-CA 124.332 0.968 . . . . 0.35 111.86 -168.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -159.37 177.54 10.89 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.261 0.624 . . . . 0.35 111.443 -163.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.1 t -102.71 150.63 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.982 1.713 . . . . 0.35 110.142 -175.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 88.3 t -54.52 114.91 7.5 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.308 1.043 . . . . 0.33 108.88 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.08 148.81 19.55 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.791 2.327 . . . . 0.35 111.016 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -94.18 -178.19 4.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.956 1.303 . . . . 0.35 110.132 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.85 165.35 25.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.725 0.81 . . . . 0.35 111.518 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.3 t -142.22 -68.42 0.37 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.464 1.106 . . . . 0.35 109.57 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -163.87 -52.71 0.03 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.208 1.003 . . . . 0.35 109.497 -174.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -42.08 -43.81 3.38 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.872 2.069 . . . . 0.35 114.068 -173.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.1 pt -133.82 173.9 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.606 0.762 . . . . 0.35 111.398 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -107.06 -44.92 4.27 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 126.203 1.801 . . . . 0.35 108.685 173.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -120.4 101.56 46.39 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.907 1.283 . . . . 0.36 110.865 -170.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -57.83 -59.51 0.54 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.452 2.768 . . . . 0.35 111.926 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 64.92 66.89 2.25 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.759 -0.937 . . . . 0.35 110.759 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -70.72 144.67 50.89 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.392 1.077 . . . . 0.35 111.162 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -132.16 92.93 3.18 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.371 1.068 . . . . 0.36 108.995 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.74 62.92 7.76 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.442 1.097 . . . . 0.35 108.628 174.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.98 125.14 54.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 125.465 1.506 . . . . 0.35 107.141 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.9 m -141.88 172.65 12.39 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.251 1.82 . . . . 0.35 107.631 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.69 131.55 56.92 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.556 1.142 . . . . 0.35 109.49 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.4 m -130.24 155.21 41.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 C-N-CA 124.677 1.191 . . . . 0.35 110.371 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.63 103.51 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.977 1.311 . . . . 0.35 108.716 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 29.1 mt -81.37 139.05 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.122 0.969 . . . . 0.35 110.772 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -102.66 128.99 49.13 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.417 -1.697 . . . . 0.35 106.417 162.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -84.33 74.2 10.37 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.497 -0.927 . . . . 0.35 108.497 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.341 0.228 0 C-N-CA 125.735 1.614 . . . . 0.25 109.475 -173.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.8 m . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 109.829 -0.434 . . . . 0.35 109.829 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 t 50.0 50.33 18.7 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.359 1.464 . . . . 0.35 111.407 -172.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 t -102.93 109.27 20.77 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.56 1.144 . . . . 0.35 108.722 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -73.16 104.72 4.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.674 0.79 . . . . 0.35 109.441 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -124.96 53.37 1.5 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.335 1.054 . . . . 0.35 110.392 -174.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -122.52 -51.78 1.94 Allowed 'General case' 0 C--N 1.34 0.173 0 C-N-CA 124.497 1.119 . . . . 0.35 108.573 173.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.61 78.85 0.8 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.648 . . . . 0.35 112.331 169.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp 58.21 73.4 0.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.686 1.194 . . . . 0.35 111.484 166.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -111.84 60.55 0.62 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.44 1.096 . . . . 0.35 109.802 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.19 177.89 8.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.756 0.823 . . . . 0.35 112.482 -168.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.7 tttm 60.48 52.86 4.44 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 127.111 2.165 . . . . 0.35 110.447 -172.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.42 -86.38 0.46 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 106.828 -2.509 . . . . 0.35 106.828 172.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t0 53.28 61.96 2.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.259 1.024 . . . . 0.35 109.499 176.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 64.87 53.92 1.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.425 1.49 . . . . 0.35 110.953 -171.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.74 91.06 0.05 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.936 1.694 . . . . 0.35 112.362 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -55.23 -53.86 50.76 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.503 1.121 . . . . 0.35 111.44 -176.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -77.12 175.84 9.26 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.11 0.964 . . . . 0.35 111.851 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.3 t80 60.12 84.86 0.11 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 126.38 1.872 . . . . 0.35 111.107 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 66.37 158.92 0.13 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 126.491 1.916 . . . . 0.33 112.144 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.06 129.97 35.82 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.157 2.572 . . . . 0.35 111.592 167.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.5 p -121.92 -57.54 1.79 Allowed 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.506 1.123 . . . . 0.35 109.122 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.69 172.96 43.61 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 112.343 -0.303 . . . . 0.33 112.343 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.48 166.47 19.52 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 124.223 3.282 . . . . 0.35 113.835 -173.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -154.75 161.52 41.48 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.811 1.244 . . . . 0.35 109.668 167.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 tt -157.32 99.15 1.76 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.446 -0.946 . . . . 0.35 108.446 -170.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 26.9 mtp -92.14 146.34 23.8 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.396 1.479 . . . . 0.35 110.329 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.6 t -146.05 90.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.4 0 C-N-CA 124.046 0.939 . . . . 0.35 110.458 -167.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -156.01 -179.7 8.39 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.356 1.062 . . . . 0.36 110.949 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.7 m -129.33 150.61 34.79 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 125.028 1.331 . . . . 0.35 111.494 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.1 m -80.62 91.77 5.88 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 107.014 -1.476 . . . . 0.35 107.014 169.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.31 73.05 2.71 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.071 -0.812 . . . . 0.35 111.071 -172.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.89 147.29 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 122.944 0.498 . . . . 0.35 110.679 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.99 178.88 5.95 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.598 1.159 . . . . 0.35 109.323 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -47.31 -45.31 24.25 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.202 1.001 . . . . 0.35 110.599 164.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -105.95 34.36 3.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.723 1.209 . . . . 0.35 111.562 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.62 -25.14 8.7 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.111 -0.827 . . . . 0.35 115.032 167.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -61.32 124.93 21.99 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.344 1.072 . . . . 0.36 111.64 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.62 101.01 0.95 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.581 0.752 . . . . 0.35 110.205 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.74 -50.09 39.85 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.384 1.074 . . . . 0.35 110.007 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 pp -130.47 150.76 51.53 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.663 1.185 . . . . 0.35 110.224 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 t -82.8 147.49 55.13 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.044 0.937 . . . . 0.33 111.604 -164.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.03 27.58 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 124.31 3.34 . . . . 0.35 112.588 171.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -169.09 132.44 1.33 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.931 0.893 . . . . 0.35 109.652 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -165.28 -72.47 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.381 1.073 . . . . 0.35 109.481 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.07 147.05 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.702 0.801 . . . . 0.35 109.716 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -142.94 166.79 23.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.723 0.809 . . . . 0.35 111.142 174.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -141.04 144.82 36.53 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 125.049 1.339 . . . . 0.33 108.576 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.06 64.77 8.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.948 3.099 . . . . 0.35 110.655 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.258 9.0 tt 39.42 110.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 129.567 3.147 . . . . 0.35 114.608 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -119.83 82.32 27.48 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.263 1.025 . . . . 0.33 108.528 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -82.9 -170.31 0.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.952 3.101 . . . . 0.35 110.576 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.41 -41.57 2.1 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.739 -0.945 . . . . 0.35 110.739 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.9 t -66.32 152.61 44.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.604 0.762 . . . . 0.35 110.347 174.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.5 m -69.18 150.31 47.64 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.779 -0.823 . . . . 0.35 108.779 171.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.3 tp -127.41 102.93 7.1 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.912 -1.144 . . . . 0.35 107.912 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -151.61 176.07 11.72 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.505 1.522 . . . . 0.35 109.43 -170.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -63.13 -47.49 82.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.738 0.415 . . . . 0.35 111.46 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.93 -30.73 70.95 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.012 0.745 . . . . 0.35 113.012 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -64.39 -54.61 30.17 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.205 0.602 . . . . 0.35 109.377 171.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mm -51.55 -49.88 31.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 125.143 1.377 . . . . 0.35 111.18 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -45.49 -56.71 4.77 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.665 1.186 . . . . 0.35 112.518 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -75.31 -37.14 60.96 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.969 0.359 . . . . 0.35 111.969 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -67.11 -48.65 67.48 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.669 0.787 . . . . 0.35 111.958 -169.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.4 m -67.99 -33.0 58.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.884 0.473 . . . . 0.35 111.266 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -65.13 -41.17 95.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.541 0.737 . . . . 0.35 110.678 177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -35.12 75.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.453 0.701 . . . . 0.35 111.148 176.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.77 -48.58 76.39 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.592 0.757 . . . . 0.35 111.334 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.8 -19.98 61.24 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.386 0.675 . . . . 0.35 112.423 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -77.29 13.41 1.18 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.448 0.699 . . . . 0.35 112.197 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.57 -41.4 65.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.375 -0.602 . . . . 0.35 109.375 160.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 70.2 p -103.35 -49.4 3.73 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.208 1.403 . . . . 0.35 111.748 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.75 -85.67 0.09 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.8 0.84 . . . . 0.35 111.32 -170.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.8 p90 51.62 18.17 0.68 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.3 2.24 . . . . 0.35 116.016 174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -131.99 -81.02 0.51 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.31 0.959 . . . . 0.35 112.097 -164.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -97.26 -54.46 3.15 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.577 0.751 . . . . 0.35 111.943 -158.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -45.37 145.57 1.16 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.433 2.293 . . . . 0.35 114.378 -173.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -85.69 -63.08 1.38 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.872 1.269 . . . . 0.35 111.348 -172.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.3 t 72.1 97.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 126.071 1.748 . . . . 0.35 108.984 -164.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.8 t -71.69 -65.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.085 0.954 . . . . 0.35 109.305 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -162.51 135.78 6.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.879 0.872 . . . . 0.35 109.186 -174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.67 152.83 24.55 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.838 0.855 . . . . 0.35 110.927 177.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.87 145.53 50.25 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.948 -0.76 . . . . 0.33 108.948 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.12 -17.12 40.64 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.47 2.78 . . . . 0.35 111.993 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -83.39 61.51 6.22 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.509 1.124 . . . . 0.35 111.069 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.98 141.24 45.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.223 -1.399 . . . . 0.35 107.223 159.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -148.61 131.57 16.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.191 0.52 . . . . 0.35 112.4 -171.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 mp -75.88 116.41 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.439 -1.689 . . . . 0.35 106.439 168.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -107.68 68.82 0.72 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.343 -1.354 . . . . 0.35 107.343 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.98 115.01 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.924 0.89 . . . . 0.35 110.519 -175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.0 m -110.16 87.33 2.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.47 1.508 . . . . 0.35 108.496 -172.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.62 87.12 3.99 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 125.018 1.327 . . . . 0.35 111.22 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -74.77 85.5 2.17 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.961 1.305 . . . . 0.35 109.674 173.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -132.81 71.77 1.48 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.376 -0.972 . . . . 0.35 108.376 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -53.12 -22.43 6.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.646 1.578 . . . . 0.35 113.834 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -58.14 -31.41 67.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.73 1.212 . . . . 0.36 112.438 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.7 -52.48 0.34 Allowed 'General case' 0 C--N 1.344 0.367 0 N-CA-C 112.662 0.615 . . . . 0.35 112.662 173.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -87.4 -58.45 2.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.647 0.658 . . . . 0.35 111.644 -168.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt 85.65 160.99 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.975 2.11 . . . . 0.35 110.492 -176.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.41 97.9 0.6 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.791 1.236 . . . . 0.35 111.506 -174.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -119.18 123.63 44.82 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 107.729 -1.211 . . . . 0.35 107.729 168.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.1 m -87.99 83.14 7.07 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.453 1.101 . . . . 0.35 108.179 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -75.16 119.81 19.81 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.344 1.057 . . . . 0.35 109.916 -170.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 55.6 m -83.09 74.75 9.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.101 1.361 . . . . 0.35 111.488 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -80.52 132.99 56.93 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.75 -1.204 . . . . 0.33 107.75 165.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.72 -118.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.309 2.673 . . . . 0.35 110.178 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.4 tp -159.87 155.38 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.462 1.105 . . . . 0.35 108.777 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.8 p -124.01 136.8 54.52 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.147 0.979 . . . . 0.35 109.058 174.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -73.17 -33.1 65.26 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.945 0.898 . . . . 0.35 110.776 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -21.13 65.1 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.424 0.69 . . . . 0.35 112.205 172.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.96 174.96 43.56 Favored Glycine 0 C--N 1.341 0.85 0 C-N-CA 123.904 0.764 . . . . 0.35 114.223 166.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -161.43 136.16 7.25 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.406 1.083 . . . . 0.35 109.867 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.16 126.48 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.653 -0.869 . . . . 0.35 108.653 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.2 t -73.02 121.62 85.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 107.475 -1.305 . . . . 0.33 107.475 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.43 -102.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.246 2.63 . . . . 0.35 110.432 -173.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -163.52 111.44 1.2 Allowed 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.497 1.119 . . . . 0.35 108.271 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.413 HD12 ' HD3' ' A' ' 123' ' ' PRO . 2.9 tm? -87.9 97.22 10.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.157 0.983 . . . . 0.35 108.587 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.5 t -170.76 86.68 0.11 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.951 1.3 . . . . 0.35 108.391 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -153.34 -71.48 0.14 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.329 0.652 . . . . 0.35 109.485 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -92.76 -52.29 4.69 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.469 1.108 . . . . 0.35 109.355 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.5 pt -109.51 169.13 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.392 1.477 . . . . 0.35 108.934 170.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.89 19.63 0.26 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.372 1.249 . . . . 0.35 114.372 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.96 61.52 28.68 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.093 0.86 . . . . 0.36 111.85 175.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.413 ' HD3' HD12 ' A' ' 116' ' ' LEU . 94.7 Cg_endo -73.53 172.73 15.13 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.219 3.279 . . . . 0.35 111.36 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.38 68.49 0.43 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.051 -1.219 . . . . 0.35 110.051 -177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -64.02 88.93 0.05 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.353 1.461 . . . . 0.35 110.407 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -99.51 100.65 11.7 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.641 -0.874 . . . . 0.36 108.641 -174.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.6 93.47 8.38 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.385 1.074 . . . . 0.35 109.055 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.17 134.49 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 107.504 -1.295 . . . . 0.35 107.504 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 44.7 m -142.67 116.58 9.34 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 107.269 -1.382 . . . . 0.35 107.269 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -73.42 133.17 43.67 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.421 -0.585 . . . . 0.35 109.421 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.9 m -134.36 136.7 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.111 0.965 . . . . 0.35 109.604 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 77.6 t -82.58 137.35 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.406 -0.961 . . . . 0.35 108.406 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 47.2 mt -137.26 133.45 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.697 1.199 . . . . 0.35 108.978 -175.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -97.44 130.26 44.57 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.324 -1.361 . . . . 0.35 107.324 161.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -72.2 96.26 1.78 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.724 -0.843 . . . . 0.35 108.724 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.34 0.168 0 C-N-CA 125.538 1.535 . . . . 0.25 109.325 -167.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.8 m . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 109.166 -0.679 . . . . 0.35 109.166 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 t 61.26 48.23 6.35 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.551 1.14 . . . . 0.35 111.404 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.4 t 66.07 159.88 0.13 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.922 1.689 . . . . 0.35 111.367 -171.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.1 t80 57.69 65.37 1.34 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.005 1.322 . . . . 0.35 110.885 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -112.57 42.03 1.91 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.405 1.082 . . . . 0.35 109.101 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.63 -47.7 0.69 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.029 1.732 . . . . 0.35 109.523 -177.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.67 56.16 1.92 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.766 -0.934 . . . . 0.35 110.766 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 56.99 70.72 0.63 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.295 1.438 . . . . 0.35 111.458 176.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -90.58 0.41 57.37 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.178 1.391 . . . . 0.35 112.449 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -175.59 3.24 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.268 1.027 . . . . 0.35 112.009 -176.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.5 tttp 93.94 -22.41 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.601 2.36 . . . . 0.35 112.456 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.22 -32.6 81.21 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.859 1.219 . . . . 0.35 114.523 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -84.55 56.02 3.65 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.227 1.013 . . . . 0.35 111.068 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 48.99 45.05 22.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.494 1.517 . . . . 0.35 111.758 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.46 53.08 0.89 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.401 1.081 . . . . 0.35 109.679 -172.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.5 m -87.47 -122.26 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.762 0.825 . . . . 0.35 110.526 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -163.41 145.11 9.58 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.043 1.337 . . . . 0.35 108.11 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.1 t80 66.85 119.22 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.828 1.651 . . . . 0.35 111.369 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 68.55 151.85 0.13 Allowed Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 126.454 1.902 . . . . 0.33 111.699 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.71 92.08 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.335 2.69 . . . . 0.35 110.82 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.5 p -75.47 -42.96 51.82 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.807 0.843 . . . . 0.35 109.938 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.78 166.06 26.22 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.468 -0.653 . . . . 0.33 111.468 172.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.93 168.43 19.1 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.186 3.258 . . . . 0.35 111.09 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -163.34 176.62 9.69 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.389 1.076 . . . . 0.35 110.628 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 tt -156.59 94.14 1.44 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.079 0.951 . . . . 0.35 108.706 -175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 75.6 mtm -89.1 143.28 26.95 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.327 0.651 . . . . 0.35 109.923 174.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.9 t -144.67 91.41 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.244 1.017 . . . . 0.35 108.585 -172.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -153.31 162.49 41.24 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.607 1.163 . . . . 0.36 110.709 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -95.85 153.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 124.963 1.305 . . . . 0.35 110.097 174.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -88.91 93.84 9.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.412 -1.699 . . . . 0.35 106.412 169.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.77 105.77 1.63 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.505 -1.038 . . . . 0.35 110.505 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.49 169.64 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.927 1.291 . . . . 0.35 109.996 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -87.3 -179.78 6.47 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.829 0.852 . . . . 0.35 109.128 166.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 t -60.54 -38.79 85.6 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.663 0.785 . . . . 0.35 110.869 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -76.78 -0.91 25.59 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.427 1.091 . . . . 0.35 112.571 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.59 52.13 6.15 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 110.968 -0.853 . . . . 0.35 110.968 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -120.45 108.35 14.0 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.623 1.169 . . . . 0.36 108.416 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -65.96 118.29 9.54 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.793 0.837 . . . . 0.35 111.79 -172.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.34 -40.22 30.79 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.5 1.12 . . . . 0.35 109.875 169.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 pp -151.89 154.42 36.09 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.358 1.063 . . . . 0.35 112.304 -164.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.7 m -88.5 154.31 50.98 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.151 1.38 . . . . 0.33 110.353 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -86.14 49.79 2.32 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.314 3.342 . . . . 0.35 110.47 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -149.13 97.2 2.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.685 0.794 . . . . 0.35 109.523 -166.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -162.15 -55.73 0.04 OUTLIER 'General case' 0 C--N 1.344 0.352 0 CA-C-O 118.85 -0.595 . . . . 0.35 112.451 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 m -82.66 141.06 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 119.328 0.967 . . . . 0.35 109.304 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -146.49 109.83 4.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.297 1.039 . . . . 0.35 109.089 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -94.28 154.4 40.41 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 125.366 1.466 . . . . 0.33 109.72 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.77 147.46 44.7 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.189 2.593 . . . . 0.35 109.844 169.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.81 137.0 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 122.977 0.511 . . . . 0.35 110.404 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -142.49 114.09 6.14 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.801 1.24 . . . . 0.33 107.837 171.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.74 179.87 6.1 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.61 2.874 . . . . 0.35 110.903 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.56 -26.66 18.92 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.424 -0.653 . . . . 0.35 112.643 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 t -67.07 141.36 57.52 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.801 0.8 . . . . 0.35 111.021 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.5 m -72.62 139.12 47.18 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.606 -0.887 . . . . 0.35 108.606 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.67 117.24 16.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.978 0.911 . . . . 0.35 108.963 -171.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.5 t -167.44 176.07 6.81 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.151 1.781 . . . . 0.35 108.458 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -57.76 -52.38 65.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.933 0.893 . . . . 0.35 110.796 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -64.56 -32.43 74.07 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.934 0.716 . . . . 0.35 112.934 -177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -65.98 -57.69 7.22 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.567 0.621 . . . . 0.35 110.369 175.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.79 -23.37 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.166 0.986 . . . . 0.35 111.805 -172.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.54 -58.35 8.93 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 124.174 0.99 . . . . 0.35 111.067 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -66.04 -37.85 86.88 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.14 0.427 . . . . 0.35 111.2 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -62.96 -48.7 77.75 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.559 0.744 . . . . 0.35 111.795 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.9 -36.77 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 118.256 0.48 . . . . 0.35 111.585 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -63.53 -37.1 86.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.807 0.843 . . . . 0.35 111.111 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -74.12 -37.8 64.0 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.872 0.469 . . . . 0.35 111.041 176.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.16 -44.03 97.52 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.297 1.039 . . . . 0.35 111.485 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.19 -41.49 63.78 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.904 0.482 . . . . 0.35 111.644 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -76.83 -3.4 38.23 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.436 0.694 . . . . 0.35 112.758 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.71 -42.45 83.77 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 118.866 0.757 . . . . 0.35 110.33 173.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.9 t -103.2 -38.93 7.06 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.105 1.362 . . . . 0.35 111.579 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.89 -101.18 0.03 OUTLIER 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.676 -0.678 . . . . 0.35 110.795 -173.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.1 t80 75.74 -43.33 0.48 Allowed 'General case' 0 C--N 1.345 0.391 0 C-N-CA 126.572 1.949 . . . . 0.35 113.751 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -55.27 -67.1 0.3 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.345 1.458 . . . . 0.35 112.593 -169.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -107.11 24.22 13.16 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.235 0.614 . . . . 0.35 112.189 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -92.63 136.75 32.96 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.243 0.617 . . . . 0.35 111.431 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -164.05 109.24 1.02 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.962 1.305 . . . . 0.35 108.485 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 p -77.61 148.63 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.299 0.64 . . . . 0.35 109.87 171.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.47 -44.48 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.699 1.2 . . . . 0.35 109.888 173.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -129.39 151.54 49.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.269 1.428 . . . . 0.35 108.853 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.75 143.52 32.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.313 1.045 . . . . 0.35 109.909 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -72.39 117.24 57.04 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.787 0.835 . . . . 0.33 108.978 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.89 -27.4 21.12 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.867 2.378 . . . . 0.35 111.118 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.1 m -87.87 58.03 4.64 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.513 1.125 . . . . 0.35 110.358 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.97 167.08 5.05 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.26 0.624 . . . . 0.35 109.624 169.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -155.85 142.32 18.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.531 0.681 . . . . 0.35 112.352 -171.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 mp -85.74 111.73 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 106.144 -1.798 . . . . 0.35 106.144 174.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -100.99 70.78 1.38 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.614 -1.254 . . . . 0.35 107.614 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.16 99.16 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.333 0.653 . . . . 0.35 109.819 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 94.0 m -98.83 125.19 44.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.195 1.398 . . . . 0.35 109.012 -173.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -139.43 132.84 30.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.255 1.022 . . . . 0.35 109.484 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -101.26 60.34 0.91 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.451 1.5 . . . . 0.35 108.669 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -81.71 82.29 7.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.226 0.61 . . . . 0.35 109.665 -177.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -83.19 67.43 9.19 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.423 -0.955 . . . . 0.35 108.423 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -143.77 -49.14 0.3 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.905 1.682 . . . . 0.36 108.729 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.1 pttt -159.03 -54.93 0.06 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.512 0.725 . . . . 0.35 111.856 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -74.97 -22.24 58.67 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.884 0.698 . . . . 0.35 112.884 -172.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 81.0 tttt 75.5 164.18 0.26 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.785 1.634 . . . . 0.35 111.973 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -56.62 106.18 0.27 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.332 1.453 . . . . 0.35 110.528 172.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -145.17 145.28 31.29 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.414 1.086 . . . . 0.35 109.637 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 94.0 m -119.6 95.84 4.95 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 125.182 1.393 . . . . 0.35 108.056 176.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -70.64 125.44 26.83 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 109.253 -0.647 . . . . 0.35 109.253 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -96.18 63.16 2.2 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.886 1.274 . . . . 0.35 110.094 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -75.35 124.64 89.21 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 109.337 -0.616 . . . . 0.33 109.337 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.76 162.47 26.93 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.205 2.604 . . . . 0.35 111.454 -175.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.3 tp -76.97 152.68 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.017 0.927 . . . . 0.35 109.866 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.1 p -105.24 -179.41 3.94 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.137 0.975 . . . . 0.35 110.419 178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.57 -11.3 14.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.694 1.597 . . . . 0.35 110.81 166.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -78.06 -87.69 0.05 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.625 1.17 . . . . 0.35 110.506 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.15 63.79 0.01 OUTLIER Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.475 -1.05 . . . . 0.35 110.475 -172.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -73.56 126.03 29.33 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.285 -0.635 . . . . 0.35 109.285 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.6 t -75.67 135.25 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.663 -0.866 . . . . 0.35 108.663 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.9 112.05 6.02 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 107.592 -1.262 . . . . 0.33 107.592 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -89.32 14.66 2.16 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.927 2.418 . . . . 0.35 112.673 -165.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.3 t70 60.11 -157.44 0.33 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.266 1.027 . . . . 0.35 109.572 -168.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.5 tt -163.6 146.31 9.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.64 0.655 . . . . 0.35 110.396 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.5 t -154.33 164.72 38.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.299 1.04 . . . . 0.35 110.025 172.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 82.42 -76.7 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.172 1.789 . . . . 0.35 112.635 165.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -69.15 -41.14 77.69 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.886 0.875 . . . . 0.35 113.039 -168.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.1 pt -135.17 -173.35 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.699 0.8 . . . . 0.35 109.367 169.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -158.81 28.86 0.22 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.176 0.59 . . . . 0.35 112.113 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.1 50.13 0.45 Allowed Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.783 0.66 . . . . 0.36 112.783 175.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -66.57 120.82 7.98 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.163 2.575 . . . . 0.35 111.32 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.11 75.84 0.22 Allowed Glycine 0 C--N 1.339 0.697 0 C-N-CA 124.91 1.243 . . . . 0.35 110.419 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -64.05 85.79 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.515 1.926 . . . . 0.35 112.157 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -92.41 99.49 12.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.24 0.616 . . . . 0.36 109.603 -176.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.83 95.16 3.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.618 -0.882 . . . . 0.35 108.618 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.6 mt -108.8 121.76 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 124.838 1.255 . . . . 0.35 108.22 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.4 m -119.36 175.27 5.9 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.918 1.687 . . . . 0.35 107.402 174.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -136.06 114.47 11.7 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 124.133 0.973 . . . . 0.35 108.442 175.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.5 146.12 32.89 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 C-N-CA 123.462 0.705 . . . . 0.35 110.841 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.1 t -81.22 111.63 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.297 1.039 . . . . 0.35 108.318 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mt -101.09 110.39 27.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 108.219 -1.03 . . . . 0.35 108.219 176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -85.85 97.52 10.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.914 -1.143 . . . . 0.35 107.914 172.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -61.57 126.75 28.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.427 0.691 . . . . 0.35 110.832 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt . . . . . 0 N--CA 1.455 -0.185 0 C-N-CA 123.53 0.732 . . . . 0.25 109.915 179.171 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 112.163 0.431 . . . . 0.35 112.163 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 t 55.03 49.64 17.16 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.369 1.468 . . . . 0.35 110.792 -173.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.7 p -164.78 3.3 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.875 0.87 . . . . 0.35 112.716 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 t80 55.15 69.09 0.77 Allowed 'General case' 0 C--N 1.344 0.336 0 C-N-CA 124.651 1.181 . . . . 0.35 109.914 -173.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -89.13 75.78 7.83 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.43 1.092 . . . . 0.35 110.111 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -162.19 -62.88 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.441 1.096 . . . . 0.35 108.881 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.43 92.88 0.21 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.538 0.59 . . . . 0.35 112.536 169.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt 58.8 51.69 7.31 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.764 1.225 . . . . 0.35 111.674 164.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -85.17 -64.9 1.08 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.589 0.756 . . . . 0.35 111.499 -174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp 75.96 118.82 0.05 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 127.143 2.177 . . . . 0.35 109.664 -165.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -50.11 -47.94 53.71 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.024 1.329 . . . . 0.35 110.418 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.33 -92.79 0.22 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.283 -1.527 . . . . 0.35 109.283 175.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t70 52.51 66.62 1.16 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 125.218 1.407 . . . . 0.35 110.688 -173.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -93.64 47.3 1.23 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.135 -1.061 . . . . 0.35 108.135 170.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.05 70.13 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.152 1.781 . . . . 0.35 107.083 -170.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 t -67.72 -71.29 0.21 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.308 0.643 . . . . 0.35 111.523 -168.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -162.31 39.64 0.12 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 117.622 0.192 . . . . 0.35 111.325 -167.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -157.36 115.67 3.19 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.032 0.533 . . . . 0.35 110.726 -173.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 65.74 164.67 0.12 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 126.91 2.084 . . . . 0.33 112.951 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -63.19 74.48 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.577 3.518 . . . . 0.35 112.84 172.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 p -100.71 -39.91 7.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.063 1.745 . . . . 0.35 109.077 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.84 157.43 10.03 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 112.02 -0.432 . . . . 0.33 112.02 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -82.24 -178.62 4.15 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.504 3.469 . . . . 0.35 110.827 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -157.46 169.4 24.78 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.115 0.966 . . . . 0.35 110.39 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.1 tp -142.81 86.24 1.92 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.355 1.462 . . . . 0.35 107.806 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.7 mtp -82.56 89.56 6.7 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.605 1.162 . . . . 0.35 110.59 -176.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.49 91.95 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.362 1.065 . . . . 0.35 109.059 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -149.18 172.58 14.6 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.492 1.117 . . . . 0.36 109.985 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.58 153.45 19.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 C-N-CA 123.993 0.917 . . . . 0.35 111.204 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.5 m -94.39 94.66 8.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.885 1.274 . . . . 0.35 107.909 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.78 116.26 7.64 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 109.479 -1.448 . . . . 0.35 109.479 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.5 m -122.98 157.15 28.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 C-N-CA 125.661 1.584 . . . . 0.35 109.191 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -79.43 178.33 8.19 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.581 -0.525 . . . . 0.35 109.581 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 t -60.04 -46.11 90.61 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.533 0.733 . . . . 0.35 110.304 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -68.98 -16.77 63.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.382 1.073 . . . . 0.35 112.91 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.05 29.09 7.38 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.314 0.959 . . . . 0.35 113.09 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -91.17 114.25 26.72 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 117.818 0.809 . . . . 0.36 108.9 177.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.15 123.77 21.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.327 0.651 . . . . 0.35 110.817 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 mp -93.63 -38.66 11.23 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.844 1.258 . . . . 0.35 109.957 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 pp -144.52 152.59 40.8 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.254 1.022 . . . . 0.35 111.549 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.2 t -99.26 148.75 35.07 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.002 1.721 . . . . 0.33 109.664 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -84.33 70.45 5.86 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.624 2.883 . . . . 0.35 111.456 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -148.74 -177.74 5.96 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.783 0.833 . . . . 0.35 110.508 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . 0.314 0.0 OUTLIER 100.02 -44.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.597 2.759 . . . . 0.35 112.854 173.361 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.74 136.62 23.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 109.553 -0.536 . . . . 0.35 109.553 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.04 171.98 15.5 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.091 0.956 . . . . 0.35 109.35 164.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -161.12 132.9 4.1 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.657 -0.687 . . . . 0.33 109.731 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.31 111.78 1.91 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.654 2.236 . . . . 0.35 108.66 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 tt -60.92 144.8 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.147 0.979 . . . . 0.35 112.944 -162.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -130.54 87.16 50.91 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.593 1.557 . . . . 0.33 107.372 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.97 159.66 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.492 2.795 . . . . 0.35 111.263 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.03 -33.4 2.46 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.268 0.937 . . . . 0.35 111.364 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.7 t -71.58 157.43 38.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.211 1.004 . . . . 0.35 111.321 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.4 p -72.81 167.24 21.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.191 0.996 . . . . 0.35 110.953 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.29 119.64 3.5 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.754 0.822 . . . . 0.35 108.888 -174.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -167.4 178.66 5.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.191 1.796 . . . . 0.35 108.015 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -57.08 -46.92 82.16 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.56 -0.712 . . . . 0.35 111.343 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.47 -34.25 77.76 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.197 0.599 . . . . 0.35 111.967 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -104.06 53.66 0.74 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.788 1.235 . . . . 0.35 109.97 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -159.18 -41.94 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.655 1.182 . . . . 0.35 108.674 170.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.02 -44.38 82.78 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.11 0.964 . . . . 0.35 111.765 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -59.33 -39.41 83.07 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.612 0.765 . . . . 0.35 111.029 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -50.29 62.95 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.295 1.438 . . . . 0.35 110.18 -171.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -72.28 -32.33 42.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 124.565 1.146 . . . . 0.35 112.121 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -60.29 -49.18 78.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.531 -0.544 . . . . 0.35 109.531 172.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -33.29 75.68 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.791 0.437 . . . . 0.35 111.517 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.77 -55.23 32.36 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.564 0.746 . . . . 0.35 110.965 177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 pp -74.69 -15.76 60.78 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.956 0.724 . . . . 0.35 112.956 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -79.41 71.39 5.97 Favored 'General case' 0 C--N 1.344 0.337 0 C-N-CA 123.878 0.871 . . . . 0.35 110.033 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -168.68 -53.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.372 1.869 . . . . 0.35 107.723 172.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.2 p -88.08 -35.11 17.68 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.656 1.583 . . . . 0.35 111.202 -178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.19 74.76 1.32 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.273 1.429 . . . . 0.35 108.436 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -133.3 -19.14 2.2 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.987 1.106 . . . . 0.35 113.987 -165.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -59.58 -41.19 89.7 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.676 0.791 . . . . 0.35 112.542 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -141.65 -66.62 0.41 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.151 1.38 . . . . 0.35 109.311 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.9 p90 34.85 88.45 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.172 2.589 . . . . 0.35 114.193 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -73.63 106.73 5.52 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 109.322 -0.622 . . . . 0.35 109.322 177.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.21 120.4 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 108.332 -0.988 . . . . 0.35 108.332 174.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.3 t -75.92 -73.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.587 -1.264 . . . . 0.35 107.587 171.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -167.78 146.58 4.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.381 1.073 . . . . 0.35 109.446 174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.85 156.84 29.53 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.546 0.738 . . . . 0.35 111.262 173.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.49 135.56 81.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 108.136 -1.061 . . . . 0.33 108.136 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -67.62 -33.02 29.53 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.318 2.679 . . . . 0.35 111.774 -176.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.0 m -86.77 70.21 10.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.337 1.055 . . . . 0.35 110.263 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.61 169.99 16.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.379 0.672 . . . . 0.35 109.746 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -159.41 143.43 14.95 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.512 0.56 . . . . 0.35 112.512 -167.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.74 122.53 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 126.855 2.062 . . . . 0.35 106.133 172.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -118.1 64.73 0.75 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.97 0.908 . . . . 0.35 109.183 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -70.04 118.33 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.416 0.686 . . . . 0.35 110.942 -176.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.2 m -111.57 100.59 9.11 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.509 1.123 . . . . 0.35 109.529 -173.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.29 99.4 12.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.154 0.982 . . . . 0.35 109.851 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -94.38 47.89 1.21 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.596 1.558 . . . . 0.35 111.099 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -69.68 106.92 3.24 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.03 0.932 . . . . 0.35 109.628 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -32.6 73.13 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.07 1.348 . . . . 0.35 111.635 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -55.06 -50.15 69.85 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.702 1.201 . . . . 0.36 113.017 -170.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.53 -41.44 0.09 Allowed 'General case' 0 C--N 1.342 0.279 0 N-CA-C 113.347 0.869 . . . . 0.35 113.347 -175.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -70.56 -47.84 58.33 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.326 0.512 . . . . 0.35 112.016 -168.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt 80.56 155.9 0.14 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.328 1.851 . . . . 0.35 110.741 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -43.8 124.4 3.68 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 126.719 2.008 . . . . 0.35 111.265 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.35 106.53 2.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.216 -1.031 . . . . 0.35 108.216 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.3 m -78.15 97.96 5.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.454 1.102 . . . . 0.35 109.171 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -82.13 96.94 7.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.785 0.834 . . . . 0.35 108.957 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.8 m -76.07 120.01 20.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.671 0.789 . . . . 0.35 109.272 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -134.79 125.33 17.3 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 125.351 1.46 . . . . 0.33 108.527 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.51 162.36 33.31 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.063 2.509 . . . . 0.35 111.559 -175.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.7 tp -73.88 159.96 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.574 1.149 . . . . 0.35 110.13 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 p -116.21 177.79 4.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.221 1.009 . . . . 0.35 110.202 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -103.11 -12.3 17.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.111 1.364 . . . . 0.35 110.924 165.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -76.31 -76.34 0.16 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.606 1.163 . . . . 0.35 111.116 -171.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 139.43 61.91 0.04 OUTLIER Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.846 -0.902 . . . . 0.35 110.846 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -71.53 132.91 45.36 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 117.351 0.575 . . . . 0.35 109.918 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.5 t -73.13 136.18 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.073 -0.714 . . . . 0.35 109.073 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.98 118.49 43.05 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 107.33 -1.359 . . . . 0.33 107.33 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.24 165.98 27.02 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.019 2.479 . . . . 0.35 112.37 -165.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.42 165.85 22.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.6 1.16 . . . . 0.35 110.866 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.1 mp -94.86 30.99 1.93 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.993 0.917 . . . . 0.35 111.412 -173.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.0 t 46.71 -102.34 0.07 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.092 1.757 . . . . 0.35 112.468 175.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -162.24 -44.22 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.986 1.315 . . . . 0.35 109.653 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -83.1 22.17 1.0 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.244 1.418 . . . . 0.35 113.186 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.4 tp -160.53 129.61 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.514 0.726 . . . . 0.35 110.082 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -140.7 27.73 2.02 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.831 1.252 . . . . 0.35 111.61 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -150.2 51.05 0.82 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 113.221 0.822 . . . . 0.36 113.221 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -70.45 115.02 4.0 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.856 2.371 . . . . 0.35 109.291 172.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -92.79 79.22 1.13 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.866 -1.294 . . . . 0.35 109.866 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -62.4 107.15 0.86 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.003 0.921 . . . . 0.35 110.387 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -99.79 94.56 6.39 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.34 1.056 . . . . 0.36 108.743 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.75 74.72 10.14 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.554 -1.276 . . . . 0.35 107.554 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.67 126.54 71.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 C-N-CA 126.041 1.736 . . . . 0.35 107.948 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.8 m -148.94 142.47 25.36 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.917 0.887 . . . . 0.35 110.26 -173.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -72.85 140.35 47.54 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.264 1.026 . . . . 0.35 109.96 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.1 m -142.36 144.52 24.75 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 123.891 0.876 . . . . 0.35 109.661 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.05 100.23 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.876 -0.787 . . . . 0.35 108.876 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 75.3 mt -119.67 144.14 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.46 1.504 . . . . 0.35 109.062 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -131.29 80.79 1.95 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.556 1.542 . . . . 0.35 107.773 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -58.41 150.2 22.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.731 0.812 . . . . 0.35 111.954 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.196 -1.039 . . . . 0.25 108.196 178.62 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.485 ' H1 ' ' HB3' ' A' ' 74' ' ' LYS . 33.1 t . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 119.31 -0.376 . . . . 0.35 110.902 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 p 65.33 146.21 0.03 OUTLIER 'General case' 0 C--N 1.344 0.339 0 C-N-CA 127.355 2.262 . . . . 0.35 111.823 -170.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 p 69.34 -6.33 0.98 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.372 1.869 . . . . 0.35 113.845 -170.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.6 p90 48.44 19.02 0.2 Allowed 'General case' 0 C--N 1.346 0.455 0 C-N-CA 127.686 2.394 . . . . 0.35 114.966 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 53.42 -141.45 0.86 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.046 0.938 . . . . 0.35 109.73 -171.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.4 pttt 11.29 76.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.631 2.772 . . . . 0.35 114.922 169.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.53 113.02 5.28 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 124.683 1.135 . . . . 0.35 111.663 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt 56.64 69.64 0.72 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.251 1.42 . . . . 0.35 110.278 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -70.82 -45.9 63.73 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.611 0.764 . . . . 0.35 111.143 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 66.34 5.31 3.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.165 1.786 . . . . 0.35 114.006 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.3 tttm 54.07 -92.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.898 1.279 . . . . 0.35 110.808 -172.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.86 58.72 0.07 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.393 -1.483 . . . . 0.35 109.393 173.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -132.55 66.58 1.55 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.382 1.073 . . . . 0.35 109.254 -176.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 64.47 -176.74 0.17 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.267 1.427 . . . . 0.35 112.12 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.88 178.23 9.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.294 1.037 . . . . 0.35 110.696 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.7 m -76.55 147.76 37.49 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.614 1.166 . . . . 0.35 111.234 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 65.31 175.98 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.014 1.726 . . . . 0.35 113.421 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.4 t80 59.35 90.56 0.05 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 126.448 1.899 . . . . 0.35 111.257 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 66.96 161.33 0.14 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 125.573 1.549 . . . . 0.33 111.131 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.28 90.52 1.0 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.359 2.039 . . . . 0.35 108.619 173.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.2 p -63.86 -60.52 3.18 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.234 1.014 . . . . 0.35 111.724 -166.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.68 172.0 32.55 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.962 -0.855 . . . . 0.33 110.962 174.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -66.53 149.0 84.46 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.469 2.779 . . . . 0.35 112.212 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -163.04 168.48 20.92 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.508 0.723 . . . . 0.35 111.292 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tt -145.11 100.86 3.54 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.737 1.215 . . . . 0.35 108.304 -173.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.6 mtp -88.16 134.06 33.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.722 1.609 . . . . 0.35 109.541 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.1 t -137.01 87.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.346 0 C-N-CA 124.075 0.95 . . . . 0.35 110.485 -168.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -159.35 165.64 32.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.958 1.303 . . . . 0.36 110.395 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -94.02 153.17 3.44 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 124.627 1.171 . . . . 0.35 112.267 -172.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.1 m -82.68 92.65 7.21 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.755 -1.572 . . . . 0.35 106.755 163.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.88 80.79 1.64 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.95 -0.86 . . . . 0.35 110.95 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 m -92.56 165.58 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.133 0 C-N-CA 124.447 1.099 . . . . 0.35 110.318 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -82.4 -162.1 0.53 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.877 0.871 . . . . 0.35 110.41 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.5 t -53.28 -50.42 64.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.753 1.221 . . . . 0.35 111.598 175.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -75.37 -84.11 0.05 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.368 1.067 . . . . 0.35 110.33 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.76 46.89 0.06 OUTLIER Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.049 -0.82 . . . . 0.35 111.049 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -112.37 108.09 17.14 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.152 1.381 . . . . 0.36 108.257 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -70.49 112.34 6.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.886 0.874 . . . . 0.35 111.433 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.1 mp -73.88 -45.87 48.23 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.749 0.82 . . . . 0.35 109.442 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.2 147.3 36.33 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.858 0.863 . . . . 0.35 111.413 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.0 m -91.75 159.45 38.32 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.282 1.433 . . . . 0.33 111.29 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -87.27 49.86 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.507 2.805 . . . . 0.35 111.914 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -168.72 120.49 0.78 Allowed 'General case' 0 C--N 1.343 0.293 0 N-CA-C 112.915 0.709 . . . . 0.35 112.915 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -162.26 -45.09 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.528 1.531 . . . . 0.35 109.223 159.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.98 130.87 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.522 -0.918 . . . . 0.35 108.522 169.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -144.77 154.09 42.35 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.364 1.066 . . . . 0.35 109.05 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -131.77 155.1 81.83 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 125.31 1.444 . . . . 0.33 108.735 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.71 34.75 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.554 2.836 . . . . 0.35 111.945 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.25 2.8 tt 59.45 134.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 128.679 2.792 . . . . 0.35 114.372 -175.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -142.61 98.24 5.9 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.815 1.246 . . . . 0.33 107.793 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.61 177.96 8.12 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.533 2.822 . . . . 0.35 110.999 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.07 -32.99 6.95 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.977 0.799 . . . . 0.35 111.695 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.6 t -67.18 148.71 51.44 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.471 0.708 . . . . 0.35 110.682 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.2 m -76.63 109.93 10.79 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.892 -0.781 . . . . 0.35 108.892 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.08 96.58 7.81 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.573 -1.269 . . . . 0.35 107.573 176.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.3 t -147.31 160.56 42.37 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.502 1.121 . . . . 0.35 109.924 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -60.29 -42.84 96.33 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 119.5 -0.286 . . . . 0.35 111.576 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.06 -22.4 66.42 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.86 0.689 . . . . 0.35 112.86 -177.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -75.31 -58.85 3.03 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 123.401 0.68 . . . . 0.35 109.895 167.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.4 mm -63.15 -39.42 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.457 1.103 . . . . 0.35 112.813 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -52.25 -48.1 65.4 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.881 0.872 . . . . 0.35 112.037 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -76.52 -39.84 51.78 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.063 0.392 . . . . 0.35 111.526 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -69.89 -39.3 76.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.45 0.7 . . . . 0.35 112.407 -169.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.89 -35.77 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.626 0.771 . . . . 0.35 110.752 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -72.4 -34.64 68.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.303 1.041 . . . . 0.35 111.071 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -47.08 73.86 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.746 0.819 . . . . 0.35 110.051 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.8 -39.96 75.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.276 1.03 . . . . 0.35 111.237 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.9 tp -69.1 -50.67 46.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.28 1.032 . . . . 0.35 111.467 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -74.43 8.29 2.36 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.727 1.01 . . . . 0.35 113.727 -174.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.84 -46.41 89.61 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.51 0.724 . . . . 0.35 109.959 166.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 m -118.58 -51.93 2.37 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.679 1.192 . . . . 0.35 110.352 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.96 82.38 6.7 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.164 0.985 . . . . 0.35 110.866 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -128.89 -43.87 1.34 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.057 1.343 . . . . 0.35 111.437 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.485 ' HB3' ' H1 ' ' A' ' 1' ' ' SER . 32.1 ttmt -59.08 -71.31 0.12 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.212 1.405 . . . . 0.35 110.576 -173.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.08 -35.74 74.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.378 1.071 . . . . 0.35 110.771 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -58.32 146.41 34.52 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.833 1.253 . . . . 0.35 111.629 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -156.13 141.24 17.37 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.564 1.146 . . . . 0.35 109.562 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.6 t -88.06 137.16 21.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 124.317 1.047 . . . . 0.35 109.449 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.95 -56.87 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.067 1.347 . . . . 0.35 107.666 167.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -156.96 110.42 2.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.198 0.999 . . . . 0.35 108.395 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 pp -87.82 132.22 34.25 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.36 0.664 . . . . 0.35 109.823 175.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.77 124.46 90.77 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 108.322 -0.992 . . . . 0.33 108.322 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.91 -54.1 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.829 2.353 . . . . 0.35 111.793 -170.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.7 m -74.5 96.14 2.87 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.989 0.916 . . . . 0.35 109.969 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.44 133.58 49.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.871 0.868 . . . . 0.35 110.132 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -95.81 108.77 21.14 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.166 0.987 . . . . 0.35 110.26 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.04 113.04 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.694 -1.595 . . . . 0.35 106.694 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.7 64.73 0.65 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.417 1.087 . . . . 0.35 108.984 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.3 p -67.86 115.33 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.347 0.659 . . . . 0.35 110.627 -176.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 m -111.32 101.38 9.86 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.418 1.087 . . . . 0.35 108.985 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -92.92 102.91 15.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.748 1.219 . . . . 0.35 108.962 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -81.03 61.65 4.69 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.647 1.179 . . . . 0.35 109.611 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -99.03 85.66 3.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.391 1.477 . . . . 0.35 108.453 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -82.59 52.19 2.03 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.763 0.825 . . . . 0.35 110.706 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -137.36 -44.53 0.55 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.839 1.256 . . . . 0.36 109.828 -170.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -140.64 -66.46 0.43 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.23 1.012 . . . . 0.35 110.1 -173.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -89.58 -22.0 22.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.487 0.921 . . . . 0.35 113.487 -164.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 tttm 74.92 159.43 0.22 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.855 1.662 . . . . 0.35 111.494 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -53.8 117.63 3.32 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.506 1.122 . . . . 0.35 109.951 168.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -141.33 111.74 6.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.827 -1.175 . . . . 0.35 107.827 171.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.2 m -75.76 86.17 2.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.828 -1.175 . . . . 0.35 107.828 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -80.42 97.17 6.96 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.051 0.94 . . . . 0.35 108.957 -171.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.9 m -90.24 132.7 35.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.083 1.353 . . . . 0.35 110.348 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -163.71 141.2 5.77 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 123.625 0.77 . . . . 0.33 110.377 176.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.24 178.91 6.36 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 124.256 3.304 . . . . 0.35 110.952 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.0 tp -138.02 143.44 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.228 0.611 . . . . 0.35 110.56 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.2 p -100.27 -179.97 4.29 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.999 1.32 . . . . 0.35 111.376 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.99 -36.36 72.52 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.738 1.615 . . . . 0.35 112.805 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -88.54 -50.73 6.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.269 1.028 . . . . 0.35 109.895 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.67 -144.27 45.17 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.156 -0.777 . . . . 0.35 111.156 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -161.0 152.57 19.34 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.74 0.816 . . . . 0.35 110.756 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.9 t -78.35 133.08 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.097 0.959 . . . . 0.35 109.677 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.71 126.22 91.95 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 108.479 -0.934 . . . . 0.33 108.479 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.21 -80.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.782 2.322 . . . . 0.35 110.77 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -169.05 -56.55 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.902 1.281 . . . . 0.35 109.205 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.461 HD11 HG13 ' A' ' 120' ' ' ILE . 2.6 tm? 69.48 99.08 0.06 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.491 1.916 . . . . 0.35 110.434 -179.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.8 t -171.12 78.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.092 1.357 . . . . 0.35 108.273 173.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -153.86 -77.35 0.11 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 122.782 0.433 . . . . 0.35 110.146 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -88.24 -50.15 6.54 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.265 1.026 . . . . 0.35 110.282 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.461 HG13 HD11 ' A' ' 116' ' ' LEU . 10.7 pt -103.51 169.37 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.38 1.072 . . . . 0.35 109.333 166.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -137.53 -26.95 0.96 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.027 0.931 . . . . 0.35 112.631 -166.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.05 58.1 27.38 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 123.702 0.801 . . . . 0.36 112.92 -169.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.09 119.64 6.45 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.178 2.585 . . . . 0.35 110.65 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.9 77.72 0.69 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 109.574 -1.411 . . . . 0.35 109.574 177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -62.67 96.69 0.09 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.163 1.385 . . . . 0.35 110.65 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -92.62 98.69 11.59 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.629 -0.878 . . . . 0.36 108.629 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.36 76.97 8.28 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 108.075 -1.083 . . . . 0.35 108.075 176.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.9 mt -90.24 122.34 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.181 -1.415 . . . . 0.35 107.181 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.3 m -131.0 111.67 12.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.97 -1.122 . . . . 0.35 107.97 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -62.99 137.01 58.15 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.365 0.666 . . . . 0.35 110.299 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.7 149.67 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.869 0.867 . . . . 0.35 109.517 169.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.96 142.54 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.857 1.263 . . . . 0.35 108.214 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.6 mt -129.96 147.7 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.698 1.199 . . . . 0.35 109.569 -171.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -126.28 -23.85 3.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.326 1.45 . . . . 0.35 112.487 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? 93.08 134.88 0.02 OUTLIER 'General case' 0 C--N 1.345 0.395 0 C-N-CA 127.834 2.454 . . . . 0.35 110.418 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? . . . . . 0 N--CA 1.455 -0.213 0 C-N-CA 125.007 1.323 . . . . 0.25 109.956 178.655 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 110.137 -0.32 . . . . 0.35 110.137 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -80.71 95.91 6.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.86 1.264 . . . . 0.35 109.283 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.8 p -80.7 75.81 7.6 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.212 1.005 . . . . 0.35 110.991 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -71.39 153.82 42.02 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.028 0.931 . . . . 0.35 109.082 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -155.22 65.42 0.63 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.292 1.037 . . . . 0.35 108.83 -174.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -95.34 57.3 1.96 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.251 1.02 . . . . 0.35 110.186 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 49.9 26.33 8.29 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.275 1.893 . . . . 0.35 114.922 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt 47.16 49.01 15.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.645 1.578 . . . . 0.35 112.582 -176.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -86.23 105.13 16.39 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 123.649 0.78 . . . . 0.35 109.958 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -77.6 72.34 4.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.307 1.443 . . . . 0.35 110.608 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 42.57 -91.05 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.029 2.532 . . . . 0.35 112.721 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -140.39 -111.04 0.89 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 108.718 -1.753 . . . . 0.35 108.718 175.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 50.73 65.25 1.52 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 125.038 1.335 . . . . 0.35 110.938 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -84.02 75.8 10.11 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.938 0.895 . . . . 0.35 109.158 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -128.36 73.15 1.46 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.374 1.47 . . . . 0.35 108.776 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 t -74.71 175.39 7.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.24 1.016 . . . . 0.35 110.996 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -80.94 76.71 7.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.566 1.147 . . . . 0.35 109.771 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -154.07 76.82 1.07 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.013 1.325 . . . . 0.35 107.559 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 68.04 169.65 0.11 Allowed Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.378 1.471 . . . . 0.33 111.108 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.46 108.01 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.56 2.84 . . . . 0.35 113.051 170.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.0 p -106.0 -60.32 1.66 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.408 1.483 . . . . 0.35 108.695 175.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.7 150.24 7.65 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 110.451 -1.06 . . . . 0.33 110.451 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.76 162.78 27.08 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.81 2.34 . . . . 0.35 113.332 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -158.68 164.46 35.92 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.331 1.052 . . . . 0.35 110.085 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 tt -148.51 103.28 3.4 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.295 -1.002 . . . . 0.35 108.295 -173.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 41.9 mtm -82.17 120.68 25.64 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.985 0.914 . . . . 0.35 111.128 -176.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -114.87 96.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 124.824 1.249 . . . . 0.35 110.092 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -156.33 -176.01 5.73 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.529 0.732 . . . . 0.36 110.998 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.2 m -140.27 -170.62 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.767 1.227 . . . . 0.35 110.248 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.2 m -135.89 94.12 3.02 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.897 -1.52 . . . . 0.35 106.897 168.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.09 98.33 2.39 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 124.649 1.119 . . . . 0.35 111.885 -169.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 m -103.12 162.64 3.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 124.466 1.106 . . . . 0.35 111.731 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -74.03 -52.25 13.31 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.468 -0.938 . . . . 0.35 108.468 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 m -157.58 -64.37 0.09 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.989 1.316 . . . . 0.35 109.474 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -106.7 63.78 0.64 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.2 1.0 . . . . 0.35 111.264 -165.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.75 -40.62 3.04 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-O 119.758 -0.468 . . . . 0.35 113.012 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -49.41 103.77 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.751 2.02 . . . . 0.36 112.509 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.81 136.43 34.14 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.489 1.115 . . . . 0.35 110.731 -174.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 mp -79.09 -62.3 1.74 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.456 0.703 . . . . 0.35 109.457 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mt -94.88 -148.28 0.28 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.695 1.198 . . . . 0.35 108.879 -170.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.9 m -143.07 68.11 17.65 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 108.036 -1.098 . . . . 0.33 108.036 164.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -83.18 75.58 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.567 2.845 . . . . 0.35 110.006 -166.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -152.86 54.22 0.77 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.58 1.552 . . . . 0.35 108.016 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.99 48.38 0.44 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.272 0.842 . . . . 0.35 113.272 -171.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -169.71 136.74 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.722 0.809 . . . . 0.35 109.875 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -161.27 178.18 9.48 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.632 0.773 . . . . 0.35 111.378 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -145.39 157.81 52.0 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.627 1.571 . . . . 0.33 108.848 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.17 168.76 18.32 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.0 2.467 . . . . 0.35 110.866 171.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 tp -61.41 144.64 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.707 0.803 . . . . 0.35 111.33 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -156.68 94.75 2.28 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.823 -1.177 . . . . 0.33 107.823 173.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.96 -179.03 4.94 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.393 2.729 . . . . 0.35 110.585 -175.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.96 -37.47 3.7 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.748 0.69 . . . . 0.35 111.555 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.1 t -62.85 142.87 58.07 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.847 0.859 . . . . 0.35 111.459 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.6 m -82.29 135.94 35.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.475 1.11 . . . . 0.35 109.187 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 mp -117.03 131.37 56.96 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.232 1.413 . . . . 0.35 109.794 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.8 t -172.59 172.05 4.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.073 2.549 . . . . 0.35 106.808 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -61.06 -29.54 69.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.366 0.876 . . . . 0.35 113.366 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -83.7 -13.08 54.92 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.863 0.69 . . . . 0.35 112.863 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -98.27 -27.54 14.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.6 1.16 . . . . 0.35 111.913 173.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -39.71 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.219 -0.66 . . . . 0.35 109.219 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -67.92 -54.99 14.53 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 124.401 1.081 . . . . 0.35 113.198 -169.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -66.27 -35.02 79.32 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.78 0.718 . . . . 0.35 111.226 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -64.09 -53.81 43.79 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.954 1.302 . . . . 0.35 111.5 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.1 m -69.32 -36.36 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 123.007 0.523 . . . . 0.35 111.656 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.79 -41.37 95.46 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.824 0.85 . . . . 0.35 111.254 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -33.53 68.78 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.806 0.443 . . . . 0.35 111.201 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.64 -53.83 35.95 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.357 0.663 . . . . 0.35 110.861 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.3 -27.87 67.53 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.225 0.61 . . . . 0.35 112.01 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -67.78 -33.43 74.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.264 0.484 . . . . 0.35 110.439 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.9 28.58 0.35 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.456 0.702 . . . . 0.35 112.15 174.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 88.5 m -146.27 -65.36 0.3 Allowed 'General case' 0 C--N 1.344 0.336 0 C-N-CA 125.063 1.345 . . . . 0.35 108.229 171.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.85 -52.25 13.62 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.741 1.216 . . . . 0.35 111.207 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 73.42 150.86 0.11 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.532 1.933 . . . . 0.35 113.776 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.4 tttm 100.72 37.05 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 129.17 2.988 . . . . 0.35 111.29 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 62.21 -74.43 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.176 2.19 . . . . 0.35 114.308 166.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 87.75 159.26 0.07 Allowed 'General case' 0 C--N 1.341 0.219 0 C-N-CA 128.459 2.703 . . . . 0.35 110.689 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -54.69 -59.96 4.0 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.128 0.971 . . . . 0.35 110.209 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.4 t 56.25 76.64 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.952 1.301 . . . . 0.35 108.736 -171.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.9 t -56.99 -60.92 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 124.612 1.165 . . . . 0.35 109.984 -177.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -162.76 126.93 3.02 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.773 0.829 . . . . 0.35 109.0 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.507 ' H ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -81.0 157.36 25.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.342 0.657 . . . . 0.35 110.206 172.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.63 123.73 89.13 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.457 -0.942 . . . . 0.33 108.457 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.86 -31.81 30.68 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.171 2.581 . . . . 0.35 110.67 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 52.8 m -89.64 60.91 5.28 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.763 1.225 . . . . 0.35 109.536 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.34 170.1 7.83 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.249 1.02 . . . . 0.35 110.458 171.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -150.74 148.36 28.45 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 113.137 0.791 . . . . 0.35 113.137 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.5 mp -119.68 105.33 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.692 1.597 . . . . 0.35 107.19 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -85.88 76.83 9.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.607 -0.886 . . . . 0.35 108.607 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.31 94.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.065 -1.087 . . . . 0.35 108.065 172.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.8 m -88.14 75.51 8.64 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.202 -1.036 . . . . 0.35 108.202 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -68.92 121.09 15.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.035 -0.53 . . . . 0.35 110.951 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -138.94 146.71 41.35 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.9 1.68 . . . . 0.35 109.785 -172.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -154.2 -177.54 6.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.108 1.363 . . . . 0.35 109.48 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -133.45 59.29 1.74 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.571 -1.27 . . . . 0.35 107.571 167.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -143.78 -66.62 0.35 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.498 1.119 . . . . 0.36 109.71 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 56.54 0.23 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.827 0.451 . . . . 0.35 111.998 -171.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -159.84 -55.85 0.06 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-O 119.118 -0.468 . . . . 0.35 111.761 169.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt 80.52 160.18 0.16 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.449 1.9 . . . . 0.35 110.122 -168.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.34 136.66 58.04 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.139 0.976 . . . . 0.35 110.969 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -151.85 113.25 4.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.468 1.107 . . . . 0.35 108.272 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.1 m -79.89 82.92 5.9 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.672 1.189 . . . . 0.35 109.05 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -82.66 108.27 15.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.674 -0.861 . . . . 0.35 108.674 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 73.6 p -85.86 63.66 8.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.743 1.217 . . . . 0.35 110.504 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -61.51 111.85 5.04 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.262 1.425 . . . . 0.33 107.904 172.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.67 -109.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.661 2.241 . . . . 0.35 111.461 -160.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.3 tp -160.64 155.84 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.893 0.877 . . . . 0.35 109.132 -177.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.7 p -106.87 173.02 6.5 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.3 1.04 . . . . 0.35 110.073 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.07 51.12 0.98 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.337 -1.357 . . . . 0.35 107.337 167.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -156.37 -76.65 0.09 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.308 1.043 . . . . 0.35 109.29 -169.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 152.07 143.46 3.7 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.85 -0.9 . . . . 0.35 110.85 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -153.17 128.01 9.54 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.694 0.798 . . . . 0.35 109.757 167.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.06 130.62 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.201 1.0 . . . . 0.35 108.983 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.1 t -69.76 122.69 86.71 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.727 -1.212 . . . . 0.33 107.727 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.02 -98.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.152 2.568 . . . . 0.35 111.059 -172.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -169.25 172.0 7.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.607 1.163 . . . . 0.35 110.08 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.26 137.3 13.62 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.646 1.178 . . . . 0.35 109.767 176.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.9 t -167.69 -174.81 2.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.65 0.78 . . . . 0.35 110.706 -171.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 74.05 -82.03 0.03 OUTLIER 'General case' 0 C--N 1.342 0.245 0 C-N-CA 127.055 2.142 . . . . 0.35 111.366 170.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -104.57 -50.27 3.35 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.983 1.313 . . . . 0.35 109.162 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.0 tp -78.67 104.77 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.238 1.015 . . . . 0.35 109.207 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -143.47 10.03 1.63 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.275 1.03 . . . . 0.35 112.502 -170.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.32 63.48 4.62 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 119.31 0.959 . . . . 0.36 111.817 170.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.2 -90.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.941 3.094 . . . . 0.35 112.974 -177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.96 78.75 0.52 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 109.338 -1.505 . . . . 0.35 109.338 -168.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -75.02 95.18 2.98 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.909 1.284 . . . . 0.35 108.894 176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -91.6 91.4 8.02 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.634 0.374 . . . . 0.36 110.683 -168.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.96 61.39 1.95 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.274 1.429 . . . . 0.35 109.027 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.58 127.91 58.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.143 1.777 . . . . 0.35 106.748 174.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 51.6 m -147.42 131.58 17.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.376 1.07 . . . . 0.35 109.371 -171.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -64.38 131.55 47.53 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.493 0.717 . . . . 0.35 109.56 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.5 m -136.98 159.74 36.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.159 0 C-N-CA 123.922 0.889 . . . . 0.35 109.655 174.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.2 124.84 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 124.369 1.067 . . . . 0.35 108.203 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.5 mt -129.43 145.49 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.854 1.261 . . . . 0.35 109.548 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -127.22 156.28 42.1 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.567 1.547 . . . . 0.35 108.822 168.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -77.02 140.79 40.47 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.561 -0.533 . . . . 0.35 109.561 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.147 0 C-N-CA 124.307 1.043 . . . . 0.25 110.667 177.333 . . . . . . . . 1 1 . 1 stop_ save_